Clustering O 0 0.09862273186445236
of O 0 0.034507013857364655
missense O 0 0.06279970705509186
mutations O 0 0.024325799196958542
in O 0 0.014911854639649391
the O 0 0.0268572885543108
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 0.01975858025252819
in O 0 0.012848025187849998
a O 0 0.018768740817904472
sporadic B-Disease 1 0.9485191702842712
T I-Disease 1 1.0
- I-Disease 1 1.0
cell I-Disease 1 0.9994093179702759
leukaemia I-Disease 1 0.9999995231628418
. O 0 0.06652048975229263

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.04294780641794205
A B-Disease 1 0.999961256980896
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
) O 0 0.014590377919375896
is O 0 0.010422379709780216
a O 0 0.013871929608285427
recessive B-Disease 1 0.595312237739563
multi I-Disease 1 0.999997615814209
- I-Disease 1 1.0
system I-Disease 1 0.9998250603675842
disorder I-Disease 1 1.0
caused O 1 0.9877914190292358
by O 0 0.011484073475003242
mutations O 0 0.015389779582619667
in O 0 0.009562992490828037
the O 0 0.01459072157740593
ATM O 0 0.12096232920885086
gene O 0 0.020258108153939247
at O 0 0.02144542895257473
11q22 O 1 0.9325451254844666
- O 1 0.9977073669433594
q23 O 1 0.9785351157188416
( O 0 0.034618839621543884
ref O 1 0.9870789051055908
. O 0 0.026397880166769028
3 O 0 0.04089783877134323
) O 0 0.036213506013154984
. O 0 0.04823446273803711

The O 0 0.03621789067983627
risk O 0 0.06167544797062874
of O 0 0.05949118360877037
cancer B-Disease 1 1.0
, O 1 0.5176947712898254
especially O 1 0.7764858603477478
lymphoid B-Disease 1 0.9999998807907104
neoplasias I-Disease 1 0.9999969005584717
, O 0 0.017030438408255577
is O 0 0.011835523881018162
substantially O 0 0.018721457570791245
elevated O 0 0.04995734989643097
in O 0 0.01266423985362053
A B-Disease 1 0.9999252557754517
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9996181726455688
and O 0 0.010213382542133331
has O 0 0.010328941978514194
long O 0 0.01318602729588747
been O 0 0.011207067407667637
associated O 0 0.01615123450756073
with O 0 0.022519726306200027
chromosomal O 1 0.9999926090240479
instability O 1 0.999997615814209
. O 0 0.06575854867696762

By O 0 0.03472040221095085
analysing O 0 0.11578202247619629
tumour B-Disease 1 0.9999992847442627
DNA O 0 0.023439254611730576
from O 0 0.013746625743806362
patients O 0 0.03726431354880333
with O 0 0.012687981128692627
sporadic B-Disease 1 0.5857769250869751
T I-Disease 1 0.9999997615814209
- I-Disease 1 0.9999880790710449
cell I-Disease 1 0.7727881669998169
prolymphocytic I-Disease 1 0.9999916553497314
leukaemia I-Disease 1 1.0
( O 1 0.8642540574073792
T B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
PLL I-Disease 1 0.999998927116394
) O 0 0.01652049832046032
, O 0 0.013748642057180405
a O 0 0.015967706218361855
rare O 0 0.030629782006144524
clonal B-Disease 1 0.9916754961013794
malignancy I-Disease 1 0.9999778270721436
with O 0 0.01450137235224247
similarities O 0 0.01738206297159195
to O 0 0.011519122868776321
a O 0 0.015258061699569225
mature B-Disease 1 0.8295814394950867
T I-Disease 1 0.9999997615814209
- I-Disease 1 0.9999980926513672
cell I-Disease 1 0.9354873895645142
leukaemia I-Disease 1 0.9999972581863403
seen O 0 0.015589171089231968
in O 0 0.011602172628045082
A B-Disease 1 0.9985193610191345
- I-Disease 1 1.0
T I-Disease 1 0.9999997615814209
, O 0 0.012106143869459629
we O 0 0.009225721471011639
demonstrate O 0 0.014171533286571503
a O 0 0.011255391873419285
high O 0 0.013462650589644909
frequency O 0 0.013130387291312218
of O 0 0.012955796904861927
ATM O 0 0.0897960513830185
mutations O 0 0.021714020520448685
in O 0 0.02311752364039421
T B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999961853027344
PLL I-Disease 1 0.9999743700027466
. O 0 0.06770263612270355

In O 0 0.0343111976981163
marked O 0 0.03455427661538124
contrast O 0 0.01981688290834427
to O 0 0.012220410630106926
the O 0 0.014585031196475029
ATM O 0 0.051080238074064255
mutation O 0 0.016242336481809616
pattern O 0 0.013433923944830894
in O 0 0.01046526338905096
A B-Disease 1 0.9985833168029785
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999992847442627
, O 0 0.012547927908599377
the O 0 0.01053448673337698
most O 0 0.01032949797809124
frequent O 0 0.017232857644557953
nucleotide O 0 0.018938705325126648
changes O 0 0.011122060008347034
in O 0 0.013469701632857323
this O 0 0.016254333779215813
leukaemia B-Disease 1 0.9999977350234985
were O 0 0.02679789438843727
missense O 0 0.09726426005363464
mutations O 0 0.055451419204473495
. O 0 0.042931389063596725

These O 0 0.028544284403324127
clustered O 0 0.040482424199581146
in O 0 0.01480937097221613
the O 0 0.014362632296979427
region O 0 0.014193098992109299
corresponding O 0 0.01320799719542265
to O 0 0.010949027724564075
the O 0 0.015346379950642586
kinase O 0 0.047726333141326904
domain O 0 0.022585183382034302
, O 0 0.012752317823469639
which O 0 0.008846000768244267
is O 0 0.009893965907394886
highly O 0 0.013411594554781914
conserved O 0 0.017281299456954002
in O 0 0.012955225072801113
ATM O 1 0.907244861125946
- O 1 0.9915932416915894
related O 0 0.01908278837800026
proteins O 0 0.016526084393262863
in O 0 0.01620865799486637
mouse O 0 0.05064184591174126
, O 0 0.020103024318814278
yeast O 0 0.05674125254154205
and O 0 0.030086612328886986
Drosophila O 0 0.08126749098300934
. O 0 0.05387849360704422

The O 0 0.04141047224402428
resulting O 0 0.04050238057971001
amino O 0 0.04623216763138771
- O 1 0.9997478127479553
acid O 0 0.04656033217906952
substitutions O 0 0.03517294302582741
are O 0 0.010101590305566788
predicted O 0 0.018635347485542297
to O 0 0.011917097494006157
interfere O 0 0.022863734513521194
with O 0 0.016710108146071434
ATP O 1 0.9997853636741638
binding O 0 0.032302599400281906
or O 0 0.022770119830965996
substrate O 0 0.0515870600938797
recognition O 0 0.0464840829372406
. O 0 0.0501248799264431

Two O 0 0.02846723049879074
of O 0 0.02762451209127903
seventeen O 0 0.06423672288656235
mutated O 1 0.9496273398399353
T B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999727010726929
PLL I-Disease 1 0.9993892908096313
samples O 0 0.023321012035012245
had O 0 0.01610616035759449
a O 0 0.013635950163006783
previously O 0 0.016669869422912598
reported O 0 0.018031155690550804
A B-Disease 1 0.9964404702186584
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999996423721313
allele O 0 0.09880977869033813
. O 0 0.05766366422176361

In O 0 0.03704705089330673
contrast O 0 0.03588390350341797
, O 0 0.019940419122576714
no O 0 0.01556597463786602
mutations O 0 0.01519532036036253
were O 0 0.009014365263283253
detected O 0 0.013204522430896759
in O 0 0.009492381475865841
the O 0 0.013145399279892445
p53 O 0 0.06800480931997299
gene O 0 0.013289998285472393
, O 0 0.010593833401799202
suggesting O 0 0.010258114896714687
that O 0 0.007503379601985216
this O 0 0.012962941080331802
tumour B-Disease 1 1.0
suppressor O 1 0.9999935626983643
is O 0 0.013945544138550758
not O 0 0.010261165909469128
frequently O 0 0.014173111878335476
altered O 0 0.01885325461626053
in O 0 0.014817694202065468
this O 0 0.024668807163834572
leukaemia B-Disease 1 0.9999992847442627
. O 0 0.05266737565398216

Occasional O 0 0.09226641803979874
missense O 0 0.08163464814424515
mutations O 0 0.029893744736909866
in O 0 0.01705002970993519
ATM O 0 0.059516552835702896
were O 0 0.01050998643040657
also O 0 0.011349156498908997
found O 0 0.011175901629030704
in O 0 0.013080980628728867
tumour B-Disease 1 0.9999983310699463
DNA O 0 0.020304152742028236
from O 0 0.013330616056919098
patients O 0 0.0259652528911829
with O 0 0.013855748809874058
B B-Disease 1 0.9994415640830994
- I-Disease 1 0.9998928308486938
cell I-Disease 0 0.11157135665416718
non I-Disease 1 0.9388558864593506
- I-Disease 1 1.0
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 1.0
( O 0 0.3106880784034729
B B-Disease 1 0.9999568462371826
- I-Disease 1 0.9995303153991699
NHL I-Disease 0 0.09812666475772858
) O 0 0.01527903787791729
and O 0 0.01288638822734356
a O 0 0.020955972373485565
B B-Disease 1 0.9996820688247681
- I-Disease 1 0.9998654127120972
NHL I-Disease 1 0.99234938621521
cell O 0 0.07932795584201813
line O 0 0.05583517998456955
. O 0 0.04721897095441818

The O 0 0.02992221526801586
evidence O 0 0.016585731878876686
of O 0 0.011306139640510082
a O 0 0.011077271774411201
significant O 0 0.009148499928414822
proportion O 0 0.009931869804859161
of O 0 0.00828941073268652
loss O 1 0.570266842842102
- O 1 0.999751627445221
of O 0 0.015336821787059307
- O 1 0.9999741315841675
function O 0 0.013635770417749882
mutations O 0 0.011155126616358757
and O 0 0.0068048047833144665
a O 0 0.009377539157867432
complete O 0 0.013117454946041107
absence O 0 0.014520559459924698
of O 0 0.009423297829926014
the O 0 0.009859170764684677
normal O 0 0.011487046256661415
copy O 0 0.017290936782956123
of O 0 0.01301973033696413
ATM O 0 0.03234594315290451
in O 0 0.010265199467539787
the O 0 0.012527287937700748
majority O 0 0.014614171348512173
of O 0 0.019440151751041412
mutated O 1 0.9775617718696594
tumours B-Disease 1 0.9999998807907104
establishes O 1 0.9989045858383179
somatic O 1 0.9555632472038269
inactivation O 1 0.9973862767219543
of O 0 0.018117278814315796
this O 0 0.011290010996162891
gene O 0 0.012726398184895515
in O 0 0.010268065147101879
the O 0 0.01239024754613638
pathogenesis O 1 0.9866346120834351
of O 0 0.01747201196849346
sporadic B-Disease 1 0.9968830943107605
T I-Disease 1 1.0
- I-Disease 1 0.9999995231628418
PLL I-Disease 1 0.9999620914459229
and O 0 0.019760169088840485
suggests O 0 0.01923518069088459
that O 0 0.012041179463267326
ATM O 0 0.040430210530757904
acts O 0 0.016161885112524033
as O 0 0.01850799471139908
a O 0 0.2114015817642212
tumour B-Disease 1 1.0
suppressor O 1 0.9999730587005615
. O 0 0.07129403948783875

As O 0 0.03584993630647659
constitutional O 0 0.03792428597807884
DNA O 0 0.027021097019314766
was O 0 0.017437484115362167
not O 0 0.008441091515123844
available O 0 0.010617795400321484
, O 0 0.011337824165821075
a O 0 0.016614627093076706
putative O 0 0.48748722672462463
hereditary O 1 0.9999947547912598
predisposition O 1 0.9999970197677612
to O 1 0.8732646107673645
T B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
PLL I-Disease 1 0.9999690055847168
will O 0 0.02260749600827694
require O 0 0.019561367109417915
further O 0 0.01963966339826584
investigation O 0 0.03269172087311745
. O 0 0.03266224265098572
. O 0 0.04604385048151016

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 1 0.9584771394729614
kinase O 1 0.7447284460067749
is O 0 0.015744097530841827
involved O 0 0.012897055596113205
in O 0 0.009049284271895885
the O 0 0.010398917831480503
modulation O 0 0.023245474323630333
of O 0 0.013736402615904808
the O 0 0.0211629755795002
Ca2 O 1 0.9998316764831543
+ O 1 0.9945304989814758
homeostasis O 1 0.999685525894165
in O 0 0.0714150220155716
skeletal O 1 0.9999995231628418
muscle O 1 0.9999959468841553
cells O 0 0.28531190752983093
. O 0 0.05635550990700722

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999946355819702
DM B-Disease 1 1.0
) O 0 0.024661442264914513
, O 0 0.014212848618626595
the O 0 0.012121310457587242
most O 0 0.014859292656183243
prevalent O 1 0.9999905824661255
muscular B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9747589826583862
adults O 1 0.888821005821228
, O 0 0.013917087577283382
is O 0 0.009329404681921005
caused O 0 0.018284089863300323
by O 0 0.009954504668712616
( O 0 0.018668409436941147
CTG O 1 0.9999748468399048
) O 0 0.021696478128433228
n O 0 0.03416847065091133
- O 1 0.599144458770752
repeat O 0 0.02757924422621727
expansion O 0 0.022155078127980232
in O 0 0.011521022766828537
a O 0 0.014674178324639797
gene O 0 0.01720823533833027
encoding O 0 0.016262419521808624
a O 0 0.017629187554121017
protein O 0 0.025925908237695694
kinase O 0 0.1163879781961441
( O 0 0.03152713552117348
DM B-Disease 1 1.0
protein O 0 0.06532853096723557
kinase O 1 0.7953435778617859
; O 0 0.02519378997385502
DMPK O 1 0.9999420642852783
) O 0 0.016547130420804024
and O 0 0.01268932968378067
involves O 0 0.014238265343010426
changes O 0 0.012635189108550549
in O 0 0.017295870929956436
cytoarchitecture O 1 0.9994332194328308
and O 0 0.038054030388593674
ion O 1 0.9967023730278015
homeostasis O 1 0.9997016787528992
. O 0 0.0626416876912117

To O 0 0.0339050218462944
obtain O 0 0.0292661115527153
clues O 0 0.026377510279417038
to O 0 0.0126155661419034
the O 0 0.01181810349225998
normal O 0 0.013377961702644825
biological O 0 0.016026562079787254
role O 0 0.014679516665637493
of O 0 0.014409431256353855
DMPK O 1 0.9995753169059753
in O 0 0.018935736268758774
cellular O 1 0.9980775117874146
ion O 1 0.9983707070350647
homeostasis O 1 0.9995797276496887
, O 0 0.013038824312388897
we O 0 0.00794075895100832
have O 0 0.005513743497431278
compared O 0 0.010577746666967869
the O 0 0.012663107365369797
resting O 1 0.9711914658546448
[ O 1 0.6235489845275879
Ca2 O 1 0.9999693632125854
+ O 1 0.9934073686599731
] O 0 0.0360255129635334
i O 0 0.01931716687977314
, O 0 0.011753869242966175
the O 0 0.011739509180188179
amplitude O 0 0.02276989072561264
and O 0 0.01217496395111084
shape O 0 0.019225291907787323
of O 0 0.01863769255578518
depolarization O 1 0.9999980926513672
- O 1 1.0
induced O 1 0.9999998807907104
Ca2 O 1 0.999998927116394
+ O 1 0.9987596273422241
transients O 1 0.6691204905509949
, O 0 0.014953960664570332
and O 0 0.01053362712264061
the O 0 0.010275228880345821
content O 0 0.01272501889616251
of O 0 0.014212793670594692
ATP O 1 0.9999372959136963
- O 1 0.9990966320037842
driven O 0 0.04080459848046303
ion O 0 0.06002058833837509
pumps O 0 0.06038814038038254
in O 0 0.023112120106816292
cultured O 1 0.9841164946556091
skeletal O 1 0.9999980926513672
muscle O 1 0.9997425675392151
cells O 0 0.019137969240546227
of O 0 0.013720466755330563
wild O 0 0.021706990897655487
- O 1 0.9937182664871216
type O 0 0.023266198113560677
and O 0 0.01752699539065361
DMPK O 1 0.9999775886535645
[ O 1 0.9241871237754822
- O 1 0.9999974966049194
/ O 1 0.9999901056289673
- O 1 0.9999979734420776
] O 1 0.8448746800422668
knockout O 1 0.9960493445396423
mice O 0 0.0915503278374672
. O 0 0.060707323253154755

In O 0 0.04549980163574219
vitro O 0 0.08254688233137131
- O 1 0.9668707251548767
differentiated O 1 0.5490033030509949
DMPK O 1 0.9999533891677856
[ O 1 0.8953069448471069
- O 1 0.9999977350234985
/ O 1 0.9999743700027466
- O 1 0.9999532699584961
] O 0 0.05925438553094864
myotubes O 0 0.12034095078706741
exhibit O 0 0.03177415579557419
a O 0 0.0207296684384346
higher O 0 0.02638988383114338
resting O 1 0.9221314787864685
[ O 0 0.41794243454933167
Ca2 O 1 0.999880313873291
+ O 1 0.9660323858261108
] O 0 0.03590581193566322
i O 0 0.01972944475710392
than O 0 0.010492605157196522
do O 0 0.011267178691923618
wild O 0 0.021703990176320076
- O 1 0.9991328120231628
type O 0 0.04400458559393883
myotubes O 0 0.16448722779750824
because O 0 0.012232295237481594
of O 0 0.00954305287450552
an O 0 0.010381082072854042
altered O 0 0.01564093306660652
open O 0 0.014603669755160809
probability O 0 0.011396684683859348
of O 0 0.01200706698000431
voltage O 0 0.029669053852558136
- O 1 0.9723904132843018
dependent O 0 0.031286776065826416
l O 1 0.9991481304168701
- O 1 0.9998472929000854
type O 1 0.5824553966522217
Ca2 O 1 0.9942635893821716
+ O 0 0.31289541721343994
and O 0 0.0388476625084877
Na O 1 0.9999198913574219
+ O 0 0.10191339254379272
channels O 0 0.059576768428087234
. O 0 0.054253511130809784

The O 0 0.050139229744672775
mutant O 0 0.0938621312379837
myotubes O 1 0.9772615432739258
exhibit O 0 0.04340294376015663
smaller O 0 0.0229844581335783
and O 0 0.017406007274985313
slower O 0 0.04106864333152771
Ca2 O 1 0.9935497641563416
+ O 0 0.043358832597732544
responses O 0 0.02292625606060028
upon O 0 0.02147309109568596
triggering O 0 0.03629615157842636
by O 0 0.01647586189210415
acetylcholine O 0 0.1682741940021515
or O 0 0.01912331022322178
high O 0 0.04518021270632744
external O 0 0.07931140810251236
K O 1 0.9957925081253052
+ O 0 0.10714828222990036
. O 0 0.06548810005187988

In O 0 0.02815968170762062
addition O 0 0.02241816744208336
, O 0 0.015318009071052074
we O 0 0.00944204069674015
observed O 0 0.009549679234623909
that O 0 0.008490929380059242
these O 0 0.013473978266119957
Ca2 O 1 0.9912194609642029
+ O 1 0.8123769760131836
transients O 0 0.3217509388923645
partially O 0 0.03881378471851349
result O 0 0.014199333265423775
from O 0 0.011191310361027718
an O 0 0.0119588952511549
influx O 0 0.02689964510500431
of O 0 0.01871301420032978
extracellular O 0 0.18650949001312256
Ca2 O 1 0.8680872321128845
+ O 0 0.03803267702460289
through O 0 0.017390120774507523
the O 0 0.022685352712869644
l O 1 0.9990359544754028
- O 1 0.9999715089797974
type O 1 0.7700470685958862
Ca2 O 1 0.990566074848175
+ O 0 0.09011370688676834
channel O 0 0.07075850665569305
. O 0 0.06332384794950485

Neither O 0 0.05074846372008324
the O 0 0.02432471141219139
content O 0 0.020448004826903343
nor O 0 0.018167827278375626
the O 0 0.012018999084830284
activity O 0 0.016402356326580048
of O 0 0.0219576433300972
Na O 1 0.9999983310699463
+ O 1 0.9945796728134155
/ O 1 0.992784857749939
K O 1 0.7954345941543579
+ O 0 0.13619296252727509
ATPase O 1 0.9020484685897827
and O 0 0.042742952704429626
sarcoplasmic O 1 0.9999614953994751
reticulum O 1 0.9999910593032837
Ca2 O 1 0.9999933242797852
+ O 1 0.9998770952224731
- O 1 0.9999508857727051
ATPase O 1 0.9600206017494202
are O 0 0.016671402379870415
affected O 0 0.027095437049865723
by O 0 0.025325778871774673
DMPK O 1 0.9999655485153198
absence O 0 0.3946629464626312
. O 0 0.05947922542691231

In O 0 0.029604477807879448
conclusion O 0 0.025248274207115173
, O 0 0.016632573679089546
our O 0 0.012411779724061489
data O 0 0.011243977583944798
suggest O 0 0.014318753965198994
that O 0 0.012158607132732868
DMPK O 1 0.9963952898979187
is O 0 0.013076087459921837
involved O 0 0.011307237669825554
in O 0 0.012729033827781677
modulating O 0 0.03388739004731178
the O 0 0.010847900062799454
initial O 0 0.015017012134194374
events O 0 0.011094477958977222
of O 0 0.014374502003192902
excitation O 1 0.6473726630210876
- O 1 0.9999942779541016
contraction O 1 0.9670695662498474
coupling O 0 0.05854731425642967
in O 0 0.03195741027593613
skeletal O 1 0.9999997615814209
muscle O 1 0.9999980926513672
. O 0 0.031198538839817047
. O 0 0.04339787736535072

Constitutional O 0 0.13506926596164703
RB1 O 1 0.9999984502792358
- O 1 0.9999147653579712
gene O 0 0.03326006233692169
mutations O 0 0.023606985807418823
in O 0 0.015325618907809258
patients O 1 0.9785913228988647
with O 0 0.018060822039842606
isolated O 1 0.9333085417747498
unilateral B-Disease 1 0.9970231652259827
retinoblastoma I-Disease 1 0.9999997615814209
. O 0 0.06560840457677841

In O 0 0.0296043548732996
most O 0 0.022171353921294212
patients O 0 0.05138707906007767
with O 0 0.016204627230763435
isolated O 0 0.03811698406934738
unilateral B-Disease 1 0.8512635231018066
retinoblastoma I-Disease 1 1.0
, O 1 0.9986470341682434
tumor B-Disease 1 0.9999997615814209
development O 0 0.03626856207847595
is O 0 0.014720258302986622
initiated O 0 0.026136253029108047
by O 0 0.012967126443982124
somatic O 0 0.040791403502225876
inactivation O 1 0.7085257768630981
of O 0 0.017461543902754784
both O 0 0.014054948464035988
alleles O 0 0.02449021302163601
of O 0 0.017413431778550148
the O 0 0.03173580765724182
RB1 O 1 0.9999958276748657
gene O 0 0.05116349458694458
. O 0 0.04753514379262924

However O 0 0.02960098348557949
, O 0 0.014403323642909527
some O 0 0.009274337440729141
of O 0 0.010285246185958385
these O 0 0.00869390182197094
patients O 1 0.9829388856887817
can O 0 0.013409986160695553
transmit O 1 0.9884812831878662
retinoblastoma B-Disease 1 0.9999998807907104
predisposition O 1 0.9999891519546509
to O 0 0.01935426890850067
their O 0 0.021215802058577538
offspring O 0 0.06990408897399902
. O 0 0.044766657054424286

To O 0 0.026501955464482307
determine O 0 0.020660389214754105
the O 0 0.015358555130660534
frequency O 0 0.01566786877810955
and O 0 0.010705169290304184
nature O 0 0.011781228706240654
of O 0 0.011497131548821926
constitutional O 0 0.05628161132335663
RB1 O 1 1.0
- O 1 0.9999961853027344
gene O 0 0.02433251217007637
mutations O 0 0.016537781804800034
in O 0 0.011090532876551151
patients O 0 0.288517564535141
with O 0 0.01264647301286459
isolated O 0 0.07103073596954346
unilateral B-Disease 1 0.5456562638282776
retinoblastoma I-Disease 1 0.9999970197677612
, O 0 0.01608583889901638
we O 0 0.011169832199811935
analyzed O 0 0.016527356579899788
DNA O 0 0.015246201306581497
from O 0 0.012370127253234386
peripheral O 1 0.9999246597290039
blood O 1 0.8543856739997864
and O 0 0.02032897248864174
from O 1 0.5270469784736633
tumor B-Disease 1 1.0
tissue O 1 0.9999947547912598
. O 0 0.05094215273857117

The O 0 0.03337021917104721
analysis O 0 0.02670997940003872
of O 0 0.02480587549507618
tumors B-Disease 1 0.999099850654602
from O 0 0.01838589645922184
54 O 0 0.03535723313689232
( O 0 0.021369455382227898
71 O 0 0.036331627517938614
% O 0 0.016409365460276604
) O 0 0.013388256542384624
of O 0 0.01574891060590744
76 O 0 0.05425385385751724
informative O 0 0.04768948256969452
patients O 0 0.4066043794155121
showed O 0 0.019452175125479698
loss O 0 0.021507954224944115
of O 0 0.015016602352261543
constitutional O 0 0.05662406608462334
heterozygosity O 1 0.9999998807907104
( O 1 0.994920551776886
LOH O 1 1.0
) O 0 0.04126117751002312
at O 0 0.0486154668033123
intragenic O 1 0.9531185626983643
loci O 0 0.08881179243326187
. O 0 0.05848749727010727

Three O 0 0.033737923949956894
of O 0 0.02928530052304268
13 O 0 0.04647066444158554
uninformative O 1 0.9999336004257202
patients O 1 0.997666597366333
had O 0 0.03304968774318695
constitutional O 0 0.05155182629823685
deletions O 0 0.26871180534362793
. O 0 0.0652814731001854

For O 0 0.03664064034819603
39 O 0 0.05278101935982704
randomly O 0 0.034576743841171265
selected O 0 0.042046498507261276
tumors B-Disease 1 0.9995695948600769
, O 0 0.028050674125552177
SSCP O 1 0.9999560117721558
, O 0 0.041604943573474884
hetero O 1 0.9999963045120239
- O 1 0.9999589920043945
duplex O 1 0.8842477202415466
analysis O 0 0.0161711685359478
, O 0 0.014437807723879814
sequencing O 0 0.02164541371166706
, O 0 0.012030656449496746
and O 0 0.011922159232199192
Southern O 0 0.01942402496933937
blot O 1 0.6344270706176758
analysis O 0 0.013808032497763634
were O 0 0.010069265961647034
used O 0 0.012893985025584698
to O 0 0.015671268105506897
identify O 0 0.02947136014699936
mutations O 0 0.0358431302011013
. O 0 0.04034935310482979

Mutations O 0 0.05366767570376396
were O 0 0.01900823600590229
detected O 0 0.022925635799765587
in O 0 0.014406073838472366
21 O 0 0.022481242194771767
( O 0 0.01774478331208229
91 O 0 0.03488980233669281
% O 0 0.016384894028306007
) O 0 0.013915733434259892
of O 0 0.01743602752685547
23 O 0 0.3725354075431824
tumors B-Disease 1 0.9999998807907104
with O 0 0.4754171371459961
LOH O 1 1.0
. O 0 0.07820431888103485

In O 0 0.03396708518266678
6 O 0 0.03258773311972618
( O 0 0.019174369052052498
38 O 0 0.025284508243203163
% O 0 0.012274425476789474
) O 0 0.010447729378938675
of O 0 0.011850111186504364
16 O 0 0.03293459489941597
tumors B-Disease 1 0.9999983310699463
without O 0 0.030124971643090248
LOH O 1 1.0
, O 0 0.018955299630761147
one O 0 0.014254242181777954
mutation O 0 0.017540115863084793
was O 0 0.015863141044974327
detected O 0 0.015781767666339874
, O 0 0.008902943693101406
and O 0 0.007167679723352194
in O 0 0.00876681786030531
9 O 0 0.015803031623363495
( O 0 0.012079437263309956
56 O 0 0.021048858761787415
% O 0 0.010576863773167133
) O 0 0.009138254448771477
of O 0 0.009864715859293938
the O 0 0.019281892105937004
tumors B-Disease 1 0.9999994039535522
without O 0 0.08014944940805435
LOH O 1 1.0
, O 0 0.02483886294066906
both O 0 0.01584765315055847
mutations O 0 0.022274188697338104
were O 0 0.015224487520754337
found O 0 0.023086467757821083
. O 0 0.03753191605210304

Thus O 0 0.03580848127603531
, O 0 0.018193667754530907
a O 0 0.014716302044689655
total O 0 0.013384825550019741
of O 0 0.013118091970682144
45 O 0 0.020361706614494324
mutations O 0 0.01522443164139986
were O 0 0.007952047511935234
identified O 0 0.012027589604258537
in O 0 0.013272775337100029
tumors B-Disease 1 0.9999842643737793
of O 0 0.028824204578995705
36 O 1 0.88504958152771
patients O 1 0.9998365640640259
. O 0 0.04756808280944824

Thirty O 0 0.0773664116859436
- O 0 0.05594150722026825
nine O 0 0.019112616777420044
of O 0 0.014029433019459248
the O 0 0.014711117371916771
mutations O 0 0.019710518419742584
- O 0 0.36390191316604614
including O 0 0.011452223174273968
34 O 0 0.02198261208832264
small O 0 0.014354439452290535
mutations O 0 0.014537273906171322
, O 0 0.009938211180269718
2 O 0 0.015962693840265274
large O 0 0.0152981486171484
structural O 0 0.47102391719818115
alterations O 0 0.06461221724748611
, O 0 0.013216271996498108
and O 0 0.013363279402256012
hypermethylation O 1 0.955204427242279
in O 0 0.015572868287563324
3 O 0 0.21033577620983124
tumors O 1 0.9999996423721313
- O 1 0.9968305230140686
were O 0 0.009012899361550808
not O 0 0.007523679174482822
detected O 0 0.011713890358805656
in O 0 0.008108992129564285
the O 0 0.012034510262310505
corresponding O 0 0.026428204029798508
peripheral O 1 0.9999910593032837
blood O 1 0.9872701168060303
DNA O 0 0.05072891712188721
. O 0 0.042478036135435104

In O 0 0.03158456087112427
6 O 0 0.03455793112516403
( O 0 0.018983066082000732
17 O 0 0.0234221164137125
% O 0 0.013795856386423111
) O 0 0.008489608764648438
of O 0 0.008677544072270393
the O 0 0.01095337700098753
36 O 0 0.023408876731991768
patients O 1 0.8495258092880249
, O 0 0.01158191915601492
a O 0 0.013589913956820965
mutation O 0 0.017134062945842743
was O 0 0.015025470405817032
detected O 0 0.015918606892228127
in O 0 0.009391885250806808
constitutional O 0 0.017921531572937965
DNA O 0 0.014074500650167465
, O 0 0.009903798811137676
and O 0 0.008330041542649269
1 O 0 0.012408267706632614
of O 0 0.008179109543561935
these O 0 0.006866323295980692
mutations O 0 0.012523001059889793
is O 0 0.008190322667360306
known O 0 0.00921347364783287
to O 0 0.00892858300358057
be O 0 0.00931162666529417
associated O 0 0.014240065589547157
with O 0 0.018204158172011375
reduced O 0 0.0631624162197113
expressivity O 1 0.9999194145202637
. O 0 0.05137438327074051

The O 0 0.03003651835024357
presence O 0 0.024027438834309578
of O 0 0.014964084140956402
a O 0 0.01492603775113821
constitutional O 0 0.0220562145113945
mutation O 0 0.02320607751607895
was O 0 0.015930190682411194
not O 0 0.007352017797529697
associated O 0 0.009472142904996872
with O 0 0.006444599013775587
an O 0 0.008532874286174774
early O 0 0.014058754779398441
age O 0 0.024863319471478462
at O 0 0.041841328144073486
treatment O 1 0.99815434217453
. O 0 0.039857055991888046

In O 0 0.03420499339699745
1 O 0 0.04068777710199356
patient O 1 0.9156554341316223
, O 0 0.028605885803699493
somatic O 1 0.9650498628616333
mosaicism O 1 0.999976634979248
was O 0 0.028517166152596474
demonstrated O 0 0.01909981109201908
by O 0 0.009311332367360592
molecular O 0 0.013165058568120003
analysis O 0 0.008993295952677727
of O 0 0.009888488799333572
DNA O 0 0.016093771904706955
and O 0 0.012235879898071289
RNA O 0 0.03241601586341858
from O 0 0.02235799841582775
peripheral O 1 0.9999814033508301
blood O 1 0.9549684524536133
. O 0 0.046614326536655426

In O 0 0.03950176388025284
2 O 0 0.04381834715604782
patients O 0 0.03995499759912491
without O 0 0.014277664944529533
a O 0 0.019726060330867767
detectable O 0 0.34361177682876587
mutation O 0 0.024706603959202766
in O 0 0.017219651490449905
peripheral O 1 0.9999985694885254
blood O 1 0.9989193677902222
, O 0 0.021588565781712532
mosaicism O 1 0.9999724626541138
was O 0 0.018485177308321
suggested O 0 0.011902223341166973
because O 0 0.007481477223336697
1 O 0 0.010864599607884884
of O 0 0.008895869366824627
the O 0 0.011838381178677082
patients O 1 0.9999150037765503
showed O 1 0.9990436434745789
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 0.0128944031894207
the O 0 0.011170169338583946
other O 0 0.009224693290889263
later O 0 0.02041466347873211
developed O 0 0.04017668217420578
bilateral B-Disease 1 0.5518275499343872
retinoblastoma I-Disease 1 0.9999711513519287
. O 0 0.06770549714565277

In O 0 0.03395302593708038
conclusion O 0 0.026238922029733658
, O 0 0.01628401316702366
our O 0 0.014634601771831512
results O 0 0.013167697004973888
emphasize O 0 0.021184822544455528
that O 0 0.00890256930142641
the O 0 0.012814932502806187
manifestation O 1 0.9820134043693542
and O 0 0.020451009273529053
transmissibility O 1 0.9999575614929199
of O 0 0.08562014997005463
retinoblastoma B-Disease 1 0.9999971389770508
depend O 0 0.015099622309207916
on O 0 0.010285907424986362
the O 0 0.009935944341123104
nature O 0 0.010325095616281033
of O 0 0.008401390165090561
the O 0 0.009740132838487625
first O 0 0.013260490261018276
mutation O 0 0.015051478520035744
, O 0 0.00834521185606718
its O 0 0.007048056460916996
time O 0 0.0070083364844322205
in O 0 0.007344359066337347
development O 0 0.009061119519174099
, O 0 0.007892178371548653
and O 0 0.005339714232832193
the O 0 0.006592669058591127
number O 0 0.006057168822735548
and O 0 0.006416641175746918
types O 0 0.007468217983841896
of O 0 0.009450804442167282
cells O 0 0.013854366727173328
that O 0 0.0071869357489049435
are O 0 0.008143098093569279
affected O 0 0.020274164155125618
. O 0 0.020830275490880013
. O 0 0.03459532558917999

Hereditary B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
of I-Disease 0 0.034684717655181885
the I-Disease 0 0.03365163132548332
fifth I-Disease 1 0.9992495179176331
component I-Disease 1 0.9328753352165222
of I-Disease 0 0.02478967420756817
complement I-Disease 0 0.047554101794958115
in O 0 0.0261626448482275
man O 0 0.05350733920931816
. O 0 0.04550342261791229

I O 0 0.1762702912092209
. O 0 0.08800183236598969

Clinical O 1 0.9989720582962036
, O 0 0.04430169612169266
immunochemical O 1 0.9989991784095764
, O 0 0.02707001566886902
and O 0 0.021173404529690742
family O 0 0.03584572672843933
studies O 0 0.034360602498054504
. O 0 0.042973436415195465

The O 0 0.02745741978287697
first O 0 0.021003644913434982
recognized O 0 0.025150872766971588
human O 0 0.019778206944465637
kindred O 1 0.9999769926071167
with O 1 0.8339369893074036
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.7432314157485962
the I-Disease 0 0.10885878652334213
fifth I-Disease 1 0.9974026083946228
component I-Disease 1 0.9149635434150696
of I-Disease 0 0.020183898508548737
complement I-Disease 1 0.9725217819213867
( O 0 0.23768195509910583
C5 O 1 0.9999980926513672
) O 0 0.025691358372569084
is O 0 0.026094533503055573
described O 0 0.04137606918811798
. O 0 0.0444645993411541

The O 0 0.04731438308954239
proband O 0 0.08294974267482758
, O 0 0.017918720841407776
a O 0 0.014913184568285942
20 O 0 0.018230577930808067
- O 1 0.6721620559692383
year O 0 0.015391603112220764
- O 1 0.9734461307525635
old O 0 0.024172471836209297
black O 0 0.022314274683594704
female O 0 0.027431301772594452
with O 1 0.9103159308433533
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9988273978233337
age O 1 0.9242497086524963
11 O 0 0.02859896793961525
, O 0 0.02473665215075016
lacked O 1 0.9983487129211426
serum O 1 0.9999997615814209
hemolytic O 1 1.0
complement O 1 0.975920557975769
activity O 0 0.025201333686709404
, O 0 0.017245572060346603
even O 0 0.019717782735824585
during O 0 0.03361770138144493
remission O 1 0.9994394183158875
. O 0 0.05365508794784546

C5 O 1 0.99994957447052
was O 0 0.10191020369529724
undetectable O 1 0.987135112285614
in O 0 0.020857254043221474
her O 0 0.026387566700577736
serum O 1 0.7748400568962097
by O 0 0.012217619456350803
both O 0 0.01567063480615616
immunodiffusion O 1 0.9999953508377075
and O 1 0.9729937314987183
hemolytic O 1 1.0
assays O 1 0.9038714170455933
. O 0 0.06741062551736832

Other O 0 0.028695378452539444
complement O 0 0.03849241882562637
components O 0 0.026151025667786598
were O 0 0.011105730198323727
normal O 0 0.013238783925771713
during O 0 0.01711997762322426
remission O 1 0.9999239444732666
of O 1 0.829676628112793
lupus O 1 1.0
, O 1 0.5332486033439636
but O 0 0.026722611859440804
C1 O 1 1.0
, O 0 0.03800258785486221
C4 O 1 0.9999921321868896
, O 0 0.03510994091629982
C2 O 1 0.9999996423721313
, O 0 0.022387567907571793
and O 0 0.025704069063067436
C3 O 1 0.9999991655349731
levels O 0 0.0466894768178463
fell O 1 0.9497263431549072
during O 0 0.05412396788597107
exacerbations O 1 0.9999918937683105
. O 0 0.073762446641922

A O 0 0.051875852048397064
younger O 0 0.046243127435445786
half O 0 0.025562647730112076
- O 1 0.9983628392219543
sister O 0 0.027623217552900314
, O 0 0.01016850583255291
who O 0 0.009763537906110287
had O 0 0.010293224826455116
no O 0 0.012360397726297379
underlying O 1 0.9999927282333374
disease O 1 1.0
, O 1 0.7643657326698303
was O 1 0.549370527267456
also O 0 0.010065292939543724
found O 0 0.009783576242625713
to O 0 0.01313141267746687
lack O 0 0.03088492900133133
immunochemically O 1 0.999992847442627
detectable O 1 0.9999717473983765
C5 O 1 0.9999793767929077
. O 0 0.06716456264257431

By O 0 0.0551416240632534
hemolytic O 1 1.0
assay O 1 0.506798505783081
, O 0 0.024498699232935905
she O 0 0.023334722965955734
exhibited O 0 0.030482348054647446
1 O 0 0.024972911924123764
- O 1 0.6775767803192139
2 O 0 0.01836564764380455
% O 0 0.01009470783174038
of O 0 0.009080303832888603
the O 0 0.012073908932507038
normal O 0 0.02065715566277504
serum O 1 0.999914288520813
C5 O 1 0.9999892711639404
level O 0 0.021421382203698158
and O 0 0.014148441143333912
normal O 0 0.015836670994758606
concentrations O 0 0.021739279851317406
of O 0 0.015286702662706375
other O 0 0.016100669279694557
complement O 0 0.0496918149292469
components O 0 0.05652756989002228
. O 0 0.04462353140115738

C5 O 1 0.9997130036354065
levels O 0 0.028665293008089066
of O 0 0.01693890057504177
other O 0 0.011566901579499245
family O 0 0.012769847176969051
members O 0 0.007741525303572416
were O 0 0.0066979690454900265
either O 0 0.006810130551457405
normal O 0 0.008160322904586792
or O 0 0.007453563157469034
approximately O 0 0.00910471472889185
half O 0 0.01305975392460823
- O 1 0.94162917137146
normal O 0 0.011507172137498856
, O 0 0.010964643210172653
consistent O 0 0.016582559794187546
with O 0 0.01467038132250309
autosomal O 1 0.9488188624382019
codominant O 1 0.9991863369941711
inheritance O 0 0.033831749111413956
of O 0 0.015284442342817783
the O 0 0.0171530582010746
gene O 0 0.042169637978076935
determining O 1 0.8623133301734924
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.13050508499145508

Normal O 0 0.3371823728084564
hemolytic O 1 1.0
titers O 1 0.9991942048072815
were O 0 0.02285483293235302
restored O 0 0.03227849304676056
to O 0 0.015503067523241043
both O 0 0.015080324374139309
homozygous O 0 0.24985328316688538
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999998807907104
( O 1 0.639280378818512
C5D B-Disease 1 1.0
) O 0 0.029093598946928978
sera O 1 0.8199093341827393
by O 0 0.012397754937410355
addition O 0 0.016890088096261024
of O 0 0.01770533062517643
highly O 0 0.059186890721321106
purified O 1 0.971592366695404
human O 0 0.058256231248378754
C5 O 1 0.9999614953994751
. O 0 0.07469585537910461

In O 0 0.04283234104514122
specific O 0 0.03622127324342728
C5 O 1 0.9999922513961792
titrations O 1 0.9996885061264038
, O 0 0.019337110221385956
however O 0 0.011467169970273972
, O 0 0.010273841209709644
it O 0 0.007615359034389257
was O 0 0.01118109468370676
noted O 0 0.009522248059511185
that O 0 0.006229029968380928
when O 0 0.008967714384198189
limited O 0 0.01122836023569107
amounts O 0 0.012019100598990917
of O 0 0.015370117500424385
C5 O 1 0.9975171089172363
were O 0 0.014877431094646454
assayed O 0 0.03537902981042862
in O 0 0.010286111384630203
the O 0 0.010954559780657291
presence O 0 0.01312342006713152
of O 0 0.01292430516332388
low O 0 0.02216952294111252
dilutions O 0 0.09820251911878586
of O 0 0.017130771651864052
either O 0 0.02374400570988655
C5D B-Disease 1 0.9999998807907104
serum O 1 0.9999154806137085
, O 0 0.023555023595690727
curving O 0 0.039135098457336426
rather O 0 0.013130461797118187
than O 0 0.011016552336513996
linear O 0 0.021549608558416367
dose O 1 0.9961918592453003
- O 1 0.9874343276023865
response O 0 0.017909862101078033
plots O 0 0.01972828432917595
were O 0 0.009799688123166561
consistently O 0 0.017103543505072594
obtained O 0 0.01538223959505558
, O 0 0.014629898592829704
suggesting O 0 0.019313974305987358
some O 0 0.015278637409210205
inhibitory O 0 0.04676081985235214
effect O 0 0.03462333232164383
. O 0 0.04315667226910591

Further O 0 0.03220976144075394
studies O 0 0.022935498505830765
suggested O 0 0.019079018384218216
that O 0 0.012047113850712776
low O 0 0.02377716265618801
dilutions O 0 0.4208211600780487
of O 0 0.02569638378918171
C5D B-Disease 1 0.9999998807907104
serum O 1 0.9990672469139099
contain O 0 0.02144186571240425
a O 0 0.01805802993476391
factor O 0 0.03420253470540047
( O 0 0.013623679056763649
or O 0 0.011411956511437893
factors O 0 0.01265596691519022
) O 0 0.011777476407587528
interfering O 0 0.01799715682864189
at O 0 0.011502709239721298
some O 0 0.0072790030390024185
step O 0 0.01488242857158184
in O 0 0.01163906417787075
the O 0 0.02000311017036438
hemolytic O 1 1.0
assay O 1 0.8008806109428406
of O 0 0.04074278846383095
C5 O 1 0.9999890327453613
, O 0 0.019347213208675385
rather O 0 0.014995556324720383
than O 0 0.0134609779343009
a O 0 0.024161743000149727
true O 0 0.05194024369120598
C5 O 1 0.9999985694885254
inhibitor O 1 0.9998735189437866
or O 0 0.04766573756933212
inactivator O 1 0.9961124062538147
. O 0 0.06595935672521591

Of O 0 0.0420331209897995
clinical O 1 0.9631788730621338
interest O 0 0.018766915425658226
are O 0 0.008716837503015995
( O 0 0.010120103135704994
a O 0 0.01100359857082367
) O 0 0.01014646701514721
the O 0 0.010840029455721378
documentation O 0 0.020945003256201744
of O 0 0.021114468574523926
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 1 0.9999972581863403
vasculitis B-Disease 1 1.0
, O 1 0.9998682737350464
and O 1 0.999895453453064
arthritis B-Disease 1 1.0
in O 0 0.02127751335501671
an O 0 0.01560116931796074
individual O 0 0.018117982894182205
lacking O 1 0.9981958270072937
C5 O 1 0.9999995231628418
( O 0 0.014995740726590157
and O 0 0.01110989972949028
its O 0 0.013316593132913113
biologic O 1 0.993198812007904
functions O 0 0.012164302170276642
) O 0 0.011296101845800877
, O 0 0.011155642569065094
and O 0 0.0122867152094841
( O 0 0.016852891072630882
b O 0 0.03125489875674248
) O 0 0.012218251824378967
a O 0 0.013437562622129917
remarkable O 0 0.02138669416308403
propensity O 0 0.43299776315689087
to O 0 0.023905975744128227
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 0.014784324914216995
the O 0 0.019842717796564102
proband O 1 0.9998045563697815
, O 0 0.013905529864132404
even O 0 0.0094353798776865
during O 0 0.011312196962535381
periods O 0 0.014580502174794674
of O 0 0.012810560874640942
low O 0 0.03012794256210327
- O 1 0.9972851276397705
dose O 0 0.19112920761108398
or O 0 0.014848638325929642
alternate O 0 0.030236685648560524
- O 1 0.9996381998062134
day O 0 0.19130466878414154
corticosteroid O 1 0.9999992847442627
therapy O 1 0.9999423027038574
. O 0 0.062207456678152084

Other O 0 0.028352130204439163
observations O 0 0.031138621270656586
indicate O 0 0.016159240156412125
that O 0 0.010442952625453472
the O 0 0.016512518748641014
C5D B-Disease 1 0.9998431205749512
state O 0 0.012634830549359322
is O 0 0.012558277696371078
compatible O 0 0.02115575224161148
with O 0 0.0125222597271204
normal O 0 0.021140243858098984
coagulation O 1 0.9996862411499023
function O 0 0.013135616667568684
and O 0 0.01070691179484129
the O 0 0.011615834198892117
capacity O 0 0.01832294650375843
to O 0 0.014337643049657345
mount O 0 0.28664568066596985
a O 0 0.03578604757785797
neutrophilic O 1 0.9999998807907104
leukocytosis O 1 0.9999998807907104
during O 1 0.9997259974479675
pyogenic B-Disease 1 1.0
infection I-Disease 1 0.9999997615814209
. O 0 0.04494977742433548
. O 0 0.054026711732149124

Susceptibility O 1 0.9993108510971069
to O 1 0.5757246017456055
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 1 0.543783962726593
twins O 1 0.9885433912277222
: O 0 0.016759492456912994
the O 0 0.01169959083199501
role O 0 0.012930961325764656
of O 0 0.01285314280539751
genes O 0 0.01752857305109501
, O 0 0.28378987312316895
HLA O 1 1.0
, O 0 0.018935654312372208
and O 0 0.01615142449736595
the O 0 0.022001653909683228
environment O 0 0.04195123538374901
. O 0 0.041860565543174744

OBJECTIVE O 0 0.0655866265296936
To O 0 0.0206072386354208
determine O 0 0.016238132491707802
the O 0 0.014336667023599148
relative O 0 0.018945761024951935
effects O 0 0.01790020987391472
of O 0 0.01223212294280529
genetic O 0 0.01625978760421276
and O 0 0.010758801363408566
environmental O 0 0.020999226719141006
factors O 0 0.014581270515918732
in O 0 0.014966031536459923
susceptibility O 1 0.9999842643737793
to O 1 0.9953374862670898
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9999470710754395
AS B-Disease 1 0.9999336004257202
) O 0 0.042130257934331894
. O 0 0.052304673939943314

METHODS O 0 0.051110755652189255
Twins O 0 0.06241117790341377
with O 0 0.01625378429889679
AS B-Disease 0 0.02053830400109291
were O 0 0.008609717711806297
identified O 0 0.008923335932195187
from O 0 0.007226763758808374
the O 0 0.009270352311432362
Royal O 1 0.7170069217681885
National O 1 0.9955848455429077
Hospital O 1 1.0
for O 1 0.9999687671661377
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 1 0.9986131191253662
. O 0 0.06826408952474594

Clinical O 1 0.9993035793304443
and O 0 0.03940562531352043
radiographic O 1 0.9997090697288513
examinations O 0 0.15054281055927277
were O 0 0.013750257901847363
performed O 0 0.015005300752818584
to O 0 0.011674728244543076
establish O 0 0.021455835551023483
diagnoses O 1 0.9999794960021973
, O 0 0.13250282406806946
and O 1 0.9884776473045349
disease O 1 1.0
severity O 1 0.9999996423721313
was O 1 0.9451106190681458
assessed O 0 0.022028638049960136
using O 0 0.012073004618287086
a O 0 0.014993816614151001
combination O 0 0.021402329206466675
of O 0 0.015267184935510159
validated O 0 0.04097651317715645
scoring O 0 0.03598692640662193
systems O 0 0.052821848541498184
. O 0 0.045062579214572906

HLA O 1 0.9999727010726929
typing O 0 0.14141634106636047
for O 0 0.04606132209300995
HLA O 1 0.9999998807907104
- O 1 0.9998815059661865
B27 O 1 0.9929842948913574
, O 0 0.045675404369831085
HLA O 1 0.9999998807907104
- O 1 0.9998759031295776
B60 O 1 0.9588685631752014
, O 0 0.02404681406915188
and O 0 0.031006544828414917
HLA O 1 1.0
- O 1 0.9999996423721313
DR1 O 1 0.9999959468841553
was O 0 0.029976118355989456
performed O 0 0.02191757783293724
by O 0 0.014795559458434582
polymerase O 0 0.03451643884181976
chain O 0 0.024818889796733856
reaction O 0 0.014040940441191196
with O 0 0.010010641068220139
sequence O 0 0.01445399783551693
- O 0 0.30986088514328003
specific O 0 0.01340625062584877
primers O 0 0.0390416719019413
, O 0 0.016225388273596764
and O 0 0.016528083011507988
zygosity O 1 0.8411580920219421
was O 0 0.025231974199414253
assessed O 0 0.0312579981982708
using O 0 0.026720860973000526
microsatellite O 1 0.9674344658851624
markers O 0 0.08583831042051315
. O 0 0.06111372262239456

Genetic O 0 0.05042445659637451
and O 0 0.02265133522450924
environmental O 0 0.027370484545826912
variance O 0 0.02073381282389164
components O 0 0.01984371803700924
were O 0 0.009321133606135845
assessed O 0 0.015500613488256931
with O 0 0.00866564828902483
the O 0 0.012064299546182156
program O 0 0.023171160370111465
Mx O 1 0.9995643496513367
, O 0 0.011340913362801075
using O 0 0.008003371767699718
data O 0 0.0068276976235210896
from O 0 0.007312307599931955
this O 0 0.007070336025208235
and O 0 0.00778236985206604
previous O 0 0.012265150435268879
studies O 0 0.012826821766793728
of O 0 0.01406860537827015
twins O 0 0.14805200695991516
with O 0 0.02155197411775589
AS B-Disease 1 0.8913761377334595
. O 0 0.04536674544215202

RESULTS O 0 0.03867323324084282
Six O 0 0.026479525491595268
of O 0 0.022274084389209747
8 O 0 0.03910193219780922
monozygotic O 1 0.9991264939308167
( O 0 0.08982360363006592
MZ O 1 0.9999998807907104
) O 0 0.03267435356974602
twin O 0 0.13940398395061493
pairs O 0 0.02869981899857521
were O 0 0.018572548404335976
disease O 1 0.9999945163726807
concordant O 1 0.9930678606033325
, O 0 0.013955513015389442
compared O 0 0.01232567522674799
with O 0 0.00889187678694725
4 O 0 0.01666245423257351
of O 0 0.014120527543127537
15 O 0 0.024480212479829788
B27 O 1 0.9572651386260986
- O 1 0.9638881683349609
positive O 0 0.030128922313451767
dizygotic O 1 0.9561165571212769
( O 0 0.039305295795202255
DZ O 1 0.9999675750732422
) O 0 0.03015059046447277
twin O 0 0.06203535571694374
pairs O 0 0.024770984426140785
( O 0 0.017486553639173508
27 O 0 0.024699172005057335
% O 0 0.014620587229728699
) O 0 0.012246661819517612
and O 0 0.01019756868481636
4 O 0 0.017038365826010704
of O 0 0.014660375192761421
32 O 0 0.03393255174160004
DZ O 1 0.9999253749847412
twin O 0 0.17739111185073853
pairs O 0 0.026657365262508392
overall O 0 0.024681394919753075
( O 0 0.015086976811289787
12 O 0 0.01941027119755745
. O 0 0.015406052581965923
5 O 0 0.026457397267222404
% O 0 0.02508576400578022
) O 0 0.032374102622270584
. O 0 0.04530666768550873

Nonsignificant O 1 0.9954257607460022
increases O 0 0.030856696888804436
in O 0 0.015393068082630634
similarity O 0 0.015866484493017197
with O 0 0.008980564773082733
regard O 0 0.010927200317382812
to O 0 0.009617024101316929
age O 0 0.06370615214109421
at O 1 0.995858371257782
disease O 1 1.0
onset O 1 0.9999998807907104
and O 0 0.011644364334642887
all O 0 0.008245076984167099
of O 0 0.011725102551281452
the O 0 0.050459858030080795
disease O 1 0.9999997615814209
severity O 1 0.9998928308486938
scores O 0 0.019048305228352547
assessed O 0 0.017158057540655136
were O 0 0.009307567961513996
noted O 0 0.013398975133895874
in O 0 0.016651950776576996
disease O 1 0.9999992847442627
- O 1 0.9999996423721313
concordant O 1 0.9999734163284302
MZ O 1 1.0
twins O 1 0.8393658399581909
compared O 0 0.036906734108924866
with O 0 0.035875581204891205
concordant O 1 0.9956936836242676
DZ O 1 0.9999964237213135
twins O 1 0.9829918742179871
. O 0 0.06982997804880142

HLA O 1 0.9999998807907104
- O 1 0.99997878074646
B27 O 1 0.9881786704063416
and O 0 0.021892432123422623
B60 O 1 0.5847309231758118
were O 0 0.009650617837905884
associated O 0 0.00961329136043787
with O 0 0.00844485592097044
the O 0 0.02193760871887207
disease O 1 0.9999997615814209
in O 0 0.03640415519475937
probands O 1 0.9999874830245972
, O 0 0.01067479606717825
and O 0 0.009321313351392746
the O 0 0.00895147304981947
rate O 0 0.011470683850347996
of O 0 0.013170585967600346
disease O 1 0.9999992847442627
concordance O 1 0.992142915725708
was O 0 0.030714135617017746
significantly O 0 0.017540961503982544
increased O 0 0.016048869118094444
among O 0 0.020823905244469643
DZ O 1 0.9999932050704956
twin O 0 0.415755957365036
pairs O 0 0.01739068329334259
in O 0 0.009237161837518215
which O 0 0.007593835704028606
the O 0 0.0116469981148839
co O 1 0.9976009726524353
- O 1 0.9999620914459229
twin O 1 0.9299253225326538
was O 0 0.01787307858467102
positive O 0 0.013812514021992683
for O 0 0.012724433094263077
both O 0 0.019546102732419968
B27 O 1 0.9940339922904968
and O 0 0.041594505310058594
DR1 O 1 0.9999086856842041
. O 0 0.06257619708776474

Additive O 0 0.11064644902944565
genetic O 0 0.04830268397927284
effects O 0 0.03023865632712841
were O 0 0.010862154886126518
estimated O 0 0.013468085788190365
to O 0 0.010594934225082397
contribute O 0 0.020139113068580627
97 O 0 0.033920954912900925
% O 0 0.014775837771594524
of O 0 0.01142064854502678
the O 0 0.01452304981648922
population O 0 0.016591021791100502
variance O 0 0.03249078989028931
. O 0 0.04051092639565468

CONCLUSION O 0 0.08007066696882248
Susceptibility O 1 0.607874870300293
to O 0 0.021115519106388092
AS B-Disease 0 0.025683866813778877
is O 0 0.011975052766501904
largely O 0 0.0137480478733778
genetically O 0 0.015529791824519634
determined O 0 0.011959012597799301
, O 0 0.00890190526843071
and O 0 0.007132501807063818
the O 0 0.009218921884894371
environmental O 0 0.01629643701016903
trigger O 0 0.0722852274775505
for O 0 0.012652071192860603
the O 1 0.6778832674026489
disease O 1 1.0
is O 0 0.033733099699020386
probably O 0 0.0665867030620575
ubiquitous O 1 0.9852327704429626
. O 0 0.04504213482141495

HLA O 1 0.9999997615814209
- O 1 0.9999028444290161
B27 O 0 0.46454888582229614
accounts O 0 0.020393628627061844
for O 0 0.012715631164610386
a O 0 0.013259753584861755
minority O 0 0.014663929119706154
of O 0 0.0090855173766613
the O 0 0.012214655056595802
overall O 0 0.4655965268611908
genetic O 0 0.493341326713562
susceptibility O 1 0.9996362924575806
to O 0 0.02278628945350647
AS B-Disease 0 0.327865868806839
. O 0 0.045023731887340546

Cell O 0 0.10453666001558304
cycle O 0 0.06430013477802277
- O 1 0.8391722440719604
dependent O 0 0.03753326088190079
colocalization O 0 0.13681663572788239
of O 0 0.027974115684628487
BARD1 O 1 0.9999972581863403
and O 0 0.036696795374155045
BRCA1 O 1 0.9997321963310242
proteins O 0 0.027073334902524948
in O 0 0.02029263973236084
discrete O 0 0.03879211097955704
nuclear O 0 0.046711575239896774
domains O 0 0.0678679496049881
. O 0 0.053413648158311844

Germ O 1 0.9999721050262451
- O 1 0.9971845746040344
line O 0 0.03857402503490448
mutations O 0 0.023650825023651123
of O 0 0.014100302010774612
the O 0 0.019250817596912384
BRCA1 O 1 0.9999407529830933
gene O 0 0.025457052513957024
predispose O 0 0.12801964581012726
women O 0 0.013762149959802628
to O 0 0.010272959247231483
early O 0 0.02014549821615219
- O 1 0.9999998807907104
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9999986886978149
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 0.015252050943672657
compromising O 1 0.974579930305481
the O 0 0.01949944905936718
genes O 0 0.024083547294139862
presumptive O 1 0.9999797344207764
function O 0 0.019586797803640366
as O 0 0.021102020516991615
a O 0 0.10938697308301926
tumor B-Disease 1 0.9999996423721313
suppressor O 1 0.9998443126678467
. O 0 0.06592657417058945

Although O 0 0.03489254415035248
the O 0 0.026784906163811684
biochemical O 0 0.04527612030506134
properties O 0 0.02731926552951336
of O 0 0.02171197719871998
BRCA1 O 1 0.9999954700469971
polypeptides O 0 0.07271231710910797
are O 0 0.008937177248299122
not O 0 0.009062746539711952
understood O 0 0.015506588853895664
, O 0 0.01124846376478672
their O 0 0.009826031513512135
expression O 0 0.015296324156224728
pattern O 0 0.017868561670184135
and O 0 0.01625037007033825
subcellular O 0 0.05301539599895477
localization O 0 0.03539638593792915
suggest O 0 0.017190495505928993
a O 0 0.014607347548007965
role O 0 0.01829618029296398
in O 0 0.01932533085346222
cell O 0 0.08955694735050201
- O 1 0.9967934489250183
cycle O 0 0.05063515529036522
regulation O 0 0.05490074306726456
. O 0 0.04896882548928261

When O 0 0.05763097107410431
resting O 1 0.9971838593482971
cells O 0 0.029320210218429565
are O 0 0.011780157685279846
induced O 1 0.9449471831321716
to O 0 0.015952227637171745
proliferate O 0 0.04006701707839966
, O 0 0.012891048565506935
the O 0 0.011223199777305126
steady O 0 0.024376481771469116
- O 0 0.03682049736380577
state O 0 0.009798817336559296
levels O 0 0.013141768053174019
of O 0 0.012701510451734066
BRCA1 O 1 0.7036421895027161
increase O 0 0.014175578020513058
in O 0 0.014247262850403786
late O 0 0.029115671291947365
G1 O 1 0.9975975155830383
and O 0 0.014897242188453674
reach O 0 0.018590524792671204
a O 0 0.01637304201722145
maximum O 0 0.025946568697690964
during O 0 0.030274920165538788
S O 1 0.9953370094299316
phase O 0 0.07996083796024323
. O 0 0.054393090307712555

Moreover O 0 0.052626583725214005
, O 0 0.022614959627389908
in O 0 0.02147962525486946
S O 1 0.9973672032356262
phase O 1 0.5285415649414062
cells O 0 0.03464058041572571
, O 0 0.027647271752357483
BRCA1 O 1 0.9965054988861084
polypeptides O 0 0.046446818858385086
are O 0 0.01341918669641018
hyperphosphorylated O 0 0.43669363856315613
and O 0 0.01942726969718933
accumulate O 0 0.0342223085463047
into O 0 0.018818605691194534
discrete O 0 0.04018334299325943
subnuclear O 1 0.9968231916427612
foci O 1 0.9982001781463623
termed O 1 0.943030059337616
" O 0 0.04785642772912979
BRCA1 O 1 0.9993368983268738
nuclear O 0 0.07198390364646912
dots O 0 0.11255265027284622
. O 0 0.06813106685876846

" O 0 0.06217584386467934
BRCA1 O 1 0.9999016523361206
associates O 1 0.6602541208267212
in O 0 0.01804175041615963
vivo O 0 0.038710810244083405
with O 0 0.015273207798600197
a O 0 0.022196592763066292
structurally O 1 0.9229792952537537
related O 0 0.035458579659461975
protein O 0 0.04533955827355385
termed O 1 0.8253986835479736
BARD1 O 1 0.9998854398727417
. O 0 0.0703994408249855

Here O 0 0.03120732679963112
we O 0 0.014216477051377296
show O 0 0.012688237242400646
that O 0 0.007054914254695177
the O 0 0.010207079350948334
steady O 0 0.02109544165432453
- O 0 0.10560712218284607
state O 0 0.010814347304403782
levels O 0 0.014137418009340763
of O 0 0.014417195692658424
BARD1 O 1 0.9992270469665527
, O 0 0.014385654591023922
unlike O 0 0.014175856485962868
those O 0 0.009402787312865257
of O 0 0.015278629958629608
BRCA1 O 1 0.9999275207519531
, O 0 0.012305288575589657
remain O 0 0.014958967454731464
relatively O 0 0.01550270989537239
constant O 0 0.022126121446490288
during O 0 0.028250692412257195
cell O 0 0.2444174438714981
cycle O 0 0.06167903542518616
progression O 1 0.8004661202430725
. O 0 0.058437444269657135

However O 0 0.035136956721544266
, O 0 0.02931963838636875
immunostaining O 1 0.9745623469352722
revealed O 0 0.024833666160702705
that O 0 0.015661723911762238
BARD1 O 1 0.9983419179916382
resides O 0 0.047670647501945496
within O 0 0.020642099902033806
BRCA1 O 1 0.9806913137435913
nuclear O 0 0.024532591924071312
dots O 0 0.03142356127500534
during O 0 0.020664384588599205
S O 1 0.5458479523658752
phase O 0 0.0196992177516222
of O 0 0.01127889659255743
the O 0 0.012775054201483727
cell O 0 0.02698417566716671
cycle O 0 0.01747106947004795
, O 0 0.009981434792280197
but O 0 0.00718688452616334
not O 0 0.006746373139321804
during O 0 0.013949102722108364
the O 0 0.023068448528647423
G1 O 1 0.9999862909317017
phase O 0 0.08725252747535706
. O 0 0.058320432901382446

Nevertheless O 0 0.08865533769130707
, O 0 0.049418769776821136
BARD1 O 1 0.99986732006073
polypeptides O 0 0.05750516429543495
are O 0 0.012667268514633179
found O 0 0.013670149259269238
exclusively O 0 0.017150340601801872
in O 0 0.011705005541443825
the O 0 0.012764979153871536
nuclear O 0 0.01803836040198803
fractions O 0 0.0197726059705019
of O 0 0.011587613262236118
both O 0 0.014918656088411808
G1 O 1 0.9999969005584717
- O 1 0.9996480941772461
and O 0 0.02482767403125763
S O 1 0.9998716115951538
- O 1 0.9999527931213379
phase O 0 0.3619275391101837
cells O 0 0.049618158489465714
. O 0 0.04321040213108063

Therefore O 0 0.03748401626944542
, O 0 0.02638395130634308
progression O 0 0.05125711113214493
to O 0 0.021338514983654022
S O 1 0.9940258264541626
phase O 0 0.03613252565264702
is O 0 0.014196822419762611
accompanied O 0 0.01986830309033394
by O 0 0.010042781941592693
the O 0 0.012523639015853405
aggregation O 0 0.02593214064836502
of O 0 0.018971804529428482
nuclear O 0 0.04593435302376747
BARD1 O 1 0.99647456407547
polypeptides O 0 0.0721314400434494
into O 0 0.038874126970767975
BRCA1 O 1 0.9992781281471252
nuclear O 0 0.061821483075618744
dots O 0 0.09591412544250488
. O 0 0.06162772327661514

This O 0 0.03372248634696007
cell O 0 0.04921713471412659
cycle O 0 0.04292893782258034
- O 1 0.8605989217758179
dependent O 0 0.029081614688038826
colocalization O 0 0.2783982455730438
of O 0 0.023412387818098068
BARD1 O 1 0.9999922513961792
and O 0 0.03633478283882141
BRCA1 O 1 0.9998823404312134
indicates O 0 0.020307151600718498
a O 0 0.014730066992342472
role O 0 0.015518342144787312
for O 0 0.013195211067795753
BARD1 O 1 0.9993119239807129
in O 0 0.02790091186761856
BRCA1 O 1 0.9999997615814209
- O 1 0.9999998807907104
mediated O 1 0.9999898672103882
tumor B-Disease 1 0.9999997615814209
suppression O 1 0.999947190284729
. O 0 0.06666388362646103

Ethnic O 0 0.03859402611851692
differences O 0 0.02950563281774521
in O 0 0.021900001913309097
the O 0 0.03189102187752724
HFE O 1 0.9990677237510681
codon O 0 0.0739169791340828
282 O 1 0.96875
( O 0 0.20492710173130035
Cys O 1 0.9999997615814209
/ O 1 0.9999966621398926
Tyr O 1 0.9999978542327881
) O 0 0.05965178832411766
polymorphism O 0 0.10276561975479126
. O 0 0.06576008349657059

Recent O 0 0.029766840860247612
studies O 0 0.01693364419043064
have O 0 0.008009879849851131
shown O 0 0.012266184203326702
that O 0 0.014751273207366467
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 1 0.9999998807907104
HH B-Disease 1 1.0
) O 0 0.024058450013399124
is O 0 0.013063873164355755
likely O 0 0.012034487910568714
to O 0 0.009285319596529007
be O 0 0.009711617603898048
caused O 0 0.0159755889326334
by O 0 0.010807787999510765
homozygosity O 0 0.3099336624145508
for O 0 0.01391342468559742
a O 0 0.02055593580007553
Cys282Tyr O 1 0.9946823716163635
mutation O 0 0.026622265577316284
in O 0 0.015524775721132755
the O 0 0.022046633064746857
HFE O 1 0.9999443292617798
gene O 0 0.03970378264784813
located O 0 0.04678530618548393
4 O 0 0.055422522127628326
. O 0 0.05227718502283096

5 O 0 0.10163192451000214
Mb O 1 0.9445487260818481
telomeric O 1 0.8363515734672546
to O 0 0.06577547639608383
HLA O 1 0.9999997615814209
- O 1 0.9999147653579712
A O 0 0.08479195833206177
. O 0 0.06412198394536972

Population O 0 0.02613506279885769
studies O 0 0.020827950909733772
of O 0 0.013349859043955803
this O 0 0.0111428527161479
polymorphism O 0 0.02392595075070858
are O 0 0.008228257298469543
facilitated O 0 0.018589584156870842
by O 0 0.008516269735991955
the O 0 0.009296674281358719
fact O 0 0.010328863747417927
that O 0 0.008673889562487602
the O 0 0.015053308568894863
Cys282Tyr O 1 0.9973976612091064
mutation O 0 0.031119640916585922
creates O 0 0.04062287136912346
a O 0 0.030486615374684334
Rsal O 1 0.9947817921638489
restriction O 0 0.05451608821749687
site O 0 0.06577794998884201
. O 0 0.05206980183720589

We O 0 0.030023928731679916
have O 0 0.016462460160255432
studied O 0 0.02363155223429203
the O 0 0.019730135798454285
codon O 0 0.04989514499902725
282 O 0 0.21432112157344818
( O 0 0.05850579962134361
Cys O 1 0.9999997615814209
/ O 1 0.9999922513961792
Tyr O 1 0.9999961853027344
) O 0 0.031175876036286354
polymorphism O 0 0.04391498863697052
in O 0 0.018950074911117554
different O 0 0.013209800235927105
ethnic O 0 0.01987970434129238
groups O 0 0.0220421701669693
. O 0 0.04092787951231003

In O 0 0.028983982279896736
agreement O 0 0.022266162559390068
with O 0 0.013827787712216377
previous O 0 0.01788083091378212
observations O 0 0.02567935176193714
the O 0 0.018928000703454018
Tyr O 1 0.9999949932098389
allele O 0 0.03970184177160263
appeared O 0 0.017590055242180824
to O 0 0.010224812664091587
be O 0 0.009331273846328259
rare O 0 0.015002102591097355
or O 0 0.011777426116168499
absent O 0 0.026049649342894554
in O 0 0.018630849197506905
Asiatic O 1 0.9997560381889343
( O 0 0.02210148423910141
Indian O 0 0.03324921056628227
, O 0 0.024879343807697296
Chinese O 0 0.03514505550265312
) O 0 0.03145430237054825
populations O 0 0.03841918334364891
. O 0 0.04681456461548805

The O 0 0.04416703060269356
highest O 0 0.04713793843984604
allele O 0 0.04270271956920624
frequency O 0 0.02269795350730419
( O 0 0.015507703647017479
7 O 0 0.02028951793909073
. O 0 0.011552027426660061
5 O 0 0.018504755571484566
% O 0 0.014388198032975197
) O 0 0.01263806875795126
was O 0 0.017349524423480034
found O 0 0.014098428189754486
in O 0 0.01902431808412075
Swedes O 0 0.06833714991807938
. O 0 0.044919874519109726

Saamis O 1 0.9491696953773499
( O 0 0.03070135973393917
2 O 0 0.030256740748882294
% O 0 0.020349502563476562
) O 0 0.014300203882157803
and O 0 0.014710883609950542
Mordvinians O 1 0.9745184183120728
( O 0 0.013478061184287071
1 O 0 0.016828875988721848
. O 0 0.010527675971388817
8 O 0 0.018204020336270332
% O 0 0.01247007679194212
) O 0 0.011810076422989368
had O 0 0.0122227119281888
significantly O 0 0.016918078064918518
lower O 0 0.016705963760614395
frequencies O 0 0.017160018905997276
of O 0 0.01732291281223297
the O 0 0.031778302043676376
Tyr O 1 0.9999887943267822
allele O 0 0.11111311614513397
. O 0 0.06169220432639122

Comparisons O 0 0.05757125839591026
with O 0 0.02887212112545967
allele O 0 0.0406469851732254
frequencies O 0 0.020628390833735466
based O 0 0.016802717000246048
on O 0 0.014448912814259529
prevalence O 0 0.03330593928694725
estimates O 0 0.01766534335911274
of O 0 0.019036317244172096
HH B-Disease 1 1.0
showed O 0 0.01900264248251915
some O 0 0.010463722981512547
disagreements O 0 0.02011939510703087
with O 0 0.011015196330845356
the O 0 0.0166693776845932
RFLP O 1 0.9334974884986877
data O 0 0.017398124560713768
, O 0 0.01746717467904091
particularly O 0 0.02171296998858452
in O 0 0.024975085631012917
Finns O 0 0.12567178905010223
. O 0 0.0546761192381382

The O 0 0.04982859641313553
newly O 0 0.06818739324808121
described O 0 0.04934415593743324
HFE O 1 0.999994158744812
marker O 0 0.34980854392051697
provides O 0 0.018935903906822205
a O 0 0.013280333951115608
new O 0 0.01185198687016964
approach O 0 0.011397650465369225
to O 0 0.007756050676107407
the O 0 0.00997867900878191
screening O 0 0.02224206179380417
of O 0 0.018741318956017494
HH B-Disease 1 1.0
as O 0 0.013995636254549026
well O 0 0.010355901904404163
as O 0 0.009086518548429012
studies O 0 0.008625678718090057
of O 0 0.008215666748583317
the O 0 0.00974400993436575
relationship O 0 0.012356462888419628
between O 0 0.0112157566472888
the O 0 0.02278193086385727
HFE O 1 0.9999998807907104
Tyr O 1 0.9999998807907104
allele O 1 0.528075635433197
and O 0 0.02212914079427719
different O 0 0.021192029118537903
disorders O 1 0.9999997615814209
including O 1 0.9764308333396912
cancer B-Disease 1 1.0

Autosomal B-Disease 1 0.9999686479568481
dominant I-Disease 1 0.9999827146530151
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
associated O 0 0.0431213453412056
with O 0 0.01876242645084858
a O 0 0.023281123489141464
missense O 0 0.05532051622867584
mutation O 0 0.03317742794752121
encoding O 0 0.035499706864356995
Gly23 O 1 0.9999198913574219
- O 1 0.9999933242797852
- O 1 0.9999818801879883
> O 1 0.9963492155075073
Val O 1 0.9918489456176758
in O 0 0.04738549888134003
neurophysin O 1 0.9997127652168274
II O 1 0.9999836683273315
. O 0 0.07498722523450851

Autosomal B-Disease 1 0.9999396800994873
dominant I-Disease 1 0.9999841451644897
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9967241883277893
ADNDI B-Disease 1 0.9999998807907104
) O 0 0.015602905303239822
is O 0 0.010686506517231464
an O 1 0.5366179347038269
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999997615814209
by O 1 0.9141882658004761
progressive O 1 0.9999998807907104
degeneration O 1 1.0
of O 1 0.7164987325668335
the O 1 0.7259348630905151
magnocellular O 1 0.9999986886978149
neurons O 0 0.03062114678323269
of O 0 0.014386329799890518
the O 0 0.01651514507830143
hypothalamus O 1 0.7855852246284485
leading O 0 0.04324589669704437
to O 0 0.0133573729544878
decreased O 0 0.018222926184535027
ability O 0 0.012756869196891785
to O 0 0.011116943322122097
produce O 0 0.015353723429143429
the O 0 0.017871305346488953
hormone O 1 0.9836248159408569
arginine O 1 0.9503480195999146
vasopressin O 1 0.9976716637611389
( O 0 0.07352987676858902
AVP O 1 0.9999910593032837
) O 0 0.05435915291309357
. O 0 0.056842703372240067

Affected O 0 0.044800419360399246
individuals O 0 0.015936238691210747
are O 0 0.007869339548051357
not O 0 0.009572862647473812
symptomatic O 1 0.9999933242797852
at O 0 0.16437488794326782
birth O 0 0.48607495427131653
, O 0 0.009970985352993011
but O 0 0.008033093065023422
usually O 0 0.011385622434318066
develop O 1 0.998450756072998
diabetes B-Disease 1 1.0
insipidus I-Disease 1 1.0
at O 0 0.3175472319126129
1 O 0 0.044961199164390564
- O 1 0.9979543685913086
6 O 0 0.04674316197633743
yr O 1 0.9854071140289307
of O 0 0.03870222344994545
age O 0 0.053591497242450714
. O 0 0.0571056604385376

The O 0 0.035724181681871414
genetic O 0 0.032636336982250214
locus O 0 0.04984501376748085
of O 0 0.017602847889065742
the O 0 0.021698450669646263
disease O 1 0.9999821186065674
is O 0 0.013189464807510376
the O 0 0.020413845777511597
AVP O 1 1.0
- O 1 0.9999997615814209
neurophysin O 1 0.9999992847442627
II O 1 1.0
( O 0 0.030870743095874786
NPII O 1 0.9999768733978271
) O 0 0.016623808071017265
gene O 0 0.013601264916360378
, O 0 0.00971305277198553
and O 0 0.008987815119326115
mutations O 0 0.01090206578373909
that O 0 0.007784450892359018
cause O 1 0.9630761742591858
ADNDI B-Disease 1 0.9999992847442627
have O 0 0.009557349607348442
been O 0 0.009328287094831467
found O 0 0.008699895814061165
in O 0 0.007704992778599262
both O 0 0.008449213579297066
the O 0 0.011646119877696037
signal O 0 0.020498085767030716
peptide O 0 0.02752109244465828
of O 0 0.015313851647078991
the O 0 0.021091368049383163
prepro O 1 0.9998584985733032
- O 1 0.9999986886978149
AVP O 1 0.9999997615814209
- O 1 0.9999977350234985
NPII O 1 0.9999591112136841
precursor O 0 0.09202440828084946
and O 0 0.02746335230767727
within O 0 0.03197304904460907
NPII O 1 0.9997404217720032
itself O 0 0.06470751762390137
. O 0 0.05968174338340759

An O 0 0.03506061062216759
affected O 0 0.03103945590555668
girl O 0 0.05477634817361832
who O 0 0.017051715403795242
presented O 0 0.019429881125688553
at O 0 0.014358137734234333
9 O 0 0.015495208092033863
months O 0 0.011738060042262077
of O 0 0.009456251747906208
age O 0 0.013861151412129402
and O 0 0.01119192223995924
her O 0 0.01527522224932909
similarly O 0 0.017741041257977486
affected O 0 0.020493261516094208
younger O 1 0.5202235579490662
brother O 1 0.8259413242340088
and O 0 0.012067057192325592
father O 0 0.018564626574516296
were O 0 0.006973975338041782
all O 0 0.006306787487119436
found O 0 0.007248544599860907
to O 0 0.006972146686166525
have O 0 0.006625006906688213
a O 0 0.011236107908189297
novel O 0 0.020006539300084114
missense O 0 0.03184787184000015
mutation O 0 0.018204286694526672
( O 0 0.01648624986410141
G1758 O 1 0.999180018901825
- O 1 0.9999995231628418
- O 1 0.9999997615814209
> O 1 0.9999487400054932
T O 1 0.9993560910224915
) O 0 0.0173628069460392
encoding O 0 0.01816016249358654
the O 0 0.01742032915353775
amino O 0 0.022941676899790764
acid O 0 0.033651553094387054
substitution O 0 0.045108236372470856
Gly23 O 1 0.9999810457229614
- O 1 0.9999970197677612
- O 1 0.999994158744812
> O 1 0.9955883026123047
Val O 1 0.9821540117263794
within O 0 0.05381277576088905
NPII O 1 0.9970958232879639
. O 0 0.0784631073474884

The O 0 0.04686152562499046
mutation O 0 0.0403396412730217
was O 0 0.028066372498869896
confirmed O 0 0.023554692044854164
by O 0 0.018549827858805656
restriction O 0 0.04531920701265335
endonuclease O 0 0.15381161868572235
analysis O 0 0.04844983294606209
. O 0 0.05601463094353676

A O 0 0.14278016984462738
T1 O 1 0.999915361404419
- O 1 0.9375736117362976
weighted O 0 0.05361882224678993
magnetic O 0 0.04501708969473839
resonance O 0 0.043095991015434265
imaging O 0 0.04558565467596054
of O 0 0.019632497802376747
the O 0 0.027340440079569817
fathers O 1 0.9930192828178406
pituitary O 1 1.0
gland O 1 0.9999994039535522
demonstrates O 1 0.9832537770271301
an O 1 0.5223389863967896
attenuated O 1 0.9999990463256836
posterior O 1 0.999996542930603
pituitary O 1 0.9999998807907104
bright O 1 0.9999215602874756
spot O 1 0.8436008095741272
. O 0 0.06915035843849182

This O 0 0.03623407334089279
mutation O 0 0.0333489365875721
may O 0 0.014670862816274166
be O 0 0.009621494449675083
valuable O 0 0.01856866106390953
for O 0 0.011700350791215897
developing O 0 0.017292654141783714
models O 0 0.022723833099007607
of O 0 0.022385893389582634
dominantly B-Disease 1 0.9999998807907104
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 0.018202347680926323
as O 0 0.01036160346120596
the O 0 0.009398141875863075
early O 0 0.011468412354588509
age O 0 0.012052382342517376
of O 0 0.011435780674219131
onset O 1 0.9999998807907104
of O 1 0.9954392313957214
symptoms O 1 1.0
suggests O 0 0.21516083180904388
that O 0 0.006851679645478725
this O 0 0.007900326512753963
mutation O 0 0.014119140803813934
may O 0 0.00814494676887989
be O 0 0.008307013660669327
particularly O 0 0.013359622098505497
deleterious O 0 0.03116171807050705
to O 0 0.015354365110397339
the O 0 0.02615768276154995
magnocellular O 1 0.9999868869781494
neuron O 1 0.9996881484985352
. O 0 0.03657390922307968
. O 0 0.04972090572118759

Frequent O 0 0.07434608787298203
inactivation O 1 0.9814054369926453
of O 0 0.05064235255122185
PTEN O 1 0.9999985694885254
/ O 1 0.9999263286590576
MMAC1 O 1 0.9999890327453613
in O 0 0.09514281153678894
primary O 1 0.9999955892562866
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.6718353629112244

Sporadic B-Disease 1 0.9999955892562866
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.02424045279622078
the O 0 0.014039303176105022
most O 0 0.011096873320639133
common O 0 0.01678031124174595
male B-Disease 1 0.9235817790031433
cancer I-Disease 1 0.9999992847442627
in O 0 0.009105110540986061
the O 0 0.010150063782930374
Western O 0 0.015264339745044708
world O 0 0.017646795138716698
, O 0 0.009414376690983772
yet O 0 0.0076915193349123
many O 0 0.0049921791069209576
of O 0 0.006300449371337891
the O 0 0.008070889860391617
major O 0 0.012516428716480732
genetic O 0 0.009291356429457664
events O 0 0.008225595578551292
involved O 0 0.0067964824847877026
in O 0 0.005992735270410776
the O 0 0.007988901808857918
progression O 0 0.06703723222017288
of O 0 0.008511018007993698
this O 0 0.007821408100426197
often O 0 0.015728486701846123
fatal O 1 0.9999996423721313
cancer B-Disease 1 1.0
remain O 0 0.024383263662457466
to O 0 0.01992650143802166
be O 0 0.025284791365265846
elucidated O 0 0.4104386270046234
. O 0 0.0532231479883194

Numerous O 0 0.059333618730306625
cytogenetic O 1 0.9602920413017273
and O 0 0.029694747179746628
allelotype O 1 0.9926884174346924
studies O 0 0.01928851194679737
have O 0 0.010143215768039227
reported O 0 0.0160833727568388
frequent O 0 0.019511209800839424
loss O 0 0.028761478140950203
of O 0 0.017056865617632866
heterozygosity O 1 0.9996115565299988
on O 0 0.02249395102262497
chromosomal O 1 0.9882251024246216
arm O 1 0.9992818236351013
10q O 1 0.9996160268783569
in O 0 0.06487683206796646
sporadic B-Disease 1 0.9999942779541016
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.5819657444953918

Deletion O 0 0.11057714372873306
mapping O 0 0.049387264996767044
studies O 0 0.024481508880853653
have O 0 0.013426934368908405
unambiguously O 0 0.032893307507038116
identified O 0 0.01422672439366579
a O 0 0.012219471856951714
region O 0 0.014832895249128342
of O 0 0.014289828948676586
chromosome O 0 0.030817022547125816
10q23 O 1 0.8811455368995667
to O 0 0.012362401001155376
be O 0 0.009223529137670994
the O 0 0.012596426531672478
minimal O 0 0.022151421755552292
area O 0 0.019628258422017097
of O 0 0.022370290011167526
loss O 1 0.875361979007721
. O 0 0.047150854021310806

A O 0 0.050858259201049805
new O 0 0.047059718519449234
tumor B-Disease 1 0.9999830722808838
suppressor O 1 0.9995105266571045
gene O 0 0.03840440884232521
, O 0 0.034236397594213486
PTEN O 1 0.9999996423721313
/ O 1 0.9999942779541016
MMAC1 O 1 0.9999961853027344
, O 0 0.021352127194404602
was O 0 0.023172615095973015
isolated O 0 0.02151845581829548
recently O 0 0.01640382595360279
at O 0 0.011598389595746994
this O 0 0.007862744852900505
region O 0 0.012995620258152485
of O 0 0.013406731188297272
chromosome O 0 0.03566304221749306
10q23 O 1 0.962828516960144
and O 0 0.011830790899693966
found O 0 0.009249165654182434
to O 0 0.008803557604551315
be O 0 0.009848494082689285
inactivated O 0 0.04485533758997917
by O 0 0.009932633489370346
mutation O 0 0.014950418844819069
in O 0 0.013228367082774639
three O 0 0.20981238782405853
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.999945878982544
lines O 0 0.05650312080979347
. O 0 0.048861898481845856

We O 0 0.03608744218945503
screened O 0 0.07404709607362747
80 O 1 0.9166013598442078
prostate B-Disease 1 1.0
tumors I-Disease 1 0.9999983310699463
by O 0 0.02199813909828663
microsatellite O 1 0.9895721673965454
analysis O 0 0.01678423024713993
and O 0 0.01319687720388174
found O 0 0.014499551616609097
chromosome O 0 0.024923481047153473
10q23 O 0 0.06436184793710709
to O 0 0.012528492137789726
be O 0 0.011624920181930065
deleted O 0 0.025398587808012962
in O 0 0.016635138541460037
23 O 0 0.03513572737574577
cases O 0 0.030600039288401604
. O 0 0.04278497397899628

We O 0 0.031213603913784027
then O 0 0.025047214701771736
proceeded O 0 0.02686137892305851
with O 0 0.011083642952144146
sequence O 0 0.010353469289839268
analysis O 0 0.007772813551127911
of O 0 0.008188595063984394
the O 0 0.011681485921144485
entire O 0 0.03955908119678497
PTEN O 1 0.9999997615814209
/ O 1 0.9999867677688599
MMAC1 O 1 0.9999927282333374
coding O 0 0.07250074297189713
region O 0 0.022316528484225273
and O 0 0.015571391209959984
tested O 0 0.02548300474882126
for O 0 0.013807735405862331
homozygous O 0 0.030638588592410088
deletion O 0 0.02649349346756935
with O 0 0.011748812161386013
new O 0 0.02147492580115795
intragenic O 1 0.993287980556488
markers O 0 0.02650454454123974
in O 0 0.011285945773124695
these O 0 0.007944283075630665
23 O 0 0.016814380884170532
cases O 0 0.012136537581682205
with O 0 0.013502517715096474
10q23 O 1 0.9964540004730225
loss O 1 0.8569189310073853
of O 0 0.03954881802201271
heterozygosity O 1 0.9999327659606934
. O 0 0.06725496053695679

The O 0 0.030315406620502472
identification O 0 0.02235090360045433
of O 0 0.013867128640413284
the O 0 0.014698087237775326
second O 0 0.02699568308889866
mutational O 1 0.997763991355896
event O 0 0.022504542022943497
in O 0 0.01215213630348444
10 O 0 0.01361139491200447
( O 0 0.014582298696041107
43 O 0 0.02664080634713173
% O 0 0.019006814807653427
) O 0 0.025510674342513084
tumors B-Disease 1 0.9999972581863403
establishes O 1 0.9999713897705078
PTEN O 1 1.0
/ O 1 0.9999951124191284
MMAC1 O 1 0.999925971031189
as O 0 0.016544003039598465
a O 0 0.0182094257324934
main O 0 0.02284941077232361
inactivation O 0 0.11579274386167526
target O 0 0.01707386039197445
of O 0 0.014631018973886967
10q O 1 0.6973581314086914
loss O 0 0.17441466450691223
in O 0 0.03028806671500206
sporadic B-Disease 1 0.9999985694885254
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.23809419572353363
. O 0 0.05395746976137161

Risk O 0 0.16807718575000763
reversals O 0 0.0800299346446991
in O 0 0.024242646992206573
predictive O 0 0.1560569405555725
testing O 0 0.08538036048412323
for O 1 0.5831838250160217
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.1355101317167282

The O 0 0.029095632955431938
first O 0 0.023665737360715866
predictive O 0 0.033760204911231995
testing O 0 0.022950880229473114
for O 0 0.06735287606716156
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9862896800041199
HD B-Disease 1 0.9999735355377197
) O 0 0.017061032354831696
was O 0 0.01668548583984375
based O 0 0.011911546811461449
on O 0 0.008915322832763195
analysis O 0 0.010873708873987198
of O 0 0.0126280402764678
linked O 0 0.021837666630744934
polymorphic O 0 0.15143446624279022
DNA O 0 0.02107672207057476
markers O 0 0.022269846871495247
to O 0 0.011484252288937569
estimate O 0 0.015312767587602139
the O 0 0.013512264005839825
likelihood O 0 0.020486880093812943
of O 0 0.017765140160918236
inheriting O 1 0.6790822744369507
the O 0 0.02245338447391987
mutation O 0 0.03306882083415985
for O 0 0.029941579326987267
HD B-Disease 1 0.9652486443519592
. O 0 0.060422133654356

Limits O 0 0.0356801338493824
to O 0 0.019311191514134407
accuracy O 0 0.02353072352707386
included O 0 0.017763542011380196
recombination O 0 0.025926293805241585
between O 0 0.010510026477277279
the O 0 0.012712733820080757
DNA O 0 0.017017750069499016
markers O 0 0.021941009908914566
and O 0 0.01074694748967886
the O 0 0.011984586715698242
mutation O 0 0.018032193183898926
, O 0 0.014753947965800762
pedigree O 1 0.7912130951881409
structure O 0 0.017281442880630493
, O 0 0.01082849595695734
and O 0 0.008059436455368996
whether O 0 0.009486949071288109
DNA O 0 0.014287332072854042
samples O 0 0.011864458210766315
were O 0 0.008115598931908607
available O 0 0.010523375123739243
from O 0 0.012695149518549442
family O 0 0.024569932371377945
members O 0 0.02321670576930046
. O 0 0.039064306765794754

With O 0 0.025508033111691475
direct O 0 0.018893655389547348
tests O 0 0.0156999584287405
for O 0 0.010887183248996735
the O 0 0.014870583079755306
HD B-Disease 1 0.9997078776359558
mutation O 0 0.023758286610245705
, O 0 0.012149149551987648
we O 0 0.007636504713445902
have O 0 0.006835996638983488
assessed O 0 0.012897117994725704
the O 0 0.008338888175785542
accuracy O 0 0.011104054749011993
of O 0 0.008186724968254566
results O 0 0.0096247848123312
obtained O 0 0.010505391284823418
by O 0 0.008534867316484451
linkage O 0 0.02388542890548706
approaches O 0 0.02084052935242653
when O 0 0.012293864972889423
requested O 0 0.01735084317624569
to O 0 0.012114940211176872
do O 0 0.00952808279544115
so O 0 0.009479067288339138
by O 0 0.008563847281038761
the O 0 0.01490714680403471
test O 0 0.027462055906653404
individuals O 0 0.02228461392223835
. O 0 0.04027607664465904

For O 0 0.02657356671988964
six O 0 0.020041562616825104
such O 0 0.011529849842190742
individuals O 0 0.009827285073697567
, O 0 0.010331545025110245
there O 0 0.009302579797804356
was O 0 0.016069862991571426
significant O 0 0.014949226751923561
disparity O 0 0.03432184085249901
between O 0 0.014090748503804207
the O 0 0.020987076684832573
tests O 0 0.03272935003042221
. O 0 0.039768338203430176

Three O 0 0.02680663764476776
went O 0 0.025196438655257225
from O 0 0.012903930619359016
a O 0 0.014663910493254662
decreased O 0 0.025134384632110596
risk O 0 0.011359190568327904
to O 0 0.006749304011464119
an O 0 0.006724311038851738
increased O 0 0.01567203179001808
risk O 0 0.4617604911327362
, O 0 0.007549030240625143
while O 0 0.006635126192122698
in O 0 0.006834893021732569
another O 0 0.009074436500668526
three O 0 0.007909184321761131
the O 0 0.013053560629487038
risk O 1 0.9052071571350098
was O 1 0.5788573026657104
decreased O 0 0.49024397134780884
. O 0 0.04200846329331398

Knowledge O 0 0.04518655315041542
of O 0 0.021964391693472862
the O 0 0.01821504347026348
potential O 0 0.021365636959671974
reasons O 0 0.013873234391212463
for O 0 0.008039828389883041
these O 0 0.005241876933723688
changes O 0 0.006629165727645159
in O 0 0.006933040916919708
results O 0 0.008140716701745987
and O 0 0.006910739932209253
impact O 0 0.010219448246061802
of O 0 0.008859707042574883
these O 0 0.007192977704107761
risk O 0 0.023807596415281296
reversals O 1 0.7366504073143005
on O 0 0.009605524130165577
both O 0 0.010144234634935856
patients O 1 0.829865038394928
and O 0 0.009349850006401539
the O 0 0.011624098755419254
counseling O 1 0.9957150816917419
team O 0 0.016193358227610588
can O 0 0.008215091191232204
assist O 0 0.015019184909760952
in O 0 0.007695085369050503
the O 0 0.0074548195116221905
development O 0 0.01004347950220108
of O 0 0.009111402556300163
strategies O 0 0.014231793582439423
for O 0 0.007995955646038055
the O 0 0.012462399899959564
prevention O 1 0.9999983310699463
and O 0 0.012169569730758667
, O 0 0.009123899973928928
where O 0 0.008502952754497528
necessary O 0 0.009500904008746147
, O 0 0.008902081288397312
management O 0 0.014491194859147072
of O 0 0.010460183024406433
a O 0 0.016055282205343246
risk O 0 0.3631944954395294
reversal O 0 0.025626165792346
in O 0 0.012460228055715561
any O 0 0.013866360299289227
predictive O 0 0.03639135882258415
testing O 0 0.032151028513908386
program O 0 0.03617750108242035
. O 0 0.03110021911561489
. O 0 0.04888118430972099

A O 0 0.05645697936415672
novel O 0 0.04909936338663101
common O 0 0.027112435549497604
missense O 0 0.05489769205451012
mutation O 0 0.033046141266822815
G301C O 0 0.05726473033428192
in O 0 0.013960960321128368
the O 0 0.017630930989980698
N O 0 0.06150932237505913
- O 1 0.9970290064811707
acetylgalactosamine O 1 0.9991600513458252
- O 1 0.999906063079834
6 O 0 0.17774559557437897
- O 1 0.999948263168335
sulfate O 1 0.999983549118042
sulfatase O 1 0.9999294281005859
gene O 0 0.04891149699687958
in O 0 0.04216482490301132
mucopolysaccharidosis B-Disease 1 0.9999438524246216
IVA I-Disease 1 0.9999996423721313
. O 0 0.07870995253324509

Mucopolysaccharidosis B-Disease 1 0.9999854564666748
IVA I-Disease 1 0.9999998807907104
( O 0 0.0734626054763794
MPS B-Disease 1 0.9992295503616333
IVA I-Disease 1 1.0
) O 0 0.02128804847598076
is O 0 0.014477825723588467
an O 0 0.016597846522927284
autosomal B-Disease 1 0.999995231628418
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999724626541138
by O 0 0.012637151405215263
a O 0 0.1696295291185379
genetic B-Disease 1 0.9913156032562256
defect I-Disease 1 0.9999839067459106
in O 0 0.01989159733057022
N O 0 0.4374438226222992
- O 1 0.9994900226593018
acetylgalactosamine O 1 0.9988614320755005
- O 1 0.9997935891151428
6 O 0 0.18518905341625214
- O 1 0.999991774559021
sulfate O 1 0.9999951124191284
sulfatase O 1 0.9999978542327881
( O 0 0.1921328902244568
GALNS O 1 0.9999809265136719
) O 0 0.05288474261760712
. O 0 0.05296177789568901

In O 0 0.02663314715027809
previous O 0 0.020237457007169724
studies O 0 0.015454686246812344
, O 0 0.01081185694783926
we O 0 0.0072146872989833355
have O 0 0.005661465227603912
found O 0 0.006925684865564108
two O 0 0.006734959315508604
common O 0 0.011098401620984077
mutations O 0 0.014499042183160782
in O 0 0.014446331188082695
Caucasians O 1 0.9944302439689636
and O 0 0.01945752091705799
Japanese O 0 0.1729162633419037
, O 0 0.027329586446285248
respectively O 0 0.0418616347014904
. O 0 0.046180181205272675

To O 0 0.04383573308587074
characterize O 0 0.06489512324333191
the O 0 0.03259991109371185
mutational O 1 0.9359468221664429
spectrum O 0 0.03890623152256012
in O 0 0.015522059984505177
various O 0 0.011589940637350082
ethnic O 0 0.01220729760825634
groups O 0 0.009677589870989323
, O 0 0.013665868900716305
mutations O 0 0.012566674500703812
in O 0 0.010848469100892544
the O 0 0.015709606930613518
GALNS O 1 0.9997684359550476
gene O 0 0.018392685800790787
in O 0 0.015731792896986008
Colombian O 0 0.12230592966079712
MPS B-Disease 1 0.9996838569641113
IVA I-Disease 1 1.0
patients O 1 0.9995094537734985
were O 0 0.015020502731204033
investigated O 0 0.02291572093963623
, O 0 0.01432446762919426
and O 0 0.012305010110139847
genetic O 0 0.014326265081763268
backgrounds O 0 0.012777460739016533
were O 0 0.007640243042260408
extensively O 0 0.014144293032586575
analyzed O 0 0.01444777101278305
to O 0 0.009628521278500557
identify O 0 0.012977909296751022
racial O 0 0.015472820028662682
origin O 0 0.010762277990579605
, O 0 0.011547552421689034
based O 0 0.01353336963802576
on O 0 0.012499848380684853
mitochondrial O 0 0.02356591634452343
DNA O 0 0.023152925074100494
( O 0 0.02036787010729313
mtDNA O 0 0.035972703248262405
) O 0 0.028082413598895073
lineages O 0 0.05392806977033615
. O 0 0.0419418066740036

Three O 0 0.043746281415224075
novel O 0 0.05541572719812393
missense O 0 0.06030445545911789
mutations O 0 0.024793501943349838
never O 0 0.019976822659373283
identified O 0 0.01566961221396923
previously O 0 0.014359620399773121
in O 0 0.008585099130868912
other O 0 0.007442382629960775
populations O 0 0.008140628226101398
and O 0 0.008306245319545269
found O 0 0.007705667521804571
in O 0 0.007761325687170029
16 O 0 0.01133783534169197
out O 0 0.011081918142735958
of O 0 0.012952645309269428
19 O 0 0.027129989117383957
Colombian O 0 0.057500071823596954
MPS B-Disease 1 0.979390025138855
IVA I-Disease 1 0.9999998807907104
unrelated O 0 0.06177302077412605
alleles O 0 0.040146518498659134
account O 0 0.02121066302061081
for O 0 0.0228243637830019
84 O 0 0.07489198446273804
. O 0 0.051439449191093445

2 O 0 0.04306654632091522
% O 0 0.02086571790277958
of O 0 0.016762683168053627
the O 0 0.018794653937220573
alleles O 0 0.028728188946843147
in O 0 0.014549546875059605
this O 0 0.014849334955215454
study O 0 0.03421355411410332
. O 0 0.03982182964682579

The O 0 0.06340240687131882
G301C O 1 0.954754650592804
and O 0 0.03534775972366333
S162F O 1 0.856640100479126
mutations O 0 0.033755380660295486
account O 0 0.021611636504530907
for O 0 0.023814786225557327
68 O 0 0.07286085933446884
. O 0 0.05150144174695015

4 O 0 0.06990130245685577
% O 0 0.03987745940685272
and O 0 0.03029794432222843
10 O 0 0.04819638654589653
. O 0 0.055083759129047394

5 O 0 0.04419628903269768
% O 0 0.02284981682896614
of O 0 0.017144257202744484
mutations O 0 0.019188985228538513
, O 0 0.013107236474752426
respectively O 0 0.013836410827934742
, O 0 0.01103504654020071
whereas O 0 0.011379461735486984
the O 0 0.011307131499052048
remaining O 0 0.024303195998072624
F69V O 1 0.9999483823776245
is O 0 0.015396270900964737
limited O 0 0.017765123397111893
to O 0 0.014585647732019424
a O 0 0.023765407502651215
single O 0 0.03512323647737503
allele O 0 0.061973292380571365
. O 0 0.04515531286597252

The O 0 0.05158410221338272
skewed O 0 0.07169217616319656
prevalence O 0 0.4316592514514923
of O 0 0.025878097862005234
G301C O 1 0.861321210861206
in O 0 0.01748773269355297
only O 0 0.015207218937575817
Colombian O 0 0.10153532028198242
patients O 1 0.7420290112495422
and O 0 0.016139866784214973
haplotype O 0 0.03943442553281784
analysis O 0 0.01930772326886654
by O 0 0.015049505978822708
restriction O 0 0.027898428961634636
fragment O 0 0.03392055258154869
length O 0 0.02040686644613743
polymorphisms O 0 0.029176805168390274
in O 0 0.013706309720873833
the O 0 0.01700129546225071
GALNS O 1 0.9999494552612305
gene O 0 0.021074794232845306
suggest O 0 0.015644103288650513
that O 0 0.01245681382715702
G301C O 0 0.08032026886940002
originated O 0 0.023909639567136765
from O 0 0.01465547177940607
a O 0 0.02383510395884514
common O 0 0.02571827918291092
ancestor O 0 0.05287325754761696
. O 0 0.04941035062074661

Investigation O 0 0.04456080496311188
of O 0 0.020426645874977112
the O 0 0.017629418522119522
genetic O 0 0.017621632665395737
background O 0 0.01662890799343586
by O 0 0.00960515160113573
means O 0 0.012747803702950478
of O 0 0.01373919378966093
mtDNA O 0 0.025414718315005302
lineages O 0 0.01877775974571705
indicate O 0 0.010782450437545776
that O 0 0.006925750523805618
all O 0 0.007505407556891441
our O 0 0.012187878601253033
patients O 0 0.2626977860927582
are O 0 0.00732417544350028
probably O 0 0.014628250151872635
of O 0 0.01465960405766964
native O 0 0.026705248281359673
American O 0 0.047513581812381744
descent O 0 0.08399958163499832

Low O 0 0.05598161369562149
frequency O 0 0.03035711869597435
of O 0 0.02718365378677845
BRCA1 O 1 0.994601845741272
germline O 0 0.07853619754314423
mutations O 0 0.0213706623762846
in O 0 0.012412486597895622
45 O 0 0.028609624132514
German O 1 0.9999738931655884
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.8121122717857361
. O 0 0.05685868486762047

In O 0 0.027743831276893616
this O 0 0.012665444053709507
study O 0 0.013673578388988972
we O 0 0.009051207453012466
investigated O 0 0.016217175871133804
45 O 0 0.022963879629969597
German O 1 0.999909520149231
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.037519730627536774
for O 0 0.021017026156187057
germline O 1 0.9162635207176208
mutations O 0 0.025289515033364296
in O 0 0.017899764701724052
the O 0 0.02892172522842884
BRCA1 O 1 0.9999326467514038
gene O 0 0.04771188274025917
. O 0 0.04756114259362221

We O 0 0.0290098637342453
identified O 0 0.023333072662353516
four O 0 0.018960345536470413
germline O 0 0.04179852455854416
mutations O 0 0.016874173656105995
in O 0 0.011953875422477722
three O 0 0.017958713695406914
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.011555860750377178
and O 0 0.006753578782081604
in O 0 0.007396751549094915
one O 0 0.28843632340431213
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.972115159034729
. O 0 0.010279996320605278
among O 0 0.009330137632787228
these O 0 0.00578736700117588
were O 0 0.0078544020652771
one O 0 0.011960112489759922
frameshift O 1 0.9480094909667969
mutation O 0 0.02101271040737629
, O 0 0.013803644105792046
one O 0 0.012174722738564014
nonsense O 0 0.045641642063856125
mutation O 0 0.02048206701874733
, O 0 0.012596804648637772
one O 0 0.012026797980070114
novel O 0 0.024931464344263077
splice O 0 0.06757014989852905
site O 0 0.02668258175253868
mutation O 0 0.02269626408815384
, O 0 0.015247068367898464
and O 0 0.01500002946704626
one O 0 0.02210569940507412
missense O 0 0.07044690102338791
mutation O 0 0.048334863036870956
. O 0 0.04130646958947182

The O 0 0.05533171072602272
missense O 0 0.09103093296289444
mutation O 0 0.041189856827259064
was O 0 0.02682242915034294
also O 0 0.017317453399300575
found O 0 0.015706317499279976
in O 0 0.018648162484169006
2 O 0 0.04194732755422592
. O 0 0.04741659015417099

8 O 0 0.04568982869386673
% O 0 0.016954541206359863
of O 0 0.01203099638223648
the O 0 0.011060579679906368
general O 0 0.013167697004973888
population O 0 0.007124895229935646
, O 0 0.008393730968236923
suggesting O 0 0.008840040303766727
that O 0 0.004890313372015953
it O 0 0.006552219390869141
is O 0 0.009320812299847603
not O 0 0.01327819749712944
disease O 1 0.999998927116394
associated O 0 0.08435634523630142
. O 0 0.03777848556637764

The O 0 0.031976085156202316
average O 0 0.02907896228134632
age O 0 0.026176445186138153
of O 0 0.34432968497276306
disease O 1 1.0
onset O 1 1.0
in O 0 0.02180880308151245
those O 0 0.016037730500102043
families O 0 0.026564598083496094
harbouring O 1 0.9999723434448242
causative O 1 0.9999624490737915
mutations O 0 0.03621957451105118
was O 0 0.029386330395936966
between O 0 0.02270997129380703
32 O 0 0.05016864463686943
. O 0 0.04798698052763939

3 O 0 0.07417099922895432
and O 0 0.04650169983506203
37 O 0 0.08119071274995804
. O 0 0.06635171920061111

4 O 0 0.05346434563398361
years O 0 0.02678029052913189
, O 0 0.01880655437707901
whereas O 0 0.017861273139715195
the O 0 0.01698281057178974
family O 0 0.02404271997511387
harbouring O 1 0.9682804942131042
the O 0 0.019065668806433678
missense O 0 0.07321339845657349
mutation O 0 0.019983181729912758
had O 0 0.012106712907552719
an O 0 0.009955919347703457
average O 0 0.015391248278319836
age O 0 0.01622074283659458
of O 0 0.01651402935385704
onset O 1 0.9999113082885742
of O 0 0.03293275088071823
51 O 0 0.2910647988319397
. O 0 0.05424503982067108

2 O 0 0.09137754887342453
years O 0 0.06358194351196289
. O 0 0.06507792323827744

These O 0 0.02334856241941452
findings O 0 0.022852009162306786
show O 0 0.017818352207541466
that O 0 0.013574364595115185
BRCA1 O 1 0.9954525828361511
is O 0 0.0128971291705966
implicated O 0 0.022767983376979828
in O 0 0.009171863086521626
a O 0 0.010872375220060349
small O 0 0.009342478588223457
fraction O 0 0.016852116212248802
of O 0 0.3790322542190552
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.023802831768989563
suggesting O 0 0.020240996032953262
the O 0 0.013996089808642864
involvement O 0 0.021326430141925812
of O 0 0.014341452158987522
another O 0 0.03169994428753853
susceptibility O 1 0.9999620914459229
gene O 0 0.19212625920772552
( O 0 0.04270975664258003
s O 0 0.35362696647644043
) O 0 0.06654883176088333

Paternal O 1 0.9906356930732727
transmission O 1 0.9974039196968079
of O 1 0.9998601675033569
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9998533725738525

We O 0 0.0281117744743824
report O 0 0.020124251022934914
a O 0 0.017386479303240776
rare O 0 0.019732609391212463
case O 0 0.018619954586029053
of O 0 0.023247895762324333
paternally O 1 0.9999990463256836
transmitted O 1 0.9999998807907104
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 1 0.8506397604942322
. O 0 0.06599896401166916

The O 0 0.049019645899534225
proband O 0 0.34474876523017883
is O 0 0.017906062304973602
a O 0 0.01859116181731224
23 O 0 0.022758806124329567
year O 0 0.01880643516778946
old O 0 0.05747349560260773
, O 0 0.024331990629434586
mentally B-Disease 1 0.9999978542327881
retarded I-Disease 1 0.9999649524688721
male O 1 0.9979175925254822
who O 1 0.9999943971633911
suffers O 1 1.0
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9926214218139648

He O 0 0.03570905327796936
presented O 0 0.0374370701611042
with O 1 0.6707994937896729
respiratory O 1 1.0
and O 1 0.980030357837677
feeding O 1 0.9981575608253479
difficulties O 1 0.9999643564224243
at O 1 0.95339435338974
birth O 1 0.9280447959899902
. O 0 0.050021205097436905

His O 0 0.051354363560676575
two O 0 0.0334462970495224
sibs O 1 0.9999783039093018
suffer O 1 0.9999419450759888
from O 1 0.5679042339324951
childhood O 1 1.0
onset O 1 1.0
DM B-Disease 1 1.0
. O 1 0.9177269339561462

Their O 0 0.03404631093144417
late O 0 0.03751925006508827
father O 0 0.028748175129294395
had O 0 0.013569934293627739
the O 0 0.011494173668324947
adult O 0 0.017118755728006363
type O 0 0.01970660127699375
of O 0 0.03218783438205719
DM B-Disease 1 1.0
, O 0 0.02285817451775074
with O 0 0.018186483532190323
onset O 1 0.9999951124191284
around O 0 0.022714538499712944
30 O 0 0.032875459641218185
years O 0 0.034905873239040375
. O 0 0.045637380331754684

Only O 0 0.023271722719073296
six O 0 0.016819670796394348
other O 0 0.008411402814090252
cases O 0 0.00975760631263256
of O 0 0.01245562918484211
paternal O 1 0.9912866950035095
transmission O 1 0.9999172687530518
of O 1 0.9999942779541016
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.25744006037712097
been O 0 0.02294657938182354
reported O 0 0.03445730730891228
recently O 0 0.04609169065952301
. O 0 0.04516008496284485

We O 0 0.02399563603103161
review O 0 0.023949235677719116
the O 0 0.017076142132282257
sex O 0 0.01962778903543949
related O 0 0.01470166351646185
effects O 0 0.018279187381267548
on O 0 0.015561738982796669
transmission O 1 0.9964239001274109
of O 1 0.9996802806854248
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9979286193847656

Decreased O 0 0.0695311650633812
fertility O 0 0.049159690737724304
of O 0 0.01627943105995655
males O 0 0.016289323568344116
with O 0 0.014199425466358662
adult O 1 0.9271842837333679
onset O 1 1.0
DM B-Disease 1 1.0
and O 0 0.24265889823436737
contraction O 1 0.5277051329612732
of O 0 0.01307725626975298
the O 0 0.014250791631639004
repeat O 0 0.02530147135257721
upon O 0 0.016551414504647255
male O 0 0.025006651878356934
transmission O 0 0.024402787908911705
contribute O 0 0.017377302050590515
to O 0 0.010608037002384663
the O 0 0.011654246598482132
almost O 0 0.011981865391135216
absent O 0 0.02250785194337368
occurrence O 0 0.023369884118437767
of O 0 0.01896439678966999
paternal O 1 0.9431622624397278
transmission O 1 0.9977436065673828
of O 1 0.9995562434196472
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.9941926598548889

Also O 0 0.032366398721933365
the O 0 0.02289014868438244
fathers O 0 0.03138071671128273
of O 0 0.014279107563197613
the O 0 0.015515560284256935
reported O 0 0.06144111230969429
congenitally O 1 0.9999703168869019
affected O 0 0.05679637938737869
children O 0 0.02049059420824051
showed O 0 0.015595853328704834
, O 0 0.010989160276949406
on O 0 0.010625160299241543
average O 0 0.016324929893016815
, O 0 0.01649506762623787
shorter O 0 0.03351316973567009
CTG O 1 0.9904919266700745
repeat O 0 0.037343744188547134
lengths O 0 0.03020917810499668
and O 0 0.012939106673002243
hence O 0 0.016144001856446266
less O 0 0.01713264361023903
severe O 1 0.9999996423721313
clinical O 1 1.0
symptoms O 1 0.9999998807907104
than O 0 0.013400298543274403
the O 0 0.015437772497534752
mothers O 0 0.25749334692955017
of O 0 0.015600751154124737
children O 1 0.8857917189598083
with O 1 0.9997721314430237
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.996948778629303

We O 0 0.02561354450881481
conclude O 0 0.02932027541100979
that O 0 0.013903417624533176
paternal O 0 0.06722123175859451
transmission O 1 0.9218593239784241
of O 1 0.9998052716255188
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 1 0.9996267557144165
rare O 1 0.9673923254013062
and O 0 0.01701192371547222
preferentially O 0 0.03308911994099617
occurs O 0 0.012815084308385849
with O 0 0.013095702044665813
onset O 1 0.999921441078186
of O 0 0.26856106519699097
DM B-Disease 1 1.0
past O 0 0.02418770268559456
30 O 0 0.022204313427209854
years O 0 0.014092225581407547
in O 0 0.014500567689538002
the O 0 0.02074270136654377
father O 0 0.04117739573121071
. O 0 0.02806118316948414
. O 0 0.042338136583566666

The O 0 0.061680056154727936
RB1 O 1 0.9999685287475586
gene O 0 0.04102982580661774
mutation O 0 0.027604512870311737
in O 0 0.01315879076719284
a O 0 0.01929016411304474
child O 1 0.7497674226760864
with O 1 0.5109783411026001
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.1739756464958191

The O 0 0.07484139502048492
RB1 O 1 0.9998799562454224
gene O 0 0.043912943452596664
mutation O 0 0.031249772757291794
was O 0 0.02179551124572754
investigated O 0 0.021462300792336464
in O 0 0.011552941985428333
a O 0 0.016528362408280373
child O 0 0.22925618290901184
with O 0 0.0549483560025692
ectopic B-Disease 1 1.0
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 0.9999980926513672
using O 0 0.019696949049830437
DNA O 0 0.018596800044178963
obtained O 0 0.012789863161742687
from O 0 0.009057711809873581
both O 0 0.009192729368805885
the O 0 0.016185663640499115
pineal B-Disease 1 0.9999946355819702
and I-Disease 1 0.905646026134491
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.7191107273101807
the O 1 0.8173089623451233
patient O 1 0.9999954700469971
. O 0 0.05405889078974724

A O 0 0.06624753773212433
nonsense O 0 0.0756959393620491
mutation O 0 0.03576236590743065
in O 0 0.020277829840779305
exon O 0 0.0851261168718338
17 O 0 0.03345539793372154
( O 0 0.022719653323292732
codon O 0 0.043182022869586945
556 O 0 0.0579988956451416
) O 0 0.01711326278746128
of O 0 0.015731822699308395
the O 0 0.021664265543222427
RB1 O 1 0.9999940395355225
gene O 0 0.020817024633288383
was O 0 0.016893280670046806
found O 0 0.009483661502599716
to O 0 0.008419699035584927
be O 0 0.007973754778504372
present O 0 0.01190879289060831
homozygously O 0 0.05063501372933388
in O 0 0.011441188864409924
both O 0 0.011757082305848598
the O 0 0.019259216263890266
retinal B-Disease 1 0.9999916553497314
and I-Disease 0 0.029796553775668144
the I-Disease 0 0.3763163387775421
pineal I-Disease 1 0.9999997615814209
tumours I-Disease 1 1.0
. O 0 0.07451210170984268

The O 0 0.036071207374334335
same O 0 0.02403838001191616
mutation O 0 0.02672094851732254
was O 0 0.0211854949593544
present O 0 0.01671975664794445
heterozygously O 1 0.681822657585144
in O 0 0.012164472602307796
the O 0 0.010249976068735123
DNA O 0 0.011655179783701897
from O 0 0.0068494477309286594
the O 0 0.009235712699592113
constitutional O 0 0.014653020538389683
cells O 0 0.011578410863876343
of O 0 0.0099454615265131
the O 0 0.013798296451568604
patient O 1 0.9942008852958679
, O 0 0.0158388651907444
proving O 0 0.031044799834489822
it O 0 0.008822827599942684
to O 0 0.00950657855719328
be O 0 0.009852325543761253
of O 0 0.017006732523441315
germline O 0 0.07219728082418442
origin O 0 0.031828250735998154
. O 0 0.03941204398870468

The O 0 0.03765399008989334
initial O 0 0.03597797080874443
mutation O 0 0.02697170525789261
was O 0 0.018871014937758446
shown O 0 0.012493128888309002
to O 0 0.009576517157256603
have O 0 0.008151011541485786
occurred O 0 0.012926020659506321
in O 0 0.011721189133822918
the O 0 0.02074391208589077
paternally O 1 0.9143088459968567
derived O 0 0.05240724980831146
RB1 O 1 0.9999523162841797
allele O 0 0.10779731720685959
. O 0 0.06387695670127869

The O 0 0.037937283515930176
mutation O 0 0.030154842883348465
is O 0 0.013093773275613785
in O 0 0.009767692536115646
an O 0 0.008218982256948948
area O 0 0.010753386653959751
of O 0 0.007867742329835892
the O 0 0.009945094585418701
gene O 0 0.010703456588089466
that O 0 0.007378756999969482
encodes O 0 0.017658676952123642
the O 0 0.012194270268082619
protein O 0 0.018866201862692833
- O 0 0.1910126954317093
binding O 0 0.015661126002669334
region O 0 0.01255518477410078
known O 0 0.010557938367128372
as O 0 0.009165382944047451
the O 0 0.012829182669520378
pocket O 1 0.9998685121536255
region O 0 0.01623440906405449
and O 0 0.010178896598517895
has O 0 0.009549147449433804
been O 0 0.0100906016305089
detected O 0 0.01238049566745758
in O 0 0.008229292929172516
other O 0 0.0077364277094602585
cases O 0 0.013446497730910778
of O 0 0.022972960025072098
retinoblastoma B-Disease 1 0.9999994039535522
. O 0 0.032062046229839325
. O 0 0.04628366604447365

Low O 0 0.05274803191423416
levels O 0 0.024279147386550903
of O 0 0.018692946061491966
beta O 0 0.05092761293053627
hexosaminidase O 1 0.8994908928871155
A O 0 0.0199840497225523
in O 0 0.013199335895478725
healthy O 0 0.02297615073621273
individuals O 0 0.00995294377207756
with O 0 0.015418775379657745
apparent O 1 0.9999933242797852
deficiency O 1 1.0
of O 1 0.9255326986312866
this O 0 0.030207328498363495
enzyme O 0 0.10102399438619614
. O 0 0.046628836542367935

Appreciable O 0 0.2206553816795349
beta O 0 0.10127365589141846
hexosaminidase O 1 0.8994914889335632
A O 0 0.04316669702529907
( O 0 0.02582288533449173
hex O 0 0.062270503491163254
A O 0 0.027297930791974068
) O 0 0.015354970470070839
activity O 0 0.012017118744552135
has O 0 0.009210779331624508
been O 0 0.008534319698810577
detected O 0 0.015628686174750328
in O 0 0.013394909910857677
cultured O 1 0.9985176920890808
skin O 1 1.0
fibroblasts O 1 0.9999996423721313
and O 1 0.9999818801879883
melanoma B-Disease 1 1.0
tissue O 1 0.9999998807907104
from O 0 0.018566472455859184
healthy O 0 0.15635526180267334
individuals O 0 0.008356778882443905
previously O 0 0.013156074099242687
reported O 0 0.014326158910989761
as O 0 0.011809191666543484
having O 0 0.45153915882110596
deficiency B-Disease 1 1.0
of I-Disease 0 0.15227560698986053
hex I-Disease 1 0.9590892791748047
A I-Disease 0 0.02805475704371929
activity O 0 0.015795735642313957
indistinguishable O 0 0.022464707493782043
from O 0 0.007321672514081001
that O 0 0.005936525296419859
of O 0 0.008502848446369171
patients O 1 0.9493036270141602
with O 1 0.9125880599021912
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997690320014954
TSD B-Disease 1 1.0
) O 0 0.05540715903043747
. O 0 0.057515062391757965

Identification O 0 0.05402733013033867
and O 0 0.03107021562755108
quantitation O 1 0.8688635230064392
of O 0 0.02785402536392212
hex O 0 0.3381698429584503
A O 0 0.03776254132390022
, O 0 0.025611508637666702
amounting O 0 0.04212367162108421
to O 0 0.027643412351608276
3 O 0 0.048495907336473465
. O 0 0.05068274959921837

5 O 0 0.07155178487300873
% O 0 0.051893845200538635
- O 1 0.9905397891998291
6 O 0 0.07504571974277496
. O 0 0.05953740328550339

9 O 0 0.04947151616215706
% O 0 0.022990496829152107
of O 0 0.016819307580590248
total O 0 0.018890000879764557
beta O 0 0.08574414253234863
hexosaminidase O 1 0.9892541170120239
activity O 0 0.017866292968392372
, O 0 0.013427558355033398
has O 0 0.012908181175589561
been O 0 0.01226434763520956
obtained O 0 0.01651126518845558
by O 0 0.018203264102339745
cellulose O 1 0.999880313873291
acetate O 1 0.9999810457229614
gel O 1 0.9998729228973389
electrophoresis O 1 0.900071918964386
, O 0 0.03858734294772148
DEAE O 1 0.9999730587005615
- O 1 0.9999403953552246
cellulose O 1 0.9989559650421143
ion O 1 0.7339792847633362
- O 1 0.9816077947616577
exchange O 0 0.03535113483667374
chromatography O 1 0.873206615447998
, O 0 0.03158370405435562
radial O 1 0.7566571235656738
immunodiffusion O 1 0.9976971745491028
, O 0 0.03466301038861275
and O 0 0.03617751598358154
radioimmunoassay O 1 0.9962627291679382
. O 0 0.054456569254398346

Previous O 0 0.04213404655456543
family O 0 0.02761089988052845
studies O 0 0.015807053074240685
suggested O 0 0.012084947898983955
that O 0 0.006092288065701723
these O 0 0.004891019314527512
individuals O 0 0.005361105781048536
may O 0 0.007533848285675049
be O 0 0.008684437721967697
compound O 0 0.02794722095131874
heterozygotes O 0 0.06811843812465668
for O 0 0.011412215419113636
the O 0 0.013990107923746109
common O 0 0.0176125168800354
mutant O 1 0.8919970393180847
TSD B-Disease 1 0.9999994039535522
gene O 0 0.024149198085069656
and O 0 0.012916211038827896
a O 0 0.017130235210061073
rare O 0 0.1290266066789627
( O 0 0.028822455555200577
allelic O 1 0.9959283471107483
) O 0 0.03921724483370781
mutant O 0 0.08437991887331009
gene O 0 0.05249493941664696
. O 0 0.04826899245381355

Thus O 0 0.035332757979631424
, O 0 0.020801778882741928
the O 0 0.018733637407422066
postulated O 0 0.04114958271384239
rate O 0 0.021090658381581306
mutant O 0 0.0390278622508049
gene O 0 0.017758268862962723
appears O 0 0.014750191941857338
to O 0 0.008382902480661869
code O 0 0.01018668245524168
for O 0 0.007916027680039406
the O 0 0.010356707498431206
expression O 0 0.012327910400927067
of O 0 0.013559004291892052
low O 0 0.021881531924009323
amounts O 0 0.01891941763460636
of O 0 0.020488400012254715
hex O 0 0.089815653860569
A O 0 0.059081874787807465
. O 0 0.05615857616066933

Heterozygotes O 0 0.13147494196891785
for O 0 0.026938864961266518
the O 0 0.022160956636071205
rare O 0 0.04830975458025932
mutant O 0 0.1697607934474945
may O 0 0.018663356080651283
be O 0 0.014675178565084934
indistinguishable O 0 0.030948391184210777
from O 0 0.01702960953116417
heterozygotes O 0 0.05333136022090912
for O 0 0.01644870825111866
the O 0 0.02339276112616062
common O 0 0.054213978350162506
TSD B-Disease 1 0.9999996423721313
mutant O 1 0.96357262134552
. O 0 0.06396763026714325

However O 0 0.03797469288110733
, O 0 0.025006866082549095
direct O 0 0.02468055672943592
visualization O 0 0.050796326249837875
and O 0 0.021851927042007446
quantitation O 1 0.7244779467582703
of O 0 0.02082238905131817
hex O 0 0.06529536098241806
A O 0 0.021323762834072113
by O 0 0.009845062159001827
the O 0 0.012069376185536385
methods O 0 0.011141291819512844
described O 0 0.013324921950697899
may O 0 0.010972713120281696
prevent O 0 0.016501078382134438
false O 0 0.0246299896389246
- O 1 0.9999284744262695
positive O 0 0.022784898057579994
prenatal O 1 0.9999650716781616
diagnosis O 1 0.9999808073043823
of O 0 0.27303269505500793
TSD B-Disease 1 1.0
in O 0 0.02086559124290943
fetuses O 1 0.7348765730857849
having O 0 0.01644706539809704
the O 0 0.014631487429141998
incomplete O 0 0.023141996935009956
hex B-Disease 1 0.8635386824607849
A I-Disease 1 0.9805507659912109
deficiency I-Disease 1 1.0
of O 0 0.017735973000526428
the O 0 0.02049759030342102
type O 0 0.12674015760421753
described O 0 0.01895214058458805
in O 0 0.013542311266064644
the O 0 0.017902985215187073
four O 0 0.024037132039666176
healthy O 0 0.056995563209056854
individuals O 0 0.044849175959825516

The O 0 0.06865758448839188
tumor B-Disease 1 0.999992847442627
suppressor O 1 0.999884843826294
gene O 0 0.10394090414047241
Smad4 O 1 0.999994158744812
/ O 1 0.9999477863311768
Dpc4 O 1 0.9980394244194031
is O 0 0.013158135116100311
required O 0 0.01170069258660078
for O 0 0.013225261121988297
gastrulation O 1 0.9875167012214661
and O 0 0.013690482825040817
later O 0 0.017223848029971123
for O 0 0.016555948182940483
anterior O 1 0.9880304932594299
development O 0 0.020654330030083656
of O 0 0.01893644407391548
the O 0 0.029137499630451202
mouse O 1 0.8482337594032288
embryo O 0 0.07739482820034027
. O 0 0.05122743546962738

Mutations O 0 0.05170758068561554
in O 0 0.023134848102927208
the O 0 0.0331653468310833
SMAD4 O 1 0.9999936819076538
/ O 1 0.9999961853027344
DPC4 O 1 0.9999998807907104
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999359846115112
gene O 0 0.02977724000811577
, O 0 0.015227191150188446
a O 0 0.015850761905312538
key O 0 0.022405294701457024
signal O 0 0.023723939433693886
transducer O 0 0.04240928962826729
in O 0 0.01430663000792265
most O 0 0.017113398760557175
TGFbeta O 1 0.9999501705169678
- O 1 0.9999358654022217
related O 0 0.032678522169589996
pathways O 0 0.02499370649456978
, O 0 0.010850013233721256
are O 0 0.005631730891764164
involved O 0 0.007793874479830265
in O 0 0.007682766765356064
50 O 0 0.014735561795532703
% O 0 0.01697961613535881
of O 0 0.2751190960407257
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0683869868516922

Homozygous O 0 0.30151939392089844
Smad4 O 1 0.9997386336326599
mutant O 1 0.9924348592758179
mice O 1 0.9267149567604065
die O 0 0.43793267011642456
before O 0 0.028032097965478897
day O 0 0.035973645746707916
7 O 0 0.04908718913793564
. O 0 0.0485578253865242

5 O 0 0.08007752150297165
of O 0 0.06284642219543457
embryogenesis O 0 0.27344974875450134
. O 0 0.07893209159374237

Mutant O 0 0.0880524143576622
embryos O 0 0.03250303119421005
have O 0 0.012937767431139946
reduced O 0 0.020775437355041504
size O 0 0.01895574852824211
, O 0 0.013783439062535763
fail O 0 0.01824149861931801
to O 0 0.013966855593025684
gastrulate O 0 0.14186282455921173
or O 0 0.014988015405833721
express O 0 0.0243485439568758
a O 0 0.022783296182751656
mesodermal O 1 0.999815046787262
marker O 1 0.9973154664039612
, O 0 0.019787905737757683
and O 0 0.017995106056332588
show O 0 0.03608420491218567
abnormal O 1 0.9932467937469482
visceral O 1 0.9999692440032959
endoderm O 1 0.999990701675415
development O 0 0.17914791405200958
. O 0 0.07110606878995895

Growth B-Disease 1 0.8915702700614929
retardation I-Disease 1 0.9999555349349976
of O 0 0.026109972968697548
the O 0 0.040853116661310196
Smad4 O 1 0.9999996423721313
- O 1 0.9999961853027344
deficient O 1 0.9958198070526123
embryos O 0 0.018862774595618248
results O 0 0.013373796828091145
from O 0 0.010010899975895882
reduced O 0 0.02211306430399418
cell O 0 0.03472164273262024
proliferation O 0 0.03290139511227608
rather O 0 0.014222285710275173
than O 0 0.014816433191299438
increased O 0 0.02598590776324272
apoptosis O 0 0.3941958546638489
. O 0 0.04951753467321396

Aggregation O 0 0.08422119915485382
of O 0 0.04198987036943436
mutant O 1 0.6543900966644287
Smad4 O 1 0.9999798536300659
ES O 1 0.9999328851699829
cells O 0 0.02961171418428421
with O 0 0.019473502412438393
wild O 0 0.034948498010635376
- O 1 0.9993342757225037
type O 0 0.11219407618045807
tetraploid O 0 0.38645198941230774
morulae O 1 0.9982786178588867
rescues O 1 0.968980073928833
the O 0 0.05720899999141693
gastrulation B-Disease 1 0.9999861717224121
defect I-Disease 1 0.999920129776001
. O 0 0.08163143694400787

These O 0 0.022564778104424477
results O 0 0.021697450429201126
indicate O 0 0.017161116003990173
that O 0 0.012958456762135029
Smad4 O 1 0.9747226238250732
is O 0 0.011978426948189735
initially O 0 0.014184189029037952
required O 0 0.008952551521360874
for O 0 0.00916155893355608
the O 0 0.012700739316642284
differentiation O 0 0.021512964740395546
of O 0 0.015403500758111477
the O 0 0.022783134132623672
visceral O 1 0.9993311166763306
endoderm O 1 0.999854564666748
and O 0 0.0164477676153183
that O 0 0.01157206017524004
the O 0 0.01891147904098034
gastrulation B-Disease 1 0.9999376535415649
defect I-Disease 1 0.9960758090019226
in O 0 0.015881115570664406
the O 0 0.017439674586057663
epiblast O 1 0.9999877214431763
is O 0 0.016240600496530533
secondary O 0 0.026174206286668777
and O 0 0.01601543463766575
non O 0 0.3709236681461334
- O 1 0.9999620914459229
cell O 0 0.06173908710479736
autonomous O 0 0.06143088638782501
. O 0 0.05597782880067825

Rescued O 0 0.11629199236631393
embryos O 0 0.04389309510588646
show O 0 0.04549223929643631
severe O 1 0.9999991655349731
anterior O 1 0.9999998807907104
truncations O 1 0.9999996423721313
, O 0 0.028551602736115456
indicating O 0 0.021775467321276665
a O 0 0.01645556092262268
second O 0 0.019769713282585144
important O 0 0.013815724290907383
role O 0 0.01586965098977089
for O 0 0.016365639865398407
Smad4 O 1 0.998933732509613
in O 0 0.03071938455104828
anterior O 1 0.9999765157699585
patterning O 1 0.9999024868011475
during O 1 0.5305089354515076
embryogenesis O 1 0.9842489361763
. O 0 0.0665518194437027

Prevalence O 1 0.9319750070571899
of O 0 0.04459066689014435
p16 O 1 0.9936969876289368
and O 0 0.037859395146369934
CDK4 O 1 0.999915599822998
germline O 0 0.22038616240024567
mutations O 0 0.0315193310379982
in O 0 0.020340323448181152
48 O 1 0.8117693662643433
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999964237213135
families O 0 0.023223692551255226
in O 0 0.023012811318039894
France O 0 0.09510234743356705
. O 0 0.036777034401893616

The O 0 0.06588125973939896
French O 1 0.9948803186416626
Familial B-Disease 1 1.0
Melanoma I-Disease 1 1.0
Study O 1 0.9881001710891724
Group O 0 0.225254625082016
. O 0 0.05412886664271355

Germline O 0 0.46993333101272583
mutations O 0 0.03516393154859543
in O 0 0.016245637089014053
the O 0 0.019330762326717377
p16 O 1 0.9881568551063538
and O 0 0.022515779361128807
CDK4 O 1 0.9999773502349854
genes O 0 0.01657165214419365
have O 0 0.0081853698939085
been O 0 0.008886750787496567
reported O 0 0.009768099524080753
in O 0 0.007612216752022505
a O 0 0.011213663034141064
subset O 0 0.024351069703698158
of O 0 0.02235393412411213
melanoma B-Disease 1 1.0
pedigrees O 1 0.9970523118972778
, O 0 0.01311829499900341
but O 0 0.00889807753264904
their O 0 0.009606244042515755
prevalence O 1 0.9971300959587097
is O 0 0.010427008382976055
not O 0 0.010895177721977234
well O 0 0.017520684748888016
known O 0 0.030292648822069168
. O 0 0.04175479710102081

We O 0 0.03321921080350876
searched O 0 0.04067056626081467
for O 0 0.015070561319589615
such O 0 0.015098522417247295
germline O 0 0.04058819264173508
mutations O 0 0.0182447861880064
in O 0 0.011695428751409054
48 O 0 0.03116622380912304
French O 1 0.9988265633583069
melanoma B-Disease 1 1.0
- O 1 1.0
prone O 1 0.9999469518661499
families O 0 0.013081817887723446
selected O 0 0.013028162531554699
according O 0 0.006591313518583775
to O 0 0.006409873720258474
two O 0 0.005919211078435183
major O 0 0.010295585729181767
criteria O 0 0.011914701201021671
families O 0 0.008210686966776848
with O 0 0.006015119608491659
at O 0 0.008073195815086365
least O 0 0.005737961735576391
three O 0 0.005958223715424538
affected O 0 0.008946461603045464
members O 0 0.007238573860377073
( O 0 0.012514430098235607
n O 0 0.022691283375024796
= O 0 0.026141216978430748
20 O 0 0.015770861878991127
) O 0 0.01051324512809515
or O 0 0.007769643794745207
families O 0 0.0073273382149636745
with O 0 0.006497952621430159
two O 0 0.006144072860479355
affected O 0 0.009650809690356255
members O 0 0.0064943949691951275
, O 0 0.007220113184303045
one O 0 0.00628348533064127
of O 0 0.005772586911916733
them O 0 0.00568000553175807
affected O 0 0.008557909168303013
before O 0 0.007970063015818596
the O 0 0.00837192963808775
age O 0 0.009999286383390427
of O 0 0.008875776082277298
50 O 0 0.01486678421497345
( O 0 0.013564853928983212
n O 0 0.02723233588039875
= O 0 0.029913093894720078
28 O 0 0.022816698998212814
) O 0 0.013241040520370007
, O 0 0.011438255198299885
and O 0 0.01069005485624075
one O 0 0.01275274995714426
additional O 0 0.02250686287879944
minor O 0 0.3342367112636566
criterion O 1 0.9865639209747314
. O 0 0.0463840626180172

Sixteen O 0 0.09165146946907043
different O 0 0.031789977103471756
p16 O 0 0.17654699087142944
germline O 0 0.08969410508871078
mutations O 0 0.027593735605478287
were O 0 0.011706727556884289
found O 0 0.008996683172881603
in O 0 0.00914954673498869
21 O 0 0.013938607648015022
families O 0 0.00961298868060112
, O 0 0.01019754447042942
while O 0 0.009337042458355427
one O 0 0.011847715824842453
germline O 1 0.647956132888794
mutation O 0 0.02376013621687889
, O 0 0.018546920269727707
Arg24His O 1 0.9981706142425537
, O 0 0.01695173606276512
was O 0 0.018671130761504173
detected O 0 0.01891353167593479
in O 0 0.014664080925285816
the O 0 0.0255661029368639
CDK4 O 1 0.9999732971191406
gene O 0 0.04793855547904968
. O 0 0.042771827429533005

The O 0 0.03655284643173218
frequency O 0 0.028682196512818336
of O 0 0.025770671665668488
p16 O 1 0.9224955439567566
gene O 0 0.02424115501344204
mutation O 0 0.019888395443558693
in O 0 0.010418308898806572
our O 0 0.011841253377497196
sample O 0 0.012552092783153057
( O 0 0.014026807621121407
44 O 0 0.024718867614865303
% O 0 0.015271837823092937
) O 0 0.010684600099921227
is O 0 0.00814761221408844
among O 0 0.008945518173277378
the O 0 0.008994605392217636
highest O 0 0.01580789126455784
rates O 0 0.011157341301441193
yet O 0 0.009384780190885067
reported O 0 0.011158693581819534
and O 0 0.00831244420260191
the O 0 0.013563718646764755
CDK4 O 1 0.9999790191650391
mutation O 0 0.01785089448094368
is O 0 0.00981467217206955
the O 0 0.010926731862127781
second O 0 0.02132578007876873
mutation O 0 0.02044493518769741
detected O 0 0.016886256635189056
in O 0 0.01159652043133974
this O 0 0.012676766142249107
gene O 0 0.02776636742055416
worldwide O 0 0.037009097635746
. O 0 0.04539286345243454

In O 0 0.03193751722574234
summary O 0 0.0335380919277668
, O 0 0.016853103414177895
our O 0 0.015495703555643559
results O 0 0.014125472865998745
show O 0 0.014071562327444553
frequent O 0 0.014953630976378918
involvement O 0 0.016473622992634773
of O 0 0.010558945126831532
the O 0 0.014538570307195187
p16 O 1 0.990968644618988
gene O 0 0.01989496685564518
in O 0 0.019764214754104614
familial B-Disease 1 0.9999997615814209
melanoma I-Disease 1 1.0
and O 0 0.022966330870985985
confirm O 0 0.01693674735724926
the O 0 0.01091714110225439
role O 0 0.012376717291772366
of O 0 0.010430064052343369
the O 0 0.014072991907596588
CDK4 O 1 0.9999587535858154
gene O 0 0.015015874989330769
as O 0 0.012833507731556892
a O 0 0.27468642592430115
melanoma B-Disease 1 1.0
- O 1 1.0
predisposing O 1 0.9999936819076538
gene O 0 0.041602540761232376
. O 0 0.030234964564442635
. O 0 0.04208314046263695

Progression O 0 0.48419857025146484
of O 0 0.04864531382918358
somatic O 1 0.8269427418708801
CTG O 1 0.9996023774147034
repeat O 0 0.05149517580866814
length O 0 0.027396658435463905
heterogeneity O 0 0.03780174255371094
in O 0 0.01314831804484129
the O 0 0.015928223729133606
blood O 1 0.6261748671531677
cells O 0 0.07254213839769363
of O 1 0.9920521974563599
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9128932356834412

The O 0 0.03466986492276192
genetic O 0 0.0260502677410841
basis O 0 0.020263008773326874
of O 0 0.11728426814079285
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.025606369599699974
is O 0 0.014779241755604744
the O 0 0.012101330794394016
expansion O 0 0.019072625786066055
of O 0 0.014996557496488094
an O 0 0.020599156618118286
unstable O 1 0.9992357492446899
CTG O 1 0.9999793767929077
repeat O 0 0.03556475788354874
in O 0 0.016088789328932762
the O 0 0.015902405604720116
34 O 0 0.03191189095377922
UTR O 0 0.08318733423948288
of O 0 0.02254839800298214
the O 0 0.03169349581003189
DM B-Disease 1 1.0
protein O 0 0.07508369535207748
kinase O 0 0.07342451810836792
gene O 0 0.027453510090708733
on O 0 0.0250406377017498
chromosome O 0 0.049381155520677567
19 O 0 0.059327442198991776
. O 0 0.05347802862524986

One O 0 0.025041017681360245
of O 0 0.014943069778382778
the O 0 0.013594644144177437
principal O 0 0.01720896176993847
features O 0 0.013606082648038864
of O 0 0.011688011698424816
the O 0 0.23288755118846893
DM B-Disease 1 1.0
mutation O 1 0.6492301225662231
is O 0 0.011306854896247387
an O 0 0.010621252469718456
extraordinarily O 0 0.06740837544202805
high O 0 0.0160160381346941
level O 0 0.01301791612058878
of O 0 0.01536159124225378
somatic O 1 0.8736070394515991
mosaicism O 1 0.9998682737350464
, O 0 0.01429142989218235
due O 0 0.010046477429568768
to O 0 0.008774644695222378
an O 0 0.010163295082747936
extremely O 0 0.013582603074610233
high O 0 0.015854205936193466
degree O 0 0.016943538561463356
of O 0 0.014450703747570515
somatic O 0 0.1717536896467209
instability O 0 0.09720925986766815
both O 0 0.010511222295463085
within O 0 0.009350672364234924
and O 0 0.012052744626998901
between O 0 0.014589404687285423
different O 0 0.016418570652604103
tissues O 0 0.19643059372901917
. O 0 0.04214348644018173

This O 0 0.037841904908418655
instability O 0 0.10370827466249466
appears O 0 0.025943497195839882
to O 0 0.012457247823476791
be O 0 0.010163025930523872
biased O 0 0.01938742585480213
towards O 0 0.012199567630887032
further O 0 0.011421789415180683
expansion O 0 0.017848538234829903
and O 0 0.010923754423856735
continuous O 0 0.013746443204581738
throughout O 0 0.010168909095227718
the O 0 0.010403167456388474
life O 0 0.011574558913707733
of O 0 0.007682643365114927
an O 0 0.007874606177210808
individual O 0 0.008645910769701004
, O 0 0.009074230678379536
features O 0 0.009881534613668919
that O 0 0.005356567446142435
could O 0 0.007125819101929665
be O 0 0.005715302191674709
associated O 0 0.008384885266423225
with O 0 0.006315573118627071
the O 0 0.00923254992812872
progressive O 0 0.4601389765739441
nature O 0 0.01689218543469906
of O 0 0.019278448075056076
the O 1 0.8556573390960693
disease O 1 0.9999998807907104
. O 0 0.05687996372580528

Although O 0 0.03618147596716881
increasing O 0 0.02864173613488674
measured O 0 0.027911782264709473
allele O 0 0.03312108665704727
size O 0 0.022919751703739166
between O 0 0.01495919469743967
patients O 1 0.6874465942382812
clearly O 0 0.01628880389034748
correlates O 0 0.022463418543338776
with O 0 0.007983190007507801
an O 0 0.00862925872206688
increased O 0 0.016484029591083527
severity O 1 0.9999606609344482
of O 1 0.8308336734771729
symptoms O 1 0.9999998807907104
and O 0 0.010114248842000961
an O 0 0.008580722846090794
earlier O 0 0.010842381976544857
age O 0 0.013897992670536041
of O 0 0.01576204225420952
onset O 1 0.999998927116394
, O 0 0.011889975517988205
this O 0 0.00874242838472128
correlation O 0 0.011865083128213882
is O 0 0.00706489197909832
not O 0 0.005779301282018423
precise O 0 0.009659290313720703
and O 0 0.008211067877709866
measured O 0 0.012590175494551659
allele O 0 0.0222560316324234
length O 0 0.012697456404566765
cannot O 0 0.00900570023804903
be O 0 0.006160656455904245
used O 0 0.007709926925599575
as O 0 0.007410530466586351
an O 0 0.00856860913336277
accurate O 0 0.01726682484149933
predictor O 0 0.04419977217912674
of O 0 0.014685076661407948
age O 0 0.023021239787340164
of O 0 0.02872384712100029
onset O 1 0.9999990463256836
. O 0 0.057551056146621704

In O 0 0.030080977827310562
order O 0 0.020912013947963715
to O 0 0.015946583822369576
further O 0 0.015287457033991814
characterize O 0 0.031535450369119644
the O 0 0.019474420696496964
dynamics O 0 0.0449487529695034
of O 0 0.03597097098827362
DM B-Disease 1 1.0
CTG O 1 0.9999996423721313
repeat O 1 0.997952938079834
somatic O 1 0.9476882815361023
instability O 1 0.9596642851829529
, O 0 0.015131375752389431
we O 0 0.009139889851212502
have O 0 0.0073545509949326515
studied O 0 0.014776595868170261
repeat O 0 0.019594985991716385
length O 0 0.011829759925603867
changes O 0 0.008825997821986675
over O 0 0.00951641146093607
time O 0 0.010722261853516102
in O 0 0.015521547757089138
111 O 1 0.9999574422836304
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9999978542327881
with O 0 0.021011944860219955
varying O 0 0.02723212167620659
clinical O 1 0.999995231628418
severity O 1 0.9999806880950928
and O 0 0.1570475995540619
CTG O 1 0.9999781847000122
repeat O 0 0.04230204224586487
size O 0 0.02107427641749382
over O 0 0.012394752353429794
time O 0 0.010430941358208656
intervals O 0 0.013723422773182392
of O 0 0.011912070214748383
1 O 0 0.02723636105656624
- O 1 0.9121999144554138
7 O 0 0.03771460801362991
years O 0 0.03404472768306732
. O 0 0.043594371527433395

We O 0 0.02465444803237915
have O 0 0.013307981193065643
found O 0 0.01288652140647173
a O 0 0.013624140992760658
direct O 0 0.01437057089060545
progression O 0 0.02532808482646942
of O 0 0.011378271505236626
the O 0 0.011855649761855602
size O 0 0.020364634692668915
heterogeneity O 0 0.027514230459928513
over O 0 0.012528952211141586
time O 0 0.010966571979224682
related O 0 0.01158165279775858
to O 0 0.010366512462496758
initial O 0 0.023158781230449677
CTG O 1 0.9997482895851135
repeat O 0 0.031965792179107666
size O 0 0.019032593816518784
and O 0 0.010400635190308094
the O 0 0.01079814787954092
time O 0 0.01399691216647625
interval O 0 0.023321447893977165
and O 0 0.014005825854837894
always O 0 0.01968654803931713
biased O 0 0.02323220670223236
towards O 0 0.022663511335849762
further O 0 0.022730592638254166
expansion O 0 0.05468791350722313
. O 0 0.047350384294986725

Attempts O 0 0.03800109401345253
to O 0 0.020013628527522087
mathematically O 0 0.03390525281429291
model O 0 0.021425604820251465
the O 0 0.01415038388222456
dynamics O 0 0.023867610841989517
have O 0 0.008810167200863361
proved O 0 0.01472360547631979
only O 0 0.009123308584094048
partially O 0 0.01903238147497177
successful O 0 0.014377814717590809
suggesting O 0 0.010984041728079319
that O 0 0.005130067467689514
individual O 0 0.00650241831317544
specific O 0 0.006374467629939318
genetic O 0 0.011643222533166409
and O 0 0.046647872775793076
/ O 1 0.9999855756759644
or O 0 0.011080737225711346
environmental O 0 0.01828511618077755
factors O 0 0.01003560796380043
also O 0 0.008982916362583637
play O 0 0.011175057850778103
a O 0 0.012570842169225216
role O 0 0.019079215824604034
in O 0 0.020227476954460144
somatic O 1 0.8869464993476868
mosaicism O 1 0.9998127818107605
. O 0 0.042449403554201126
. O 0 0.05071280151605606

Aspartylglucosaminuria B-Disease 1 0.999798595905304
among O 0 0.04916269704699516
Palestinian O 0 0.05969228968024254
Arabs O 0 0.07672426104545593
. O 0 0.06613427400588989

Aspartylglucosaminuria B-Disease 1 0.9999991655349731
( O 1 0.9442768692970276
AGU B-Disease 1 1.0
) O 0 0.023603294044733047
is O 0 0.014437263831496239
a O 0 0.017238890752196312
rare O 1 0.9849444031715393
disorder B-Disease 1 0.9999998807907104
of I-Disease 1 0.9951831698417664
glycoprotein I-Disease 1 1.0
metabolism I-Disease 1 0.9999732971191406
caused O 0 0.18885686993598938
by O 0 0.012762382626533508
the O 0 0.03886635601520538
deficiency B-Disease 1 1.0
of I-Disease 0 0.04118240252137184
the I-Disease 1 0.85640949010849
lysosomal I-Disease 1 1.0
enzyme I-Disease 1 0.9983779191970825
aspartylglucosaminidase I-Disease 1 0.9999953508377075
( O 1 0.5199031829833984
AGA O 1 0.9999997615814209
) O 0 0.05373908951878548
. O 0 0.053242750465869904

AGU B-Disease 1 0.9999997615814209
is O 0 0.04089393839240074
inherited O 1 0.9992309808731079
as O 0 0.015521570108830929
an O 0 0.03767974302172661
autosomal O 1 1.0
recessive O 1 1.0
trait O 1 0.9999995231628418
and O 0 0.12586800754070282
occurs O 0 0.009974129498004913
with O 0 0.007528909016400576
a O 0 0.011371166445314884
high O 0 0.015310668386518955
frequency O 0 0.012585174292325974
in O 0 0.010448921471834183
Finland O 0 0.026511147618293762
because O 0 0.011579092592000961
of O 0 0.012910053133964539
a O 0 0.0229022353887558
founder O 1 0.9949949979782104
effect O 0 0.03587225452065468
. O 0 0.04289102554321289

While O 0 0.03136053308844566
very O 0 0.01740783452987671
few O 0 0.018449679017066956
patients O 1 0.9747408628463745
with O 0 0.028354493901133537
AGU B-Disease 1 1.0
have O 0 0.009277326054871082
been O 0 0.008064058609306812
reported O 0 0.009511436335742474
from O 0 0.007288394495844841
non O 0 0.017237113788723946
- O 1 0.99836665391922
Finnish O 1 0.859642744064331
origin O 0 0.011113987304270267
, O 0 0.010676342993974686
we O 0 0.011790958233177662
diagnosed O 1 0.9999985694885254
the O 0 0.08841779828071594
disorder O 1 0.9999997615814209
in O 0 0.022212112322449684
8 O 0 0.3567693531513214
patients O 1 0.9360193014144897
originating O 0 0.01661444827914238
from O 0 0.010863034054636955
3 O 0 0.017636248841881752
unrelated O 0 0.01797325164079666
families O 0 0.010558799840509892
, O 0 0.0077970088459551334
all O 0 0.006810174789279699
Palestinian O 0 0.012417029589414597
Arabs O 0 0.016615331172943115
from O 0 0.0128261037170887
the O 0 0.014873226173222065
region O 0 0.022248489782214165
of O 0 0.025407275184988976
Jerusalem O 0 0.08578677475452423
. O 0 0.04959630221128464

The O 0 0.0464458242058754
clinical O 1 0.9997617602348328
diagnosis O 1 0.9999992847442627
of O 1 0.9961612224578857
AGU B-Disease 1 1.0
is O 0 0.0764555111527443
often O 0 0.011572218500077724
difficult O 0 0.011216195300221443
, O 0 0.00932917557656765
in O 0 0.006508828140795231
particular O 0 0.006508421618491411
early O 0 0.0065894341096282005
in O 0 0.005846467334777117
the O 0 0.006511677987873554
course O 0 0.01097419299185276
of O 0 0.008096988312900066
the O 0 0.04450133070349693
disease O 1 0.9999998807907104
, O 0 0.007761270273476839
and O 0 0.0053374250419437885
most O 0 0.005127242766320705
of O 0 0.0060597932897508144
the O 0 0.014597702771425247
patients O 1 0.999976634979248
are O 0 0.009419282898306847
diagnosed O 1 0.9999997615814209
after O 0 0.012715019285678864
the O 0 0.011567337438464165
age O 0 0.016508059576153755
of O 0 0.0156529750674963
5 O 0 0.027675727382302284
years O 0 0.030113358050584793
. O 0 0.04156307503581047

However O 0 0.02999102883040905
, O 0 0.019354738295078278
since O 0 0.016332732513546944
these O 0 0.012524840421974659
patients O 1 0.8830552697181702
excrete O 1 0.9609196186065674
early O 0 0.017531711608171463
large O 0 0.013308919966220856
amounts O 0 0.012476456351578236
of O 0 0.012529158033430576
aspartylglucosamine O 1 0.9245790839195251
in O 0 0.015535660088062286
urine O 0 0.02998349815607071
, O 0 0.017770016565918922
biochemical O 0 0.03549635410308838
screening O 0 0.02779586799442768
is O 0 0.015450404956936836
easy O 0 0.021498503163456917
by O 0 0.016960997134447098
urine O 0 0.09710804373025894
chromatography O 1 0.5677663087844849
. O 0 0.03801911324262619
. O 0 0.04785864055156708

Detection O 0 0.0758904367685318
of O 0 0.031972650438547134
heterozygous O 0 0.04251264035701752
carriers O 0 0.03054814040660858
of O 0 0.01954730786383152
the O 0 0.030195506289601326
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.4274168610572815
ATM O 1 0.967552900314331
) O 0 0.023298390209674835
gene O 0 0.021991901099681854
by O 0 0.02018127590417862
G2 O 1 0.9999451637268066
phase O 0 0.0689922496676445
chromosomal O 1 0.5854340195655823
radiosensitivity O 1 0.9994263648986816
of O 1 0.7956892251968384
peripheral O 1 1.0
blood O 1 0.9999932050704956
lymphocytes O 1 0.9999817609786987
. O 0 0.06370729207992554

In O 0 0.06158741936087608
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.0338992141187191
A B-Disease 1 0.9999493360519409
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.026074079796671867
patients O 1 0.8888087272644043
, O 0 0.01304095983505249
mutations O 0 0.012202797457575798
in O 0 0.0076519218273460865
a O 0 0.010202956385910511
single O 0 0.01351993903517723
gene O 0 0.013438580557703972
, O 0 0.011638143099844456
ATM O 0 0.030336184427142143
, O 0 0.009763624519109726
result O 0 0.007788381073623896
in O 0 0.00845638383179903
an O 0 0.08624675124883652
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 0.2807336449623108
embraces O 1 0.9991455078125
a O 0 0.015100458636879921
variety O 0 0.01332168746739626
of O 0 0.013065692037343979
clinical O 1 0.9997456669807434
features O 0 0.027684008702635765
and O 0 0.018867027014493942
manifests O 1 0.9283030033111572
extreme O 1 0.9295809268951416
radiosensitivity O 1 0.999494194984436
and O 0 0.014421024359762669
a O 0 0.014872638508677483
strong O 0 0.021369611844420433
pre O 1 0.9995177984237671
- O 1 0.9999891519546509
disposition O 1 0.9891121983528137
to O 0 0.04459083080291748
malignancy B-Disease 1 0.9999935626983643
. O 0 0.056834932416677475

Heterozygotes O 0 0.10886970907449722
for O 0 0.022234657779335976
the O 0 0.021751737222075462
ATM O 1 0.7900513410568237
gene O 0 0.016305185854434967
have O 0 0.007618733216077089
no O 0 0.009374156594276428
clinical O 0 0.01858380250632763
expression O 0 0.010362834669649601
of O 0 0.010962942615151405
A B-Disease 1 0.9999887943267822
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 0.009537617675960064
may O 0 0.01006124448031187
be O 0 0.012487153522670269
cancer B-Disease 1 0.9999994039535522
prone O 1 0.9953436255455017
with O 0 0.011208508163690567
a O 0 0.014763806015253067
moderate O 0 0.0338730663061142
increase O 0 0.015036355704069138
in O 0 0.01608692668378353
in O 0 0.02384760230779648
vitro O 0 0.11665497720241547
radiosensitivity O 1 0.9010685086250305
. O 0 0.06691782176494598

We O 0 0.0337102897465229
performed O 0 0.03268678858876228
a O 0 0.02583438903093338
blind O 0 0.050612397491931915
chromosomal O 0 0.0401422381401062
analysis O 0 0.017464594915509224
on O 0 0.021642697975039482
G2 O 1 0.9999997615814209
- O 1 0.9999728202819824
phase O 0 0.06489943712949753
lymphocytes O 0 0.05569455027580261
from O 0 0.015349463559687138
7 O 0 0.02220539003610611
unrelated O 0 0.024250121787190437
A B-Disease 1 0.9947852492332458
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.8936952352523804
, O 0 0.01684960536658764
13 O 0 0.022318553179502487
obligate O 0 0.03930343687534332
A B-Disease 1 0.9986315369606018
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
heterozygotes O 1 0.9821471571922302
( O 0 0.017588067799806595
parents O 0 0.013551970943808556
of O 0 0.010035119950771332
the O 0 0.01369575597345829
patients O 1 0.9988664388656616
) O 0 0.010643071494996548
, O 0 0.009283937513828278
and O 0 0.008175017312169075
14 O 0 0.011407765559852123
normal O 0 0.010908334515988827
controls O 0 0.017314741387963295
following O 0 0.012817134149372578
X O 1 0.9229179620742798
- O 1 0.9643850922584534
irradiation O 0 0.039695657789707184
with O 0 0.01776714436709881
1 O 0 0.030987346544861794
Gy O 1 0.9995692372322083
in O 0 0.013298618607223034
order O 0 0.01314935740083456
to O 0 0.01201771292835474
evaluate O 0 0.025743450969457626
this O 0 0.013155645690858364
cytogenetic O 0 0.049929179251194
method O 0 0.015605488792061806
as O 0 0.012199273332953453
a O 0 0.015889590606093407
tool O 0 0.02384078875184059
for O 0 0.013194113969802856
detection O 0 0.0306625347584486
of O 0 0.024936184287071228
ATM O 1 0.9942730069160461
carriers O 0 0.19820992648601532
. O 0 0.049356915056705475

Both O 0 0.03752294182777405
A B-Disease 1 0.9818934202194214
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999998807907104
homozygotes O 1 0.9996752738952637
and O 0 0.027909928932785988
heterozygotes O 0 0.27510973811149597
showed O 0 0.02190403640270233
significantly O 0 0.016234515234827995
increased O 0 0.011118756607174873
levels O 0 0.011642455123364925
of O 0 0.013819336891174316
radiation O 1 0.9999856948852539
- O 1 0.9999998807907104
induced O 1 0.9999991655349731
chromatid O 1 0.9999985694885254
damage O 1 0.9526520371437073
relative O 0 0.018803885206580162
to O 0 0.011484560556709766
that O 0 0.009117052890360355
of O 0 0.014460554346442223
normal O 0 0.024809764698147774
controls O 0 0.04843992367386818
. O 0 0.04093565046787262

These O 0 0.021743420511484146
results O 0 0.019111698493361473
show O 0 0.012949439696967602
that O 0 0.008872621692717075
the O 0 0.017046082764863968
G2 O 1 0.9999998807907104
- O 1 0.9999924898147583
phase O 1 0.8627060055732727
chromosomal O 1 0.9977008700370789
radiosensitivity O 1 0.9999531507492065
assay O 0 0.04985421523451805
can O 0 0.009717226959764957
be O 0 0.00740328012034297
used O 0 0.007401577662676573
for O 0 0.0072843520902097225
the O 0 0.01030435599386692
detection O 0 0.01915617473423481
of O 0 0.01670128107070923
A B-Disease 1 0.9999339580535889
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
heterozygotes O 1 0.9916364550590515
. O 0 0.06386774778366089

In O 0 0.03603680059313774
combination O 0 0.03371905907988548
with O 0 0.0173021387308836
molecular O 0 0.022732457146048546
genetic O 0 0.0187244713306427
analyses O 0 0.016668910160660744
, O 0 0.010652007535099983
this O 0 0.006880149710923433
test O 0 0.013526713475584984
may O 0 0.007617182098329067
be O 0 0.005478500388562679
of O 0 0.006568012293428183
value O 0 0.0070524369366467
in O 0 0.006743328645825386
studies O 0 0.008507802151143551
of O 0 0.009829173795878887
familial B-Disease 1 0.9999057054519653
and I-Disease 0 0.019069712609052658
sporadic I-Disease 1 0.9809462428092957
cancers I-Disease 1 0.9999967813491821
aimed O 0 0.02839590422809124
at O 0 0.015304658561944962
determination O 0 0.019085021689534187
of O 0 0.010462518781423569
the O 0 0.011183989234268665
potential O 0 0.015216933563351631
involvement O 0 0.01589297689497471
of O 0 0.013241680338978767
ATM O 1 0.9549953937530518
mutations O 0 0.02002069726586342
in O 0 0.02068251185119152
tumor B-Disease 1 0.9999998807907104
risk O 1 0.9992004036903381
or O 0 0.018330739811062813
development O 0 0.046265676617622375
. O 0 0.026691263541579247
. O 0 0.04250200465321541

Ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999991655349731
: O 0 0.03171844780445099
identification O 0 0.02104855515062809
and O 0 0.013490404933691025
detection O 0 0.021809129044413567
of O 0 0.01578730158507824
founder O 1 0.9999822378158569
- O 1 0.9999750852584839
effect O 0 0.01794067583978176
mutations O 0 0.01552808377891779
in O 0 0.01049901358783245
the O 0 0.015709126368165016
ATM O 1 0.606306254863739
gene O 0 0.020123295485973358
in O 0 0.016299480572342873
ethnic O 0 0.021079642698168755
populations O 0 0.02794443629682064
. O 0 0.04003638029098511

To O 0 0.03493029251694679
facilitate O 0 0.03200015798211098
the O 0 0.02016746997833252
evaluation O 0 0.03230684995651245
of O 0 0.02231571637094021
ATM O 1 0.8500043749809265
heterozygotes O 0 0.3178100287914276
for O 0 0.015822207555174828
susceptibility O 1 0.5020199418067932
to O 0 0.010278352536261082
other O 0 0.010215464048087597
diseases O 1 0.9999990463256836
, O 0 0.00902106799185276
such O 0 0.008400028571486473
as O 1 0.9989728927612305
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.01672128401696682
we O 0 0.008242901414632797
have O 0 0.0070144920609891415
attempted O 0 0.013374364003539085
to O 0 0.008018271997570992
define O 0 0.012382512912154198
the O 0 0.00930484663695097
most O 0 0.00933238584548235
common O 0 0.009857239201664925
mutations O 0 0.01166931539773941
and O 0 0.006671683397144079
their O 0 0.006594677921384573
frequencies O 0 0.012410646304488182
in O 0 0.01684427261352539
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.03712737560272217
A B-Disease 1 0.9998948574066162
- I-Disease 1 1.0
T I-Disease 1 0.9999997615814209
) O 0 0.02988170087337494
homozygotes O 0 0.0774119570851326
from O 0 0.018176238983869553
10 O 0 0.022934606298804283
ethnic O 0 0.024773309007287025
populations O 0 0.028251079842448235
. O 0 0.042164579033851624

Both O 0 0.03841416537761688
genomic O 0 0.06520957499742508
mutations O 0 0.030826793983578682
and O 0 0.015024525113403797
their O 0 0.012617651373147964
effects O 0 0.0231942068785429
on O 0 0.01820782572031021
cDNA O 0 0.049847640097141266
were O 0 0.023815788328647614
characterized O 0 0.046213600784540176
. O 0 0.04356730356812477

Protein O 0 0.0848931074142456
- O 1 0.7809149026870728
truncation O 0 0.07067686319351196
testing O 0 0.033723074942827225
of O 0 0.01786447875201702
the O 0 0.017221298068761826
entire O 0 0.030251409858465195
ATM O 0 0.05688781663775444
cDNA O 0 0.050193432718515396
detected O 0 0.02929680608212948
92 O 0 0.04330779239535332
( O 0 0.020279763266444206
66 O 0 0.03788752853870392
% O 0 0.01943734474480152
) O 0 0.020938800647854805
truncating O 0 0.06466972082853317
mutations O 0 0.024829590693116188
in O 0 0.018258167430758476
140 O 0 0.04689989611506462
mutant O 0 0.10664744675159454
alleles O 0 0.07075471431016922
screened O 0 0.08611175417900085
. O 0 0.05769693851470947

The O 0 0.04402728006243706
haplotyping O 1 0.7625697255134583
of O 0 0.023092113435268402
patients O 1 0.8900862336158752
with O 0 0.013354087248444557
identical O 0 0.02336294576525688
mutations O 0 0.015178903006017208
indicates O 0 0.012077503837645054
that O 0 0.005756086204200983
almost O 0 0.006336714141070843
all O 0 0.005570585839450359
of O 0 0.006316748913377523
these O 0 0.005092845298349857
represent O 0 0.008435538969933987
common O 0 0.009462292306125164
ancestry O 0 0.012355666607618332
and O 0 0.009444218128919601
that O 0 0.007271247450262308
very O 0 0.01220424473285675
few O 0 0.01857779361307621
spontaneously O 0 0.06315834075212479
recurring O 1 0.9985652565956116
ATM O 1 0.9994578957557678
mutations O 0 0.046784739941358566
exist O 0 0.028598742559552193
. O 0 0.041780129075050354

Assays O 0 0.09288742393255234
requiring O 0 0.0398513600230217
minimal O 0 0.041718874126672745
amounts O 0 0.019521644338965416
of O 0 0.01653214544057846
genomic O 0 0.0330156609416008
DNA O 0 0.018472526222467422
were O 0 0.009454072453081608
designed O 0 0.01724478229880333
to O 0 0.010580168105661869
allow O 0 0.01375726517289877
rapid O 0 0.027254730463027954
screening O 0 0.028569627553224564
for O 0 0.01712295413017273
common O 0 0.021849237382411957
ethnic O 0 0.027911748737096786
mutations O 0 0.04604148864746094
. O 0 0.04523605853319168

These O 0 0.032134562730789185
rapid O 0 0.05029265210032463
assays O 0 0.052815355360507965
detected O 0 0.0310361310839653
mutations O 0 0.0226841252297163
in O 0 0.012516800314188004
76 O 0 0.03155040740966797
% O 0 0.014565628953278065
of O 0 0.013620655983686447
Costa O 0 0.09590627998113632
Rican O 1 0.9646533131599426
patients O 1 0.9978868365287781
( O 0 0.015937209129333496
3 O 0 0.017766395583748817
) O 0 0.011997759342193604
, O 0 0.010889762081205845
50 O 0 0.014368660748004913
% O 0 0.010344951413571835
of O 0 0.011311503127217293
Norwegian O 0 0.11675779521465302
patients O 1 0.9884393215179443
( O 0 0.014037271030247211
1 O 0 0.019674547016620636
) O 0 0.011288531124591827
, O 0 0.009373663924634457
25 O 0 0.012452163733541965
% O 0 0.009199628606438637
of O 0 0.01074542198330164
Polish O 1 0.9999574422836304
patients O 1 0.9998370409011841
( O 0 0.016502749174833298
4 O 0 0.01970595307648182
) O 0 0.012161890044808388
, O 0 0.010417385026812553
and O 0 0.007792067248374224
14 O 0 0.012638567946851254
% O 0 0.009662579745054245
of O 0 0.009939726442098618
Italian O 1 0.9990691542625427
patients O 1 0.9999665021896362
( O 0 0.016177762299776077
1 O 0 0.020516451448202133
) O 0 0.011479456909000874
, O 0 0.009698808193206787
as O 0 0.009142491035163403
well O 0 0.009631841443479061
as O 0 0.009623675607144833
in O 0 0.010579988360404968
patients O 0 0.05103898048400879
of O 0 0.0178521741181612
Amish O 1 0.9981198906898499
/ O 1 0.9996260404586792
Mennonite O 0 0.46503257751464844
and O 0 0.02347688563168049
Irish O 0 0.040766991674900055
English O 0 0.03534755855798721
backgrounds O 0 0.0465204082429409
. O 0 0.046024393290281296

Additional O 0 0.052625447511672974
mutations O 0 0.03140756115317345
were O 0 0.013129280880093575
observed O 0 0.01321354229003191
in O 0 0.01244654692709446
Japanese O 0 0.027103299275040627
, O 0 0.014980034902691841
Utah O 0 0.03281361609697342
Mormon O 0 0.0356583409011364
, O 0 0.014294802211225033
and O 0 0.01355874352157116
African O 0 0.05108338221907616
American O 0 0.4742646813392639
patients O 1 0.9992132186889648
. O 0 0.0441865548491478

These O 0 0.024585822597146034
assays O 0 0.03240405023097992
should O 0 0.012709537521004677
facilitate O 0 0.01701194792985916
screening O 0 0.02134222723543644
for O 0 0.013053671456873417
A B-Disease 1 0.9987642765045166
- I-Disease 1 1.0
T I-Disease 1 0.9999996423721313
heterozygotes O 1 0.7009015083312988
in O 0 0.015453488565981388
the O 0 0.0169425867497921
populations O 0 0.01857145130634308
studied O 0 0.03113703988492489
. O 0 0.02587096393108368
. O 0 0.041969407349824905

The O 0 0.05459887906908989
von B-Disease 1 0.9911403059959412
Hippel I-Disease 1 0.999998927116394
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9999998807907104
suppressor O 1 0.9999419450759888
gene O 0 0.0261943731456995
is O 0 0.01141031738370657
required O 0 0.010894416831433773
for O 0 0.013114647008478642
cell O 0 0.025959238409996033
cycle O 0 0.02818397432565689
exit O 0 0.03875535726547241
upon O 0 0.03229131922125816
serum O 1 0.9961581826210022
withdrawal O 0 0.25257307291030884
. O 0 0.05342251807451248

The O 0 0.046071525663137436
inactivation O 0 0.19762541353702545
of O 0 0.02611338347196579
the O 0 0.028040381148457527
von B-Disease 1 0.9987683892250061
Hippel I-Disease 1 0.9999996423721313
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.9999995231628418
( I-Disease 0 0.3359047472476959
VHL I-Disease 1 0.9999998807907104
) I-Disease 0 0.23578524589538574
tumor I-Disease 1 0.9999986886978149
suppressor O 1 0.9999768733978271
gene O 0 0.04241485893726349
predisposes O 1 0.9727007150650024
affected O 0 0.017470119521021843
individuals O 0 0.007545908913016319
to O 0 0.009129906073212624
the O 0 0.012226899154484272
human O 1 0.9967727065086365
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9915698766708374
is O 0 0.012129032984375954
associated O 0 0.011101861484348774
with O 0 0.012696477584540844
sporadic B-Disease 1 0.9999300241470337
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 1 0.9999909400939941
RCC B-Disease 1 1.0
) O 0 0.2810150682926178
and O 0 0.1064191684126854
brain B-Disease 1 0.9996956586837769
hemangioblastomas I-Disease 1 0.999731719493866
. O 0 0.06371608376502991

VHL O 1 0.9999479055404663
- O 1 0.9921314120292664
negative O 0 0.0534234493970871
786 O 1 0.9989676475524902
- O 1 0.9999808073043823
0 O 0 0.2600748836994171
RCC B-Disease 1 0.9999995231628418
cells O 0 0.030958672985434532
are O 0 0.0133547717705369
tumorigenic O 1 0.734286904335022
in O 0 0.021078718826174736
nude O 1 0.9991451501846313
mice O 0 0.0964721217751503
which O 0 0.012349765747785568
is O 0 0.011828025802969933
suppressed O 0 0.025175927206873894
by O 0 0.011252633295953274
the O 0 0.017631905153393745
reintroduction O 1 0.6254738569259644
of O 0 0.04501719027757645
VHL B-Disease 1 0.9999959468841553
. O 0 0.07165800780057907

Remarkably O 0 0.39014968276023865
, O 0 0.022668588906526566
this O 0 0.012788411229848862
occurs O 0 0.012114050798118114
without O 0 0.00993069726973772
affecting O 0 0.01509134192019701
the O 0 0.010451223701238632
growth O 0 0.013530862517654896
rate O 0 0.010290360078215599
and O 0 0.010799778625369072
cell O 0 0.01771252229809761
cycle O 0 0.01677762344479561
profile O 0 0.019958538934588432
of O 0 0.011583181098103523
these O 0 0.009906016290187836
cells O 0 0.01694575324654579
in O 0 0.017186112701892853
culture O 0 0.037596117705106735
. O 0 0.044289689511060715

The O 0 0.04964541643857956
786 O 1 0.9780060052871704
- O 1 0.9988645315170288
0 O 0 0.0414065346121788
cell O 0 0.026009900495409966
line O 0 0.020971043035387993
, O 0 0.012305357493460178
like O 0 0.01252046599984169
many O 0 0.013132660649716854
cancer B-Disease 1 1.0
cells O 0 0.022500965744256973
, O 0 0.011240548454225063
fails O 0 0.02126092091202736
to O 0 0.010770433582365513
exit O 0 0.02313349023461342
the O 0 0.016280829906463623
cell O 0 0.029259487986564636
cycle O 0 0.03448891267180443
upon O 0 0.03432450443506241
serum O 1 0.9955766201019287
withdrawal O 0 0.11286137253046036
. O 0 0.0630447044968605

Here O 0 0.033751945942640305
, O 0 0.02007894031703472
it O 0 0.010991954244673252
is O 0 0.010066774673759937
shown O 0 0.008847709745168686
that O 0 0.006282598711550236
reintroduction O 0 0.022272465750575066
of O 0 0.009938253089785576
the O 0 0.013591843657195568
wild O 0 0.025154225528240204
- O 1 0.9999793767929077
type O 1 0.5962287187576294
VHL B-Disease 1 0.9998705387115479
gene O 0 0.028086528182029724
restores O 0 0.04051724821329117
the O 0 0.014503736980259418
ability O 0 0.015782613307237625
of O 0 0.019150935113430023
VHL O 1 1.0
- O 1 0.9999998807907104
negative O 1 0.9976020455360413
RCC B-Disease 1 1.0
cancer I-Disease 1 1.0
cells O 0 0.022479014471173286
to O 0 0.014351686462759972
exit O 0 0.023460177704691887
the O 0 0.017399776726961136
cell O 0 0.024158570915460587
cycle O 0 0.023340245708823204
and O 0 0.019070835784077644
enter O 0 0.03887467831373215
G0 O 1 0.9999748468399048
/ O 1 0.9851834177970886
quiescence O 1 0.9572963714599609
in O 0 0.037869445979595184
low O 0 0.1801113784313202
serum O 1 0.9951090216636658
. O 0 0.06580784171819687

Both O 0 0.05363840609788895
VHL O 1 0.9999946355819702
- O 1 0.9969542026519775
positive O 0 0.025233883410692215
and O 0 0.02774694375693798
VHL O 1 0.9999997615814209
- O 1 0.9999954700469971
negative O 0 0.20980209112167358
RCC B-Disease 1 0.9999995231628418
cells O 0 0.029556503519415855
exit O 0 0.030727922916412354
the O 0 0.020207790657877922
cell O 0 0.03310651332139969
cycle O 0 0.029007229954004288
by O 0 0.01826190948486328
contact O 0 0.04392463341355324
inhibition O 0 0.17809177935123444
. O 0 0.0478321835398674

The O 0 0.0673593208193779
cyclin O 1 0.9988788962364197
- O 1 0.9981822967529297
dependent O 0 0.05337633937597275
kinase O 1 0.9516534209251404
inhibitor O 1 0.9982761144638062
, O 0 0.025630617514252663
p27 O 1 0.9996917247772217
, O 0 0.02222415991127491
accumulates O 0 0.055311545729637146
upon O 0 0.019646231085062027
serum O 1 0.9993854761123657
withdrawal O 0 0.06437081098556519
, O 0 0.010488838888704777
only O 0 0.006509717088192701
in O 0 0.007055114954710007
the O 0 0.008378788828849792
presence O 0 0.01245600450783968
of O 0 0.015276550315320492
VHL B-Disease 1 0.999997615814209
, O 0 0.014014137908816338
as O 0 0.010064749978482723
a O 0 0.00970021914690733
result O 0 0.008657477796077728
of O 0 0.008418675512075424
the O 0 0.011316741816699505
stabilization O 1 0.6588414907455444
of O 0 0.016665633767843246
the O 0 0.024217085912823677
protein O 0 0.038419872522354126
. O 0 0.039196427911520004

We O 0 0.03053015097975731
propose O 0 0.03165958449244499
that O 0 0.010530774481594563
the O 0 0.011901398189365864
loss O 0 0.018688339740037918
of O 0 0.012195688672363758
wild O 0 0.02668125554919243
- O 1 0.9999984502792358
type O 1 0.9904819130897522
VHL B-Disease 1 0.9999938011169434
gene O 0 0.019288629293441772
results O 0 0.012100540101528168
in O 0 0.008113549090921879
a O 0 0.01061457023024559
specific O 0 0.01228497363626957
cellular O 0 0.35749340057373047
defect O 1 0.9839829206466675
in O 0 0.018013307824730873
serum O 1 0.9999972581863403
- O 1 0.9999905824661255
dependent O 0 0.019035283476114273
growth O 0 0.015033405274152756
control O 0 0.015397030860185623
, O 0 0.011326263658702374
which O 0 0.011155433021485806
may O 0 0.01718566194176674
initiate O 1 0.9079334735870361
tumor B-Disease 1 0.9999934434890747
formation O 0 0.2617374658584595
. O 0 0.05332805588841438

This O 0 0.033587321639060974
is O 0 0.02358962595462799
corrected O 0 0.03424135223031044
by O 0 0.012817689217627048
the O 0 0.013864665292203426
reintroduction O 0 0.03472750261425972
of O 0 0.016414983198046684
wild O 0 0.029840094968676567
- O 1 0.9999688863754272
type O 1 0.9276910424232483
VHL B-Disease 1 0.9999890327453613
, O 0 0.028120115399360657
implicating O 1 0.995895266532898
VHL B-Disease 1 0.9999748468399048
as O 0 0.015483582392334938
the O 0 0.01762457937002182
first O 0 0.035524655133485794
tumor B-Disease 1 0.9999973773956299
suppressor O 1 0.9923895001411438
involved O 0 0.012856755405664444
in O 0 0.008942695334553719
the O 0 0.010363343171775341
regulation O 0 0.012572245672345161
of O 0 0.010247213765978813
cell O 0 0.019939664751291275
cycle O 0 0.016751006245613098
exit O 0 0.017992619425058365
, O 0 0.010042550042271614
which O 0 0.006774186622351408
is O 0 0.007053768262267113
consistent O 0 0.010071158409118652
with O 0 0.007725768256932497
its O 0 0.01148550771176815
gatekeeper O 1 0.9999618530273438
function O 0 0.014214558526873589
in O 0 0.014014782384037971
the O 0 0.19964085519313812
kidney O 1 1.0
. O 0 0.030032921582460403
. O 0 0.039918575435876846

Piebaldism B-Disease 1 0.9999951124191284
with O 1 0.5607612133026123
deafness B-Disease 1 1.0
: O 0 0.028677813708782196
molecular O 0 0.02465703897178173
evidence O 0 0.012611711397767067
for O 0 0.012325802817940712
an O 0 0.01961304061114788
expanded O 1 0.99346923828125
syndrome O 1 1.0
. O 0 0.0855480283498764

In O 0 0.035403940826654434
a O 0 0.030260903760790825
South O 0 0.032776426523923874
African O 0 0.02961977757513523
girl O 0 0.033989839255809784
of O 0 0.019345149397850037
Xhosa O 1 0.9999188184738159
stock O 0 0.0825221911072731
with O 0 0.016931254416704178
severe O 1 0.9999964237213135
piebaldism B-Disease 1 0.9999998807907104
and O 1 0.9980695843696594
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.43765947222709656
identified O 0 0.026974786072969437
a O 0 0.022058358415961266
novel O 0 0.03294520452618599
missense O 0 0.041178107261657715
substitution O 0 0.02687971666455269
at O 0 0.018571987748146057
a O 0 0.01654541678726673
highly O 0 0.022203929722309113
conserved O 0 0.025852903723716736
residue O 0 0.026972640305757523
in O 0 0.013947791419923306
the O 0 0.020730027928948402
intracellular O 0 0.05008752644062042
kinase O 0 0.044983409345149994
domain O 0 0.025171715766191483
of O 0 0.0185814518481493
the O 0 0.02663162723183632
KIT O 1 0.9999996423721313
proto O 1 0.9999988079071045
- O 1 0.9999992847442627
oncogene O 1 0.9999955892562866
, O 0 0.059223636984825134
R796G O 1 0.9210541248321533
. O 0 0.07151338458061218

Though O 0 0.054643094539642334
auditory B-Disease 1 0.9695485830307007
anomalies I-Disease 0 0.3861461579799652
have O 0 0.012288770638406277
been O 0 0.011204293929040432
observed O 0 0.011011747643351555
in O 0 0.011116198264062405
mice O 0 0.018168142065405846
with O 0 0.011835992336273193
dominant O 0 0.10968630760908127
white O 1 0.7127013802528381
spotting O 1 0.9999556541442871
( O 0 0.2848583161830902
W O 1 0.9999921321868896
) O 0 0.01237175241112709
due O 0 0.012135103344917297
to O 0 0.014866386540234089
KIT O 1 0.999998927116394
mutations O 0 0.3930472731590271
, O 1 0.8107593059539795
deafness B-Disease 1 1.0
is O 0 0.01476903073489666
not O 0 0.009400805458426476
typical O 0 0.018564946949481964
in O 0 0.016386160627007484
human O 0 0.026539331302046776
piebaldism B-Disease 1 0.9989967942237854
. O 0 0.05674140155315399

Thus O 0 0.03277664631605148
, O 0 0.019128428772091866
the O 0 0.015844691544771194
occurrence O 0 0.027780992910265923
of O 0 0.041276589035987854
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.06820639222860336
this O 0 0.015454620122909546
patient O 1 0.9895379543304443
extends O 0 0.031197672709822655
considerably O 0 0.022540748119354248
the O 0 0.014231948181986809
phenotypic O 0 0.024156086146831512
range O 0 0.016016457229852676
of O 0 0.013872398994863033
piebaldism B-Disease 0 0.38152027130126953
due O 0 0.015902388840913773
to O 0 0.018082590773701668
KIT O 1 0.999962329864502
gene O 0 0.02196018025279045
mutation O 0 0.017414361238479614
in O 0 0.01035081222653389
humans O 0 0.011164051480591297
and O 0 0.010693525895476341
tightens O 1 0.9829649329185486
the O 0 0.015881018713116646
clinical O 1 0.992455005645752
similarity O 0 0.018165268003940582
between O 0 0.014288715086877346
piebaldism B-Disease 1 0.7808180451393127
and O 0 0.010728055611252785
the O 0 0.010040957480669022
various O 0 0.009676460176706314
forms O 0 0.016697397455573082
of O 1 0.9849498271942139
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.7770776748657227
. O 0 0.05589105933904648

Cycloheximide O 1 0.8397849202156067
facilitates O 0 0.06552644819021225
the O 0 0.02444581687450409
identification O 0 0.02436523698270321
of O 0 0.018219223245978355
aberrant O 0 0.04726504161953926
transcripts O 0 0.027535784989595413
resulting O 0 0.01531473733484745
from O 0 0.011883053928613663
a O 0 0.014870023354887962
novel O 0 0.02625192329287529
splice O 1 0.9245395660400391
- O 1 0.9872488379478455
site O 0 0.02241138555109501
mutation O 0 0.01823180727660656
in O 0 0.013281534425914288
COL17A1 O 1 0.9889591932296753
in O 0 0.013353878632187843
a O 0 0.01979438215494156
patient O 1 0.9986710548400879
with O 0 0.04238373413681984
generalized O 1 0.9999966621398926
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 1 0.5299525260925293

Patients O 1 0.9976606369018555
with O 0 0.04863845184445381
generalized O 1 0.9999971389770508
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 0.02927207201719284
show O 0 0.024975227192044258
decreased O 0 0.02507455088198185
expression O 0 0.01899155229330063
of O 0 0.022032592445611954
type O 1 0.9999767541885376
XVII O 1 1.0
collagen O 1 0.9999998807907104
, O 0 0.03196517005562782
a O 0 0.035641852766275406
transmembrane O 1 0.9776896834373474
hemidesmosomal O 1 0.9987751841545105
protein O 0 0.03596824035048485
encoded O 0 0.034744586795568466
by O 0 0.030599232763051987
COL17A1 O 1 0.9956405162811279
. O 0 0.05884174630045891

This O 0 0.02447355166077614
report O 0 0.019457384943962097
documents O 0 0.01951182447373867
a O 0 0.019468678161501884
novel O 0 0.03181350231170654
splice O 1 0.5296808481216431
- O 1 0.9202017784118652
site O 0 0.025884883478283882
mutation O 0 0.02197243459522724
in O 0 0.013790421187877655
COL17A1 O 1 0.9736611843109131
in O 0 0.014609146863222122
a O 0 0.017302893102169037
patient O 1 0.8889670968055725
with O 0 0.02459522895514965
generalized O 1 0.999997615814209
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.43987709283828735
and O 0 0.01613953523337841
applies O 0 0.019099131226539612
a O 0 0.014639203436672688
new O 0 0.015562732703983784
methodology O 0 0.022250378504395485
to O 0 0.014274029061198235
define O 0 0.023636240512132645
and O 0 0.016281042248010635
characterize O 0 0.03715701401233673
the O 0 0.022189676761627197
resulting O 0 0.03131154179573059
mRNA O 0 0.0600549653172493
splice O 0 0.1277114450931549
variants O 0 0.07139153778553009
. O 0 0.058773916214704514

Mutational O 0 0.2308300882577896
analysis O 0 0.03968261927366257
of O 0 0.0288714412599802
COL17A1 O 1 0.9959266185760498
identified O 0 0.02342611365020275
a O 0 0.02622939459979534
maternally O 1 0.9991490840911865
inherited O 1 0.9999972581863403
G O 1 0.9999786615371704
- O 1 0.999887228012085
to O 0 0.022545170038938522
- O 1 0.999971866607666
T O 1 0.9996134638786316
transversion O 0 0.13259200751781464
at O 0 0.020070604979991913
the O 0 0.01924773119390011
- O 0 0.37610313296318054
1 O 0 0.027210867032408714
position O 0 0.029328681528568268
of O 0 0.025900330394506454
exon O 0 0.08831228315830231
32 O 0 0.06841579079627991
. O 0 0.055908575654029846

This O 0 0.036906853318214417
acceptor O 0 0.07421096414327621
splice O 1 0.7206517457962036
- O 1 0.9601811170578003
site O 0 0.0344744473695755
mutation O 0 0.025636058300733566
led O 0 0.020329464226961136
to O 0 0.011546655558049679
the O 0 0.012655884027481079
formation O 0 0.019905168563127518
of O 0 0.014300365000963211
aberrant O 0 0.04050738736987114
transcripts O 0 0.025032181292772293
present O 0 0.016002243384718895
at O 0 0.02015647664666176
extremely O 0 0.02642212063074112
low O 0 0.03575099632143974
levels O 0 0.03401043638586998
. O 0 0.04301302507519722

Based O 0 0.035564057528972626
on O 0 0.016946295276284218
our O 0 0.017817368730902672
recent O 0 0.016919955611228943
finding O 0 0.020971141755580902
that O 0 0.016612526029348373
cycloheximide O 1 0.9981794357299805
stabilized O 1 0.9979479908943176
mutant O 0 0.10636012256145477
COL17A1 O 1 0.9958779811859131
transcripts O 0 0.04257258400321007
in O 0 0.022581830620765686
keratinocytes O 0 0.06952622532844543
homozygous O 0 0.03538225218653679
for O 0 0.016135595738887787
a O 0 0.021876921877264977
frameshift O 1 0.9593014717102051
mutation O 0 0.021601129323244095
, O 0 0.012314495630562305
the O 0 0.0109706437215209
effects O 0 0.01332340482622385
of O 0 0.00999623816460371
the O 0 0.014315025880932808
splice O 1 0.9658932685852051
- O 1 0.9895026683807373
site O 0 0.026736250147223473
mutation O 0 0.01786976493895054
on O 0 0.011027108877897263
splicing O 0 0.025771712884306908
of O 0 0.017533937469124794
COL17A1 O 1 0.9878963232040405
transcripts O 0 0.027922095730900764
were O 0 0.01039648987352848
determined O 0 0.015271334908902645
using O 0 0.01525752991437912
reverse O 0 0.03488941118121147
transcriptase O 0 0.3038583993911743
polymerase O 0 0.05803386867046356
chain O 0 0.036527350544929504
reaction O 0 0.022507458925247192
of O 0 0.01684054732322693
total O 0 0.021114427596330643
RNA O 0 0.038054514676332474
from O 0 0.022087493911385536
keratinocytes O 0 0.1303594559431076
incubated O 0 0.0706344023346901
for O 0 0.03139479085803032
2 O 0 0.055468201637268066
. O 0 0.054676592350006104

5 O 0 0.05926136299967766
h O 0 0.05847182124853134
in O 0 0.0172185767441988
the O 0 0.015114775858819485
presence O 0 0.014407170005142689
or O 0 0.011522608809173107
absence O 0 0.017987104132771492
of O 0 0.01435638964176178
10 O 0 0.02767133340239525
microg O 1 0.998699426651001
cycloheximide O 1 0.9995001554489136
per O 0 0.04695076867938042
ml O 1 0.9649577140808105
. O 0 0.061293479055166245

Using O 0 0.02794717438519001
this O 0 0.015155802480876446
approach O 0 0.021664386615157127
, O 0 0.014140264131128788
an O 0 0.013884980231523514
abnormally O 0 0.3697609603404999
spliced O 0 0.044273946434259415
transcript O 0 0.03384077548980713
was O 0 0.021344264969229698
identified O 0 0.01688106544315815
that O 0 0.009501873515546322
contains O 0 0.013554036617279053
an O 0 0.011846336536109447
extra O 0 0.024396052584052086
264 O 0 0.04339410364627838
bases O 0 0.02705352194607258
upstream O 0 0.03021877259016037
from O 0 0.018054842948913574
exon O 0 0.05445316061377525
32 O 0 0.031764086335897446
, O 0 0.017006412148475647
resulting O 0 0.016586415469646454
in O 0 0.012908922508358955
a O 0 0.020425934344530106
premature O 0 0.4948654770851135
termination O 1 0.6155615448951721
codon O 0 0.056184738874435425
27 O 0 0.04721113666892052
bp O 0 0.06144993379712105
downstream O 0 0.03940291702747345
from O 0 0.020791443064808846
the O 0 0.02778373286128044
cryptic O 0 0.10746314376592636
splice O 0 0.28341782093048096
site O 0 0.0679689422249794
. O 0 0.05375775322318077

Three O 0 0.033282481133937836
other O 0 0.022146040573716164
splice O 0 0.06218116357922554
variants O 0 0.027435271069407463
, O 0 0.014916743151843548
including O 0 0.010689722374081612
one O 0 0.01031172089278698
derived O 0 0.011031903326511383
from O 0 0.009340818040072918
the O 0 0.011974642053246498
skipping O 0 0.030664587393403053
of O 0 0.016901003196835518
exon O 0 0.0564551018178463
32 O 0 0.02571926824748516
, O 0 0.015253705903887749
were O 0 0.013113567605614662
also O 0 0.019341621547937393
identified O 0 0.030008884146809578
. O 0 0.038104698061943054

These O 0 0.023583047091960907
results O 0 0.022927943617105484
indicate O 0 0.020032742992043495
the O 0 0.018897486850619316
usefulness O 0 0.041458550840616226
of O 0 0.022105474025011063
cycloheximide O 1 0.9999599456787109
treatment O 1 0.9704151153564453
in O 0 0.014664219692349434
evaluating O 0 0.02591029368340969
the O 0 0.014618980698287487
abnormal O 0 0.0200954657047987
processing O 0 0.013707606121897697
of O 0 0.009659728035330772
mRNA O 0 0.016230707988142967
due O 0 0.010283727198839188
to O 0 0.011387049220502377
splice O 0 0.06163674220442772
- O 1 0.9219074249267578
site O 0 0.02263091690838337
mutations O 0 0.015953214839100838
, O 0 0.01189134456217289
because O 0 0.011289979331195354
( O 0 0.013516727834939957
i O 0 0.019429588690400124
) O 0 0.017408961430191994
aberrant O 0 0.03958744555711746
splicing O 0 0.028148720040917397
often O 0 0.01238707359880209
generates O 0 0.025536904111504555
a O 0 0.019430311396718025
premature O 0 0.07898250967264175
termination O 0 0.3978632390499115
codon O 0 0.03961069509387016
, O 0 0.02001809887588024
( O 0 0.021268393844366074
ii O 1 0.9880814552307129
) O 0 0.015620410442352295
transcripts O 0 0.020901167765259743
with O 0 0.01606648601591587
premature O 1 0.8247326612472534
termination O 1 0.9130375385284424
codons O 0 0.026415584608912468
can O 0 0.010567775927484035
occur O 0 0.009036246687173843
at O 0 0.013486445881426334
low O 0 0.01683679036796093
or O 0 0.013536910526454449
undetectable O 1 0.9846674203872681
levels O 0 0.012690344825387001
due O 0 0.011371290311217308
to O 0 0.012797246687114239
nonsense O 0 0.03484277054667473
- O 1 0.9547905325889587
mediated O 0 0.035629816353321075
mRNA O 0 0.029801467433571815
decay O 0 0.026446502655744553
, O 0 0.013487421907484531
and O 0 0.01273211557418108
( O 0 0.016918163746595383
iii O 1 0.9951085448265076
) O 0 0.012530338019132614
the O 0 0.01024121418595314
levels O 0 0.011797311715781689
of O 0 0.009499325416982174
these O 0 0.0074601988308131695
transcripts O 0 0.01790955848991871
can O 0 0.009167894721031189
be O 0 0.009656909853219986
increased O 0 0.01638113707304001
by O 0 0.01988154463469982
cycloheximide O 1 0.9856921434402466
. O 0 0.05300024524331093

A O 0 0.06843078881502151
deletion O 0 0.08874252438545227
mutation O 0 0.04162319749593735
in O 0 0.02395230159163475
COL17A1 O 1 0.8814809322357178
in O 0 0.016780830919742584
five O 0 0.01844886690378189
Austrian O 0 0.05070769786834717
families O 0 0.02038400247693062
with O 0 0.024592213332653046
generalized O 1 0.9999929666519165
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
represents O 1 0.928936243057251
propagation O 0 0.05673494562506676
of O 0 0.026635922491550446
an O 0 0.03354393690824509
ancestral O 1 0.8209737539291382
allele O 0 0.1436142921447754
. O 0 0.06304242461919785

Patients O 1 0.9971054196357727
with O 0 0.0493038110435009
generalized O 1 0.9999971389770508
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.10071274638175964
a O 0 0.026968328282237053
usually O 0 0.02016434445977211
nonlethal O 0 0.05815940722823143
form O 0 0.022404106333851814
of O 0 0.03264332562685013
junctional B-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 0.029168419539928436
have O 0 0.013284845277667046
generalized O 1 0.503852367401123
blistering B-Disease 1 0.9999953508377075
, O 1 0.9990812540054321
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.9995132684707642
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 1 0.999919056892395
and O 1 0.9995892643928528
dental B-Disease 1 1.0
abnormalities I-Disease 1 0.9999998807907104
. O 0 0.14821696281433105

Skin B-Disease 1 0.9999998807907104
fragility I-Disease 1 0.999991774559021
in O 0 0.02177216298878193
most O 0 0.014575056731700897
cases O 0 0.011264077387750149
is O 0 0.009919465519487858
due O 0 0.010256479494273663
to O 0 0.010042085312306881
mutations O 0 0.011632527224719524
in O 0 0.00829781498759985
the O 0 0.010007933713495731
gene O 0 0.015997936949133873
encoding O 0 0.02591298706829548
type O 1 0.9961093068122864
XVII O 1 1.0
collagen O 1 1.0
( O 1 0.9633210897445679
COL17A1 O 1 0.9999992847442627
) O 0 0.05156419053673744
. O 0 0.0560169480741024

Recently O 0 0.06123027577996254
, O 0 0.02259722352027893
we O 0 0.013707606121897697
reported O 0 0.015530161559581757
five O 0 0.01298541110008955
Austrian O 0 0.08073320239782333
families O 0 0.017318377271294594
with O 0 0.01968742534518242
generalized O 1 0.9999969005584717
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 0.46961817145347595
share O 0 0.026798920705914497
the O 0 0.02096266858279705
same O 0 0.028460057452321053
COL17A1 O 1 0.9999876022338867
mutation O 0 0.06998980790376663
. O 0 0.05182439833879471

Affected O 0 0.044865358620882034
individuals O 0 0.016867736354470253
in O 0 0.013211949728429317
three O 0 0.011164398863911629
families O 0 0.011772770434617996
are O 0 0.006760308053344488
homozygous O 0 0.01885533705353737
for O 0 0.01249151024967432
4003delTC O 1 0.9997091889381409
, O 0 0.013984426856040955
whereas O 0 0.01324338000267744
those O 0 0.007408559788018465
in O 0 0.00927918590605259
two O 0 0.010574199259281158
others O 0 0.0141244912520051
are O 0 0.013807111419737339
compound O 0 0.1368604153394699
heterozygotes O 1 0.9749361276626587
. O 0 0.05914309248328209

To O 0 0.030396515503525734
determine O 0 0.022296462208032608
if O 0 0.012739872559905052
the O 0 0.013378793373703957
occurrence O 0 0.02203572727739811
of O 0 0.014601035974919796
4003delTC O 1 0.9101404547691345
in O 0 0.014414633624255657
these O 0 0.008909505791962147
unrelated O 0 0.0195951908826828
families O 0 0.015975913032889366
signifies O 0 0.048477016389369965
propagation O 0 0.024742458015680313
of O 0 0.014333358965814114
an O 0 0.015172002837061882
ancestral O 0 0.1334882378578186
allele O 0 0.031029118224978447
or O 0 0.013245349749922752
a O 0 0.019947292283177376
mutational O 1 0.9998769760131836
hot O 1 0.9828205108642578
spot O 0 0.06513817608356476
, O 0 0.017804140225052834
haplotypes O 0 0.031959015876054764
were O 0 0.011112194508314133
determined O 0 0.014733859337866306
for O 0 0.012182260863482952
polymorphisms O 0 0.024525268003344536
both O 0 0.012003441341221333
within O 0 0.012969964183866978
and O 0 0.024796243757009506
flanking O 1 0.999849796295166
COL17A1 O 1 0.9999980926513672
. O 0 0.0595444031059742

Five O 0 0.06282468885183334
intragenic O 1 0.6433038711547852
polymorphisms O 0 0.04881615564227104
were O 0 0.01688213460147381
chosen O 0 0.020500529557466507
based O 0 0.018060162663459778
on O 0 0.018399709835648537
their O 0 0.024792522192001343
informativeness O 1 0.9568532705307007
. O 0 0.05512950196862221

One O 0 0.02686123736202717
of O 0 0.015087508596479893
these O 0 0.007649803534150124
, O 0 0.009126473218202591
not O 0 0.006826453376561403
previously O 0 0.011991754174232483
reported O 0 0.011895041912794113
, O 0 0.010765710845589638
was O 0 0.017405934631824493
2988 O 1 0.7363982200622559
A O 0 0.02765769325196743
or O 0 0.016986772418022156
C O 0 0.09284557402133942
that O 0 0.00976740662008524
introduces O 0 0.02882537804543972
a O 0 0.0166670810431242
new O 0 0.01869300939142704
restriction O 0 0.024750463664531708
site O 0 0.02688826620578766
for O 0 0.022784966975450516
Eco0109 O 1 0.9847373366355896
I O 0 0.06785117834806442
. O 0 0.05339151993393898

All O 0 0.03274662047624588
the O 0 0.03153835982084274
4003delTC O 1 0.8926283717155457
alleles O 0 0.03558306396007538
showed O 0 0.02051803097128868
the O 0 0.014054150320589542
same O 0 0.01385437324643135
haplotype O 0 0.0334593690931797
for O 0 0.013743503950536251
these O 0 0.010975218378007412
five O 0 0.023990310728549957
polymorphic O 0 0.45019063353538513
markers O 0 0.09107998013496399
. O 0 0.05329553410410881

Fourteen O 0 0.11868713796138763
microsatellite O 1 0.9429446458816528
polymorphisms O 0 0.059486936777830124
were O 0 0.016595084220170975
selected O 0 0.021374650299549103
based O 0 0.014346090145409107
on O 0 0.010643293149769306
their O 0 0.010466196574270725
high O 0 0.022704754024744034
heterozygosity O 1 0.9008446931838989
and O 0 0.010967430658638477
their O 0 0.009883112274110317
location O 0 0.014039836823940277
within O 0 0.016648052260279655
10q23 O 1 0.9985314607620239
- O 1 0.9999573230743408
q25 O 1 0.9990478157997131
near O 0 0.07852530479431152
COL17A1 O 1 0.9995405673980713
. O 0 0.06469865888357162

Three O 0 0.03621166571974754
families O 0 0.03179636225104332
shared O 0 0.03868986666202545
microsatellite O 1 0.9645112752914429
polymorphisms O 0 0.04242055118083954
covering O 0 0.034296534955501556
at O 0 0.016199300065636635
most O 0 0.012035089544951916
19 O 0 0.023337211459875107
cM O 0 0.04222080856561661
, O 0 0.014588088728487492
whereas O 0 0.013841499574482441
the O 0 0.010737608186900616
others O 0 0.01207847148180008
shared O 0 0.014297892339527607
smaller O 0 0.01195673830807209
regions O 0 0.00897609256207943
consistent O 0 0.011679318733513355
with O 0 0.00880289264023304
cross O 0 0.020811544731259346
- O 1 0.9454894065856934
over O 0 0.010617159307003021
events O 0 0.010381767526268959
during O 0 0.009937328286468983
passage O 0 0.012246960774064064
of O 0 0.010489555075764656
this O 0 0.010491962544620037
mutation O 0 0.01810551807284355
through O 0 0.01575157791376114
several O 0 0.01749247871339321
generations O 0 0.04072771966457367
. O 0 0.03721306100487709

These O 0 0.027448443695902824
results O 0 0.02324492298066616
indicate O 0 0.01787446066737175
that O 0 0.012604731135070324
4003delTC O 0 0.17117172479629517
occurs O 0 0.015077059157192707
on O 0 0.012082806788384914
a O 0 0.016333192586898804
single O 0 0.025155112147331238
ancestral O 1 0.521622896194458
allele O 0 0.0566069558262825
. O 0 0.027371810749173164
. O 0 0.04127111658453941

The O 0 0.05895325541496277
haptoglobin O 1 0.9996111989021301
- O 1 0.9997661709785461
gene O 0 0.038437072187662125
deletion O 0 0.0512554869055748
responsible O 0 0.031173424795269966
for O 0 0.03174111247062683
anhaptoglobinemia B-Disease 1 0.9964112639427185
. O 0 0.051534876227378845

We O 0 0.028619257733225822
have O 0 0.013080672360956669
found O 0 0.0138250682502985
an O 0 0.014815214090049267
allelic O 0 0.05324600264430046
deletion O 0 0.03321921080350876
of O 0 0.016337353736162186
the O 0 0.02046733908355236
haptoglobin O 1 0.9999887943267822
( O 0 0.03690170869231224
Hp O 1 0.9989957213401794
) O 0 0.016894513741135597
gene O 0 0.014538954012095928
from O 0 0.009833653457462788
an O 0 0.012140683829784393
individual O 0 0.016288114711642265
with O 0 0.022892408072948456
anhaptoglobinemia B-Disease 1 0.9983354210853577
. O 0 0.05373581498861313

The O 0 0.049205176532268524
Hp O 1 0.8644359111785889
gene O 0 0.03337106481194496
cluster O 0 0.032780442386865616
consists O 0 0.020644083619117737
of O 0 0.013176994398236275
coding O 0 0.02292550913989544
regions O 0 0.01176893338561058
of O 0 0.010474806651473045
the O 0 0.013629102148115635
alpha O 0 0.12259279936552048
chain O 0 0.033448148518800735
and O 0 0.011846906505525112
beta O 0 0.02710806019604206
chain O 0 0.02104172483086586
of O 0 0.01052510179579258
the O 0 0.015169189311563969
haptoglobin O 1 0.9991612434387207
gene O 0 0.02358737587928772
( O 0 0.019634094089269638
Hp O 1 0.9245078563690186
) O 0 0.012168426997959614
and O 0 0.008787411265075207
of O 0 0.009171368554234505
the O 0 0.012911194935441017
alpha O 0 0.06321818381547928
chain O 0 0.030173519626259804
and O 0 0.01365916058421135
beta O 0 0.02727651409804821
chain O 0 0.023109879344701767
of O 0 0.01182590238749981
the O 0 0.017606567591428757
haptoglobin O 1 0.9995341300964355
- O 1 0.9987282156944275
related O 0 0.025993064045906067
gene O 0 0.023099051788449287
( O 0 0.02406380884349346
Hpr O 1 0.9985425472259521
) O 0 0.017233317717909813
, O 0 0.01371671911329031
in O 0 0.012510224245488644
tandem O 0 0.03595162555575371
from O 0 0.013409431092441082
the O 0 0.02088719978928566
5 O 0 0.034754928201436996
side O 0 0.04543616250157356
. O 0 0.043545499444007874

Southern O 0 0.07664533704519272
blot O 1 0.9874894022941589
and O 0 0.03147050365805626
PCR O 0 0.058930911123752594
analyses O 0 0.02680380269885063
have O 0 0.010091639123857021
indicated O 0 0.012373722158372402
that O 0 0.006772872060537338
the O 0 0.008976397104561329
individual O 0 0.010342110879719257
with O 0 0.012228655628859997
anhaptoglobinemia B-Disease 1 0.9988038539886475
was O 0 0.020230459049344063
homozygous O 0 0.021447552368044853
for O 0 0.010024335235357285
the O 0 0.013073406182229519
gene O 0 0.015670547261834145
deletion O 0 0.0222388356924057
and O 0 0.00946479570120573
that O 0 0.007284862920641899
the O 0 0.011537205427885056
gene O 0 0.015758756548166275
deletion O 0 0.02328329160809517
was O 0 0.015119630843400955
included O 0 0.012029408477246761
at O 0 0.012126749381422997
least O 0 0.008808053098618984
from O 0 0.009033984504640102
the O 0 0.013379831798374653
promoter O 0 0.28680047392845154
region O 0 0.01991390250623226
of O 0 0.01661030575633049
Hp O 1 0.9268645644187927
to O 0 0.025140877813100815
Hpr O 1 0.9883014559745789
alpha O 0 0.039234988391399384
but O 0 0.011964716017246246
not O 0 0.009821569547057152
to O 0 0.0199729036539793
Hpr O 1 0.9989790916442871
beta O 1 0.7265225648880005
( O 0 0.04313092678785324
Hpdel O 1 0.9984799027442932
) O 0 0.046226661652326584
. O 0 0.057069242000579834

In O 0 0.031135039404034615
addition O 0 0.023800380527973175
, O 0 0.012969814240932465
we O 0 0.008400806225836277
found O 0 0.007685906253755093
seven O 0 0.007796935271471739
individuals O 0 0.006241259165108204
with O 0 0.008744767867028713
hypohaptoglobinemia B-Disease 1 0.8949299454689026
in O 0 0.009714814834296703
three O 0 0.008563402108848095
families O 0 0.009745649062097073
, O 0 0.008382609114050865
and O 0 0.007054820656776428
the O 0 0.010054504498839378
genotypes O 0 0.02553880773484707
of O 0 0.008774935267865658
six O 0 0.009258237667381763
of O 0 0.008321915753185749
the O 0 0.009203972294926643
seven O 0 0.009846585802733898
individuals O 0 0.0058833216316998005
were O 0 0.00629015825688839
found O 0 0.007935463450849056
to O 0 0.010695836506783962
be O 0 0.016850333660840988
Hp2 O 1 0.9999784231185913
/ O 1 0.9996395111083984
Hpdel O 1 0.99868243932724
. O 0 0.06860692799091339

The O 0 0.05186101794242859
phenotypes O 0 0.1503755748271942
and O 0 0.02124100551009178
genotypes O 0 0.24675630033016205
in O 0 0.010201329365372658
one O 0 0.009304337203502655
of O 0 0.00739133358001709
these O 0 0.005447473376989365
three O 0 0.006249888800084591
families O 0 0.00882062129676342
showed O 0 0.010407106019556522
the O 0 0.008986587636172771
father O 0 0.014239182695746422
to O 0 0.008546529337763786
be O 0 0.009879996068775654
hypohaptoglobinemic B-Disease 1 0.9935320615768433
( O 0 0.017950190231204033
Hp2 O 1 0.9971434473991394
) O 0 0.016046885401010513
and O 0 0.017339834943413734
Hp2 O 1 0.9999715089797974
/ O 1 0.9998340606689453
Hpdel O 1 0.9992607235908508
, O 0 0.014936375431716442
the O 0 0.010857631452381611
mother O 0 0.01755606196820736
to O 0 0.01030123420059681
be O 0 0.010696431621909142
Hp2 O 1 0.9967948794364929
- O 1 0.9961944818496704
1 O 0 0.023019174113869667
and O 0 0.019133949652314186
Hp1 O 1 0.9999186992645264
/ O 1 0.9984148740768433
Hp2 O 1 0.9190949201583862
, O 0 0.01470775157213211
one O 0 0.00963527150452137
of O 0 0.008364459499716759
the O 0 0.008579513058066368
two O 0 0.008021230809390545
children O 0 0.00930796004831791
to O 0 0.009288842789828777
be O 0 0.010980933904647827
hypohaptoglobinemic B-Disease 1 0.9458191394805908
( O 0 0.02167493849992752
Hp2 O 1 0.9864380359649658
) O 0 0.018325984477996826
and O 0 0.018391404300928116
Hp2 O 1 0.999971866607666
/ O 1 0.9999706745147705
Hpdel O 1 0.9998375177383423
, O 0 0.015913058072328568
and O 0 0.010141080245375633
the O 0 0.010198681615293026
other O 0 0.008581102825701237
child O 0 0.012529830448329449
to O 0 0.009024418890476227
be O 0 0.00921875610947609
Hp1 O 1 0.9920433163642883
and O 0 0.020236385986208916
Hp1 O 1 0.9999966621398926
/ O 1 0.9999668598175049
Hpdel O 1 0.9995311498641968
, O 0 0.01949789933860302
showing O 0 0.021603789180517197
an O 0 0.01844717562198639
anomalous O 0 0.04773985967040062
inheritance O 0 0.03828085586428642
of O 0 0.022994745522737503
Hp O 1 0.999946117401123
phenotypes O 0 0.33155426383018494
in O 0 0.01759003847837448
the O 0 0.021998660638928413
child O 0 0.11644579470157623
with O 0 0.031419020146131516
Hp1 O 1 0.9996793270111084
. O 0 0.05605815351009369

The O 0 0.06039593741297722
Hp2 O 1 0.9999809265136719
/ O 1 0.9999217987060547
Hpdel O 1 0.9993183612823486
individuals O 0 0.012757972814142704
had O 0 0.011662311851978302
an O 0 0.009390074759721756
extremely O 0 0.016584621742367744
low O 0 0.015680590644478798
level O 0 0.012508479878306389
of O 0 0.013403761200606823
Hp O 1 0.9935344457626343
( O 0 0.01827378012239933
mean O 0 0.021820135414600372
+ O 0 0.10545580089092255
/ O 1 0.895248293876648
- O 1 0.9942270517349243
SD O 1 0.991124153137207
= O 0 0.049082424491643906
0 O 0 0.034063976258039474
. O 0 0.019933104515075684
049 O 1 0.9934845566749573
+ O 1 0.6117726564407349
/ O 1 0.8485284447669983
- O 0 0.4581998288631439
0 O 0 0.03323330730199814
. O 0 0.020263586193323135
043 O 1 0.9592607021331787
mg O 1 0.9999057054519653
/ O 1 0.997478187084198
ml O 1 0.9977091550827026
; O 0 0.020039523020386696
n O 0 0.029306765645742416
= O 0 0.03208610415458679
6 O 0 0.020707910880446434
) O 0 0.01191182341426611
, O 0 0.009991449303925037
compared O 0 0.008560717105865479
with O 0 0.007326643913984299
the O 0 0.008082548156380653
level O 0 0.01180380117148161
( O 0 0.010522749274969101
1 O 0 0.014911126345396042
. O 0 0.01010079961270094
64 O 0 0.027656039223074913
+ O 0 0.07722654938697815
/ O 0 0.34511321783065796
- O 0 0.17972366511821747
1 O 0 0.022994063794612885
. O 0 0.017246486619114876
07 O 1 0.995210587978363
mg O 1 0.9999954700469971
/ O 1 0.9999411106109619
ml O 1 0.9988263249397278
) O 0 0.014665217138826847
obtained O 0 0.013189440593123436
from O 0 0.01393930334597826
52 O 0 0.031106268987059593
healthy O 0 0.035245347768068314
volunteers O 0 0.03447495400905609
having O 0 0.026151154190301895
phenotype O 1 0.98184734582901
Hp2 O 1 0.9994122982025146
, O 0 0.018225012347102165
whereas O 0 0.018290186300873756
the O 0 0.01662534289062023
serum O 1 0.9975603818893433
Hp O 1 0.9253296256065369
level O 0 0.01660475879907608
of O 0 0.010068362578749657
an O 0 0.010496437549591064
individual O 0 0.011598585173487663
with O 0 0.015354416333138943
Hp1 O 1 0.9999985694885254
/ O 1 0.999990701675415
Hpdel O 1 0.9999707937240601
was O 0 0.057334236800670624
0 O 0 0.05291561037302017
. O 0 0.04691609740257263

50 O 0 0.08245329558849335
mg O 1 0.9999884366989136
/ O 1 0.9999470710754395
ml O 1 0.9998785257339478
, O 0 0.018970007076859474
which O 0 0.011189895682036877
was O 0 0.013705686666071415
approximately O 0 0.011178716085851192
half O 0 0.010149344801902771
the O 0 0.009706166572868824
level O 0 0.01093552727252245
of O 0 0.0114463334903121
Hp O 1 0.7592419981956482
in O 0 0.012430964969098568
control O 0 0.021329080685973167
sera O 1 0.9469963312149048
from O 0 0.011757370084524155
the O 0 0.015946434810757637
Hp1 O 1 0.9999439716339111
phenotype O 1 0.5162381529808044
( O 0 0.01384730078279972
1 O 0 0.01809435710310936
. O 0 0.0120563805103302
26 O 0 0.023268623277544975
+ O 0 0.04982259124517441
/ O 0 0.45661455392837524
- O 0 0.1361970603466034
0 O 0 0.025267062708735466
. O 0 0.013128201477229595
33 O 0 0.0338570699095726
mg O 1 0.9980631470680237
/ O 1 0.9815759658813477
ml O 1 0.9914372563362122
; O 0 0.023904502391815186
n O 0 0.03371540457010269
= O 0 0.03644688054919243
9 O 0 0.023862896487116814
) O 0 0.014772550202906132
, O 0 0.012350517325103283
showing O 0 0.017231637611985207
a O 0 0.020032254979014397
gene O 0 0.03645351156592369
- O 1 0.9999699592590332
dosage O 1 0.9989519119262695
effect O 0 0.03976542130112648
. O 0 0.045182932168245316

The O 0 0.038875941187143326
other O 0 0.02634606696665287
allele O 0 0.05300690978765488
( O 0 0.026645181700587273
Hp2 O 1 0.9367972612380981
) O 0 0.015274692326784134
of O 0 0.011682752519845963
individuals O 0 0.009625494480133057
with O 0 0.015171918086707592
Hp2 O 1 0.9999988079071045
/ O 1 0.9999939203262329
Hpdel O 1 0.9999650716781616
was O 0 0.023628665134310722
found O 0 0.009463570080697536
to O 0 0.00930895283818245
have O 0 0.006579927168786526
, O 0 0.008444001898169518
in O 0 0.006827316712588072
all O 0 0.008185872808098793
exons O 0 0.02234174683690071
, O 0 0.012292730621993542
no O 0 0.013026741333305836
mutation O 0 0.015919584780931473
, O 0 0.012076080776751041
by O 0 0.01222206186503172
DNA O 0 0.028147010132670403
sequencing O 0 0.046729184687137604
. O 0 0.0374704971909523

On O 0 0.025050103664398193
the O 0 0.015961362048983574
basis O 0 0.011886829510331154
of O 0 0.011224692687392235
the O 0 0.01214014645665884
present O 0 0.012976444326341152
study O 0 0.012580831535160542
, O 0 0.011123927310109138
the O 0 0.010444296523928642
mechanism O 0 0.014606821350753307
of O 0 0.013416643254458904
anhaptoglobinemia B-Disease 1 0.9720041751861572
and O 0 0.01213999092578888
the O 0 0.012946320697665215
mechanism O 0 0.016510235145688057
of O 0 0.014565416611731052
anomalous O 0 0.313069224357605
inheritance O 1 0.5195712447166443
of O 0 0.029104268178343773
Hp O 1 0.9999892711639404
phenotypes O 1 0.8052049875259399
were O 0 0.016873715445399284
well O 0 0.022946849465370178
explained O 0 0.04220767691731453
. O 0 0.039046913385391235

However O 0 0.03255375847220421
, O 0 0.020270470529794693
the O 0 0.019061055034399033
mechanism O 0 0.02972422167658806
of O 0 0.02787816897034645
hypohaptoglobinemia B-Disease 1 0.9991222023963928
remains O 0 0.08021029084920883
unknown O 0 0.0884782001376152

ATM O 0 0.2826647162437439
mutations O 0 0.040170468389987946
and O 0 0.020162571221590042
phenotypes O 0 0.15362583100795746
in O 0 0.15062370896339417
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 0.02174634486436844
in O 0 0.013185666874051094
the O 0 0.014615601859986782
British O 0 0.023843303322792053
Isles O 0 0.05030955746769905
: O 0 0.015120272524654865
expression O 0 0.014344322495162487
of O 0 0.014175723306834698
mutant O 0 0.04175393283367157
ATM O 0 0.16234339773654938
and O 0 0.011184579692780972
the O 0 0.012807871215045452
risk O 0 0.02208724245429039
of O 0 0.30576515197753906
leukemia B-Disease 1 1.0
, O 1 0.9999998807907104
lymphoma B-Disease 1 1.0
, O 1 0.9999856948852539
and O 1 0.9999874830245972
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.23667776584625244

We O 0 0.02635303884744644
report O 0 0.019572719931602478
the O 0 0.01545148529112339
spectrum O 0 0.02419358119368553
of O 0 0.01621333323419094
59 O 0 0.04105934500694275
ATM O 0 0.11301887780427933
mutations O 0 0.023083187639713287
observed O 0 0.015952495858073235
in O 0 0.020782871171832085
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.032085925340652466
A B-Disease 1 0.9999715089797974
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.025714965537190437
patients O 0 0.20716693997383118
in O 0 0.014183583669364452
the O 0 0.02145441062748432
British O 0 0.04477807879447937
Isles O 0 0.14055554568767548
. O 0 0.050697121769189835

Of O 0 0.047158028930425644
51 O 0 0.07536396384239197
ATM O 1 0.6529969573020935
mutations O 0 0.027923615649342537
identified O 0 0.016587724909186363
in O 0 0.01115638017654419
families O 0 0.011773902922868729
native O 0 0.011302812956273556
to O 0 0.008080843836069107
the O 0 0.01025383546948433
British O 0 0.018118776381015778
Isles O 0 0.028042862191796303
, O 0 0.009217971935868263
11 O 0 0.012016699649393559
were O 0 0.008998430334031582
founder O 1 0.9634642601013184
mutations O 0 0.012675502337515354
, O 0 0.0089068952947855
and O 0 0.008566129952669144
2 O 0 0.012202216312289238
of O 0 0.0077326432801783085
these O 0 0.00720875384286046
11 O 0 0.014377246610820293
conferred O 0 0.033705491572618484
a O 0 0.02154281549155712
milder O 1 0.9835862517356873
clinical O 1 0.9999583959579468
phenotype O 0 0.36490216851234436
with O 0 0.012271298095583916
respect O 0 0.012504452839493752
to O 0 0.014362158253788948
both O 0 0.021535750478506088
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.9993914365768433
cellular O 1 0.9999347925186157
features O 0 0.07196824997663498
. O 0 0.05538658797740936

We O 0 0.026618042960762978
report O 0 0.01790231466293335
, O 0 0.01148021500557661
in O 0 0.008853772655129433
two O 0 0.00979740172624588
A B-Disease 1 0.9583812952041626
- I-Disease 1 0.9999997615814209
T I-Disease 1 0.9999949932098389
families O 0 0.016664134338498116
, O 0 0.01139969751238823
an O 0 0.011766481213271618
ATM O 0 0.05059642717242241
mutation O 0 0.021509792655706406
( O 0 0.01653434708714485
7271T O 1 0.9967378973960876
- O 1 0.9999990463256836
- O 1 0.9999991655349731
> O 1 0.999925971031189
G O 1 0.9996933937072754
) O 0 0.013006709516048431
that O 0 0.007505257613956928
may O 0 0.007493907585740089
be O 0 0.005726037081331015
associated O 0 0.006861194036900997
with O 0 0.005103194620460272
an O 0 0.006653146352618933
increased O 0 0.01103434432297945
risk O 1 0.862111508846283
of O 1 0.9683911800384521
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.01330750435590744
both O 0 0.014141892082989216
homozygotes O 1 0.9997925162315369
and O 0 0.01934226229786873
heterozygotes O 1 0.9795478582382202
( O 0 0.016021177172660828
relative O 0 0.017959026619791985
risk O 0 0.015722360461950302
12 O 0 0.014483677223324776
. O 0 0.00891853403300047
7 O 0 0.017034344375133514
; O 0 0.014606441371142864
P O 1 0.7420530319213867
= O 0 0.033336181193590164
. O 0 0.016116183251142502
0025 O 1 0.9993271827697754
) O 0 0.015628492459654808
, O 0 0.011440201662480831
although O 0 0.007823827676475048
there O 0 0.0055962372571229935
is O 0 0.006172931287437677
a O 0 0.008628353476524353
less O 0 0.009626621380448341
severe O 1 0.9999953508377075
A B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 0.11396894603967667
in O 0 0.010358895175158978
terms O 0 0.009958011098206043
of O 0 0.011345352046191692
the O 0 0.013725405558943748
degree O 0 0.030703170225024223
of O 1 0.7156546711921692
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 1 0.879669725894928

This O 0 0.031161639839410782
mutation O 0 0.034490086138248444
( O 0 0.023842638358473778
7271T O 1 0.9970675110816956
- O 1 0.9999960660934448
- O 1 0.9999988079071045
> O 1 0.9999682903289795
G O 1 0.9969561100006104
) O 0 0.016579627990722656
also O 0 0.012726589106023312
allows O 0 0.011591711081564426
expression O 0 0.010579658672213554
of O 0 0.011613650247454643
full O 0 0.01897442154586315
- O 1 0.8978108763694763
length O 0 0.02000696025788784
ATM O 0 0.04266161099076271
protein O 0 0.01570681855082512
at O 0 0.01172552164644003
a O 0 0.011070678010582924
level O 0 0.012640461325645447
comparable O 0 0.018401237204670906
with O 0 0.008810034021735191
that O 0 0.009155618026852608
in O 0 0.015024743042886257
unaffected O 0 0.12498395144939423
individuals O 0 0.023048674687743187
. O 0 0.04234641417860985

In O 0 0.02744927816092968
addition O 0 0.019013606011867523
, O 0 0.012045162729918957
we O 0 0.006764318328350782
have O 0 0.005127002019435167
studied O 0 0.01097163651138544
18 O 0 0.013171925209462643
A B-Disease 1 0.9968234300613403
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9929783940315247
, O 0 0.011136816814541817
in O 0 0.009535465389490128
15 O 0 0.012145526707172394
families O 0 0.009467528201639652
, O 0 0.010280825197696686
who O 0 0.01581457629799843
developed O 1 0.9880174398422241
leukemia B-Disease 1 1.0
, O 1 0.9998062252998352
lymphoma B-Disease 1 1.0
, O 1 0.9802876710891724
preleukemic O 1 0.9999997615814209
T O 1 0.9999998807907104
- O 1 0.9999905824661255
cell O 0 0.37415993213653564
proliferation O 1 0.7129973769187927
, O 0 0.08001410216093063
or O 1 0.9990841150283813
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 1 0.9922613501548767
mostly O 0 0.023513447493314743
in O 0 0.027445467188954353
childhood O 1 0.9994254112243652
. O 0 0.04402196407318115

A O 0 0.04203050956130028
wide O 0 0.027749814093112946
variety O 0 0.020367363467812538
of O 0 0.018295109272003174
ATM O 1 0.9467427134513855
mutation O 0 0.026035074144601822
types O 0 0.015035685151815414
, O 0 0.012098276056349277
including O 0 0.012421620078384876
missense O 0 0.030843831598758698
mutations O 0 0.013907824642956257
and O 0 0.008340863510966301
in O 0 0.01288555096834898
- O 1 0.9999265670776367
frame O 0 0.20148861408233643
deletions O 0 0.0324510857462883
, O 0 0.013984446413815022
were O 0 0.009743702597916126
seen O 0 0.01389340776950121
in O 0 0.013492891564965248
these O 0 0.01575663685798645
patients O 1 0.5846022963523865
. O 0 0.04126843810081482

We O 0 0.027891330420970917
also O 0 0.018642166629433632
show O 0 0.01367206685245037
that O 0 0.007229258771985769
25 O 0 0.012254149653017521
% O 0 0.007063852623105049
of O 0 0.006935149431228638
all O 0 0.007455912884324789
A B-Disease 1 0.9983721375465393
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.8666588068008423
carried O 0 0.013433372601866722
in O 0 0.013033492490649223
- O 1 0.9944220185279846
frame O 0 0.031852103769779205
deletions O 0 0.034039728343486786
or O 0 0.015123190358281136
missense O 0 0.03522840514779091
mutations O 0 0.01616363786160946
, O 0 0.00847549270838499
many O 0 0.0054725236259400845
of O 0 0.006718965247273445
which O 0 0.006629046518355608
were O 0 0.006366155110299587
also O 0 0.007841666229069233
associated O 0 0.009084903635084629
with O 0 0.00888547021895647
expression O 0 0.014543641358613968
of O 0 0.01959194615483284
mutant O 1 0.9023908376693726
ATM O 1 0.989616870880127
protein O 0 0.056025560945272446
. O 0 0.056408558040857315

The O 0 0.045786626636981964
DMPK O 1 0.9891031980514526
gene O 0 0.03275958448648453
of O 0 0.02465876191854477
severely O 1 0.9999969005584717
affected O 1 0.9999971389770508
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 1.0
is O 1 0.9993125200271606
hypermethylated O 1 0.9999997615814209
proximal O 1 0.9998466968536377
to O 0 0.021191969513893127
the O 0 0.02289978228509426
largely O 0 0.0323835164308548
expanded O 0 0.0591142475605011
CTG O 1 0.9995139837265015
repeat O 0 0.1154537945985794
. O 0 0.06342384964227676

Using O 0 0.04190767556428909
methylation O 0 0.054371338337659836
- O 1 0.959991991519928
sensitive O 0 0.03654860332608223
restriction O 0 0.029935769736766815
enzymes O 0 0.023282183334231377
, O 0 0.012508820742368698
we O 0 0.008686145767569542
characterized O 0 0.013353664427995682
the O 0 0.010981720872223377
methylation O 0 0.016512233763933182
pattern O 0 0.013974200934171677
on O 0 0.008625865913927555
the O 0 0.010459083132445812
5 O 0 0.016086632385849953
side O 0 0.015396436676383018
of O 0 0.01063583418726921
the O 0 0.016471736133098602
CTG O 1 0.99958735704422
repeat O 0 0.028543993830680847
in O 0 0.014378990978002548
the O 0 0.01745733991265297
DMPK O 1 0.9990496039390564
gene O 0 0.014794105663895607
of O 0 0.009834934026002884
normal O 0 0.009899101220071316
individuals O 0 0.006407252978533506
and O 0 0.007227164227515459
of O 0 0.01219748891890049
patients O 1 0.9999916553497314
affected O 1 0.9958332777023315
with O 1 0.9990684390068054
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 1 0.707230806350708
showing O 0 0.03209970146417618
expansions O 0 0.04280521348118782
of O 0 0.022027993574738503
the O 0 0.024869104847311974
repetitive O 0 0.3316086530685425
sequence O 0 0.039759524166584015
. O 0 0.0453469455242157

The O 0 0.043837033212184906
gene O 0 0.03850578889250755
segment O 0 0.041699979454278946
analyzed O 0 0.02802889235317707
corresponds O 0 0.02412150427699089
to O 0 0.015262661501765251
the O 0 0.025466887280344963
genomic O 0 0.060826364904642105
SacI O 1 0.9994366765022278
- O 1 0.9946016073226929
HindIII O 1 0.6116771697998047
fragment O 0 0.052670132368803024
carrying O 0 0.036159664392471313
exons O 0 0.048567384481430054
11 O 0 0.041391436010599136
- O 1 0.884112536907196
15 O 0 0.052701450884342194
. O 0 0.04939837008714676

There O 0 0.037749964743852615
is O 0 0.029309380799531937
constitutive O 0 0.06463921070098877
methylation O 0 0.039286836981773376
in O 0 0.02607714757323265
intron O 1 0.8446756601333618
12 O 0 0.023082444444298744
at O 0 0.020007476210594177
restriction O 0 0.021207232028245926
sites O 0 0.016639677807688713
of O 0 0.017185775563120842
SacII O 1 0.9587728977203369
and O 0 0.02118654176592827
HhaI O 1 0.9928792119026184
, O 0 0.020367508754134178
localized O 0 0.033487431704998016
1 O 0 0.024612927809357643
, O 0 0.01878165267407894
159 O 0 0.048933934420347214
- O 1 0.8165683150291443
1 O 0 0.02487715519964695
, O 0 0.018331868574023247
232 O 0 0.03820479288697243
bp O 0 0.04157967120409012
upstream O 0 0.026752030476927757
of O 0 0.013045012019574642
the O 0 0.018125493079423904
CTG O 1 0.999811589717865
repeat O 0 0.09377409517765045
, O 0 0.014441701583564281
whereas O 0 0.01436068769544363
most O 0 0.008753200061619282
, O 0 0.008868579752743244
if O 0 0.006036689039319754
not O 0 0.004964242223650217
all O 0 0.006208251696079969
, O 0 0.006683607120066881
of O 0 0.006589497439563274
the O 0 0.007054279558360577
other O 0 0.006721492391079664
sites O 0 0.011049095541238785
of O 0 0.012172705493867397
SacII O 1 0.9977859258651733
, O 0 0.01892939954996109
HhaI O 1 0.9951323866844177
, O 0 0.015662677586078644
and O 0 0.014024637639522552
HpaII O 1 0.9488036036491394
in O 0 0.010171624831855297
this O 0 0.0069839549250900745
region O 0 0.011698918417096138
are O 0 0.006675077136605978
unmethylated O 1 0.6148414015769958
, O 0 0.009370445273816586
in O 0 0.00771035673096776
normal O 0 0.009967539459466934
individuals O 0 0.007495482452213764
and O 0 0.008378935977816582
most O 0 0.009786260314285755
of O 0 0.014058482833206654
the O 0 0.027947843074798584
patients O 1 0.9995075464248657
. O 0 0.048271097242832184

In O 0 0.02204476110637188
a O 0 0.014688298106193542
number O 0 0.008918078616261482
of O 0 0.009966928511857986
young O 0 0.08575686067342758
and O 0 0.04418126493692398
severely O 1 0.9999992847442627
affected O 1 0.9977352619171143
patients O 1 0.999976634979248
, O 0 0.01394672505557537
however O 0 0.01068081147968769
, O 0 0.01076360885053873
complete O 0 0.015514349564909935
methylation O 0 0.01991899497807026
of O 0 0.010672691278159618
these O 0 0.007226062938570976
restriction O 0 0.015155305154621601
sites O 0 0.014213250018656254
was O 0 0.016054216772317886
found O 0 0.011336038820445538
in O 0 0.013030696660280228
the O 0 0.023215387016534805
mutated O 0 0.07704952359199524
allele O 0 0.0771346464753151
. O 0 0.05174630135297775

In O 0 0.024781929329037666
most O 0 0.013620168901979923
of O 0 0.012148142792284489
these O 0 0.00818310584872961
patients O 0 0.37187832593917847
, O 0 0.008858835324645042
the O 0 0.010695277713239193
onset O 1 0.9999772310256958
of O 0 0.47833865880966187
the O 1 0.9999730587005615
disease O 1 1.0
was O 1 1.0
congenital O 1 1.0
. O 1 0.9900709986686707

Preliminary O 0 0.060041654855012894
in O 0 0.038782622665166855
vivo O 0 0.0958242416381836
footprinting O 1 0.7087417840957642
data O 0 0.018572194501757622
gave O 0 0.019385265186429024
evidence O 0 0.0115042170509696
for O 0 0.012043981812894344
protein O 0 0.018973447382450104
- O 0 0.47694283723831177
DNA O 0 0.016909997910261154
contact O 0 0.013294851407408714
in O 0 0.009733181446790695
normal O 0 0.012400333769619465
genes O 0 0.012823217548429966
at O 0 0.013515048660337925
an O 0 0.01601998321712017
Sp1 O 1 0.998559296131134
consensus O 0 0.027131982147693634
binding O 0 0.023451194167137146
site O 0 0.026208193972706795
upstream O 0 0.02416669949889183
of O 0 0.014706079848110676
the O 0 0.02169928140938282
CTG O 1 0.9997323155403137
repeat O 0 0.0336163230240345
and O 0 0.011782484129071236
for O 0 0.008917070925235748
a O 0 0.011598389595746994
significant O 0 0.011622109450399876
reduction O 0 0.015464786440134048
of O 0 0.008844846859574318
this O 0 0.007341057062149048
interaction O 0 0.011808567680418491
in O 0 0.01073576882481575
cells O 0 0.014180615544319153
with O 0 0.011220934800803661
a O 0 0.024581555277109146
hypermethylated O 1 0.9999072551727295
DMPK O 1 0.9999967813491821
gene O 0 0.0363769456744194
. O 0 0.03136575222015381
. O 0 0.04261041805148125

The O 0 0.07332518696784973
hemochromatosis B-Disease 1 1.0
gene O 0 0.04055842012166977
product O 0 0.03216115012764931
complexes O 0 0.03555062413215637
with O 0 0.01654503494501114
the O 0 0.022090908139944077
transferrin O 1 0.999948263168335
receptor O 0 0.046700067818164825
and O 0 0.023018263280391693
lowers O 1 0.8646973371505737
its O 0 0.021953163668513298
affinity O 0 0.0358576737344265
for O 0 0.027346117421984673
ligand O 0 0.09230057895183563
binding O 0 0.04786263778805733
. O 0 0.05151998624205589

We O 0 0.0388166718184948
recently O 0 0.03525583818554878
reported O 0 0.02349822223186493
the O 0 0.018687084317207336
positional O 0 0.04155108705163002
cloning O 0 0.027705475687980652
of O 0 0.01349748857319355
a O 0 0.016119102016091347
candidate O 0 0.02320190519094467
gene O 0 0.021612444892525673
for O 0 0.027374837547540665
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999948740005493
HFE O 1 0.9999998807907104
. O 0 0.08342002332210541

The O 0 0.041298333555459976
gene O 0 0.02786465734243393
product O 0 0.022791586816310883
, O 0 0.01231556199491024
a O 0 0.011239822953939438
member O 0 0.012620587833225727
of O 0 0.00968514196574688
the O 0 0.012636950239539146
major O 0 0.10991895198822021
histocompatibility O 1 0.9999998807907104
complex O 0 0.1835428923368454
class O 1 0.775001049041748
I O 1 0.8618494272232056
- O 1 0.9923090934753418
like O 0 0.018076380714774132
family O 0 0.01662612333893776
, O 0 0.010773838497698307
was O 0 0.011309168301522732
found O 0 0.0077721839770674706
to O 0 0.0067577543668448925
have O 0 0.0054862950928509235
a O 0 0.010815326124429703
mutation O 0 0.016184093430638313
, O 0 0.01666899397969246
Cys O 1 0.999980092048645
- O 1 0.9997116923332214
282 O 1 0.9963446259498596
- O 1 0.999996542930603
- O 1 0.9999970197677612
> O 1 0.9999207258224487
Tyr O 1 0.9999988079071045
( O 0 0.030095018446445465
C282Y O 1 0.8062194585800171
) O 0 0.015717333182692528
, O 0 0.012369918636977673
in O 0 0.011819127947092056
85 O 0 0.027552185580134392
% O 0 0.018742525950074196
of O 0 0.021924417465925217
patient O 1 0.997873067855835
chromosomes O 0 0.05199022591114044
. O 0 0.04380376264452934

This O 0 0.02942473441362381
mutation O 0 0.0359049029648304
eliminates O 0 0.04808451607823372
the O 0 0.01614728942513466
ability O 0 0.016932396218180656
of O 0 0.016507213935256004
HFE O 1 0.9999071359634399
to O 0 0.014767087996006012
associate O 0 0.023310774937272072
with O 0 0.015731777995824814
beta2 O 1 0.999961256980896
- O 1 0.999996542930603
microglobulin O 1 0.999930739402771
( O 0 0.025176076218485832
beta2m O 1 0.9897000789642334
) O 0 0.01801692135632038
and O 0 0.017002323642373085
prevents O 0 0.26074451208114624
cell O 1 0.9762766361236572
- O 1 0.9999818801879883
surface O 0 0.04741772636771202
expression O 0 0.039858244359493256
. O 0 0.04497240111231804

A O 0 0.04313689097762108
second O 0 0.03407403081655502
mutation O 0 0.020202424377202988
that O 0 0.008043777197599411
has O 0 0.008990006521344185
no O 0 0.008250268176198006
effect O 0 0.010640637017786503
on O 0 0.012496058829128742
beta2m O 1 0.9851675629615784
association O 0 0.029431231319904327
, O 0 0.020816786214709282
H63D O 1 0.9999954700469971
, O 0 0.014644031412899494
was O 0 0.015932468697428703
found O 0 0.008906146511435509
in O 0 0.008529921993613243
eight O 0 0.010768615640699863
out O 0 0.011255146935582161
of O 0 0.013167183846235275
nine O 0 0.02150876820087433
patients O 0 0.35427796840667725
heterozygous O 0 0.03368760645389557
for O 0 0.018891476094722748
the O 0 0.03197568282485008
C282Y O 1 0.9954695701599121
mutant O 0 0.1669366955757141
. O 0 0.05486889183521271

In O 0 0.02904481068253517
this O 0 0.014731908217072487
report O 0 0.01676224358379841
, O 0 0.0123152956366539
we O 0 0.010750186629593372
demonstrate O 0 0.01638890616595745
in O 0 0.015083646401762962
cultured O 0 0.045661479234695435
293 O 0 0.1901683360338211
cells O 0 0.0326458215713501
overexpressing O 1 0.8681825995445251
wild O 0 0.03359712287783623
- O 1 0.9997338652610779
type O 0 0.04995397478342056
or O 0 0.020581616088747978
mutant O 0 0.4082191288471222
HFE O 1 0.9999572038650513
proteins O 0 0.018112201243638992
that O 0 0.007216593250632286
both O 0 0.007362102624028921
the O 0 0.009091516956686974
wild O 0 0.01784621551632881
- O 1 0.9999618530273438
type O 0 0.06405779719352722
and O 0 0.023830022662878036
H63D O 1 0.9999974966049194
HFE O 1 0.9999974966049194
proteins O 0 0.030768325552344322
form O 0 0.01973489671945572
stable O 0 0.03330959379673004
complexes O 0 0.0336683914065361
with O 0 0.014516828581690788
the O 0 0.024801190942525864
transferrin O 1 0.999981164932251
receptor O 1 0.9893490076065063
( O 0 0.048119623214006424
TfR O 1 0.9999635219573975
) O 0 0.047174785286188126
. O 0 0.04921379312872887

The O 0 0.0554911307990551
C282Y O 1 0.8114591240882874
mutation O 0 0.03619472682476044
nearly O 0 0.023969821631908417
completely O 0 0.02606971561908722
prevents O 0 0.025339500978589058
the O 0 0.013863048516213894
association O 0 0.017987405881285667
of O 0 0.014853255823254585
the O 0 0.019904237240552902
mutant O 1 0.982982337474823
HFE O 1 0.999997615814209
protein O 0 0.03408197686076164
with O 0 0.02467942051589489
the O 0 0.036555249243974686
TfR O 1 0.9996053576469421
. O 0 0.06485647708177567

Studies O 0 0.03876618295907974
on O 0 0.028701718896627426
cell O 0 0.046276822686195374
- O 1 0.8775577545166016
associated O 0 0.026743952184915543
transferrin O 0 0.13060250878334045
at O 0 0.02444937825202942
37 O 0 0.031259141862392426
degrees O 0 0.030512969940900803
C O 0 0.04179096221923828
suggest O 0 0.016184844076633453
that O 0 0.008872931823134422
the O 0 0.014279826544225216
overexpressed O 0 0.11832217872142792
wild O 0 0.02862115390598774
- O 1 0.9996469020843506
type O 1 0.5593641400337219
HFE O 1 0.9999902248382568
protein O 0 0.031119005754590034
decreases O 0 0.02579677104949951
the O 0 0.01540462113916874
affinity O 0 0.02903991937637329
of O 0 0.019001541659235954
the O 0 0.027797721326351166
TfR O 1 0.9998788833618164
for O 0 0.04445141553878784
transferrin O 1 0.9994170665740967
. O 0 0.07347947359085083

The O 0 0.06258559972047806
overexpressed O 1 0.9996716976165771
H63D O 1 0.9999897480010986
protein O 0 0.031615134328603745
does O 0 0.013588819652795792
not O 0 0.007705044001340866
have O 0 0.006461428944021463
this O 0 0.005960825830698013
effect O 0 0.009299147874116898
, O 0 0.008451915346086025
providing O 0 0.009467575699090958
the O 0 0.008200597949326038
first O 0 0.009279518388211727
direct O 0 0.009654602967202663
evidence O 0 0.007901069708168507
for O 0 0.008293645456433296
a O 0 0.013862982392311096
functional O 0 0.021431967616081238
consequence O 0 0.02198653854429722
of O 0 0.01661006361246109
the O 0 0.03286104276776314
H63D O 1 0.9999966621398926
mutation O 0 0.06502664089202881
. O 0 0.05391340330243111

Addition O 0 0.04012896865606308
of O 0 0.030279217287898064
soluble O 1 0.8332230448722839
wild O 0 0.04167140647768974
- O 1 0.9999673366546631
type O 1 0.9960378408432007
HFE O 1 0.9999997615814209
/ O 1 0.9999841451644897
beta2m O 1 0.9999486207962036
heterodimers O 1 0.9998972415924072
to O 0 0.026634443551301956
cultured O 0 0.45137330889701843
cells O 0 0.024698907509446144
also O 0 0.01593889854848385
decreased O 0 0.01981276459991932
the O 0 0.01538595836609602
apparent O 0 0.02757047489285469
affinity O 0 0.029314173385500908
of O 0 0.01503816433250904
the O 0 0.01795874908566475
TfR O 1 0.9821805953979492
for O 0 0.013834784738719463
its O 0 0.01678726077079773
ligand O 0 0.033940572291612625
under O 0 0.018105847761034966
steady O 0 0.03182206302881241
- O 1 0.7652981877326965
state O 0 0.010889814235270023
conditions O 0 0.014106536284089088
, O 0 0.009772924706339836
both O 0 0.007811977062374353
in O 0 0.013005828484892845
293 O 1 0.9565116167068481
cells O 0 0.022490890696644783
and O 0 0.016362493857741356
in O 0 0.025912918150424957
HeLa O 1 0.9999980926513672
cells O 0 0.06040382757782936
. O 0 0.04869617894291878

Furthermore O 0 0.05275963991880417
, O 0 0.024051286280155182
at O 0 0.020307768136262894
4 O 0 0.02461971715092659
degrees O 0 0.0300526674836874
C O 0 0.04684276133775711
, O 0 0.013917657546699047
the O 0 0.01341676153242588
added O 0 0.021541453897953033
soluble O 0 0.2601528465747833
complex O 0 0.027141733095049858
of O 0 0.026691902428865433
HFE O 1 0.9999997615814209
/ O 1 0.999982476234436
beta2m O 1 0.9991825222969055
inhibited O 0 0.06993600726127625
binding O 0 0.031451787799596786
of O 0 0.023184727877378464
transferrin O 1 0.9739007949829102
to O 0 0.031178481876850128
HeLa O 1 0.9999780654907227
cell O 0 0.2532174289226532
TfR O 1 0.9523720145225525
in O 0 0.016322579234838486
a O 0 0.022026419639587402
concentration O 1 0.9909659624099731
- O 1 0.9998528957366943
dependent O 0 0.04326322674751282
manner O 0 0.042795777320861816
. O 0 0.04960094764828682

Scatchard O 0 0.12999768555164337
plots O 0 0.0427141897380352
of O 0 0.017278552055358887
these O 0 0.009092015214264393
data O 0 0.010224900208413601
indicate O 0 0.010876273736357689
that O 0 0.007461003493517637
the O 0 0.012535946443676949
added O 0 0.023080118000507355
heterodimer O 1 0.9918067455291748
substantially O 0 0.03367491066455841
reduced O 0 0.024949660524725914
the O 0 0.019773973152041435
affinity O 0 0.033935368061065674
of O 0 0.028500240296125412
TfR O 1 0.9998142123222351
for O 0 0.04890788719058037
transferrin O 1 0.9984270334243774
. O 0 0.07897275686264038

These O 0 0.020977994427084923
results O 0 0.019756026566028595
establish O 0 0.01957419514656067
a O 0 0.0181391853839159
molecular O 0 0.023122282698750496
link O 0 0.021587951108813286
between O 0 0.016679689288139343
HFE O 1 0.9999822378158569
and O 0 0.012364995665848255
a O 0 0.012816867791116238
key O 0 0.016924263909459114
protein O 0 0.012364157475531101
involved O 0 0.01079689059406519
in O 0 0.01241186074912548
iron O 1 0.9994356036186218
transport O 0 0.02272534742951393
, O 0 0.013874970376491547
the O 0 0.015167194418609142
TfR O 1 0.999970555305481
, O 0 0.014195661060512066
and O 0 0.010472534224390984
raise O 0 0.016091153025627136
the O 0 0.01041223481297493
possibility O 0 0.013779401779174805
that O 0 0.008105088956654072
alterations O 0 0.018748553469777107
in O 0 0.008994698524475098
this O 0 0.007925593294203281
regulatory O 0 0.01874978095293045
mechanism O 0 0.0174934770911932
may O 0 0.010418514721095562
play O 0 0.010164426639676094
a O 0 0.010554715991020203
role O 0 0.011575148440897465
in O 0 0.009419376961886883
the O 0 0.014823846518993378
pathogenesis O 1 0.9999966621398926
of O 1 0.997564435005188
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.993728518486023
. O 0 0.06331934779882431

Genomic O 0 0.07673146575689316
organization O 0 0.03214746713638306
of O 0 0.021439531818032265
the O 0 0.02962534874677658
UBE3A O 1 0.9999986886978149
/ O 1 0.9999934434890747
E6 O 1 0.9999910593032837
- O 1 0.9999862909317017
AP O 1 0.9514644145965576
gene O 0 0.03670963644981384
and O 0 0.02825515903532505
related O 0 0.03772825002670288
pseudogenes O 0 0.14704841375350952
. O 0 0.05353134498000145

The O 0 0.06612903624773026
UBE3A O 1 0.9813745617866516
gene O 0 0.038880981504917145
encodes O 0 0.041114576160907745
the O 0 0.0258929580450058
E6 O 1 0.9982422590255737
- O 1 0.9998868703842163
AP O 1 0.9861921072006226
ubiquitin O 1 0.9715861678123474
- O 1 0.9990898370742798
protein O 0 0.030984491109848022
ligase O 0 0.04327811300754547
and O 0 0.013950972817838192
has O 0 0.01152742002159357
recently O 0 0.015192978084087372
been O 0 0.008856094442307949
shown O 0 0.008124329149723053
to O 0 0.008137807250022888
be O 0 0.009154407307505608
mutated O 0 0.17989656329154968
in O 1 0.9839469194412231
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
who O 1 0.9951438903808594
lack O 1 0.9982866644859314
15q11 O 1 0.9999986886978149
- O 1 0.9999961853027344
q13 O 1 0.9970830082893372
deletions O 0 0.06409148126840591
or O 0 0.028889359906315804
chromosome O 0 0.045328039675951004
15 O 0 0.049126189202070236
paternal O 1 0.971379816532135
uniparental B-Disease 1 0.9999994039535522
disomy I-Disease 1 0.9999474287033081
. O 0 0.08017708361148834

Previous O 0 0.08827020972967148
UBE3A O 1 0.9801880121231079
cDNA O 0 0.08270955085754395
analysis O 0 0.025414617732167244
has O 0 0.018185289576649666
shown O 0 0.014743388630449772
a O 0 0.019174234941601753
coding O 0 0.030243201181292534
region O 0 0.0209102351218462
of O 0 0.01645609363913536
approximately O 0 0.027136055752635002
2 O 0 0.045595984905958176
. O 0 0.04634367674589157

6 O 0 0.06516889482736588
kb O 0 0.11452844738960266
and O 0 0.017037728801369667
a O 0 0.020080288872122765
3 O 0 0.030644739046692848
- O 1 0.9921018481254578
untranslated O 1 0.9780765175819397
region O 0 0.02644152007997036
( O 0 0.02366301789879799
UTR O 1 0.9977220892906189
) O 0 0.01689700223505497
of O 0 0.0171035286039114
< O 1 0.554425835609436
50 O 0 0.028018023818731308
bp O 0 0.04458487406373024
, O 0 0.01806400902569294
whereas O 0 0.01742733083665371
Northern O 0 0.016540132462978363
analysis O 0 0.013425532728433609
has O 0 0.011942368932068348
indicated O 0 0.016012145206332207
mRNA O 0 0.01889984868466854
sizes O 0 0.01783822476863861
of O 0 0.014967001974582672
5 O 0 0.03149242699146271
- O 1 0.9507722854614258
8 O 0 0.05793322995305061
kb O 0 0.335661917924881
. O 0 0.06217353790998459

We O 0 0.02891579270362854
have O 0 0.014787324704229832
analyzed O 0 0.02666124887764454
additional O 0 0.023951247334480286
cDNA O 0 0.04978153109550476
clones O 0 0.03852259740233421
and O 0 0.013361163437366486
provide O 0 0.013380593620240688
evidence O 0 0.009616306982934475
for O 0 0.010336719453334808
an O 0 0.014358757063746452
additional O 0 0.02876642346382141
0 O 0 0.051001016050577164
. O 0 0.04498188570141792

5 O 0 0.0595988966524601
kb O 0 0.08735162019729614
of O 0 0.02749783731997013
5 O 0 0.03852098807692528
- O 1 0.9847516417503357
UTR O 1 0.9922335147857666
and O 0 0.02820482663810253
> O 0 0.07642039656639099
2 O 0 0.037172555923461914
kb O 0 0.07351433485746384
of O 0 0.026023445650935173
3 O 0 0.04708339646458626
- O 1 0.998884379863739
UTR O 1 0.9960840940475464
. O 0 0.07018409669399261

We O 0 0.02725922502577305
have O 0 0.01383365411311388
established O 0 0.018936268985271454
the O 0 0.015374109148979187
genomic O 0 0.030935753136873245
organization O 0 0.022405389696359634
of O 0 0.020832085981965065
UBE3A O 1 0.9999219179153442
and O 0 0.017532771453261375
the O 0 0.017525609582662582
sequence O 0 0.018366331234574318
of O 0 0.026422549039125443
intron O 1 0.9999055862426758
- O 1 0.999900221824646
exon O 0 0.46405836939811707
borders O 0 0.0604100376367569
. O 0 0.055424850434064865

We O 0 0.02603975497186184
have O 0 0.013871237635612488
also O 0 0.01615280471742153
mapped O 0 0.028335800394415855
two O 0 0.012703818269073963
highly O 0 0.020841270685195923
homologous O 0 0.030101532116532326
processed O 0 0.027157021686434746
pseudogenes O 0 0.05270541459321976
, O 0 0.023764977231621742
UBE3AP1 O 1 0.999832272529602
and O 0 0.02145286276936531
UBE3AP2 O 1 0.9993664622306824
, O 0 0.013893968425691128
to O 0 0.012035236693918705
chromosomes O 0 0.01680425927042961
2 O 0 0.015505809336900711
and O 0 0.010280156508088112
21 O 0 0.016305292025208473
, O 0 0.01216871477663517
respectively O 0 0.014754502102732658
, O 0 0.011438018642365932
and O 0 0.010026104748249054
determined O 0 0.014786310493946075
their O 0 0.013524627313017845
genomic O 0 0.04234369471669197
organization O 0 0.03870679438114166
. O 0 0.043205223977565765

These O 0 0.02284715510904789
results O 0 0.019166121259331703
will O 0 0.011821266263723373
form O 0 0.00920140277594328
the O 0 0.008045642636716366
basis O 0 0.007425933610647917
for O 0 0.008261524140834808
studies O 0 0.011552833020687103
of O 0 0.012718564830720425
mutation O 0 0.022410297766327858
and O 0 0.0178068820387125
imprinting O 1 0.9347172975540161
of O 0 0.04376004636287689
UBE3A O 1 0.9999849796295166
. O 0 0.06702537089586258

Mutation O 0 0.06393774598836899
spectrum O 0 0.055910009890794754
and O 0 0.030516060069203377
genotype O 1 0.9836359620094299
- O 1 0.9994069337844849
phenotype O 0 0.0700157880783081
analyses O 0 0.03203003853559494
in O 0 0.02529323659837246
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9524348378181458
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.0480753518640995
two O 0 0.027862628921866417
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
with O 1 0.9959793090820312
germline O 1 0.9999995231628418
PTEN O 1 0.9999998807907104
mutation O 1 0.8689519762992859
. O 0 0.058017320930957794

The O 0 0.11905016005039215
tumour B-Disease 1 1.0
suppressor O 1 0.999998927116394
gene O 1 0.96022629737854
PTEN O 1 0.9999920129776001
, O 0 0.026254678145051003
which O 0 0.019708890467882156
maps O 0 0.033196981996297836
to O 0 0.03241176903247833
10q23 O 0 0.3215642273426056
. O 0 0.061346154659986496

3 O 0 0.05780654028058052
and O 0 0.030098607763648033
encodes O 0 0.04453304037451744
a O 0 0.029246175661683083
403 O 0 0.06967564672231674
amino O 0 0.039974991232156754
acid O 0 0.041123226284980774
dual O 0 0.05203714221715927
specificity O 0 0.07425211369991302
phosphatase O 1 0.9957098960876465
( O 0 0.027934502810239792
protein O 0 0.030607273802161217
tyrosine O 0 0.06476955115795135
phosphatase O 1 0.9812441468238831
; O 0 0.026537014171481133
PTPase O 1 0.9998685121536255
) O 0 0.016272740438580513
, O 0 0.013743198476731777
was O 0 0.016074154525995255
shown O 0 0.011409122496843338
recently O 0 0.014109731651842594
to O 0 0.009675176814198494
play O 0 0.011188910342752934
a O 0 0.014049828052520752
broad O 0 0.018952209502458572
role O 0 0.01895776204764843
in O 0 0.018509989604353905
human O 0 0.04487117379903793
malignancy B-Disease 1 0.9999992847442627
. O 0 0.059483014047145844

Somatic O 1 0.9396883249282837
PTEN O 1 0.9995393753051758
deletions O 0 0.07431851327419281
and O 0 0.02239047922194004
mutations O 0 0.017991842702031136
were O 0 0.008566729724407196
observed O 0 0.010448348708450794
in O 0 0.009701437316834927
sporadic B-Disease 1 0.7601276636123657
breast I-Disease 1 1.0
, I-Disease 1 0.8906693458557129
brain I-Disease 1 0.999980092048645
, I-Disease 1 0.9855307340621948
prostate I-Disease 1 1.0
and I-Disease 1 0.999998927116394
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 1 0.9998315572738647
lines O 0 0.015033361501991749
and O 0 0.007828693836927414
in O 0 0.0071002766489982605
several O 0 0.008330514654517174
primary O 0 0.024412833154201508
tumours B-Disease 1 0.9999977350234985
such O 0 0.0097119165584445
as O 1 0.9109441637992859
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.9729132652282715

In O 0 0.03499377891421318
addition O 0 0.02923557534813881
, O 0 0.02607770636677742
PTEN O 1 0.9996423721313477
was O 0 0.0256542656570673
identified O 0 0.014602531678974628
as O 0 0.011724951677024364
the O 0 0.012478687800467014
susceptibility O 0 0.1506037712097168
gene O 0 0.012619362212717533
for O 0 0.010713368654251099
two O 0 0.019198201596736908
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.998562753200531
CD B-Disease 1 0.9999380111694336
; O 0 0.050269801169633865
MIM O 1 0.999998927116394
158350 O 1 0.998491644859314
) O 0 0.026132045313715935
and O 0 0.027595067396759987
Bannayan B-Disease 1 0.9995342493057251
- I-Disease 1 0.9999945163726807
Zonana I-Disease 1 0.9999979734420776
( I-Disease 0 0.040617648512125015
BZS I-Disease 1 0.9996658563613892
) I-Disease 0 0.024751199409365654
or I-Disease 0 0.024787824600934982
Ruvalcaba I-Disease 1 0.9996786117553711
- I-Disease 1 0.9999309778213501
Riley I-Disease 1 0.9999246597290039
- I-Disease 1 0.9999998807907104
Smith I-Disease 1 0.9999980926513672
syndrome I-Disease 1 1.0
( O 1 0.9928514957427979
MIM O 1 1.0
153480 O 1 0.9999979734420776
) O 0 0.05484776198863983
. O 0 0.05815817415714264

Constitutive O 0 0.13035328686237335
DNA O 0 0.043212346732616425
from O 0 0.02429882064461708
37 O 0 0.043363820761442184
CD B-Disease 0 0.05367089807987213
families O 0 0.021962283179163933
and O 0 0.015832092612981796
seven O 0 0.025314833968877792
BZS B-Disease 1 0.9989755153656006
families O 0 0.024405386298894882
was O 0 0.030913827940821648
screened O 0 0.046024102717638016
for O 0 0.03045431524515152
germline O 1 0.9988021850585938
PTEN O 1 0.9999954700469971
mutations O 0 0.08151961117982864
. O 0 0.06337693333625793

PTEN O 1 0.9997878670692444
mutations O 0 0.03942849859595299
were O 0 0.014858651906251907
identified O 0 0.01416593138128519
in O 0 0.009457590989768505
30 O 0 0.01352685410529375
of O 0 0.011986659839749336
37 O 0 0.022938990965485573
( O 0 0.017423992976546288
81 O 0 0.042941246181726456
% O 0 0.019423315301537514
) O 0 0.02062511444091797
CD B-Disease 0 0.045343272387981415
families O 0 0.01802108809351921
, O 0 0.013141154311597347
including O 0 0.01481254119426012
missense O 0 0.03332666680216789
and O 0 0.016632206737995148
nonsense O 0 0.03793540969491005
point O 0 0.024337977170944214
mutations O 0 0.022033296525478363
, O 0 0.017101438716053963
deletions O 0 0.034927647560834885
, O 0 0.018553100526332855
insertions O 0 0.04263519123196602
, O 0 0.014900581911206245
a O 0 0.020561909303069115
deletion O 1 0.5174700617790222
/ O 1 0.9886361956596375
insertion O 0 0.05513451248407364
and O 0 0.02661719173192978
splice O 0 0.17543241381645203
site O 0 0.05752597376704216
mutations O 0 0.05806703492999077
. O 0 0.05260699987411499

These O 0 0.030190257355570793
mutations O 0 0.026538174599409103
were O 0 0.012315040454268456
scattered O 0 0.01565014012157917
over O 0 0.011679306626319885
the O 0 0.012558323331177235
entire O 0 0.02060418576002121
length O 0 0.018515169620513916
of O 0 0.01705348491668701
PTEN O 1 0.9999091625213623
, O 0 0.013492999598383904
with O 0 0.009550302289426327
the O 0 0.009597851894795895
exception O 0 0.011317114345729351
of O 0 0.00801660306751728
the O 0 0.009604089893400669
first O 0 0.013489123433828354
, O 0 0.014684855937957764
fourth O 0 0.030008677393198013
and O 0 0.018224818632006645
last O 0 0.030247312039136887
exons O 0 0.07253437489271164
. O 0 0.04661145433783531

A O 0 0.060383833944797516
hot O 0 0.08396726101636887
spot O 0 0.04614073783159256
for O 0 0.02729101851582527
PTEN O 1 0.9999432563781738
mutation O 0 0.030805449932813644
in O 0 0.016974611207842827
CD B-Disease 0 0.06862622499465942
was O 0 0.02304500713944435
identified O 0 0.014629967510700226
in O 0 0.013108779676258564
exon O 0 0.03391014412045479
5 O 0 0.014873084612190723
that O 0 0.007777050603181124
contains O 0 0.012791061773896217
the O 0 0.016100911423563957
PTPase O 1 0.9933783411979675
core O 0 0.05560529604554176
motif O 0 0.040276650339365005
, O 0 0.012209547683596611
with O 0 0.009587186388671398
13 O 0 0.014603574760258198
of O 0 0.011272003874182701
30 O 0 0.015370485372841358
( O 0 0.013101021759212017
43 O 0 0.02844397723674774
% O 0 0.018680164590477943
) O 0 0.019219281151890755
CD B-Disease 0 0.06334665417671204
mutations O 0 0.02736496366560459
identified O 0 0.01974962279200554
in O 0 0.01862393692135811
this O 0 0.02316748909652233
exon O 0 0.09888384491205215
. O 0 0.05113823711872101

Seven O 0 0.03619910776615143
of O 0 0.01995128206908703
30 O 0 0.023716062307357788
( O 0 0.01987479440867901
23 O 0 0.025334665551781654
% O 0 0.014942305162549019
) O 0 0.010270699858665466
were O 0 0.007776605896651745
within O 0 0.00862005352973938
the O 0 0.013407663442194462
core O 0 0.034409746527671814
motif O 0 0.036842357367277145
, O 0 0.012595013715326786
the O 0 0.010937725193798542
majority O 0 0.011941131204366684
( O 0 0.009826170280575752
five O 0 0.0091536371037364
of O 0 0.008560148067772388
seven O 0 0.010610934346914291
) O 0 0.008608953095972538
of O 0 0.00839967094361782
which O 0 0.007824146188795567
were O 0 0.010146955028176308
missense O 0 0.03549710661172867
mutations O 0 0.018076801672577858
, O 0 0.012124154716730118
possibly O 0 0.014276685193181038
pointing O 0 0.015237513929605484
to O 0 0.00983909610658884
the O 0 0.012934230268001556
functional O 0 0.02081456407904625
significance O 0 0.021558310836553574
of O 0 0.01376823429018259
this O 0 0.014248501509428024
region O 0 0.03339432552456856
. O 0 0.0372796505689621

Germline O 1 0.9993139505386353
PTEN O 1 0.9999674558639526
mutations O 0 0.04012186825275421
were O 0 0.01334322802722454
identified O 0 0.012959244661033154
in O 0 0.007883350364863873
four O 0 0.008258567191660404
of O 0 0.00931081734597683
seven O 0 0.01206920389086008
( O 0 0.015665259212255478
57 O 0 0.039617788046598434
% O 0 0.02359270304441452
) O 0 0.031207315623760223
BZS B-Disease 1 0.992380678653717
families O 0 0.04011889174580574
studied O 0 0.05606205761432648
. O 0 0.05113768205046654

Interestingly O 0 0.07689221948385239
, O 0 0.020316554233431816
none O 0 0.01717415824532509
of O 0 0.012355019338428974
these O 0 0.008949210867285728
mutations O 0 0.01437344215810299
was O 0 0.014041494578123093
observed O 0 0.012309376150369644
in O 0 0.01256399042904377
the O 0 0.023194581270217896
PTPase O 1 0.9997404217720032
core O 1 0.7489320635795593
motif O 0 0.477695494890213
. O 0 0.056432269513607025

It O 0 0.028166180476546288
is O 0 0.017936769872903824
also O 0 0.016748707741498947
worthy O 0 0.024975642561912537
of O 0 0.010905212722718716
note O 0 0.014512108638882637
that O 0 0.006630671210587025
a O 0 0.012365357019007206
single O 0 0.01585475541651249
nonsense O 0 0.03003760240972042
point O 0 0.018140969797968864
mutation O 0 0.020892124623060226
, O 0 0.015472223982214928
R233X O 1 0.5151580572128296
, O 0 0.014286526478827
was O 0 0.015905996784567833
observed O 0 0.012776474468410015
in O 0 0.009848875924944878
the O 0 0.013602819293737411
germline O 0 0.03855326026678085
DNA O 0 0.016874173656105995
from O 0 0.011267517693340778
two O 0 0.012054494582116604
unrelated O 0 0.024229545146226883
CD B-Disease 0 0.05078527331352234
families O 0 0.019788522273302078
and O 0 0.0211055688560009
one O 0 0.02913064695894718
BZS B-Disease 1 0.9999669790267944
family O 0 0.061186254024505615
. O 0 0.053025022149086

Genotype O 1 0.9994779229164124
- O 1 0.9999656677246094
phenotype O 1 0.8170879483222961
studies O 0 0.019185716286301613
were O 0 0.009808918461203575
not O 0 0.0084000825881958
performed O 0 0.014046626165509224
on O 0 0.009878773242235184
this O 0 0.009620231576263905
small O 0 0.014075154438614845
group O 0 0.02314957231283188
of O 0 0.026028668507933617
BZS B-Disease 1 0.9999456405639648
families O 0 0.04981965199112892
. O 0 0.04820938780903816

However O 0 0.03847520798444748
, O 0 0.03396603465080261
genotype O 1 0.5291034579277039
- O 1 0.9987002611160278
phenotype O 0 0.10955315083265305
analysis O 0 0.023462960496544838
inthe O 0 0.1412554234266281
group O 0 0.02227412536740303
of O 0 0.01740957237780094
CD B-Disease 1 0.6190729141235352
families O 0 0.014438404701650143
revealed O 0 0.015257338061928749
two O 0 0.00697674322873354
possible O 0 0.009821301326155663
associations O 0 0.010767488740384579
worthy O 0 0.021383559331297874
of O 0 0.011904607526957989
follow O 0 0.01713128760457039
- O 1 0.8577282428741455
up O 0 0.018541261553764343
in O 0 0.014782421290874481
independent O 0 0.023670246824622154
analyses O 0 0.04057842865586281
. O 0 0.040203556418418884

The O 0 0.026665981858968735
first O 0 0.022351114079356194
was O 0 0.020002998411655426
an O 0 0.012380115687847137
association O 0 0.018512286245822906
noted O 0 0.013502162881195545
in O 0 0.009355205111205578
the O 0 0.009542213752865791
group O 0 0.014617949724197388
of O 0 0.012002554722130299
CD B-Disease 1 0.830115020275116
families O 0 0.023248465731739998
with O 1 0.8099673390388489
breast B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.26520976424217224

A O 0 0.050914060324430466
correlation O 0 0.03429896757006645
was O 0 0.02136213146150112
observed O 0 0.014095730148255825
between O 0 0.009188804775476456
the O 0 0.011433953419327736
presence O 0 0.017621897161006927
/ O 1 0.5499057173728943
absence O 0 0.017679333686828613
of O 0 0.013619444333016872
a O 0 0.022850923240184784
PTEN O 1 0.9999963045120239
mutation O 0 0.020328648388385773
and O 0 0.009201202541589737
the O 0 0.011309605091810226
type O 0 0.020295919850468636
of O 0 0.02211732044816017
breast O 1 1.0
involvement O 1 0.9960522651672363
( O 0 0.10875122249126434
unaffected O 1 0.9996228218078613
versus O 1 0.9998964071273804
benign O 1 0.9999996423721313
versus O 1 0.9999977350234985
malignant O 1 1.0
) O 0 0.06253621727228165
. O 0 0.06355650722980499

Specifically O 0 0.032811522483825684
and O 0 0.01420598104596138
more O 0 0.009130717255175114
directly O 0 0.009391067549586296
, O 0 0.00851602852344513
an O 0 0.008750076405704021
association O 0 0.02960978075861931
was O 0 0.03888259828090668
also O 0 0.008529744111001492
observed O 0 0.007305941544473171
between O 0 0.005583821330219507
the O 0 0.006952197756618261
presence O 0 0.00972217507660389
of O 0 0.009222423657774925
a O 0 0.0193060003221035
PTEN O 1 0.9999998807907104
mutation O 1 0.9949361085891724
and O 1 0.9999645948410034
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9957193732261658

Secondly O 1 0.6532947421073914
, O 0 0.021432653069496155
there O 0 0.01058986596763134
appeared O 0 0.013379774056375027
to O 0 0.008453801274299622
be O 0 0.006841415073722601
an O 0 0.009987632744014263
interdependent O 1 0.7700115442276001
association O 0 0.02449329011142254
between O 0 0.014287506230175495
mutations O 0 0.015535784885287285
upstream O 0 0.01653985306620598
and O 0 0.009920033626258373
within O 0 0.008750155568122864
the O 0 0.013921433128416538
PTPase O 1 0.9990228414535522
core O 0 0.17661090195178986
motif O 0 0.05136876180768013
, O 0 0.015275295823812485
the O 0 0.015382296405732632
core O 0 0.03294070437550545
motif O 0 0.03450140357017517
containing O 0 0.017048370093107224
the O 0 0.012521055527031422
majority O 0 0.01161165814846754
of O 0 0.01366818230599165
missense O 0 0.0487835593521595
mutations O 0 0.016120797023177147
, O 0 0.010508856736123562
and O 0 0.007717675529420376
the O 0 0.0088497344404459
involvement O 0 0.010383564978837967
of O 0 0.008122694678604603
all O 0 0.007755478378385305
major O 0 0.026754507794976234
organ O 1 0.9985455274581909
systems O 1 0.5583040714263916
( O 0 0.012269120663404465
central O 0 0.014942774549126625
nervous O 1 0.7374913692474365
system O 0 0.021496394649147987
, O 1 0.8595055341720581
thyroid O 1 1.0
, O 1 0.9999343156814575
breast O 1 1.0
, O 1 0.9999972581863403
skin O 1 1.0
and O 1 0.9999994039535522
gastrointestinal O 1 1.0
tract O 1 1.0
) O 1 0.9876428842544556
. O 0 0.06124496087431908

However O 0 0.030264247208833694
, O 0 0.018011029809713364
these O 0 0.007598059717565775
observations O 0 0.013681240379810333
would O 0 0.008530550636351109
need O 0 0.00979037769138813
to O 0 0.009108433499932289
be O 0 0.007689815480262041
confirmed O 0 0.01071837916970253
by O 0 0.007390446029603481
studying O 0 0.01247953437268734
a O 0 0.011489753611385822
larger O 0 0.013000564649701118
number O 0 0.010440242476761341
of O 0 0.01686359941959381
CD B-Disease 0 0.332876056432724
families O 0 0.040240079164505005
. O 0 0.04473259299993515

Molecular O 1 0.8441821932792664
defects O 1 0.9987397789955139
leading O 0 0.0297112837433815
to O 0 0.01565796509385109
human O 0 0.02015550807118416
complement B-Disease 1 0.9946411848068237
component I-Disease 1 0.9999998807907104
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.018999328836798668
an O 0 0.02012314461171627
African O 1 0.933233380317688
- O 1 0.9999924898147583
American O 0 0.09483132511377335
family O 0 0.04318436607718468
. O 0 0.04038918390870094

Complement B-Disease 1 0.9341779947280884
component I-Disease 1 0.9999957084655762
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.99652498960495
C6D B-Disease 1 1.0
) O 0 0.029912903904914856
was O 0 0.33449581265449524
diagnosed O 1 0.9999669790267944
in O 0 0.012786087580025196
a O 0 0.014140183106064796
16 O 0 0.021655777469277382
- O 1 0.7621219158172607
year O 0 0.019552599638700485
- O 1 0.920178234577179
old O 0 0.031199270859360695
African O 0 0.029475003480911255
- O 1 0.997461199760437
American O 0 0.03512090817093849
male O 0 0.07031721621751785
with O 0 0.23327414691448212
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 0.3294943571090698

The O 0 0.045268915593624115
patients O 1 0.9887645244598389
father O 0 0.03335040807723999
and O 0 0.012349691241979599
two O 0 0.010251224040985107
brothers O 0 0.029067613184452057
also O 0 0.010934598743915558
had O 0 0.015674781054258347
C6D B-Disease 1 0.9999513626098633
, O 0 0.010199576616287231
but O 0 0.006863956339657307
gave O 0 0.009893485344946384
no O 0 0.008319180458784103
history O 0 0.013256759382784367
of O 0 0.03163253888487816
meningitis B-Disease 1 1.0
or O 0 0.24456852674484253
other O 0 0.0279635451734066
neisserial B-Disease 1 0.9999998807907104
infection I-Disease 1 0.9999998807907104
. O 0 0.05579175800085068

By O 0 0.02931879833340645
using O 0 0.02899348735809326
exon O 0 0.07441353797912598
- O 0 0.23454582691192627
specific O 0 0.019359581172466278
polymerase O 0 0.050877735018730164
chain O 0 0.03946518152952194
reaction O 0 0.024573491886258125
( O 0 0.02426845207810402
PCR O 0 0.06258893013000488
) O 0 0.02434103935956955
/ O 0 0.12731246650218964
single O 0 0.029124349355697632
- O 1 0.8753678202629089
strand O 0 0.039514921605587006
conformation O 0 0.03570925071835518
polymorphism O 0 0.033185552805662155
as O 0 0.014841349795460701
a O 0 0.01697433367371559
screening O 0 0.027070295065641403
step O 0 0.022180691361427307
and O 0 0.015050777234137058
nucleotide O 0 0.02214820310473442
sequencing O 0 0.020874451845884323
of O 0 0.012058413587510586
target O 0 0.01749199442565441
exons O 0 0.02519393339753151
, O 0 0.011938521638512611
we O 0 0.009076794609427452
determined O 0 0.010630954056978226
that O 0 0.008042878471314907
the O 0 0.012741444632411003
proband O 1 0.5862197875976562
was O 0 0.020323075354099274
a O 0 0.02078646793961525
compound O 0 0.042767737060785294
heterozygote O 0 0.1026688814163208
for O 0 0.020550984889268875
two O 0 0.027257276698946953
C6 O 1 0.9999929666519165
gene O 0 0.059802550822496414
mutations O 0 0.06118693947792053
. O 0 0.05080451816320419

The O 0 0.03936527669429779
first O 0 0.033615224063396454
, O 0 0.025458531454205513
1195delC O 0 0.07090005278587341
located O 0 0.02890324406325817
in O 0 0.016604317352175713
exon O 0 0.04985632747411728
7 O 0 0.02656223066151142
, O 0 0.014810378663241863
is O 0 0.011933054774999619
a O 0 0.014700960367918015
novel O 0 0.023853767663240433
mutation O 0 0.016484472900629044
, O 0 0.009623830206692219
while O 0 0.008877084590494633
the O 0 0.009929328225553036
second O 0 0.01628263294696808
, O 0 0.014627127908170223
1936delG O 0 0.0500820130109787
in O 0 0.013715467415750027
exon O 0 0.048236168920993805
12 O 0 0.017277410253882408
, O 0 0.01037569995969534
has O 0 0.009296569041907787
been O 0 0.008221330121159554
described O 0 0.010337954387068748
before O 0 0.009551998227834702
to O 0 0.011222061701118946
cause O 0 0.1228368729352951
C6D B-Disease 1 0.9999136924743652
in O 0 0.013170164078474045
an O 0 0.01356452889740467
unrelated O 0 0.02834184840321541
African O 0 0.3766671419143677
- O 1 0.9996616840362549
American O 0 0.040438443422317505
individual O 0 0.038217950612306595
. O 0 0.04457727447152138

Both O 0 0.03653459995985031
mutations O 0 0.035602521151304245
result O 0 0.018163567408919334
in O 0 0.018385017290711403
premature O 1 0.9769331216812134
termination O 1 0.9983513355255127
codons O 0 0.11574894934892654
and O 0 0.04741688072681427
C6 O 1 0.9999977350234985
null O 0 0.4632790982723236
alleles O 0 0.0890469178557396
. O 0 0.06201566755771637

Allele O 0 0.2916213274002075
- O 1 0.621780514717102
specific O 0 0.02448035031557083
PCR O 0 0.04748855531215668
indicated O 0 0.02068401873111725
that O 0 0.00968230701982975
the O 0 0.012747731059789658
probands O 0 0.3916512429714203
two O 0 0.01418180949985981
brothers O 0 0.030205877497792244
also O 0 0.01703321747481823
inherited O 1 0.9890788197517395
the O 0 0.017772331833839417
1195delC O 1 0.9995996356010437
mutation O 0 0.021286578848958015
from O 0 0.011777142994105816
their O 0 0.012485930696129799
heterozygous O 0 0.0270010307431221
mother O 0 0.023237528279423714
and O 0 0.013502494432032108
the O 0 0.018048346042633057
1936delG O 1 0.9978542923927307
mutation O 0 0.02598477527499199
from O 0 0.015559373423457146
their O 0 0.016295168548822403
homozygous O 0 0.0486832819879055
father O 0 0.17477144300937653
. O 0 0.026646139100193977
. O 0 0.04217670485377312

PAX6 O 1 0.9997168183326721
mutations O 0 0.10540158301591873
reviewed O 0 0.09389717876911163
. O 0 0.06578958034515381

Mutations O 0 0.06388194113969803
in O 0 0.026504874229431152
PAX6 O 1 0.9995915293693542
are O 0 0.010609998367726803
responsible O 0 0.01379277091473341
for O 0 0.010596523061394691
human O 0 0.016487348824739456
aniridia B-Disease 1 0.9999991655349731
and O 0 0.011695247143507004
have O 0 0.006212725304067135
also O 0 0.007377465255558491
been O 0 0.006198333576321602
found O 0 0.005964477546513081
in O 0 0.007280167192220688
patients O 0 0.2581947147846222
with O 0 0.010515879839658737
Peters B-Disease 1 0.9999933242797852
anomaly I-Disease 1 0.9999986886978149
, O 1 0.7615625858306885
with O 1 0.9998596906661987
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 1 0.9980478286743164
with O 1 0.9399622082710266
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
keratitis I-Disease 1 1.0
, O 0 0.4383868873119354
and O 0 0.020082224160432816
with O 0 0.026580533012747765
isolated B-Disease 1 0.9988858103752136
foveal I-Disease 1 0.9999998807907104
hypoplasia I-Disease 1 1.0
. O 0 0.24869202077388763

No O 0 0.044359028339385986
locus O 0 0.05683321878314018
other O 0 0.013376465067267418
than O 0 0.014603429473936558
chromosome O 0 0.028351014479994774
11p13 O 1 0.7764013409614563
has O 0 0.01288419310003519
been O 0 0.011057477444410324
implicated O 0 0.024566562846302986
in O 0 0.016254693269729614
aniridia B-Disease 1 0.9999954700469971
, O 0 0.01683012954890728
and O 0 0.01640145480632782
PAX6 O 1 0.9999972581863403
is O 0 0.013826610520482063
clearly O 0 0.013585573062300682
the O 0 0.010127237066626549
major O 0 0.016439391300082207
, O 0 0.01020042784512043
if O 0 0.007059625815600157
not O 0 0.006843777373433113
only O 0 0.009990067221224308
, O 0 0.014801411889493465
gene O 0 0.022639716044068336
responsible O 0 0.030832508578896523
. O 0 0.04031018167734146

Twenty O 0 0.0722086951136589
- O 0 0.09876321256160736
eight O 0 0.02554975263774395
percent O 0 0.018579278141260147
of O 0 0.013936609029769897
identified O 0 0.02233516424894333
PAX6 O 1 0.9999268054962158
mutations O 0 0.02247115969657898
are O 0 0.012950762175023556
C O 1 0.9996999502182007
- O 1 0.9999703168869019
T O 1 0.9988038539886475
changes O 0 0.017590327188372612
at O 0 0.02526788040995598
CpG O 0 0.12419699132442474
dinucleotides O 0 0.48429885506629944
, O 0 0.01681208424270153
20 O 0 0.01664838008582592
% O 0 0.011208192445337772
are O 0 0.007225727662444115
splicing O 0 0.02217385545372963
errors O 0 0.01710381731390953
, O 0 0.010871308855712414
and O 0 0.0077497996389865875
more O 0 0.006076309829950333
than O 0 0.008431961759924889
30 O 0 0.014514392241835594
% O 0 0.01264226995408535
are O 0 0.008734217844903469
deletion O 0 0.03299936652183533
or O 0 0.01884022355079651
insertion O 0 0.057736173272132874
events O 0 0.038701675832271576
. O 0 0.045489925891160965

There O 0 0.024243488907814026
is O 0 0.01836567372083664
a O 0 0.019179347902536392
noticeably O 0 0.1696610450744629
elevated O 1 0.95179283618927
level O 0 0.018467320129275322
of O 0 0.014285208657383919
mutation O 0 0.01594707742333412
in O 0 0.010880742222070694
the O 0 0.01344805397093296
paired O 0 0.0277000293135643
domain O 0 0.01730070449411869
compared O 0 0.01200466975569725
with O 0 0.009793207980692387
the O 0 0.011339748278260231
rest O 0 0.016275888308882713
of O 0 0.013790149241685867
the O 0 0.021373555064201355
gene O 0 0.03369610011577606
. O 0 0.042360421270132065

Increased O 0 0.04812644049525261
mutation O 0 0.036978937685489655
in O 0 0.016797423362731934
the O 0 0.02106267772614956
homeodomain O 1 0.996181845664978
is O 0 0.01674199476838112
accounted O 0 0.02051493525505066
for O 0 0.011290405876934528
by O 0 0.011903529986739159
the O 0 0.02129923552274704
hypermutable O 1 0.9963374137878418
CpG O 1 0.8844937682151794
dinucleotide O 1 0.9413409233093262
in O 0 0.034133750945329666
codon O 0 0.06714747101068497
240 O 0 0.08911537379026413
. O 0 0.05796436220407486

Very O 0 0.029775895178318024
nearly O 0 0.022958222776651382
all O 0 0.013406535610556602
mutations O 0 0.01711387373507023
appear O 0 0.01142494473606348
to O 0 0.011319589801132679
cause O 0 0.03197479248046875
loss O 0 0.13261212408542633
of O 0 0.011160357855260372
function O 0 0.01066311914473772
of O 0 0.011144823394715786
the O 0 0.015658091753721237
mutant O 0 0.20495253801345825
allele O 0 0.027206523343920708
, O 0 0.012112520635128021
and O 0 0.008100444450974464
more O 0 0.0069277323782444
than O 0 0.008274574764072895
80 O 0 0.015708299353718758
% O 0 0.013637681491672993
of O 0 0.016062114387750626
exonic O 1 0.8851653933525085
substitutions O 0 0.03684946894645691
result O 0 0.01882832683622837
in O 0 0.023080693557858467
nonsense O 0 0.07787728309631348
codons O 0 0.07790878415107727
. O 0 0.05515754967927933

In O 0 0.02851206436753273
a O 0 0.022630279883742332
gene O 0 0.01906910352408886
with O 0 0.01155959814786911
such O 0 0.010737608186900616
extraordinarily O 0 0.08017667382955551
high O 0 0.022179769352078438
sequence O 0 0.012697840109467506
conservation O 0 0.019477225840091705
throughout O 0 0.012584533542394638
evolution O 0 0.013999216258525848
, O 0 0.01156642660498619
there O 0 0.008972465991973877
are O 0 0.008019576780498028
presumed O 0 0.028235336765646935
undiscovered O 1 0.966385543346405
missense O 0 0.17133840918540955
mutations O 0 0.021607570350170135
, O 0 0.011666109785437584
these O 0 0.005786632187664509
are O 0 0.005274434108287096
hypothesized O 0 0.014203059487044811
to O 0 0.00802890956401825
exist O 0 0.006396461743861437
in O 0 0.007423863280564547
as O 0 0.012516374699771404
- O 1 0.9973635077476501
yet O 0 0.022905873134732246
unidentified O 0 0.04972077161073685
phenotypes O 0 0.08764564245939255
. O 0 0.02894807979464531
. O 0 0.041178446263074875

Genetic O 0 0.07023170590400696
heterogeneity O 0 0.0772051140666008
and O 0 0.025212794542312622
penetrance O 0 0.2507455050945282
analysis O 0 0.015354135073721409
of O 0 0.01352460216730833
the O 0 0.019464833661913872
BRCA1 O 1 0.9999639987945557
and O 0 0.024471953511238098
BRCA2 O 1 0.9999873638153076
genes O 0 0.030513551086187363
in O 1 0.7747835516929626
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.611518144607544
. O 0 0.04289771988987923

The O 1 0.9989098310470581
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.9999823570251465
Consortium O 1 0.9747231602668762
. O 0 0.0665009468793869

The O 0 0.03365130349993706
contribution O 0 0.03773082420229912
of O 0 0.022777896374464035
BRCA1 O 1 0.9994832277297974
and O 0 0.021401138976216316
BRCA2 O 1 0.9999762773513794
to O 0 0.44163748621940613
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 1 0.9995442032814026
assessed O 0 0.030042702332139015
by O 0 0.01469864509999752
linkage O 0 0.031108180060982704
and O 0 0.015735972672700882
mutation O 0 0.01916077919304371
analysis O 0 0.012506102211773396
in O 0 0.011486319825053215
237 O 0 0.0338076613843441
families O 0 0.012521686963737011
, O 0 0.0097093740478158
each O 0 0.0060301232151687145
with O 0 0.006311929319053888
at O 0 0.008968973532319069
least O 0 0.007366794161498547
four O 0 0.008049653843045235
cases O 0 0.01023737620562315
of O 0 0.10753972083330154
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.014241257682442665
collected O 0 0.014784032478928566
by O 0 0.013793976046144962
the O 1 0.6935815811157227
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 1 0.999961256980896
Consortium O 1 0.9209179878234863
. O 0 0.06606066226959229

Families O 0 0.03825344145298004
were O 0 0.017034072428941727
included O 0 0.016093622893095016
without O 0 0.010153589770197868
regard O 0 0.011167026124894619
to O 0 0.008719068020582199
the O 0 0.009736310690641403
occurrence O 0 0.02474314346909523
of O 0 0.3381742238998413
ovarian B-Disease 1 1.0
or I-Disease 1 0.9506493806838989
other I-Disease 0 0.08081445842981339
cancers I-Disease 1 0.9999992847442627
. O 0 0.04522911459207535

Overall O 1 0.8185918927192688
, O 0 0.13843855261802673
disease O 1 0.9999963045120239
was O 0 0.34472551941871643
linked O 0 0.042298316955566406
to O 0 0.014503306709229946
BRCA1 O 1 0.9866837859153748
in O 0 0.009379095397889614
an O 0 0.008733656257390976
estimated O 0 0.01288908813148737
52 O 0 0.02015179768204689
% O 0 0.01098528504371643
of O 0 0.009544254280626774
families O 0 0.009883321821689606
, O 0 0.009614231996238232
to O 0 0.011591318063437939
BRCA2 O 0 0.39822468161582947
in O 0 0.01071980781853199
32 O 0 0.017535284161567688
% O 0 0.01035870797932148
of O 0 0.009260223247110844
families O 0 0.010453207418322563
, O 0 0.00808313675224781
and O 0 0.006538019515573978
to O 0 0.007597276009619236
neither O 0 0.012417444959282875
gene O 0 0.009604942984879017
in O 0 0.00778193911537528
16 O 0 0.014162503182888031
% O 0 0.011537249200046062
( O 0 0.011335869319736958
95 O 0 0.023503463715314865
% O 0 0.015213312581181526
confidence O 0 0.026299627497792244
interval O 0 0.031404078006744385
[ O 0 0.04052067548036575
CI O 1 0.9997525811195374
] O 0 0.03550873324275017
6 O 0 0.023845035582780838
% O 0 0.017550988122820854
- O 0 0.42969536781311035
28 O 0 0.02236044965684414
% O 0 0.015359087847173214
) O 0 0.013680788688361645
, O 0 0.014896949753165245
suggesting O 0 0.02036742866039276
other O 0 0.016468986868858337
predisposition O 1 0.9979490637779236
genes O 0 0.03892173990607262
. O 0 0.045661561191082

The O 0 0.028916852548718452
majority O 0 0.021152354776859283
( O 0 0.017347531393170357
81 O 0 0.03121667541563511
% O 0 0.01270715706050396
) O 0 0.00938691757619381
of O 0 0.009040565229952335
the O 0 0.11428536474704742
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.01892281509935856
were O 0 0.008943971246480942
due O 0 0.009201081469655037
to O 0 0.011903977952897549
BRCA1 O 1 0.9992697834968567
, O 0 0.008749567903578281
with O 0 0.006634770892560482
most O 0 0.006875349208712578
others O 0 0.007954051718115807
( O 0 0.00957274530082941
14 O 0 0.015460184775292873
% O 0 0.013543826527893543
) O 0 0.014230883680284023
due O 0 0.019485214725136757
to O 0 0.03228508308529854
BRCA2 O 1 0.9982225298881531
. O 0 0.054609812796115875

Conversely O 0 0.06949732452630997
, O 0 0.018965238705277443
the O 0 0.013230986893177032
majority O 0 0.010303189046680927
of O 0 0.008653621189296246
families O 0 0.008589123375713825
with O 0 0.007943053729832172
male B-Disease 0 0.019474899396300316
and I-Disease 0 0.044304098933935165
female I-Disease 1 0.9999858140945435
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.010962761007249355
due O 0 0.012814830057322979
to O 0 0.01671912893652916
BRCA2 O 1 0.999987006187439
( O 0 0.024282364174723625
76 O 1 0.9383082389831543
% O 0 0.02904033474624157
) O 0 0.03457503393292427
. O 0 0.04748760536313057

The O 0 0.04077339172363281
largest O 0 0.04454208165407181
proportion O 0 0.027552617713809013
( O 0 0.020998746156692505
67 O 0 0.03123568743467331
% O 0 0.016703065484762192
) O 0 0.011121698655188084
of O 0 0.010058562271296978
families O 0 0.009414279833436012
due O 0 0.008722962811589241
to O 0 0.008482388220727444
other O 0 0.007455355953425169
genes O 0 0.009645665064454079
was O 0 0.010786088183522224
found O 0 0.007510801311582327
in O 0 0.0062443651258945465
families O 0 0.007157720625400543
with O 0 0.005922436248511076
four O 0 0.007572068367153406
or O 0 0.007336145732551813
five O 0 0.008509802632033825
cases O 0 0.009691203944385052
of O 0 0.015482925809919834
female O 1 0.9999551773071289
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
only O 0 0.030422016978263855
. O 0 0.04624462500214577

These O 0 0.023242484778165817
estimates O 0 0.023433657363057137
were O 0 0.013189476914703846
not O 0 0.011488698422908783
substantially O 0 0.024340534582734108
affected O 0 0.013369852676987648
either O 0 0.009470697492361069
by O 0 0.008386707864701748
changing O 0 0.013136154040694237
the O 0 0.012298556976020336
assumed O 0 0.03171994164586067
penetrance O 1 0.8830068111419678
model O 0 0.027550512924790382
for O 0 0.01944812573492527
BRCA1 O 1 0.9988572597503662
or O 0 0.011529767885804176
by O 0 0.009326109662652016
including O 0 0.012918448075652122
or O 0 0.015902435407042503
excluding O 0 0.23349319398403168
BRCA1 O 1 0.9999610185623169
mutation O 0 0.03906359523534775
data O 0 0.03111930936574936
. O 0 0.042658258229494095

Among O 0 0.029018433764576912
those O 0 0.014391680248081684
families O 0 0.015098132193088531
with O 0 0.019440816715359688
disease O 1 0.9999998807907104
due O 0 0.34173956513404846
to O 0 0.018502462655305862
BRCA1 O 1 0.99996018409729
that O 0 0.007973343133926392
were O 0 0.008332673460245132
tested O 0 0.015308237634599209
by O 0 0.006248367018997669
one O 0 0.0070521351881325245
of O 0 0.007549595553427935
the O 0 0.009704937227070332
standard O 0 0.01682807132601738
screening O 0 0.020243557170033455
methods O 0 0.012112772092223167
, O 0 0.012026377953588963
mutations O 0 0.012896534986793995
were O 0 0.0073603680357337
detected O 0 0.013684791512787342
in O 0 0.009062455035746098
the O 0 0.012781069613993168
coding O 0 0.02427186258137226
sequence O 0 0.01436486653983593
or O 0 0.012867901474237442
splice O 0 0.032234806567430496
sites O 0 0.014152579009532928
in O 0 0.008991341106593609
an O 0 0.010678432881832123
estimated O 0 0.016758887097239494
63 O 0 0.030792178586125374
% O 0 0.016428425908088684
( O 0 0.015740124508738518
95 O 0 0.03090527281165123
% O 0 0.023487688973546028
CI O 1 0.9282073378562927
51 O 0 0.045212265104055405
% O 0 0.026006482541561127
- O 1 0.9958070516586304
77 O 0 0.07999128848314285
% O 0 0.031440671533346176
) O 0 0.035033367574214935
. O 0 0.042600031942129135

The O 0 0.04058156535029411
estimated O 0 0.0332542322576046
sensitivity O 0 0.04123209789395332
was O 0 0.02692437171936035
identical O 0 0.018719179555773735
for O 0 0.01168050803244114
direct O 0 0.01455235667526722
sequencing O 0 0.026207273826003075
and O 0 0.016376128420233727
other O 0 0.01861686259508133
techniques O 0 0.0396343395113945
. O 0 0.04565870016813278

The O 0 0.0585254542529583
penetrance O 1 0.6769197583198547
of O 0 0.041172824800014496
BRCA2 O 1 0.9998505115509033
was O 0 0.0280454121530056
estimated O 0 0.018310703337192535
by O 0 0.015604398213326931
maximizing O 0 0.04307074844837189
the O 0 0.02001163549721241
LOD O 1 0.999239444732666
score O 0 0.02704555168747902
in O 0 0.022956397384405136
BRCA2 O 1 0.9999560117721558
- O 1 0.9997842907905579
mutation O 0 0.024110224097967148
families O 0 0.01321486011147499
, O 0 0.011277732439339161
over O 0 0.011048147454857826
all O 0 0.010906534269452095
possible O 0 0.020770275965332985
penetrance O 1 0.8995225429534912
functions O 0 0.03544273227453232
. O 0 0.04821474105119705

The O 0 0.039384424686431885
estimated O 0 0.032508302479982376
cumulative O 0 0.03832526132464409
risk O 0 0.04093772545456886
of O 0 0.15001492202281952
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
reached O 0 0.15112784504890442
28 O 0 0.026278935372829437
% O 0 0.017455164343118668
( O 0 0.016570284962654114
95 O 0 0.030177023261785507
% O 0 0.022314967587590218
CI O 1 0.995258629322052
9 O 0 0.02850152738392353
% O 0 0.0206599161028862
- O 0 0.3636467456817627
44 O 0 0.024264724925160408
% O 0 0.013124038465321064
) O 0 0.009671157225966454
by O 0 0.007902086712419987
age O 0 0.012762155383825302
50 O 0 0.013304950669407845
years O 0 0.011367988772690296
and O 0 0.0119705805554986
84 O 0 0.028816355392336845
% O 0 0.01637515239417553
( O 0 0.01725739985704422
95 O 0 0.032302360981702805
% O 0 0.022604357451200485
CI O 1 0.8933891654014587
43 O 0 0.03649775683879852
% O 0 0.020659105852246284
- O 0 0.24538196623325348
95 O 0 0.031038513407111168
% O 0 0.016858335584402084
) O 0 0.011146199889481068
by O 0 0.010144885629415512
age O 0 0.018507415428757668
70 O 0 0.030666925013065338
years O 0 0.031084198504686356
. O 0 0.044080473482608795

The O 0 0.058296140283346176
corresponding O 1 0.9961919784545898
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.9999712705612183
were O 0 0.03275222331285477
0 O 0 0.0546741746366024
. O 0 0.04587573930621147

4 O 0 0.05604512244462967
% O 0 0.02853456884622574
( O 0 0.02031608857214451
95 O 0 0.03834613040089607
% O 0 0.024548960849642754
CI O 1 0.983998715877533
0 O 0 0.034847188740968704
% O 0 0.020870685577392578
- O 0 0.4286867380142212
1 O 0 0.022276120260357857
% O 0 0.014709686860442162
) O 0 0.010395718738436699
by O 0 0.008298149332404137
age O 0 0.013453141786158085
50 O 0 0.014959931373596191
years O 0 0.011739006265997887
and O 0 0.011287434957921505
27 O 0 0.019766790792346
% O 0 0.014068136923015118
( O 0 0.015298938378691673
95 O 0 0.029820721596479416
% O 0 0.022659745067358017
CI O 1 0.986580491065979
0 O 0 0.03395755589008331
% O 0 0.02066022902727127
- O 0 0.06697811931371689
47 O 0 0.03847010061144829
% O 0 0.01737079583108425
) O 0 0.014458577148616314
by O 0 0.012523225508630276
age O 0 0.023603446781635284
70 O 0 0.0329049713909626
years O 0 0.0342961885035038
. O 0 0.04276268184185028

The O 0 0.03374253958463669
lifetime O 0 0.08771715313196182
risk O 1 0.9267814755439758
of O 1 0.9873752593994141
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
appears O 0 0.21897383034229279
similar O 0 0.008667479269206524
to O 0 0.008108275011181831
the O 0 0.009031219407916069
risk O 0 0.07805389910936356
in O 0 0.016544990241527557
BRCA1 O 1 0.9999997615814209
carriers O 1 0.9617562294006348
, O 0 0.00950260553508997
but O 0 0.006532248575240374
there O 0 0.006844399496912956
was O 0 0.009590021334588528
some O 0 0.0065097808837890625
suggestion O 0 0.014663385227322578
of O 0 0.008417577482759953
a O 0 0.012073407880961895
lower O 0 0.018127193674445152
risk O 0 0.02377120591700077
in O 0 0.015514926053583622
BRCA2 O 1 0.9999929666519165
carriers O 1 0.7645178437232971
< O 1 0.6637771129608154
50 O 0 0.02573772519826889
years O 0 0.018422506749629974
of O 0 0.01986929215490818
age O 0 0.03601380065083504
. O 0 0.042114533483982086

Eye B-Disease 1 0.9999831914901733
movement I-Disease 0 0.32141876220703125
abnormalities I-Disease 1 0.9937357306480408
correlate O 0 0.050105608999729156
with O 0 0.02258530631661415
genotype O 0 0.39563819766044617
in O 0 0.02603122964501381
autosomal O 1 0.9999932050704956
dominant O 1 0.9999990463256836
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 0.9999998807907104
I I-Disease 1 0.999964714050293
. O 0 0.059063877910375595

We O 0 0.031059395521879196
compared O 0 0.032229915261268616
horizontal O 0 0.05857975408434868
eye O 1 0.9979730248451233
movements O 0 0.027383368462324142
( O 0 0.027326753363013268
visually O 0 0.06737520545721054
guided O 0 0.18859577178955078
saccades O 1 0.9999383687973022
, O 0 0.027657782658934593
antisaccades O 1 0.953737199306488
, O 0 0.018111208453774452
and O 0 0.014415493234992027
smooth O 0 0.026439877226948738
pursuit O 0 0.06853877007961273
) O 0 0.013235775753855705
in O 0 0.010433086194097996
control O 0 0.016181625425815582
subjects O 0 0.01842256635427475
( O 0 0.015623264014720917
n O 0 0.026455434039235115
= O 0 0.033586207777261734
14 O 0 0.021932372823357582
) O 0 0.014558691531419754
and O 0 0.013819290325045586
patients O 0 0.017810937017202377
with O 0 0.009149481542408466
three O 0 0.008698767982423306
forms O 0 0.011125135235488415
of O 0 0.014796309173107147
autosomal O 1 0.9999556541442871
dominant O 1 0.9999725818634033
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 1.0
type I-Disease 1 0.9999475479125977
I I-Disease 1 0.9981303811073303
spinocerebellar B-Disease 1 0.9999996423721313
ataxias I-Disease 1 0.9988958835601807
1 I-Disease 0 0.028842151165008545
and I-Disease 0 0.014514339156448841
2 I-Disease 0 0.023187709972262383
( O 0 0.021091043949127197
SCA1 B-Disease 1 0.9928401708602905
, O 0 0.019184408709406853
n O 0 0.03285206854343414
= O 0 0.03785274177789688
11 O 0 0.023006096482276917
; O 0 0.02175152488052845
SCA2 B-Disease 1 0.9226417541503906
, O 0 0.01726285181939602
n O 0 0.027018800377845764
= O 0 0.026456402614712715
10 O 0 0.016812559217214584
) O 0 0.01385051291435957
and O 0 0.01672893948853016
SCA3 B-Disease 1 0.9999992847442627
/ O 1 0.999984860420227
Machado B-Disease 1 0.999987006187439
- I-Disease 1 0.9999984502792358
Joseph I-Disease 1 0.9999232292175293
disease I-Disease 1 0.9999997615814209
( O 0 0.17668521404266357
MJD B-Disease 1 0.9999998807907104
) O 0 0.02648431994020939
( O 0 0.02395334281027317
n O 0 0.04558965563774109
= O 0 0.05331483855843544
16 O 0 0.040805667638778687
) O 0 0.037474848330020905
. O 0 0.04267847537994385

In O 0 0.057403258979320526
SCA1 B-Disease 1 0.9987882971763611
, O 0 0.03910570591688156
saccade O 1 0.7790908217430115
amplitude O 0 0.04345113784074783
was O 0 0.026886828243732452
significantly O 0 0.02445702627301216
increased O 0 0.019441207870841026
, O 0 0.019927890971302986
resulting O 0 0.02629314363002777
in O 0 0.028961345553398132
hypermetria B-Disease 1 0.9934951663017273
. O 0 0.055602286010980606

The O 0 0.044815193861722946
smooth O 0 0.057385947555303574
pursuit O 0 0.076783187687397
gain O 0 0.05170933157205582
was O 0 0.29564395546913147
decreased O 0 0.23199397325515747
. O 0 0.049192268401384354

In O 0 0.06276064366102219
SCA2 B-Disease 1 0.9993255138397217
, O 0 0.04206499084830284
saccade O 1 0.9528525471687317
velocity O 0 0.06008854880928993
was O 0 0.051670994609594345
markedly O 0 0.13975884020328522
decreased O 0 0.08970171213150024
. O 0 0.060236793011426926

The O 0 0.03610507771372795
percentage O 0 0.027153531089425087
of O 0 0.01663544960319996
errors O 0 0.019185645505785942
in O 0 0.01524587906897068
antisaccades O 1 0.9997586607933044
was O 0 0.03409258648753166
greatly O 0 0.018674539402127266
increased O 0 0.013126050122082233
and O 0 0.010003582574427128
was O 0 0.013317514210939407
significantly O 0 0.014962413348257542
correlated O 0 0.01999465748667717
with O 0 0.010763400234282017
age O 0 0.1210075169801712
at O 1 0.9972689747810364
disease O 1 1.0
onset O 1 1.0
. O 0 0.2947918772697449

In O 0 0.03344134986400604
addition O 0 0.024632805958390236
, O 0 0.016605360433459282
a O 0 0.013916983269155025
correlation O 0 0.017520561814308167
between O 0 0.010649621486663818
smooth O 0 0.022122656926512718
pursuit O 0 0.036738622933626175
gain O 0 0.019367298111319542
and O 0 0.00992595311254263
the O 0 0.00983446091413498
number O 0 0.010141300968825817
of O 0 0.016921766102313995
trinucleotide O 1 0.9997990727424622
repeats O 0 0.04763403534889221
was O 0 0.036479245871305466
found O 0 0.027981454506516457
. O 0 0.0373837947845459

In O 0 0.045648906379938126
SCA3 B-Disease 1 0.999992847442627
, O 0 0.03374703228473663
gaze B-Disease 1 0.9971001744270325
- I-Disease 1 0.9999986886978149
evoked I-Disease 1 0.9999479055404663
nystagmus I-Disease 1 0.9999973773956299
was O 0 0.05116401985287666
often O 0 0.011570822447538376
present O 0 0.011653642170131207
as O 0 0.012360665947198868
was O 0 0.0287465900182724
saccade O 1 0.9996711015701294
hypometria O 1 0.9972146153450012
and O 0 0.01670392043888569
smooth O 0 0.032229434698820114
pursuit O 0 0.2708647549152374
gain O 0 0.036142900586128235
was O 0 0.3259470760822296
markedly O 1 0.5613043904304504
decreased O 0 0.15696127712726593
. O 0 0.04663042724132538

Three O 0 0.03731124848127365
major O 0 0.0374145582318306
criteria O 0 0.03385248780250549
, O 0 0.031015561893582344
saccade O 1 0.8992818593978882
amplitude O 0 0.04632772505283356
, O 0 0.028863845393061638
saccade O 1 0.7748330235481262
velocity O 0 0.032109495252370834
, O 0 0.01522945798933506
and O 0 0.011424767784774303
presence O 0 0.01548527367413044
of O 0 0.017404360696673393
gaze B-Disease 1 0.9970383644104004
- I-Disease 1 0.9999953508377075
evoked I-Disease 1 0.9998829364776611
nystagmus I-Disease 1 0.999927282333374
, O 0 0.01838243193924427
permitted O 0 0.016473738476634026
the O 0 0.01335009653121233
correct O 0 0.019568532705307007
assignment O 0 0.025471054017543793
of O 0 0.01231471635401249
90 O 0 0.01713917963206768
% O 0 0.011513795703649521
of O 0 0.012999855913221836
the O 0 0.01741861365735531
SCA1 B-Disease 1 0.9915851354598999
, O 0 0.015952635556459427
90 O 0 0.017832621932029724
% O 0 0.012347880750894547
of O 0 0.011636891402304173
the O 0 0.015094077214598656
SCA2 B-Disease 1 0.9995834231376648
, O 0 0.012952085584402084
and O 0 0.011144019663333893
93 O 0 0.02435307763516903
% O 0 0.010906478390097618
of O 0 0.009797735139727592
the O 0 0.012147615663707256
patients O 1 0.9745184183120728
with O 0 0.014010381884872913
SCA3 B-Disease 1 0.9999970197677612
to O 0 0.011391494423151016
their O 0 0.009240417741239071
genetically O 0 0.016618911176919937
confirmed O 0 0.015527998097240925
patient O 1 0.9443596601486206
group O 0 0.01834002137184143
and O 0 0.010399369522929192
, O 0 0.011256346479058266
therefore O 0 0.011337042786180973
, O 0 0.010395856574177742
may O 0 0.010648089461028576
help O 0 0.01854212023317814
orient O 0 0.11881478875875473
diagnoses O 1 0.9953291416168213
of O 0 0.019860519096255302
SCA1 B-Disease 1 0.9999978542327881
, O 0 0.02650946006178856
SCA2 B-Disease 1 0.9999421834945679
, O 0 0.01615919917821884
and O 0 0.01399083249270916
SCA3 B-Disease 1 0.9999940395355225
at O 0 0.013664428144693375
early O 0 0.013313911855220795
clinical O 1 0.5759606957435608
stages O 0 0.018499301746487617
of O 0 0.016168899834156036
the O 1 0.8977149724960327
diseases O 1 1.0
. O 0 0.02935960330069065
. O 0 0.03867960721254349

Genetic O 0 0.04154839366674423
basis O 0 0.018058277666568756
and O 0 0.015831179916858673
molecular O 0 0.02978813834488392
mechanism O 0 0.04393206536769867
for O 1 0.9121136665344238
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 1 0.9931502938270569

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.9999998807907104
causes O 1 0.9470974802970886
more O 0 0.014759049750864506
than O 0 0.013037793338298798
300 O 0 0.02259198948740959
, O 0 0.01456641685217619
000 O 0 0.03378370776772499
sudden O 0 0.1802818775177002
deaths O 0 0.017934812232851982
each O 0 0.008597307838499546
year O 0 0.012466930784285069
in O 0 0.014687374234199524
the O 0 0.022846657782793045
USA O 0 0.08543774485588074
alone O 0 0.05107325688004494
. O 0 0.051012977957725525

In O 0 0.025927580893039703
approximately O 0 0.022626152262091637
5 O 0 0.02436790056526661
- O 0 0.08179118484258652
12 O 0 0.015549318864941597
% O 0 0.010132692754268646
of O 0 0.007538241799920797
these O 0 0.005988419521600008
cases O 0 0.007948169484734535
, O 0 0.0071595339104533195
there O 0 0.006362156476825476
are O 0 0.005165272857993841
no O 0 0.01114497147500515
demonstrable O 1 0.9999121427536011
cardiac O 1 1.0
or O 1 0.7325402498245239
non O 1 0.9999923706054688
- O 1 1.0
cardiac O 1 1.0
causes O 1 0.986994206905365
to O 0 0.012190790846943855
account O 0 0.010463397018611431
for O 0 0.009132047183811665
the O 0 0.011000588536262512
episode O 0 0.01760423555970192
, O 0 0.010773817077279091
which O 0 0.007568059489130974
is O 0 0.008048835210502148
therefore O 0 0.009399384260177612
classified O 0 0.02146170847117901
as O 1 0.9124444127082825
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 1 0.9999961853027344
IVF B-Disease 1 1.0
) O 0 0.05385936424136162
. O 0 0.05580760911107063

A O 0 0.04277002066373825
distinct O 0 0.02536231465637684
group O 0 0.025360677391290665
of O 0 0.021552085876464844
IVF B-Disease 1 1.0
patients O 1 0.9999915361404419
has O 0 0.012365182861685753
been O 0 0.008550084196031094
found O 0 0.006439816672354937
to O 0 0.006207575090229511
present O 0 0.008316407911479473
with O 0 0.00964815728366375
a O 0 0.020172644406557083
characteristic O 1 0.7126078605651855
electrocardiographic O 1 0.9999679327011108
pattern O 0 0.07949360460042953
. O 0 0.05606089159846306

Because O 0 0.022815395146608353
of O 0 0.014500199817121029
the O 0 0.013634155504405499
small O 0 0.011272682808339596
size O 0 0.01284179836511612
of O 0 0.009404513984918594
most O 0 0.008864247240126133
pedigrees O 0 0.021638721227645874
and O 0 0.008900163695216179
the O 0 0.009904028847813606
high O 0 0.023045850917696953
incidence O 1 0.9578151106834412
of O 0 0.01332588866353035
sudden B-Disease 1 0.9998685121536255
death I-Disease 1 0.8129297494888306
, O 0 0.010373104363679886
however O 0 0.007363064680248499
, O 0 0.009765303693711758
molecular O 0 0.014227740466594696
genetic O 0 0.010910902172327042
studies O 0 0.011320914141833782
of O 0 0.013614736497402191
IVF B-Disease 1 0.9999932050704956
have O 0 0.010187740437686443
not O 0 0.00898110680282116
yet O 0 0.014705485664308071
been O 0 0.015301840379834175
done O 0 0.025712303817272186
. O 0 0.033434487879276276

Because O 0 0.05639084428548813
IVF B-Disease 1 0.9999997615814209
causes O 1 0.9999978542327881
cardiac O 1 1.0
rhythm O 1 0.9999994039535522
disturbance O 1 0.9999916553497314
, O 0 0.016214309260249138
we O 0 0.01221733633428812
investigated O 0 0.01667036861181259
whether O 0 0.012246194295585155
malfunction O 1 0.7848718166351318
of O 0 0.014861770905554295
ion O 0 0.04696444049477577
channels O 0 0.014961463399231434
could O 0 0.014233734458684921
cause O 0 0.02291622944176197
the O 0 0.01776028238236904
disorder O 1 0.9999972581863403
by O 0 0.012188712134957314
studying O 0 0.01962212286889553
mutations O 0 0.015659838914871216
in O 0 0.0107360128313303
the O 0 0.020275261253118515
cardiac O 1 0.9999998807907104
sodium O 1 0.9969731569290161
channel O 0 0.05950150266289711
gene O 0 0.05898934602737427
SCN5A O 1 0.992194652557373
. O 0 0.061109814792871475

We O 0 0.02781752496957779
have O 0 0.014151168055832386
now O 0 0.016068363562226295
identified O 0 0.01477909367531538
a O 0 0.016726884990930557
missense O 0 0.0344855897128582
mutation O 0 0.01899459771811962
, O 0 0.011337706819176674
a O 0 0.017666660249233246
splice O 1 0.9952654838562012
- O 1 0.999953031539917
donor O 0 0.22649337351322174
mutation O 0 0.02458789572119713
, O 0 0.013409323990345001
and O 0 0.011811400763690472
a O 0 0.019169097766280174
frameshift O 1 0.7015195488929749
mutation O 0 0.020216742530465126
in O 0 0.010603553615510464
the O 0 0.014230611734092236
coding O 0 0.027970677241683006
region O 0 0.01779869571328163
of O 0 0.01929849199950695
SCN5A O 1 0.9993225336074829
in O 0 0.0202186219394207
three O 0 0.024437183514237404
IVF B-Disease 1 0.9999330043792725
families O 0 0.041342079639434814
. O 0 0.049642689526081085

We O 0 0.02732245810329914
show O 0 0.021401479840278625
that O 0 0.013024228624999523
sodium O 0 0.030407635495066643
channels O 0 0.013787360861897469
with O 0 0.01117465365678072
the O 0 0.01619279570877552
missense O 0 0.04405054450035095
mutation O 0 0.025657059624791145
recover O 0 0.07124026119709015
from O 0 0.015245864167809486
inactivation O 1 0.996526300907135
more O 0 0.013194156810641289
rapidly O 0 0.01999504305422306
than O 0 0.009833058342337608
normal O 0 0.011189061217010021
and O 0 0.008974505588412285
that O 0 0.0077081723138689995
the O 0 0.013669751584529877
frameshift O 1 0.9136075973510742
mutation O 0 0.024603301659226418
causes O 0 0.021660534664988518
the O 0 0.01627691090106964
sodium O 0 0.03714859485626221
channel O 0 0.019857723265886307
to O 0 0.012278293259441853
be O 0 0.014382409863173962
non O 0 0.035478625446558
- O 1 0.9982705116271973
functional O 0 0.07924295216798782
. O 0 0.05065695568919182

Our O 0 0.039493247866630554
results O 0 0.024896224960684776
indicate O 0 0.016426242887973785
that O 0 0.010910598561167717
mutations O 0 0.0172584131360054
in O 0 0.016228148713707924
cardiac O 1 0.9999998807907104
ion O 1 0.9998032450675964
- O 1 0.9998778104782104
channel O 0 0.0278415959328413
genes O 0 0.016051575541496277
contribute O 0 0.014733070507645607
to O 0 0.011043584905564785
the O 0 0.012076742947101593
risk O 0 0.019679797813296318
of O 0 0.015210182406008244
developing O 1 0.975461483001709
IVF B-Disease 1 0.9999996423721313
. O 0 0.03348596766591072
. O 0 0.04646380990743637

Molecular O 0 0.08950762450695038
heterogeneity O 0 0.0850774347782135
in O 0 0.03597039729356766
mucopolysaccharidosis B-Disease 1 0.9999806880950928
IVA I-Disease 1 0.9999996423721313
in O 0 0.020642507821321487
Australia O 0 0.023205460980534554
and O 0 0.014223701320588589
Northern O 0 0.0185647401958704
Ireland O 0 0.01995960809290409
: O 0 0.017176805064082146
nine O 0 0.01813824288547039
novel O 0 0.024307161569595337
mutations O 0 0.018786882981657982
including O 0 0.012917248532176018
T312S O 1 0.8987617492675781
, O 0 0.014106734655797482
a O 0 0.014898775145411491
common O 0 0.014690956100821495
allele O 0 0.026768634095788002
that O 0 0.01252493541687727
confers O 1 0.9996492862701416
a O 1 0.847378671169281
mild O 1 0.9999994039535522
phenotype O 1 0.9998788833618164
. O 0 0.06103533133864403

Mucopolysaccharidosis B-Disease 1 0.9999333620071411
IVA I-Disease 1 0.9999995231628418
( O 0 0.07959070056676865
MPS B-Disease 1 0.9995577931404114
IVA I-Disease 1 1.0
) O 0 0.023890268057584763
is O 0 0.015363401733338833
an O 0 0.018749229609966278
autosomal B-Disease 1 0.9999943971633911
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 1 0.9999688863754272
by O 0 0.01162317767739296
a O 0 0.09938711673021317
genetic B-Disease 1 0.9828253388404846
defect I-Disease 1 0.99998939037323
in O 0 0.017986934632062912
N O 0 0.3867999017238617
- O 1 0.9991412162780762
acetylgalactosamine O 1 0.996392548084259
- O 1 0.9998732805252075
6 O 0 0.2349022775888443
- O 1 0.9999916553497314
sulfate O 1 0.9999988079071045
sulfatase O 1 0.9999986886978149
( O 0 0.2612709105014801
GALNS O 1 0.9999856948852539
) O 0 0.050387416034936905
. O 0 0.06027008965611458

Previous O 0 0.04008987173438072
studies O 0 0.02310723252594471
of O 0 0.017285898327827454
patients O 0 0.05832786485552788
from O 0 0.009756980463862419
a O 0 0.012035836465656757
British O 0 0.1336798518896103
- O 1 0.9993151426315308
Irish O 0 0.017732255160808563
population O 0 0.008079846389591694
showed O 0 0.009523209184408188
that O 0 0.006427392829209566
the O 0 0.011797083541750908
I113F O 1 0.9951292276382446
mutation O 0 0.015290558338165283
is O 0 0.008558075875043869
the O 0 0.009149132296442986
most O 0 0.008066495880484581
common O 0 0.01041679922491312
single O 0 0.014192860573530197
mutation O 0 0.019163236021995544
among O 0 0.017144907265901566
MPS B-Disease 1 0.9999750852584839
IVA I-Disease 1 1.0
patients O 1 0.9999986886978149
and O 0 0.023932110518217087
produces O 0 0.2778607904911041
a O 1 0.5737613439559937
severe O 1 1.0
clinical O 1 1.0
phenotype O 1 0.9999957084655762
. O 0 0.06063096597790718

We O 0 0.0358019657433033
studied O 0 0.042200006544589996
mutations O 0 0.02467750385403633
in O 0 0.013248192146420479
the O 0 0.020251795649528503
GALNS O 1 0.9898272752761841
gene O 0 0.017850225791335106
from O 0 0.01185848843306303
23 O 0 0.01963326893746853
additional O 0 0.021368827670812607
MPS B-Disease 1 0.9990604519844055
IVA I-Disease 1 1.0
patients O 1 0.9999679327011108
( O 0 0.015320438891649246
15 O 0 0.01517270877957344
from O 0 0.009494265541434288
Australia O 0 0.014221081510186195
, O 0 0.010366654954850674
8 O 0 0.013640554621815681
from O 0 0.009341754019260406
Northern O 0 0.014064989052712917
Ireland O 0 0.014896898530423641
) O 0 0.009232205338776112
, O 0 0.008455920033156872
with O 0 0.006801647134125233
various O 0 0.008478185161948204
clinical O 1 0.9998942613601685
phenotypes O 1 0.999968409538269
( O 0 0.19591541588306427
severe O 1 0.9999979734420776
, O 0 0.015796663239598274
16 O 0 0.016935788094997406
cases O 0 0.01128946803510189
; O 0 0.011662938632071018
intermediate O 0 0.020180316641926765
, O 0 0.012052508071064949
4 O 0 0.01639021933078766
cases O 0 0.0132622504606843
; O 0 0.014819690026342869
mild O 1 0.9939671754837036
, O 0 0.01692461408674717
3 O 0 0.02348438650369644
cases O 0 0.02053127810359001
) O 0 0.025858348235487938
. O 0 0.0385887585580349

We O 0 0.02556333690881729
found O 0 0.015497236512601376
two O 0 0.012901050969958305
common O 0 0.013594266958534718
mutations O 0 0.014332002960145473
that O 0 0.0075525324791669846
together O 0 0.011957277543842793
accounted O 0 0.014214479364454746
for O 0 0.009832264855504036
32 O 0 0.019494162872433662
% O 0 0.011620943434536457
of O 0 0.010331842117011547
the O 0 0.013921288773417473
44 O 0 0.028599310666322708
unrelated O 0 0.02764268033206463
alleles O 0 0.02582181617617607
in O 0 0.01625499688088894
these O 0 0.018982280045747757
patients O 1 0.9564816355705261
. O 0 0.047392599284648895

One O 0 0.031061893329024315
is O 0 0.018193457275629044
the O 0 0.021968265995383263
T312S O 1 0.9785783886909485
mutation O 0 0.027562804520130157
, O 0 0.014461439102888107
a O 0 0.016957275569438934
novel O 0 0.025863327085971832
mutation O 0 0.019111977890133858
found O 0 0.01225263811647892
exclusively O 0 0.020885152742266655
in O 0 0.023385027423501015
milder O 1 0.9983246922492981
patients O 1 0.9983921647071838
. O 0 0.05413959175348282

The O 0 0.028898941352963448
other O 0 0.013611382804811
is O 0 0.012405228801071644
the O 0 0.01315286010503769
previously O 0 0.018531354144215584
described O 0 0.02240614779293537
I113F O 1 0.8817571401596069
that O 0 0.013259673491120338
produces O 0 0.03017657808959484
a O 0 0.03899102285504341
severe O 1 0.999997615814209
phenotype O 1 0.9999070167541504
. O 0 0.060259342193603516

The O 0 0.05437420681118965
I113F O 0 0.46262916922569275
and O 0 0.0313250906765461
T312S O 1 0.7568781971931458
mutations O 0 0.026725566014647484
accounted O 0 0.023135358467698097
for O 0 0.012793837115168571
8 O 0 0.020293960347771645
( O 0 0.01407667063176632
18 O 0 0.017107408493757248
% O 0 0.012299632653594017
) O 0 0.009696596302092075
and O 0 0.009883630089461803
6 O 0 0.016590477898716927
( O 0 0.012259264476597309
14 O 0 0.016394250094890594
% O 0 0.013445599935948849
) O 0 0.011961554177105427
of O 0 0.01517699845135212
44 O 0 0.035638049244880676
unrelated O 0 0.03877449035644531
alleles O 0 0.0457230806350708
, O 0 0.03099576011300087
respectively O 0 0.05202507600188255
. O 0 0.0520775206387043

The O 0 0.035730332136154175
relatively O 0 0.028181569650769234
high O 0 0.039627328515052795
residual O 1 0.9960044026374817
GALNS O 1 0.9999810457229614
activity O 0 0.023676443845033646
seen O 0 0.021221766248345375
when O 0 0.018687410280108452
the O 0 0.022007353603839874
T312S O 0 0.11299531161785126
mutant O 0 0.0578104592859745
cDNA O 0 0.062463633716106415
is O 0 0.023586168885231018
overexpressed O 0 0.08775722235441208
in O 0 0.015724632889032364
mutant O 0 0.05751579999923706
cells O 0 0.014247310347855091
provides O 0 0.01143899280577898
an O 0 0.00796506553888321
explanation O 0 0.011321058496832848
for O 0 0.009607230313122272
the O 0 0.013822637498378754
mild O 1 0.9999927282333374
phenotype O 1 0.9998893737792969
in O 0 0.02842571772634983
patients O 1 0.9994367957115173
with O 0 0.01465246919542551
this O 0 0.01755744405090809
mutation O 0 0.041931357234716415
. O 0 0.04034049063920975

The O 0 0.03490203246474266
distribution O 0 0.023468272760510445
and O 0 0.014534923247992992
relative O 0 0.0170244462788105
frequencies O 0 0.014920500107109547
of O 0 0.012203970924019814
the O 0 0.014953061938285828
I113F O 1 0.8643012642860413
and O 0 0.018232086673378944
T312S O 1 0.971704363822937
mutations O 0 0.020722825080156326
in O 0 0.011849484406411648
Australia O 0 0.015654975548386574
corresponded O 0 0.01790011115372181
to O 0 0.007772897370159626
those O 0 0.00576560664921999
observed O 0 0.00714736245572567
in O 0 0.008030243217945099
Northern O 0 0.012402157299220562
Ireland O 0 0.012559831142425537
and O 0 0.006708401720970869
are O 0 0.00403951620683074
unique O 0 0.007288587745279074
to O 0 0.005759014748036861
these O 0 0.004485236946493387
two O 0 0.005405241157859564
populations O 0 0.007148299366235733
, O 0 0.007281559519469738
suggesting O 0 0.008615890517830849
that O 0 0.005792231298983097
both O 0 0.007084202021360397
mutations O 0 0.010547970421612263
were O 0 0.007629223167896271
probably O 0 0.01168927364051342
introduced O 0 0.013539114966988564
to O 0 0.010955200530588627
Australia O 0 0.015061186626553535
by O 0 0.010135289281606674
Irish O 0 0.02123934030532837
migrants O 0 0.01886572316288948
during O 0 0.0183244738727808
the O 0 0.019280213862657547
19th O 0 0.046621207147836685
century O 0 0.05410618707537651
. O 0 0.044302262365818024

Haplotype O 0 0.0985337495803833
analysis O 0 0.029599780216813087
using O 0 0.02406541258096695
6 O 0 0.04200456291437149
RFLPs O 0 0.2854532301425934
provides O 0 0.021654685959219933
additional O 0 0.016500236466526985
data O 0 0.011482909321784973
that O 0 0.00936350878328085
the O 0 0.0159591231495142
I113F O 1 0.6148796677589417
mutation O 0 0.025471560657024384
originated O 0 0.02528970316052437
from O 0 0.013947359286248684
a O 0 0.021984117105603218
common O 0 0.026896798983216286
ancestor O 0 0.06295491755008698
. O 0 0.05025169625878334

The O 0 0.03379283845424652
other O 0 0.017482556402683258
9 O 0 0.029129328206181526
novel O 0 0.02947835624217987
mutations O 0 0.015482817776501179
identified O 0 0.010807451792061329
in O 0 0.007549295201897621
these O 0 0.0065767173655331135
23 O 0 0.017122169956564903
patients O 0 0.21253958344459534
were O 0 0.007240067236125469
each O 0 0.006871124729514122
limited O 0 0.010812826454639435
to O 0 0.010528475977480412
a O 0 0.018112394958734512
single O 0 0.028113633394241333
family O 0 0.03469812870025635
. O 0 0.03833119198679924

These O 0 0.02504025399684906
data O 0 0.018601011484861374
provide O 0 0.01741641014814377
further O 0 0.013214530423283577
evidence O 0 0.01211610995233059
for O 0 0.012035667896270752
extensive O 0 0.025613820180296898
allelic O 0 0.4703344702720642
heterogeneity O 0 0.0978396013379097
in O 0 0.021590257063508034
MPS B-Disease 1 0.9778262376785278
IVA I-Disease 1 0.9999998807907104
in O 0 0.020158758386969566
British O 1 0.8437183499336243
- O 1 0.9999961853027344
Irish O 1 0.8770971298217773
patients O 1 0.9825440049171448
and O 0 0.008238576352596283
provide O 0 0.00850361306220293
evidence O 0 0.0076654101721942425
for O 0 0.007068106904625893
their O 0 0.0075409505516290665
transmission O 0 0.014723038300871849
to O 0 0.009078330360352993
Australia O 0 0.013207320123910904
by O 0 0.00953544769436121
British O 0 0.0244859978556633
- O 1 0.9989412426948547
Irish O 0 0.03202570602297783
migrants O 0 0.02853631228208542
. O 0 0.02643764391541481
. O 0 0.038286201655864716

Identification O 0 0.04945632815361023
of O 0 0.02930421195924282
constitutional O 0 0.047212373465299606
WT1 O 1 0.9999985694885254
mutations O 0 0.03182779252529144
, O 0 0.015141738578677177
in O 0 0.01185502577573061
patients O 1 0.9051172137260437
with O 0 0.01363322976976633
isolated O 1 0.9995362758636475
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 0.2784668803215027
and O 0 0.013275248929858208
analysis O 0 0.014855182729661465
of O 0 0.021434232592582703
genotype O 1 0.9998718500137329
/ O 1 0.9999370574951172
phenotype O 1 0.702043890953064
correlations O 0 0.028347309678792953
by O 0 0.009077377617359161
use O 0 0.011850322596728802
of O 0 0.014023452065885067
a O 0 0.024738801643252373
computerized O 1 0.5379000902175903
mutation O 0 0.04407811909914017
database O 0 0.04982103407382965
. O 0 0.04985054209828377

Constitutional O 0 0.0610782727599144
mutations O 0 0.03278357908129692
of O 0 0.020553719252347946
the O 0 0.02548835054039955
WT1 O 1 0.9999752044677734
gene O 0 0.02264535427093506
, O 0 0.015279714949429035
encoding O 0 0.018553005531430244
a O 0 0.023677868768572807
zinc O 1 0.9999977350234985
- O 1 0.9999344348907471
finger O 1 0.6512958407402039
transcription O 0 0.03172421082854271
factor O 0 0.02343594841659069
involved O 0 0.014699178747832775
in O 0 0.021496588364243507
renal O 1 1.0
and O 1 0.9897304773330688
gonadal O 1 1.0
development O 1 0.602861225605011
, O 0 0.012441935017704964
are O 0 0.005680382717400789
found O 0 0.006724122911691666
in O 0 0.006613831967115402
most O 0 0.007881611585617065
patients O 0 0.030894478783011436
with O 0 0.014037514105439186
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999483823776245
DDS B-Disease 1 1.0
) O 0 0.02079092338681221
, O 0 0.015211638994514942
or O 0 0.02064003050327301
diffuse B-Disease 1 0.9999998807907104
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 1 0.9999953508377075
DMS B-Disease 1 1.0
) O 0 0.01971064880490303
associated O 0 0.014804515987634659
with O 0 0.01338723674416542
pseudohermaphroditism B-Disease 1 0.9999949932098389
and O 0 0.4033370018005371
/ O 1 0.999997615814209
or O 1 0.9948950409889221
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 1 0.996040940284729
WT B-Disease 1 0.9999998807907104
) O 0 0.05640896037220955
. O 0 0.06103577837347984

Most O 0 0.04218638315796852
mutations O 0 0.039470985531806946
in O 0 0.031931474804878235
DDS B-Disease 1 1.0
patients O 1 0.999944806098938
lie O 0 0.04274507984519005
in O 0 0.019942451268434525
exon O 0 0.07550688832998276
8 O 0 0.02852911874651909
or O 0 0.01669170707464218
exon O 0 0.0470944344997406
9 O 0 0.025291480123996735
, O 0 0.016955628991127014
encoding O 0 0.027698155492544174
zinc O 1 0.999332845211029
finger O 0 0.3253580629825592
2 O 0 0.027223415672779083
or O 0 0.022306110709905624
zinc O 1 0.9999818801879883
finger O 1 0.9054607152938843
3 O 0 0.022550752386450768
, O 0 0.012548069469630718
respectively O 0 0.013348503038287163
, O 0 0.00857883132994175
with O 0 0.007923295721411705
a O 0 0.014550736173987389
hot O 1 0.9616978764533997
spot O 0 0.36455038189888
( O 0 0.023956269025802612
R394W O 1 0.5940844416618347
) O 0 0.021011680364608765
in O 0 0.027251701802015305
exon O 0 0.08462801575660706
9 O 0 0.05788351595401764
. O 0 0.05069423466920853

We O 0 0.026326343417167664
analyzed O 0 0.022876331582665443
a O 0 0.015132262371480465
series O 0 0.014372504316270351
of O 0 0.01181864831596613
24 O 0 0.01943693496286869
patients O 0 0.24225616455078125
, O 0 0.009069695137441158
10 O 0 0.010895239189267159
with O 0 0.011450905352830887
isolated B-Disease 1 0.9424683451652527
DMS I-Disease 1 1.0
( O 1 0.7829535603523254
IDMS B-Disease 1 0.9999998807907104
) O 0 0.018422693014144897
, O 0 0.013824236579239368
10 O 0 0.015522160567343235
with O 0 0.014450079761445522
DDS B-Disease 1 0.9999998807907104
, O 0 0.016152381896972656
and O 0 0.011579839512705803
4 O 0 0.01947913132607937
with O 0 0.02081304043531418
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 0.9999998807907104
and O 1 0.9967290163040161
/ O 1 0.9999992847442627
or O 1 0.6938168406486511
WT B-Disease 1 0.9999979734420776
. O 0 0.07672962546348572

We O 0 0.04229139909148216
report O 0 0.0443556122481823
WT1 O 1 0.98946613073349
heterozygous O 0 0.0492422953248024
mutations O 0 0.023811640217900276
in O 0 0.01613335683941841
16 O 0 0.02523389644920826
patients O 0 0.24908187985420227
, O 0 0.015411457978188992
4 O 0 0.01792355440557003
of O 0 0.013756545260548592
whom O 0 0.020757241174578667
presented O 0 0.03302723541855812
with O 0 0.036870475858449936
IDMS B-Disease 1 0.9999998807907104
. O 0 0.060519300401210785

One O 0 0.03256385400891304
male O 0 0.027106989175081253
and O 0 0.013759218156337738
two O 0 0.013723731972277164
female O 1 0.6660501956939697
IDMS B-Disease 1 1.0
patients O 1 0.9999911785125732
with O 1 0.6463561654090881
WT1 O 1 1.0
mutations O 1 0.997517466545105
underwent O 1 0.9999995231628418
normal O 0 0.21425369381904602
puberty O 1 0.9920600652694702
. O 0 0.05886486545205116

Two O 0 0.03666894510388374
mutations O 0 0.03416943922638893
associated O 0 0.022250276058912277
with O 0 0.018377672880887985
IDMS B-Disease 1 0.9999995231628418
are O 0 0.007640365976840258
different O 0 0.0053668939508497715
from O 0 0.008095625787973404
those O 0 0.008578676730394363
described O 0 0.018457762897014618
in O 0 0.21606282889842987
DDS B-Disease 1 1.0
patients O 1 0.9999974966049194
. O 0 0.058101627975702286

No O 0 0.0631936565041542
WT1 O 1 0.9999678134918213
mutations O 0 0.034745242446660995
were O 0 0.014125063084065914
detected O 0 0.017027420923113823
in O 0 0.010156539268791676
the O 0 0.01212126575410366
six O 0 0.01684129610657692
other O 0 0.019489075988531113
IDMS B-Disease 1 1.0
patients O 1 0.9996887445449829
, O 0 0.017450788989663124
suggesting O 0 0.02105674520134926
genetic O 0 0.021611837670207024
heterogeneity O 0 0.33791273832321167
of O 0 0.024166250601410866
this O 0 0.03090868890285492
disease O 1 0.9999996423721313
. O 0 0.04864070191979408

We O 0 0.04400406405329704
analyzed O 0 0.05632453039288521
genotype O 1 0.9349253177642822
/ O 1 0.9994307160377502
phenotype O 1 0.7546990513801575
correlations O 0 0.035981468856334686
, O 0 0.015228744596242905
on O 0 0.009287324734032154
the O 0 0.009042667225003242
basis O 0 0.008207620121538639
of O 0 0.008525189012289047
the O 0 0.010126873850822449
constitution O 0 0.013897176831960678
of O 0 0.014139831066131592
a O 0 0.021606922149658203
WT1 O 1 0.9989227652549744
mutation O 0 0.023651259019970894
database O 0 0.01701803132891655
of O 0 0.01344345510005951
84 O 1 0.8274938464164734
germ O 1 0.9999991655349731
- O 1 0.9999977350234985
line O 0 0.029356131330132484
mutations O 0 0.013784482143819332
, O 0 0.0075210100039839745
to O 0 0.007010819390416145
compare O 0 0.011376780457794666
the O 0 0.00727470638230443
distribution O 0 0.007287027779966593
and O 0 0.006975190714001656
type O 0 0.012804108671844006
of O 0 0.009030362591147423
mutations O 0 0.011430363170802593
, O 0 0.008323638699948788
according O 0 0.006890818942338228
to O 0 0.009124314412474632
the O 0 0.014297442510724068
different O 0 0.016874885186553
symptoms O 1 0.999854326248169
. O 0 0.041360173374414444

This O 0 0.030492421239614487
demonstrated O 0 0.037936609238386154
( O 0 0.024029197171330452
1 O 0 0.027454007416963577
) O 0 0.014874950982630253
the O 0 0.014162794686853886
association O 0 0.018731392920017242
between O 0 0.012433524243533611
mutations O 0 0.01340795960277319
in O 0 0.0111464848741889
exons O 0 0.02348973974585533
8 O 0 0.016497286036610603
and O 0 0.010895311832427979
9 O 0 0.018219249323010445
and O 0 0.015463306568562984
DMS B-Disease 1 0.9999978542327881
; O 0 0.016176585108041763
( O 0 0.01313712541013956
2 O 0 0.017669035121798515
) O 0 0.011339036747813225
among O 0 0.014445788227021694
patients O 1 0.8989361524581909
with O 0 0.0181730929762125
DMS B-Disease 1 0.9999998807907104
, O 0 0.0159840639680624
a O 0 0.014026780612766743
higher O 0 0.014679648913443089
frequency O 0 0.014251763001084328
of O 0 0.014638660475611687
exon O 0 0.0478714182972908
8 O 0 0.02486664429306984
mutations O 0 0.01724686659872532
among O 0 0.014742535538971424
46 O 0 0.030029568821191788
, O 0 0.026056110858917236
XY O 1 0.9999966621398926
patients O 1 0.9573372006416321
with O 0 0.014568084850907326
female O 0 0.023197539150714874
phenotype O 0 0.028311990201473236
than O 0 0.010453999973833561
among O 0 0.013909924775362015
46 O 0 0.02619803510606289
, O 0 0.022905094549059868
XY O 1 0.9999973773956299
patients O 1 0.9722851514816284
with O 0 0.011161983013153076
sexual O 0 0.016700074076652527
ambiguity O 0 0.03371451422572136
or O 0 0.013875922188162804
male O 1 0.5047498941421509
phenotype O 1 0.9935801029205322
; O 0 0.014175736345350742
and O 0 0.011990494094789028
( O 0 0.014147118665277958
3 O 0 0.019339334219694138
) O 0 0.013166681863367558
statistically O 0 0.014604926109313965
significant O 0 0.010061112232506275
evidence O 0 0.008686662651598454
that O 0 0.0075044166296720505
mutations O 0 0.012853422202169895
in O 0 0.008888376876711845
exons O 0 0.0240968968719244
8 O 0 0.018342219293117523
and O 0 0.014323679730296135
9 O 0 0.023767666891217232
preferentially O 0 0.036726661026477814
affect O 0 0.022202925756573677
amino O 0 0.021379830315709114
acids O 0 0.01597539521753788
with O 0 0.01023626048117876
different O 0 0.008513307198882103
functions O 0 0.016862208023667336
. O 0 0.021411538124084473
. O 0 0.03731653839349747

The O 0 0.07001955062150955
185delAG O 1 0.9995254278182983
BRCA1 O 1 0.9999217987060547
mutation O 0 0.036587875336408615
originated O 0 0.02528190053999424
before O 0 0.01435265876352787
the O 0 0.013064413331449032
dispersion O 0 0.022933008149266243
of O 0 0.011309530586004257
Jews O 0 0.014152432791888714
in O 0 0.0090169133618474
the O 0 0.011746210977435112
diaspora O 0 0.022964050993323326
and O 0 0.013153968378901482
is O 0 0.011299628764390945
not O 0 0.009827210567891598
limited O 0 0.02054790034890175
to O 0 0.026834579184651375
Ashkenazim O 1 0.8418411016464233
. O 0 0.050785183906555176

The O 0 0.04871780797839165
185delAG O 1 0.9411432147026062
mutation O 0 0.04303107038140297
in O 0 0.025045480579137802
BRCA1 O 1 0.999650239944458
is O 0 0.015128781087696552
detected O 0 0.01607731357216835
in O 0 0.012390942312777042
Ashkenazi O 0 0.033255040645599365
Jews O 0 0.01299656368792057
both O 0 0.008692290633916855
in O 0 0.014493721537292004
familial B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.8482366800308228
in O 0 0.013131530024111271
the O 0 0.015014268457889557
general O 0 0.027492089197039604
population O 0 0.022689878940582275
. O 0 0.03718935325741768

All O 0 0.03579334914684296
tested O 0 0.05599529668688774
Ashkenazi O 1 0.9192100763320923
mutation O 0 0.042829014360904694
carriers O 0 0.033264126628637314
share O 0 0.018690261989831924
the O 0 0.013813838362693787
same O 0 0.014510069973766804
allelic O 0 0.06277882307767868
pattern O 0 0.02790265716612339
at O 0 0.0278056338429451
the O 0 0.036628253757953644
BRCA1 O 1 0.9999324083328247
locus O 1 0.9871669411659241
. O 0 0.060071781277656555

Our O 0 0.040237296372652054
previous O 0 0.028944946825504303
study O 0 0.020372120663523674
showed O 0 0.01511810626834631
that O 0 0.007422085385769606
this O 0 0.00922432728111744
Ashkenazi O 1 0.8207576870918274
mutation O 0 0.020378554239869118
also O 0 0.012375353835523129
occurs O 0 0.009787091054022312
in O 0 0.009425767697393894
Iraqi O 0 0.015750514343380928
Jews O 0 0.014462941326200962
with O 0 0.011399654671549797
a O 0 0.019793370738625526
similar O 0 0.026302460581064224
allelic O 1 0.985562801361084
pattern O 0 0.05477886274456978
. O 0 0.057969626039266586

We O 0 0.029288820922374725
extended O 0 0.028410669416189194
our O 0 0.016979770734906197
analysis O 0 0.01328292116522789
to O 0 0.012033285573124886
other O 0 0.012200694531202316
non O 0 0.028980590403079987
- O 1 0.9907406568527222
Ashkenazi O 0 0.07802912592887878
subsets O 0 0.051383260637521744
354 O 0 0.06807070970535278
of O 0 0.024307040497660637
Moroccan O 0 0.05319592356681824
origin O 0 0.0207331832498312
, O 0 0.023207666352391243
200 O 0 0.04047279804944992
Yemenites O 1 0.6701010465621948
and O 0 0.024291327223181725
150 O 0 0.03928481414914131
Iranian O 0 0.048320870846509933
Jews O 0 0.05628185719251633
. O 0 0.05374360829591751

Heteroduplex O 1 0.6920374035835266
analysis O 0 0.037221379578113556
complemented O 0 0.04907058924436569
by O 0 0.014687111601233482
direct O 0 0.020611431449651718
DNA O 0 0.02455221302807331
sequencing O 0 0.030245618894696236
of O 0 0.023528046905994415
abnormally O 0 0.33233124017715454
migrating O 0 0.04414352774620056
bands O 0 0.04267071187496185
were O 0 0.024643750861287117
employed O 0 0.04699699953198433
. O 0 0.04834756627678871

Four O 0 0.030853696167469025
of O 0 0.020587805658578873
Moroccan O 0 0.03690684586763382
origin O 0 0.015585307963192463
( O 0 0.014144771732389927
1 O 0 0.01895003952085972
. O 0 0.009869524277746677
1 O 0 0.017229894176125526
% O 0 0.012065509334206581
) O 0 0.009962600655853748
and O 0 0.00841820240020752
none O 0 0.010943618603050709
of O 0 0.009584976360201836
the O 0 0.014326265081763268
Yemenites O 1 0.9997116923332214
or O 0 0.0138701805844903
Iranians O 0 0.02036404423415661
was O 0 0.017468171194195747
a O 0 0.017956560477614403
carrier O 0 0.04841858521103859
of O 0 0.018784036859869957
the O 0 0.02747119776904583
185delAG O 1 0.9999313354492188
mutation O 0 0.05375266075134277
. O 0 0.05007831007242203

BRCA1 O 1 0.9998264908790588
allelic O 0 0.4596268832683563
patterns O 0 0.02698272280395031
were O 0 0.011824509128928185
determined O 0 0.011960715055465698
for O 0 0.008208031766116619
four O 0 0.008959081955254078
of O 0 0.007679463364183903
these O 0 0.004839444067329168
individuals O 0 0.005071339663118124
and O 0 0.006229286547750235
for O 0 0.0077603161334991455
12 O 0 0.013622717931866646
additional O 0 0.016050979495048523
non O 0 0.02679620310664177
- O 1 0.9987428784370422
Ashkenazi O 1 0.6906922459602356
185delAG O 1 0.7406861186027527
mutation O 0 0.028975488618016243
carriers O 0 0.026902038604021072
who O 0 0.023831093683838844
had O 1 0.9990097284317017
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7149924039840698

Six O 0 0.04475927725434303
non O 0 0.0508304163813591
- O 1 0.9982513785362244
Ashkenazi O 0 0.09659326821565628
individuals O 0 0.014255334623157978
shared O 0 0.018230844289064407
the O 0 0.014193314127624035
common O 0 0.017566518858075142
Ashkenazi O 1 0.9937348961830139
haplotype O 1 0.5626019835472107
, O 0 0.015459938906133175
four O 0 0.011259250342845917
had O 0 0.01049075834453106
a O 0 0.010884616523981094
closely O 0 0.012369411066174507
related O 0 0.010938570834696293
pattern O 0 0.01203424483537674
, O 0 0.00893100444227457
and O 0 0.007769610267132521
the O 0 0.010577143169939518
rest O 0 0.015413593500852585
( O 0 0.01611577533185482
n O 0 0.028615811839699745
= O 0 0.03364553675055504
6 O 0 0.02215811423957348
) O 0 0.01659184694290161
displayed O 0 0.024285731837153435
a O 0 0.021635733544826508
distinct O 0 0.03694644570350647
BRCA1 O 1 0.9998677968978882
allelic O 1 0.9959321618080139
pattern O 0 0.07703478634357452
. O 0 0.05897662043571472

We O 0 0.030196400359272957
conclude O 0 0.03455736115574837
that O 0 0.013013775460422039
the O 0 0.021945104002952576
185delAG O 1 0.9998540878295898
BRCA1 O 1 0.9999918937683105
mutation O 0 0.02943968027830124
occurs O 0 0.013838044367730618
in O 0 0.008572394028306007
some O 0 0.00843097548931837
non O 0 0.0229627825319767
- O 1 0.9993082284927368
Ashkenazi O 0 0.27435410022735596
populations O 0 0.010369584895670414
at O 0 0.012992913834750652
rates O 0 0.013909315690398216
comparable O 0 0.016943814232945442
with O 0 0.009728453122079372
that O 0 0.011500535532832146
of O 0 0.023649029433727264
Ashkenazim O 1 0.9564815163612366
. O 0 0.048376988619565964

The O 0 0.029868602752685547
majority O 0 0.021939238533377647
of O 0 0.016885945573449135
Jewish O 0 0.027902141213417053
185delAG O 1 0.9996015429496765
mutation O 0 0.03855889290571213
carriers O 0 0.02484942227602005
have O 0 0.007978467270731926
a O 0 0.01246094424277544
common O 0 0.014128157868981361
allelic O 1 0.944687008857727
pattern O 0 0.021018097177147865
, O 0 0.011901509948074818
supporting O 0 0.016018681228160858
the O 0 0.013382514007389545
founder O 1 0.988698422908783
effect O 0 0.015380014665424824
notion O 0 0.017181290313601494
, O 0 0.011350348591804504
but O 0 0.008864566683769226
dating O 0 0.015055478550493717
the O 0 0.011084049940109253
mutations O 0 0.011982926167547703
origin O 0 0.007372215390205383
to O 0 0.007890718057751656
an O 0 0.00846122670918703
earlier O 0 0.011891650967299938
date O 0 0.013329900801181793
than O 0 0.011422036215662956
currently O 0 0.022999979555606842
estimated O 0 0.029002077877521515
. O 0 0.03501926362514496

However O 0 0.031176449730992317
, O 0 0.018996810540556908
the O 0 0.013267830945551395
different O 0 0.008963223546743393
allelic O 0 0.045310016721487045
pattern O 0 0.018725303933024406
at O 0 0.016349082812666893
the O 0 0.017615575343370438
BRCA1 O 1 0.9999685287475586
locus O 1 0.590170681476593
even O 0 0.010667115449905396
in O 0 0.008467426523566246
some O 0 0.00806900393217802
Jewish O 0 0.016404639929533005
mutation O 0 0.02144034206867218
carriers O 0 0.04233429580926895
, O 0 0.012189533561468124
might O 0 0.011783462017774582
suggest O 0 0.01117712538689375
that O 0 0.006915865931659937
the O 0 0.013428520411252975
mutation O 0 0.0206084493547678
arose O 0 0.022966818884015083
independently O 0 0.02331552840769291
. O 0 0.024617087095975876
. O 0 0.036999769508838654

Crystal O 0 0.08306460827589035
structure O 0 0.0374562107026577
of O 0 0.02242591790854931
the O 0 0.03575386479496956
hemochromatosis B-Disease 1 1.0
protein O 1 0.9878902435302734
HFE O 1 0.9999967813491821
and O 0 0.021807387471199036
characterization O 0 0.03210952505469322
of O 0 0.015585212036967278
its O 0 0.01788121648132801
interaction O 0 0.024689702317118645
with O 0 0.026466991752386093
transferrin O 1 0.999925971031189
receptor O 0 0.10407485067844391
. O 0 0.05760908126831055

HFE O 1 0.993198812007904
is O 0 0.03079020231962204
an O 0 0.0279155932366848
MHC O 1 0.9999991655349731
- O 1 0.9999825954437256
related O 0 0.025399435311555862
protein O 0 0.017014984041452408
that O 0 0.007522921543568373
is O 0 0.0098708001896739
mutated O 0 0.017552856355905533
in O 0 0.008427146822214127
the O 0 0.01757214032113552
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9998138546943665

HFE O 1 0.9994827508926392
binds O 0 0.09420416504144669
to O 0 0.04156291112303734
transferrin O 1 0.9987677335739136
receptor O 0 0.3992319405078888
( O 0 0.03620787709951401
TfR O 1 0.9996830224990845
) O 0 0.021169021725654602
and O 0 0.017140144482254982
reduces O 0 0.02975267358124256
its O 0 0.017750268802046776
affinity O 0 0.02873213402926922
for O 0 0.019809579476714134
iron O 1 0.9999769926071167
- O 1 0.9999109506607056
loaded O 0 0.11649170517921448
transferrin O 1 0.9930976033210754
, O 0 0.037946317344903946
implicating O 1 0.9973958730697632
HFE O 1 0.9999991655349731
in O 0 0.416940301656723
iron O 1 0.9999995231628418
metabolism O 1 0.997080385684967
. O 0 0.06236504763364792

The O 0 0.07520487159490585
2 O 0 0.09216129034757614
. O 0 0.07480431348085403

6 O 0 0.058731649070978165
A O 0 0.04252824932336807
crystal O 0 0.05903958901762962
structure O 0 0.02904130145907402
of O 0 0.025233827531337738
HFE O 1 0.999957799911499
reveals O 0 0.035719260573387146
the O 0 0.01621849276125431
locations O 0 0.017629608511924744
of O 0 0.01956283114850521
hemochromatosis B-Disease 1 1.0
mutations O 0 0.03338432312011719
and O 0 0.012381171807646751
a O 0 0.01875201053917408
patch O 1 0.9999979734420776
of O 0 0.02042866311967373
histidines O 1 0.9997009038925171
that O 0 0.007260199636220932
could O 0 0.00731723103672266
be O 0 0.006333354860544205
involved O 0 0.00971489679068327
in O 0 0.013551538810133934
pH O 1 0.999971866607666
- O 1 0.9999592304229736
dependent O 0 0.04199102148413658
interactions O 0 0.04250544309616089
. O 0 0.04306108132004738

We O 0 0.02939831092953682
also O 0 0.022497305646538734
demonstrate O 0 0.030000656843185425
that O 0 0.018365854397416115
soluble O 1 0.9983548521995544
TfR O 1 0.9999667406082153
and O 0 0.03379523381590843
HFE O 1 0.999995231628418
bind O 0 0.04507415369153023
tightly O 0 0.036628857254981995
at O 0 0.016218379139900208
the O 0 0.011175638064742088
basic O 0 0.0183064267039299
pH O 0 0.07673308998346329
of O 0 0.010932907462120056
the O 0 0.012114209122955799
cell O 0 0.05715430527925491
surface O 0 0.014753060415387154
, O 0 0.010055908933281898
but O 0 0.00698666088283062
not O 0 0.006256632506847382
at O 0 0.013424609787762165
the O 0 0.017173167318105698
acidic O 1 0.9976654052734375
pH O 1 0.9978524446487427
of O 0 0.041603803634643555
intracellular O 1 0.9963917136192322
vesicles O 1 0.9774701595306396
. O 0 0.06685882806777954

TfR O 1 0.9999127388000488
HFE O 1 0.9999611377716064
stoichiometry O 0 0.49807918071746826
( O 0 0.03560807183384895
2 O 0 0.03733775392174721
1 O 0 0.03202839568257332
) O 0 0.018318692222237587
differs O 0 0.029119886457920074
from O 0 0.02224431186914444
TfR O 1 0.9984192848205566
transferrin O 1 0.9974974989891052
stoichiometry O 0 0.17169268429279327
( O 0 0.025501159951090813
2 O 0 0.03152502328157425
2 O 0 0.028531499207019806
) O 0 0.01686379872262478
, O 0 0.015590480528771877
implying O 0 0.022767355665564537
a O 0 0.013399138115346432
different O 0 0.007580960635095835
mode O 0 0.02028840407729149
of O 0 0.01192667055875063
binding O 0 0.017553217709064484
for O 0 0.018398301675915718
HFE O 1 0.9999867677688599
and O 0 0.024482784792780876
transferrin O 1 0.9979913234710693
to O 0 0.025730861350893974
TfR O 1 0.9995273351669312
, O 0 0.017248548567295074
consistent O 0 0.015700995922088623
with O 0 0.011052483692765236
our O 0 0.01312211062759161
demonstration O 0 0.0280934926122427
that O 0 0.016570160165429115
HFE O 1 0.9999940395355225
, O 0 0.03343072161078453
transferrin O 1 0.9995273351669312
, O 0 0.02339964546263218
and O 0 0.02330099232494831
TfR O 1 0.9994319081306458
form O 0 0.027794603258371353
a O 0 0.03562179580330849
ternary O 0 0.2055397778749466
complex O 0 0.0756911039352417
. O 0 0.061501070857048035

Identification O 0 0.04669694975018501
of O 0 0.020231056958436966
three O 0 0.01778525486588478
novel O 0 0.028287453576922417
mutations O 0 0.01760474219918251
and O 0 0.009118284098803997
a O 0 0.012053023092448711
high O 0 0.01630798541009426
frequency O 0 0.011976893059909344
of O 0 0.010343008674681187
the O 0 0.014006280340254307
Arg778Leu O 1 0.9984116554260254
mutation O 0 0.02138740010559559
in O 0 0.014722013846039772
Korean O 1 0.9994609951972961
patients O 1 0.999896764755249
with O 0 0.25250405073165894
Wilson B-Disease 1 0.999995231628418
disease I-Disease 1 0.9999997615814209
. O 0 0.05501078814268112

Four O 0 0.047728560864925385
mutations O 0 0.051966503262519836
- O 1 0.9998841285705566
- O 1 0.9999040365219116
R778L O 1 0.9826955795288086
, O 0 0.02226071245968342
A874V O 1 0.5846886038780212
, O 0 0.019208407029509544
L1083F O 0 0.2907164990901947
, O 0 0.014890252612531185
and O 0 0.01500712614506483
2304delC O 1 0.99949049949646
- O 1 0.9999419450759888
- O 1 0.8589091300964355
in O 0 0.013867819681763649
the O 0 0.01793002523481846
copper O 1 0.6074593663215637
- O 1 0.7698680758476257
transporting O 0 0.04088568687438965
enzyme O 0 0.027618594467639923
, O 0 0.01928391493856907
P O 1 0.9514315128326416
- O 1 0.999794065952301
type O 1 0.8444121479988098
ATPase O 1 0.9999063014984131
( O 0 0.03026624768972397
ATP7B O 1 0.9999825954437256
) O 0 0.01526099257171154
, O 0 0.010743976570665836
were O 0 0.007392970845103264
identified O 0 0.01110043190419674
in O 0 0.011567109264433384
Korean O 1 0.996390163898468
Patients O 1 0.9999585151672363
with O 0 0.30396029353141785
Wilson B-Disease 1 0.9999979734420776
disease I-Disease 1 1.0
. O 0 0.0579669363796711

Arg778Leu O 1 0.9745272994041443
, O 0 0.025646043941378593
the O 0 0.015862442553043365
most O 0 0.012115671299397945
frequently O 0 0.012219268828630447
reported O 0 0.014300324954092503
mutation O 0 0.013909668661653996
of O 0 0.008750954642891884
this O 0 0.008720160461962223
enzyme O 0 0.01779133640229702
, O 0 0.010180319659411907
was O 0 0.0118429996073246
found O 0 0.00710965134203434
in O 0 0.006836731918156147
six O 0 0.008834159933030605
of O 0 0.010464443825185299
eight O 0 0.015776028856635094
unrelated O 0 0.035897985100746155
patients O 1 0.9694867134094238
studied O 0 0.0183330699801445
, O 0 0.013059085234999657
an O 0 0.013079184107482433
allele O 0 0.028532320633530617
frequency O 0 0.019983908161520958
of O 0 0.02095264196395874
37 O 0 0.05442687124013901
. O 0 0.04870488867163658

5 O 0 0.041709356009960175
% O 0 0.02051406167447567
, O 0 0.014696506783366203
which O 0 0.008928608149290085
is O 0 0.008262836374342442
considerably O 0 0.013795921579003334
higher O 0 0.010753589682281017
than O 0 0.0073867980390787125
those O 0 0.006878312211483717
in O 0 0.009276874363422394
other O 0 0.011036952026188374
Asian O 0 0.0323081910610199
populations O 0 0.025624198839068413
. O 0 0.039257850497961044

The O 0 0.04872119054198265
novel O 0 0.05167654901742935
single O 0 0.033879633992910385
nucleotide O 0 0.04445163905620575
deletion O 0 0.04913945496082306
, O 0 0.026978591457009315
2304delC O 1 0.9679539203643799
, O 0 0.016966959461569786
was O 0 0.0188461784273386
found O 0 0.01258308719843626
in O 0 0.015209803357720375
one O 0 0.022978151217103004
patient O 1 0.9945730566978455
. O 0 0.046553704887628555

Since O 0 0.04084136337041855
a O 0 0.03164875507354736
mutation O 0 0.032394059002399445
at O 0 0.027251210063695908
cDNA O 0 0.05999012663960457
nucleotide O 0 0.05157285928726196
2302 O 1 0.9998154044151306
( O 0 0.03161799535155296
2302insC O 1 0.9908446669578552
) O 0 0.016332795843482018
had O 0 0.013867012225091457
been O 0 0.010244878008961678
previously O 0 0.013815165497362614
described O 0 0.01163395307958126
, O 0 0.007770507596433163
this O 0 0.004987151362001896
region O 0 0.008186020888388157
of O 0 0.007203203625977039
the O 0 0.013901012018322945
ATP7B O 1 0.9999998807907104
gene O 0 0.018726546317338943
may O 0 0.010639452375471592
be O 0 0.008848965167999268
susceptible O 0 0.024129528552293777
to O 0 0.01509565208107233
gene O 0 0.03205560892820358
rearrangements O 1 0.9915707111358643
causing O 1 0.9995731711387634
Wilson B-Disease 1 0.9999866485595703
disease I-Disease 1 0.9999996423721313
. O 0 0.05991310626268387

Disruption O 0 0.08121640235185623
of O 0 0.03090229071676731
splicing O 0 0.040446937084198
regulated O 0 0.024062380194664
by O 0 0.013370374217629433
a O 0 0.02523023635149002
CUG O 1 0.9999969005584717
- O 1 0.9998377561569214
binding O 0 0.034427400678396225
protein O 0 0.037731051445007324
in O 0 0.04507097229361534
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.4021364152431488

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999996423721313
DM B-Disease 1 1.0
) O 0 0.06994534283876419
is O 0 0.01843642070889473
caused O 0 0.02015063725411892
by O 0 0.011828526854515076
a O 0 0.019758708775043488
CTG O 1 0.9993342757225037
expansion O 0 0.02402852661907673
in O 0 0.014116087928414345
the O 0 0.015337511897087097
3 O 0 0.0242301132529974
untranslated O 0 0.055956143885850906
region O 0 0.02179449424147606
of O 0 0.02001454494893551
the O 0 0.05580657720565796
DM B-Disease 1 1.0
gene O 0 0.13132403790950775
. O 0 0.05566812679171562

One O 0 0.03754787892103195
model O 0 0.046032290905714035
of O 0 0.07557165622711182
DM B-Disease 1 1.0
pathogenesis O 1 1.0
suggests O 0 0.03726014122366905
that O 0 0.013233290053904057
RNAs O 0 0.03825857490301132
from O 0 0.011792558245360851
the O 0 0.012988169677555561
expanded O 0 0.02179482951760292
allele O 0 0.02364407666027546
create O 0 0.014147491194307804
a O 0 0.012905539013445377
gain O 0 0.01862175762653351
- O 1 0.9033154249191284
of O 0 0.01848619058728218
- O 1 0.9995185136795044
function O 0 0.01647949405014515
mutation O 0 0.015376029536128044
by O 0 0.00869822595268488
the O 0 0.011579850688576698
inappropriate O 0 0.022052742540836334
binding O 0 0.017413171008229256
of O 0 0.014879847876727581
proteins O 0 0.016384117305278778
to O 0 0.014708546921610832
the O 0 0.02726067043840885
CUG O 1 0.9997661709785461
repeats O 0 0.07135215401649475
. O 0 0.051891546696424484

Data O 0 0.035728126764297485
presented O 0 0.033737994730472565
here O 0 0.018747681751847267
indicate O 0 0.014712913893163204
that O 0 0.008740190416574478
the O 0 0.014828660525381565
conserved O 0 0.03078428842127323
heterogeneous O 0 0.047434791922569275
nuclear O 0 0.04335932806134224
ribonucleoprotein O 1 0.9974023699760437
, O 0 0.03272252529859543
CUG O 1 0.9999125003814697
- O 1 0.9671621322631836
binding O 0 0.0262694600969553
protein O 0 0.02378934994339943
( O 0 0.022569237276911736
CUG O 1 0.9999673366546631
- O 1 0.9999566078186035
BP O 1 0.9713635444641113
) O 0 0.01698598638176918
, O 0 0.013195130974054337
may O 0 0.010414288379251957
mediate O 0 0.02304609678685665
the O 0 0.016356907784938812
trans O 1 0.9871883988380432
- O 1 0.9999359846115112
dominant O 0 0.03619315102696419
effect O 0 0.01846589520573616
of O 0 0.017703698948025703
the O 0 0.02198147587478161
RNA O 0 0.06440360844135284
. O 0 0.04742996394634247

CUG O 1 0.9999878406524658
- O 1 0.9999693632125854
BP O 1 0.8470130562782288
was O 0 0.0245527233928442
found O 0 0.012567291036248207
to O 0 0.010246101766824722
bind O 0 0.015180897898972034
to O 0 0.010062385350465775
the O 0 0.013628262095153332
human O 0 0.03272654116153717
cardiac O 1 1.0
troponin O 1 1.0
T O 1 1.0
( O 0 0.03420426324009895
cTNT O 1 0.9872337579727173
) O 0 0.025048229843378067
pre O 0 0.19806061685085297
- O 1 0.9906625151634216
messenger O 0 0.07162635028362274
RNA O 0 0.04177640378475189
and O 0 0.020358165726065636
regulate O 0 0.03402300924062729
its O 0 0.02224099077284336
alternative O 0 0.04385999217629433
splicing O 0 0.07323963940143585
. O 0 0.05026891455054283

Splicing O 0 0.08083599805831909
of O 0 0.032279010862112045
cTNT O 1 0.8162670135498047
was O 0 0.03446057066321373
disrupted O 0 0.18578213453292847
in O 0 0.19963331520557404
DM B-Disease 1 1.0
striated O 1 1.0
muscle O 1 0.9999895095825195
and O 0 0.0215125922113657
in O 0 0.016636058688163757
normal O 0 0.020413806661963463
cells O 0 0.022448187693953514
expressing O 0 0.030684003606438637
transcripts O 0 0.033083245158195496
that O 0 0.016858581453561783
contain O 0 0.04413868486881256
CUG O 1 0.9985746145248413
repeats O 0 0.0889148861169815
. O 0 0.06030239164829254

Altered O 0 0.06156068295240402
expression O 0 0.029404345899820328
of O 0 0.023741858080029488
genes O 0 0.02332332916557789
regulated O 0 0.02714543417096138
posttranscriptionally O 0 0.1442307084798813
by O 0 0.020478397607803345
CUG O 1 0.9999988079071045
- O 1 0.999985933303833
BP O 1 0.962669849395752
therefore O 0 0.018647002056241035
may O 0 0.015792369842529297
contribute O 0 0.025199025869369507
to O 0 0.035641346126794815
DM B-Disease 1 1.0
pathogenesis O 1 0.9999998807907104
. O 0 0.05040331929922104
. O 0 0.06674020737409592

Identification O 0 0.04248454049229622
of O 0 0.02144138142466545
a O 0 0.023557862266898155
novel O 0 0.03862516209483147
nonsense O 0 0.16477465629577637
mutation O 0 0.022468380630016327
and O 0 0.012372207827866077
a O 0 0.016255158931016922
missense O 0 0.03313105180859566
substitution O 0 0.022372890263795853
in O 0 0.012464553117752075
the O 0 0.019606949761509895
vasopressin O 1 0.9322178363800049
- O 1 0.999977707862854
neurophysin O 1 0.9999597072601318
II O 1 0.9999867677688599
gene O 0 0.01945163682103157
in O 0 0.011853204108774662
two O 0 0.012114758603274822
Spanish O 0 0.030695246532559395
kindreds O 0 0.19224560260772705
with O 0 0.034700654447078705
familial B-Disease 1 0.9999998807907104
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 0.2875186800956726

Familial B-Disease 1 0.9999996423721313
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 1 0.9999029636383057
FNDI B-Disease 1 1.0
) O 0 0.016870250925421715
is O 0 0.011470900848507881
an O 0 0.014210069552063942
autosomal B-Disease 1 0.9999996423721313
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 1 0.9999998807907104
by O 1 0.993256688117981
deficiency O 1 1.0
in O 0 0.3979392647743225
the O 1 0.6255824565887451
antidiuretic O 1 0.9999990463256836
hormone O 1 0.9999090433120728
arginine O 1 0.9838762879371643
vasopressin O 1 0.993117094039917
( O 0 0.04270166531205177
AVP O 1 0.9998737573623657
) O 0 0.02194715104997158
encoded O 0 0.01732584275305271
by O 0 0.011687912978231907
the O 0 0.02175051160156727
AVP O 1 0.9999958276748657
- O 1 0.9999819993972778
neurophysin O 1 0.9998306035995483
II O 1 0.9999964237213135
( O 0 0.05601474270224571
AVP O 1 0.9999990463256836
- O 1 0.9999974966049194
NPII O 1 0.9999872446060181
) O 0 0.031226003542542458
gene O 0 0.030804719775915146
on O 0 0.030176863074302673
chromosome O 0 0.062223803251981735
20p13 O 1 0.821236789226532
. O 0 0.05782103165984154

In O 0 0.028821079060435295
this O 0 0.01579032652080059
study O 0 0.01748892292380333
, O 0 0.013246853835880756
we O 0 0.010130401700735092
analyzed O 0 0.016506502404808998
two O 0 0.009599241428077221
families O 0 0.011561624705791473
with O 0 0.01360094454139471
FNDI B-Disease 1 0.9992716908454895
using O 0 0.014169474132359028
direct O 0 0.017536375671625137
automated O 0 0.0338372066617012
fluorescent O 0 0.04745793342590332
, O 0 0.017573030665516853
solid O 0 0.02909393608570099
phase O 0 0.028652828186750412
, O 0 0.017724057659506798
single O 0 0.023459993302822113
- O 0 0.07245905697345734
stranded O 0 0.04208267107605934
DNA O 0 0.025385700166225433
sequencing O 0 0.02936050109565258
of O 0 0.02229849062860012
PCR O 0 0.10860634595155716
- O 1 0.9933955073356628
amplified O 0 0.4932950735092163
AVP O 1 0.9999921321868896
- O 1 0.9998142123222351
NPII O 1 0.9995341300964355
DNA O 0 0.07901535928249359
. O 0 0.06468140333890915

In O 0 0.026109807193279266
one O 0 0.016135618090629578
of O 0 0.01306384801864624
the O 0 0.013941872864961624
families O 0 0.016260718926787376
, O 0 0.014634311199188232
affected O 0 0.014885960146784782
individuals O 0 0.009452616795897484
presented O 0 0.01914210617542267
a O 0 0.019709331914782524
novel O 0 0.030936719849705696
nonsense O 0 0.039684634655714035
mutation O 0 0.022637374699115753
in O 0 0.014166037552058697
exon O 0 0.03794948384165764
3 O 0 0.017690086737275124
of O 0 0.011556307785212994
the O 0 0.013320133090019226
gene O 0 0.014999923296272755
, O 0 0.012315352447330952
consisting O 0 0.014293658547103405
in O 0 0.010869113728404045
a O 0 0.01624576561152935
G O 0 0.4988560676574707
to O 0 0.017367996275424957
T O 1 0.9652239680290222
transition O 0 0.03085302747786045
at O 0 0.026714909821748734
nucleotide O 0 0.045984309166669846
2101 O 1 0.9926068782806396
, O 0 0.02042829431593418
which O 0 0.013607055880129337
produces O 0 0.021889703348279
a O 0 0.015520447865128517
stop O 0 0.0191250741481781
signal O 0 0.02027888037264347
in O 0 0.015116006135940552
codon O 0 0.03777313232421875
82 O 0 0.058504197746515274
( O 0 0.039302144199609756
Glu O 1 0.999992847442627
) O 0 0.03439968451857567
of O 0 0.03843637928366661
NPII O 1 0.9991325736045837
. O 0 0.07139662653207779

The O 0 0.05163341388106346
premature O 1 0.6171765327453613
termination O 0 0.35589197278022766
eliminates O 0 0.08305851370096207
part O 0 0.02072383277118206
of O 0 0.013646061532199383
the O 0 0.01711944490671158
C O 1 0.9998959302902222
- O 1 0.9995304346084595
terminal O 0 0.06825527548789978
domain O 0 0.024871720001101494
of O 0 0.01932939514517784
NPII O 1 0.9994070529937744
, O 0 0.015004639513790607
including O 0 0.011991511099040508
a O 0 0.017295263707637787
cysteine O 0 0.02822260931134224
residue O 0 0.023525405675172806
in O 0 0.011182996444404125
position O 0 0.01805678941309452
85 O 0 0.027617521584033966
, O 0 0.01338084414601326
which O 0 0.009022283367812634
could O 0 0.008749116212129593
be O 0 0.0069031319580972195
involved O 0 0.009556541219353676
in O 0 0.009948802180588245
the O 0 0.013981560245156288
correct O 0 0.029194004833698273
folding O 1 0.5097489953041077
of O 0 0.02808896265923977
the O 0 0.041782770305871964
prohormone O 1 0.9999305009841919
. O 0 0.06846529245376587

In O 0 0.03049653396010399
the O 0 0.025646520778536797
second O 0 0.029684102162718773
family O 0 0.023911697790026665
, O 0 0.0165169108659029
a O 0 0.017990775406360626
G279A O 0 0.09485501796007156
substitution O 0 0.02526956982910633
at O 0 0.017873547971248627
position O 0 0.01986035332083702
- O 0 0.14215604960918427
1 O 0 0.017885882407426834
of O 0 0.011102107353508472
the O 0 0.01354994997382164
signal O 0 0.023495132103562355
peptide O 0 0.030263077467679977
was O 0 0.020690781995654106
observed O 0 0.014462150633335114
in O 0 0.010972889140248299
all O 0 0.013633512891829014
affected O 0 0.02159958705306053
individuals O 0 0.020041417330503464
. O 0 0.035375889390707016

This O 0 0.03445897623896599
missense O 0 0.06337135285139084
mutation O 0 0.031530074775218964
, O 0 0.017162155359983444
which O 0 0.01734919287264347
replaces O 1 0.999929666519165
Ala O 1 0.9999994039535522
with O 0 0.03154493495821953
Thr O 1 0.9999979734420776
, O 0 0.017193475738167763
is O 0 0.011031155474483967
frequent O 0 0.01770549640059471
among O 0 0.18857765197753906
FNDI B-Disease 1 1.0
patients O 1 0.9999998807907104
and O 0 0.02456401288509369
is O 0 0.009676857851445675
thought O 0 0.010718787088990211
to O 0 0.009277142584323883
reduce O 0 0.014584221877157688
the O 0 0.011979675851762295
efficiency O 0 0.023027220740914345
of O 0 0.01920638605952263
cleavage O 1 0.7328736186027527
by O 0 0.018732642754912376
signal O 0 0.04617900401353836
peptidases O 1 0.701964259147644
. O 0 0.03878980875015259
. O 0 0.047909725457429886

Genetic O 0 0.059810325503349304
heterogeneity O 0 0.0732864961028099
of O 0 0.03826981782913208
Saethre B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.025301765650510788
due O 0 0.018048200756311417
to O 0 0.020410289987921715
TWIST O 1 0.991384744644165
and O 0 0.039234887808561325
FGFR O 1 0.9999957084655762
mutations O 0 0.06268373876810074
. O 0 0.047580111771821976

Thirty O 0 0.07999963313341141
- O 1 0.8291025757789612
two O 0 0.017255129292607307
unrelated O 0 0.028041576966643333
patients O 0 0.02244521863758564
with O 0 0.009607442654669285
features O 0 0.015376526862382889
of O 0 0.01720544695854187
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.01722433976829052
a O 0 0.01537124440073967
common O 0 0.01873732917010784
autosomal B-Disease 1 0.9997515082359314
dominant I-Disease 1 0.9945307374000549
condition I-Disease 1 0.9963381290435791
of O 1 0.9936239719390869
craniosynostosis B-Disease 1 1.0
and O 1 0.9999951124191284
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999992847442627
, O 0 0.018341902643442154
were O 0 0.010647417046129704
screened O 0 0.02377140522003174
for O 0 0.012729017995297909
mutations O 0 0.017066165804862976
in O 0 0.015232383273541927
TWIST O 1 0.8287970423698425
, O 0 0.027662860229611397
FGFR2 O 1 0.9999668598175049
, O 0 0.030756140127778053
and O 0 0.03605686500668526
FGFR3 O 1 0.9997861981391907
. O 0 0.06294956803321838

Nine O 0 0.047330744564533234
novel O 0 0.040454208850860596
and O 0 0.018162749707698822
three O 0 0.018544325605034828
recurrent O 1 0.9999964237213135
TWIST O 1 0.9999114274978638
mutations O 0 0.022797822952270508
were O 0 0.010355532169342041
found O 0 0.010372394695878029
in O 0 0.012080392800271511
12 O 0 0.025686800479888916
families O 0 0.02993697300553322
. O 0 0.036855608224868774

Seven O 0 0.036200687289237976
families O 0 0.01988612860441208
were O 0 0.00934456568211317
found O 0 0.008117318153381348
to O 0 0.007546788081526756
have O 0 0.00646281847730279
the O 0 0.014011134393513203
FGFR3 O 1 0.9999967813491821
P250R O 1 0.9999451637268066
mutation O 0 0.023589659482240677
, O 0 0.011122196912765503
and O 0 0.008991485461592674
one O 0 0.008364452049136162
individual O 0 0.008746706880629063
was O 0 0.010973095893859863
found O 0 0.006843320559710264
to O 0 0.007523472886532545
have O 0 0.007116433698683977
an O 0 0.01506288442760706
FGFR2 O 1 0.9999797344207764
VV269 O 1 0.9996618032455444
- O 1 0.9996953010559082
270 O 0 0.10599818080663681
deletion O 0 0.10006991773843765
. O 0 0.05408390983939171

To O 0 0.028994951397180557
date O 0 0.02439587004482746
, O 0 0.01618240773677826
our O 0 0.01638699322938919
detection O 0 0.025353500619530678
rate O 0 0.013603957369923592
for O 0 0.012089012190699577
TWIST O 0 0.3483935296535492
or O 0 0.018157649785280228
FGFR O 1 0.9999290704727173
mutations O 0 0.01886141486465931
is O 0 0.011279965750873089
68 O 0 0.02368464134633541
% O 0 0.010356029495596886
in O 0 0.009722106158733368
our O 0 0.017477037385106087
Saethre B-Disease 1 0.9999922513961792
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999982118606567
, O 0 0.012925021350383759
including O 0 0.010163765400648117
our O 0 0.012032004073262215
five O 0 0.012333845719695091
patients O 1 0.8824400901794434
elsewhere O 0 0.014505297876894474
reported O 0 0.018976910039782524
with O 0 0.019866198301315308
TWIST O 1 0.9972148537635803
mutations O 0 0.0461820513010025
. O 0 0.03867601230740547

More O 0 0.02205745130777359
than O 0 0.015364259481430054
35 O 0 0.024273043498396873
different O 0 0.011088055558502674
TWIST O 0 0.0977664440870285
mutations O 0 0.016053171828389168
are O 0 0.007037266157567501
now O 0 0.011857986450195312
known O 0 0.012638882733881474
in O 0 0.012832758948206902
the O 0 0.019819118082523346
literature O 0 0.03514031320810318
. O 0 0.04123982787132263

The O 0 0.03363993763923645
most O 0 0.02030966430902481
common O 0 0.01848745346069336
phenotypic O 0 0.03173793479800224
features O 0 0.020033594220876694
, O 0 0.012650604359805584
present O 0 0.009454983286559582
in O 0 0.006767955143004656
more O 0 0.006266471929848194
than O 0 0.0063873096369206905
a O 0 0.008933681063354015
third O 0 0.013714931905269623
of O 0 0.010587458498775959
our O 0 0.014106880873441696
patients O 1 0.8293259739875793
with O 0 0.014829259365797043
TWIST O 1 0.9950011372566223
mutations O 0 0.021676022559404373
, O 0 0.012864884920418262
are O 0 0.009898718446493149
coronal B-Disease 0 0.23687422275543213
synostosis I-Disease 1 0.9760264754295349
, O 0 0.020755868405103683
brachycephaly B-Disease 1 0.9881271719932556
, O 0 0.022627100348472595
low B-Disease 0 0.3361916244029999
frontal I-Disease 1 0.9999992847442627
hairline I-Disease 1 1.0
, O 1 0.9958156943321228
facial B-Disease 1 1.0
asymmetry I-Disease 1 0.9999986886978149
, O 1 0.994817316532135
ptosis B-Disease 1 1.0
, O 0 0.2350662499666214
hypertelorism B-Disease 1 0.9999974966049194
, O 0 0.026100942865014076
broad B-Disease 1 0.6072292923927307
great I-Disease 1 0.9939129948616028
toes I-Disease 1 0.9999531507492065
, O 0 0.0302962064743042
and O 0 0.034547027200460434
clinodactyly B-Disease 1 0.9997923970222473
. O 0 0.05151208117604256

Significant O 0 0.05768550559878349
intra O 1 0.9916852712631226
- O 1 0.9997084736824036
and O 0 0.03008669801056385
interfamilial O 1 0.9978938698768616
phenotypic O 0 0.04933660104870796
variability O 0 0.03585025668144226
is O 0 0.013191748410463333
present O 0 0.01304718479514122
for O 0 0.010544098913669586
either O 0 0.01601955108344555
TWIST O 1 0.8942293524742126
mutations O 0 0.032507505267858505
or O 0 0.026295877993106842
FGFR O 1 0.9999827146530151
mutations O 0 0.060120318084955215
. O 0 0.052136871963739395

The O 0 0.03449280560016632
overlap O 0 0.03068472258746624
in O 0 0.017240669578313828
clinical O 1 0.8665206432342529
features O 0 0.01776653155684471
and O 0 0.01051835622638464
the O 0 0.009865693747997284
presence O 0 0.011766769923269749
, O 0 0.009446162730455399
in O 0 0.008339200168848038
the O 0 0.008189032785594463
same O 0 0.009150281548500061
genes O 0 0.009977850131690502
, O 0 0.00825840700417757
of O 0 0.008949877694249153
mutations O 0 0.008136159740388393
for O 0 0.00569336349144578
more O 0 0.005471464246511459
than O 0 0.0073746307753026485
one O 0 0.011607707478106022
craniosynostotic B-Disease 1 0.999363124370575
condition I-Disease 1 0.8056036233901978
- O 1 0.9488503932952881
such O 0 0.011293653398752213
as O 0 0.016805071383714676
Saethre B-Disease 1 0.9997407793998718
- I-Disease 1 0.9998571872711182
Chotzen I-Disease 1 0.9969724416732788
, I-Disease 0 0.02354034222662449
Crouzon I-Disease 1 0.9908221960067749
, I-Disease 0 0.021517911925911903
and I-Disease 0 0.030543863773345947
Pfeiffer I-Disease 1 1.0
syndromes I-Disease 1 1.0
- O 1 0.9999951124191284
support O 0 0.01929287798702717
the O 0 0.015414401888847351
hypothesis O 0 0.02246733568608761
that O 0 0.011290458030998707
TWIST O 0 0.2572174668312073
and O 0 0.01668015867471695
FGFRs O 1 0.7890027761459351
are O 0 0.009020458906888962
components O 0 0.01763811893761158
of O 0 0.01055769994854927
the O 0 0.011435375548899174
same O 0 0.012394064106047153
molecular O 0 0.02239052578806877
pathway O 0 0.01898271031677723
involved O 0 0.00969897210597992
in O 0 0.008426872082054615
the O 0 0.011513596400618553
modulation O 0 0.031557753682136536
of O 0 0.031627148389816284
craniofacial O 1 1.0
and O 1 0.9987795948982239
limb O 1 1.0
development O 1 0.9396219849586487
in O 0 0.024004310369491577
humans O 0 0.027025997638702393
. O 0 0.026554035022854805
. O 0 0.04296822100877762

Mutation O 0 0.05493620038032532
analysis O 0 0.025189518928527832
of O 0 0.030735541135072708
UBE3A O 1 0.9999998807907104
in O 1 0.9999841451644897
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 1.0
. O 1 0.9579418897628784

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.99960857629776
AS B-Disease 1 0.9999431371688843
) O 0 0.018028808757662773
is O 0 0.013371279463171959
caused O 0 0.018502546474337578
by O 0 0.015121257863938808
chromosome O 0 0.04088655486702919
15q11 O 1 0.9997426867485046
- O 1 0.999945878982544
q13 O 1 0.9811398983001709
deletions O 0 0.04381321370601654
of O 0 0.02034156769514084
maternal O 0 0.15568609535694122
origin O 0 0.015296339988708496
, O 0 0.0157940611243248
by O 0 0.01436648704111576
paternal O 1 0.9974708557128906
uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999998807907104
( O 1 0.9618546962738037
UPD B-Disease 1 1.0
) O 0 0.021086424589157104
15 O 0 0.021752245724201202
, O 0 0.015302660875022411
by O 0 0.013597926124930382
imprinting O 1 0.9999598264694214
defects O 1 0.9999982118606567
, O 0 0.0160375963896513
and O 0 0.011673546396195889
by O 0 0.012345206923782825
mutations O 0 0.018461788073182106
in O 0 0.015416168607771397
the O 0 0.030732903629541397
UBE3A O 1 0.9999927282333374
gene O 0 0.05652221664786339
. O 0 0.05071045830845833

UBE3A O 1 0.9638765454292297
encodes O 0 0.08893327414989471
a O 0 0.04626666381955147
ubiquitin O 1 0.8606502413749695
- O 1 0.9988992214202881
protein O 0 0.03327137604355812
ligase O 0 0.052637189626693726
and O 0 0.01963365450501442
shows O 0 0.027940882369875908
brain O 1 0.9960876703262329
- O 1 0.9993701577186584
specific O 0 0.0356987863779068
imprinting O 1 0.8820724487304688
. O 0 0.05611804500222206

Here O 0 0.040497470647096634
we O 0 0.023305974900722504
describe O 0 0.03879726678133011
UBE3A O 1 0.9997581839561462
coding O 1 0.877557098865509
- O 1 0.9987234473228455
region O 0 0.026136834174394608
mutations O 0 0.021419251337647438
detected O 0 0.019165633246302605
by O 0 0.012509912252426147
SSCP O 1 0.9471287131309509
analysis O 0 0.014817719347774982
in O 0 0.01329808495938778
13 O 0 0.021418653428554535
AS B-Disease 0 0.025703441351652145
individuals O 0 0.014722843654453754
or O 0 0.01918001100420952
families O 0 0.02744685299694538
. O 0 0.03928361088037491

Two O 0 0.04015180096030235
identical O 0 0.052208494395017624
de O 0 0.07246306538581848
novo O 0 0.09829478710889816
5 O 0 0.05114758759737015
- O 0 0.31412020325660706
bp O 0 0.07884106785058975
duplications O 0 0.07419493794441223
in O 0 0.02967357262969017
exon O 0 0.06948421895503998
16 O 0 0.0350642167031765
were O 0 0.02102947235107422
found O 0 0.02631940320134163
. O 0 0.03971363604068756

Among O 0 0.03115999326109886
the O 0 0.019090576097369194
other O 0 0.011639502830803394
11 O 0 0.01742818020284176
unique O 0 0.018640900030732155
mutations O 0 0.018314672634005547
, O 0 0.012659577652812004
8 O 0 0.01735643483698368
were O 0 0.009973149746656418
small O 0 0.01376289315521717
deletions O 0 0.02971639297902584
or O 0 0.014911782927811146
insertions O 0 0.03586683049798012
predicted O 0 0.01934845931828022
to O 0 0.013960310257971287
cause O 0 0.07492688298225403
frameshifts O 1 0.9989736080169678
, O 0 0.014643344096839428
1 O 0 0.016713714227080345
was O 0 0.015136911533772945
a O 0 0.013019178993999958
mutation O 0 0.012445438653230667
to O 0 0.008204134181141853
a O 0 0.011917250230908394
stop O 0 0.015465215779840946
codon O 0 0.02525537833571434
, O 0 0.01294256653636694
1 O 0 0.014928190037608147
was O 0 0.016268545761704445
a O 0 0.016172192990779877
missense O 0 0.03475358337163925
mutation O 0 0.018624242395162582
, O 0 0.010327612049877644
and O 0 0.009221813641488552
1 O 0 0.014967317692935467
was O 0 0.015345926396548748
predicted O 0 0.0180758498609066
to O 0 0.012408039532601833
cause O 0 0.019294394180178642
insertion O 0 0.02727479301393032
of O 0 0.013486787676811218
an O 0 0.01687024161219597
isoleucine O 1 0.9969139099121094
in O 0 0.015836412087082863
the O 0 0.017175082117319107
hect O 0 0.10914591699838638
domain O 0 0.020084792748093605
of O 0 0.014355923980474472
the O 0 0.01851108856499195
UBE3A O 1 0.9999986886978149
protein O 0 0.02075287327170372
, O 0 0.012173295952379704
which O 0 0.007984231226146221
functions O 0 0.011106290854513645
in O 0 0.016431167721748352
E2 O 1 0.9936699271202087
binding O 0 0.03236055746674538
and O 0 0.027397027239203453
ubiquitin O 0 0.15976424515247345
transfer O 0 0.042508140206336975
. O 0 0.05379199609160423

Eight O 0 0.03300190716981888
of O 0 0.017757920548319817
the O 0 0.014611240476369858
cases O 0 0.013792004436254501
were O 0 0.01274323184043169
familial O 1 0.9994251728057861
, O 0 0.014148076996207237
and O 0 0.01253420952707529
five O 0 0.014148521237075329
were O 0 0.01631123013794422
sporadic O 0 0.03924204409122467
. O 0 0.04446672648191452

In O 0 0.03171878308057785
two O 0 0.021061990410089493
familial O 1 0.9402698278427124
cases O 0 0.016351046040654182
and O 0 0.012347730807960033
one O 0 0.013608360663056374
sporadic O 0 0.021917719393968582
case O 0 0.018683109432458878
, O 0 0.01958056353032589
mosaicism O 1 0.996776282787323
for O 0 0.023902876302599907
UBE3A O 1 0.9999955892562866
mutations O 0 0.03064589761197567
was O 0 0.022455671802163124
detected O 0 0.01864665187895298
in O 0 0.009910416789352894
the O 0 0.01169526856392622
mother O 0 0.017092693597078323
of O 0 0.008394802920520306
three O 0 0.009561104699969292
AS B-Disease 1 0.5493981242179871
sons O 0 0.33051425218582153
, O 0 0.00906434003263712
in O 0 0.008746025152504444
the O 0 0.013519271276891232
maternal O 1 0.983155369758606
grandfather O 1 0.6136792898178101
of O 0 0.009960982948541641
two O 0 0.008574833162128925
AS B-Disease 0 0.01725081168115139
first O 0 0.01577702909708023
cousins O 0 0.024903669953346252
, O 0 0.009972651489078999
and O 0 0.007335111033171415
in O 0 0.007467072457075119
the O 0 0.010046442970633507
mother O 0 0.017981357872486115
of O 0 0.011740269139409065
an O 0 0.017893563956022263
AS B-Disease 1 0.998779833316803
daughter O 1 0.9905074834823608
. O 0 0.05304146558046341

The O 0 0.03191312402486801
frequencies O 0 0.020924093201756477
with O 0 0.013778268359601498
which O 0 0.00949796475470066
we O 0 0.00930001586675644
detected O 0 0.014245408587157726
mutations O 0 0.010251387022435665
were O 0 0.006402616389095783
5 O 0 0.013384056277573109
( O 0 0.010775810107588768
14 O 0 0.014399920590221882
% O 0 0.010816908441483974
) O 0 0.010390127077698708
of O 0 0.00981451477855444
35 O 0 0.015574534423649311
in O 0 0.009979410097002983
sporadic O 0 0.017225412651896477
cases O 0 0.010068762116134167
and O 0 0.009918862022459507
8 O 0 0.01602119952440262
( O 0 0.012710219249129295
80 O 0 0.01954331062734127
% O 0 0.012809239327907562
) O 0 0.011256527155637741
of O 0 0.011406137607991695
10 O 0 0.015902524814009666
in O 0 0.01784672401845455
familial O 1 0.9990806579589844
cases O 0 0.02552569843828678
. O 0 0.02471780963242054
. O 0 0.038408346474170685

The O 0 0.07789099961519241
hemochromatosis B-Disease 1 0.9999998807907104
845 O 1 0.9999982118606567
G O 1 0.9999957084655762
- O 1 0.9999959468841553
- O 1 0.9995697140693665
> O 0 0.06340736150741577
A O 0 0.025858230888843536
and O 0 0.018470285460352898
187 O 0 0.041052017360925674
C O 1 0.994544267654419
- O 1 0.9999687671661377
- O 1 0.9999581575393677
> O 1 0.991707980632782
G O 1 0.9710975885391235
mutations O 0 0.031947195529937744
: O 0 0.02579464018344879
prevalence O 0 0.24302779138088226
in O 0 0.02014768309891224
non O 1 0.755293607711792
- O 1 0.9999768733978271
Caucasian O 1 0.9977415800094604
populations O 0 0.04672202840447426
. O 0 0.0529053770005703

Hemochromatosis B-Disease 1 0.9999947547912598
, O 0 0.0355411134660244
the O 0 0.06089997664093971
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 0.9999904632568359
iron I-Disease 1 1.0
metabolism I-Disease 1 0.9999949932098389
, O 0 0.029699839651584625
leads O 0 0.10443244874477386
, O 0 0.01196515653282404
if O 0 0.013331479392945766
untreated O 1 0.9995580315589905
, O 0 0.01317330077290535
to O 0 0.01664149947464466
progressive O 1 0.9999934434890747
iron B-Disease 1 1.0
overload I-Disease 1 1.0
and O 1 0.8932616710662842
premature B-Disease 1 0.9999414682388306
death I-Disease 1 0.8799332976341248
. O 0 0.05363387241959572

The O 0 0.06539244204759598
hemochromatosis B-Disease 1 1.0
gene O 0 0.14198148250579834
, O 0 0.08747484534978867
HFE O 1 0.9999995231628418
, O 0 0.017150163650512695
recently O 0 0.019063076004385948
has O 0 0.008893637917935848
been O 0 0.00804973766207695
identified O 0 0.009346432983875275
, O 0 0.008102389983832836
and O 0 0.00774277001619339
characterization O 0 0.014982392080128193
of O 0 0.00888106320053339
this O 0 0.009069172665476799
gene O 0 0.01222244743257761
has O 0 0.009607814252376556
shown O 0 0.008309025317430496
that O 0 0.0053818440064787865
it O 0 0.006276141386479139
contains O 0 0.010172341018915176
two O 0 0.008258367888629436
mutations O 0 0.012097080238163471
that O 0 0.006799769587814808
result O 0 0.009875956922769547
in O 0 0.014364265836775303
amino O 0 0.024329116567969322
acid O 0 0.03663427382707596
substitutions O 0 0.04963745176792145
- O 0 0.06583604961633682
cDNA O 0 0.07330261170864105
nucleotides O 0 0.052849434316158295
845 O 1 0.7690243124961853
G O 1 0.9938872456550598
- O 1 0.9996728897094727
- O 1 0.999383807182312
> O 0 0.3319219648838043
A O 0 0.030444970354437828
( O 0 0.024967113509774208
C282Y O 0 0.05977679416537285
) O 0 0.013845588080585003
and O 0 0.013122561387717724
187 O 0 0.04080217331647873
C O 1 0.9907335042953491
- O 1 0.9999850988388062
- O 1 0.9999943971633911
> O 1 0.9999386072158813
G O 1 0.9999328851699829
( O 0 0.045751944184303284
H63D O 1 0.999910831451416
) O 0 0.04522768035531044
. O 0 0.04627590253949165

Although O 0 0.14828261733055115
hemochromatosis B-Disease 1 1.0
is O 0 0.023006010800600052
common O 0 0.01604555919766426
in O 0 0.015004250220954418
Caucasians O 1 0.9402913451194763
, O 0 0.018133413046598434
affecting O 0 0.030162569135427475
> O 1 0.9993071556091309
= O 0 0.11143118888139725
1 O 0 0.027400344610214233
/ O 0 0.040174804627895355
300 O 0 0.019488876685500145
individuals O 0 0.00775344530120492
of O 0 0.00862736813724041
northern O 0 0.011190550401806831
European O 0 0.01200924627482891
origin O 0 0.008952269330620766
, O 0 0.00859388243407011
it O 0 0.006907317321747541
has O 0 0.007544869557023048
not O 0 0.006624517496675253
been O 0 0.007877535186707973
recognized O 0 0.012767856940627098
in O 0 0.012925898656249046
other O 0 0.014523916877806187
populations O 0 0.023725174367427826
. O 0 0.03863603621721268

The O 0 0.036185722798109055
present O 0 0.023899272084236145
study O 0 0.018788516521453857
used O 0 0.016609713435173035
PCR O 0 0.04180580750107765
and O 0 0.018245531246066093
restriction O 0 0.03620126470923424
- O 1 0.9998675584793091
enzyme O 0 0.03489682823419571
digestion O 0 0.03855133429169655
to O 0 0.014091835357248783
analyze O 0 0.02167147397994995
the O 0 0.01219447236508131
frequency O 0 0.01346228364855051
of O 0 0.012225215323269367
the O 0 0.01733560673892498
845 O 1 0.9995043277740479
G O 1 0.9999864101409912
- O 1 0.9999935626983643
- O 1 0.9987753033638
> O 0 0.051442962139844894
A O 0 0.023193396627902985
and O 0 0.014851190149784088
187 O 0 0.041154976934194565
C O 1 0.979304313659668
- O 1 0.9997672438621521
- O 1 0.9994083642959595
> O 1 0.938008189201355
G O 1 0.7824136018753052
mutations O 0 0.03214828670024872
in O 0 0.02640729583799839
HLA O 1 0.9999996423721313
- O 1 0.9688059687614441
typed O 0 0.04636853188276291
samples O 0 0.01942632347345352
from O 0 0.014443005435168743
non O 0 0.03074020892381668
- O 1 0.9989218711853027
Caucasian O 0 0.35458123683929443
populations O 0 0.01812334544956684
, O 0 0.016028139740228653
comprising O 0 0.023510130122303963
Australian O 0 0.026561254635453224
Aboriginal O 0 0.03592299669981003
, O 0 0.015370558947324753
Chinese O 0 0.021582789719104767
, O 0 0.017010001465678215
and O 0 0.018299734219908714
Pacific O 0 0.06439521908760071
Islanders O 0 0.08698118478059769
. O 0 0.05074328929185867

Results O 0 0.04559757933020592
showed O 0 0.025154951959848404
that O 0 0.010886194184422493
the O 0 0.01970418356359005
845 O 1 0.9982611536979675
G O 1 0.9999697208404541
- O 1 0.9999961853027344
- O 1 0.9999513626098633
> O 1 0.8163742423057556
A O 0 0.029998892918229103
mutation O 0 0.02490312047302723
was O 0 0.01645536534488201
present O 0 0.01177539024502039
in O 0 0.010220952332019806
these O 0 0.0081853698939085
populations O 0 0.01094135083258152
( O 0 0.013027023524045944
allele O 0 0.024701399728655815
frequency O 0 0.014575637876987457
0 O 0 0.0180151779204607
. O 0 0.009602797217667103
32 O 0 0.019167523831129074
% O 0 0.012225395999848843
) O 0 0.010497537441551685
, O 0 0.009183908812701702
and O 0 0.009044615551829338
, O 0 0.009319530799984932
furthermore O 0 0.012288740836083889
, O 0 0.008555155247449875
it O 0 0.0073690335266292095
was O 0 0.014349636621773243
always O 0 0.011907231993973255
seen O 0 0.011098725721240044
in O 0 0.009045845828950405
conjunction O 0 0.020355647429823875
with O 0 0.020176224410533905
HLA O 1 1.0
haplotypes O 1 0.8615202307701111
common O 0 0.016623876988887787
in O 0 0.01626695692539215
Caucasians O 0 0.3961254358291626
, O 0 0.01273829024285078
suggesting O 0 0.01462539006024599
that O 0 0.01164922583848238
845 O 1 0.9986572265625
G O 1 0.9999828338623047
- O 1 0.9999974966049194
- O 1 0.9999881982803345
> O 1 0.9702915549278259
A O 0 0.022846249863505363
may O 0 0.011802243068814278
have O 0 0.006932149175554514
been O 0 0.00853427778929472
introduced O 0 0.012125584296882153
into O 0 0.009449447505176067
these O 0 0.007845830172300339
populations O 0 0.015154307708144188
by O 0 0.018009811639785767
Caucasian O 1 0.9969708919525146
admixture O 1 0.994652271270752
. O 0 0.052511923015117645

187 O 0 0.11433349549770355
C O 1 0.9698062539100647
- O 1 0.9999749660491943
- O 1 0.9999693632125854
> O 1 0.9974901676177979
G O 1 0.8828154802322388
was O 0 0.022628987208008766
present O 0 0.014976038597524166
at O 0 0.016911335289478302
an O 0 0.014791187830269337
allele O 0 0.03104386106133461
frequency O 0 0.019190097227692604
of O 0 0.02151758223772049
2 O 0 0.044341832399368286
. O 0 0.04827076941728592

68 O 0 0.07805846631526947
% O 0 0.026024386286735535
in O 0 0.014213048852980137
the O 0 0.013300430960953236
two O 0 0.009674254804849625
populations O 0 0.012016065418720245
analyzed O 0 0.020980237051844597
( O 0 0.01689295470714569
Australian O 0 0.029742049053311348
Aboriginal O 0 0.035282254219055176
and O 0 0.018688607960939407
Chinese O 0 0.0351104661822319
) O 0 0.031993161886930466
. O 0 0.04461846873164177

In O 0 0.03199801594018936
the O 0 0.026127396151423454
Australian O 0 0.03357542306184769
Aboriginal O 0 0.03303505480289459
samples O 0 0.019254310056567192
, O 0 0.015245284885168076
187 O 0 0.03726261854171753
C O 1 0.9650406241416931
- O 1 0.9999864101409912
- O 1 0.9999947547912598
> O 1 0.9996790885925293
G O 1 0.8960000872612
was O 0 0.018299568444490433
found O 0 0.008401203900575638
to O 0 0.008248692378401756
be O 0 0.007593767251819372
associated O 0 0.012728567235171795
with O 0 0.015369251370429993
HLA O 1 1.0
haplotypes O 1 0.8421776294708252
common O 0 0.015250584110617638
in O 0 0.0159122496843338
Caucasians O 1 0.9985659718513489
, O 0 0.012909166514873505
suggesting O 0 0.013405103236436844
that O 0 0.007675137370824814
it O 0 0.009407664649188519
was O 0 0.01686888374388218
introduced O 0 0.02251894772052765
by O 0 0.014710779301822186
recent O 0 0.02832416445016861
admixture O 0 0.07985685020685196
. O 0 0.04839390143752098

In O 0 0.033703844994306564
the O 0 0.0262614656239748
Chinese O 0 0.031322821974754333
samples O 0 0.02341144159436226
analyzed O 0 0.02538706362247467
, O 0 0.01832767203450203
187 O 0 0.039986997842788696
C O 1 0.8041678071022034
- O 1 0.9998348951339722
- O 1 0.999977707862854
> O 1 0.9978194236755371
G O 1 0.8703210949897766
was O 0 0.020589960739016533
present O 0 0.01105270255357027
in O 0 0.009017031639814377
association O 0 0.012341166846454144
with O 0 0.00693282438442111
a O 0 0.009223652072250843
wide O 0 0.011610958725214005
variety O 0 0.011759010143578053
of O 0 0.018435217440128326
HLA O 1 1.0
haplotypes O 1 0.875312328338623
, O 0 0.015119731426239014
showing O 0 0.01660728268325329
this O 0 0.007900501601397991
mutation O 0 0.01168604101985693
to O 0 0.007413651794195175
be O 0 0.007741660811007023
widespread O 0 0.013025663793087006
and O 0 0.010237067937850952
likely O 0 0.011307439766824245
to O 0 0.011506552807986736
predate O 0 0.02829846553504467
the O 0 0.011128838174045086
more O 0 0.010379058308899403
genetically O 0 0.019463440403342247
restricted O 0 0.022054610773921013
845 O 1 0.9988841414451599
G O 1 0.9999791383743286
- O 1 0.9999980926513672
- O 1 0.9999692440032959
> O 1 0.9421491026878357
A O 0 0.05864408612251282
mutation O 0 0.06304777413606644
. O 0 0.05447893962264061

Genotype O 1 0.9876132011413574
- O 1 0.9985780715942383
phenotype O 0 0.2635093033313751
correlations O 0 0.063761405646801
in O 0 0.04329017549753189
attenuated B-Disease 1 0.999998927116394
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 0.29242804646492004

Germ O 1 0.9999790191650391
- O 1 0.997954249382019
line O 0 0.03918779641389847
mutations O 0 0.023656638339161873
of O 0 0.015413512475788593
the O 0 0.030356770381331444
tumor B-Disease 1 1.0
suppressor O 1 0.9999990463256836
APC O 1 0.9999713897705078
are O 0 0.012620480731129646
implicated O 0 0.04055168107151985
in O 0 0.02398471161723137
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999808073043823
AAPC B-Disease 1 1.0
) O 0 0.023394474759697914
, O 0 0.016236480325460434
a O 0 0.017353883013129234
variant O 0 0.031837962567806244
of O 0 0.03009396232664585
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 1.0
FAP B-Disease 1 1.0
) O 1 0.5556202530860901
. O 0 0.058301400393247604

AAPC B-Disease 1 0.9999963045120239
is O 0 0.02745087631046772
recognized O 0 0.021342677995562553
by O 0 0.010000730864703655
the O 0 0.01146674808114767
occurrence O 0 0.02059689164161682
of O 0 0.01737755909562111
< O 1 0.9988806843757629
100 O 0 0.106535404920578
colonic B-Disease 1 0.9999991655349731
adenomas I-Disease 1 0.9999710321426392
and O 0 0.01552126370370388
a O 0 0.016123594716191292
later O 0 0.019876398146152496
onset O 1 0.999985933303833
of O 1 0.9996117949485779
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.8529711365699768
age O 1 0.5508347749710083
> O 1 0.9937082529067993
40 O 0 0.030902503058314323
years O 0 0.029278086498379707
) O 0 0.03374709188938141
. O 0 0.04439008980989456

The O 0 0.03352830186486244
aim O 0 0.03206733241677284
of O 0 0.01508154347538948
this O 0 0.00995504017919302
study O 0 0.0123796621337533
was O 0 0.015075352974236012
to O 0 0.014555449597537518
assess O 0 0.03865215927362442
genotype O 1 0.7762909531593323
- O 1 0.9998384714126587
phenotype O 1 0.8297651410102844
correlations O 0 0.057291265577077866
in O 0 0.040784113109111786
AAPC B-Disease 1 0.999998927116394
families O 0 0.06645103543996811
. O 0 0.05786294490098953

By O 0 0.032207224518060684
protein O 0 0.0414302684366703
- O 1 0.9806358218193054
truncation O 1 0.5847416520118713
test O 0 0.041417401283979416
( O 0 0.032044291496276855
PTT O 1 0.9820944666862488
) O 0 0.02319299429655075
assay O 0 0.03475155681371689
, O 0 0.013399315066635609
the O 0 0.013607810251414776
entire O 0 0.02046888694167137
coding O 0 0.026220710948109627
region O 0 0.015310990624129772
of O 0 0.012557737529277802
the O 0 0.01718856208026409
APC B-Disease 1 0.9999910593032837
gene O 0 0.021047336980700493
was O 0 0.02160976454615593
screened O 0 0.0282562505453825
in O 0 0.011531541123986244
affected O 0 0.012418298982083797
individuals O 0 0.008098222315311432
from O 0 0.011579327285289764
11 O 0 0.06254725903272629
AAPC B-Disease 1 1.0
kindreds O 1 0.9995967745780945
, O 0 0.02121155336499214
and O 0 0.013605507090687752
their O 0 0.012668640352785587
phenotypic O 0 0.0340149961411953
differences O 0 0.022800328209996223
were O 0 0.020096473395824432
examined O 0 0.04812614992260933
. O 0 0.045596711337566376

Five O 0 0.05200722813606262
novel O 0 0.06884919106960297
germ O 1 0.9999693632125854
- O 1 0.9999828338623047
line O 0 0.39510083198547363
APC B-Disease 1 0.9999456405639648
mutations O 0 0.02906550094485283
were O 0 0.013875309377908707
identified O 0 0.018992872908711433
in O 0 0.018566912040114403
seven O 0 0.03460879996418953
kindreds O 1 0.7460456490516663
. O 0 0.057559795677661896

Mutations O 0 0.050795964896678925
were O 0 0.01610647141933441
located O 0 0.018355833366513252
in O 0 0.008907346986234188
three O 0 0.006966341286897659
different O 0 0.004800132475793362
regions O 0 0.007405193522572517
of O 0 0.008110503666102886
the O 0 0.011757824569940567
APC B-Disease 1 0.9999994039535522
gene O 0 0.01637970097362995
( O 0 0.01198332104831934
1 O 0 0.015099848620593548
) O 0 0.009753957390785217
at O 0 0.010578959248960018
the O 0 0.010382561013102531
5 O 0 0.01381450891494751
end O 0 0.015970440581440926
spanning O 0 0.02304914779961109
exons O 0 0.025322141125798225
4 O 0 0.019374461844563484
and O 0 0.011756704188883305
5 O 0 0.018449313938617706
, O 0 0.01358022540807724
( O 0 0.012690464034676552
2 O 0 0.017528517171740532
) O 0 0.012146975845098495
within O 0 0.012532806023955345
exon O 0 0.040201425552368164
9 O 0 0.022182801738381386
, O 0 0.01338016614317894
and O 0 0.010818887501955032
( O 0 0.012899362482130527
3 O 0 0.01717567816376686
) O 0 0.010342784225940704
at O 0 0.012604672461748123
the O 0 0.012660210952162743
3 O 0 0.02100394479930401
distal O 0 0.0808972492814064
end O 0 0.02160947024822235
of O 0 0.018036026507616043
the O 0 0.024287916719913483
gene O 0 0.040150340646505356
. O 0 0.04309221729636192

Variability O 0 0.054363418370485306
in O 0 0.015968238934874535
the O 0 0.013358277268707752
number O 0 0.014392558485269547
of O 1 0.5928559899330139
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.9952990412712097
most O 0 0.013556664809584618
apparent O 0 0.0200998242944479
in O 0 0.010395865887403488
individuals O 0 0.007661301642656326
with O 0 0.009546026587486267
mutations O 0 0.011409767903387547
in O 0 0.008495945483446121
region O 0 0.012320715002715588
1 O 0 0.015926968306303024
, O 0 0.011158693581819534
and O 0 0.014146845787763596
upper O 1 0.9999102354049683
- O 1 1.0
gastrointestinal O 1 1.0
manifestations O 1 0.9999890327453613
were O 0 0.01738530397415161
more O 0 0.016201535239815712
severe O 1 0.9998898506164551
in O 0 0.021983053535223007
them O 0 0.0236995667219162
. O 0 0.04090534895658493

In O 0 0.026328349485993385
individuals O 0 0.013010835275053978
with O 0 0.012871353887021542
mutations O 0 0.014178402721881866
in O 0 0.00846734456717968
either O 0 0.008404413238167763
region O 0 0.012744126841425896
2 O 0 0.013640272431075573
or O 0 0.008508897386491299
region O 0 0.011688530445098877
3 O 0 0.01215888187289238
, O 0 0.008501562289893627
the O 0 0.009367826394736767
average O 0 0.011819479055702686
number O 0 0.00962213147431612
of O 0 0.013571223244071007
adenomas B-Disease 1 0.9999129772186279
tended O 0 0.021504191681742668
to O 0 0.010460848920047283
be O 0 0.008063829503953457
lower O 0 0.010875493288040161
than O 0 0.0061401487328112125
those O 0 0.005156940780580044
in O 0 0.005571436136960983
individuals O 0 0.005828899797052145
with O 0 0.007008930668234825
mutations O 0 0.009229912422597408
in O 0 0.007282665930688381
region O 0 0.011493247002363205
1 O 0 0.01462123915553093
, O 0 0.010019466280937195
although O 0 0.009142277762293816
age O 0 0.015585080720484257
at O 0 0.024109305813908577
diagnosis O 1 0.9998382329940796
was O 0 0.0349138081073761
similar O 0 0.03137720003724098
. O 0 0.0469650998711586

In O 0 0.05100065469741821
all O 0 0.04784819111227989
AAPC B-Disease 1 0.9999960660934448
kindreds O 1 0.9115551114082336
, O 0 0.029388098046183586
a O 0 0.02595776692032814
predominance O 0 0.05835700035095215
of O 0 0.02302611991763115
right O 1 0.9322272539138794
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999970197677612
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 1 0.9999974966049194
was O 1 0.9252498745918274
observed O 0 0.049686264246702194
. O 0 0.04877786710858345

No O 0 0.07771839201450348
desmoid B-Disease 1 0.9999929666519165
tumors I-Disease 1 0.9999910593032837
were O 0 0.020016899332404137
found O 0 0.01979992352426052
in O 0 0.018351314589381218
these O 0 0.019605495035648346
kindreds O 1 0.7592111825942993
. O 0 0.04994870349764824

Our O 0 0.037560202181339264
data O 0 0.021277468651533127
suggest O 0 0.018391190096735954
that O 0 0.010240811854600906
, O 0 0.012908194214105606
in O 0 0.014762142673134804
AAPC B-Disease 1 0.9999997615814209
families O 0 0.01739766076207161
, O 0 0.010563713498413563
the O 0 0.008984205313026905
location O 0 0.011883636936545372
of O 0 0.010286087170243263
the O 0 0.01718818210065365
APC B-Disease 1 0.9999997615814209
mutation O 0 0.1722385436296463
may O 0 0.019103938713669777
partially O 0 0.033701278269290924
predict O 0 0.02788953110575676
specific O 0 0.02041899599134922
phenotypic O 0 0.052091069519519806
expression O 0 0.0411871075630188
. O 0 0.04844752699136734

This O 0 0.022184578701853752
should O 0 0.01367107592523098
help O 0 0.01581660285592079
in O 0 0.009612800553441048
the O 0 0.010509035550057888
design O 0 0.017928313463926315
of O 0 0.012185565195977688
tailored O 1 0.9976109266281128
clinical O 1 0.9999996423721313
- O 1 0.9999995231628418
management O 1 0.911366879940033
protocols O 0 0.025043735280632973
in O 0 0.010332632809877396
this O 0 0.010033036582171917
subset O 0 0.029430700466036797
of O 0 0.038171228021383286
FAP B-Disease 1 1.0
patients O 1 0.9999980926513672
. O 0 0.033233653753995895
. O 0 0.04763098433613777

Wilms B-Disease 1 0.9999998807907104
' I-Disease 1 0.9921563863754272
tumor I-Disease 1 0.9998688697814941
1 O 0 0.04693736508488655
and O 0 0.03153589740395546
Dax O 1 0.9999977350234985
- O 1 0.9985606074333191
1 O 0 0.035036616027355194
modulate O 0 0.05230001360177994
the O 0 0.023683886975049973
orphan O 1 0.9833889007568359
nuclear O 0 0.05088777840137482
receptor O 1 0.501046895980835
SF O 1 0.9999997615814209
- O 1 0.999237060546875
1 O 0 0.02663840726017952
in O 0 0.01576313003897667
sex O 0 0.02616911381483078
- O 1 0.5470305681228638
specific O 0 0.02649560198187828
gene O 0 0.03510625660419464
expression O 0 0.03978347405791283
. O 0 0.04939357936382294

Products O 0 0.06580067425966263
of O 0 0.03626416251063347
steroidogenic O 1 0.9999097585678101
factor O 0 0.04433371126651764
1 O 0 0.03349531814455986
( O 0 0.03373100236058235
SF O 1 0.9999995231628418
- O 1 0.9997236132621765
1 O 0 0.031364213675260544
) O 0 0.020862305536866188
and O 0 0.023253055289387703
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9999997615814209
1 O 0 0.45334309339523315
( O 0 0.03782461956143379
WT1 O 1 0.9999687671661377
) O 0 0.025773366913199425
genes O 0 0.017777884379029274
are O 0 0.008211729116737843
essential O 0 0.015850866213440895
for O 0 0.016047153621912003
mammalian O 0 0.037835121154785156
gonadogenesis O 1 0.7497836351394653
prior O 0 0.023862745612859726
to O 0 0.02185388095676899
sexual O 0 0.03694986179471016
differentiation O 0 0.16238921880722046
. O 0 0.052294835448265076

In O 0 0.03592658415436745
males O 0 0.03504245728254318
, O 0 0.03729458525776863
SF O 1 0.9999998807907104
- O 1 0.9999326467514038
1 O 0 0.03344549983739853
participates O 0 0.031994473189115524
in O 0 0.015171055682003498
sexual O 0 0.017079632729291916
development O 0 0.015132889151573181
by O 0 0.010791833512485027
regulating O 0 0.019367165863513947
expression O 0 0.012992821633815765
of O 0 0.013988648541271687
the O 0 0.024148566648364067
polypeptide O 1 0.9988058805465698
hormone O 1 0.9997077584266663
Mullerian O 1 0.9999995231628418
inhibiting O 1 0.9999887943267822
substance O 1 0.9999790191650391
( O 1 0.8102107644081116
MIS O 1 0.9999994039535522
) O 0 0.04668321833014488
. O 0 0.051200296729803085

Here O 0 0.037937331944704056
, O 0 0.01993698440492153
we O 0 0.014879591763019562
show O 0 0.01762797310948372
that O 0 0.017350606620311737
WT1 O 1 0.9999932050704956
- O 1 0.9999568462371826
KTS O 1 0.999935507774353
isoforms O 0 0.0430331714451313
associate O 0 0.03182879090309143
and O 0 0.019793981686234474
synergize O 1 0.9829877614974976
with O 0 0.02838898077607155
SF O 1 1.0
- O 1 0.9999817609786987
1 O 0 0.031026050448417664
to O 0 0.021437963470816612
promote O 0 0.05587511137127876
MIS O 1 0.9998431205749512
expression O 0 0.058571215718984604
. O 0 0.05499691143631935

In O 0 0.03441372141242027
contrast O 0 0.04224267229437828
, O 0 0.03211786597967148
WT1 O 1 0.9999569654464722
missense O 0 0.08898540586233139
mutations O 0 0.023713944479823112
, O 0 0.014107601717114449
associated O 0 0.011269202455878258
with O 0 0.00919365044683218
male B-Disease 0 0.021566035225987434
pseudohermaphroditism I-Disease 1 0.9999939203262329
in O 0 0.06693464517593384
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 0.03126423805952072
fail O 0 0.02975822240114212
to O 0 0.01891995221376419
synergize O 1 0.9987670183181763
with O 0 0.046331241726875305
SF O 1 1.0
- O 1 0.9999982118606567
1 O 0 0.06421229243278503
. O 0 0.05245918035507202

Additionally O 0 0.0474921353161335
, O 0 0.0204768106341362
the O 0 0.020762216299772263
X O 1 0.9714164137840271
- O 1 0.9936342239379883
linked O 0 0.025339365005493164
, O 0 0.016330696642398834
candidate O 0 0.024447090923786163
dosage O 1 0.9984763264656067
- O 1 0.9985668063163757
sensitive O 0 0.025290057063102722
sex O 0 0.021368786692619324
- O 1 0.9075711965560913
reversal O 0 0.029833558946847916
gene O 0 0.02093503624200821
, O 0 0.02091599628329277
Dax O 1 0.9999951124191284
- O 1 0.9991790652275085
1 O 0 0.02873344160616398
, O 0 0.019026195630431175
antagonizes O 0 0.39187800884246826
synergy O 0 0.3294599652290344
between O 0 0.024036485701799393
SF O 1 1.0
- O 1 0.99998939037323
1 O 0 0.03466039150953293
and O 0 0.022016756236553192
WT1 O 1 0.9999328851699829
, O 0 0.017760692164301872
most O 0 0.011392591521143913
likely O 0 0.010359036736190319
through O 0 0.007543680723756552
a O 0 0.009713470004498959
direct O 0 0.011803077533841133
interaction O 0 0.015498940832912922
with O 0 0.02037898264825344
SF O 1 1.0
- O 1 0.9999926090240479
1 O 0 0.06546659022569656
. O 0 0.056928545236587524

We O 0 0.03325000777840614
propose O 0 0.04846009984612465
that O 0 0.02173013612627983
WT1 O 1 0.9991707801818848
and O 0 0.03709765896201134
Dax O 1 0.9999996423721313
- O 1 0.9999841451644897
1 O 0 0.03573818504810333
functionally O 0 0.042041994631290436
oppose O 0 0.023844176903367043
each O 0 0.010866468772292137
other O 0 0.010367217473685741
in O 0 0.013976526446640491
testis O 0 0.2753385603427887
development O 0 0.018793942406773567
by O 0 0.01694958284497261
modulating O 1 0.9996554851531982
SF O 1 1.0
- O 1 0.9999971389770508
1 O 0 0.34454095363616943
- O 1 0.9996212720870972
mediated O 1 0.6555626392364502
transactivation O 1 0.9974178075790405
. O 0 0.038111407309770584
. O 0 0.04783252999186516

A O 0 0.04664558544754982
mouse O 0 0.05023708567023277
model O 0 0.034180205315351486
for O 0 0.03263969346880913
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 1.0
centre O 1 0.999864935874939
mutations O 0 0.07417358458042145
. O 0 0.054397281259298325

Imprinting O 0 0.1167643591761589
in O 0 0.028863392770290375
the O 0 0.028396300971508026
15q11 O 1 0.9994778037071228
- O 1 0.9999454021453857
q13 O 1 0.8278665542602539
region O 0 0.023146627470850945
involves O 0 0.019216647371649742
an O 0 0.015622669830918312
imprinting O 1 0.9956355690956116
centre O 1 0.995775043964386
( O 0 0.13131575286388397
IC O 1 0.9999984502792358
) O 0 0.019447479397058487
, O 0 0.015737419947981834
mapping O 0 0.01949101686477661
in O 0 0.012438278645277023
part O 0 0.01490794774144888
to O 0 0.012347555719316006
the O 0 0.01675231009721756
promoter O 0 0.45654064416885376
and O 0 0.01662398688495159
first O 0 0.0268953125923872
exon O 0 0.15059438347816467
of O 0 0.03865479677915573
SNRPN O 1 0.9997963309288025
. O 0 0.06425867229700089

Deletion O 0 0.10118567943572998
of O 0 0.03197876363992691
this O 0 0.027956783771514893
IC O 1 0.999411940574646
abolishes O 1 0.9441403746604919
local O 0 0.02848837338387966
paternally O 0 0.31475818157196045
derived O 0 0.020983433350920677
gene O 0 0.016183417290449142
expression O 0 0.01207992248237133
and O 0 0.009072849527001381
results O 0 0.012218200601637363
in O 0 0.02315305545926094
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999992847442627
PWS B-Disease 1 1.0
) O 0 0.1278621256351471
. O 0 0.06077565997838974

We O 0 0.023410610854625702
have O 0 0.012961963191628456
created O 0 0.019523724913597107
two O 0 0.013228628784418106
deletion O 0 0.03691345825791359
mutations O 0 0.018938755616545677
in O 0 0.012488764710724354
mice O 0 0.01987271197140217
to O 0 0.011450469493865967
understand O 0 0.02738935872912407
PWS B-Disease 1 1.0
and O 0 0.013806566596031189
the O 0 0.014225454069674015
mechanism O 0 0.02040492184460163
of O 0 0.015404685400426388
this O 0 0.02159966714680195
IC O 1 0.9999765157699585
. O 0 0.057056158781051636

Mice O 0 0.3264506161212921
harbouring O 1 0.7426149249076843
an O 0 0.03661598637700081
intragenic O 1 0.9948771595954895
deletion O 0 0.1498548835515976
in O 0 0.025702031329274178
Snrpn O 1 0.9999216794967651
are O 0 0.01265142671763897
phenotypically O 1 0.7078720331192017
normal O 0 0.017780322581529617
, O 0 0.0124452980235219
suggesting O 0 0.013038039207458496
that O 0 0.008161906152963638
mutations O 0 0.014119114726781845
of O 0 0.011833143420517445
SNRPN O 1 0.9999183416366577
are O 0 0.008319679647684097
not O 0 0.008951345458626747
sufficient O 0 0.021587274968624115
to O 0 0.02703121304512024
induce O 1 0.9677993655204773
PWS B-Disease 1 0.9999998807907104
. O 0 0.07827582210302353

Mice O 0 0.06128007173538208
with O 0 0.020932180806994438
a O 0 0.0208074152469635
larger O 0 0.02344389446079731
deletion O 0 0.03250596672296524
involving O 0 0.018324214965105057
both O 0 0.012941471301019192
Snrpn O 1 0.7804233431816101
and O 0 0.013668556697666645
the O 0 0.019793715327978134
putative O 1 0.9999388456344604
PWS O 1 1.0
- O 1 1.0
IC O 1 0.9999929666519165
lack O 0 0.024275826290249825
expression O 0 0.017490340396761894
of O 0 0.013356280513107777
the O 0 0.01866164244711399
imprinted O 1 0.9978601336479187
genes O 0 0.029256492853164673
Zfp127 O 1 0.9987338185310364
( O 0 0.025507450103759766
mouse O 0 0.050163377076387405
homologue O 0 0.08428826928138733
of O 0 0.026602933183312416
ZNF127 O 1 0.9999756813049316
) O 0 0.024616362527012825
, O 0 0.026140373200178146
Ndn O 1 0.9998539686203003
and O 0 0.024221377447247505
Ipw O 1 0.997370719909668
, O 0 0.020200030878186226
and O 0 0.014175756834447384
manifest O 0 0.03373490273952484
several O 0 0.016830435022711754
phenotypes O 0 0.07037310302257538
common O 0 0.026762546971440315
to O 0 0.11264750361442566
PWS B-Disease 1 1.0
infants O 1 0.9999915361404419
. O 0 0.06861074268817902

These O 0 0.02337178774178028
data O 0 0.016373831778764725
demonstrate O 0 0.016800975427031517
that O 0 0.00763581832870841
both O 0 0.006012525875121355
the O 0 0.007305838167667389
position O 0 0.011883014813065529
of O 0 0.009809909388422966
the O 0 0.013808546587824821
IC O 1 0.9999855756759644
and O 0 0.012200257740914822
its O 0 0.009372495114803314
role O 0 0.010353087447583675
in O 0 0.007239778991788626
the O 0 0.008305266499519348
coordinate O 0 0.0161494929343462
expression O 0 0.011450209654867649
of O 0 0.011564667336642742
genes O 0 0.011692567728459835
is O 0 0.00893546361476183
conserved O 0 0.014825734309852123
between O 0 0.010201618075370789
mouse O 0 0.03263586014509201
and O 0 0.009527361951768398
human O 0 0.008573934435844421
, O 0 0.009147722274065018
and O 0 0.008525599725544453
indicate O 0 0.008060598745942116
that O 0 0.006315268110483885
the O 0 0.010600781999528408
mouse O 0 0.024749567732214928
is O 0 0.008738859556615353
a O 0 0.010720076970756054
suitable O 0 0.015684394165873528
model O 0 0.015044556930661201
system O 0 0.009464634582400322
in O 0 0.007725190836936235
which O 0 0.00585977453738451
to O 0 0.0069506666623055935
investigate O 0 0.013647113926708698
the O 0 0.011066840961575508
molecular O 0 0.019481798633933067
mechanisms O 0 0.01428578607738018
of O 0 0.013068705797195435
imprinting O 1 0.6772176027297974
in O 0 0.010850414633750916
this O 0 0.00789712369441986
region O 0 0.012519670650362968
of O 0 0.012013404630124569
the O 0 0.01868530921638012
genome O 0 0.037806473672389984
. O 0 0.024972358718514442
. O 0 0.03648749738931656

Mutations O 0 0.046803008764982224
of O 0 0.019472498446702957
the O 0 0.021176714450120926
ATM O 0 0.25432828068733215
gene O 0 0.020017649978399277
detected O 0 0.01922476291656494
in O 0 0.015284857712686062
Japanese O 1 0.9786136746406555
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9999449253082275
: O 0 0.02022615261375904
possible O 0 0.01715157926082611
preponderance O 0 0.0404738187789917
of O 0 0.01307893730700016
the O 0 0.015309962444007397
two O 0 0.01739547587931156
founder O 1 0.9983993172645569
mutations O 0 0.047857947647571564
4612del165 O 1 0.9978708028793335
and O 0 0.04027750715613365
7883del5 O 1 0.9910898208618164
. O 0 0.06403815001249313

The O 0 0.041169486939907074
ATM O 0 0.0830523744225502
( O 0 0.0278793852776289
A O 1 0.993535041809082
- O 1 0.9999998807907104
T O 1 0.9999997615814209
, O 0 0.024495450779795647
mutated O 0 0.04559185355901718
) O 0 0.018041197210550308
gene O 0 0.018378743901848793
on O 0 0.015820669010281563
human O 0 0.025097547098994255
chromosome O 0 0.07132353633642197
11q22 O 1 0.9880319833755493
. O 0 0.05069030448794365

3 O 0 0.048533421009778976
has O 0 0.021686946973204613
recently O 0 0.021020442247390747
been O 0 0.011017940007150173
identified O 0 0.010222467593848705
as O 0 0.007558098994195461
the O 0 0.008234906941652298
gene O 0 0.00851136352866888
responsible O 0 0.007608745712786913
for O 0 0.006260310765355825
the O 0 0.009135793894529343
human O 0 0.25537845492362976
recessive B-Disease 1 1.0
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9559571146965027
A B-Disease 1 0.9999974966049194
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.04985006898641586
. O 0 0.04917493462562561

In O 0 0.026524245738983154
order O 0 0.016273707151412964
to O 0 0.010287513956427574
define O 0 0.013965733349323273
the O 0 0.010642766021192074
types O 0 0.01166419219225645
of O 0 0.01898370124399662
disease O 1 1.0
- O 1 1.0
causing O 1 0.9990617632865906
ATM O 1 0.986786425113678
mutations O 0 0.01457322109490633
in O 0 0.00866034533828497
Japanese O 0 0.030290640890598297
A B-Disease 1 0.9998645782470703
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9970577955245972
as O 0 0.011192968115210533
well O 0 0.01120722945779562
as O 0 0.010025560855865479
to O 0 0.010200992226600647
look O 0 0.01596171408891678
for O 0 0.011937105096876621
possible O 0 0.019960269331932068
mutational O 1 0.9385370016098022
hotspots O 1 0.7760619521141052
, O 0 0.023251056671142578
reverse O 0 0.03685156628489494
- O 1 0.9735825061798096
transcribed O 0 0.028321370482444763
RNA O 0 0.024264318868517876
derived O 0 0.012389622628688812
from O 0 0.009626052342355251
ten O 0 0.01674473285675049
patients O 0 0.018793264403939247
belonging O 0 0.014462973922491074
to O 0 0.008644042536616325
eight O 0 0.0122701246291399
unrelated O 0 0.016442645341157913
Japanese O 0 0.03157731518149376
A B-Disease 1 0.999031662940979
- I-Disease 1 0.9999996423721313
T I-Disease 1 0.9999969005584717
families O 0 0.017563432455062866
was O 0 0.017495160922408104
analyzed O 0 0.016761166974902153
for O 0 0.011083642952144146
mutations O 0 0.014480914920568466
by O 0 0.009874697774648666
the O 0 0.017500363290309906
restriction O 0 0.039128243923187256
endonuclease O 1 0.7770369648933411
fingerprinting O 0 0.07275339215993881
method O 0 0.051247723400592804
. O 0 0.055575527250766754

As O 0 0.027757147327065468
has O 0 0.01724213920533657
been O 0 0.011295409873127937
reported O 0 0.011305883526802063
by O 0 0.007666734047234058
others O 0 0.01051086001098156
, O 0 0.011217263527214527
mutations O 0 0.010768890380859375
that O 0 0.006984954234212637
lead O 0 0.014900490641593933
to O 0 0.017140811309218407
exon O 0 0.09418445080518723
skipping O 0 0.05554555356502533
or O 0 0.02017563208937645
premature O 0 0.09634339064359665
protein O 0 0.026316383853554726
truncation O 0 0.04772520810365677
were O 0 0.0153142549097538
also O 0 0.01793687790632248
predominant O 0 0.03240348398685455
in O 0 0.019552433863282204
our O 0 0.03677966818213463
mutants O 0 0.09695829451084137
. O 0 0.05622617155313492

Six O 0 0.0372609905898571
different O 0 0.015954598784446716
mutations O 0 0.016542328521609306
were O 0 0.008267910219728947
identified O 0 0.011248038150370121
on O 0 0.008128948509693146
12 O 0 0.011719516478478909
of O 0 0.01098638866096735
the O 0 0.01483712624758482
16 O 0 0.02948753908276558
alleles O 0 0.044231344014406204
examined O 0 0.05545154586434364
. O 0 0.046598855406045914

Four O 0 0.03949141502380371
were O 0 0.02260771580040455
deletions O 0 0.04232325777411461
involving O 0 0.02230989560484886
a O 0 0.01859303191304207
loss O 0 0.02887883596122265
of O 0 0.014752227813005447
a O 0 0.02115471474826336
single O 0 0.02873949706554413
exon O 0 0.08467236906290054
exon O 0 0.07282712310552597
7 O 0 0.03439870849251747
, O 0 0.024207452312111855
exon O 0 0.05911010876297951
16 O 0 0.031013142317533493
, O 0 0.02488967403769493
exon O 0 0.0663471594452858
33 O 0 0.04585037752985954
or O 0 0.03146108612418175
exon O 0 0.09384295344352722
35 O 0 0.0633063018321991
. O 0 0.05899277701973915

The O 0 0.0371800996363163
others O 0 0.020865287631750107
were O 0 0.01636458747088909
minute O 0 0.03695393353700638
deletions O 0 0.044560838490724564
, O 0 0.02230682782828808
4649delA O 0 0.07184531539678574
in O 0 0.025465726852416992
exon O 0 0.07269493490457535
33 O 0 0.04525333642959595
and O 0 0.02787572704255581
7883del5 O 0 0.08563797175884247
in O 0 0.03372347727417946
exon O 0 0.10761146247386932
55 O 0 0.08069752901792526
. O 0 0.05952081084251404

The O 0 0.04724765568971634
mutations O 0 0.048205431550741196
4612del165 O 1 0.9487980008125305
and O 0 0.02141294628381729
7883del5 O 1 0.6279978156089783
were O 0 0.01135312020778656
found O 0 0.007688237354159355
in O 0 0.00673718610778451
more O 0 0.006006111856549978
than O 0 0.006555585656315088
two O 0 0.007296037394553423
unrelated O 0 0.01540925819426775
families O 0 0.011455964297056198
; O 0 0.011749360710382462
44 O 0 0.01875774934887886
% O 0 0.012151519767940044
( O 0 0.010821867734193802
7 O 0 0.014749983325600624
of O 0 0.010139567777514458
16 O 0 0.013978471048176289
) O 0 0.010085943154990673
of O 0 0.008873719722032547
the O 0 0.013361112214624882
mutant O 0 0.03566033020615578
alleles O 0 0.019535474479198456
had O 0 0.011718615889549255
one O 0 0.009470071643590927
of O 0 0.010455155745148659
the O 0 0.013553322292864323
two O 0 0.019168084487318993
mutations O 0 0.0362253375351429
. O 0 0.035214681178331375

The O 0 0.05104539543390274
4612del165 O 1 0.9107185006141663
mutations O 0 0.03145116567611694
in O 0 0.014147419482469559
three O 0 0.00962982140481472
different O 0 0.006641150452196598
families O 0 0.009106848388910294
were O 0 0.006542951799929142
all O 0 0.007022646721452475
ascribed O 0 0.015446878038346767
to O 0 0.007489206735044718
the O 0 0.0089552728459239
same O 0 0.013176877051591873
T O 1 0.9999986886978149
- O 1 0.9999969005584717
- O 1 0.9999098777770996
> O 0 0.10850800573825836
A O 0 0.026636602357029915
substitution O 0 0.02872241847217083
at O 0 0.018238576129078865
the O 0 0.018531857058405876
splice O 0 0.05577412247657776
donor O 0 0.03322593495249748
site O 0 0.03357146307826042
in O 0 0.02930670976638794
intron O 1 0.9941036105155945
33 O 0 0.07238135486841202
. O 0 0.0521717332303524

Microsatellite O 1 0.9125410914421082
genotyping O 0 0.12756384909152985
around O 0 0.029958875849843025
the O 0 0.02568734996020794
ATM O 1 0.946982741355896
locus O 1 0.7476721405982971
also O 0 0.01562548615038395
indicated O 0 0.014183761551976204
that O 0 0.008006841875612736
a O 0 0.012417532503604889
common O 0 0.014783281832933426
haplotype O 0 0.04961662366986275
was O 0 0.021478310227394104
shared O 0 0.018291352316737175
by O 0 0.011695709079504013
the O 0 0.01697370409965515
mutant O 0 0.04999735206365585
alleles O 0 0.029247041791677475
in O 0 0.019354017451405525
both O 0 0.02355436235666275
mutations O 0 0.03987227380275726
. O 0 0.04513878747820854

This O 0 0.026561377570033073
suggests O 0 0.022689782083034515
that O 0 0.008958759717643261
these O 0 0.007695442531257868
two O 0 0.011106705293059349
founder O 1 0.9459662437438965
mutations O 0 0.02122625894844532
may O 0 0.011937486939132214
be O 0 0.010863804258406162
predominant O 0 0.02651418000459671
among O 0 0.02016589604318142
Japanese O 0 0.055774006992578506
ATM O 1 0.9698392152786255
mutant O 0 0.13955196738243103
alleles O 0 0.07068713754415512
. O 0 0.053234249353408813

W474C O 1 0.9639279246330261
amino O 0 0.08148398250341415
acid O 0 0.074130117893219
substitution O 0 0.0457790233194828
affects O 0 0.031069157645106316
early O 0 0.017076367512345314
processing O 0 0.014956286177039146
of O 0 0.011858640238642693
the O 0 0.013745991513133049
alpha O 0 0.042029593139886856
- O 0 0.05820518359541893
subunit O 0 0.030618801712989807
of O 0 0.01622784323990345
beta O 0 0.04479113221168518
- O 1 0.9935154914855957
hexosaminidase O 1 0.6845167875289917
A O 0 0.018643906340003014
and O 0 0.011019950732588768
is O 0 0.01038073468953371
associated O 0 0.01172069925814867
with O 0 0.019010938704013824
subacute O 1 1.0
G B-Disease 1 1.0
( I-Disease 1 0.9952633380889893
M2 I-Disease 1 0.9999979734420776
) I-Disease 0 0.04832061752676964
gangliosidosis I-Disease 1 0.6048075556755066
. O 0 0.05967696011066437

Mutations O 0 0.05419381335377693
in O 0 0.023568877950310707
the O 0 0.029070978984236717
HEXA O 1 0.9999586343765259
gene O 0 0.028005337342619896
, O 0 0.017081577330827713
encoding O 0 0.017346013337373734
the O 0 0.015635404735803604
alpha O 0 0.041508857160806656
- O 0 0.0485415905714035
subunit O 0 0.03143671900033951
of O 0 0.016120554879307747
beta O 0 0.05670907720923424
- O 1 0.9987722039222717
hexosaminidase O 1 0.9045313000679016
A O 0 0.029037002474069595
( O 0 0.02276749350130558
Hex O 0 0.0742194652557373
A O 0 0.025018861517310143
) O 0 0.016109677031636238
, O 0 0.01283652801066637
that O 0 0.009654711000621319
abolish O 0 0.03493097424507141
Hex O 0 0.050450876355171204
A O 0 0.027394143864512444
enzyme O 0 0.02735605277121067
activity O 0 0.01967422477900982
cause O 1 0.9931175708770752
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9967789053916931
TSD B-Disease 1 1.0
) O 0 0.02084280550479889
, O 0 0.01499719824641943
the O 0 0.01735394075512886
fatal O 1 0.9990279674530029
infantile B-Disease 1 0.9999985694885254
form I-Disease 0 0.024720946326851845
of I-Disease 1 0.531744122505188
G I-Disease 1 0.999998927116394
( I-Disease 0 0.4120359718799591
M2 I-Disease 1 0.9999827146530151
) I-Disease 0 0.03049335442483425
gangliosidosis I-Disease 1 0.8109637498855591
, I-Disease 0 0.03429795429110527
Type I-Disease 0 0.058802563697099686
1 I-Disease 0 0.0536208301782608
. O 0 0.05337195470929146

Less O 0 0.048865627497434616
severe O 1 0.9998656511306763
, O 0 0.29164576530456543
subacute O 1 1.0
( O 1 0.6868292689323425
juvenile O 1 0.9999986886978149
- O 1 1.0
onset O 1 1.0
) O 0 0.028825553134083748
and O 0 0.24310778081417084
chronic O 1 1.0
( O 1 0.8311125636100769
adult O 1 0.9994297623634338
- O 1 1.0
onset O 1 1.0
) O 0 0.01741201989352703
variants O 0 0.017854273319244385
are O 0 0.007031733635812998
characterized O 0 0.01290493831038475
by O 0 0.007466619834303856
a O 0 0.011440304107964039
broad O 0 0.01648561656475067
spectrum O 0 0.025629103183746338
of O 0 0.019951917231082916
clinical O 1 0.9999995231628418
manifestations O 1 0.9999889135360718
and O 0 0.014793725684285164
are O 0 0.007419371046125889
associated O 0 0.010362859815359116
with O 0 0.010958336293697357
residual O 1 0.8585329651832581
levels O 0 0.017320265993475914
of O 0 0.01983378455042839
Hex O 0 0.4216454327106476
A O 0 0.055582981556653976
enzyme O 0 0.04867105931043625
activity O 0 0.03742694482207298
. O 0 0.046248745173215866

We O 0 0.031141042709350586
identified O 0 0.030416395515203476
a O 0 0.030202392488718033
1422 O 1 0.9999709129333496
G O 1 0.9998918771743774
- O 1 0.9999969005584717
- O 1 0.9999805688858032
> O 1 0.9977341890335083
C O 1 0.8528847694396973
( O 0 0.026882506906986237
amino O 0 0.029994633048772812
acid O 0 0.09551551938056946
W474C O 1 0.9519199728965759
) O 0 0.0170439425855875
substitution O 0 0.02164352498948574
in O 0 0.010674175806343555
the O 0 0.010110401548445225
first O 0 0.015018668957054615
position O 0 0.017909687012434006
of O 0 0.015644872561097145
exon O 0 0.04733571410179138
13 O 0 0.022115236148238182
of O 0 0.019096193835139275
HEXA O 1 0.9965164661407471
of O 0 0.017997581511735916
a O 0 0.018899520859122276
non O 0 0.03127428889274597
- O 1 0.9967003464698792
Jewish O 0 0.03254489228129387
proband O 1 0.9705758094787598
who O 0 0.023346280679106712
manifested O 0 0.09570448100566864
a O 0 0.026738910004496574
subacute O 1 1.0
variant O 1 0.9984111785888672
of O 1 0.8263033628463745
G B-Disease 1 0.9999994039535522
( I-Disease 1 0.5021287202835083
M2 I-Disease 1 0.9999921321868896
) I-Disease 0 0.04500579461455345
gangliosidosis I-Disease 1 0.5900582671165466
. O 0 0.06475947797298431

On O 0 0.03118808940052986
the O 0 0.025512821972370148
second O 0 0.042187076061964035
maternally O 1 0.9987886548042297
inherited O 1 0.9999587535858154
allele O 0 0.046075865626335144
, O 0 0.012980048544704914
we O 0 0.008352065458893776
identified O 0 0.01035775151103735
the O 0 0.011301375925540924
common O 1 0.5582127571105957
infantile O 1 1.0
disease O 1 1.0
- O 1 1.0
causing O 1 0.9998175501823425
4 O 0 0.26569899916648865
- O 1 0.9990074038505554
bp O 0 0.07052548229694366
insertion O 0 0.06116638705134392
, O 0 0.0346057154238224
+ O 0 0.16747184097766876
TATC O 1 0.9996297359466553
1278 O 1 0.9998358488082886
, O 0 0.03231215849518776
in O 0 0.029442904517054558
exon O 0 0.09859359264373779
11 O 0 0.055432166904211044
. O 0 0.05534352362155914

Pulse O 1 0.9759698510169983
- O 1 0.8892185091972351
chase O 0 0.05149317532777786
analysis O 0 0.023090790957212448
using O 0 0.022782674059271812
proband O 1 0.9909334182739258
fibroblasts O 0 0.11544229090213776
revealed O 0 0.0202555600553751
that O 0 0.009724470786750317
the O 0 0.01729077473282814
W474C O 1 0.9451895952224731
- O 1 0.9486244320869446
containing O 0 0.030027100816369057
alpha O 0 0.05343783274292946
- O 1 0.913630485534668
subunit O 0 0.04197303205728531
precursor O 0 0.033671777695417404
was O 0 0.021341990679502487
normally O 0 0.0208860095590353
synthesized O 0 0.02718699537217617
, O 0 0.01240004412829876
but O 0 0.010409395210444927
not O 0 0.010803038254380226
phosphorylated O 0 0.037894438952207565
or O 0 0.015612824819982052
secreted O 0 0.02605435438454151
, O 0 0.012554931454360485
and O 0 0.00977284088730812
the O 0 0.012852005660533905
mature O 0 0.1326659917831421
lysosomal O 1 0.9999855756759644
alpha O 1 0.9569308757781982
- O 1 0.9998946189880371
subunit O 0 0.04652317613363266
was O 0 0.02454810030758381
not O 0 0.01845674403011799
detected O 0 0.03756166994571686
. O 0 0.04201718792319298

When O 0 0.042927056550979614
the O 0 0.031121939420700073
W474C O 1 0.5728526711463928
- O 1 0.8612966537475586
containing O 0 0.03456845507025719
alpha O 0 0.062328364700078964
- O 1 0.8111171722412109
subunit O 0 0.046986788511276245
was O 0 0.0320715494453907
transiently O 0 0.3759585916996002
co O 0 0.2856730818748474
- O 0 0.08132905513048172
expressed O 0 0.01627412438392639
with O 0 0.011715501546859741
the O 0 0.016087938100099564
beta O 0 0.10255641490221024
- O 1 0.7120566368103027
subunit O 0 0.029587266966700554
to O 0 0.0131973996758461
produce O 0 0.01800506003201008
Hex O 0 0.045797064900398254
A O 0 0.024214033037424088
( O 0 0.021113166585564613
alphabeta O 0 0.21188589930534363
) O 0 0.017998425289988518
in O 0 0.019880002364516258
COS O 1 0.999997615814209
- O 1 0.9998005032539368
7 O 0 0.027846746146678925
cells O 0 0.016454294323921204
, O 0 0.012126234360039234
the O 0 0.012892721220850945
mature O 0 0.02585243619978428
alpha O 0 0.04393449425697327
- O 1 0.9007073044776917
subunit O 0 0.03413552790880203
was O 0 0.017810426652431488
present O 0 0.0108811529353261
, O 0 0.008289539255201817
but O 0 0.006412276532500982
its O 0 0.00798569805920124
level O 0 0.011592906899750233
was O 0 0.012395523488521576
much O 0 0.010581625625491142
lower O 0 0.011450139805674553
than O 0 0.006436711642891169
that O 0 0.0061456914991140366
from O 0 0.008812067098915577
normal O 0 0.014691362157464027
alpha O 0 0.04251031205058098
- O 1 0.9635795950889587
subunit O 0 0.04627198725938797
transfections O 0 0.40570229291915894
, O 0 0.015097041614353657
although O 0 0.01025480404496193
higher O 0 0.01041156705468893
than O 0 0.007478106766939163
in O 0 0.00883084163069725
those O 0 0.010327461175620556
cells O 0 0.018301362171769142
transfected O 0 0.05111931264400482
with O 0 0.013201149180531502
an O 0 0.016379840672016144
alpha O 0 0.06142028048634529
- O 1 0.9803478121757507
subunit O 0 0.049618832767009735
associated O 0 0.027604345232248306
with O 0 0.03509574010968208
infantile O 1 0.9999996423721313
TSD B-Disease 1 0.9999996423721313
. O 0 0.07998166978359222

Furthermore O 0 0.04850790277123451
, O 0 0.02136765979230404
the O 0 0.017842043191194534
precursor O 0 0.031040888279676437
level O 0 0.014828326180577278
of O 0 0.011822860687971115
the O 0 0.016100192442536354
W474C O 1 0.7821264863014221
alpha O 0 0.09340217709541321
- O 1 0.9650549292564392
subunit O 0 0.03137413412332535
was O 0 0.01650771126151085
found O 0 0.009085213765501976
to O 0 0.010239270515739918
accumulate O 0 0.0208860095590353
in O 0 0.009439230896532536
comparison O 0 0.012161311693489552
to O 0 0.008919473737478256
the O 0 0.012029727920889854
normal O 0 0.019529372453689575
alpha O 0 0.06038738414645195
- O 1 0.9951527118682861
subunit O 0 0.06807100027799606
precursor O 0 0.07760584354400635
levels O 0 0.042825847864151
. O 0 0.04835072532296181

We O 0 0.02881544828414917
conclude O 0 0.027885885909199715
that O 0 0.011193293146789074
the O 0 0.01833987794816494
1422 O 1 0.9999865293502808
G O 1 0.99998939037323
- O 1 0.9999995231628418
- O 1 0.9999979734420776
> O 1 0.999566376209259
C O 1 0.9355928897857666
mutation O 0 0.020657861605286598
is O 0 0.010541612282395363
the O 0 0.01261929702013731
cause O 0 0.01797371543943882
of O 0 0.016572942957282066
Hex B-Disease 1 0.9975540041923523
A I-Disease 1 0.9999536275863647
enzyme I-Disease 1 0.9999966621398926
deficiency I-Disease 1 1.0
in O 0 0.03037446178495884
the O 0 0.05845531448721886
proband O 1 0.9996929168701172
. O 0 0.05947761610150337

The O 0 0.0489102303981781
resulting O 0 0.04902343824505806
W474C O 1 0.5566871762275696
substitution O 0 0.04754682630300522
clearly O 0 0.02945760078728199
interferes O 0 0.04613017290830612
with O 0 0.019085800275206566
alpha O 0 0.0789051204919815
- O 1 0.9963865280151367
subunit O 0 0.03316401317715645
processing O 0 0.015554875135421753
, O 0 0.011776942759752274
but O 0 0.007605959661304951
because O 0 0.008798616006970406
the O 0 0.011098003946244717
base O 0 0.022697726264595985
substitution O 0 0.0248247180134058
falls O 0 0.032956741750240326
at O 0 0.01461481861770153
the O 0 0.011433446779847145
first O 0 0.014074824750423431
position O 0 0.01712261699140072
of O 0 0.016194960102438927
exon O 0 0.060615550726652145
13 O 0 0.023855147883296013
, O 0 0.01799996756017208
aberrant O 0 0.046911388635635376
splicing O 0 0.033180516213178635
may O 0 0.014504634775221348
also O 0 0.011685946956276894
contribute O 0 0.017726972699165344
to O 0 0.016065575182437897
Hex B-Disease 1 0.9095314741134644
A I-Disease 1 0.994992196559906
deficiency I-Disease 1 1.0
in O 0 0.019355423748493195
this O 0 0.018615998327732086
proband O 1 0.9993458390235901
. O 0 0.03308170661330223
. O 0 0.04735603556036949

Two O 0 0.0366312600672245
frequent O 0 0.05267602950334549
missense O 0 0.07916036248207092
mutations O 0 0.04706805571913719
in O 0 0.06506718695163727
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.8206579685211182

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.14510701596736908
an O 1 0.9979462027549744
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9999997615814209
by O 1 0.9588330388069153
early O 1 0.9999971389770508
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999982118606567
goiter B-Disease 1 1.0
. O 1 0.9911385178565979

A O 0 0.04599563777446747
century O 0 0.03311329334974289
after O 0 0.017003320157527924
its O 0 0.013303861021995544
recognition O 0 0.0172038022428751
as O 0 0.013611708767712116
a O 0 0.0703168734908104
syndrome O 1 1.0
by O 0 0.01714932918548584
Vaughan O 1 0.9996559619903564
Pendred O 1 0.999963641166687
, O 0 0.018593210726976395
the O 0 0.035353776067495346
disease O 1 0.9999998807907104
gene O 1 0.5258863568305969
( O 0 0.21776549518108368
PDS O 1 0.9999991655349731
) O 0 0.021367769688367844
was O 0 0.02392832189798355
mapped O 0 0.03535361960530281
to O 0 0.02392653003334999
chromosome O 0 0.05103389546275139
7q22 O 1 0.9997645020484924
- O 1 0.9999634027481079
q31 O 1 0.9885508418083191
. O 0 0.06387968361377716

1 O 0 0.05089865252375603
and O 0 0.024468019604682922
, O 0 0.01699143461883068
recently O 0 0.021197620779275894
, O 0 0.01375243254005909
found O 0 0.010443479754030704
to O 0 0.01147177629172802
encode O 0 0.025914348661899567
a O 0 0.03097100742161274
putative O 1 0.9982719421386719
sulfate O 1 0.9999991655349731
transporter O 1 0.9989088773727417
. O 0 0.07652001827955246

We O 0 0.030690651386976242
performed O 0 0.031329669058322906
mutation O 0 0.02117946371436119
analysis O 0 0.011641434393823147
of O 0 0.011650302447378635
the O 0 0.018865082412958145
PDS B-Disease 1 0.9999995231628418
gene O 0 0.020290005952119827
in O 0 0.013067230582237244
patients O 1 0.5761724710464478
from O 0 0.011214282363653183
14 O 0 0.020372167229652405
Pendred B-Disease 1 0.9396197199821472
families O 0 0.016707491129636765
originating O 0 0.016060110181570053
from O 0 0.008917088620364666
seven O 0 0.009934701956808567
countries O 0 0.00732642225921154
and O 0 0.01126448530703783
identified O 0 0.017316225916147232
all O 0 0.01747572049498558
mutations O 0 0.03477765619754791
. O 0 0.03771710395812988

The O 0 0.04607764631509781
mutations O 0 0.032564301043748856
include O 0 0.017181096598505974
three O 0 0.013254116289317608
single O 0 0.019007107242941856
base O 0 0.03366047888994217
deletions O 0 0.03702264651656151
, O 0 0.015431961975991726
one O 0 0.015811888501048088
splice O 0 0.04871818795800209
site O 0 0.029412487521767616
mutation O 0 0.02419956959784031
and O 0 0.016814520582556725
10 O 0 0.029544778168201447
missense O 0 0.07500909268856049
mutations O 0 0.051464952528476715
. O 0 0.04965291544795036

One O 0 0.04220135137438774
missense O 0 0.07879676669836044
mutation O 0 0.0429886057972908
( O 0 0.026311814785003662
L236P O 1 0.9987149238586426
) O 0 0.01738818921148777
was O 0 0.01766277104616165
found O 0 0.010274695232510567
in O 0 0.009938904084265232
a O 0 0.013263898901641369
homozygous O 0 0.02034119889140129
state O 0 0.009618631564080715
in O 0 0.009567121975123882
two O 0 0.01154180709272623
consanguineous O 0 0.09108715504407883
families O 0 0.012524547055363655
and O 0 0.009706277400255203
in O 0 0.010227206163108349
a O 0 0.014126776717603207
heterozygous O 0 0.019114548340439796
state O 0 0.007808230817317963
in O 0 0.009298129007220268
five O 0 0.012280566617846489
additional O 0 0.020422160625457764
non O 0 0.04699982702732086
- O 1 0.9992573857307434
consanguineous O 1 0.9260191917419434
families O 0 0.055871155112981796
. O 0 0.05849992483854294

Another O 0 0.06071379408240318
missense O 0 0.0899508073925972
mutation O 0 0.04757438972592354
( O 0 0.030475400388240814
T416P O 1 0.9967592358589172
) O 0 0.017646919935941696
was O 0 0.017732512205839157
found O 0 0.010293740779161453
in O 0 0.009360942989587784
a O 0 0.012531966902315617
homozygous O 0 0.01843876950442791
state O 0 0.008769914507865906
in O 0 0.009415394626557827
one O 0 0.011129718273878098
family O 0 0.013278510421514511
and O 0 0.008847799152135849
in O 0 0.009525859728455544
a O 0 0.01403839886188507
heterozygous O 0 0.020978640764951706
state O 0 0.010250043123960495
in O 0 0.012163873761892319
four O 0 0.01870742440223694
families O 0 0.024631695821881294
. O 0 0.03510716184973717

Pendred B-Disease 1 0.9998236298561096
patients O 0 0.3562418818473816
in O 0 0.01627562940120697
three O 0 0.014592943713068962
non O 0 0.11572010815143585
- O 1 0.9999558925628662
consanguineous O 1 0.9460052847862244
families O 0 0.015939131379127502
were O 0 0.009193120524287224
shown O 0 0.010231522843241692
to O 0 0.009510952048003674
be O 0 0.011515496298670769
compound O 0 0.03024282306432724
heterozygotes O 0 0.3153536021709442
for O 0 0.02208472415804863
L236P O 1 0.9984248876571655
and O 0 0.034096162766218185
T416P O 1 0.9980984330177307
. O 0 0.05012769252061844

In O 0 0.029132995754480362
total O 0 0.021748419851064682
, O 0 0.015489715151488781
one O 0 0.010776705108582973
or O 0 0.008340328000485897
both O 0 0.0065526231192052364
of O 0 0.008104835636913776
these O 0 0.006849558092653751
mutations O 0 0.010213352739810944
were O 0 0.006214875262230635
found O 0 0.0058350516483187675
in O 0 0.006921402644366026
nine O 0 0.010624735616147518
of O 0 0.010527010075747967
the O 0 0.013827994465827942
14 O 0 0.022971261292696
families O 0 0.023976393043994904
analyzed O 0 0.044408172369003296
. O 0 0.038184754550457

The O 0 0.029166651889681816
identification O 0 0.023020990192890167
of O 0 0.014513436704874039
two O 0 0.014389238320291042
frequent O 0 0.043837547302246094
PDS B-Disease 1 0.9999995231628418
mutations O 0 0.023832635954022408
will O 0 0.01421823538839817
facilitate O 0 0.016415422782301903
the O 0 0.016476193442940712
molecular O 0 0.04861879721283913
diagnosis O 1 0.9999947547912598
of O 1 0.9992081522941589
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9618284702301025

Insertional O 1 0.9816392660140991
mutation O 0 0.0619669146835804
by O 0 0.027515670284628868
transposable O 1 0.9406816959381104
element O 0 0.047376781702041626
, O 0 0.027788924053311348
L1 O 1 0.9992774128913879
, O 0 0.016426019370555878
in O 0 0.013414768502116203
the O 0 0.01920345239341259
DMD B-Disease 1 0.9999997615814209
gene O 0 0.018950330093503
results O 0 0.012854027561843395
in O 0 0.01630302146077156
X B-Disease 1 0.9994787573814392
- I-Disease 1 0.9999978542327881
linked I-Disease 1 0.9997432827949524
dilated I-Disease 1 0.9999995231628418
cardiomyopathy I-Disease 1 1.0
. O 0 0.45544201135635376

X B-Disease 1 0.9996882677078247
- I-Disease 1 0.999998927116394
linked I-Disease 1 0.9999816417694092
dilated I-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
( O 1 0.9998575448989868
XLDCM B-Disease 1 0.9999998807907104
) O 0 0.019562948495149612
is O 0 0.01216795202344656
a O 0 0.014723950065672398
clinical O 1 0.9948622584342957
phenotype O 1 0.8479421734809875
of O 0 0.02105766534805298
dystrophinopathy B-Disease 1 0.999994158744812
which O 0 0.010484252125024796
is O 0 0.011831547133624554
characterized O 0 0.019049853086471558
by O 0 0.012883374467492104
preferential O 1 0.9989994168281555
myocardial B-Disease 1 1.0
involvement I-Disease 1 0.7623838782310486
without O 0 0.013833548873662949
any O 0 0.015187143348157406
overt O 1 0.6218127012252808
clinical O 1 0.9999829530715942
signs O 1 0.9972014427185059
of O 1 0.9985400438308716
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9503071308135986

To O 0 0.03021910786628723
date O 0 0.02537520043551922
, O 0 0.01585954986512661
several O 0 0.012607650831341743
mutations O 0 0.017369752749800682
in O 0 0.014149106107652187
the O 0 0.07343088835477829
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 1 0.9998974800109863
, O 1 0.9900133609771729
DMD O 1 1.0
, O 0 0.016751281917095184
have O 0 0.007558596320450306
been O 0 0.00847700797021389
identified O 0 0.010734382085502148
in O 0 0.009629713371396065
patients O 1 0.9389051795005798
with O 0 0.015413490124046803
XLDCM B-Disease 1 0.9999994039535522
, O 0 0.014698770828545094
but O 0 0.01007877103984356
a O 0 0.013123895041644573
pathogenic O 0 0.0235346257686615
correlation O 0 0.01574619673192501
of O 0 0.010238585062325
these O 0 0.008838102221488953
cardiospecific O 1 0.9341795444488525
mutations O 0 0.019417131319642067
in O 0 0.016585499048233032
DMD O 1 0.9999997615814209
with O 0 0.015050523914396763
the O 0 0.024493733420968056
XLDCM B-Disease 1 0.9999998807907104
phenotype O 1 0.9966895580291748
has O 0 0.01918082684278488
remained O 0 0.02639707364141941
to O 0 0.017396405339241028
be O 0 0.019925711676478386
elucidated O 0 0.34383246302604675
. O 0 0.04793815314769745

We O 0 0.032172076404094696
report O 0 0.020795317366719246
here O 0 0.014460057951509953
the O 0 0.011680192314088345
identification O 0 0.01548065897077322
of O 0 0.013107706792652607
a O 0 0.017146609723567963
unique O 0 0.026132646948099136
de O 0 0.07688663899898529
novo O 1 0.9096697568893433
L1 O 1 0.9935811758041382
insertion O 0 0.04765954241156578
in O 0 0.017857518047094345
the O 0 0.022717535495758057
muscle O 1 0.8103692531585693
exon O 0 0.1861947476863861
1 O 0 0.027999263256788254
in O 0 0.022084472700953484
DMD O 1 0.9999911785125732
in O 0 0.016775546595454216
three O 0 0.018526548519730568
XLDCM B-Disease 1 0.9999934434890747
patients O 1 0.7708853483200073
from O 0 0.013007357716560364
two O 0 0.012633302249014378
unrelated O 0 0.02992941439151764
Japanese O 0 0.08601764589548111
families O 0 0.037891242653131485
. O 0 0.04436052590608597

The O 0 0.0430234894156456
insertion O 0 0.05207228660583496
was O 0 0.026715369895100594
a O 0 0.019940819591283798
5 O 0 0.028357714414596558
- O 1 0.6148176789283752
truncated O 0 0.03910691291093826
form O 0 0.01884130947291851
of O 0 0.01719948835670948
human O 0 0.022764138877391815
L1 O 1 0.9992746710777283
inversely O 0 0.05240398272871971
integrated O 0 0.036439672112464905
in O 0 0.012257395312190056
the O 0 0.015877142548561096
5 O 0 0.02673472836613655
- O 1 0.9899929165840149
untranslated O 0 0.37340056896209717
region O 0 0.018260354176163673
in O 0 0.011858158744871616
the O 0 0.01635362207889557
muscle O 1 0.9791517853736877
exon O 1 0.8919305801391602
1 O 0 0.022774048149585724
, O 0 0.011038878001272678
which O 0 0.008025090210139751
affected O 0 0.010611630976200104
the O 0 0.008716987445950508
transcription O 0 0.01450105756521225
or O 0 0.007698233239352703
the O 0 0.008565453812479973
stability O 0 0.016715100035071373
of O 0 0.01162156742066145
the O 0 0.015103275887668133
muscle O 1 0.9924100637435913
form O 0 0.013863270170986652
of O 0 0.017035629600286484
dystrophin O 1 0.9999687671661377
transcripts O 0 0.022888101637363434
but O 0 0.007833770476281643
not O 0 0.004736252129077911
that O 0 0.004461529664695263
of O 0 0.007226401008665562
the O 0 0.012596496380865574
brain O 1 0.9982680082321167
or O 0 0.07206272333860397
Purkinje O 1 0.9999998807907104
cell O 1 0.9072870016098022
form O 0 0.014310303144156933
, O 0 0.013116992078721523
probably O 0 0.01447279192507267
due O 0 0.009955867193639278
to O 0 0.009131580591201782
its O 0 0.01247286144644022
unique O 0 0.016865212470293045
site O 0 0.02498212456703186
of O 0 0.02238195203244686
integration O 0 0.04837207868695259
. O 0 0.04902318865060806

We O 0 0.03587942570447922
speculate O 0 0.03442809730768204
that O 0 0.011523346416652203
this O 0 0.010554785840213299
insertion O 0 0.028424113988876343
of O 0 0.01325166504830122
an O 0 0.01677713356912136
L1 O 1 0.9950177073478699
sequence O 0 0.02241910807788372
in O 0 0.020969457924365997
DMD O 1 0.9999998807907104
is O 0 0.014697936363518238
responsible O 0 0.011199797503650188
for O 0 0.006639948580414057
some O 0 0.004926188848912716
of O 0 0.005786761175841093
the O 0 0.006279533263295889
population O 0 0.006598338950425386
of O 0 0.010098587721586227
Japanese O 1 0.9639755487442017
patients O 1 0.9995092153549194
with O 0 0.027793675661087036
XLDCM B-Disease 1 0.999998927116394
. O 0 0.03160753473639488
. O 0 0.04690219834446907

Severe O 1 0.9999399185180664
early O 1 0.9572579264640808
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999951124191284
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.9999743700027466
red O 1 1.0
hair O 1 0.9999998807907104
pigmentation O 1 1.0
caused O 1 0.9997127652168274
by O 0 0.15463384985923767
POMC O 1 1.0
mutations O 0 0.0875759944319725
in O 0 0.027856454253196716
humans O 0 0.03522174432873726
. O 0 0.046913281083106995

Sequential O 0 0.10012306272983551
cleavage O 0 0.07934637367725372
of O 0 0.021533159539103508
the O 0 0.02014441415667534
precursor O 0 0.036989033222198486
protein O 0 0.024563351646065712
pre O 0 0.11397995799779892
- O 1 0.9995501637458801
pro O 1 0.9794355630874634
- O 1 0.9999967813491821
opiomelanocortin O 1 0.9999707937240601
( O 0 0.035089943557977676
POMC O 1 0.9998624324798584
) O 0 0.026960134506225586
generates O 0 0.039488520473241806
the O 0 0.027613462880253792
melanocortin O 1 0.9993755221366882
peptides O 0 0.1326475590467453
adrenocorticotrophin O 1 0.9999076128005981
( O 0 0.05811885744333267
ACTH O 1 0.9999731779098511
) O 0 0.028627295047044754
, O 0 0.029534805566072464
melanocyte O 1 0.9999990463256836
- O 1 0.9999994039535522
stimulating O 1 0.9999552965164185
hormones O 1 0.977270781993866
( O 0 0.04096308723092079
MSH O 1 0.9999990463256836
) O 0 0.02927287667989731
alpha O 0 0.04819916561245918
, O 0 0.023104822263121605
beta O 0 0.0325278602540493
and O 0 0.015842387452721596
gamma O 0 0.03175722435116768
as O 0 0.009714694693684578
well O 0 0.010462853126227856
as O 0 0.010809062048792839
the O 0 0.016557345166802406
opioid O 1 0.9974742531776428
- O 1 0.9999680519104004
receptor O 0 0.10589500516653061
ligand O 1 0.6020538806915283
beta O 1 0.9694255590438843
- O 1 0.9996274709701538
endorphin O 1 0.9991783499717712
. O 0 0.07192981988191605

While O 0 0.024901727214455605
a O 0 0.017910204827785492
few O 0 0.013039340265095234
cases O 0 0.012197453528642654
of O 0 0.018617231398820877
isolated O 1 0.9999964237213135
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 0.012886946089565754
been O 0 0.013412823900580406
reported O 0 0.023787934333086014
( O 0 0.02639123424887657
OMIM O 1 0.9999995231628418
201400 O 1 0.9997246861457825
) O 0 0.01676269993185997
, O 0 0.015422207303345203
an O 0 0.018664434552192688
inherited O 1 0.9999998807907104
POMC O 1 1.0
defect O 1 0.9999995231628418
has O 0 0.019556565210223198
not O 0 0.012058083899319172
been O 0 0.013289772905409336
described O 0 0.02018209919333458
so O 0 0.01760590635240078
far O 0 0.028507065027952194
. O 0 0.04048231989145279

Recent O 0 0.04381273314356804
studies O 0 0.027661874890327454
in O 0 0.01913309097290039
animal O 0 0.03136971965432167
models O 0 0.03277728334069252
elucidated O 0 0.05489945039153099
a O 0 0.019099339842796326
central O 0 0.018185434862971306
role O 0 0.018991971388459206
of O 0 0.018392739817500114
alpha O 1 0.9109081625938416
- O 1 0.9999582767486572
MSH O 1 0.9999527931213379
in O 0 0.01512851007282734
the O 0 0.013147982768714428
regulation O 0 0.017321281135082245
of O 0 0.012223046272993088
food O 0 0.020269904285669327
intake O 0 0.026609430089592934
by O 0 0.01127623300999403
activation O 0 0.021251725032925606
of O 0 0.013133822940289974
the O 0 0.018199848011136055
brain O 1 0.9793558716773987
melanocortin O 1 0.9999936819076538
- O 1 0.999944806098938
4 O 0 0.04125896468758583
- O 1 0.9978325963020325
receptor O 0 0.046597376465797424
( O 0 0.029706349596381187
MC4 O 1 0.9999932050704956
- O 1 0.9997543692588806
R O 1 0.507212221622467
; O 0 0.02134537696838379
refs O 0 0.05417132377624512
3 O 0 0.03149176016449928
- O 1 0.8990542888641357
5 O 0 0.02095704898238182
) O 0 0.011958022601902485
and O 0 0.009339424781501293
the O 0 0.010296500287950039
linkage O 0 0.021017596125602722
of O 0 0.012675102800130844
human O 0 0.024252967908978462
obesity B-Disease 1 1.0
to O 0 0.015188970603048801
chromosome O 0 0.02260897122323513
2 O 0 0.016160838305950165
in O 0 0.010219765827059746
close O 0 0.01390459481626749
proximity O 0 0.017827976495027542
to O 0 0.013095165602862835
the O 0 0.020931890234351158
POMC O 1 0.999997615814209
locus O 1 0.7415819764137268
, O 0 0.01864948868751526
led O 0 0.018355725333094597
to O 0 0.009178468957543373
the O 0 0.009565974585711956
proposal O 0 0.013276922516524792
of O 0 0.009537824429571629
an O 0 0.011040033772587776
association O 0 0.022749708965420723
of O 0 0.023717103525996208
POMC O 1 0.9999996423721313
with O 0 0.061931923031806946
human O 1 0.9502391815185547
obesity B-Disease 1 1.0
. O 0 0.0633373036980629

The O 0 0.03706938400864601
dual O 0 0.04199562221765518
role O 0 0.026779277250170708
of O 0 0.02351653017103672
alpha O 1 0.8975427746772766
- O 1 0.9999773502349854
MSH O 1 0.9999687671661377
in O 0 0.020306406542658806
regulating O 0 0.028230128809809685
food O 0 0.024713294580578804
intake O 0 0.04067433997988701
and O 0 0.016240404918789864
influencing O 0 0.12703536450862885
hair O 1 0.9997302889823914
pigmentation O 1 0.9999879598617554
predicts O 1 0.6374372839927673
that O 0 0.00971642043441534
the O 0 0.01282825879752636
phenotype O 1 0.5873576402664185
associated O 0 0.012598513625562191
with O 0 0.01133898925036192
a O 0 0.021871106699109077
defect O 1 0.9999698400497437
in O 0 0.02506304532289505
POMC O 1 0.9999988079071045
function O 0 0.01863660290837288
would O 0 0.015254716388881207
include O 0 0.022939592599868774
obesity B-Disease 1 0.9999998807907104
, O 0 0.021778741851449013
alteration O 1 0.994472324848175
in O 1 0.7456837892532349
pigmentation O 1 1.0
and O 1 0.9999974966049194
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.6910542249679565

The O 0 0.036726001650094986
observation O 0 0.04326003044843674
of O 0 0.01963305100798607
these O 0 0.014067349955439568
symptoms O 1 0.9996379613876343
in O 0 0.011447985656559467
two O 0 0.01313368696719408
probands O 1 0.9996659755706787
prompted O 0 0.023830005899071693
us O 0 0.016402587294578552
to O 0 0.012031461112201214
search O 0 0.01834973506629467
for O 0 0.01381066907197237
mutations O 0 0.020185289904475212
within O 0 0.015157134272158146
their O 0 0.022170308977365494
POMC O 1 0.9999940395355225
genes O 0 0.052142973989248276
. O 0 0.046526599675416946

Patient O 1 0.9957196116447449
1 O 0 0.038779277354478836
was O 0 0.02447393164038658
found O 0 0.01218789629638195
to O 0 0.00966555904597044
be O 0 0.009007214568555355
a O 0 0.013943667523562908
compound O 0 0.03175605088472366
heterozygote O 0 0.06219024956226349
for O 0 0.012639020569622517
two O 0 0.012803470715880394
mutations O 0 0.01740976981818676
in O 0 0.014047754928469658
exon O 0 0.05493156984448433
3 O 0 0.022872088477015495
( O 0 0.018284723162651062
G7013T O 1 0.8391066789627075
, O 0 0.020839594304561615
C7133delta O 1 0.9978663325309753
) O 0 0.01574806682765484
which O 0 0.010567756369709969
interfere O 0 0.015822913497686386
with O 0 0.009638025425374508
appropriate O 0 0.014313612133264542
synthesis O 0 0.02168024517595768
of O 0 0.018645117059350014
ACTH O 1 0.9999831914901733
and O 0 0.03558749333024025
alpha O 1 0.9973893761634827
- O 1 0.9999889135360718
MSH O 1 0.9999946355819702
. O 0 0.07216104120016098

Patient O 1 0.9833979606628418
2 O 0 0.04262456297874451
was O 0 0.027931924909353256
homozygous O 0 0.03208201378583908
for O 0 0.014116538688540459
a O 0 0.01909256912767887
mutation O 0 0.021733924746513367
in O 0 0.01763862930238247
exon O 0 0.08734627813100815
2 O 0 0.031707268208265305
( O 0 0.026708535850048065
C3804A O 1 0.7453076243400574
) O 0 0.02616148628294468
which O 0 0.030206413939595222
abolishes O 1 0.9950880408287048
POMC O 1 0.9999910593032837
translation O 0 0.08205059915781021
. O 0 0.06602295488119125

These O 0 0.026918791234493256
findings O 0 0.02499452233314514
represent O 0 0.01524428278207779
the O 0 0.012435737997293472
first O 0 0.01287769339978695
examples O 0 0.011526785790920258
of O 0 0.010484746657311916
a O 0 0.017731940373778343
genetic B-Disease 1 0.7087407112121582
defect I-Disease 1 0.9998829364776611
within O 0 0.013589057140052319
the O 0 0.02284996397793293
POMC O 1 0.9999997615814209
gene O 0 0.01823938824236393
and O 0 0.011363636702299118
define O 0 0.01563568413257599
a O 0 0.01621341146528721
new O 0 0.03126920759677887
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 1.0
resulting O 0 0.1330341249704361
in O 0 0.013617286458611488
early O 1 0.9308910965919495
- O 1 1.0
onset O 1 1.0
obesity B-Disease 1 1.0
, O 1 0.9999984502792358
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 1 0.99998939037323
red O 1 1.0
hair O 1 0.9999998807907104
pigmentation O 1 0.9999998807907104
. O 0 0.04147857427597046
. O 0 0.0527103915810585

A O 0 0.05605816841125488
European O 0 0.047903530299663544
multicenter O 0 0.37209415435791016
study O 0 0.028247637674212456
of O 0 0.03476029634475708
phenylalanine B-Disease 1 0.9999997615814209
hydroxylase I-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
: O 0 0.029133586212992668
classification O 0 0.02720489911735058
of O 0 0.016477074474096298
105 O 0 0.057909347116947174
mutations O 0 0.017896972596645355
and O 0 0.009598160162568092
a O 0 0.011156095191836357
general O 0 0.015272224321961403
system O 0 0.012441524304449558
for O 0 0.013968602754175663
genotype O 0 0.2838708758354187
- O 1 0.9690096378326416
based O 0 0.021113397553563118
prediction O 0 0.060490332543849945
of O 0 0.03633730486035347
metabolic O 1 0.9999866485595703
phenotype O 1 0.9963853359222412
. O 0 0.06054999679327011

Phenylketonuria B-Disease 1 0.9999992847442627
( O 1 0.6495628356933594
PKU B-Disease 1 0.9999997615814209
) O 0 0.0322745218873024
and O 0 0.030235936865210533
mild B-Disease 1 0.9999996423721313
hyperphenylalaninemia I-Disease 1 1.0
( O 1 0.9998577833175659
MHP B-Disease 1 1.0
) O 0 0.027689281851053238
are O 0 0.015511417761445045
allelic B-Disease 1 0.999996542930603
disorders I-Disease 1 1.0
caused O 1 0.9962866306304932
by O 0 0.013216775842010975
mutations O 0 0.0141140166670084
in O 0 0.009162390604615211
the O 0 0.013787477277219296
gene O 0 0.021282263100147247
encoding O 0 0.0287909135222435
phenylalanine O 1 0.9903672933578491
hydroxylase O 1 0.9999576807022095
( O 1 0.9810618758201599
PAH O 1 1.0
) O 0 0.05832119658589363
. O 0 0.05983398109674454

Previous O 0 0.04209038242697716
studies O 0 0.021121958270668983
have O 0 0.009477116167545319
suggested O 0 0.010711049661040306
that O 0 0.006266138982027769
the O 0 0.009494726546108723
highly O 0 0.017222627997398376
variable O 0 0.02295161597430706
metabolic O 1 0.9982576966285706
phenotypes O 1 0.996541440486908
of O 1 0.9999830722808838
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
correlate O 1 0.9999967813491821
with O 1 0.9999048709869385
PAH O 1 1.0
genotypes O 1 0.9999653100967407
. O 0 0.09378209710121155

We O 0 0.027341553941369057
identified O 0 0.022692183032631874
both O 0 0.016389911994338036
causative O 0 0.36837777495384216
mutations O 0 0.021107904613018036
in O 0 0.014557070098817348
686 O 1 0.999995231628418
patients O 1 0.993230938911438
from O 0 0.014701437205076218
seven O 0 0.01899033784866333
European O 0 0.028269466012716293
centers O 0 0.04148394241929054
. O 0 0.044171202927827835

On O 0 0.029556002467870712
the O 0 0.017907092347741127
basis O 0 0.0125337028875947
of O 0 0.013407359831035137
the O 0 0.016729768365621567
phenotypic O 0 0.029796024784445763
characteristics O 0 0.020922033116221428
of O 0 0.021282780915498734
297 O 1 0.9681724309921265
functionally O 1 0.9994134902954102
hemizygous O 1 0.9999759197235107
patients O 1 0.9292246699333191
, O 0 0.015302345156669617
105 O 0 0.027077093720436096
of O 0 0.01398668996989727
the O 0 0.014270834624767303
mutations O 0 0.016072304919362068
were O 0 0.009355036541819572
assigned O 0 0.01668241247534752
to O 0 0.009455152787268162
one O 0 0.010129259899258614
of O 0 0.01095416210591793
four O 0 0.014497487805783749
arbitrary O 0 0.02493775635957718
phenotype O 0 0.30649349093437195
categories O 0 0.05032718926668167
. O 0 0.04599156230688095

We O 0 0.03039560094475746
proposed O 0 0.02410297840833664
and O 0 0.017759202048182487
tested O 0 0.027096863836050034
a O 0 0.017546609044075012
simple O 0 0.018249472603201866
model O 0 0.019998427480459213
for O 0 0.012379626743495464
correlation O 0 0.023048562929034233
between O 0 0.018202073872089386
genotype O 0 0.05101127177476883
and O 0 0.024289021268486977
phenotypic O 0 0.05672463774681091
outcome O 0 0.04666968062520027
. O 0 0.0468929149210453

The O 0 0.047153983265161514
observed O 0 0.04342624917626381
phenotype O 0 0.05746227502822876
matched O 0 0.03649413585662842
the O 0 0.019585002213716507
predicted O 0 0.030113285407423973
phenotype O 0 0.030404359102249146
in O 0 0.014346371404826641
79 O 0 0.029871804639697075
% O 0 0.01165041234344244
of O 0 0.009564515203237534
the O 0 0.010834023356437683
cases O 0 0.009861614555120468
, O 0 0.008817528374493122
and O 0 0.00663771340623498
in O 0 0.006368876900523901
only O 0 0.006283941213041544
5 O 0 0.012388474307954311
of O 0 0.01092744804918766
184 O 1 0.6419592499732971
patients O 1 0.9544785022735596
was O 0 0.016187623143196106
the O 0 0.012445696629583836
observed O 0 0.01329288724809885
phenotype O 0 0.020502856001257896
more O 0 0.007546741049736738
than O 0 0.008346897549927235
one O 0 0.010221878997981548
category O 0 0.016021011397242546
away O 0 0.013507918454706669
from O 0 0.011515605263411999
that O 0 0.010797995142638683
expected O 0 0.02669740840792656
. O 0 0.03824474290013313

Among O 0 0.033861491829156876
the O 0 0.019898507744073868
seven O 0 0.020203307271003723
contributing O 0 0.021878469735383987
centers O 0 0.015769485384225845
, O 0 0.009898250922560692
the O 0 0.009344375692307949
proportion O 0 0.012465591542422771
of O 0 0.010105572640895844
patients O 1 0.7923473715782166
for O 0 0.00917903333902359
whom O 0 0.012424158863723278
the O 0 0.010857975110411644
observed O 0 0.014922574162483215
phenotype O 0 0.032981932163238525
did O 0 0.011546345427632332
not O 0 0.008826740086078644
match O 0 0.01494621578603983
the O 0 0.011727876961231232
predicted O 0 0.023135412484407425
phenotype O 0 0.029460204765200615
was O 0 0.018012741580605507
4 O 0 0.01904892548918724
% O 0 0.015029712580144405
- O 0 0.074296735227108
23 O 0 0.02165801078081131
% O 0 0.015572785399854183
( O 0 0.01835475116968155
P O 1 0.9142717719078064
< O 1 0.8485066890716553
. O 0 0.018494289368391037
0001 O 1 0.7360134720802307
) O 0 0.016456371173262596
, O 0 0.01272472646087408
suggesting O 0 0.011462186463177204
that O 0 0.006601500324904919
differences O 0 0.008442668244242668
in O 0 0.0067109535448253155
methods O 0 0.006864922121167183
used O 0 0.007136988453567028
for O 0 0.009903229773044586
mutation O 0 0.022689908742904663
detection O 0 0.49163609743118286
or O 0 0.016687214374542236
phenotype O 1 0.968183159828186
classification O 0 0.1225668266415596
may O 0 0.013303329236805439
account O 0 0.012385306879878044
for O 0 0.008585996925830841
a O 0 0.01343045849353075
considerable O 0 0.018657861277461052
proportion O 0 0.021619275212287903
of O 0 0.020920539274811745
genotype O 1 0.999618649482727
- O 1 0.999995231628418
phenotype O 1 0.9894120097160339
inconsistencies O 0 0.08238419890403748
. O 0 0.056103095412254333

Our O 0 0.038429684937000275
data O 0 0.019901271909475327
indicate O 0 0.016718808561563492
that O 0 0.012308534234762192
the O 0 0.028823263943195343
PAH O 1 1.0
- O 1 0.9999960660934448
mutation O 0 0.04463859274983406
genotype O 0 0.04213021323084831
is O 0 0.014288513921201229
the O 0 0.01413406990468502
main O 0 0.022471847012639046
determinant O 0 0.2882528305053711
of O 0 0.020695092156529427
metabolic O 1 0.9999078512191772
phenotype O 1 0.8156029582023621
in O 0 0.014303860254585743
most O 0 0.01923784799873829
patients O 1 0.9999991655349731
with O 1 0.9999945163726807
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.9864184260368347

In O 0 0.028167016804218292
the O 0 0.019082380458712578
present O 0 0.016735302284359932
study O 0 0.01415435690432787
, O 0 0.011456192471086979
the O 0 0.011593077331781387
classification O 0 0.019680073484778404
of O 0 0.018130416050553322
105 O 1 0.9996968507766724
PAH O 1 1.0
mutations O 0 0.04000578448176384
may O 0 0.014485535211861134
allow O 0 0.011947480030357838
the O 0 0.013029685243964195
prediction O 0 0.022942498326301575
of O 0 0.013908695429563522
the O 0 0.016863901168107986
biochemical O 0 0.21944954991340637
phenotype O 0 0.05775238946080208
in O 0 0.018555497750639915
> O 0 0.29204854369163513
10 O 0 0.019036414101719856
, O 0 0.015574827790260315
000 O 0 0.03399297222495079
genotypes O 0 0.19161011278629303
, O 0 0.01527020987123251
which O 0 0.009068752638995647
may O 0 0.008717752993106842
be O 0 0.006817443296313286
useful O 0 0.008998779579997063
for O 0 0.008024824783205986
the O 0 0.011221162043511868
management O 0 0.027940822765231133
of O 0 0.023382339626550674
hyperphenylalaninemia B-Disease 1 0.9999994039535522
in O 0 0.040258899331092834
newborns O 1 0.9980496168136597
. O 0 0.05519658699631691

Somatic O 0 0.13645108044147491
instability O 0 0.06741012632846832
of O 0 0.027993574738502502
the O 0 0.03164449334144592
CTG O 1 0.9999839067459106
repeat O 0 0.09683187305927277
in O 0 0.02379451133310795
mice O 0 0.03198601305484772
transgenic O 0 0.03948942944407463
for O 0 0.016797516494989395
the O 0 0.11934753507375717
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 1 0.9991554021835327
is O 0 0.05813997611403465
age O 0 0.05684879422187805
dependent O 0 0.014098472893238068
but O 0 0.008015351369976997
not O 0 0.0075059328228235245
correlated O 0 0.01403116062283516
to O 0 0.008328836411237717
the O 0 0.011626399122178555
relative O 0 0.02278885431587696
intertissue O 1 0.9964061379432678
transcription O 0 0.060497548431158066
levels O 0 0.033047858625650406
and O 0 0.040224041789770126
proliferative O 1 0.9999995231628418
capacities O 1 0.9882619976997375
. O 0 0.07137899100780487

A O 0 0.07569196820259094
( O 0 0.04875057563185692
CTG O 1 0.999886155128479
) O 0 0.027546387165784836
nexpansion O 0 0.05189363285899162
in O 0 0.01483121793717146
the O 0 0.0174862090498209
3 O 0 0.031035209074616432
- O 1 0.9856869578361511
untranslated O 1 0.9077154397964478
region O 0 0.034106187522411346
( O 0 0.027969341725111008
UTR O 1 0.6543029546737671
) O 0 0.017866836860775948
of O 0 0.01630517654120922
the O 0 0.024619663134217262
DM O 1 1.0
protein O 0 0.06350972503423691
kinase O 1 0.7042871713638306
gene O 0 0.024605726823210716
( O 0 0.020441895350813866
DMPK O 1 0.9998899698257446
) O 0 0.015244870446622372
is O 0 0.009836950339376926
responsible O 0 0.014471417292952538
for O 0 0.01863028295338154
causing O 1 0.9999998807907104
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 0.34343433380126953
. O 0 0.06387504190206528

Major O 0 0.16783660650253296
instability O 1 0.7632130980491638
, O 0 0.01873118244111538
with O 0 0.012504687532782555
very O 0 0.010226535610854626
large O 0 0.011870810762047768
expansions O 0 0.022119075059890747
between O 0 0.01163496170192957
generations O 0 0.01567753590643406
and O 0 0.009882309474050999
high O 0 0.013714254833757877
levels O 0 0.012524263001978397
of O 0 0.013924367725849152
somatic O 1 0.97881680727005
mosaicism O 1 0.9999954700469971
, O 0 0.02049529179930687
is O 0 0.01600506901741028
observed O 0 0.021102549508213997
in O 0 0.02300267666578293
patients O 1 0.9296686053276062
. O 0 0.047579314559698105

There O 0 0.026465244591236115
is O 0 0.01686372607946396
a O 0 0.014917934313416481
good O 0 0.016983207315206528
correlation O 0 0.017751483246684074
between O 0 0.011503024958074093
repeat O 0 0.023315295577049255
size O 0 0.016529379412531853
( O 0 0.012028242461383343
at O 0 0.011125108227133751
least O 0 0.008442449383437634
in O 0 0.010633982717990875
leucocytes O 1 0.9953994154930115
) O 0 0.014168893918395042
, O 0 0.014733527787029743
clinical O 1 0.9920136332511902
severity O 1 0.9957810640335083
and O 0 0.017195984721183777
age O 0 0.08344060182571411
of O 0 0.10730628669261932
onset O 1 0.9999996423721313
. O 0 0.060686469078063965

The O 0 0.06032983213663101
trinucleotide O 1 0.9991394281387329
repeat O 0 0.1698130965232849
instability O 0 0.21076184511184692
mechanisms O 0 0.02608696185052395
involved O 0 0.01601664535701275
in O 0 0.021611589938402176
DM B-Disease 1 1.0
and O 0 0.020215041935443878
other O 0 0.012834594585001469
human O 0 0.44413214921951294
genetic B-Disease 1 0.9999982118606567
diseases I-Disease 1 1.0
are O 0 0.01822073757648468
unknown O 0 0.04285874962806702
. O 0 0.03956684097647667

We O 0 0.03978649899363518
studied O 0 0.04557951167225838
somatic O 0 0.060751352459192276
instability O 0 0.04150009527802467
by O 0 0.01615743711590767
measuring O 0 0.027679720893502235
the O 0 0.0222025029361248
CTG O 1 0.9999469518661499
repeat O 0 0.041489362716674805
length O 0 0.02037964016199112
at O 0 0.016830191016197205
several O 0 0.010144123807549477
ages O 0 0.015865234658122063
in O 0 0.010821368545293808
various O 0 0.01165124773979187
tissues O 0 0.02516208030283451
of O 0 0.01769246533513069
transgenic O 1 0.5538252592086792
mice O 0 0.033993225544691086
carrying O 0 0.027320845052599907
a O 0 0.02400144375860691
( O 0 0.031913965940475464
CTG O 1 0.9995785355567932
) O 0 0.03138045594096184
55expansion O 0 0.18263021111488342
surrounded O 0 0.03597663715481758
by O 0 0.013229425065219402
45 O 0 0.026563327759504318
kb O 0 0.05022090673446655
of O 0 0.015502179972827435
the O 0 0.016410235315561295
human O 0 0.06622695177793503
DM B-Disease 1 1.0
region O 0 0.047189000993967056
, O 0 0.015605182386934757
using O 0 0.015767265111207962
small O 0 0.022998273372650146
- O 1 0.9958224296569824
pool O 0 0.2323746532201767
PCR O 0 0.10499521344900131
. O 0 0.05832653492689133

These O 0 0.0313638374209404
mice O 0 0.03559168428182602
have O 0 0.011265361681580544
been O 0 0.011192481964826584
shown O 0 0.011033055372536182
to O 0 0.01210791151970625
reproduce O 0 0.02487335167825222
the O 0 0.016685564070940018
intergenerational O 1 0.8710111975669861
and O 0 0.019398273900151253
somatic O 0 0.04508542641997337
instability O 0 0.033539049327373505
of O 0 0.017110727727413177
the O 0 0.022924408316612244
55 O 0 0.1002834215760231
CTG O 1 0.9999376535415649
repeat O 0 0.04120070859789848
suggesting O 0 0.022022228688001633
that O 0 0.01020837016403675
surrounding O 0 0.019220061600208282
sequences O 0 0.013472483493387699
and O 0 0.010714405216276646
the O 0 0.012513435445725918
chromatin O 0 0.03032049536705017
environment O 0 0.01748579367995262
are O 0 0.008490725420415401
involved O 0 0.012800854630768299
in O 0 0.018672995269298553
instability O 1 0.99004727602005
mechanisms O 0 0.09451171010732651
. O 0 0.05264338105916977

As O 0 0.02617107704281807
observed O 0 0.014744953252375126
in O 0 0.00903203897178173
some O 0 0.006975613534450531
of O 0 0.008111950010061264
the O 0 0.011360573582351208
tissues O 1 0.9821027517318726
of O 1 0.9983499050140381
DM B-Disease 1 1.0
patients O 1 0.9999998807907104
, O 0 0.017632070928812027
there O 0 0.00880457367748022
is O 0 0.008435812778770924
a O 0 0.01161688007414341
tendency O 0 0.016001831740140915
for O 0 0.011978750117123127
repeat O 0 0.026764176785945892
length O 0 0.01846914365887642
and O 0 0.01611623726785183
somatic O 0 0.05415826663374901
mosaicism O 1 0.9224530458450317
to O 0 0.012453224509954453
increase O 0 0.010282515548169613
with O 0 0.00818471610546112
the O 0 0.009707142598927021
age O 0 0.01396246999502182
of O 0 0.012769713997840881
the O 0 0.021272942423820496
mouse O 1 0.6368556022644043
. O 0 0.04150944575667381

Furthermore O 0 0.05782610550522804
, O 0 0.021515583619475365
we O 0 0.01313420757651329
observed O 0 0.012647068127989769
no O 0 0.011522781103849411
correlation O 0 0.01337980106472969
between O 0 0.008964824490249157
the O 0 0.012811103835701942
somatic O 0 0.04059530049562454
mutation O 0 0.023961123079061508
rate O 0 0.01701170764863491
and O 0 0.023155665025115013
tissue O 1 0.9999663829803467
proliferation O 1 0.9995537400245667
capacity O 0 0.1948700249195099
. O 0 0.054724253714084625

The O 0 0.05233924090862274
somatic O 0 0.07460517436265945
mutation O 0 0.03635791316628456
rates O 0 0.018748220056295395
in O 0 0.010656571015715599
different O 0 0.008038058876991272
tissues O 0 0.02272220328450203
were O 0 0.007841822691261768
also O 0 0.009356863796710968
not O 0 0.007044466212391853
correlated O 0 0.012895295396447182
to O 0 0.00759908789768815
the O 0 0.011589492671191692
relative O 0 0.02075831964612007
inter O 1 0.9908252358436584
- O 1 0.9999822378158569
tissue O 0 0.3179652690887451
difference O 0 0.015841078013181686
in O 0 0.012460450641810894
transcriptional O 0 0.02072705514729023
levels O 0 0.011769254691898823
of O 0 0.008647496812045574
the O 0 0.009592513553798199
three O 0 0.010378142818808556
genes O 0 0.015786990523338318
( O 0 0.017557626590132713
DMAHP O 1 0.9996249675750732
, O 0 0.01910383068025112
DMPK O 1 0.9992140531539917
and O 0 0.01631057821214199
59 O 0 0.03407851979136467
) O 0 0.017186950892210007
surrounding O 0 0.02086692489683628
the O 0 0.01980532892048359
repeat O 0 0.05025870352983475
. O 0 0.030256474390625954
. O 0 0.04424821212887764

A O 0 0.05978981405496597
novel O 0 0.05787576735019684
missense O 0 0.06401821970939636
mutation O 0 0.030446164309978485
in O 0 0.016210108995437622
patients O 1 0.5702499151229858
from O 0 0.012964258901774883
a O 0 0.028582733124494553
retinoblastoma B-Disease 1 0.9999991655349731
pedigree O 1 0.9890081882476807
showing O 0 0.02226269617676735
only O 0 0.012388695031404495
mild O 1 0.7207503318786621
expression O 0 0.018061237409710884
of O 0 0.01957501471042633
the O 1 0.8305355906486511
tumor B-Disease 1 1.0
phenotype O 1 0.9998874664306641
. O 0 0.05940074101090431

We O 0 0.023572644218802452
have O 0 0.013763431459665298
used O 0 0.014434774406254292
single O 0 0.01954834535717964
strand O 0 0.031778573989868164
conformation O 0 0.029072236269712448
polymorphism O 0 0.02368641458451748
analysis O 0 0.012157135643064976
to O 0 0.009931587614119053
study O 0 0.011075669899582863
the O 0 0.010306427255272865
27 O 0 0.018539482727646828
exons O 0 0.025495007634162903
of O 0 0.013393012806773186
the O 0 0.01955573633313179
RB1 O 1 0.9999912977218628
gene O 0 0.017499133944511414
in O 0 0.010175956413149834
individuals O 0 0.007075044326484203
from O 0 0.007730152923613787
a O 0 0.012962445616722107
family O 0 0.019826116040349007
showing O 0 0.02056664042174816
mild O 1 0.9981160163879395
expression O 0 0.019782118499279022
of O 0 0.019633781164884567
the O 0 0.22481386363506317
retinoblastoma B-Disease 1 0.9999998807907104
phenotype O 1 0.9997057318687439
. O 0 0.05916468799114227

In O 0 0.029410522431135178
this O 0 0.017317142337560654
family O 0 0.020358122885227203
affected O 0 0.01476751733571291
individuals O 0 0.01032370887696743
developed O 1 0.6515328288078308
unilateral B-Disease 1 0.9996962547302246
tumors I-Disease 1 1.0
and O 0 0.08862906694412231
, O 0 0.010904851369559765
as O 0 0.007902250625193119
a O 0 0.009846759028732777
result O 0 0.0091672008857131
of O 0 0.009780698455870152
linkage O 0 0.023013493046164513
analysis O 0 0.01343573722988367
, O 0 0.014138003811240196
unaffected O 1 0.7102189064025879
mutation O 0 0.024136796593666077
carriers O 0 0.026056507602334023
were O 0 0.009829030372202396
also O 0 0.013007357716560364
identified O 0 0.015199665911495686
within O 0 0.014113911427557468
the O 0 0.0223829448223114
pedigree O 1 0.5758280158042908
. O 0 0.04390397667884827

A O 0 0.04794495180249214
single O 0 0.03128347918391228
band O 0 0.03485993668437004
shift O 0 0.030177965760231018
using O 0 0.021127017214894295
SSCP O 1 0.988207995891571
was O 0 0.02377155050635338
identified O 0 0.01843886263668537
in O 0 0.014725271612405777
exon O 0 0.047436997294425964
21 O 0 0.02423226088285446
which O 0 0.011978298425674438
resulted O 0 0.016553541645407677
in O 0 0.01276298426091671
a O 0 0.018727868795394897
missense O 0 0.03926656022667885
mutation O 0 0.02564811147749424
converting O 0 0.027325402945280075
a O 0 0.029435740783810616
cys O 1 0.9999991655349731
- O 1 0.9999967813491821
- O 1 0.9999775886535645
> O 1 0.9706342220306396
arg O 1 0.8535310626029968
at O 0 0.037242598831653595
nucleotide O 0 0.039970219135284424
position O 0 0.031099529936909676
28 O 0 0.03467705100774765
in O 0 0.02163967862725258
the O 0 0.033807240426540375
exon O 0 0.126389279961586
. O 0 0.05327737331390381

The O 0 0.051207926124334335
mutation O 0 0.04779908433556557
destroyed O 0 0.04397789016366005
an O 0 0.03108535334467888
NdeI O 1 0.9990482926368713
restriction O 0 0.06491775065660477
enzyme O 0 0.06262486428022385
site O 0 0.06751000136137009
. O 0 0.05440197512507439

Analysis O 0 0.03475002571940422
of O 0 0.018658287823200226
all O 0 0.012210248969495296
family O 0 0.016755390912294388
members O 0 0.01053879875689745
demonstrated O 0 0.01835482008755207
that O 0 0.008690368384122849
the O 0 0.013618004508316517
missense O 0 0.0371854268014431
mutation O 0 0.026204586029052734
co O 1 0.8944103121757507
- O 1 0.9968017339706421
segregated O 0 0.036178696900606155
with O 0 0.014747433364391327
patients O 1 0.999649167060852
with O 1 0.8507229685783386
tumors B-Disease 1 1.0
or O 0 0.017427053302526474
who O 0 0.014969906769692898
, O 0 0.008476662449538708
as O 0 0.0071373325772583485
a O 0 0.008846000768244267
result O 0 0.007866197265684605
of O 0 0.009385231882333755
linkage O 0 0.02578679285943508
analysis O 0 0.011692579835653305
had O 0 0.012753566727042198
been O 0 0.010862492956221104
predicted O 0 0.017834557220339775
to O 0 0.011537847109138966
carry O 0 0.020841844379901886
the O 0 0.026554806157946587
predisposing O 1 0.9923204779624939
mutation O 0 0.060610271990299225
. O 0 0.05190339311957359

These O 0 0.024307332932949066
observations O 0 0.029320059344172478
point O 0 0.016669198870658875
to O 0 0.010486675426363945
another O 0 0.013473840430378914
region O 0 0.013048524037003517
of O 0 0.01100761629641056
the O 0 0.016340773552656174
RB1 O 1 0.9999991655349731
gene O 0 0.019987767562270164
where O 0 0.01437475997954607
mutations O 0 0.01227662805467844
only O 0 0.008235063403844833
modify O 0 0.01625324971973896
the O 0 0.009692265652120113
function O 0 0.00911048986017704
of O 0 0.008674271404743195
the O 0 0.010326388292014599
gene O 0 0.012634830549359322
and O 0 0.009278015233576298
raise O 0 0.013872895389795303
important O 0 0.009789264760911465
questions O 0 0.011402004398405552
for O 0 0.010713455267250538
genetic O 0 0.015856988728046417
counseling O 0 0.20360086858272552
in O 0 0.011540533974766731
families O 0 0.01244639977812767
with O 0 0.010328824631869793
these O 0 0.011622821912169456
distinctive O 0 0.32299014925956726
phenotypes O 1 0.9653545618057251
. O 0 0.0271264910697937
. O 0 0.03972829878330231

Maternal B-Disease 1 0.9905787110328674
disomy I-Disease 1 0.998264491558075
and O 1 0.753570020198822
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 1 0.9858155250549316
with O 0 0.1064678430557251
gamete O 1 0.9999526739120483
complementation O 1 0.9999790191650391
in O 0 0.017857231199741364
a O 0 0.0164535753428936
case O 0 0.0158402007073164
of O 0 0.015562375076115131
familial O 1 0.9974476099014282
translocation O 1 0.9251590967178345
( O 0 0.0174934770911932
3 O 0 0.019832098856568336
; O 0 0.014238733798265457
15 O 0 0.01631908118724823
) O 0 0.016426950693130493
( O 0 0.022348765283823013
p25 O 1 0.8893814086914062
; O 0 0.02767479233443737
q11 O 0 0.4951102137565613
. O 0 0.02441321685910225
2 O 0 0.04169550910592079
) O 0 0.0362742580473423
. O 0 0.04587116092443466

Maternal B-Disease 1 0.9999436140060425
uniparental I-Disease 1 0.9999996423721313
disomy I-Disease 1 0.999997615814209
( I-Disease 1 0.9521975517272949
UPD I-Disease 1 0.9999998807907104
) I-Disease 0 0.02513606660068035
for I-Disease 0 0.017641613259911537
chromosome I-Disease 0 0.027273867279291153
15 I-Disease 0 0.018242625519633293
is O 0 0.009753810241818428
responsible O 0 0.010482520796358585
for O 0 0.008182222954928875
an O 0 0.009071838110685349
estimated O 0 0.011745142750442028
30 O 0 0.01376389805227518
% O 0 0.010167093947529793
of O 0 0.009200436994433403
cases O 0 0.011540696956217289
of O 0 0.059943508356809616
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9999994039535522
PWS B-Disease 1 1.0
) O 0 0.1289590746164322
. O 0 0.057839535176754

We O 0 0.024966195225715637
report O 0 0.017721427604556084
on O 0 0.012635212391614914
an O 0 0.011969356797635555
unusual O 0 0.01535086240619421
case O 0 0.016554411500692368
of O 0 0.015259149484336376
maternal B-Disease 1 0.9900556802749634
disomy I-Disease 1 0.9998065829277039
15 I-Disease 0 0.02452690154314041
in O 0 0.021719375625252724
PWS B-Disease 1 1.0
that O 0 0.010897408239543438
is O 0 0.009788154624402523
most O 0 0.008092914707958698
consistent O 0 0.012117806822061539
with O 0 0.010784800164401531
adjacent O 0 0.01962609775364399
- O 1 0.5514917969703674
1 O 0 0.01766294427216053
segregation O 0 0.023210056126117706
of O 0 0.01283622719347477
a O 0 0.01824205182492733
paternal O 1 0.9867989420890808
t O 1 0.9968481659889221
( O 0 0.015269800089299679
3 O 0 0.01879432052373886
; O 0 0.01426394097507
15 O 0 0.017814431339502335
) O 0 0.015770938247442245
( O 0 0.02007812261581421
p25 O 1 0.8519936800003052
; O 0 0.02342456951737404
q11 O 0 0.11449029296636581
. O 0 0.015747040510177612
2 O 0 0.022492073476314545
) O 0 0.013652363792061806
with O 0 0.013119368813931942
simultaneous O 0 0.034027986228466034
maternal O 1 0.9568300843238831
meiotic O 1 0.9999340772628784
nondisjunction O 1 0.9990161657333374
for O 0 0.03351408243179321
chromosome O 0 0.055760495364665985
15 O 0 0.04861828684806824
. O 0 0.05020374059677124

The O 0 0.0374113991856575
patient O 1 0.9994779229164124
( O 0 0.08536898344755173
J O 1 0.9999986886978149
. O 0 0.021409669890999794
B O 1 0.9846018552780151
. O 0 0.012275836430490017
) O 0 0.010632127523422241
, O 0 0.009272996336221695
a O 0 0.011568662710487843
17 O 0 0.015618057921528816
- O 0 0.28734472393989563
year O 0 0.015205277130007744
- O 1 0.9585922360420227
old O 0 0.025830406695604324
white O 0 0.021496860310435295
male O 0 0.022745277732610703
with O 0 0.020324639976024628
PWS B-Disease 1 1.0
, O 0 0.0185443926602602
was O 0 0.016543004661798477
found O 0 0.008933710865676403
to O 0 0.00791647657752037
have O 0 0.006753325928002596
47 O 0 0.01796809397637844
chromosomes O 0 0.013740653172135353
with O 0 0.0096574192866683
a O 0 0.015071877278387547
supernumerary O 1 0.9990589022636414
, O 0 0.027428098022937775
paternal O 1 0.9995636343955994
der O 1 0.9999241828918457
( O 0 0.014679765328764915
15 O 0 0.014044188894331455
) O 0 0.008988392539322376
consisting O 0 0.009923048317432404
of O 0 0.00813312828540802
the O 0 0.009499172680079937
short O 0 0.01456399355083704
arm O 1 0.7573193311691284
and O 0 0.01191845815628767
the O 0 0.017217164859175682
proximal O 1 0.9998818635940552
long O 0 0.03465379774570465
arm O 1 0.80990070104599
of O 0 0.01722078025341034
chromosome O 0 0.029050512239336967
15 O 0 0.020636292174458504
, O 0 0.017787020653486252
and O 0 0.02363649383187294
distal O 1 0.999913215637207
chromosome O 1 0.966183066368103
arm O 1 0.9999899864196777
3p O 1 0.9999815225601196
. O 0 0.07242967188358307

The O 0 0.04653449356555939
t O 1 0.9875091910362244
( O 0 0.02091556042432785
3 O 0 0.023376043885946274
; O 0 0.014342746697366238
15 O 0 0.016317274421453476
) O 0 0.011806960217654705
was O 0 0.013784338720142841
present O 0 0.009885071776807308
in O 0 0.008557573892176151
the O 0 0.008795605041086674
balanced O 0 0.01412648893892765
state O 0 0.00694921612739563
in O 0 0.008428282104432583
the O 0 0.013721151277422905
patients O 1 0.9959874749183655
father O 0 0.25257429480552673
and O 0 0.01728670857846737
a O 0 0.031682927161455154
sister O 0 0.27480074763298035
. O 0 0.048090603202581406

Fluorescent O 0 0.24763301014900208
in O 0 0.03555382788181305
situ O 0 0.0993916392326355
hybridization O 0 0.04004664346575737
analysis O 0 0.020941046997904778
demonstrated O 0 0.021798348054289818
that O 0 0.011546486988663673
the O 0 0.020806821063160896
PWS B-Disease 1 0.9999998807907104
critical O 0 0.03694462403655052
region O 0 0.025116825476288795
resided O 0 0.029591934755444527
on O 0 0.013290486298501492
the O 0 0.01658378168940544
derivative O 0 0.03905364125967026
chromosome O 0 0.022724365815520287
3 O 0 0.014821598306298256
and O 0 0.009186305105686188
that O 0 0.007130234036594629
there O 0 0.007014438509941101
was O 0 0.010920488275587559
no O 0 0.009925493970513344
deletion O 0 0.019777536392211914
of O 0 0.012746675871312618
the O 0 0.029908765107393265
PWS B-Disease 1 1.0
region O 0 0.019945936277508736
on O 0 0.0120225939899683
the O 0 0.014305460266768932
normal O 0 0.017774704843759537
pair O 0 0.02342684380710125
of O 0 0.0194320660084486
15s O 1 0.9985547661781311
present O 0 0.028166351839900017
in O 0 0.0332719162106514
J O 1 0.999950647354126
. O 0 0.05327415093779564

B O 1 0.9868319034576416
. O 0 0.09901543706655502

Methylation O 0 0.08570244163274765
analysis O 0 0.034607287496328354
at O 0 0.040045544505119324
exon O 0 0.07275255024433136
alpha O 0 0.04083710536360741
of O 0 0.01697080209851265
the O 0 0.016658751294016838
small O 0 0.020045505836606026
nuclear O 0 0.036720115691423416
ribonucleoprotein O 1 0.9998038411140442
- O 1 0.9955770969390869
associated O 0 0.038331255316734314
polypeptide O 1 0.6378050446510315
N O 0 0.0653228610754013
( O 0 0.030231820419430733
SNRPN O 1 0.9994799494743347
) O 0 0.02043679915368557
gene O 0 0.018883896991610527
showed O 0 0.015955375507473946
a O 0 0.014087236486375332
pattern O 0 0.017591828480362892
characteristic O 0 0.01547361072152853
of O 0 0.010011331178247929
only O 0 0.010137107223272324
the O 0 0.01777402125298977
maternal O 1 0.7374402284622192
chromosome O 0 0.028401536867022514
15 O 0 0.027584193274378777
in O 0 0.030955707654356956
J O 1 0.9999009370803833
. O 0 0.05519749969244003

B O 1 0.9882715344429016
. O 0 0.10750055313110352

Maternal B-Disease 1 0.9993178844451904
disomy I-Disease 1 0.9979172348976135
was O 0 0.03795190528035164
confirmed O 0 0.027248099446296692
by O 0 0.018158970400691032
polymerase O 0 0.05804239213466644
chain O 0 0.03471653163433075
reaction O 0 0.020694803446531296
analysis O 0 0.016495710238814354
of O 0 0.019817274063825607
microsatellite O 0 0.1157054454088211
repeats O 0 0.03605226054787636
at O 0 0.021256791427731514
the O 0 0.02335764281451702
gamma O 0 0.16709232330322266
- O 1 0.9995563626289368
aminobutyric O 1 0.9948451519012451
acid O 0 0.244941845536232
receptor O 0 0.05712060257792473
beta3 O 1 0.8978138566017151
subunit O 0 0.07212473452091217
( O 0 0.044922780245542526
GABRB3 O 1 0.9997244477272034
) O 0 0.05362022668123245
locus O 0 0.13256490230560303
. O 0 0.06538454443216324

A O 0 0.06634480506181717
niece O 1 0.9997401833534241
( O 0 0.034256208688020706
B O 1 0.9989253878593445
. O 0 0.018591316416859627
B O 1 0.9891139268875122
. O 0 0.011059240438044071
) O 0 0.010216698050498962
with O 0 0.01049650739878416
45 O 0 0.0178826916962862
chromosomes O 0 0.01585952565073967
and O 0 0.010293807834386826
the O 0 0.011220432817935944
derivative O 0 0.019775284454226494
3 O 0 0.015036173164844513
but O 0 0.006774751469492912
without O 0 0.007743532769382
the O 0 0.012314273975789547
der O 1 0.9923502802848816
( O 0 0.012355427257716656
15 O 0 0.016149507835507393
) O 0 0.01244713831692934
demonstrated O 0 0.01786268688738346
a O 0 0.015115556307137012
phenotype O 0 0.04473316669464111
consistent O 0 0.016677439212799072
with O 0 0.010166519321501255
that O 0 0.008571235463023186
reported O 0 0.012952042743563652
for O 0 0.01339647825807333
haploinsufficiency O 1 0.9116418957710266
of O 0 0.026878058910369873
distal O 1 0.9994971752166748
3 O 0 0.06320668756961823
p O 0 0.0958477333188057
. O 0 0.05712292343378067

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999759197235107
associated O 0 0.0348542183637619
with O 0 0.02139955386519432
unbalanced O 1 0.6735628247261047
segregation O 0 0.04783483222126961
of O 0 0.020417774096131325
non O 1 0.8297188878059387
- O 1 0.9999927282333374
Robertsonian O 1 0.9999337196350098
translocations O 0 0.2729387879371643
has O 0 0.012785703875124454
been O 0 0.01026196964085102
reported O 0 0.011630302295088768
previously O 0 0.010984291322529316
but O 0 0.006285343784838915
has O 0 0.007090158760547638
not O 0 0.005228142254054546
, O 0 0.0063054426573216915
to O 0 0.006863553076982498
our O 0 0.008754544891417027
knowledge O 0 0.012225613929331303
, O 0 0.009412277489900589
been O 0 0.00852767564356327
observed O 0 0.00937530305236578
in O 0 0.01005429495126009
a O 0 0.015568016096949577
case O 0 0.022481100633740425
of O 0 0.03784983977675438
PWS B-Disease 1 1.0
. O 0 0.06438437104225159

Furthermore O 0 0.05994773283600807
, O 0 0.02357829548418522
our O 0 0.017154479399323463
findings O 0 0.01521081943064928
are O 0 0.008472827263176441
best O 0 0.01569051295518875
interpreted O 0 0.015782130882143974
as O 0 0.014410245232284069
true O 0 0.02833692915737629
gamete O 1 0.93223637342453
complementation O 1 0.9998875856399536
resulting O 0 0.03949325159192085
in O 0 0.030978308990597725
maternal B-Disease 1 0.9999841451644897
UPD I-Disease 1 1.0
15 I-Disease 0 0.21170993149280548
and O 0 0.08748794347047806
PWS B-Disease 1 0.9999995231628418

Schwartz B-Disease 1 0.9998206496238708
- I-Disease 1 0.9999991655349731
Jampel I-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
type I-Disease 1 0.7981758117675781
2 I-Disease 0 0.03166741505265236
and O 0 0.026145296171307564
Stuve B-Disease 1 0.9999998807907104
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 0.03654470294713974
a O 0 0.021090975031256676
case O 0 0.018383722752332687
for O 0 0.017615212127566338
" O 0 0.03024577535688877
lumping O 1 0.6813498735427856
" O 0 0.04136810079216957
. O 0 0.04722241312265396

Recent O 0 0.036657705903053284
studies O 0 0.02617945894598961
demonstrated O 0 0.023171579465270042
the O 0 0.014333931729197502
existence O 0 0.014693965204060078
of O 0 0.011121531017124653
a O 0 0.014963551424443722
genetically O 0 0.02121875062584877
distinct O 0 0.014554607681930065
, O 0 0.013347276486456394
usually O 0 0.010034930892288685
lethal O 0 0.014325350522994995
form O 0 0.008649555966258049
of O 0 0.008786596357822418
the O 0 0.0152638154104352
Schwartz B-Disease 1 0.9999715089797974
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9994046688079834
SJS B-Disease 1 1.0
) O 0 0.018770970404148102
of O 0 0.02332025207579136
myotonia B-Disease 1 1.0
and O 1 0.999487042427063
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.6393738389015198
which O 0 0.010382247157394886
we O 0 0.011532681062817574
called O 0 0.15031087398529053
SJS B-Disease 1 1.0
type I-Disease 1 0.7171180248260498
2 I-Disease 0 0.053713053464889526
. O 0 0.04935119301080704

This O 0 0.0400724783539772
disorder O 1 0.9999799728393555
is O 0 0.017934512346982956
reminiscent O 0 0.11105100810527802
of O 0 0.01277984119951725
another O 0 0.019557932391762733
rare O 0 0.21397064626216888
condition O 0 0.2173166424036026
, O 0 0.012716121971607208
the O 0 0.0164344422519207
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9997310042381287
SWS B-Disease 1 1.0
) O 0 0.021320069208741188
, O 0 0.01455108541995287
which O 0 0.009980347938835621
comprises O 0 0.020588109269738197
campomelia B-Disease 1 0.5827483534812927
at O 0 0.015902651473879814
birth O 0 0.04539075121283531
with O 0 0.04046659544110298
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 1 0.9999657869338989
contractures B-Disease 1 1.0
, O 0 0.13919515907764435
and O 0 0.0183053407818079
early B-Disease 0 0.027584385126829147
death I-Disease 0 0.10347152501344681
. O 0 0.044589873403310776

To O 0 0.025203945115208626
test O 0 0.022462371736764908
for O 0 0.013055711053311825
possible O 0 0.01564737968146801
nosologic O 0 0.3857570290565491
identity O 0 0.01567891240119934
between O 0 0.011208736337721348
these O 0 0.012283633463084698
disorders O 1 1.0
, O 0 0.017000697553157806
we O 0 0.009206690825521946
reviewed O 0 0.01583332195878029
the O 0 0.012148703448474407
literature O 0 0.014858209528028965
and O 0 0.010231107473373413
obtained O 0 0.01217120885848999
a O 0 0.012188063934445381
follow O 0 0.014907806180417538
- O 0 0.04109307751059532
up O 0 0.011136154644191265
of O 0 0.007134113926440477
the O 0 0.00769752636551857
only O 0 0.006653397809714079
two O 0 0.009159416891634464
surviving O 0 0.2701123058795929
patients O 0 0.43728023767471313
, O 0 0.00934714823961258
one O 0 0.008992480114102364
with O 0 0.012602346017956734
SJS B-Disease 1 1.0
type I-Disease 0 0.028421755880117416
2 I-Disease 0 0.01831301860511303
at O 0 0.01347269769757986
age O 0 0.012238801456987858
10 O 0 0.01149772759526968
years O 0 0.009482438676059246
and O 0 0.007933031767606735
another O 0 0.01176088210195303
with O 0 0.013956371694803238
SWS B-Disease 1 0.9999954700469971
at O 0 0.022150224074721336
age O 0 0.0243776123970747
7 O 0 0.03328501433134079
years O 0 0.033231571316719055
. O 0 0.04327983409166336

Patients O 1 0.9734910130500793
reported O 0 0.023901227861642838
as O 0 0.01566983200609684
having O 0 0.01871092990040779
either O 0 0.04144624248147011
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 1 0.5134330987930298
SWS B-Disease 1 0.9999799728393555
presented O 0 0.024651532992720604
a O 0 0.016536951065063477
combination O 0 0.017559517174959183
of O 0 0.009846337139606476
a O 0 0.013950095511972904
severe O 1 0.9999772310256958
, O 1 0.8781982660293579
prenatal O 1 1.0
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9996246099472046
with O 1 0.9996808767318726
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999998807907104
respiratory O 1 1.0
and O 1 0.9998032450675964
feeding O 1 0.9999028444290161
difficulties O 1 0.9999884366989136
, O 0 0.07017090171575546
tendency O 0 0.16229143738746643
to O 0 0.018494045361876488
hyperthermia B-Disease 1 0.9999992847442627
, O 0 0.01700860634446144
and O 0 0.012752185575664043
frequent O 0 0.018399368971586227
death O 0 0.0446295291185379
in O 0 0.014415053650736809
infancy O 1 0.9915106892585754
) O 0 0.010341544635593891
with O 0 0.008639708161354065
a O 0 0.01321056392043829
distinct O 0 0.019960137084126472
campomelic B-Disease 1 0.9999997615814209
- I-Disease 1 1.0
metaphyseal I-Disease 1 1.0
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 0.2678197920322418

The O 0 0.033166345208883286
similarity O 0 0.0250683706253767
of O 0 0.01583685725927353
the O 0 0.01617400534451008
clinical O 1 0.9999232292175293
and O 0 0.02182958647608757
radiographic O 1 0.9999786615371704
findings O 0 0.01607324928045273
is O 0 0.008764265105128288
so O 0 0.007063510362058878
extensive O 0 0.01001169066876173
that O 0 0.0071038976311683655
these O 0 0.008571315556764603
disorders O 1 0.9999990463256836
appear O 0 0.011903967708349228
to O 0 0.01072002574801445
be O 0 0.010700651444494724
a O 0 0.017798278480768204
single O 0 0.027256758883595467
entity O 0 0.04483983293175697
. O 0 0.041015397757291794

The O 0 0.03292762115597725
follow O 0 0.03084886260330677
- O 0 0.11547306925058365
up O 0 0.018133649602532387
observation O 0 0.022698791697621346
of O 0 0.009204263798892498
an O 0 0.008505296893417835
identical O 0 0.01297704130411148
and O 0 0.008132405579090118
unique O 0 0.010966897942125797
pattern O 0 0.013434333726763725
of O 0 0.0811554566025734
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 0.012813697569072247
the O 0 0.010936181992292404
two O 0 0.009535564109683037
patients O 1 0.9869447350502014
( O 0 0.009015779942274094
one O 0 0.010517710819840431
with O 0 0.015092560090124607
SJS B-Disease 1 1.0
type I-Disease 0 0.05009070038795471
2 I-Disease 0 0.01782337576150894
, O 0 0.011471753008663654
one O 0 0.0113671300932765
with O 0 0.014188630506396294
SWS B-Disease 1 0.999990701675415
) O 0 0.01840869151055813
surviving O 0 0.04340274631977081
beyond O 0 0.022475043311715126
infancy O 1 0.9548653960227966
adds O 0 0.021645909175276756
to O 0 0.011424396187067032
the O 0 0.010847101919353008
evidence O 0 0.010854216292500496
in O 0 0.010407287627458572
favor O 0 0.016359727829694748
of O 0 0.018711814656853676
identity O 0 0.03493989259004593
. O 0 0.042185861617326736

The O 0 0.040914200246334076
hypothesis O 0 0.042757272720336914
that O 0 0.01933548040688038
SWS B-Disease 1 0.9999521970748901
and O 0 0.1240922138094902
SJS B-Disease 1 1.0
type I-Disease 0 0.21584224700927734
2 I-Disease 0 0.018872031942009926
are O 0 0.007092035375535488
the O 0 0.011341243982315063
same O 0 0.014061875641345978
disorder O 1 0.9999934434890747
should O 0 0.012704686261713505
be O 0 0.01179524790495634
testable O 0 0.03153267875313759
by O 0 0.012006128206849098
molecular O 0 0.02171187661588192
methods O 0 0.017180941998958588
. O 0 0.02002779208123684
. O 0 0.033894021064043045

A O 0 0.04809250310063362
mouse O 0 0.050133440643548965
model O 0 0.029388658702373505
of O 0 0.022857941687107086
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 1 0.999992847442627
defects O 1 1.0
in O 1 0.9991113543510437
hemostasis O 1 1.0
and O 1 0.9999426603317261
thrombosis B-Disease 1 1.0
. O 1 0.7187627553939819

von B-Disease 1 0.9997809529304504
Willebrand I-Disease 1 0.9999998807907104
factor I-Disease 1 0.9094836711883545
( I-Disease 0 0.24021460115909576
vWf I-Disease 1 0.9999982118606567
) I-Disease 1 0.997795581817627
deficiency I-Disease 1 1.0
causes O 1 1.0
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 1 0.997251570224762
humans O 0 0.09418284893035889
. O 0 0.050325073301792145

We O 0 0.031210394576191902
generated O 0 0.03432204946875572
a O 0 0.02465265803039074
mouse O 0 0.03909657523036003
model O 0 0.02382856048643589
for O 0 0.013282659463584423
this O 0 0.014224919490516186
disease O 1 0.9992666840553284
by O 0 0.011773924343287945
using O 0 0.017463501542806625
gene O 0 0.02966526709496975
targeting O 0 0.03883035480976105
. O 0 0.04179738089442253

vWf B-Disease 1 0.999976634979248
- I-Disease 1 0.999997615814209
deficient I-Disease 1 0.9999711513519287
mice O 0 0.04663441702723503
appeared O 0 0.020650742575526237
normal O 0 0.018626322969794273
at O 0 0.018589438870549202
birth O 0 0.02154405601322651
; O 0 0.012927188538014889
they O 0 0.008879585191607475
were O 0 0.011441479437053204
viable O 0 0.032923005521297455
and O 0 0.022938745096325874
fertile O 0 0.076630137860775
. O 0 0.05248749256134033

Neither O 0 0.10356976836919785
vWf O 1 0.979160487651825
nor O 0 0.07602790743112564
vWf O 1 0.9895039796829224
propolypeptide O 1 0.9971332550048828
( O 0 0.053198184818029404
von B-Disease 1 0.99992835521698
Willebrand I-Disease 1 1.0
antigen O 1 0.9999998807907104
II O 1 0.9999998807907104
) O 0 0.02028486132621765
were O 0 0.01467825472354889
detectable O 0 0.03269417956471443
in O 0 0.017222935333848
plasma O 0 0.2166968286037445
, O 0 0.025656435638666153
platelets O 1 0.9991012811660767
, O 0 0.020725449547171593
or O 0 0.018944473937153816
endothelial O 1 0.9954969882965088
cells O 0 0.02280269004404545
of O 0 0.017926322296261787
the O 0 0.026157747954130173
homozygous O 0 0.2528022229671478
mutant O 1 0.9060765504837036
mice O 0 0.12798774242401123
. O 0 0.054717663675546646

The O 0 0.05784463882446289
mutant O 1 0.5865750908851624
mice O 0 0.451405793428421
exhibited O 1 0.9610466361045837
defects O 1 0.9999711513519287
in O 0 0.0211916696280241
hemostasis O 1 0.9999959468841553
with O 0 0.013624872080981731
a O 0 0.022702747955918312
highly O 1 0.9931716918945312
prolonged O 1 0.9999998807907104
bleeding O 1 1.0
time O 0 0.021051481366157532
and O 0 0.019239522516727448
spontaneous O 0 0.37182655930519104
bleeding O 1 0.9999959468841553
events O 0 0.017648108303546906
in O 0 0.015008775517344475
approximately O 0 0.01698247715830803
10 O 0 0.022244125604629517
% O 0 0.023727593943476677
of O 0 0.02998322620987892
neonates O 1 0.9861621856689453
. O 0 0.05822400748729706

As O 0 0.026961272582411766
in O 0 0.01632882095873356
the O 0 0.01767856627702713
human O 0 0.023308657109737396
disease O 1 0.9999960660934448
, O 0 0.012946800328791142
the O 0 0.014666205272078514
factor O 1 0.6655325889587402
VIII O 1 0.9999996423721313
level O 0 0.015162970870733261
in O 0 0.010585890151560307
these O 0 0.007617334369570017
mice O 0 0.0172320194542408
was O 0 0.016276339069008827
reduced O 0 0.014328299090266228
strongly O 0 0.013975730165839195
as O 0 0.00949493795633316
a O 0 0.010046741925179958
result O 0 0.008087045513093472
of O 0 0.008343353867530823
the O 0 0.00986037589609623
lack O 0 0.01446281187236309
of O 0 0.014742182567715645
protection O 1 0.8456266522407532
provided O 0 0.03499312326312065
by O 0 0.033779993653297424
vWf O 1 0.9851104021072388
. O 0 0.06072809547185898

Defective O 1 0.9999970197677612
thrombosis B-Disease 1 1.0
in O 0 0.03863217681646347
mutant O 1 0.9987776875495911
mice O 1 0.7902073860168457
was O 0 0.027213439345359802
also O 0 0.0141984261572361
evident O 0 0.017021382227540016
in O 0 0.008944166824221611
an O 0 0.009573843330144882
in O 0 0.011651664972305298
vivo O 0 0.05698208510875702
model O 0 0.03455255925655365
of O 1 0.820853590965271
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 0.17649589478969574

In O 0 0.025727739557623863
this O 0 0.0140387499704957
model O 0 0.026220938190817833
, O 0 0.016451478004455566
the O 0 0.019854960963129997
exteriorized O 1 0.9955163598060608
mesentery O 1 0.9997301697731018
was O 0 0.06915787607431412
superfused O 1 0.9987236857414246
with O 0 0.0521230548620224
ferric O 1 0.9999998807907104
chloride O 1 0.999828577041626
and O 0 0.01924615353345871
the O 0 0.018570249900221825
accumulation O 0 0.047880761325359344
of O 0 0.029583431780338287
fluorescently O 1 0.9999971389770508
labeled O 1 0.9997532963752747
platelets O 1 0.9995611310005188
was O 0 0.03321157395839691
observed O 0 0.023955613374710083
by O 0 0.02124735713005066
intravital O 1 0.9046233892440796
microscopy O 0 0.08716479688882828
. O 0 0.05542757362127304

We O 0 0.031014712527394295
conclude O 0 0.0321187861263752
that O 0 0.011262275278568268
these O 0 0.010524268262088299
mice O 0 0.019323289394378662
very O 0 0.010469011031091213
closely O 0 0.014887351542711258
mimic O 1 0.8596065640449524
severe O 1 0.9999973773956299
human O 1 0.9995730519294739
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 1 0.9942479133605957
will O 0 0.013619771227240562
be O 0 0.008789114654064178
very O 0 0.010073697194457054
useful O 0 0.01124205905944109
for O 0 0.008016292937099934
investigating O 0 0.013475056737661362
the O 0 0.010574150830507278
role O 0 0.015624848194420338
of O 0 0.015118823386728764
vWf O 1 0.9725053906440735
in O 0 0.01384213101118803
normal O 0 0.0200594961643219
physiology O 1 0.9570120573043823
and O 0 0.0175576601177454
in O 0 0.08188947290182114
disease O 1 1.0
models O 0 0.2768252491950989
. O 0 0.025943171232938766
. O 0 0.03590259328484535

Oral O 1 0.9736474752426147
contraceptives O 1 0.9992725253105164
and O 0 0.01931191422045231
the O 0 0.01728871650993824
risk O 1 0.9916250109672546
of O 1 0.9997923970222473
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9995631575584412

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 1.0
Study O 1 0.9652673006057739
Group O 0 0.14204749464988708
. O 0 0.0480329655110836

BACKGROUND O 0 0.058639056980609894
Women O 0 0.03113577328622341
with O 0 0.015377913601696491
mutations O 0 0.01820194162428379
in O 0 0.008733978495001793
either O 0 0.010133998468518257
the O 0 0.014505789615213871
BRCA1 O 1 0.9989702701568604
or O 0 0.012099364772439003
the O 0 0.016846200451254845
BRCA2 O 1 0.9999748468399048
gene O 0 0.012262384407222271
have O 0 0.005470690317451954
a O 0 0.009793083183467388
high O 0 0.01674746535718441
lifetime O 1 0.9943748712539673
risk O 1 0.999900221824646
of O 1 0.9999880790710449
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9302017688751221

Oral O 1 0.8704783916473389
contraceptives O 1 0.9999499320983887
protect O 1 0.9993720650672913
against O 1 0.9999966621398926
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.2867020070552826
general O 0 0.38481777906417847
, O 0 0.012819983065128326
but O 0 0.007749103009700775
it O 0 0.007647024001926184
is O 0 0.007175886072218418
not O 0 0.006075658835470676
known O 0 0.008137340657413006
whether O 0 0.007197058293968439
they O 0 0.005264781415462494
also O 0 0.0070071350783109665
protect O 0 0.014257639646530151
against O 0 0.014916294254362583
hereditary B-Disease 1 0.9999971389770508
forms I-Disease 1 0.9719365835189819
of I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.98897784948349

METHODS O 0 0.04805571213364601
We O 0 0.027784213423728943
enrolled O 0 0.04989806190133095
207 O 0 0.06214015930891037
women O 0 0.024738658219575882
with O 0 0.2754517197608948
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9370759129524231
161 O 1 0.8912648558616638
of O 0 0.013836815021932125
their O 0 0.011146851815283298
sisters O 0 0.027373647317290306
as O 0 0.010942565277218819
controls O 0 0.014342070557177067
in O 0 0.009647364728152752
a O 0 0.014776402153074741
case O 0 0.02311476692557335
- O 1 0.9993627667427063
control O 0 0.032755136489868164
study O 0 0.03370070457458496
. O 0 0.039028383791446686

All O 0 0.02787897177040577
the O 0 0.026797208935022354
patients O 0 0.06548213213682175
carried O 0 0.021572023630142212
a O 0 0.020807191729545593
pathogenic O 0 0.03265924006700516
mutation O 0 0.019199730828404427
in O 0 0.01183930691331625
either O 0 0.01393501739948988
BRCA1 O 1 0.99522864818573
( O 0 0.015477707609534264
179 O 0 0.10385637730360031
women O 0 0.019542451947927475
) O 0 0.016507696360349655
or O 0 0.017784379422664642
BRCA2 O 1 0.9999376535415649
( O 0 0.022077834233641624
28 O 0 0.03780188411474228
women O 0 0.036808986216783524
) O 0 0.03310449793934822
. O 0 0.044236112385988235

The O 0 0.03585454076528549
control O 0 0.03284897282719612
women O 0 0.022004609927535057
were O 0 0.013236604630947113
enrolled O 0 0.02594415843486786
regardless O 0 0.014407671056687832
of O 0 0.010571092367172241
whether O 0 0.010287979617714882
or O 0 0.008283916860818863
not O 0 0.006529727950692177
they O 0 0.007342090364545584
had O 0 0.014364724978804588
either O 0 0.01839466392993927
mutation O 0 0.033675845712423325
. O 0 0.0360906608402729

Lifetime O 0 0.07958601415157318
histories O 0 0.04228004440665245
of O 0 0.025731483474373817
oral O 1 0.9999632835388184
- O 1 0.9999998807907104
contraceptive O 1 0.9999977350234985
use O 0 0.01519643235951662
were O 0 0.011758998967707157
obtained O 0 0.014287639409303665
by O 0 0.009760587476193905
interview O 0 0.016543274745345116
or O 0 0.01016276702284813
by O 0 0.008154514245688915
written O 0 0.011789009906351566
questionnaire O 0 0.01939329318702221
and O 0 0.008347513154149055
were O 0 0.007038905285298824
compared O 0 0.010388893075287342
between O 0 0.009168638847768307
patients O 1 0.761924147605896
and O 0 0.011238602921366692
control O 0 0.11330455541610718
women O 0 0.022611258551478386
, O 0 0.011066574603319168
after O 0 0.013191662728786469
adjustment O 0 0.01979363150894642
for O 0 0.00967406202107668
year O 0 0.014240213669836521
of O 0 0.016408072784543037
birth O 0 0.14680169522762299
and O 0 0.024877099320292473
parity O 1 0.6123789548873901
. O 0 0.0474654845893383

RESULTS O 0 0.04138343036174774
The O 0 0.021998055279254913
adjusted O 0 0.0321684405207634
odds O 0 0.03429405763745308
ratio O 0 0.03204357251524925
for O 1 0.6465622186660767
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 0.034776490181684494
with O 0 0.011498682200908661
any O 0 0.009761357679963112
past O 0 0.012600946240127087
use O 0 0.011391623876988888
of O 0 0.01777029223740101
oral O 1 0.9865381717681885
contraceptives O 1 0.999996542930603
was O 1 0.5200725793838501
0 O 0 0.058516569435596466
. O 0 0.05179882049560547

5 O 0 0.05176521837711334
( O 0 0.029216717928647995
95 O 0 0.03878139331936836
percent O 0 0.02670094184577465
confidence O 0 0.03236778452992439
interval O 0 0.029992220923304558
, O 0 0.016354214400053024
0 O 0 0.02166874147951603
. O 0 0.01063707284629345
3 O 0 0.014608418568968773
to O 0 0.013184220530092716
0 O 0 0.02503180503845215
. O 0 0.016142645850777626
8 O 0 0.03125515580177307
) O 0 0.029978059232234955
. O 0 0.03695811331272125

The O 0 0.03860755264759064
risk O 0 0.3266257345676422
decreased O 0 0.023885071277618408
with O 0 0.012132217176258564
increasing O 0 0.014128868468105793
duration O 0 0.017984451726078987
of O 0 0.01072330866008997
use O 0 0.011728019453585148
( O 0 0.015129136852920055
P O 0 0.03717881813645363
for O 0 0.012579060159623623
trend O 0 0.019330186769366264
, O 0 0.01606532372534275
< O 0 0.06232878193259239
0 O 0 0.02590797282755375
. O 0 0.015660090371966362
001 O 1 0.814043402671814
) O 0 0.013646124862134457
; O 0 0.008793958462774754
use O 0 0.007447611540555954
for O 0 0.007920513860881329
six O 0 0.009636290371418
or O 0 0.007294317241758108
more O 0 0.006827607285231352
years O 0 0.00886143185198307
was O 0 0.011763830669224262
associated O 0 0.008536037057638168
with O 0 0.006714829243719578
a O 0 0.010084087029099464
60 O 0 0.01662129908800125
percent O 0 0.016116756945848465
reduction O 0 0.0224875770509243
in O 0 0.021300116553902626
risk O 0 0.25511595606803894
. O 0 0.03867681324481964

Oral O 1 0.9886248111724854
- O 1 0.9999116659164429
contraceptive O 1 0.9994534850120544
use O 0 0.020448558032512665
protected O 1 0.7566953301429749
against O 1 0.99958735704422
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 0.015524746850132942
for O 0 0.013658094219863415
carriers O 0 0.024057885631918907
of O 0 0.01488883513957262
the O 0 0.018519390374422073
BRCA1 O 1 0.9999685287475586
mutation O 0 0.025012074038386345
( O 0 0.016419710591435432
odds O 0 0.02842448092997074
ratio O 0 0.02069033682346344
, O 0 0.012882258743047714
0 O 0 0.016593201085925102
. O 0 0.009532942436635494
5 O 0 0.011932515539228916
; O 0 0.009491538628935814
95 O 0 0.01992138847708702
percent O 0 0.015837326645851135
confidence O 0 0.020490603521466255
interval O 0 0.02148290164768696
, O 0 0.01290225237607956
0 O 0 0.016873657703399658
. O 0 0.008619650267064571
3 O 0 0.01161253359168768
to O 0 0.00965682789683342
0 O 0 0.017708349972963333
. O 0 0.010823951102793217
9 O 0 0.016937794163823128
) O 0 0.009765672497451305
and O 0 0.007925297133624554
for O 0 0.00919122714549303
carriers O 0 0.01857866533100605
of O 0 0.012031744234263897
the O 0 0.017974598333239555
BRCA2 O 1 0.9999685287475586
mutation O 0 0.027439521625638008
( O 0 0.01689462549984455
odds O 0 0.029707707464694977
ratio O 0 0.021710719913244247
, O 0 0.013763302005827427
0 O 0 0.01740296743810177
. O 0 0.009814075194299221
4 O 0 0.015075254254043102
; O 0 0.010833000764250755
95 O 0 0.022653788328170776
percent O 0 0.01720604859292507
confidence O 0 0.02452036365866661
interval O 0 0.02559361793100834
, O 0 0.014604588970541954
0 O 0 0.017428983002901077
. O 0 0.009749224409461021
2 O 0 0.012730748392641544
to O 0 0.01020002830773592
1 O 0 0.018196003511548042
. O 0 0.013733726926147938
1 O 0 0.026975173503160477
) O 0 0.02895434759557247
. O 0 0.044389646500349045

CONCLUSIONS O 0 0.06348702311515808
Oral O 1 0.9988351464271545
- O 1 0.9999959468841553
contraceptive O 1 0.999996542930603
use O 0 0.015520491637289524
may O 0 0.012455505318939686
reduce O 0 0.016487108543515205
the O 0 0.013997373171150684
risk O 1 0.9615347385406494
of O 1 0.9996805191040039
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.21851025521755219
women O 0 0.047107480466365814
with O 0 0.014462715946137905
pathogenic O 0 0.039699114859104156
mutations O 0 0.020927434787154198
in O 0 0.0158547330647707
the O 0 0.024767296388745308
BRCA1 O 1 0.9999873638153076
or O 0 0.08177313208580017
BRCA2 O 1 0.9999387264251709
gene O 0 0.09376702457666397

A O 0 0.058598849922418594
Japanese O 0 0.060623686760663986
family O 0 0.038184527307748795
with O 0 0.028085239231586456
adrenoleukodystrophy B-Disease 1 0.9999998807907104
with O 0 0.019364995881915092
a O 0 0.023130105808377266
codon O 0 0.0408426895737648
291 O 0 0.054361604154109955
deletion O 0 0.037695251405239105
: O 0 0.017052780836820602
a O 0 0.016266414895653725
clinical O 1 0.9953487515449524
, O 0 0.016619201749563217
biochemical O 1 0.8614464402198792
, O 0 0.018408548086881638
pathological O 1 0.9997239708900452
, O 0 0.018899723887443542
and O 0 0.015563222579658031
genetic O 0 0.025677373632788658
report O 0 0.026574265211820602
. O 0 0.036391038447618484

We O 0 0.022697703912854195
report O 0 0.016187457367777824
a O 0 0.015493781305849552
Japanese O 0 0.026150930672883987
family O 0 0.025770315900444984
with O 0 0.11653169989585876
adrenoleukodystrophy B-Disease 1 1.0
( O 1 0.9999960660934448
ALD B-Disease 1 1.0
) O 0 0.016491832211613655
with O 0 0.010789355263113976
a O 0 0.013439642265439034
three O 0 0.011539805680513382
base O 0 0.028896892443299294
pair O 0 0.03224145248532295
deletion O 0 0.05160883069038391
( O 0 0.022649796679615974
delGAG O 1 0.989940345287323
291 O 0 0.08289045095443726
) O 0 0.019426541402935982
in O 0 0.0216255821287632
the O 0 0.03699624165892601
ALD B-Disease 1 1.0
gene O 0 0.07776757329702377
. O 0 0.05500655248761177

A O 0 0.04650837182998657
variety O 0 0.028748435899615288
of O 0 0.021083099767565727
phenotypes O 0 0.038717955350875854
were O 0 0.012748667038977146
observed O 0 0.013457837514579296
within O 0 0.01343001052737236
this O 0 0.01633140817284584
family O 0 0.03352588787674904
. O 0 0.037334222346544266

While O 0 0.03232390806078911
the O 0 0.02464144676923752
proband O 1 0.999576985836029
( O 0 0.02332128770649433
patient O 1 0.993355393409729
1 O 0 0.02873598225414753
) O 0 0.01249897200614214
was O 0 0.016201457008719444
classified O 0 0.015546916052699089
as O 0 0.00891388114541769
having O 0 0.010769295506179333
a O 0 0.011143708601593971
rare O 0 0.01786217652261257
intermediate O 0 0.0320749394595623
type O 0 0.018500886857509613
of O 0 0.012678629718720913
adult O 0 0.029840553179383278
cerebral O 1 0.9999933242797852
and O 0 0.19721610844135284
cerebello O 1 1.0
- O 1 1.0
brain O 1 0.9999463558197021
stem O 0 0.022931888699531555
forms O 0 0.01129955891519785
, O 0 0.010919401422142982
his O 0 0.017000028863549232
younger O 1 0.6373609304428101
brother O 1 0.8098227977752686
( O 0 0.016405925154685974
patient O 1 0.9610469937324524
2 O 0 0.01998264156281948
) O 0 0.012335088104009628
and O 0 0.013711906969547272
nephew O 1 0.9990000128746033
( O 0 0.01682564802467823
patient O 1 0.9843384623527527
3 O 0 0.019228070974349976
) O 0 0.012847323901951313
had O 0 0.016533775255084038
a O 0 0.06465674191713333
childhood O 1 1.0
ALD B-Disease 1 1.0
type O 1 0.9999810457229614
. O 0 0.053838033229112625

Another O 0 0.06190377101302147
nephew O 1 0.9990600943565369
( O 0 0.029147982597351074
patient O 1 0.9084482789039612
4 O 0 0.02435084618628025
) O 0 0.014601831324398518
of O 0 0.013372059911489487
patient O 1 0.9772811532020569
1 O 0 0.02273084595799446
was O 0 0.01991894282400608
classified O 0 0.01893140748143196
as O 0 0.01244164165109396
having O 0 0.01583767496049404
an O 0 0.021500440314412117
adolescent O 1 0.9999732971191406
form O 0 0.03679746016860008
. O 0 0.04794234409928322

The O 0 0.047923728823661804
tau O 0 0.08057498186826706
level O 0 0.028052883222699165
in O 0 0.01724587008357048
the O 0 0.022582270205020905
cerebrospinal O 1 0.9999927282333374
fluid O 1 0.9998691082000732
( O 1 0.7026009559631348
CSF O 1 0.9999998807907104
) O 0 0.01679975353181362
in O 0 0.01470585074275732
patient O 1 0.6302081942558289
1 O 0 0.018549395725131035
was O 0 0.015014317817986012
as O 0 0.009950256906449795
high O 0 0.011779319494962692
as O 0 0.007183718029409647
that O 0 0.005959656089544296
of O 0 0.010491249151527882
patients O 1 0.9999088048934937
with O 1 0.9999637603759766
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 1 0.9997530579566956
AD B-Disease 1 0.999923825263977
) O 0 0.04621732980012894
. O 0 0.05809018388390541

His O 0 0.09739744663238525
brain O 1 0.7752417922019958
magnetic O 0 0.04022904857993126
resonance O 0 0.04964759573340416
image O 1 0.8455361127853394
( O 0 0.10482796281576157
MRI O 1 0.9999890327453613
) O 0 0.018106110394001007
showed O 0 0.020578887313604355
abnormalities B-Disease 0 0.07943453639745712
in I-Disease 0 0.009397035464644432
the I-Disease 0 0.014329551719129086
bilateral I-Disease 1 0.9486756920814514
cerebellar I-Disease 1 0.9999998807907104
hemispheres I-Disease 1 0.9998639822006226
and O 1 0.9574990272521973
brain O 1 0.9999781847000122
stem O 1 0.5788202285766602
, O 0 0.010296465829014778
but O 0 0.0065551321022212505
not O 0 0.0047893342562019825
in O 0 0.007796300109475851
the O 0 0.013746211305260658
cerebral O 1 0.9999980926513672
white O 1 0.6931893825531006
matter O 0 0.0115773631259799
, O 0 0.010530193336308002
where O 0 0.00948148500174284
marked O 0 0.013400135561823845
reductions O 0 0.017075655981898308
of O 0 0.011577209457755089
the O 0 0.017560143023729324
cerebral O 1 0.9999998807907104
blood O 1 0.9983658194541931
flow O 0 0.019144920632243156
and O 0 0.017489831894636154
oxygen O 1 0.9468160271644592
metabolism O 0 0.09262198954820633
were O 0 0.011280534788966179
clearly O 0 0.016963712871074677
demonstrated O 0 0.019853491336107254
by O 0 0.015377205796539783
positron O 0 0.1516455113887787
emission O 0 0.0466674342751503
tomography O 0 0.06827899068593979
( O 0 0.03590960428118706
PET O 1 0.9879279732704163
) O 0 0.040296636521816254
. O 0 0.04369327425956726

In O 0 0.03563010320067406
patients O 1 0.807338535785675
2 O 0 0.024759652093052864
and O 0 0.012894773855805397
3 O 0 0.017829012125730515
, O 0 0.011808973737061024
the O 0 0.01229711901396513
autopsy O 0 0.025365641340613365
findings O 0 0.016676656901836395
showed O 0 0.02000061608850956
massive O 0 0.4886082708835602
demyelination B-Disease 1 0.9999997615814209
of I-Disease 0 0.03798961639404297
the I-Disease 1 0.9281941056251526
cerebral I-Disease 1 0.9999996423721313
white I-Disease 1 0.5385055541992188
matter I-Disease 0 0.015888359397649765
with O 0 0.01084588561207056
sparing O 0 0.026270555332303047
of O 0 0.012697475962340832
the O 0 0.018665816634893417
U O 1 0.9999998807907104
- O 1 0.9999998807907104
fibers O 1 0.9980140924453735
, O 0 0.013749688863754272
compatible O 0 0.020128421485424042
with O 0 0.009075962007045746
the O 0 0.012968958355486393
findings O 0 0.01914146915078163
of O 0 0.030817417427897453
childhood O 1 0.9999995231628418
ALD B-Disease 1 1.0
. O 0 0.1492081731557846

Oleic O 1 0.9958113431930542
and O 0 0.05572771281003952
erucic O 1 0.9999837875366211
acids O 0 0.047886863350868225
( O 0 0.03086097724735737
Lorenzos O 1 0.9935294985771179
Oil O 0 0.026122333481907845
) O 0 0.013512584380805492
were O 0 0.009086273610591888
administered O 0 0.015052126720547676
to O 0 0.01135267037898302
patients O 0 0.3876170814037323
1 O 0 0.017032921314239502
and O 0 0.010701075196266174
4 O 0 0.017062805593013763
, O 0 0.010771877132356167
but O 0 0.008787319995462894
sufficient O 0 0.017644621431827545
effectiveness O 0 0.03246639296412468
was O 0 0.022778986021876335
not O 0 0.01656961813569069
obtained O 0 0.034112632274627686
. O 0 0.044249095022678375

The O 0 0.03403428941965103
findings O 0 0.023231813684105873
in O 0 0.012766360305249691
this O 0 0.01012273970991373
family O 0 0.015986453741788864
suggest O 0 0.012399833649396896
that O 0 0.009668983519077301
delGAG291 O 0 0.23854023218154907
is O 0 0.010457410477101803
part O 0 0.011174257844686508
of O 0 0.009225874207913876
the O 0 0.011272938922047615
cause O 0 0.041998691856861115
of O 0 0.024259986355900764
Japanese O 1 0.9999853372573853
ALD B-Disease 1 1.0
with O 0 0.0386558398604393
phenotypic O 0 0.22683170437812805
variations O 0 0.05659692361950874
. O 0 0.0562107153236866

Moreover O 0 0.048812638968229294
, O 0 0.018655484542250633
although O 0 0.009961471892893314
the O 0 0.010618743486702442
scale O 0 0.014209295623004436
of O 0 0.009556998498737812
the O 0 0.009288736619055271
study O 0 0.010633716359734535
is O 0 0.009067355655133724
limited O 0 0.011559205129742622
, O 0 0.009633311070501804
there O 0 0.006324623711407185
is O 0 0.007375091779977083
a O 0 0.009997809305787086
possibility O 0 0.012670978903770447
that O 0 0.00889070425182581
PET O 1 0.7076873779296875
can O 0 0.011228084564208984
detect O 0 0.02376522310078144
an O 0 0.01961616612970829
insidious B-Disease 1 0.9999994039535522
lesion I-Disease 1 0.9999997615814209
which O 0 0.01390121504664421
is O 0 0.014324664138257504
undetectable O 1 0.6118929386138916
by O 0 0.011010579764842987
computed O 0 0.024403225630521774
tomogram O 1 0.9991496801376343
( O 0 0.03099079243838787
CT O 1 0.9999945163726807
) O 0 0.01842256635427475
or O 0 0.015614870004355907
MRI O 1 0.892976701259613
analysis O 0 0.015051024965941906
, O 0 0.009919662028551102
and O 0 0.007635229732841253
that O 0 0.005118602886795998
the O 0 0.0069167702458798885
higher O 0 0.010206115432083607
level O 0 0.011343641206622124
of O 0 0.012308534234762192
tau O 0 0.31029295921325684
reflects O 0 0.017672503367066383
the O 0 0.011775955557823181
process O 0 0.012465134263038635
of O 0 0.020098505541682243
neuronal B-Disease 1 0.9991517066955566
degeneration I-Disease 1 1.0
in O 1 0.995130181312561
ALD B-Disease 1 1.0
. O 0 0.10536954551935196

Lorenzos O 1 0.9837265610694885
Oil O 0 0.0439005121588707
should O 0 0.016294321045279503
be O 0 0.009775273501873016
given O 0 0.009798785671591759
in O 0 0.009871192276477814
the O 0 0.011963589116930962
early O 0 0.019931327551603317
stage O 0 0.04258113354444504
. O 0 0.022863321006298065
. O 0 0.03719409927725792

Nonsense O 0 0.11321695148944855
mutation O 0 0.04567749798297882
in O 0 0.024412421509623528
exon O 0 0.05399041250348091
4 O 0 0.023266872391104698
of O 0 0.015299728140234947
human O 0 0.017338521778583527
complement O 1 0.5705252289772034
C9 O 1 0.9999997615814209
gene O 0 0.020879313349723816
is O 0 0.01187131367623806
the O 0 0.011442601680755615
major O 0 0.016567185521125793
cause O 0 0.023099569603800774
of O 0 0.0192264337092638
Japanese O 1 0.9993253946304321
complement B-Disease 1 0.9999862909317017
C9 I-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.08145217597484589

Deficiency B-Disease 1 0.9999995231628418
of I-Disease 0 0.029573719948530197
the I-Disease 0 0.023324696347117424
ninth I-Disease 1 0.992352306842804
component I-Disease 0 0.14712876081466675
of I-Disease 0 0.013880861923098564
human I-Disease 0 0.01484298799186945
complement I-Disease 1 0.742961049079895
( O 0 0.21804656088352203
C9 O 1 0.9999997615814209
) O 0 0.014040947891771793
is O 0 0.009420880116522312
the O 0 0.009569761343300343
most O 0 0.010018590837717056
common O 0 0.018855443224310875
complement B-Disease 1 0.9999920129776001
deficiency I-Disease 1 1.0
in O 0 0.040361836552619934
Japan O 1 0.6672766208648682
but O 0 0.012276194989681244
is O 0 0.012368583120405674
rare O 0 0.01597580499947071
in O 0 0.012987429276108742
other O 0 0.012741552665829659
countries O 0 0.017846915870904922
. O 0 0.037160251289606094

We O 0 0.02987491525709629
studied O 0 0.02666766382753849
the O 0 0.01642209105193615
molecular O 0 0.023506954312324524
basis O 0 0.01452724914997816
of O 0 0.026444490998983383
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.016985954716801643
four O 0 0.01818874664604664
Japanese O 1 0.9894524812698364
C9 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.999998927116394
patients O 1 0.9994451403617859
who O 0 0.15363435447216034
had O 1 0.9299993515014648
suffered O 1 1.0
from O 1 0.9999818801879883
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 1 0.988252580165863

Direct O 0 0.06112297251820564
sequencing O 0 0.06504511833190918
of O 0 0.04167022183537483
amplified O 0 0.09706313908100128
C9 O 1 0.9997648596763611
cDNA O 0 0.07571616768836975
and O 0 0.028810134157538414
DNA O 0 0.028552483767271042
revealed O 0 0.02373417653143406
a O 0 0.020316964015364647
nonsense O 0 0.04167367145419121
substitution O 0 0.03490961343050003
( O 0 0.027621183544397354
CGA O 1 0.7553548216819763
- O 1 0.9999576807022095
- O 1 0.9999868869781494
> O 1 0.9994868040084839
TGA O 1 0.9999533891677856
) O 0 0.025366952642798424
at O 0 0.025286827236413956
codon O 0 0.03617337718605995
95 O 0 0.034436773508787155
in O 0 0.01770147494971752
exon O 0 0.04799719899892807
4 O 0 0.019882535561919212
in O 0 0.010746526531875134
the O 0 0.014172392897307873
four O 0 0.027689777314662933
C9 B-Disease 1 1.0
- I-Disease 1 0.9999982118606567
deficient I-Disease 1 0.9997068047523499
individuals O 0 0.03467772156000137
. O 0 0.052137572318315506

An O 0 0.049697231501340866
allele O 0 0.07382932305335999
- O 1 0.8029110431671143
specific O 0 0.023701263591647148
polymerase O 0 0.06685959547758102
chain O 0 0.0382414273917675
reaction O 0 0.02289808727800846
system O 0 0.01831023022532463
designed O 0 0.026617880910634995
to O 0 0.014654741622507572
detect O 0 0.022008737549185753
exclusively O 0 0.013966817408800125
only O 0 0.007702939677983522
one O 0 0.007598678581416607
of O 0 0.007334485650062561
the O 0 0.00891242828220129
normal O 0 0.01130165159702301
and O 0 0.011769820936024189
mutant O 0 0.034161292016506195
alleles O 0 0.019096756353974342
indicated O 0 0.011888721026480198
that O 0 0.00608645798638463
all O 0 0.006166285369545221
the O 0 0.009379169903695583
four O 0 0.012637569569051266
patients O 0 0.06045613810420036
were O 0 0.010827872902154922
homozygous O 0 0.019952496513724327
for O 0 0.010978157632052898
the O 0 0.012955847196280956
mutation O 0 0.018432753160595894
in O 0 0.012942871078848839
exon O 0 0.04411116614937782
4 O 0 0.0185809675604105
and O 0 0.009606299921870232
that O 0 0.006970047019422054
the O 0 0.010198493488132954
parents O 0 0.012858311645686626
of O 0 0.01253578532487154
patient O 1 0.9964072108268738
2 O 0 0.029797552153468132
were O 0 0.022830883041024208
heterozygous O 0 0.052385326474905014
. O 0 0.044974569231271744

The O 0 0.04050108417868614
common O 0 0.027138318866491318
mutation O 0 0.02671889215707779
at O 0 0.01998882368206978
codon O 0 0.03140499070286751
95 O 0 0.030100690200924873
in O 0 0.01738879270851612
exon O 0 0.052148737013339996
4 O 0 0.020484229549765587
might O 0 0.013080531731247902
be O 0 0.008880986832082272
responsible O 0 0.01118553802371025
for O 0 0.010102362371981144
most O 0 0.016336197033524513
Japanese O 1 0.9998947381973267
C9 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 0.05232223495841026
. O 0 0.0530024953186512

BRCA1 O 1 0.8013210892677307
required O 0 0.026970868930220604
for O 0 0.02129330486059189
transcription O 0 0.051676347851753235
- O 1 0.9996778964996338
coupled O 0 0.16374750435352325
repair O 1 0.9963964819908142
of O 0 0.03412702679634094
oxidative O 1 0.9997085928916931
DNA O 0 0.15609678626060486
damage O 1 0.9704381227493286
. O 0 0.0493149608373642

The O 0 0.1756029725074768
breast B-Disease 1 1.0
and I-Disease 1 0.9997876286506653
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 1 1.0
gene O 1 0.9952415227890015
BRCA1 O 1 0.9999973773956299
encodes O 0 0.06653047353029251
a O 0 0.05457978695631027
zinc O 1 0.9999970197677612
finger O 1 0.9267603158950806
protein O 0 0.02440059371292591
of O 0 0.021099502220749855
unknown O 0 0.02789382077753544
function O 0 0.028379373252391815
. O 0 0.040504615753889084

Association O 0 0.043648939579725266
of O 0 0.0217041727155447
the O 0 0.023646866902709007
BRCA1 O 1 0.999616265296936
protein O 0 0.017767859622836113
with O 0 0.010368832387030125
the O 0 0.013952154666185379
DNA O 0 0.027548519894480705
repair O 1 0.9997159838676453
protein O 0 0.03393176943063736
Rad51 O 1 0.9935626983642578
and O 0 0.013606186024844646
changes O 0 0.012338669039309025
in O 0 0.01000643614679575
the O 0 0.01218042429536581
phosphorylation O 0 0.020382363349199295
and O 0 0.013579269871115685
cellular O 0 0.03029145672917366
localization O 0 0.027891624718904495
of O 0 0.013478416018188
the O 0 0.012941933237016201
protein O 0 0.016394980251789093
after O 0 0.01514365803450346
exposure O 0 0.018856007605791092
to O 0 0.011471386067569256
DNA O 0 0.022245392203330994
- O 1 0.9878042936325073
damaging O 0 0.03154744952917099
agents O 0 0.014183003455400467
are O 0 0.0070467484183609486
consistent O 0 0.011167110875248909
with O 0 0.009158037602901459
a O 0 0.011725831776857376
role O 0 0.015359210781753063
for O 0 0.016561096534132957
BRCA1 O 1 0.999833345413208
in O 0 0.022310156375169754
DNA O 0 0.04791170731186867
repair O 1 0.9978439807891846
. O 0 0.05541344732046127

Here O 0 0.031781554222106934
, O 0 0.016596803441643715
it O 0 0.00885507371276617
is O 0 0.008736489340662956
shown O 0 0.008816507644951344
that O 0 0.007143545895814896
mouse O 0 0.03125438466668129
embryonic O 0 0.03546878695487976
stem O 0 0.1661861687898636
cells O 0 0.029930898919701576
deficient B-Disease 1 0.9939888715744019
in I-Disease 0 0.019770469516515732
BRCA1 I-Disease 1 0.9999922513961792
are O 0 0.009799646213650703
defective O 1 0.8744769096374512
in O 0 0.008376887999475002
the O 0 0.008981005288660526
ability O 0 0.009567959234118462
to O 0 0.007830197922885418
carry O 0 0.010676892474293709
out O 0 0.011935872957110405
transcription O 0 0.023108556866645813
- O 1 0.9971373081207275
coupled O 0 0.060728203505277634
repair O 1 0.9702281355857849
of O 0 0.018776794895529747
oxidative O 1 0.9987635612487793
DNA O 0 0.036904674023389816
damage O 1 0.8941929340362549
, O 0 0.013739335350692272
and O 0 0.010841424576938152
are O 0 0.009488007053732872
hypersensitive O 1 0.9990203380584717
to O 0 0.025026660412549973
ionizing O 1 0.9998714923858643
radiation O 1 0.9991783499717712
and O 0 0.03989029675722122
hydrogen O 1 0.693884015083313
peroxide O 1 0.9958048462867737
. O 0 0.06157546490430832

These O 0 0.02213897742331028
results O 0 0.020472809672355652
suggest O 0 0.01831892877817154
that O 0 0.013176318258047104
BRCA1 O 1 0.9981233477592468
participates O 0 0.030971679836511612
, O 0 0.013163745403289795
directly O 0 0.010963868349790573
or O 0 0.00895217526704073
indirectly O 0 0.013960633426904678
, O 0 0.008730362169444561
in O 0 0.00921330414712429
transcription O 0 0.040419261902570724
- O 1 0.9997193217277527
coupled O 1 0.6970450282096863
repair O 1 0.9984732270240784
of O 0 0.026370028033852577
oxidative O 1 0.9998397827148438
DNA O 0 0.20055422186851501
damage O 1 0.9823439121246338
. O 0 0.027337586507201195
. O 0 0.04086819663643837

Truncation O 1 0.6566452980041504
mutations O 0 0.03922560065984726
in O 0 0.01832130365073681
the O 0 0.020225822925567627
transactivation O 1 0.9754942655563354
region O 0 0.02220778353512287
of O 0 0.021274132654070854
PAX6 O 1 0.9999958276748657
result O 0 0.02065959759056568
in O 0 0.02025974541902542
dominant O 1 0.8947983384132385
- O 1 0.9999531507492065
negative O 0 0.04837987199425697
mutants O 0 0.10421951115131378
. O 0 0.059033144265413284

PAX6 O 1 0.9992542862892151
is O 0 0.03207520395517349
a O 0 0.029813755303621292
transcription O 0 0.032836154103279114
factor O 0 0.020739339292049408
with O 0 0.011738044209778309
two O 0 0.011608889326453209
DNA O 0 0.020811619237065315
- O 1 0.8545960783958435
binding O 0 0.021814236417412758
domains O 0 0.025887906551361084
( O 0 0.02017293870449066
paired O 0 0.0432560034096241
box O 0 0.2541981339454651
and O 0 0.02124181017279625
homeobox O 1 0.9928619265556335
) O 0 0.01771688647568226
and O 0 0.0139478649944067
a O 0 0.021403400227427483
proline O 1 0.8861029148101807
- O 1 0.999846339225769
serine O 1 0.7330895662307739
- O 1 0.9996922016143799
threonine O 1 0.8602798581123352
( O 0 0.03180672973394394
PST O 1 0.9998419284820557
) O 0 0.037077851593494415
- O 1 0.9347230195999146
rich O 0 0.059150345623493195
transactivation O 1 0.9485719799995422
domain O 0 0.07058436423540115
. O 0 0.05925917625427246

PAX6 O 1 0.9999933242797852
regulates O 1 0.9635537266731262
eye O 1 0.998542070388794
development O 0 0.02475137449800968
in O 0 0.01504922192543745
animals O 0 0.013323484919965267
ranging O 0 0.016083667054772377
from O 0 0.0132897412404418
jellyfish O 0 0.03652399405837059
to O 0 0.016249433159828186
Drosophila O 0 0.0429370291531086
to O 0 0.022351685911417007
humans O 0 0.030611887574195862
. O 0 0.042444661259651184

Heterozygous O 0 0.09139101207256317
mutations O 0 0.03623722493648529
in O 0 0.016700146719813347
the O 0 0.01772153563797474
human O 0 0.0220941249281168
PAX6 O 1 0.9999990463256836
gene O 0 0.02297651208937168
result O 0 0.013302410021424294
in O 0 0.010069693438708782
various O 0 0.0098745571449399
phenotypes O 0 0.025377454236149788
, O 0 0.010898112319409847
including O 0 0.014983327127993107
aniridia B-Disease 1 0.9999997615814209
, O 0 0.17839500308036804
Peters B-Disease 1 0.999984860420227
anomaly I-Disease 1 0.9999351501464844
, O 0 0.0499882698059082
autosomal B-Disease 1 0.9999517202377319
dominant I-Disease 1 0.999984860420227
keratitis I-Disease 1 1.0
, O 1 0.9357053637504578
and O 1 0.9819682240486145
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.7163166403770447

It O 0 0.027424000203609467
is O 0 0.019795440137386322
believed O 0 0.01861504092812538
that O 0 0.009939477778971195
the O 0 0.016037505120038986
mutated O 0 0.037059299647808075
allele O 0 0.0368301123380661
of O 0 0.02448161132633686
PAX6 O 1 0.9999892711639404
produces O 0 0.03110184334218502
an O 0 0.017213601619005203
inactive O 1 0.7297534346580505
protein O 0 0.024144472554326057
and O 0 0.018587717786431313
aniridia B-Disease 1 0.9999889135360718
is O 0 0.018843036144971848
caused O 0 0.03044893592596054
due O 0 0.0201983954757452
to O 0 0.025734925642609596
genetic O 0 0.049915265291929245
haploinsufficiency O 1 0.9958475232124329
. O 0 0.05887502431869507

However O 0 0.026616238057613373
, O 0 0.016756301745772362
several O 0 0.014002678915858269
truncation O 0 0.20403482019901276
mutations O 0 0.017485156655311584
have O 0 0.007200322579592466
been O 0 0.007720023859292269
found O 0 0.007331848610192537
to O 0 0.007171745877712965
occur O 0 0.006098353769630194
in O 0 0.0073371464386582375
the O 0 0.011162597686052322
C O 1 0.9910463690757751
- O 1 0.998532772064209
terminal O 0 0.03659389168024063
half O 0 0.015506749972701073
of O 0 0.01584460400044918
PAX6 O 1 0.9999713897705078
in O 0 0.018511764705181122
patients O 1 0.9748465418815613
with O 0 0.016714151948690414
Aniridia B-Disease 1 0.9999986886978149
resulting O 0 0.022207295522093773
in O 0 0.01499709952622652
mutant O 0 0.030752455815672874
proteins O 0 0.011596312746405602
that O 0 0.00645121606066823
retain O 0 0.018096180632710457
the O 0 0.011268548667430878
DNA O 0 0.019913118332624435
- O 1 0.9777365326881409
binding O 0 0.017409229651093483
domains O 0 0.015084822662174702
but O 0 0.007766942493617535
have O 0 0.00689493864774704
lost O 0 0.01501652505248785
most O 0 0.008592079393565655
of O 0 0.011683577671647072
the O 0 0.01931365393102169
transactivation O 1 0.9996916055679321
domain O 0 0.05986688286066055
. O 0 0.04516240581870079

It O 0 0.02355521358549595
is O 0 0.014856256544589996
not O 0 0.008366191759705544
clear O 0 0.011233856901526451
whether O 0 0.008240469731390476
such O 0 0.009685233235359192
mutants O 0 0.03666892647743225
really O 0 0.016137588769197464
behave O 0 0.014443236403167248
as O 0 0.010619211941957474
loss O 0 0.343512624502182
- O 1 0.9997690320014954
of O 0 0.019462507218122482
- O 1 0.9999418258666992
function O 0 0.02137598767876625
mutants O 0 0.042747076600790024
as O 0 0.021360548213124275
predicted O 0 0.04127868637442589
by O 0 0.031738828867673874
haploinsufficiency O 1 0.9012081027030945
. O 0 0.0623864121735096

Contrary O 0 0.041229840368032455
to O 0 0.016792036592960358
this O 0 0.010568464174866676
theory O 0 0.014691720716655254
, O 0 0.011102505028247833
our O 0 0.009683889336884022
data O 0 0.010280641727149487
showed O 0 0.01158865261822939
that O 0 0.005947481840848923
these O 0 0.006819955073297024
mutants O 0 0.021582815796136856
are O 0 0.008413033559918404
dominant O 0 0.07359223067760468
- O 1 0.9963594079017639
negative O 0 0.019710272550582886
in O 0 0.018012193962931633
transient O 1 0.9090544581413269
transfection O 1 0.997025191783905
assays O 0 0.03313938528299332
when O 0 0.01259346678853035
they O 0 0.007370536681264639
are O 0 0.006495988927781582
coexpressed O 0 0.037254784256219864
with O 0 0.012571800500154495
wild O 0 0.04212099686264992
- O 1 0.9999961853027344
type O 1 0.9714632034301758
PAX6 O 1 0.9999819993972778
. O 0 0.06435734033584595

We O 0 0.024257387965917587
found O 0 0.011523248627781868
that O 0 0.007149473764002323
the O 0 0.011229240335524082
dominant O 1 0.7704535126686096
- O 1 0.9999290704727173
negative O 0 0.01729356311261654
effects O 0 0.019317224621772766
result O 0 0.00993875041604042
from O 0 0.008591974154114723
the O 0 0.011422899551689625
enhanced O 0 0.025207186117768288
DNA O 0 0.02030297741293907
binding O 0 0.017492232844233513
ability O 0 0.015624649822711945
of O 0 0.016270339488983154
these O 0 0.015954675152897835
mutants O 0 0.07097157835960388
. O 0 0.04650958627462387

Kinetic O 0 0.09011567384004593
studies O 0 0.0340033695101738
of O 0 0.021911311894655228
binding O 0 0.026821130886673927
and O 0 0.020500874146819115
dissociation O 0 0.06795206665992737
revealed O 0 0.021077845245599747
that O 0 0.010125448927283287
various O 0 0.011423436924815178
truncation O 0 0.04010585695505142
mutants O 0 0.0323650985956192
have O 0 0.009935207664966583
3 O 0 0.02126927673816681
- O 1 0.6976417899131775
5 O 0 0.02488398179411888
- O 1 0.7327234745025635
fold O 0 0.0354311540722847
higher O 0 0.01611251011490822
affinity O 0 0.01635723002254963
to O 0 0.009335745126008987
various O 0 0.009839940816164017
DNA O 0 0.017047226428985596
- O 0 0.14774921536445618
binding O 0 0.015418571420013905
sites O 0 0.01233779639005661
when O 0 0.009438777342438698
compared O 0 0.010692284442484379
with O 0 0.008752004243433475
the O 0 0.013024539686739445
wild O 0 0.032304566353559494
- O 1 0.99998939037323
type O 1 0.9786497354507446
PAX6 O 1 0.9999871253967285
. O 0 0.056649722158908844

These O 0 0.02372528612613678
results O 0 0.018857579678297043
provide O 0 0.01596922054886818
a O 0 0.015392431989312172
new O 0 0.018259378150105476
insight O 0 0.03152582421898842
into O 0 0.01358757447451353
the O 0 0.012489717453718185
role O 0 0.018189189955592155
of O 0 0.021111637353897095
mutant O 1 0.8783069849014282
PAX6 O 1 0.999997615814209
in O 0 0.04114534333348274
causing O 1 0.9930397272109985
aniridia B-Disease 1 0.9999904632568359
. O 0 0.04161275550723076
. O 0 0.057718053460121155

Reversal O 0 0.22551146149635315
of O 1 0.9291982054710388
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 1 0.9999579191207886
excellent O 1 0.999819815158844
neuropsychologic O 1 0.9998691082000732
outcome O 0 0.019214434549212456
in O 0 0.011923029087483883
very B-Disease 0 0.012784138321876526
- I-Disease 1 0.9907006025314331
long I-Disease 0 0.025336571037769318
- I-Disease 1 0.9998990297317505
chain I-Disease 1 0.6242244839668274
acyl I-Disease 1 0.9996315240859985
- I-Disease 1 0.9999724626541138
coenzyme I-Disease 1 0.9996291399002075
A I-Disease 1 0.999864935874939
dehydrogenase I-Disease 1 0.9999970197677612
deficiency I-Disease 1 1.0
. O 0 0.07277809828519821

Very B-Disease 0 0.042378686368465424
- I-Disease 1 0.98084557056427
long I-Disease 0 0.03696244955062866
- I-Disease 1 0.9993459582328796
chain I-Disease 1 0.6072896122932434
acyl I-Disease 1 0.9986810088157654
- I-Disease 1 0.9998132586479187
coenzyme I-Disease 1 0.9149197340011597
A I-Disease 1 0.7919004559516907
dehydrogenase I-Disease 1 0.9952595829963684
( I-Disease 0 0.03235278278589249
VLCAD I-Disease 1 0.9999998807907104
) I-Disease 0 0.4638158977031708
deficiency I-Disease 1 1.0
is O 0 0.013846565037965775
a O 0 0.15954282879829407
disorder O 1 1.0
of O 1 0.9998047947883606
fatty O 1 1.0
acid O 1 0.9999980926513672
beta O 1 0.9973219037055969
oxidation O 0 0.02624058723449707
that O 0 0.010273963212966919
reportedly O 0 0.0217620637267828
has O 0 0.011308388784527779
high O 0 0.01894179731607437
rates O 0 0.018950968980789185
of O 0 0.019879072904586792
morbidity O 1 0.9999964237213135
and O 0 0.21924252808094025
mortality O 1 0.9996597766876221
. O 0 0.057354167103767395

We O 0 0.026410508900880814
describe O 0 0.023745128884911537
the O 0 0.012730010785162449
outcome O 0 0.014539364725351334
of O 0 0.00981795322149992
a O 0 0.013133526779711246
5 O 0 0.017920348793268204
- O 1 0.703184962272644
year O 0 0.01745140179991722
- O 1 0.9661656022071838
old O 0 0.033814188092947006
girl O 0 0.14182229340076447
with O 0 0.039946746081113815
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 1 0.7668577432632446
was O 0 0.018119866028428078
first O 0 0.013022572733461857
seen O 0 0.011919710785150528
at O 0 0.011088268831372261
5 O 0 0.01106349565088749
months O 0 0.009106961078941822
of O 0 0.008361374959349632
age O 0 0.013360013253986835
with O 0 0.030674580484628677
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 1.0
hepatomegaly B-Disease 1 1.0
, O 1 0.9999998807907104
encephalopathy B-Disease 1 1.0
, O 1 0.9994970560073853
and O 1 0.9464812874794006
hypotonia B-Disease 1 0.9999986886978149
. O 0 0.07105538249015808

Biochemical O 0 0.14063818752765656
studies O 0 0.043069902807474136
indicated O 1 0.982698917388916
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 1 0.9995139837265015
by O 0 0.015903323888778687
a O 0 0.06318331509828568
stable O 1 0.9943812489509583
yet O 0 0.04193469509482384
inactive O 1 0.9967018961906433
enzyme O 0 0.07174773514270782
. O 0 0.05472920835018158

Molecular O 0 0.06275992095470428
genetic O 0 0.030118606984615326
analysis O 0 0.01766030676662922
of O 0 0.017456956207752228
her O 0 0.03972804918885231
VLCAD O 1 0.9999982118606567
gene O 0 0.02180860936641693
revealed O 0 0.02190161496400833
a O 0 0.02211814746260643
T1372C O 1 0.9928205609321594
( O 0 0.026619767770171165
F458L O 1 0.7909262180328369
) O 0 0.027603665366768837
missense O 0 0.05711036175489426
mutation O 0 0.028547629714012146
and O 0 0.01962423510849476
a O 0 0.032321538776159286
1668 O 1 0.9999914169311523
ACAG O 1 0.999997615814209
1669 O 1 0.9999957084655762
splice O 1 0.9831178188323975
site O 0 0.07528756558895111
mutation O 0 0.06556728482246399
. O 0 0.05800637975335121

After O 0 0.04459487646818161
initial O 0 0.036837656050920486
treatment O 1 0.8314232230186462
with O 0 0.027354389429092407
intravenous O 1 0.9999998807907104
glucose O 1 0.9998358488082886
and O 0 0.054694440215826035
carnitine O 1 0.9999991655349731
, O 0 0.017577730119228363
the O 0 0.015983404591679573
patient O 1 0.8554539680480957
has O 0 0.013685500249266624
thrived O 0 0.03157591447234154
on O 0 0.01070886105298996
a O 0 0.015215298160910606
low O 0 0.1413860321044922
- O 1 0.9998084902763367
fat O 0 0.1556393802165985
diet O 0 0.03857377916574478
supplemented O 0 0.027478983625769615
with O 0 0.01565062627196312
medium O 0 0.05840759351849556
- O 1 0.9998441934585571
chain O 0 0.2243470549583435
triglyceride O 0 0.16934964060783386
oil O 0 0.028657222166657448
and O 0 0.023157399147748947
carnitine O 1 0.9999593496322632
and O 0 0.02913247048854828
avoidance O 1 0.9998292922973633
of O 0 0.04904302582144737
fasting O 1 0.9440011978149414
. O 0 0.05834382027387619

Her O 1 0.9980733394622803
ventricular O 1 1.0
hypertrophy O 1 0.9999997615814209
resolved O 0 0.04476529359817505
significantly O 0 0.023223182186484337
over O 0 0.015375293791294098
1 O 0 0.019024904817342758
year O 0 0.013921997509896755
, O 0 0.013210173696279526
and O 0 0.014620174653828144
cognitively O 1 0.9998815059661865
, O 0 0.01463440153747797
she O 0 0.014771319925785065
is O 0 0.009504548273980618
in O 0 0.008773094043135643
the O 0 0.012399282306432724
superior O 0 0.023838145658373833
range O 0 0.018770918250083923
for O 0 0.01914815790951252
age O 0 0.036694083362817764
. O 0 0.04163451865315437

Clinical O 1 0.5970205068588257
recognition O 0 0.07757662981748581
of O 1 0.9990803003311157
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 1 0.5642391443252563
important O 0 0.014514747075736523
because O 0 0.008511403575539589
it O 0 0.006892800331115723
is O 0 0.006451072636991739
one O 0 0.0065866634249687195
of O 0 0.005879167467355728
the O 0 0.008121754974126816
few O 0 0.0108922328799963
directly O 0 0.019487712532281876
treatable O 1 1.0
causes O 1 0.9999309778213501
of O 1 0.9998137354850769
cardiomyopathy B-Disease 1 1.0
in O 1 0.9987379908561707
children O 1 0.9742088913917542
. O 0 0.028500841930508614
. O 0 0.04314519464969635

Cloning O 0 0.07219795137643814
of O 0 0.02538619376718998
a O 0 0.02012234553694725
novel O 0 0.024315422400832176
member O 0 0.01481835450977087
of O 0 0.01110877376049757
the O 0 0.015278666280210018
low O 0 0.33887550234794617
- O 1 0.9999871253967285
density O 0 0.17078091204166412
lipoprotein O 1 0.9999903440475464
receptor O 0 0.11613564193248749
family O 0 0.05363460257649422
. O 0 0.0546012707054615

A O 0 0.05236120522022247
gene O 0 0.030709082260727882
encoding O 0 0.02399013377726078
a O 0 0.022766053676605225
novel O 0 0.035898275673389435
transmembrane O 1 0.5348014235496521
protein O 0 0.02218874916434288
was O 0 0.017768552526831627
identified O 0 0.01352167408913374
by O 0 0.007799492217600346
DNA O 0 0.01126629114151001
sequence O 0 0.006860517431050539
analysis O 0 0.006360357161611319
within O 0 0.00688909599557519
the O 0 0.011861025355756283
insulin B-Disease 1 0.9999972581863403
- I-Disease 1 0.9999998807907104
dependent I-Disease 1 0.999945878982544
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 1 0.9939702749252319
IDDM B-Disease 1 0.9999994039535522
) O 0 0.04110748693346977
locus O 1 0.9494518041610718
IDDM4 O 1 0.999824583530426
on O 0 0.04284394904971123
chromosome O 0 0.10000205785036087
11q13 O 1 0.8893219828605652
. O 0 0.07417283207178116

Based O 0 0.02927495911717415
on O 0 0.018063994124531746
its O 0 0.0188920721411705
chromosomal O 0 0.12036073207855225
position O 0 0.01876096986234188
, O 0 0.0125056067481637
this O 0 0.00928160548210144
gene O 0 0.012733655981719494
is O 0 0.008405606262385845
a O 0 0.010873407125473022
candidate O 0 0.017105020582675934
for O 0 0.014366965740919113
conferring O 1 0.9696478843688965
susceptibility O 1 0.9999853372573853
to O 0 0.42370840907096863
diabetes B-Disease 1 1.0
. O 0 0.060434285551309586

The O 0 0.0378636009991169
gene O 0 0.030367931351065636
, O 0 0.01722327433526516
termed O 0 0.03251122683286667
low O 0 0.04016600921750069
- O 1 0.9991969466209412
density O 0 0.034212253987789154
lipoprotein O 1 0.9993878602981567
receptor O 0 0.03592458739876747
related O 0 0.02201230451464653
protein O 0 0.022556377574801445
5 O 0 0.026421433314681053
( O 0 0.02394755370914936
LRP5 O 1 0.9989751577377319
) O 0 0.018347028642892838
, O 0 0.017062652856111526
encodes O 0 0.024140140041708946
a O 0 0.017241887748241425
protein O 0 0.018823616206645966
of O 0 0.017276667058467865
1615 O 1 0.581880509853363
amino O 0 0.02632446214556694
acids O 0 0.017186233773827553
that O 0 0.00920659489929676
contains O 0 0.016216019168496132
conserved O 0 0.01987350918352604
modules O 0 0.024254998192191124
which O 0 0.008749672211706638
are O 0 0.005247319582849741
characteristic O 0 0.00901242345571518
of O 0 0.006304135546088219
the O 0 0.00960294809192419
low O 1 0.5257397294044495
- O 1 0.9999963045120239
density O 0 0.24685809016227722
lipoprotein O 1 0.9999991655349731
( O 0 0.49969515204429626
LDL O 1 0.9999995231628418
) O 0 0.03443107753992081
receptor O 0 0.06251822412014008
family O 0 0.05004807189106941
. O 0 0.04920373857021332

These O 0 0.03462575748562813
modules O 0 0.06273389607667923
include O 0 0.025392554700374603
a O 0 0.026214808225631714
putative O 0 0.07303864508867264
signal O 0 0.0314357690513134
peptide O 0 0.03162936866283417
for O 0 0.0141602186486125
protein O 0 0.016126591712236404
export O 0 0.015959106385707855
, O 0 0.012200027704238892
four O 0 0.016062891110777855
epidermal O 1 0.9902979731559753
growth O 0 0.0330711230635643
factor O 0 0.07817469537258148
( O 0 0.028892425820231438
EGF O 1 0.9999725818634033
) O 0 0.019164256751537323
repeats O 0 0.026999464258551598
with O 0 0.013242870569229126
associated O 0 0.017055569216609
spacer O 0 0.15470755100250244
domains O 0 0.024031532928347588
, O 0 0.01506586093455553
three O 0 0.02045111358165741
LDL O 1 0.9999995231628418
- O 1 0.9999977350234985
receptor O 0 0.14233596622943878
( O 0 0.025610437616705894
LDLR O 1 0.9994401335716248
) O 0 0.020955007523298264
repeats O 0 0.029282329604029655
, O 0 0.015478131361305714
a O 0 0.017032712697982788
single O 0 0.024100519716739655
transmembrane O 0 0.06194932013750076
spanning O 0 0.03541755676269531
domain O 0 0.0256436038762331
, O 0 0.017700446769595146
and O 0 0.017167415469884872
a O 0 0.027400176972150803
cytoplasmic O 0 0.07447922229766846
domain O 0 0.055882155895233154
. O 0 0.04921133816242218

The O 0 0.03871597722172737
encoded O 0 0.03253015875816345
protein O 0 0.02491220459342003
has O 0 0.015252852812409401
a O 0 0.014868468046188354
unique O 0 0.015326578170061111
organization O 0 0.01824137754738331
of O 0 0.018336355686187744
EGF O 1 0.999998927116394
and O 0 0.03840664401650429
LDLR O 1 0.9999986886978149
repeats O 0 0.05453005060553551
; O 0 0.017089273780584335
therefore O 0 0.014526660554111004
, O 0 0.016290102154016495
LRP5 O 1 0.9959174990653992
likely O 0 0.01801939681172371
represents O 0 0.01640634797513485
a O 0 0.01333254761993885
new O 0 0.0156972985714674
category O 0 0.020794525742530823
of O 0 0.014517312869429588
the O 0 0.02296784706413746
LDLR O 1 0.9999953508377075
family O 0 0.06697490066289902
. O 0 0.04539655148983002

Both O 0 0.029438002035021782
human O 0 0.02397065795958042
and O 0 0.02324891835451126
mouse O 1 0.9450573921203613
LRP5 O 1 0.9999991655349731
cDNAs O 1 0.9993736147880554
have O 0 0.013847893103957176
been O 0 0.012135387398302555
isolated O 0 0.016474425792694092
and O 0 0.01046848390251398
the O 0 0.01263414230197668
encoded O 0 0.015787214040756226
mature O 0 0.020234866067767143
proteins O 0 0.012522134929895401
are O 0 0.00616393331438303
95 O 0 0.019208325073122978
% O 0 0.013348829001188278
identical O 0 0.016245651990175247
, O 0 0.010852158069610596
indicating O 0 0.01399749144911766
a O 0 0.012455910444259644
high O 0 0.016406618058681488
degree O 0 0.01766929402947426
of O 0 0.015917040407657623
evolutionary O 0 0.02968580834567547
conservation O 0 0.03876489773392677
. O 0 0.028083987534046173
. O 0 0.03914480283856392

The O 0 0.060022998601198196
APC B-Disease 1 0.999842643737793
variants O 0 0.049666691571474075
I1307K O 1 0.6699584126472473
and O 0 0.01914859190583229
E1317Q O 0 0.14468054473400116
are O 0 0.009813718497753143
associated O 0 0.018305353820323944
with O 1 0.998995840549469
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.8565875291824341
but O 0 0.01037875097244978
not O 0 0.009171386249363422
always O 0 0.013333425857126713
with O 0 0.01014434453099966
a O 0 0.01922963745892048
family O 0 0.027104489505290985
history O 0 0.03624958172440529
. O 0 0.04053384065628052

Classical O 0 0.15936659276485443
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999908208847046
FAP B-Disease 1 1.0
) O 0 0.021959714591503143
is O 0 0.012024972587823868
a O 0 0.014534970745444298
high O 0 0.07958966493606567
- O 1 0.9999923706054688
penetrance O 1 0.9999985694885254
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.9999969005584717
disease I-Disease 1 1.0
that O 0 0.014384720474481583
predisposes O 1 0.9990052580833435
to O 0 0.011662454344332218
hundreds O 0 0.012745500542223454
or O 0 0.008382966741919518
thousands O 0 0.015376151539385319
of O 1 0.9777536392211914
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
and O 0 0.09023115038871765
that O 0 0.00993143767118454
results O 0 0.015290558338165283
from O 0 0.014666921459138393
truncating O 0 0.1803424209356308
mutations O 0 0.02296336181461811
in O 0 0.018103301525115967
the O 0 0.029868945479393005
APC B-Disease 1 0.9999802112579346
gene O 0 0.05316908657550812
. O 0 0.0501934178173542

A O 0 0.057178035378456116
variant O 0 0.05616921931505203
of O 0 0.03680292144417763
FAP B-Disease 1 1.0
is O 1 0.8452762961387634
attenuated B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 0.022232061251997948
which O 0 0.011126130819320679
results O 0 0.011712167412042618
from O 0 0.014375969767570496
germ O 1 0.9999979734420776
- O 1 0.9999780654907227
line O 0 0.023483432829380035
mutations O 0 0.012296372093260288
in O 0 0.00890578143298626
the O 0 0.00975995697081089
5 O 0 0.013946053571999073
and O 0 0.009859361685812473
3 O 0 0.013350077904760838
regions O 0 0.011936519294977188
of O 0 0.014240955002605915
the O 0 0.02504565566778183
APC B-Disease 1 0.9999959468841553
gene O 0 0.04960799962282181
. O 0 0.04919913038611412

Attenuated B-Disease 1 0.9999984502792358
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 0.9999995231628418
have O 0 0.013238446786999702
" O 0 0.016324255615472794
multiple O 0 0.20498019456863403
" O 1 0.9998119473457336
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 0.0437844954431057
typically O 0 0.017032667994499207
fewer O 0 0.013599543832242489
than O 0 0.009830579161643982
100 O 0 0.01802579127252102
) O 0 0.014076764695346355
without O 0 0.01577579975128174
the O 0 0.02187834307551384
florid O 1 0.987815260887146
phenotype O 0 0.14665646851062775
of O 0 0.04045543074607849
classical O 0 0.14926396310329437
FAP B-Disease 1 0.9999991655349731
. O 0 0.08533751219511032

Another O 0 0.04048309475183487
group O 0 0.02707277052104473
of O 0 0.018313009291887283
patients O 1 0.954285204410553
with O 0 0.01263334508985281
multiple O 1 0.760296642780304
adenomas B-Disease 1 1.0
has O 0 0.017908520996570587
no O 0 0.012024123221635818
mutations O 0 0.011844751425087452
in O 0 0.008725998923182487
the O 0 0.013636687770485878
APC B-Disease 1 0.9999958276748657
gene O 0 0.016098197549581528
, O 0 0.011228698305785656
and O 0 0.010454099625349045
their O 0 0.010706881992518902
phenotype O 0 0.0969049483537674
probably O 0 0.01289710495620966
results O 0 0.009259247221052647
from O 0 0.00880722887814045
variation O 0 0.01175164245069027
at O 0 0.012879839166998863
a O 0 0.015469014644622803
locus O 1 0.8364925384521484
, O 0 0.01430478785187006
or O 0 0.012263204902410507
loci O 0 0.02060185745358467
, O 0 0.01309893187135458
elsewhere O 0 0.014793251641094685
in O 0 0.012455194257199764
the O 0 0.0197091493755579
genome O 0 0.04483145847916603
. O 0 0.04338940232992172

Recently O 0 0.06306352466344833
, O 0 0.023995565250515938
however O 0 0.01270738523453474
, O 0 0.013559075072407722
a O 0 0.016255181282758713
missense O 0 0.03984222561120987
variant O 0 0.03247259557247162
of O 0 0.02227768674492836
APC B-Disease 1 0.9999995231628418
( O 0 0.03410092741250992
I1307K O 1 0.9993956089019775
) O 0 0.018775805830955505
was O 0 0.01835077442228794
described O 0 0.014913801103830338
that O 0 0.008182521909475327
confers O 0 0.027692468836903572
an O 0 0.010200374759733677
increased O 0 0.014783338643610477
risk O 1 0.9985054731369019
of O 1 0.999972939491272
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 1 0.7706971168518066
including O 0 0.021835695952177048
multiple O 0 0.4051552712917328
adenomas B-Disease 1 0.9999996423721313
, O 0 0.03092178888618946
in O 0 0.03477463126182556
Ashkenazim O 1 0.9710960984230042
. O 0 0.060661301016807556

We O 0 0.026639806106686592
have O 0 0.013307804241776466
studied O 0 0.018689636141061783
a O 0 0.012699536979198456
set O 0 0.012571842409670353
of O 0 0.012599735520780087
164 O 0 0.03629860281944275
patients O 0 0.11039245873689651
with O 0 0.015391595661640167
multiple O 1 0.9981516003608704
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999942779541016
/ I-Disease 1 1.0
or I-Disease 1 0.9871792793273926
carcinoma I-Disease 1 1.0
and O 0 0.024296563118696213
analyzed O 0 0.04021531343460083
codons O 0 0.05753866955637932
1263 O 1 0.9998666048049927
- O 1 0.9999406337738037
1377 O 1 0.9998471736907959
( O 0 0.049224503338336945
exon O 0 0.1990308165550232
15G O 1 0.70905601978302
) O 0 0.01925179921090603
of O 0 0.017773495987057686
the O 0 0.020512914285063744
APC B-Disease 1 0.9964156150817871
gene O 0 0.02499460056424141
for O 0 0.02210197038948536
germ O 1 0.9999988079071045
- O 1 0.9999933242797852
line O 0 0.05408210679888725
variants O 0 0.05898255854845047
. O 0 0.05359245836734772

Three O 0 0.037096019834280014
patients O 0 0.047848884016275406
with O 0 0.013796323910355568
the O 0 0.019812021404504776
I1307K O 1 0.9973020553588867
allele O 0 0.03533587232232094
were O 0 0.01360749639570713
detected O 0 0.018250519409775734
, O 0 0.013395179994404316
each O 0 0.00988282635807991
of O 0 0.017078367993235588
Ashkenazi O 1 0.9703682065010071
descent O 0 0.05627307668328285
. O 0 0.051024310290813446

Four O 0 0.04741213098168373
patients O 0 0.23841118812561035
had O 0 0.020762033760547638
a O 0 0.027344346046447754
germ O 1 0.9999924898147583
- O 1 0.9997112154960632
line O 0 0.040250133723020554
E1317Q O 0 0.2992067039012909
missense O 0 0.045899853110313416
variant O 0 0.03165546432137489
of O 0 0.019664762541651726
APC O 1 0.9998906850814819
that O 0 0.009337518364191055
was O 0 0.012394946999847889
not O 0 0.006415655370801687
present O 0 0.00794433057308197
in O 0 0.008349238894879818
controls O 0 0.015521555207669735
; O 0 0.008711615577340126
one O 0 0.006749546620994806
of O 0 0.006474589928984642
these O 0 0.005062493495643139
individuals O 0 0.005301572382450104
had O 0 0.009027085267007351
an O 0 0.01005383487790823
unusually O 0 0.02029561623930931
large O 0 0.012173425406217575
number O 0 0.011574444361031055
of O 0 0.019832881167531013
metaplastic B-Disease 1 0.9998334646224976
polyps I-Disease 1 0.9994567036628723
of I-Disease 0 0.02908163145184517
the I-Disease 0 0.0401320680975914
colorectum I-Disease 1 0.9991042017936707
. O 0 0.05822787806391716

There O 0 0.023114239796996117
is O 0 0.015559750609099865
increasing O 0 0.01362524926662445
evidence O 0 0.010433903895318508
that O 0 0.006005371455103159
there O 0 0.007122332230210304
exist O 0 0.012252015992999077
germ O 1 0.999961256980896
- O 1 0.9998868703842163
line O 0 0.02036980912089348
variants O 0 0.018269453197717667
of O 0 0.0122281014919281
the O 0 0.01799902506172657
APC B-Disease 1 0.9998518228530884
gene O 0 0.017736250534653664
that O 0 0.010990622453391552
predispose O 0 0.027067827060818672
to O 0 0.008984392508864403
the O 0 0.009649965912103653
development O 0 0.011875799857079983
of O 0 0.014036723412573338
multiple O 1 0.9995444416999817
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 0.21699170768260956
but O 0 0.011062797158956528
without O 0 0.010358874686062336
the O 0 0.01687447354197502
florid O 1 0.9974620342254639
phenotype O 0 0.08993350714445114
of O 0 0.018100224435329437
classical O 0 0.19146423041820526
FAP B-Disease 1 1.0
, O 0 0.01601370796561241
and O 0 0.009028769098222256
possibly O 0 0.010546894744038582
with O 0 0.007750159595161676
importance O 0 0.018192391842603683
for O 1 0.9988995790481567
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 1 0.999956488609314
in O 0 0.015533954836428165
the O 0 0.015696434304118156
general O 0 0.025242416188120842
population O 0 0.018981702625751495
. O 0 0.025839192792773247
. O 0 0.043105173856019974

Genomic O 0 0.057413745671510696
structure O 0 0.024014094844460487
of O 0 0.013527287170290947
the O 0 0.01934720203280449
human O 1 0.9999679327011108
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 1.0
CLD B-Disease 1 1.0
) O 1 0.7309213876724243
gene O 0 0.05311800539493561
. O 0 0.04645726829767227

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 1 0.9999991655349731
CLD B-Disease 1 1.0
) O 0 0.14064565300941467
is O 0 0.01591392606496811
caused O 0 0.018611358478665352
by O 0 0.009934973903000355
mutations O 0 0.013955911621451378
in O 0 0.009218628518283367
a O 0 0.012692526914179325
gene O 0 0.014903486706316471
which O 0 0.011345620267093182
encodes O 0 0.0303083136677742
an O 0 0.05868753418326378
intestinal O 1 1.0
anion O 1 0.9999994039535522
transporter O 1 0.9998929500579834
. O 0 0.07752310484647751

We O 0 0.03190481290221214
report O 0 0.022306928411126137
here O 0 0.015674371272325516
the O 0 0.01361943781375885
complete O 0 0.019215377047657967
genomic O 0 0.026214759796857834
organization O 0 0.014024249278008938
of O 0 0.01088022906333208
the O 0 0.013545867055654526
human O 0 0.022151388227939606
CLD B-Disease 1 0.9999998807907104
gene O 0 0.022898787632584572
which O 0 0.014612848870456219
spans O 0 0.028994759544730186
approximately O 0 0.021094556897878647
39kb O 1 0.8479578495025635
, O 0 0.017153974622488022
and O 0 0.0192458126693964
comprises O 0 0.03745701536536217
21 O 0 0.044455792754888535
exons O 0 0.08082232624292374
. O 0 0.054614562541246414

All O 0 0.05291350930929184
exon O 0 0.354362815618515
/ O 1 0.7615166902542114
intron O 0 0.3153552711009979
boundaries O 0 0.024789176881313324
conform O 0 0.030132845044136047
to O 0 0.016956130042672157
the O 0 0.025041382759809494
GT O 1 0.9999997615814209
/ O 1 0.9999986886978149
AG O 1 0.9999984502792358
rule O 0 0.05623766407370567
. O 0 0.0531693734228611

An O 0 0.029094407334923744
analysis O 0 0.022915568202733994
of O 0 0.018128836527466774
the O 0 0.022880231961607933
putative O 1 0.914484441280365
promoter O 1 0.9562541842460632
region O 0 0.02211947552859783
sequence O 0 0.01612572744488716
shows O 0 0.016830136999487877
a O 0 0.02214379981160164
putative O 1 0.9974141120910645
TATA O 1 0.9999998807907104
box O 1 0.8899797201156616
and O 0 0.02156134881079197
predicts O 0 0.046482477337121964
multiple O 0 0.027019359171390533
transcription O 0 0.04396490752696991
factor O 0 0.04200180247426033
binding O 0 0.033972859382629395
sites O 0 0.037694644182920456
. O 0 0.045476529747247696

The O 0 0.04376331344246864
genomic O 0 0.05685719847679138
structure O 0 0.03159865364432335
was O 0 0.023226113989949226
determined O 0 0.01754835806787014
using O 0 0.011983005329966545
DNA O 0 0.014985080808401108
from O 0 0.00820848997682333
several O 0 0.0063083660788834095
sources O 0 0.008989599533379078
including O 0 0.00880233570933342
multiple O 0 0.013062932528555393
large O 0 0.01763947121798992
- O 1 0.9998189806938171
insert O 1 0.8979707956314087
libaries O 0 0.48527994751930237
and O 0 0.018301619216799736
genomic O 0 0.03192837908864021
DNA O 0 0.019424034282565117
from O 0 0.019024476408958435
Finnish O 1 0.9999865293502808
CLD B-Disease 1 1.0
patients O 1 0.9999867677688599
and O 0 0.036316752433776855
controls O 0 0.06773180514574051
. O 0 0.052428919821977615

Exon O 1 0.9536339640617371
- O 1 0.9548651576042175
specific O 0 0.026616495102643967
primers O 0 0.06833266466856003
developed O 0 0.021861588582396507
in O 0 0.011532721109688282
this O 0 0.007640184834599495
study O 0 0.010503532364964485
will O 0 0.01053636148571968
facilitate O 0 0.017639942467212677
mutation O 0 0.019356820732355118
screening O 0 0.019300615414977074
studies O 0 0.013440749607980251
of O 0 0.013622180558741093
patients O 1 0.9732244610786438
with O 0 0.016829995438456535
the O 1 0.8045505285263062
disease O 1 1.0
. O 0 0.05684799700975418

Genomic O 0 0.08917279541492462
sequencing O 0 0.04756616801023483
of O 0 0.02574007958173752
a O 0 0.035579461604356766
BAC O 1 0.999997615814209
clone O 1 0.9999511241912842
H O 1 0.9999992847442627
_ O 0 0.0365566685795784
RG364P16 O 0 0.4079138934612274
revealed O 0 0.02219311334192753
the O 0 0.01285435352474451
presence O 0 0.014183908700942993
of O 0 0.012109839357435703
another O 0 0.016111427918076515
, O 0 0.013780374079942703
highly O 0 0.019106360152363777
homologous O 0 0.022393476217985153
gene O 0 0.01339749526232481
3 O 0 0.015547610819339752
of O 0 0.011238396167755127
the O 0 0.016949662938714027
CLD B-Disease 1 0.9999998807907104
gene O 0 0.016857126727700233
, O 0 0.0104978634044528
with O 0 0.008059677667915821
a O 0 0.009811650961637497
similar O 0 0.010578780435025692
genomic O 0 0.02279621921479702
structure O 0 0.013728095218539238
, O 0 0.008829575963318348
recently O 0 0.01135629415512085
identified O 0 0.008977869525551796
as O 0 0.008469167165458202
the O 0 0.023090941831469536
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 1 0.9999891519546509
( O 1 0.998866081237793
PDS B-Disease 1 1.0
) O 0 0.037126947194337845
. O 0 0.029872054234147072
. O 0 0.04423218220472336

The O 0 0.05184192955493927
APCI1307K O 1 0.9999822378158569
allele O 1 0.6820986866950989
and O 1 0.7484670281410217
cancer B-Disease 1 1.0
risk O 1 0.8577085137367249
in O 0 0.01196256373077631
a O 0 0.013754915446043015
community O 0 0.015825586393475533
- O 1 0.7009924650192261
based O 0 0.01703592576086521
study O 0 0.017580093815922737
of O 0 0.019615478813648224
Ashkenazi O 1 0.9518182277679443
Jews O 0 0.044141896069049835
. O 0 0.0433710515499115

Mutations O 0 0.06997177749872208
in O 0 0.030930036678910255
APC O 1 0.9972710013389587
are O 0 0.01613098755478859
classically O 1 0.860905110836029
associated O 0 0.02216244302690029
with O 0 0.04311367869377136
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999988079071045
FAP B-Disease 1 1.0
) O 0 0.02579014003276825
, O 0 0.016142727807164192
a O 0 0.01649467833340168
highly O 0 0.41499969363212585
penetrant O 1 0.9999998807907104
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999998807907104
disorder I-Disease 1 1.0
characterized O 1 0.9999953508377075
by O 1 0.698186457157135
multiple O 1 0.999997615814209
intestinal O 1 1.0
polyps B-Disease 1 1.0
and O 1 0.7638571858406067
, O 0 0.01798727922141552
without O 0 0.015363357029855251
surgical O 1 1.0
intervention O 1 0.9523476958274841
, O 0 0.009028309024870396
the O 0 0.00931596104055643
development O 0 0.020283503457903862
of O 1 0.9999542236328125
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999947547912598
CRC B-Disease 1 1.0
) O 0 0.04805568978190422
. O 0 0.052869513630867004

APC B-Disease 1 0.9962765574455261
is O 0 0.03460172563791275
a O 0 0.06845391541719437
tumour O 1 1.0
- O 1 0.9999996423721313
suppressor O 1 0.9999608993530273
gene O 0 0.026530802249908447
, O 0 0.016634110361337662
and O 0 0.018675671890378
somatic O 0 0.20403577387332916
loss O 1 0.9781965613365173
occurs O 0 0.03625776618719101
in O 0 0.04409926384687424
tumours B-Disease 1 0.9999997615814209
. O 0 0.06581393629312515

The O 0 0.05854833498597145
germline O 1 0.9910776615142822
T O 1 0.9999675750732422
- O 1 0.9562367796897888
to O 0 0.02141265571117401
- O 1 0.9530242681503296
A O 0 0.03069116175174713
transversion O 0 0.3710075914859772
responsible O 0 0.02135876752436161
for O 0 0.017518721520900726
the O 0 0.02349948137998581
APC O 1 0.9998916387557983
I1307K O 1 0.9406269192695618
allele O 0 0.04042530059814453
converts O 0 0.028774775564670563
the O 0 0.017035868018865585
wild O 0 0.024843275547027588
- O 0 0.4471997022628784
type O 0 0.01907537318766117
sequence O 0 0.009421258233487606
to O 0 0.009246653877198696
a O 0 0.017475545406341553
homopolymer O 1 0.9999992847442627
tract O 1 1.0
( O 1 0.9958653450012207
A8 O 1 1.0
) O 0 0.01580571010708809
that O 0 0.009854634292423725
is O 0 0.012733781710267067
genetically O 0 0.027235010638833046
unstable O 1 0.9919412136077881
and O 0 0.020004913210868835
prone O 1 0.9998899698257446
to O 0 0.025919059291481972
somatic O 1 0.9689539074897766
mutation O 0 0.05764174461364746
. O 0 0.045847054570913315

The O 0 0.06043750420212746
I1307K O 1 0.9199461340904236
allele O 0 0.06497711688280106
was O 0 0.030402574688196182
found O 0 0.02081894874572754
in O 0 0.021532325074076653
6 O 0 0.04995182529091835
. O 0 0.05080884322524071

1 O 0 0.05872717872262001
% O 0 0.02820757031440735
of O 0 0.024765893816947937
unselected O 1 0.9942003488540649
Ashkenazi O 1 0.9461877346038818
Jews O 0 0.03073088824748993
and O 0 0.01841307431459427
higher O 0 0.02044329233467579
proportions O 0 0.03198273107409477
of O 0 0.0168170053511858
Ashkenazim O 1 0.9614036083221436
with O 0 0.01608867198228836
family O 0 0.020073870196938515
or O 0 0.012727536261081696
personal O 0 0.024335259571671486
histories O 0 0.02915017493069172
of O 0 0.08012303709983826
CRC B-Disease 1 1.0
( O 0 0.21225090324878693
ref O 1 0.9999380111694336
. O 0 0.021805426105856895
2 O 0 0.037285178899765015
) O 0 0.0332755483686924
. O 0 0.04552531987428665

To O 0 0.03324466571211815
evaluate O 0 0.04111175611615181
the O 0 0.01710890792310238
role O 0 0.018903756514191628
of O 0 0.01539065595716238
I1307K O 1 0.9999266862869263
in O 0 0.06341820955276489
cancer B-Disease 1 0.9999998807907104
, O 0 0.013486223295331001
we O 0 0.01195282768458128
genotyped O 1 0.71824049949646
5 O 0 0.024782400578260422
, O 0 0.023791078478097916
081 O 1 0.9990972280502319
Ashkenazi O 1 0.7195895314216614
volunteers O 0 0.0459001287817955
in O 0 0.019410595297813416
a O 0 0.026267176494002342
community O 0 0.03204380348324776
survey O 0 0.048796478658914566
. O 0 0.047337498515844345

Risk O 0 0.04982854798436165
of O 0 0.02725660614669323
developing O 1 0.9998291730880737
colorectal B-Disease 1 1.0
, I-Disease 1 0.9998948574066162
breast I-Disease 1 1.0
and I-Disease 0 0.2281421273946762
other I-Disease 0 0.013087661936879158
cancers I-Disease 1 0.9997238516807556
were O 0 0.009564736858010292
compared O 0 0.012964575551450253
between O 0 0.014525555074214935
genotyped O 1 0.9862303137779236
I1307K O 1 0.9985182881355286
carriers O 0 0.04519566521048546
and O 0 0.014686739072203636
non O 0 0.04575907438993454
- O 1 0.9992284774780273
carriers O 0 0.02871585264801979
and O 0 0.011570271104574203
their O 0 0.009813046082854271
first O 0 0.020952586084604263
- O 1 0.9958322644233704
degree O 0 0.036537300795316696
relatives O 0 0.04448891431093216
. O 0 0.04525124281644821

Sperm O 0 0.06282847374677658
DNA O 0 0.03354286774992943
analysis O 0 0.02051197551190853
in O 0 0.020270897075533867
a O 0 0.03856825828552246
Friedreich B-Disease 1 0.9999992847442627
ataxia I-Disease 1 1.0
premutation O 1 0.999997615814209
carrier O 1 0.9996805191040039
suggests O 0 0.041522882878780365
both O 0 0.0257639829069376
meiotic O 1 0.996488094329834
and O 0 0.02542891353368759
mitotic O 0 0.19846078753471375
expansion O 0 0.036220237612724304
in O 0 0.022176925092935562
the O 0 0.032159753143787384
FRDA B-Disease 1 0.999873161315918
gene O 0 0.05908020958304405
. O 0 0.055491846054792404

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 0.2606211304664612
usually O 0 0.01956315152347088
caused O 0 0.017610643059015274
by O 0 0.008770855143666267
an O 0 0.01050459872931242
expansion O 0 0.020815817639231682
of O 0 0.014926058240234852
a O 0 0.023616399616003036
GAA O 1 0.9820759296417236
trinucleotide O 1 0.9917306303977966
repeat O 0 0.04196598380804062
in O 0 0.023110482841730118
intron O 1 0.8327304720878601
1 O 0 0.026199327781796455
of O 0 0.019716935232281685
the O 0 0.029446221888065338
FRDA B-Disease 1 0.9999752044677734
gene O 0 0.05710633099079132
. O 0 0.051433514803647995

Occasionally O 0 0.04880023002624512
, O 0 0.02023998461663723
a O 0 0.016385503113269806
fully O 0 0.021255316212773323
expanded O 0 0.024920843541622162
allele O 0 0.026473404839634895
has O 0 0.01076454296708107
been O 0 0.009942809119820595
found O 0 0.008541002869606018
to O 0 0.008588886819779873
arise O 0 0.012960024178028107
from O 0 0.009557114914059639
a O 0 0.013821377418935299
premutation O 1 0.5148768424987793
of O 0 0.014017458073794842
100 O 0 0.023163700476288795
or O 0 0.01998257264494896
less O 0 0.02979511395096779
triplet O 0 0.4594183564186096
repeats O 0 0.07633089274168015
. O 0 0.056917041540145874

We O 0 0.026076676324009895
have O 0 0.013824938796460629
examined O 0 0.02551138587296009
the O 0 0.01771923527121544
sperm O 0 0.0245058573782444
DNA O 0 0.02061830833554268
of O 0 0.016613950952887535
a O 0 0.02842678688466549
premutation O 1 0.9996898174285889
carrier O 1 0.9976911544799805
. O 0 0.062283094972372055

This O 0 0.04251359403133392
mans O 0 0.11918380111455917
leucocyte O 0 0.15379340946674347
DNA O 0 0.02944752760231495
showed O 0 0.021625131368637085
one O 0 0.014533584006130695
normal O 0 0.01677914708852768
allele O 0 0.023930992931127548
and O 0 0.011324544437229633
one O 0 0.01348375529050827
allele O 0 0.024876264855265617
of O 0 0.014733139425516129
approximately O 0 0.02394326590001583
100 O 0 0.037823133170604706
repeats O 0 0.057328980416059494
. O 0 0.04847402125597

His O 0 0.055111803114414215
sperm O 0 0.03551675006747246
showed O 0 0.019146570935845375
an O 0 0.014944199472665787
expanded O 0 0.025757022202014923
allele O 0 0.02715327963232994
in O 0 0.011218729428946972
a O 0 0.015435702167451382
tight O 0 0.02461310848593712
range O 0 0.02016274258494377
centering O 0 0.0300266295671463
on O 0 0.012054131366312504
a O 0 0.015084375627338886
size O 0 0.020348096266388893
of O 0 0.01765928976237774
approximately O 0 0.031234383583068848
320 O 0 0.0915362760424614
trinucleotide O 1 0.9716423153877258
repeats O 0 0.10164346545934677
. O 0 0.06329582631587982

His O 0 0.0622967928647995
affected O 0 0.0404178723692894
son O 1 0.770173966884613
has O 0 0.023158695548772812
repeat O 0 0.03569414094090462
sizes O 0 0.029877614229917526
of O 0 0.02434065006673336
1040 O 1 0.9956114888191223
and O 0 0.0362061932682991
540 O 1 0.5818630456924438
. O 0 0.06104915589094162

These O 0 0.01910974457859993
data O 0 0.01636854186654091
suggest O 0 0.013850830495357513
that O 0 0.008096957579255104
expansion O 0 0.017069149762392044
occurs O 0 0.009662135504186153
in O 0 0.008434223011136055
two O 0 0.008067270740866661
stages O 0 0.014232410117983818
, O 0 0.008415045216679573
the O 0 0.008869250304996967
first O 0 0.013425714336335659
during O 0 0.018785424530506134
meiosis O 0 0.03913100063800812
followed O 0 0.017422866076231003
by O 0 0.011462457478046417
a O 0 0.02132437191903591
second O 0 0.03745409473776817
mitotic O 0 0.49585214257240295
expansion O 0 0.06356669962406158
. O 0 0.0550263375043869

We O 0 0.028218630701303482
also O 0 0.017680983990430832
show O 0 0.01360504049807787
that O 0 0.007523060776293278
in O 0 0.008267069235444069
all O 0 0.008825396187603474
informative O 0 0.02828032337129116
carrier O 1 0.7187222242355347
father O 0 0.01835186406970024
to O 0 0.01213579997420311
affected O 0 0.01645231805741787
child O 0 0.03088739886879921
transmissions O 0 0.020686162635684013
, O 0 0.00961876381188631
with O 0 0.007632322143763304
the O 0 0.008473481051623821
notable O 0 0.012213014997541904
exception O 0 0.013686934486031532
of O 0 0.010707931593060493
the O 0 0.014119393192231655
premutation O 1 0.9995892643928528
carrier O 1 0.9561949968338013
, O 0 0.013197262771427631
the O 0 0.013315508142113686
expansion O 0 0.029353652149438858
size O 0 0.031533773988485336
decreases O 0 0.04390125721693039
. O 0 0.03050667978823185
. O 0 0.04521646723151207

The O 0 0.0538707859814167
R496H O 1 0.538322389125824
mutation O 0 0.033519767224788666
of O 0 0.02269343100488186
arylsulfatase O 1 0.9967425465583801
A O 0 0.05147421732544899
does O 0 0.02033265121281147
not O 0 0.018200308084487915
cause O 1 0.983616054058075
metachromatic B-Disease 1 0.9999997615814209
leukodystrophy I-Disease 1 1.0
. O 0 0.08379236608743668

Deficiency B-Disease 1 0.9999998807907104
of I-Disease 0 0.04300094395875931
arylsulfatase I-Disease 1 0.9999386072158813
A I-Disease 1 0.9589849710464478
( O 0 0.22424517571926117
ARSA O 1 0.9999990463256836
) O 0 0.02730645053088665
enzyme O 0 0.032754428684711456
activity O 0 0.023664109408855438
causes O 1 0.997180700302124
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9999005794525146
MLD B-Disease 1 1.0
) O 0 0.06376667320728302
. O 0 0.06090199574828148

A O 0 0.0463511124253273
number O 0 0.023494312539696693
of O 0 0.029865959659218788
ARSA O 1 0.9999927282333374
gene O 0 0.03386105224490166
mutations O 0 0.02508736215531826
responsible O 0 0.018772710114717484
for O 0 0.02320074290037155
MLD B-Disease 1 1.0
have O 0 0.018406841903924942
been O 0 0.02176610939204693
identified O 0 0.03304135054349899
. O 0 0.03933113068342209

Recently O 0 0.059722647070884705
, O 0 0.027270250022411346
the O 0 0.02364581823348999
R496H O 1 0.5957449078559875
mutation O 0 0.03332402557134628
of O 0 0.024768460541963577
ARSA O 1 0.9999939203262329
was O 0 0.023472731932997704
proposed O 0 0.013896254822611809
to O 0 0.010163341648876667
be O 0 0.00795679073780775
a O 0 0.013432133942842484
cause O 0 0.01925303228199482
of O 0 0.023070743307471275
MLD B-Disease 1 1.0
( O 0 0.06518486887216568
Draghia O 1 0.9999538660049438
et O 0 0.11431006342172623
al O 0 0.05054476484656334
. O 0 0.016940061002969742
, O 0 0.021408362314105034
1997 O 0 0.043074287474155426
) O 0 0.031241804361343384
. O 0 0.03944633528590202

We O 0 0.02632468193769455
have O 0 0.01435800176113844
investigated O 0 0.025552375242114067
the O 0 0.017916446551680565
R496H O 1 0.9842680096626282
mutation O 0 0.022062549367547035
and O 0 0.011623753234744072
found O 0 0.008732084184885025
this O 0 0.007162733934819698
mutation O 0 0.013450926169753075
at O 0 0.009924755431711674
a O 0 0.009147576056420803
relatively O 0 0.011210449039936066
high O 0 0.01317385770380497
frequency O 0 0.011141055263578892
in O 0 0.008213996887207031
an O 0 0.008896462619304657
African O 0 0.015083341859281063
American O 0 0.012617900967597961
population O 0 0.00989284086972475
( O 0 0.015192780643701553
f O 0 0.04668998718261719
= O 0 0.03926669806241989
0 O 0 0.029082611203193665
. O 0 0.018910357728600502
09 O 0 0.06369853019714355
, O 0 0.02559659816324711
n O 0 0.04151066765189171
= O 0 0.05541933327913284
61 O 0 0.06012909859418869
subjects O 0 0.052970338612794876
) O 0 0.03959048539400101
. O 0 0.046196188777685165

The O 0 0.0675618052482605
ARSA O 1 0.9999912977218628
enzyme O 0 0.04701705649495125
activity O 0 0.018091224133968353
in O 0 0.012295880354940891
subjects O 0 0.015511232428252697
with O 0 0.009111789986491203
and O 0 0.008298886008560658
without O 0 0.00916473288089037
the O 0 0.013014350086450577
R496H O 1 0.9994858503341675
mutation O 0 0.02003367990255356
was O 0 0.01648944988846779
determined O 0 0.01242024078965187
and O 0 0.009553938172757626
found O 0 0.009803722612559795
to O 0 0.011253162287175655
be O 0 0.012412247247993946
normal O 0 0.026010660454630852
. O 0 0.039348773658275604

It O 0 0.0287350881844759
is O 0 0.017260070890188217
therefore O 0 0.013920660130679607
concluded O 0 0.015808485448360443
that O 0 0.008082650601863861
the O 0 0.016107559204101562
R496H O 1 0.8228843212127686
mutation O 0 0.028966858983039856
of O 0 0.023411331698298454
ARSA O 1 0.9999996423721313
does O 0 0.016598617658019066
not O 0 0.010092373006045818
negatively O 0 0.016788244247436523
influence O 0 0.013760012574493885
the O 0 0.011119763366878033
activity O 0 0.013189451768994331
of O 0 0.016901906579732895
ARSA O 1 0.9999970197677612
and O 0 0.015516332350671291
is O 0 0.011525660753250122
not O 0 0.009857844561338425
a O 0 0.020254310220479965
cause O 0 0.15520262718200684
of O 0 0.0578872375190258
MLD B-Disease 1 0.9999998807907104

Down O 0 0.07813286036252975
- O 0 0.10485374182462692
regulation O 0 0.03530813008546829
of O 0 0.02915138565003872
transmembrane O 1 0.5439985394477844
carbonic O 1 0.995617151260376
anhydrases O 1 0.9999195337295532
in O 1 0.9225988984107971
renal B-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
cell O 1 0.8962969183921814
lines O 0 0.023544447496533394
by O 0 0.014453760348260403
wild O 0 0.02701379358768463
- O 1 0.9994138479232788
type O 0 0.29225417971611023
von B-Disease 1 0.9991775155067444
Hippel I-Disease 1 0.9999977350234985
- I-Disease 1 0.9999988079071045
Lindau I-Disease 1 0.9998868703842163
transgenes O 1 0.8070019483566284
. O 0 0.07757867872714996

To O 0 0.04407263919711113
discover O 0 0.047045327723026276
genes O 0 0.021854514256119728
involved O 0 0.016520211473107338
in O 0 0.018631815910339355
von B-Disease 1 0.990522563457489
Hippel I-Disease 1 0.9999996423721313
- I-Disease 1 0.9999995231628418
Lindau I-Disease 1 0.9999982118606567
( O 0 0.04304870218038559
VHL B-Disease 1 0.9999982118606567
) O 0 0.03360547497868538
- O 1 0.999810516834259
mediated O 1 0.9434264302253723
carcinogenesis O 1 0.999933123588562
, O 0 0.017516858875751495
we O 0 0.015782803297042847
used O 0 0.02567911706864834
renal B-Disease 1 1.0
cell I-Disease 1 0.9999991655349731
carcinoma I-Disease 1 1.0
cell O 1 0.9955399632453918
lines O 0 0.043164730072021484
stably O 1 0.5646550059318542
transfected O 0 0.32392144203186035
with O 0 0.02004442922770977
wild O 0 0.03831800818443298
- O 1 0.9999932050704956
type O 1 0.998245120048523
VHL O 1 0.9999998807907104
- O 1 0.9999780654907227
expressing O 0 0.13379989564418793
transgenes O 1 0.7151415944099426
. O 0 0.07312608510255814

Large O 0 0.047557905316352844
- O 1 0.5487085580825806
scale O 0 0.03254113346338272
RNA O 0 0.034279175102710724
differential O 0 0.03185448795557022
display O 0 0.024228624999523163
technology O 0 0.02202465385198593
applied O 0 0.015215640887618065
to O 0 0.010398456826806068
these O 0 0.00867875013500452
cell O 0 0.01707419939339161
lines O 0 0.014267709106206894
identified O 0 0.012244411744177341
several O 0 0.010541323572397232
differentially O 0 0.03382154554128647
expressed O 0 0.01969665102660656
genes O 0 0.014627059921622276
, O 0 0.012287774123251438
including O 0 0.012098309583961964
an O 0 0.01941468007862568
alpha O 1 0.6556023955345154
carbonic O 1 0.999554455280304
anhydrase O 1 0.9999096393585205
gene O 0 0.045721836388111115
, O 0 0.033746685832738876
termed O 0 0.13714835047721863
CA12 O 1 0.9994252920150757
. O 0 0.06826712191104889

The O 0 0.0468561127781868
deduced O 0 0.0610734187066555
protein O 0 0.028115088120102882
sequence O 0 0.02025187946856022
was O 0 0.017320608720183372
classified O 0 0.01773899979889393
as O 0 0.010335885919630527
a O 0 0.013201260939240456
one O 0 0.015346789732575417
- O 1 0.9859407544136047
pass O 0 0.030131174251437187
transmembrane O 1 0.6394369006156921
CA O 0 0.04601183906197548
possessing O 0 0.027871685102581978
an O 0 0.01814892143011093
apparently O 0 0.028739310801029205
intact O 0 0.03945426270365715
catalytic O 0 0.03768431767821312
domain O 0 0.022496361285448074
in O 0 0.017071502283215523
the O 0 0.025603989139199257
extracellular O 1 0.8434193730354309
CA O 1 0.9365500807762146
module O 1 0.7548074126243591
. O 0 0.06617563962936401

Reintroduced O 0 0.10510943830013275
wild O 0 0.06686734408140182
- O 1 0.9996833801269531
type O 1 0.5526252388954163
VHL B-Disease 1 0.9999114274978638
strongly O 0 0.04311494156718254
inhibited O 0 0.048464879393577576
the O 0 0.02273162640631199
overexpression O 0 0.05377113074064255
of O 0 0.017007416114211082
the O 0 0.019373705610632896
CA12 O 1 0.9996651411056519
gene O 0 0.016464337706565857
in O 0 0.011159682646393776
the O 0 0.015984587371349335
parental O 1 0.9999861717224121
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 0.9999676942825317
lines O 0 0.07496324926614761
. O 0 0.05389858037233353

Similar O 0 0.038151826709508896
results O 0 0.023177150636911392
were O 0 0.01382874883711338
obtained O 0 0.01724029891192913
with O 0 0.019709233194589615
CA9 O 1 0.9997512698173523
, O 0 0.020463354885578156
encoding O 0 0.025976216420531273
another O 0 0.026176612824201584
transmembrane O 1 0.9522969722747803
CA O 0 0.04102884605526924
with O 0 0.014483202248811722
an O 0 0.02240389585494995
intact O 0 0.24028988182544708
catalytic O 0 0.1181211993098259
domain O 0 0.06131260469555855
. O 0 0.05187803506851196

Although O 0 0.029049182310700417
both O 0 0.017455849796533585
domains O 0 0.02675163373351097
of O 0 0.01732637919485569
the O 0 0.023004811257123947
VHL B-Disease 1 0.9999991655349731
protein O 0 0.02671094425022602
contribute O 0 0.01941373012959957
to O 0 0.011138114146888256
regulation O 0 0.01864350214600563
of O 0 0.018132979050278664
CA12 O 1 0.9999064207077026
expression O 0 0.02035551518201828
, O 0 0.016169697046279907
the O 0 0.0178738571703434
elongin O 0 0.4691888689994812
binding O 0 0.025973742827773094
domain O 0 0.027537357062101364
alone O 0 0.02453247644007206
could O 0 0.01793084107339382
effectively O 0 0.034047067165374756
regulate O 0 0.05247940495610237
CA9 O 1 0.9999878406524658
expression O 0 0.05580849200487137
. O 0 0.0599304623901844

We O 0 0.048638563603162766
mapped O 0 0.07298010587692261
CA12 O 1 0.9993295669555664
and O 0 0.038553640246391296
CA9 O 1 0.9999939203262329
loci O 0 0.05289829149842262
to O 0 0.023125041276216507
chromosome O 0 0.043298088014125824
bands O 0 0.05037140101194382
15q22 O 1 0.9897924661636353
and O 0 0.03965149447321892
17q21 O 1 0.975109875202179
. O 0 0.06068309396505356

2 O 0 0.05558333173394203
respectively O 0 0.03684298321604729
, O 0 0.021751418709754944
regions O 0 0.020845316350460052
prone O 0 0.4064294993877411
to O 0 0.014902366325259209
amplification O 0 0.03494252637028694
in O 0 0.014573699794709682
some O 0 0.01557788997888565
human O 0 0.038632459938526154
cancers B-Disease 1 0.999996542930603
. O 0 0.049638014286756516

Additional O 0 0.04291859641671181
experiments O 0 0.02767936699092388
are O 0 0.008785301819443703
needed O 0 0.014768675900995731
to O 0 0.008559110574424267
define O 0 0.013786583207547665
the O 0 0.010146327316761017
role O 0 0.013445853255689144
of O 0 0.014460112899541855
CA O 1 0.9997032284736633
IX O 1 1.0
and O 0 0.08413899689912796
CA O 1 0.9963605999946594
XII O 1 0.9999984502792358
enzymes O 0 0.022230925038456917
in O 0 0.011068657971918583
the O 0 0.011640134267508984
regulation O 0 0.015986613929271698
of O 0 0.014958391897380352
pH O 0 0.30248013138771057
in O 0 0.012522329576313496
the O 0 0.018236193805933
extracellular O 0 0.052624646574258804
microenvironment O 1 0.6550608277320862
and O 0 0.011841441504657269
its O 0 0.010565622709691525
potential O 0 0.013485684059560299
impact O 0 0.018180161714553833
on O 0 0.02201809175312519
cancer B-Disease 1 1.0
cell O 1 0.9715335369110107
growth O 0 0.05884602665901184
. O 0 0.04550670459866524

A O 0 0.0526246577501297
gene O 0 0.0325012132525444
encoding O 0 0.030057935044169426
a O 0 0.026127684861421585
transmembrane O 0 0.23002314567565918
protein O 0 0.02212619036436081
is O 0 0.012691779993474483
mutated O 0 0.022195082157850266
in O 0 0.01026409212499857
patients O 1 0.9939488172531128
with O 1 0.9965426325798035
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 1.0
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 1 0.8438414931297302
. O 0 0.07033655047416687

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.9988214373588562
WFS B-Disease 1 1.0
; O 1 0.9621033668518066
OMIM O 1 1.0
222300 O 1 0.9999537467956543
) O 0 0.019038213416934013
is O 0 0.013593391515314579
an O 0 0.019427912309765816
autosomal B-Disease 1 0.9999997615814209
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 1 0.8519684076309204
by O 0 0.013560312800109386
young O 1 0.9986984729766846
- O 1 0.9999996423721313
onset O 1 0.9999997615814209
non O 1 0.9998292922973633
- O 1 1.0
immune O 1 1.0
insulin B-Disease 1 1.0
- I-Disease 1 1.0
dependent I-Disease 1 0.9999977350234985
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999992847442627
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 1 0.9457036852836609

Linkage O 0 0.07759378105401993
to O 0 0.02586982771754265
markers O 0 0.03680756688117981
on O 0 0.022667646408081055
chromosome O 0 0.052599988877773285
4p O 1 0.999996542930603
was O 0 0.027967125177383423
confirmed O 0 0.018646443262696266
in O 0 0.014106933027505875
five O 0 0.0203260388225317
families O 0 0.030417125672101974
. O 0 0.03909371793270111

On O 0 0.023959314450621605
the O 0 0.015257781371474266
basis O 0 0.01391595508903265
of O 0 0.018417350947856903
meiotic O 1 0.9999831914901733
recombinants O 1 0.9999988079071045
and O 1 0.9757358431816101
disease O 1 1.0
- O 1 0.9999988079071045
associated O 0 0.02559734508395195
haplotypes O 0 0.046521060168743134
, O 0 0.015133144333958626
the O 0 0.020969094708561897
WFS B-Disease 1 0.9999997615814209
gene O 0 0.02405327372252941
was O 0 0.02141592465341091
localized O 0 0.029534397646784782
to O 0 0.01570317894220352
a O 0 0.030324095860123634
BAC O 1 0.999998927116394
/ O 1 0.999523401260376
P1 O 1 0.9990872144699097
contig O 0 0.09297247976064682
of O 0 0.021920256316661835
less O 0 0.021024346351623535
than O 0 0.02288692817091942
250 O 0 0.058370523154735565
kb O 0 0.2677839994430542
. O 0 0.061636216938495636

Mutations O 0 0.045701805502176285
in O 0 0.018563497811555862
a O 0 0.023205505684018135
novel O 0 0.0376187339425087
gene O 0 0.02565145120024681
( O 0 0.023585541173815727
WFS1 O 1 0.986636221408844
) O 0 0.01963641494512558
encoding O 0 0.01980654150247574
a O 0 0.022021375596523285
putative O 0 0.07349860668182373
transmembrane O 0 0.4251083433628082
protein O 0 0.017840465530753136
were O 0 0.00929319579154253
found O 0 0.008119575679302216
in O 0 0.00792680773884058
all O 0 0.007501345593482256
affected O 0 0.010259616188704967
individuals O 0 0.006118612363934517
in O 0 0.010066613554954529
six O 0 0.01827702298760414
WFS B-Disease 1 0.9999998807907104
families O 0 0.016743091866374016
, O 0 0.011036025360226631
and O 0 0.008981536142528057
these O 0 0.0061385310254991055
mutations O 0 0.009330631233751774
were O 0 0.005815624259412289
associated O 0 0.008288281038403511
with O 0 0.01141921617090702
the O 1 0.995137631893158
disease O 1 1.0
phenotype O 1 0.999995231628418
. O 0 0.06617524474859238

WFS1 O 1 0.9996414184570312
appears O 0 0.03803637996315956
to O 0 0.016048569232225418
function O 0 0.013048400171101093
in O 0 0.011592116206884384
survival O 0 0.041902586817741394
of O 0 0.01658962480723858
islet O 1 0.9999263286590576
beta O 1 0.999913215637207
- O 1 0.9999992847442627
cells O 0 0.061898212879896164
and O 0 0.023676803335547447
neurons O 0 0.03999000042676926
. O 0 0.027759667485952377
. O 0 0.045661166310310364

Stable O 0 0.06895042210817337
interaction O 0 0.028832415118813515
between O 0 0.014472601003944874
the O 0 0.012015272863209248
products O 0 0.015442428179085255
of O 0 0.012014017440378666
the O 0 0.02014354057610035
BRCA1 O 1 0.9999986886978149
and O 1 0.8937667012214661
BRCA2 O 1 1.0
tumor B-Disease 1 0.9999998807907104
suppressor O 1 0.9999434947967529
genes O 0 0.02737400494515896
in O 0 0.020890213549137115
mitotic O 1 0.9991167187690735
and O 0 0.17748700082302094
meiotic O 1 0.9999982118606567
cells O 0 0.17867963016033173
. O 0 0.05414219945669174

BRCA1 O 1 0.9998571872711182
and O 0 0.04008249565958977
BRCA2 O 1 0.9759926199913025
account O 0 0.015819266438484192
for O 0 0.009826449677348137
most O 0 0.008417620323598385
cases O 0 0.007789995986968279
of O 0 0.009802261367440224
familial O 1 0.999534010887146
, O 0 0.013481352478265762
early O 0 0.19342653453350067
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 0.9989492297172546
/ I-Disease 1 1.0
or I-Disease 1 0.9999934434890747
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.2128482460975647
encode O 0 0.02541539818048477
products O 0 0.021186156198382378
that O 0 0.009301339276134968
each O 0 0.012719953432679176
interact O 0 0.025188228115439415
with O 0 0.02455579861998558
hRAD51 O 1 0.9746347069740295
. O 0 0.0532691515982151

Results O 0 0.04122801125049591
presented O 0 0.030881674960255623
here O 0 0.017280178144574165
show O 0 0.019024334847927094
that O 0 0.013991174288094044
BRCA1 O 1 0.9997301697731018
and O 0 0.0252939872443676
BRCA2 O 1 0.9999420642852783
coexist O 0 0.03263814374804497
in O 0 0.015936516225337982
a O 0 0.021841421723365784
biochemical O 0 0.06726651638746262
complex O 0 0.025430651381611824
and O 0 0.0176587775349617
colocalize O 1 0.8991710543632507
in O 0 0.02247783914208412
subnuclear O 1 0.9980727434158325
foci O 1 0.9601025581359863
in O 0 0.022867199033498764
somatic O 0 0.1515011340379715
cells O 0 0.01973436400294304
and O 0 0.011871827766299248
on O 0 0.011805012822151184
the O 0 0.013747705146670341
axial O 0 0.03236769884824753
elements O 0 0.019479475915431976
of O 0 0.018998045474290848
developing O 0 0.24469390511512756
synaptonemal O 1 0.9999427795410156
complexes O 1 0.8665430545806885
. O 0 0.06447192281484604

Like O 0 0.08347392827272415
BRCA1 O 1 0.9989393353462219
and O 0 0.052725572139024734
RAD51 O 1 0.999976396560669
, O 0 0.05314028635621071
BRCA2 O 1 0.9990315437316895
relocates O 1 0.7310624122619629
to O 0 0.03580247238278389
PCNA O 1 0.9997889399528503
+ O 0 0.06140289455652237
replication O 0 0.03558816760778427
sites O 0 0.017965324223041534
following O 0 0.015161911956965923
exposure O 0 0.02971474640071392
of O 0 0.0182887464761734
S O 1 0.9992207288742065
phase O 0 0.12388414889574051
cells O 0 0.02925998717546463
to O 0 0.02570563741028309
hydroxyurea O 1 0.999915599822998
or O 0 0.060583725571632385
UV O 1 0.9999980926513672
irradiation O 1 0.9947303533554077
. O 0 0.0771745815873146

Thus O 0 0.0467020645737648
, O 0 0.0349084809422493
BRCA1 O 1 0.9994813799858093
and O 0 0.024402771145105362
BRCA2 O 1 0.9997372031211853
participate O 0 0.018448669463396072
, O 0 0.011863620020449162
together O 0 0.011985004879534245
, O 0 0.008674231357872486
in O 0 0.009253209456801414
a O 0 0.014332030899822712
pathway O 0 0.02674681693315506
( O 0 0.019020475447177887
s O 1 0.5701920390129089
) O 0 0.01167555246502161
associated O 0 0.009897008538246155
with O 0 0.007527640555053949
the O 0 0.009455939754843712
activation O 0 0.0183491762727499
of O 0 0.011550318449735641
double O 0 0.05040854588150978
- O 1 0.9987372756004333
strand O 0 0.032693833112716675
break O 0 0.02969762124121189
repair O 1 0.9967114925384521
and O 0 0.0248579028993845
/ O 1 0.996701180934906
or O 0 0.0279733594506979
homologous O 0 0.05632131174206734
recombination O 0 0.06957248598337173
. O 0 0.04829535633325577

Dysfunction O 1 0.9999915361404419
of O 0 0.02628432959318161
this O 0 0.015648774802684784
pathway O 0 0.029997175559401512
may O 0 0.01179262064397335
be O 0 0.007872750982642174
a O 0 0.011263949796557426
general O 0 0.014618651941418648
phenomenon O 0 0.01328757219016552
in O 0 0.00716245686635375
the O 0 0.007602224126458168
majority O 0 0.0072950213216245174
of O 0 0.006709781475365162
cases O 0 0.007999183610081673
of O 0 0.013604988344013691
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999964237213135
/ I-Disease 1 1.0
or I-Disease 1 0.9999994039535522
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.08277018368244171
. O 0 0.05228496342897415

A O 0 0.06828401237726212
novel O 0 0.07045364379882812
Arg362Ser O 1 0.9503011703491211
mutation O 0 0.028113795444369316
in O 0 0.01392739824950695
the O 0 0.017113488167524338
sterol O 0 0.45747455954551697
27 O 0 0.057158324867486954
- O 1 0.9999163150787354
hydroxylase O 1 0.9957499504089355
gene O 0 0.030599385499954224
( O 0 0.023883048444986343
CYP27 O 1 0.9996246099472046
) O 0 0.01549199316650629
: O 0 0.014297408051788807
its O 0 0.011789858341217041
effects O 0 0.016237622126936913
on O 0 0.012957005761563778
pre O 0 0.4387565851211548
- O 1 0.9867889285087585
mRNA O 0 0.03669138625264168
splicing O 0 0.040098294615745544
and O 0 0.02699838951230049
enzyme O 0 0.04387892782688141
activity O 0 0.03139860928058624
. O 0 0.041221506893634796

A O 0 0.0641750767827034
novel O 0 0.059703342616558075
C O 0 0.06218837574124336
to O 0 0.019384248182177544
A O 0 0.028164876624941826
mutation O 0 0.02276582643389702
in O 0 0.012953243218362331
the O 0 0.017413578927516937
sterol O 0 0.2752281129360199
27 O 0 0.051058847457170486
- O 1 0.9998427629470825
hydroxylase O 1 0.9883249998092651
gene O 0 0.034158095717430115
( O 0 0.02790829725563526
CYP27 O 1 0.9997254014015198
) O 0 0.019066890701651573
was O 0 0.018265560269355774
identified O 0 0.011658607982099056
by O 0 0.009369999170303345
sequencing O 0 0.02298424392938614
amplified O 0 0.08233216404914856
CYP27 O 1 0.9999517202377319
gene O 0 0.018466265872120857
products O 0 0.01626408100128174
from O 0 0.010326982475817204
a O 0 0.01633812114596367
patient O 1 0.6289965510368347
with O 0 0.025074465200304985
cerebrotendinous B-Disease 1 0.9999998807907104
xanthomatosis I-Disease 1 1.0
( O 1 0.9831153750419617
CTX B-Disease 1 0.9999998807907104
) O 0 0.060953289270401
. O 0 0.06636455655097961

The O 0 0.04618566110730171
mutation O 0 0.04506208375096321
changed O 0 0.031711798161268234
the O 0 0.029746633023023605
adrenodoxin O 1 0.9972053170204163
cofactor O 1 0.9971480965614319
binding O 0 0.04490092769265175
residue O 0 0.06370142847299576
362Arg O 1 0.5109512209892273
to O 0 0.02976333349943161
362Ser O 1 0.9628884196281433
( O 0 0.03783232346177101
CGT O 1 0.9764476418495178
362Arg O 1 0.8030301332473755
to O 0 0.034353576600551605
AGT O 1 1.0
362Ser O 1 0.999982476234436
) O 0 0.0221501924097538
, O 0 0.014851827174425125
and O 0 0.011213616468012333
was O 0 0.016173217445611954
responsible O 0 0.016611497849225998
for O 0 0.01950256898999214
deficiency O 1 1.0
in O 0 0.013462625443935394
the O 0 0.018650798127055168
sterol O 1 0.9913171529769897
27 O 1 0.6302176713943481
- O 1 0.9999959468841553
hydroxylase O 1 0.9651930928230286
activity O 0 0.017560003325343132
, O 0 0.011690248735249043
as O 0 0.010264109820127487
confirmed O 0 0.012800999917089939
by O 0 0.0089489184319973
expression O 0 0.015690859407186508
of O 0 0.016339577734470367
mutant O 0 0.04187833517789841
cDNA O 0 0.05448923259973526
into O 0 0.0345316156744957
COS O 1 0.9999992847442627
- O 1 0.9998797178268433
1 O 0 0.05811212211847305
cells O 0 0.05264299362897873
. O 0 0.05181705206632614

Quantitative O 0 0.05369267612695694
analysis O 0 0.022281739860773087
showed O 0 0.017045147716999054
that O 0 0.008370203897356987
the O 0 0.010324199683964252
expression O 0 0.014853863045573235
of O 0 0.016247466206550598
CYP27 O 1 0.9999707937240601
gene O 0 0.021440327167510986
mRNA O 0 0.024852044880390167
in O 0 0.015782693400979042
the O 0 0.019793814048171043
patient O 0 0.043895453214645386
represented O 0 0.03204505518078804
52 O 0 0.0632745772600174
. O 0 0.046800944954156876

5 O 0 0.04791153222322464
% O 0 0.0254199355840683
of O 0 0.01772679015994072
the O 0 0.021248305216431618
normal O 0 0.030761627480387688
level O 0 0.038911499083042145
. O 0 0.0477110892534256

As O 0 0.03518690913915634
the O 0 0.028511814773082733
mutation O 0 0.031974613666534424
occurred O 0 0.02104959450662136
at O 0 0.018031373620033264
the O 0 0.018335936591029167
penultimate O 0 0.08926229178905487
nucleotide O 0 0.02752614952623844
of O 0 0.017089545726776123
exon O 0 0.057567041367292404
6 O 0 0.030413763597607613
( O 0 0.022316886112093925
- O 0 0.0730535015463829
2 O 0 0.02485465630888939
position O 0 0.019534559920430183
of O 0 0.016896512359380722
exon O 0 0.05613308027386665
6 O 0 0.03756008297204971
- O 1 0.962670087814331
intron O 1 0.9672936797142029
6 O 0 0.0334884375333786
splice O 0 0.05155324563384056
site O 0 0.02263132855296135
) O 0 0.010692869313061237
of O 0 0.009585493244230747
the O 0 0.01187131367623806
gene O 0 0.012315144762396812
, O 0 0.008680686354637146
we O 0 0.00749578420072794
hypothesized O 0 0.016611013561487198
that O 0 0.005722685717046261
the O 0 0.010714461095631123
mutation O 0 0.017570288851857185
may O 0 0.01037658005952835
partially O 0 0.020714307203888893
affect O 0 0.013479202054440975
the O 0 0.011975922621786594
normal O 0 0.015248792245984077
splicing O 0 0.025640441104769707
efficiency O 0 0.024593977257609367
in O 0 0.015180064365267754
exon O 0 0.05046076700091362
6 O 0 0.025004353374242783
and O 0 0.01486795675009489
cause O 0 0.018449945375323296
alternative O 0 0.017272116616368294
splicing O 0 0.0229327529668808
elsewhere O 0 0.013993607833981514
, O 0 0.0111836614087224
which O 0 0.00845358520746231
resulted O 0 0.014630923978984356
in O 0 0.01246394868940115
decreased O 0 0.02263469435274601
transcript O 0 0.02671053446829319
in O 0 0.01958252117037773
the O 0 0.026028884574770927
patient O 1 0.9826869368553162
. O 0 0.051964182406663895

Transfection O 0 0.2302418351173401
of O 0 0.03635839745402336
constructed O 0 0.05130578204989433
minigenes O 1 0.9883769154548645
, O 0 0.01604403741657734
with O 0 0.010271752253174782
or O 0 0.007820635102689266
without O 0 0.0072756195440888405
the O 0 0.00944566261023283
mutation O 0 0.013147836551070213
, O 0 0.010042654350399971
into O 0 0.015795914456248283
COS O 1 1.0
- O 1 0.9999347925186157
1 O 0 0.027176877483725548
cells O 0 0.017520420253276825
confirmed O 0 0.01346337329596281
that O 0 0.008245727978646755
the O 0 0.013143060728907585
mutant O 0 0.05064241588115692
minigene O 1 0.9912376403808594
was O 0 0.019368058070540428
responsible O 0 0.013978063128888607
for O 0 0.009627989493310452
a O 0 0.014682055450975895
mRNA O 0 0.023180408403277397
species O 0 0.011743415147066116
alternatively O 0 0.025065679103136063
spliced O 0 0.030998021364212036
at O 0 0.01851082779467106
an O 0 0.01875150203704834
activated O 0 0.07980336993932724
cryptic O 0 0.05300074443221092
5 O 0 0.03329490125179291
splice O 0 0.060118112713098526
site O 0 0.0340636745095253
88 O 0 0.05064515024423599
bp O 0 0.0513131357729435
upstream O 0 0.027440525591373444
from O 0 0.012922760099172592
the O 0 0.014979442581534386
3 O 0 0.024405378848314285
end O 0 0.025912510231137276
of O 0 0.028490740805864334
exon O 0 0.12379669398069382
6 O 0 0.07000318169593811
. O 0 0.0602521076798439

Our O 0 0.03339620307087898
data O 0 0.01751566119492054
suggest O 0 0.013892792165279388
that O 0 0.007428833749145269
the O 0 0.013012680225074291
C O 0 0.03194275125861168
to O 0 0.013447852805256844
A O 0 0.019725428894162178
mutation O 0 0.018639596179127693
at O 0 0.013963894918560982
the O 0 0.014800557866692543
penultimate O 0 0.08592752367258072
nucleotide O 0 0.027159856632351875
of O 0 0.015316979959607124
exon O 0 0.04050443693995476
6 O 0 0.01999352127313614
of O 0 0.012330054305493832
the O 0 0.017348436638712883
CYP27 O 1 0.9998040795326233
gene O 0 0.014823519624769688
not O 0 0.008543732576072216
only O 0 0.010687746107578278
causes O 0 0.11348318308591843
the O 0 0.023584360256791115
deficiency B-Disease 1 1.0
in I-Disease 0 0.012542097829282284
the I-Disease 0 0.017653092741966248
sterol I-Disease 1 0.9965105652809143
27 I-Disease 0 0.48388922214508057
- I-Disease 1 0.9998949766159058
hydroxylase I-Disease 1 0.8228208422660828
activity I-Disease 0 0.020267192274332047
, O 0 0.01461207028478384
but O 0 0.011762114241719246
also O 0 0.013437891378998756
partially O 0 0.024798469617962837
leads O 0 0.018374865874648094
to O 0 0.012471497990190983
alternative O 0 0.022751880809664726
pre O 0 0.04780541732907295
- O 0 0.09826693683862686
mRNA O 0 0.03460187464952469
splicing O 0 0.03533996269106865
of O 0 0.02126614935696125
the O 0 0.02602030523121357
gene O 0 0.043960850685834885
. O 0 0.04693512246012688

To O 0 0.026541240513324738
our O 0 0.020300766453146935
knowledge O 0 0.01979118026793003
, O 0 0.012557330541312695
this O 0 0.0068082017824053764
is O 0 0.007681146264076233
the O 0 0.00817044172435999
first O 0 0.009984645061194897
report O 0 0.010106092318892479
regarding O 0 0.011155779473483562
effects O 0 0.015190139412879944
on O 0 0.013320921920239925
pre O 0 0.2743026614189148
- O 0 0.2650246024131775
mRNA O 0 0.02489464543759823
splicing O 0 0.022404981777071953
of O 0 0.01105495449155569
a O 0 0.01344810426235199
mutation O 0 0.013882369734346867
at O 0 0.011313817463815212
the O 0 0.011474414728581905
- O 0 0.35021883249282837
2 O 0 0.01816580444574356
position O 0 0.016323206946253777
of O 0 0.013551984913647175
a O 0 0.019762404263019562
5 O 0 0.03326015919446945
splice O 0 0.08638442307710648
site O 0 0.05958288535475731
. O 0 0.049598414450883865

ATM O 0 0.4316486716270447
germline O 0 0.10851063579320908
mutations O 0 0.03274044767022133
in O 0 0.022004704922437668
classical O 0 0.11774078011512756
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.999981164932251
in O 0 0.019242364913225174
the O 0 0.02231932245194912
Dutch O 0 0.10604316741228104
population O 0 0.02551971562206745
. O 0 0.043764833360910416

Germline O 0 0.24498163163661957
mutations O 0 0.03735416382551193
in O 0 0.016309622675180435
the O 0 0.01764802634716034
ATM O 1 0.8269103169441223
gene O 0 0.012713342905044556
are O 0 0.005135273560881615
responsible O 0 0.009217153303325176
for O 0 0.008773657493293285
the O 0 0.020623797550797462
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 1 0.9950333833694458
A B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 0.044323571026325226
. O 0 0.04891027882695198

In O 0 0.03044651821255684
our O 0 0.022554852068424225
study O 0 0.017326125875115395
, O 0 0.012840093113481998
we O 0 0.008140405640006065
have O 0 0.007178152445703745
determined O 0 0.01223115436732769
the O 0 0.014417803846299648
ATM O 0 0.04743717983365059
mutation O 0 0.0198013074696064
spectrum O 0 0.020554035902023315
in O 0 0.009733990766108036
19 O 0 0.016837049275636673
classical O 0 0.019911756739020348
A B-Disease 1 0.9917888045310974
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9967252612113953
, O 0 0.010266444645822048
including O 0 0.008509242907166481
some O 0 0.008369341492652893
immigrant O 0 0.01585935242474079
populations O 0 0.011232458055019379
, O 0 0.009140053763985634
as O 0 0.008843936026096344
well O 0 0.009078099392354488
as O 0 0.00984417088329792
12 O 0 0.015739424154162407
of O 0 0.014763841405510902
Dutch O 0 0.03654469549655914
ethnic O 0 0.02196820266544819
origin O 0 0.027703920379281044
. O 0 0.042869243770837784

Both O 0 0.03143280744552612
the O 0 0.027704009786248207
protein O 0 0.03230730816721916
truncation O 0 0.05882086232304573
test O 0 0.03797106444835663
( O 0 0.0315064936876297
PTT O 1 0.9766173958778381
) O 0 0.016725651919841766
and O 0 0.013325085863471031
the O 0 0.015208262950181961
restriction O 0 0.027608558535575867
endonuclease O 1 0.583634614944458
fingerprinting O 0 0.1056281104683876
( O 0 0.03331464156508446
REF O 1 0.9998810291290283
) O 0 0.01891198381781578
method O 0 0.014524927362799644
were O 0 0.009181834757328033
used O 0 0.00820737611502409
and O 0 0.008560377173125744
compared O 0 0.010431482456624508
for O 0 0.00784546323120594
their O 0 0.009004334919154644
detection O 0 0.023729462176561356
efficiency O 0 0.02178545482456684
, O 0 0.014383329078555107
identifying O 0 0.02246733568608761
76 O 0 0.03582901880145073
% O 0 0.01316479779779911
and O 0 0.01020860206335783
60 O 0 0.014841525815427303
% O 0 0.010959696024656296
of O 0 0.010739913210272789
the O 0 0.01603384129703045
mutations O 0 0.026044011116027832
, O 0 0.022535433992743492
respectively O 0 0.036539532244205475
. O 0 0.04430589824914932

Most O 0 0.03943287208676338
patients O 1 0.5343571305274963
were O 0 0.012386531569063663
found O 0 0.011426899582147598
to O 0 0.013028286397457123
be O 0 0.01893950067460537
compound O 0 0.07278041541576385
heterozygote O 1 0.9726763367652893
. O 0 0.05601496249437332

Seventeen O 0 0.08181769400835037
mutations O 0 0.03385554254055023
were O 0 0.012020350433886051
distinct O 0 0.012276598252356052
, O 0 0.010414514690637589
of O 0 0.008459514938294888
which O 0 0.007155955769121647
10 O 0 0.010499578900635242
were O 0 0.00762975076213479
not O 0 0.009169488213956356
reported O 0 0.02018163539469242
previously O 0 0.031100792810320854
. O 0 0.0377388559281826

Mutations O 0 0.04953760281205177
are O 0 0.013720802031457424
small O 0 0.0183268915861845
deletions O 0 0.03406646102666855
or O 0 0.015735285356640816
point O 0 0.020837552845478058
mutations O 0 0.02321658469736576
frequently O 0 0.02420845441520214
affecting O 0 0.032288823276758194
splice O 0 0.09174424409866333
sites O 0 0.04225575923919678
. O 0 0.04646287113428116

Moreover O 0 0.07066989690065384
, O 0 0.03205054998397827
a O 0 0.03245607018470764
16 O 0 0.04959264025092125
. O 0 0.05345059558749199

7 O 0 0.09121309220790863
- O 1 0.9103405475616455
kb O 0 0.1271410435438156
genomic O 0 0.05313538759946823
deletion O 0 0.03646160662174225
of O 0 0.015383509919047356
the O 0 0.012119895778596401
3 O 0 0.01661667786538601
end O 0 0.01152895949780941
of O 0 0.008222079835832119
the O 0 0.009449019096791744
gene O 0 0.010960124433040619
, O 0 0.007978738285601139
most O 0 0.006821202114224434
likely O 0 0.008358442224562168
a O 0 0.008074347861111164
result O 0 0.007795740384608507
of O 0 0.008381337858736515
recombination O 0 0.013958394527435303
between O 0 0.008311965502798557
two O 0 0.008544270880520344
LINE O 0 0.023130781948566437
elements O 0 0.015864238142967224
, O 0 0.01578829623758793
was O 0 0.02670927718281746
identified O 0 0.02973969653248787
. O 0 0.03780703991651535

The O 0 0.03329483047127724
most O 0 0.018408965319395065
frequently O 0 0.01908874697983265
found O 0 0.013620104640722275
mutation O 0 0.01745515689253807
, O 0 0.010089467279613018
identified O 0 0.008889297023415565
in O 0 0.006666508503258228
three O 0 0.007158320862799883
unrelated O 0 0.012865492142736912
Turkish O 0 0.022043250501155853
A B-Disease 1 0.9995087385177612
- I-Disease 1 1.0
T I-Disease 1 0.9999988079071045
individuals O 0 0.010966132394969463
, O 0 0.01109712477773428
was O 0 0.013617592863738537
previously O 0 0.013824684545397758
described O 0 0.01046767272055149
to O 0 0.007674973923712969
be O 0 0.006495416630059481
a O 0 0.010977338999509811
Turkish O 0 0.026162883266806602
A B-Disease 1 0.996988832950592
- I-Disease 1 0.9999998807907104
T I-Disease 1 0.9999996423721313
founder O 1 0.9962577819824219
mutation O 0 0.07244857400655746
. O 0 0.05355428159236908

The O 0 0.030092718079686165
presence O 0 0.020922726020216942
of O 0 0.014345023781061172
a O 0 0.020350396633148193
founder O 1 0.998027503490448
mutation O 0 0.023870564997196198
among O 0 0.013686001300811768
relatively O 0 0.012155481614172459
small O 0 0.011004043743014336
ethnic O 0 0.008442760445177555
population O 0 0.007104179821908474
groups O 0 0.006214657332748175
in O 0 0.007652703672647476
Western O 0 0.011436739936470985
Europe O 0 0.013059213757514954
could O 0 0.008093975484371185
indicate O 0 0.009794931858778
a O 0 0.012014932930469513
high O 0 0.02113523706793785
carrier O 1 0.5397566556930542
frequency O 0 0.01805943250656128
in O 0 0.014952057041227818
such O 0 0.016023200005292892
communities O 0 0.02567378431558609
. O 0 0.03670348972082138

In O 0 0.03346572443842888
patients O 0 0.04717020317912102
of O 0 0.01723223552107811
Dutch O 0 0.03311118483543396
ethnic O 0 0.013431578874588013
origin O 0 0.010348379611968994
, O 0 0.010144875384867191
however O 0 0.009969685226678848
, O 0 0.010572453960776329
no O 0 0.01024212222546339
significant O 0 0.014256112277507782
founder O 1 0.919689953327179
effect O 0 0.019739415496587753
could O 0 0.01633293926715851
be O 0 0.017429005354642868
identified O 0 0.028861625120043755
. O 0 0.039106618613004684

The O 0 0.03847479820251465
observed O 0 0.027114098891615868
genetic O 0 0.02489425614476204
heterogeneity O 0 0.033539701253175735
including O 0 0.010903341695666313
the O 0 0.010857631452381611
relative O 0 0.013607400469481945
high O 0 0.01344265230000019
percentage O 0 0.013856290839612484
of O 0 0.011649852618575096
splice O 1 0.9289277791976929
- O 1 0.9986453652381897
site O 0 0.024173887446522713
mutations O 0 0.01681237667798996
had O 0 0.012973157688975334
no O 0 0.011134044267237186
reflection O 0 0.024198094382882118
on O 0 0.016877029091119766
the O 0 0.027976082637906075
phenotype O 1 0.8618016839027405
. O 0 0.05124634876847267

All O 0 0.03893280029296875
patients O 0 0.20536264777183533
manifested O 0 0.06298068910837173
classical O 0 0.029348816722631454
A B-Disease 1 0.9997699856758118
- I-Disease 1 1.0
T I-Disease 1 0.9999998807907104
and O 0 0.019313033670186996
increased O 0 0.025836262851953506
cellular O 0 0.37388676404953003
radioresistant O 1 0.9686266183853149
DNA O 0 0.05562945827841759
synthesis O 0 0.06331434100866318
. O 0 0.053036678582429886

Determination O 0 0.05797642096877098
of O 0 0.023598050698637962
the O 0 0.01994786411523819
genomic O 0 0.030730469152331352
structure O 0 0.017662905156612396
of O 0 0.013368110172450542
the O 0 0.017451616004109383
COL4A4 O 1 0.9999814033508301
gene O 0 0.01654144935309887
and O 0 0.010763927362859249
of O 0 0.01172754354774952
novel O 0 0.03807387873530388
mutations O 0 0.04328105226159096
causing O 1 0.9997161030769348
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999352693557739

Autosomal B-Disease 1 0.9999998807907104
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9405624866485596
a O 1 0.9767792820930481
progressive O 1 0.9999995231628418
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 1 0.9993554949760437
by O 0 0.11124338954687119
glomerular B-Disease 1 1.0
basement I-Disease 1 0.9999998807907104
membrane I-Disease 1 0.9998680353164673
abnormalities I-Disease 1 0.9998841285705566
and O 0 0.016179682686924934
associated O 0 0.015454175882041454
with O 0 0.010847133584320545
mutations O 0 0.014158342964947224
in O 0 0.00916318316012621
either O 0 0.011304082348942757
the O 0 0.015759602189064026
COL4A3 O 1 0.9998658895492554
or O 0 0.015959203243255615
the O 0 0.01975487545132637
COL4A4 O 1 0.999915361404419
gene O 0 0.02016947604715824
, O 0 0.013013621792197227
which O 0 0.01053241454064846
encode O 0 0.0184297077357769
the O 0 0.015154215507209301
alpha3 O 0 0.2784973978996277
and O 0 0.019586609676480293
alpha4 O 1 0.9999783039093018
type O 1 0.9999439716339111
IV O 1 1.0
collagen O 1 1.0
chains O 1 0.9997106194496155
, O 0 0.032865483313798904
respectively O 0 0.042938482016325
. O 0 0.044302020221948624

To O 0 0.02806871198117733
date O 0 0.0248114001005888
, O 0 0.018778499215841293
mutation O 0 0.019033674150705338
screening O 0 0.01692659594118595
in O 0 0.008368858136236668
the O 0 0.00871158204972744
two O 0 0.008417298085987568
genes O 0 0.009089777246117592
has O 0 0.008276390843093395
been O 0 0.008196940645575523
hampered O 0 0.08561798185110092
by O 0 0.007820324040949345
the O 0 0.01103238295763731
lack O 0 0.01436315756291151
of O 0 0.01603824459016323
genomic O 0 0.061902064830064774
structure O 0 0.033221736550331116
information O 0 0.029307089745998383
. O 0 0.03907272219657898

We O 0 0.030260644853115082
report O 0 0.02055041864514351
here O 0 0.016559354960918427
the O 0 0.011697732843458652
complete O 0 0.01698163151741028
characterization O 0 0.019540617242455482
of O 0 0.011363347992300987
the O 0 0.011518209241330624
48 O 0 0.01960393786430359
exons O 0 0.023048415780067444
of O 0 0.011422338895499706
the O 0 0.015635808929800987
COL4A4 O 1 0.9999735355377197
gene O 0 0.017656732350587845
, O 0 0.011099091731011868
a O 0 0.011549056507647038
comprehensive O 0 0.021679410710930824
gene O 0 0.01637887768447399
screen O 0 0.02138935774564743
, O 0 0.010086562484502792
and O 0 0.007918438874185085
the O 0 0.008005133830010891
subsequent O 0 0.012953780591487885
detection O 0 0.01657106541097164
of O 0 0.010398329235613346
10 O 0 0.013296590186655521
novel O 0 0.018111426383256912
mutations O 0 0.012443446554243565
in O 0 0.00972716137766838
eight O 0 0.018735187128186226
patients O 1 0.9999819993972778
diagnosed O 1 1.0
with O 1 0.9994999170303345
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9998928308486938

Furthermore O 0 0.054630428552627563
, O 0 0.021103667095303535
we O 0 0.013695704750716686
identified O 0 0.016012338921427727
a O 0 0.01768358238041401
glycine O 0 0.03850467503070831
to O 0 0.01735549233853817
alanine O 0 0.04411454498767853
substitution O 0 0.0251906868070364
in O 0 0.013326628133654594
the O 0 0.01965135522186756
collagenous O 1 0.999881386756897
domain O 0 0.025149794295430183
that O 0 0.010278798639774323
is O 0 0.01236284151673317
apparently O 0 0.01691681705415249
silent O 0 0.02610517479479313
in O 0 0.011491778306663036
the O 0 0.014857380650937557
heterozygous O 0 0.03230176493525505
carriers O 0 0.03268297389149666
, O 0 0.016283731907606125
in O 0 0.01640584133565426
11 O 0 0.030079908668994904
. O 0 0.03758278861641884

5 O 0 0.0426994264125824
% O 0 0.01731302961707115
of O 0 0.01223854348063469
all O 0 0.008406718261539936
control O 0 0.014002492651343346
individuals O 0 0.008185796439647675
, O 0 0.009072060696780682
and O 0 0.008184046484529972
in O 0 0.009027562104165554
one O 0 0.009904219768941402
control O 0 0.015364382416009903
individual O 0 0.012576702050864697
homozygous O 0 0.026185952126979828
for O 0 0.01603994518518448
this O 0 0.02001730538904667
glycine O 0 0.06354158371686935
substitution O 0 0.05845336988568306
. O 0 0.04927375912666321

There O 0 0.027628779411315918
has O 0 0.018887249752879143
been O 0 0.011373685672879219
no O 0 0.008945350535213947
previous O 0 0.010837968438863754
finding O 0 0.011717340908944607
of O 0 0.009623362682759762
a O 0 0.014540682546794415
glycine O 0 0.035398319363594055
substitution O 0 0.01989954151213169
that O 0 0.008056829683482647
is O 0 0.008082938380539417
not O 0 0.005950205493718386
associated O 0 0.0082841282710433
with O 0 0.008411029353737831
any O 0 0.011564753949642181
obvious O 0 0.04006835073232651
phenotype O 1 0.6908840537071228
in O 0 0.01963869296014309
homozygous O 0 0.052306611090898514
individuals O 0 0.024048907682299614
. O 0 0.03701110556721687

Founder O 1 0.9995515942573547
BRCA1 O 1 0.9998809099197388
and O 0 0.03623655438423157
BRCA2 O 1 0.9986775517463684
mutations O 0 0.022410539910197258
in O 0 0.01272056344896555
French O 1 0.7073229551315308
Canadian O 1 0.9998719692230225
breast B-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.989459753036499
. O 0 0.05974625423550606

We O 0 0.02481771446764469
have O 0 0.014512394554913044
identified O 0 0.014951762743294239
four O 0 0.011423991061747074
mutations O 0 0.010918947868049145
in O 0 0.006272675469517708
each O 0 0.004958719480782747
of O 0 0.007798011880367994
the O 0 0.07740278542041779
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
- O 1 1.0
susceptibility O 1 0.9999837875366211
genes O 0 0.0232324730604887
, O 0 0.020273717120289803
BRCA1 O 1 0.9999294281005859
and O 0 0.016787590458989143
BRCA2 O 1 0.9979743361473083
, O 0 0.010891365818679333
in O 0 0.009768351912498474
French O 0 0.022392725571990013
Canadian O 1 0.9435117244720459
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999995231628418
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 0.4964941740036011
from O 0 0.03161802142858505
Quebec O 1 0.8381458520889282
. O 0 0.055912602692842484

To O 0 0.03520238772034645
identify O 0 0.038825247436761856
founder O 1 0.9758883118629456
effects O 0 0.06013791635632515
, O 0 0.014263954013586044
we O 0 0.010472039692103863
examined O 0 0.018281470984220505
independently O 0 0.013366670347750187
ascertained O 0 0.026802781969308853
French O 0 0.04604317992925644
Canadian O 1 0.6205583810806274
cancer B-Disease 1 0.9999891519546509
families O 0 0.012232237495481968
for O 0 0.0097819734364748
the O 0 0.011527270078659058
distribution O 0 0.012559578754007816
of O 0 0.011265754699707031
these O 0 0.011032174341380596
eight O 0 0.025925884023308754
mutations O 0 0.04137204587459564
. O 0 0.04031757265329361

Mutations O 0 0.05218110978603363
were O 0 0.015493003651499748
found O 0 0.014198079705238342
in O 0 0.012342063710093498
41 O 0 0.025940626859664917
of O 0 0.02042575366795063
97 O 0 0.08222270756959915
families O 0 0.039825182408094406
. O 0 0.050556305795907974

Six O 0 0.03282235935330391
of O 0 0.0206243097782135
eight O 0 0.02196895331144333
mutations O 0 0.018408726900815964
were O 0 0.010306154377758503
observed O 0 0.012912957929074764
at O 0 0.01667105033993721
least O 0 0.01644943840801716
twice O 0 0.03107040748000145
. O 0 0.035860080271959305

The O 0 0.059632666409015656
BRCA1 O 1 0.9996176958084106
C4446T O 1 0.9724048376083374
mutation O 0 0.030144771561026573
was O 0 0.01701800711452961
the O 0 0.011173857375979424
most O 0 0.009496144019067287
common O 0 0.010994847863912582
mutation O 0 0.01620943285524845
found O 0 0.009197787381708622
, O 0 0.00959323812276125
followed O 0 0.01266761589795351
by O 0 0.011086506769061089
the O 0 0.02623983658850193
BRCA2 O 1 0.9999880790710449
8765delAG O 1 0.9999459981918335
mutation O 0 0.08432110399007797
. O 0 0.05515601485967636

Together O 0 0.04344196245074272
, O 0 0.021065451204776764
these O 0 0.012497477233409882
mutations O 0 0.015288002789020538
were O 0 0.008688782341778278
found O 0 0.008801053278148174
in O 0 0.00866630394011736
28 O 0 0.016171850264072418
of O 0 0.01104440726339817
41 O 0 0.02247723564505577
families O 0 0.014692122116684914
identified O 0 0.01287433598190546
to O 0 0.009821634739637375
have O 0 0.0106375552713871
a O 0 0.02422208897769451
mutation O 0 0.04033779352903366
. O 0 0.040597494691610336

The O 0 0.0369037427008152
odds O 0 0.04042884334921837
of O 0 0.017030807211995125
detection O 0 0.02667102962732315
of O 0 0.0109972283244133
any O 0 0.008903111331164837
of O 0 0.011260327883064747
the O 0 0.014216484501957893
four O 0 0.02399289980530739
BRCA1 O 1 0.9997929930686951
mutations O 0 0.035308100283145905
was O 0 0.034844789654016495
18 O 0 0.0465739443898201
. O 0 0.04983453080058098

7x O 1 0.9994537234306335
greater O 0 0.03256263583898544
if O 0 0.014445027336478233
one O 0 0.009609806351363659
or O 0 0.006929460912942886
more O 0 0.006481479853391647
cases O 0 0.008949197828769684
of O 1 0.9969582557678223
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 0.01880009099841118
also O 0 0.01148667186498642
present O 0 0.011765184812247753
in O 0 0.013291560113430023
the O 0 0.020325589925050735
family O 0 0.0392957404255867
. O 0 0.04215897619724274

The O 0 0.03838255628943443
odds O 0 0.04556572064757347
of O 0 0.01802460476756096
detection O 0 0.022114232182502747
of O 0 0.00939896795898676
any O 0 0.007381153758615255
of O 0 0.008478465490043163
the O 0 0.011703798547387123
four O 0 0.01759798265993595
BRCA2 O 1 0.9999887943267822
mutations O 0 0.028357937932014465
was O 0 0.032806213945150375
5 O 0 0.03565685451030731
. O 0 0.044732410460710526

3x O 1 0.7239941954612732
greater O 0 0.031875334680080414
if O 0 0.013617241755127907
there O 0 0.007486247923225164
were O 0 0.0060708774253726006
at O 0 0.007468146272003651
least O 0 0.005861347541213036
five O 0 0.007186524569988251
cases O 0 0.009362786076962948
of O 0 0.4624192714691162
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 0.04753806069493294
the O 0 0.02950836345553398
family O 0 0.047678086906671524
. O 0 0.0469629243016243

Interestingly O 0 0.07332850247621536
, O 0 0.02020743303000927
the O 0 0.013903679326176643
presence O 0 0.017107488587498665
of O 0 0.013865330256521702
a O 1 0.7899199724197388
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
case O 0 0.2506609857082367
< O 1 0.9340147972106934
36 O 0 0.022684907540678978
years O 0 0.012567846104502678
of O 0 0.010717291384935379
age O 0 0.014432597905397415
was O 0 0.014779518358409405
strongly O 0 0.012765580788254738
predictive O 0 0.01876809075474739
of O 0 0.008728728629648685
the O 0 0.009716933593153954
presence O 0 0.010112477466464043
of O 0 0.007954224944114685
any O 0 0.008098023012280464
of O 0 0.010414927266538143
the O 0 0.015400875359773636
eight O 0 0.02849862165749073
mutations O 0 0.04166611284017563
screened O 0 0.06723441928625107
. O 0 0.05577035993337631

Carriers O 0 0.05939536541700363
of O 0 0.019590672105550766
the O 0 0.01580122299492359
same O 0 0.01466368231922388
mutation O 0 0.018329191952943802
, O 0 0.010038403794169426
from O 0 0.007349052932113409
different O 0 0.005937009584158659
families O 0 0.00980883464217186
, O 0 0.010489621199667454
shared O 0 0.01403240580111742
similar O 0 0.012227986007928848
haplotypes O 0 0.03290289267897606
, O 0 0.00986064225435257
indicating O 0 0.011852053925395012
that O 0 0.006089896894991398
the O 0 0.010517650283873081
mutant O 0 0.031302258372306824
alleles O 0 0.015809552744030952
were O 0 0.007813922129571438
likely O 0 0.008779856376349926
to O 0 0.006982526276260614
be O 0 0.007183360867202282
identical O 0 0.01067298837006092
by O 0 0.0066997273825109005
descent O 0 0.013880809769034386
for O 0 0.008542085066437721
a O 0 0.014088528230786324
mutation O 0 0.015440201386809349
in O 0 0.011987726204097271
the O 0 0.017285475507378578
founder O 1 0.9653001427650452
population O 0 0.021740339696407318
. O 0 0.03945954889059067

The O 0 0.028672145679593086
identification O 0 0.022251559421420097
of O 0 0.015488787554204464
common O 0 0.02871464565396309
BRCA1 O 1 0.9999979734420776
and O 0 0.27475959062576294
BRCA2 O 1 0.9999924898147583
mutations O 0 0.02023962140083313
will O 0 0.012508349493145943
facilitate O 0 0.02034161612391472
carrier O 0 0.23230987787246704
detection O 0 0.019840538501739502
in O 0 0.009679083712399006
French O 0 0.024135272949934006
Canadian O 1 0.9407769441604614
breast B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 1 0.9999992847442627
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 1 0.8946840763092041
. O 0 0.058517832309007645

Are O 0 0.03421381115913391
Dp71 O 1 0.985795259475708
and O 0 0.037854213267564774
Dp140 O 1 0.9999544620513916
brain O 1 0.9995924830436707
dystrophin O 1 0.9996397495269775
isoforms O 0 0.037847135215997696
related O 0 0.02105121687054634
to O 0 0.01895909197628498
cognitive B-Disease 1 0.9998306035995483
impairment I-Disease 1 1.0
in O 1 0.9999977350234985
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999864101409912

Molecular O 0 0.06126152724027634
study O 0 0.027999993413686752
and O 0 0.02062041498720646
neuropsychological O 0 0.056456152349710464
analysis O 0 0.01518439780920744
were O 0 0.009144040755927563
performed O 0 0.015692679211497307
concurrently O 0 0.017391057685017586
on O 0 0.010901602916419506
49 O 0 0.028894754126667976
patients O 1 0.9874259233474731
with O 1 0.9954001307487488
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DMD B-Disease 1 1.0
) O 0 0.020882967859506607
in O 0 0.012501961551606655
order O 0 0.011871256865561008
to O 0 0.010527457110583782
find O 0 0.011901387013494968
a O 0 0.010723075829446316
molecular O 0 0.012443399988114834
explanation O 0 0.01118798553943634
for O 0 0.008723638951778412
the O 0 0.013744000345468521
cognitive B-Disease 1 0.9981751441955566
impairment I-Disease 1 0.999998927116394
observed O 0 0.018755773082375526
in O 0 0.018780125305056572
most O 0 0.39149209856987
DMD B-Disease 1 1.0
patients O 1 0.9999924898147583
. O 0 0.061476096510887146

Complete O 0 0.04079049453139305
analysis O 0 0.023146705701947212
of O 0 0.01890917867422104
the O 0 0.0213942788541317
dystrophin O 1 0.9998641014099121
gene O 0 0.023237962275743484
was O 0 0.02119077369570732
performed O 0 0.01763339899480343
to O 0 0.010064799338579178
define O 0 0.01662363111972809
the O 0 0.01367893535643816
localization O 0 0.028166389092803
of O 0 0.015944069251418114
deletions O 0 0.034615568816661835
and O 0 0.016075540333986282
duplications O 0 0.036665234714746475
in O 0 0.012854015454649925
relation O 0 0.014576173387467861
to O 0 0.012389489449560642
the O 0 0.016794346272945404
different O 0 0.01898942142724991
DMD B-Disease 1 0.9999998807907104
promoters O 1 0.9926364421844482
. O 0 0.061299946159124374

Qualitative O 0 0.05983896553516388
analysis O 0 0.0256331879645586
of O 0 0.01777314767241478
the O 0 0.018444014713168144
Dp71 O 1 0.9851747155189514
transcript O 0 0.03347776457667351
and O 0 0.012985424138605595
testing O 0 0.015598013065755367
for O 0 0.008237008936703205
the O 0 0.00954492762684822
specific O 0 0.00892002135515213
first O 0 0.015771469101309776
exon O 0 0.03893376141786575
of O 0 0.016716057434678078
Dp140 O 0 0.47772714495658875
were O 0 0.013693495653569698
also O 0 0.015784773975610733
carried O 0 0.022984575480222702
out O 0 0.024578094482421875
. O 0 0.03521623834967613

Neuropsychological O 0 0.2887655198574066
analysis O 0 0.033791910856962204
assessed O 0 0.03943689912557602
verbal O 0 0.04350966215133667
and O 0 0.021524108946323395
visuospatial O 1 0.9987471103668213
intelligence O 0 0.026756495237350464
, O 0 0.01856527291238308
verbal O 1 0.972274124622345
memory O 1 0.9998335838317871
, O 0 0.021019071340560913
and O 0 0.017993059009313583
reading O 0 0.03948728367686272
skills O 0 0.05849571153521538
. O 0 0.043680205941200256

Comparison O 0 0.045486219227313995
of O 0 0.02294977754354477
molecular O 0 0.03265497833490372
and O 0 0.02032274194061756
psychometric O 0 0.38609203696250916
findings O 0 0.02009132318198681
demonstrated O 0 0.020811544731259346
that O 0 0.011757236905395985
deletions O 0 0.030371904373168945
and O 0 0.015600948594510555
duplications O 0 0.03547843545675278
that O 0 0.008199644275009632
were O 0 0.009206311777234077
localized O 0 0.020070916041731834
in O 0 0.01039140298962593
the O 0 0.013552787713706493
distal O 1 0.5453559756278992
part O 0 0.01431834977120161
of O 0 0.010596487671136856
the O 0 0.012278485111892223
gene O 0 0.014222579076886177
seemed O 0 0.01588595099747181
to O 0 0.01072689052671194
be O 0 0.01112819742411375
preferentially O 0 0.030593562871217728
associated O 0 0.02013753540813923
with O 0 0.022689994424581528
cognitive B-Disease 1 0.9995242357254028
impairment I-Disease 1 0.9999994039535522
. O 0 0.06670266389846802

Two O 0 0.0447177030146122
altered O 0 0.059194691479206085
Dp71 O 0 0.12015050649642944
transcripts O 0 0.0381966270506382
and O 0 0.016148924827575684
two O 0 0.01385118905454874
deleted O 0 0.03321218490600586
Dp140 O 0 0.05227978527545929
DNA O 0 0.019012166187167168
sequences O 0 0.010665856301784515
were O 0 0.005976275075227022
found O 0 0.0055753388442099094
in O 0 0.006498922593891621
four O 0 0.010775282047688961
patients O 1 0.9994682669639587
with O 1 0.9925609230995178
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.9988934397697449

These O 0 0.022979531437158585
findings O 0 0.022454917430877686
suggest O 0 0.01339983195066452
that O 0 0.007519764360040426
some O 0 0.007072251755744219
sequences O 0 0.011090407148003578
located O 0 0.013893679715692997
in O 0 0.008998031727969646
the O 0 0.012397345155477524
distal O 0 0.039144910871982574
part O 0 0.012460603378713131
of O 0 0.010481382720172405
the O 0 0.011266636662185192
gene O 0 0.011980448849499226
and O 0 0.008403459563851357
, O 0 0.007641197182238102
in O 0 0.006862903479486704
particular O 0 0.007712510414421558
, O 0 0.007860539481043816
some O 0 0.009077034890651703
DMD B-Disease 1 0.9999996423721313
isoforms O 0 0.0185822993516922
expressed O 0 0.01110451202839613
in O 0 0.010554571636021137
the O 0 0.030542638152837753
brain O 1 0.9969531297683716
may O 0 0.008841277100145817
be O 0 0.006251180078834295
related O 0 0.008803820237517357
to O 0 0.009760601446032524
the O 0 0.014563740231096745
cognitive B-Disease 1 0.9985895752906799
impairment I-Disease 1 0.9999998807907104
associated O 1 0.8702958822250366
with O 1 0.9324690103530884
DMD B-Disease 1 1.0
. O 0 0.047871656715869904
. O 0 0.05383941903710365

I1307K O 1 0.9986338019371033
APC O 1 0.9998489618301392
and O 0 0.03925420343875885
hMLH1 O 1 0.9858149290084839
mutations O 0 0.023731041699647903
in O 0 0.012079751119017601
a O 0 0.015475899912416935
non O 0 0.02290811575949192
- O 1 0.7534329295158386
Jewish O 0 0.017109990119934082
family O 0 0.016135185956954956
with O 0 0.013128459453582764
hereditary B-Disease 1 0.9999998807907104
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9637147784233093

We O 0 0.03249174728989601
describe O 0 0.02863658405840397
a O 0 0.019732413813471794
French O 0 0.029153354465961456
Canadian O 0 0.03195742890238762
hereditary B-Disease 1 0.9999978542327881
non I-Disease 1 0.9999967813491821
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 1 0.9999994039535522
HNPCC B-Disease 1 1.0
) O 0 0.3166079819202423
kindred O 1 0.9999107122421265
which O 0 0.01821378618478775
carries O 0 0.03027240000665188
a O 0 0.025617113336920738
novel O 0 0.05537756159901619
truncating O 1 0.9589173197746277
mutation O 0 0.04821336641907692
in O 0 0.0350261926651001
hMLH1 O 1 0.927475094795227
. O 0 0.06344583630561829

Interestingly O 0 0.08541763573884964
, O 0 0.028903894126415253
the O 0 0.026328137144446373
I1307K O 1 0.9995668530464172
APC O 1 0.9999759197235107
polymorphism O 0 0.05392159894108772
, O 0 0.015423855744302273
associated O 0 0.010051941499114037
with O 0 0.00639371620491147
an O 0 0.00766478618606925
increased O 0 0.012151610106229782
risk O 1 0.9875538349151611
of O 1 0.9999788999557495
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9858224987983704
is O 0 0.012387674301862717
also O 0 0.010558366775512695
present O 0 0.011449858546257019
in O 0 0.01165183074772358
this O 0 0.013526191003620625
family O 0 0.03261478617787361
. O 0 0.04128037765622139

The O 0 0.05439004674553871
I1307K O 1 0.8952168226242065
polymorphism O 0 0.04773266240954399
has O 0 0.01829863153398037
previously O 0 0.015418985858559608
only O 0 0.00943619105964899
been O 0 0.009107856079936028
identified O 0 0.009745036251842976
in O 0 0.006852695718407631
individuals O 0 0.006593324709683657
of O 0 0.01052746269851923
self O 1 0.998812198638916
- O 1 0.9999948740005493
reported O 0 0.04258617013692856
Ashkenazi O 1 0.7951963543891907
Jewish O 0 0.040713321417570114
origins O 0 0.05557982996106148
. O 0 0.051576074212789536

In O 0 0.030420953407883644
addition O 0 0.019753649830818176
, O 0 0.013006501831114292
in O 0 0.00907230470329523
this O 0 0.008406265638768673
family O 0 0.013369669206440449
, O 0 0.008647162467241287
there O 0 0.006739574018865824
appears O 0 0.010155843570828438
to O 0 0.007538770325481892
be O 0 0.0060764504596591
no O 0 0.007509799208492041
relationship O 0 0.009517746046185493
between O 0 0.008928469382226467
the O 0 0.012103736400604248
I1307K O 1 0.9010765552520752
polymorphism O 0 0.028274690732359886
and O 0 0.01170420553535223
the O 0 0.011126634664833546
presence O 0 0.013584430329501629
or O 0 0.012143450789153576
absence O 0 0.09618934988975525
of O 1 0.7054896950721741
cancer B-Disease 1 1.0
. O 0 0.03212273120880127
. O 0 0.03970082104206085

Identification O 0 0.046439044177532196
of O 0 0.02409145049750805
a O 0 0.025338588282465935
novel O 0 0.03263939172029495
mutation O 0 0.021206781268119812
of O 0 0.015338930301368237
the O 0 0.019360478967428207
CPO O 1 0.9978297352790833
gene O 0 0.019436080008745193
in O 0 0.013691138476133347
a O 0 0.021148378029465675
Japanese O 1 0.8080554604530334
hereditary B-Disease 1 0.9999960660934448
coproporphyria I-Disease 1 0.9999971389770508
family O 0 0.16412308812141418
. O 0 0.05723413825035095

Hereditary B-Disease 1 0.9999967813491821
coproporphyria I-Disease 1 0.9999948740005493
( O 1 0.7714241147041321
HCP B-Disease 1 0.9999960660934448
) O 0 0.0182049423456192
is O 0 0.014484412968158722
an O 0 0.01576027274131775
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.9999998807907104
disease I-Disease 1 1.0
characterized O 1 0.9995796084403992
by O 0 0.012761777266860008
a O 1 0.988670825958252
deficiency B-Disease 1 1.0
of I-Disease 1 0.9996675252914429
coproporphyrinogen I-Disease 1 1.0
oxidase I-Disease 1 0.9999996423721313
( O 1 0.7200012803077698
CPO O 1 0.9999386072158813
) O 0 0.02224392630159855
caused O 0 0.02044040709733963
by O 0 0.01134356576949358
a O 0 0.016895007342100143
mutation O 0 0.020126258954405785
in O 0 0.015787648037075996
the O 0 0.02680668607354164
CPO O 1 0.9997275471687317
gene O 0 0.052354615181684494
. O 0 0.049433980137109756

Only O 0 0.02672756090760231
11 O 0 0.026073988527059555
mutations O 0 0.019276004284620285
of O 0 0.010961943306028843
the O 0 0.012996288947761059
gene O 0 0.012290403246879578
have O 0 0.007077101618051529
been O 0 0.010342169553041458
reported O 0 0.018160423263907433
in O 0 0.026265081018209457
HCP B-Disease 1 0.9999998807907104
patients O 1 0.9999463558197021
. O 0 0.059269338846206665

We O 0 0.025544529780745506
report O 0 0.02311527356505394
another O 0 0.02358354441821575
mutation O 0 0.022130701690912247
in O 0 0.01536179892718792
a O 0 0.026012424379587173
Japanese O 0 0.05936013534665108
family O 0 0.051578689366579056
. O 0 0.04852842167019844

Polymerase O 0 0.24262939393520355
chain O 0 0.08356782048940659
reaction O 0 0.04514539614319801
- O 1 0.8448886871337891
single O 0 0.03364260494709015
strand O 0 0.04642658680677414
conformational O 0 0.04692699387669563
polymorphism O 0 0.04214967042207718
and O 0 0.016656041145324707
direct O 0 0.017331438139081
sequence O 0 0.014747260138392448
analyses O 0 0.018543709069490433
demonstrated O 0 0.019039541482925415
a O 0 0.01888430304825306
C O 0 0.14732390642166138
to O 0 0.020219942554831505
T O 1 0.7114570140838623
substitution O 0 0.026248304173350334
in O 0 0.015389216132462025
exon O 0 0.04223006218671799
1 O 0 0.019686313346028328
of O 0 0.012633039616048336
the O 0 0.017237229272723198
CPO O 0 0.2439771294593811
gene O 0 0.020631810650229454
at O 0 0.017519256100058556
nucleotide O 0 0.020810531452298164
position O 0 0.020886780694127083
85 O 0 0.033715758472681046
, O 0 0.015697473660111427
which O 0 0.01285517681390047
lies O 0 0.019154276698827744
in O 0 0.013377232477068901
the O 0 0.019465455785393715
putative O 0 0.09661865234375
presequence O 1 0.6754207015037537
for O 0 0.02290918305516243
targeting O 0 0.0368795171380043
to O 0 0.03004445880651474
mitochondria O 0 0.06874572485685349
. O 0 0.049721941351890564

This O 0 0.029892103746533394
mutation O 0 0.033201999962329865
changes O 0 0.015289903618395329
the O 0 0.015140524134039879
codon O 0 0.031037993729114532
for O 0 0.014430861920118332
glutamine O 0 0.034314755350351334
to O 0 0.013997149653732777
a O 0 0.018706677481532097
termination O 0 0.05639239028096199
codon O 0 0.039138875901699066
at O 0 0.027090471237897873
amino O 0 0.03221041336655617
acid O 0 0.038878150284290314
position O 0 0.03968224674463272
29 O 0 0.059215426445007324
. O 0 0.0511317141354084

MaeI O 1 0.8864059448242188
restriction O 0 0.04425148665904999
analysis O 0 0.02217741124331951
showed O 0 0.019701160490512848
two O 0 0.01079147681593895
other O 0 0.01164808589965105
carriers O 0 0.0238905418664217
in O 0 0.015074115246534348
the O 0 0.021391376852989197
family O 0 0.03829612955451012
. O 0 0.04283837974071503

The O 0 0.05347132310271263
C O 1 0.9998075366020203
- O 1 0.9999979734420776
T O 1 0.999990701675415
mutation O 0 0.026735646650195122
is O 0 0.012639554217457771
located O 0 0.016365844756364822
within O 0 0.009477227926254272
a O 0 0.013679849915206432
recently O 0 0.020599259063601494
proposed O 0 0.01923779770731926
putative O 0 0.04221957549452782
alternative O 0 0.020352765917778015
translation O 0 0.02167680114507675
initiation O 0 0.03462344408035278
codon O 0 0.04185744747519493
( O 0 0.02854269929230213
TIC O 1 0.999969482421875
- O 1 0.9996993541717529
1 O 0 0.027220282703638077
) O 0 0.01319399569183588
, O 0 0.01120487879961729
supporting O 0 0.014070676639676094
that O 0 0.011379257775843143
TIC O 1 0.9999986886978149
- O 1 0.9996412992477417
1 O 0 0.019992811605334282
is O 0 0.011587640270590782
the O 0 0.01420638244599104
real O 0 0.02631871961057186
TIC O 1 0.9972884654998779
rather O 0 0.017163529992103577
than O 0 0.017243124544620514
TIC O 1 0.9999995231628418
- O 1 0.999915361404419
2 O 0 0.037150442600250244
. O 0 0.029043186455965042
. O 0 0.04501272365450859

Human B-Disease 0 0.04315986484289169
complement I-Disease 0 0.22979451715946198
factor I-Disease 1 0.9991865754127502
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 1 0.999937891960144
with O 1 0.9999998807907104
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 1 0.9999911785125732

This O 0 0.020634345710277557
study O 0 0.015175758861005306
reports O 0 0.012838594615459442
on O 0 0.00880597997456789
six O 0 0.011534660123288631
cases O 0 0.011979082599282265
of O 0 0.07417043298482895
deficiency B-Disease 1 1.0
in I-Disease 0 0.014100448228418827
the I-Disease 0 0.012611462734639645
human I-Disease 0 0.013372194021940231
complement I-Disease 0 0.024310722947120667
regulatory I-Disease 0 0.03030162863433361
protein I-Disease 0 0.029023343697190285
Factor I-Disease 0 0.4784376621246338
H I-Disease 1 0.9999949932098389
( O 0 0.031406547874212265
FH O 1 0.9999843835830688
) O 0 0.013621949590742588
in O 0 0.008180555887520313
the O 0 0.008702379651367664
context O 0 0.01167136151343584
of O 0 0.014096551574766636
an O 1 0.999971866607666
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9999727010726929

Five O 0 0.026011204347014427
of O 0 0.01568763330578804
the O 0 0.012927357107400894
cases O 0 0.01051488146185875
were O 0 0.007733683567494154
observed O 0 0.008417326956987381
in O 0 0.00813787616789341
children O 0 0.011809708550572395
presenting O 0 0.04316224530339241
with O 1 0.9994725584983826
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 1.0
HUS B-Disease 1 1.0
) O 1 0.968910276889801
. O 0 0.0698053240776062

Two O 0 0.025660213083028793
of O 0 0.019580110907554626
the O 0 0.020705055445432663
children O 0 0.022677404806017876
exhibited O 0 0.3460455536842346
a O 1 0.6549561023712158
homozygous O 1 0.9999984502792358
deficiency O 1 1.0
characterized O 1 0.9911541938781738
by O 0 0.011840835213661194
the O 0 0.01170638669282198
absence O 0 0.016414115205407143
of O 0 0.011317167431116104
the O 0 0.013449104502797127
150 O 0 0.029143813997507095
- O 1 0.9989882111549377
kD O 1 0.9692790508270264
form O 0 0.0158779788762331
of O 0 0.015838149935007095
Factor O 0 0.42729106545448303
H O 1 0.9999697208404541
and O 0 0.012751128524541855
the O 0 0.0112565066665411
presence O 0 0.012174871750175953
, O 0 0.010419139638543129
upon O 0 0.013946238905191422
immunoblotting O 0 0.12281475216150284
, O 0 0.011229356750845909
of O 0 0.009831739589571953
the O 0 0.011864122934639454
42 O 0 0.03422936797142029
- O 1 0.9996048808097839
kD O 1 0.9999680519104004
Factor O 1 0.8193614482879639
H O 1 0.9999927282333374
- O 1 0.9543907642364502
like O 0 0.019657917320728302
protein O 0 0.01860062964260578
1 O 0 0.02269444614648819
( O 0 0.024290697649121284
FHL O 1 0.9999713897705078
- O 1 0.9972756505012512
1 O 0 0.024625616148114204
) O 0 0.012513387016952038
and O 0 0.010331595316529274
other O 0 0.011630088090896606
FH O 1 0.9999994039535522
- O 1 0.9999674558639526
related O 0 0.04032321646809578
protein O 0 0.031109962612390518
( O 0 0.03380311280488968
FHR O 1 0.999836802482605
) O 0 0.0405828095972538
bands O 0 0.05963597446680069
. O 0 0.05770506337285042

Southern O 0 0.08508829772472382
blot O 1 0.7726479172706604
and O 0 0.03116658516228199
PCR O 0 0.05099271610379219
analysis O 0 0.017367957159876823
of O 0 0.013162779621779919
DNA O 0 0.013728923164308071
of O 0 0.010294376872479916
one O 0 0.012640364468097687
patient O 1 0.9788170456886292
with O 0 0.020016534253954887
homozygous O 1 0.9999008178710938
deficiency O 1 1.0
ruled O 0 0.40908363461494446
out O 0 0.014193407259881496
the O 0 0.01159964594990015
presence O 0 0.0135513786226511
of O 0 0.010199523530900478
a O 0 0.012792005203664303
large O 0 0.01323594432324171
deletion O 0 0.02186109870672226
of O 0 0.012179702520370483
the O 0 0.017297564074397087
FH O 1 0.9999990463256836
gene O 0 0.01838928833603859
as O 0 0.013024209067225456
the O 0 0.017479214817285538
underlying O 1 0.6167580485343933
defect O 1 0.9998365640640259
for O 0 0.034681230783462524
the O 1 0.9876036643981934
deficiency O 1 1.0
. O 0 0.1945236772298813

The O 0 0.025047775357961655
other O 0 0.012472262606024742
four O 0 0.013483882881700993
children O 0 0.013936234638094902
presented O 0 0.019553961232304573
with O 0 0.018750052899122238
heterozygous O 1 0.99845290184021
deficiency O 1 1.0
and O 0 0.428348571062088
exhibited O 1 0.9604997634887695
a O 0 0.021433260291814804
normal O 0 0.021987933665513992
immunoblotting O 1 0.6790642142295837
pattern O 0 0.02257636934518814
of O 0 0.015608037821948528
proteins O 0 0.017376882955431938
of O 0 0.01612372323870659
the O 0 0.03215930610895157
FH O 1 0.9999997615814209
family O 0 0.1838928759098053
. O 0 0.04804813861846924

Factor B-Disease 1 0.9999881982803345
H I-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 0.017656253650784492
the O 0 0.014769814908504486
only O 0 0.019443312659859657
complement B-Disease 1 0.999996542930603
deficiency I-Disease 1 1.0
associated O 1 0.999215841293335
with O 1 0.9947315454483032
HUS B-Disease 1 1.0
. O 0 0.25689175724983215

These O 0 0.02472078613936901
observations O 0 0.028845954686403275
suggest O 0 0.016672426834702492
a O 0 0.014397477731108665
role O 0 0.016316011548042297
for O 0 0.01604350470006466
FH O 1 0.9999998807907104
and O 0 0.13679346442222595
/ O 1 0.9999167919158936
or O 0 0.02438035048544407
FH O 1 0.9999946355819702
receptors O 0 0.030007721856236458
in O 0 0.015746749937534332
the O 0 0.02240189164876938
pathogenesis O 1 0.9999998807907104
of O 1 0.9995738863945007
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 1 0.7426513433456421
. O 0 0.06487701088190079

Further O 0 0.033204831182956696
evidence O 0 0.0196409709751606
for O 0 0.013150131329894066
a O 0 0.014885232783854008
major O 0 0.02028580941259861
ancient O 0 0.026973698288202286
mutation O 0 0.48614302277565
underlying O 1 0.9999815225601196
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 1 0.9937319159507751
linkage O 1 0.9999741315841675
disequilibrium O 1 0.9999912977218628
studies O 0 0.020893801003694534
in O 0 0.014414321631193161
the O 0 0.01828724890947342
Japanese O 0 0.043170616030693054
population O 0 0.02315596677362919
. O 0 0.042096227407455444

The O 1 0.8737174272537231
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999984502792358
DM B-Disease 1 1.0
) O 0 0.07038936764001846
mutation O 0 0.02663048356771469
is O 0 0.012132976204156876
an O 0 0.01446570735424757
unstable O 1 0.9994803071022034
( O 0 0.07695568352937698
CTG O 1 0.999997615814209
) O 0 0.022564131766557693
n O 0 0.029010701924562454
repeat O 0 0.024705583229660988
, O 0 0.012906772084534168
present O 0 0.0117019172757864
at O 0 0.011576325632631779
a O 0 0.011265382170677185
copy O 0 0.01613268256187439
number O 0 0.007645196747034788
of O 0 0.009535139426589012
5 O 0 0.0176103375852108
- O 0 0.07181911915540695
37 O 0 0.028362851589918137
repeats O 0 0.023554012179374695
on O 0 0.013918686658143997
normal O 0 0.018620707094669342
chromosomes O 0 0.02169221267104149
but O 0 0.012959729880094528
amplified O 0 0.03329296410083771
to O 0 0.017063597217202187
50 O 0 0.03141417354345322
- O 1 0.5394451022148132
3000 O 0 0.06701069325208664
copies O 0 0.03792208060622215
on O 0 0.04293747991323471
DM B-Disease 1 0.9999998807907104
chromosomes O 0 0.08541011065244675
. O 0 0.05872413516044617

Previous O 0 0.048794664442539215
findings O 0 0.03190676122903824
in O 0 0.020293783396482468
Caucasian O 0 0.045804619789123535
populations O 0 0.015598541125655174
of O 0 0.015472609549760818
a O 0 0.19109489023685455
DM B-Disease 1 1.0
founder O 1 0.9999967813491821
chromosome O 0 0.08466526865959167
raise O 0 0.022955842316150665
a O 0 0.014190685003995895
question O 0 0.012982435524463654
about O 0 0.010045414790511131
the O 0 0.01120283454656601
molecular O 0 0.01826457679271698
events O 0 0.01312674954533577
involved O 0 0.009839736856520176
in O 0 0.010243060998618603
the O 0 0.015076356939971447
expansion O 0 0.03919801115989685
mutation O 0 0.04348611459136009
. O 0 0.045228682458400726

To O 0 0.03464314714074135
investigate O 0 0.03348948806524277
whether O 0 0.01749289594590664
a O 0 0.019942468032240868
founder O 0 0.22408030927181244
chromosome O 0 0.023867467418313026
for O 0 0.013679062947630882
the O 0 0.027462385594844818
DM B-Disease 1 1.0
mutation O 0 0.13436074554920197
exists O 0 0.017555832862854004
in O 0 0.010880357585847378
the O 0 0.012012828141450882
Japanese O 0 0.024638501927256584
population O 0 0.009815877303481102
, O 0 0.012755979783833027
we O 0 0.012438888661563396
genotyped O 0 0.04385766386985779
families O 0 0.01625615730881691
using O 0 0.014610081911087036
polymorphic O 0 0.04267347231507301
markers O 0 0.027821365743875504
near O 0 0.023067127913236618
the O 0 0.017198005691170692
( O 0 0.02539493888616562
CTG O 1 0.9999332427978516
) O 0 0.026135053485631943
n O 0 0.03823927417397499
repeat O 0 0.039281971752643585
region O 0 0.025866445153951645
and O 0 0.022038862109184265
constructed O 0 0.059218697249889374
haplotypes O 0 0.09840568900108337
. O 0 0.05306832492351532

Six O 0 0.036739178001880646
different O 0 0.016540419310331345
haplotypes O 0 0.03679791837930679
were O 0 0.010929855518043041
found O 0 0.013972767628729343
and O 0 0.02074935846030712
DM B-Disease 1 1.0
alleles O 0 0.12766775488853455
were O 0 0.019654231145977974
always O 0 0.027799202129244804
haplotype O 0 0.06903944909572601
A O 0 0.04983127489686012
. O 0 0.04909664765000343

To O 0 0.0263162013143301
find O 0 0.021264979615807533
an O 0 0.012739164754748344
origin O 0 0.009520620107650757
of O 0 0.010241146199405193
the O 0 0.015335127711296082
( O 0 0.022623231634497643
CTG O 1 0.9999945163726807
) O 0 0.02099248394370079
n O 0 0.0309333186596632
repeat O 0 0.03380829468369484
mutation O 0 0.019459465518593788
and O 0 0.009750816971063614
to O 0 0.009079411625862122
investigate O 0 0.014926500618457794
the O 0 0.00967954471707344
mechanism O 0 0.011163120158016682
of O 0 0.008342244662344456
the O 0 0.010487141087651253
expansion O 0 0.021134207025170326
mutation O 0 0.013909930363297462
in O 0 0.008008795790374279
the O 0 0.01100227516144514
Japanese O 0 0.019871952012181282
population O 0 0.008338253945112228
we O 0 0.007937460206449032
have O 0 0.006838791538029909
studied O 0 0.014883330091834068
90 O 0 0.022714708000421524
Japanese O 0 0.10686428099870682
DM B-Disease 1 1.0
families O 0 0.02976839616894722
comprising O 0 0.036182522773742676
190 O 0 0.0489303357899189
affected O 0 0.025890974327921867
and O 0 0.02298249863088131
130 O 0 0.049911532551050186
unaffected O 0 0.07311290502548218
members O 0 0.035191427916288376
. O 0 0.05112225189805031

The O 0 0.031346023082733154
results O 0 0.018036676570773125
suggest O 0 0.014760186895728111
that O 0 0.007033392321318388
a O 0 0.010261165909469128
few O 0 0.010022489354014397
common O 0 0.011736351065337658
ancestral O 0 0.041421111673116684
mutations O 0 0.014919708482921124
in O 0 0.010189173743128777
both O 0 0.012059868313372135
Caucasian O 1 0.9940740466117859
and O 0 0.013739166781306267
Japanese O 0 0.03258011117577553
populations O 0 0.012489423155784607
have O 0 0.00833562109619379
originated O 0 0.013927849940955639
by O 0 0.0070994263514876366
expansion O 0 0.01558657269924879
of O 0 0.010434997268021107
an O 0 0.014206623658537865
ancestral O 0 0.0410400852560997
n O 0 0.03174738585948944
= O 0 0.031780585646629333
5 O 0 0.021955501288175583
repeat O 0 0.025439303368330002
to O 0 0.01745331473648548
n O 0 0.032866090536117554
= O 0 0.04453139379620552
19 O 0 0.041233569383621216
- O 0 0.2056906372308731
37 O 0 0.05330829322338104
copies O 0 0.047423191368579865
. O 0 0.04810997098684311

These O 0 0.024243267253041267
data O 0 0.018939977511763573
support O 0 0.024129418656229973
multistep O 0 0.04673466086387634
models O 0 0.02516534924507141
of O 0 0.01879374124109745
triplet O 1 0.856884777545929
repeat O 0 0.03672730177640915
expansion O 0 0.02064916118979454
that O 0 0.007360221352428198
have O 0 0.006287786643952131
been O 0 0.006970733404159546
proposed O 0 0.010345215909183025
for O 0 0.010419145226478577
both O 0 0.018267014995217323
DM B-Disease 1 1.0
and O 1 0.9921958446502686
Friedreichs B-Disease 1 1.0
ataxia I-Disease 1 0.9999998807907104
. O 0 0.045570749789476395
. O 0 0.05213949829339981

The O 0 0.03615573048591614
molecular O 0 0.033560559153556824
basis O 0 0.022087527438998222
of O 1 0.542750358581543
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 0.023440396413207054
the O 0 0.020929494872689247
western O 0 0.02974058873951435
Cape O 1 0.9468501210212708
, O 0 0.02371247671544552
South O 0 0.03744978457689285
Africa O 0 0.049853719770908356
. O 0 0.05212618038058281

Deficiency B-Disease 1 0.9999992847442627
of I-Disease 0 0.022556014358997345
the I-Disease 0 0.019107647240161896
sixth I-Disease 1 0.9629532098770142
component I-Disease 0 0.10373076051473618
of I-Disease 0 0.01329027209430933
human I-Disease 0 0.014491364359855652
complement I-Disease 1 0.905508279800415
( O 0 0.26252374053001404
C6 O 1 0.9999997615814209
) O 0 0.0160974133759737
has O 0 0.01117364689707756
been O 0 0.010208326391875744
reported O 0 0.01164298690855503
in O 0 0.008096463978290558
a O 0 0.009084873832762241
number O 0 0.007037418894469738
of O 0 0.008477937430143356
families O 0 0.009328021667897701
from O 0 0.007864114828407764
the O 0 0.012991164810955524
western O 0 0.020000264048576355
Cape O 0 0.4116700291633606
, O 0 0.023831026628613472
South O 0 0.03536341339349747
Africa O 0 0.048594776540994644
. O 0 0.044035691767930984

Meningococcal B-Disease 1 1.0
disease I-Disease 1 1.0
is O 0 0.03888535127043724
endemic O 1 0.9778514504432678
in O 0 0.014597907662391663
the O 0 0.01648050732910633
Cape O 0 0.4512750804424286
and O 0 0.01045896578580141
almost O 0 0.010297305881977081
all O 0 0.007979897782206535
pedigrees O 0 0.02275792695581913
of O 0 0.013959359377622604
total O 1 0.9457734823226929
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 1 0.9997366070747375
C6Q0 O 1 1.0
) O 0 0.014539403840899467
have O 0 0.008919059298932552
been O 0 0.01069162879139185
ascertained O 0 0.029887909069657326
because O 0 0.016991043463349342
of O 0 0.16182896494865417
recurrent O 1 1.0
disease O 1 1.0
. O 1 0.8504275679588318

We O 0 0.031530510634183884
have O 0 0.01640128716826439
sequenced O 0 0.029357634484767914
the O 0 0.015314649790525436
expressed O 0 0.01696697436273098
exons O 0 0.028628896921873093
of O 0 0.015396639704704285
the O 0 0.019512154161930084
C6 O 1 0.9999920129776001
gene O 0 0.01772947981953621
from O 0 0.011970959603786469
selected O 0 0.018321480602025986
cases O 0 0.011224783025681973
and O 0 0.008222123607993126
have O 0 0.005721684079617262
found O 0 0.0068151638843119144
three O 0 0.00934444647282362
molecular O 0 0.022926801815629005
defects O 1 0.9942371845245361
leading O 0 0.018141428008675575
to O 0 0.011598448269069195
total O 0 0.050470005720853806
deficiency O 1 1.0
879delG O 1 0.9999995231628418
, O 0 0.0163798239082098
which O 0 0.007596736308187246
is O 0 0.0072848075069487095
the O 0 0.009072172455489635
common O 0 0.013057516887784004
defect O 1 0.9967233538627625
in O 0 0.012562960386276245
the O 0 0.015690375119447708
Cape O 0 0.3240847885608673
and O 0 0.016445498913526535
hitherto O 0 0.044331144541502
unreported O 0 0.029478315263986588
, O 0 0.013347535394132137
and O 0 0.013057714328169823
1195delC O 1 0.9980260133743286
and O 0 0.015463726595044136
1936delG O 1 0.9992759823799133
, O 0 0.012397881597280502
which O 0 0.007552674971520901
have O 0 0.005510452203452587
been O 0 0.0069609698839485645
previously O 0 0.012006915174424648
reported O 0 0.01145932450890541
in O 0 0.012500901706516743
African O 0 0.05527545511722565
- O 1 0.9995763897895813
Americans O 0 0.041518449783325195
. O 0 0.04575890302658081

We O 0 0.028880801051855087
also O 0 0.017362821847200394
show O 0 0.014401234686374664
that O 0 0.00785762444138527
the O 0 0.012909367680549622
879delG O 1 0.996319055557251
and O 0 0.023841053247451782
1195delC O 1 0.9999954700469971
defects O 1 0.9996340274810791
are O 0 0.009411385282874107
associated O 0 0.014578651636838913
with O 0 0.01562442071735859
characteristic O 1 0.9993517994880676
C6 O 1 1.0
/ O 1 0.9999986886978149
C7 O 1 0.9999970197677612
region O 0 0.036402616649866104
DNA O 0 0.03340189903974533
marker O 1 0.6099626421928406
haplotypes O 0 0.055105436593294144
, O 0 0.01759914495050907
although O 0 0.01368628442287445
small O 0 0.015772312879562378
variations O 0 0.018714239820837975
were O 0 0.014543743804097176
observed O 0 0.027025289833545685
. O 0 0.0408458448946476

The O 0 0.05418821796774864
1936delG O 1 0.9999713897705078
defect O 1 0.9999291896820068
was O 0 0.03187571465969086
observed O 0 0.014691225253045559
only O 0 0.009915575385093689
once O 0 0.012703986838459969
in O 0 0.009153174236416817
the O 0 0.011547145433723927
Cape O 0 0.05292540788650513
, O 0 0.010097977705299854
but O 0 0.007146073505282402
its O 0 0.011183386668562889
associated O 0 0.01678863912820816
haplotype O 0 0.216913104057312
could O 0 0.01512323971837759
be O 0 0.01707109995186329
deduced O 0 0.057621441781520844
. O 0 0.043182868510484695

The O 0 0.030331088230013847
data O 0 0.018398189917206764
from O 0 0.0135172875598073
the O 0 0.01536670420318842
haplotypes O 0 0.031974907964468
indicate O 0 0.013790355995297432
that O 0 0.006842273287475109
these O 0 0.007085389923304319
three O 0 0.010183636099100113
molecular O 0 0.02734115719795227
defects O 1 0.9912712574005127
account O 0 0.011544919572770596
for O 0 0.010896523483097553
the O 0 0.015019988641142845
defects O 1 0.9948660135269165
in O 0 0.011035275645554066
all O 0 0.008166767656803131
the O 0 0.012846816331148148
38 O 0 0.028052184730768204
unrelated O 0 0.03325468301773071
C6Q0 O 1 0.9999290704727173
individuals O 0 0.010705376975238323
we O 0 0.008312246762216091
have O 0 0.0068969689309597015
studied O 0 0.015954142436385155
from O 0 0.015352382324635983
the O 0 0.02313164621591568
Cape O 0 0.1555785834789276
. O 0 0.0520508773624897

We O 0 0.025682909414172173
have O 0 0.012855381704866886
also O 0 0.014143242500722408
observed O 0 0.014739066362380981
the O 0 0.019374871626496315
879delG O 1 0.9881735444068909
defect O 1 0.5015470385551453
in O 0 0.01380777359008789
two O 0 0.015097182244062424
Dutch O 1 0.9992231130599976
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 0.9999995231628418
kindreds O 1 0.9980560541152954
, O 0 0.01563330553472042
but O 0 0.01039568055421114
the O 0 0.015478536486625671
879delG O 1 0.9999347925186157
defect O 1 0.9972988963127136
in O 0 0.013124889694154263
the O 0 0.014323586598038673
Cape O 1 0.9590367078781128
probably O 0 0.015063620172441006
did O 0 0.010051733814179897
not O 0 0.006383376661688089
come O 0 0.009798253886401653
from O 0 0.00861311610788107
The O 0 0.015692908316850662
Netherlands O 0 0.044201355427503586
. O 0 0.02323949709534645
. O 0 0.03749898821115494

Complement B-Disease 1 0.999981164932251
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 0.032213080674409866
seven O 0 0.022422848269343376
further O 0 0.020336788147687912
molecular O 1 0.5150099396705627
defects O 1 0.9999308586120605
and O 0 0.015199972316622734
their O 0 0.014531999826431274
associated O 0 0.038109537214040756
marker O 1 0.9930116534233093
haplotypes O 0 0.35215961933135986
. O 0 0.05568600445985794

Seven O 0 0.036217186599969864
further O 0 0.023465247824788094
molecular O 0 0.03328075259923935
bases O 0 0.03633637726306915
of O 1 0.9632779955863953
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.031027527526021004
described O 0 0.06613359600305557
. O 0 0.04964671656489372

All O 0 0.02351866289973259
these O 0 0.014214740134775639
new O 0 0.024902375414967537
molecular O 0 0.03775006905198097
defects O 1 0.9900277256965637
involve O 0 0.022365929558873177
single O 0 0.024537084624171257
- O 1 0.9937456846237183
nucleotide O 0 0.027866777032613754
events O 0 0.018674936145544052
, O 0 0.016292303800582886
deletions O 0 0.027628665789961815
and O 0 0.013906936161220074
substitutions O 0 0.022627871483564377
, O 0 0.009897193871438503
some O 0 0.006818718276917934
of O 0 0.00926858652383089
which O 0 0.010824195109307766
alter O 0 0.02549632452428341
splice O 0 0.044905949383974075
sites O 0 0.019443687051534653
, O 0 0.016883833333849907
and O 0 0.018304897472262383
others O 0 0.0239503625780344
codons O 0 0.059190575033426285
. O 0 0.04746638610959053

They O 0 0.02011171542108059
are O 0 0.00900992751121521
distributed O 0 0.013695827685296535
along O 0 0.014064631424844265
the O 0 0.01824682019650936
C7 O 1 0.9999998807907104
gene O 0 0.021154768764972687
, O 0 0.012563374824821949
but O 0 0.009605995379388332
predominantly O 0 0.013481422327458858
towards O 0 0.014495349489152431
the O 0 0.01843101903796196
3 O 0 0.03025842271745205
end O 0 0.03414555639028549
. O 0 0.04419810324907303

All O 0 0.026453306898474693
were O 0 0.018255721777677536
found O 0 0.015169751830399036
in O 0 0.01817137561738491
compound O 0 0.04619576409459114
heterozygous O 0 0.04571343958377838
individuals O 0 0.026798365637660027
. O 0 0.044681988656520844

The O 0 0.07968239486217499
C6 O 1 0.9999996423721313
/ O 1 0.9999890327453613
C7 O 1 0.9999973773956299
marker O 1 0.8980532884597778
haplotypes O 0 0.08387473970651627
associated O 0 0.02438506856560707
with O 0 0.019235987216234207
most O 0 0.3707607090473175
C7 B-Disease 1 1.0
defects I-Disease 1 0.999998927116394
are O 0 0.01789439469575882
tabulated O 0 0.04705885797739029
. O 0 0.03234716132283211
. O 0 0.04692916199564934

A O 0 0.05710746347904205
genome O 0 0.05321156233549118
- O 0 0.3741772174835205
wide O 0 0.02493162825703621
search O 0 0.022789809852838516
for O 0 0.017275337129831314
chromosomal O 0 0.082737997174263
loci O 0 0.035249657928943634
linked O 0 0.028419779613614082
to O 0 0.01686013676226139
mental O 1 1.0
health O 1 0.9999997615814209
wellness O 1 0.9999995231628418
in O 0 0.014444254338741302
relatives O 0 0.01931603252887726
at O 0 0.01530298963189125
high O 0 0.056365005671978
risk O 1 0.9778599739074707
for O 1 0.9865378141403198
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 0.43595945835113525
the O 0 0.10546118766069412
Old O 1 0.966107964515686
Order O 0 0.04405944421887398
Amish O 0 0.2663635015487671
. O 0 0.05471203848719597

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 1 0.9995189905166626
BPAD B-Disease 1 1.0
; O 1 0.9999978542327881
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 1 0.9462375640869141
is O 0 0.013470937497913837
characterized O 0 0.01748124696314335
by O 0 0.00895704235881567
episodes O 0 0.018178999423980713
of O 0 0.02136535756289959
mania B-Disease 1 1.0
and O 1 0.857867956161499
/ O 1 0.9999942779541016
or O 0 0.045434050261974335
hypomania B-Disease 1 0.999998927116394
interspersed O 0 0.042269267141819
with O 0 0.016864286735653877
periods O 0 0.03141848370432854
of O 0 0.0433758907020092
depression B-Disease 1 0.9999998807907104
. O 0 0.06564958393573761

Compelling O 0 0.06243685260415077
evidence O 0 0.022441474720835686
supports O 0 0.0244357381016016
a O 0 0.015999911352992058
significant O 0 0.017308561131358147
genetic O 0 0.01986095681786537
component O 0 0.02617831528186798
in O 0 0.012999695725739002
the O 0 0.01876537688076496
susceptibility O 1 0.9921958446502686
to O 0 0.027955707162618637
develop O 1 0.9912548065185547
BPAD B-Disease 1 0.9999995231628418
. O 0 0.0638166069984436

To O 0 0.02898227795958519
date O 0 0.02361239492893219
, O 0 0.016632532700896263
however O 0 0.010729461908340454
, O 0 0.013661826960742474
linkage O 0 0.020669352263212204
studies O 0 0.011049424298107624
have O 0 0.006264574825763702
attempted O 0 0.01310567744076252
only O 0 0.006671588402241468
to O 0 0.008839498274028301
identify O 0 0.01558593101799488
chromosomal O 1 0.5334370136260986
loci O 0 0.02510329894721508
that O 0 0.009806687012314796
cause O 0 0.0859065055847168
or O 0 0.009168490767478943
increase O 0 0.0124973114579916
the O 0 0.01331728883087635
risk O 0 0.061555903404951096
of O 0 0.023656871169805527
developing O 1 0.9972953200340271
BPAD B-Disease 1 0.9999998807907104
. O 0 0.06477244943380356

To O 0 0.02461295947432518
determine O 0 0.01807156577706337
whether O 0 0.011583869345486164
there O 0 0.007873009890317917
could O 0 0.010649002157151699
be O 0 0.010788093321025372
protective O 1 0.969773530960083
alleles O 0 0.021259868517518044
that O 0 0.009863524697721004
prevent O 0 0.014261445961892605
or O 0 0.009606254287064075
reduce O 0 0.015634965151548386
the O 0 0.011596755124628544
risk O 0 0.017447829246520996
of O 0 0.013147935271263123
developing O 1 0.9245878458023071
BPAD B-Disease 1 1.0
, O 0 0.013152712024748325
similar O 0 0.009157201275229454
to O 0 0.00776459788903594
what O 0 0.007572720758616924
is O 0 0.006315573118627071
observed O 0 0.007119803223758936
in O 0 0.007859219796955585
other O 0 0.009516848251223564
genetic B-Disease 1 0.9996395111083984
disorders I-Disease 1 1.0
, O 0 0.025954751297831535
we O 0 0.01068271603435278
used O 0 0.016509506851434708
mental O 1 0.9999998807907104
health O 1 1.0
wellness O 1 1.0
( O 0 0.017991119995713234
absence O 0 0.018399568274617195
of O 0 0.012988956645131111
any O 0 0.10212651640176773
psychiatric B-Disease 1 1.0
disorder I-Disease 1 1.0
) O 0 0.1375846415758133
as O 0 0.012701665982604027
the O 0 0.013225870206952095
phenotype O 0 0.03396659716963768
in O 0 0.013238098472356796
our O 0 0.016511837020516396
genome O 0 0.03088785521686077
- O 1 0.9611743688583374
wide O 0 0.02408279851078987
linkage O 0 0.038188204169273376
scan O 0 0.03152010217308998
of O 0 0.013098222203552723
several O 0 0.010128968395292759
large O 0 0.016678674146533012
multigeneration O 1 0.9518928527832031
Old O 0 0.039584867656230927
Order O 0 0.028073927387595177
Amish O 0 0.05875081568956375
pedigrees O 0 0.054571643471717834
exhibiting O 0 0.0367933064699173
an O 0 0.017591627314686775
extremely O 0 0.034777309745550156
high O 1 0.5970479846000671
incidence O 1 0.9998883008956909
of O 0 0.4531463384628296
BPAD B-Disease 1 1.0
. O 0 0.0682779923081398

We O 0 0.027094444260001183
have O 0 0.01484040915966034
found O 0 0.013411436229944229
strong O 0 0.014591035433113575
evidence O 0 0.01088807824999094
for O 0 0.010393330827355385
a O 0 0.015338225290179253
locus O 0 0.05287149176001549
on O 0 0.020646460354328156
chromosome O 0 0.04311390593647957
4p O 1 0.9999827146530151
at O 0 0.03419305384159088
D4S2949 O 1 0.6228938698768616
( O 0 0.02523905597627163
maximum O 0 0.03651389107108116
GENEHUNTER O 1 0.9997652173042297
- O 1 0.9313116669654846
PLUS O 0 0.06306783854961395
nonparametric O 0 0.08272534608840942
linkage O 0 0.05146891996264458
score O 0 0.03073292225599289
= O 0 0.03777129203081131
4 O 0 0.02246028557419777
. O 0 0.014021769165992737
05 O 1 0.5425967574119568
, O 0 0.022509533911943436
P O 0 0.1266317516565323
= O 0 0.031993571668863297
5 O 0 0.017444241791963577
. O 0 0.00933254323899746
22 O 0 0.016012610867619514
x O 0 0.022145390510559082
10 O 0 0.015711037442088127
( O 0 0.0151233971118927
- O 1 0.8377417325973511
4 O 0 0.023953918367624283
) O 0 0.018367256969213486
; O 0 0.019663603976368904
SIBPAL O 1 0.77984219789505
Pempirical O 0 0.16649135947227478
value O 0 0.02148670144379139
< O 0 0.048193104565143585
3 O 0 0.022296566516160965
x O 0 0.025104381144046783
10 O 0 0.016664134338498116
( O 0 0.016321437433362007
- O 1 0.9838799834251404
5 O 0 0.021747536957263947
) O 0 0.015424152836203575
) O 0 0.013577870093286037
and O 0 0.01372380368411541
suggestive O 0 0.025364933535456657
evidence O 0 0.010004593059420586
for O 0 0.009482963010668755
a O 0 0.01645968295633793
locus O 0 0.05131293460726738
on O 0 0.020506514236330986
chromosome O 0 0.03947370871901512
4q O 1 0.9997434020042419
at O 0 0.032240621745586395
D4S397 O 1 0.6481385231018066
( O 0 0.02442420832812786
maximum O 0 0.03980060666799545
GENEHUNTER O 1 0.9993311166763306
- O 1 0.8025204539299011
PLUS O 0 0.05708619952201843
nonparametric O 0 0.06855661422014236
linkage O 0 0.04044988006353378
score O 0 0.024869633838534355
= O 0 0.033487025648355484
3 O 0 0.019116578623652458
. O 0 0.013007774017751217
29 O 0 0.022686822339892387
, O 0 0.01827809400856495
P O 0 0.07406985014677048
= O 0 0.030196554958820343
2 O 0 0.020457228645682335
. O 0 0.012363995425403118
57 O 0 0.027663132175803185
x O 0 0.025080867111682892
10 O 0 0.018740316852927208
( O 0 0.01867426373064518
- O 1 0.8777984380722046
3 O 0 0.023673871532082558
) O 0 0.018479125574231148
; O 0 0.020805994048714638
SIBPAL O 1 0.7369850277900696
Pempirical O 0 0.08179032802581787
value O 0 0.024623794481158257
< O 0 0.048447661101818085
1 O 0 0.024189269170165062
x O 0 0.02456996962428093
10 O 0 0.017835041508078575
( O 0 0.01683015190064907
- O 1 0.9911683797836304
3 O 0 0.020025011152029037
) O 0 0.01214251946657896
) O 0 0.008924406953155994
that O 0 0.006187331397086382
are O 0 0.0066873058676719666
linked O 0 0.016191640868782997
to O 0 0.019047725945711136
mental O 1 1.0
health O 1 1.0
wellness O 1 1.0
. O 0 0.2769920229911804

These O 0 0.022530656307935715
findings O 0 0.020935026928782463
are O 0 0.008014063350856304
consistent O 0 0.014292859472334385
with O 0 0.009612766094505787
the O 0 0.011170475743710995
hypothesis O 0 0.01719103567302227
that O 0 0.007468605879694223
certain O 0 0.009362746961414814
alleles O 0 0.015734193846583366
could O 0 0.00941094383597374
prevent O 0 0.01388661377131939
or O 0 0.009670937433838844
modify O 0 0.02112499251961708
the O 0 0.015438077040016651
clinical O 1 0.9991944432258606
manifestations O 1 0.9949918389320374
of O 0 0.4229261577129364
BPAD B-Disease 1 1.0
and O 0 0.020587356761097908
perhaps O 0 0.022958965972065926
other O 0 0.015223709866404533
related O 1 0.9970023036003113
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 1 0.789566159248352

Segregation O 1 0.9983783960342407
distortion O 1 0.999427080154419
in O 1 0.9447332620620728
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.8848440051078796

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999949932098389
DM B-Disease 1 1.0
) O 0 0.02332455664873123
is O 0 0.012735075317323208
an O 0 0.016644515097141266
autosomal B-Disease 1 0.9999997615814209
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
which O 0 0.014040716923773289
, O 0 0.010310212150216103
in O 0 0.009041458368301392
the O 0 0.012991989962756634
typical O 0 0.022360648959875107
pedigree O 0 0.10852514207363129
, O 0 0.013140599243342876
shows O 0 0.014047887176275253
a O 0 0.0159150380641222
three O 0 0.016603313386440277
generation O 0 0.06327856332063675
anticipation O 0 0.1187869980931282
cascade O 1 0.9418189525604248
. O 0 0.06101306527853012

This O 0 0.022027743980288506
results O 0 0.01862429268658161
in O 0 0.019056256860494614
infertility B-Disease 1 1.0
and O 1 0.9999991655349731
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
CDM B-Disease 1 1.0
) O 0 0.018409352749586105
with O 0 0.011488254182040691
the O 0 0.012566142715513706
disappearance O 0 0.027149703353643417
of O 0 0.05567822977900505
DM B-Disease 1 1.0
in O 0 0.027207130566239357
that O 0 0.022068891674280167
pedigree O 0 0.2980099320411682
. O 0 0.05085255205631256

The O 0 0.0378524512052536
concept O 0 0.03515830263495445
of O 0 0.02336728200316429
segregation O 1 0.9397328495979309
distortion O 1 0.9832166433334351
, O 0 0.01729092001914978
where O 0 0.011761480942368507
there O 0 0.009215558879077435
is O 0 0.009519661776721478
preferential O 0 0.021572880446910858
transmission O 0 0.015984436497092247
of O 0 0.008316926658153534
the O 0 0.009504782035946846
larger O 0 0.014167742803692818
allele O 0 0.018878331407904625
at O 0 0.01380778569728136
the O 0 0.0191411804407835
DM B-Disease 1 1.0
locus O 1 0.9996809959411621
, O 0 0.015606660395860672
has O 0 0.011699503287672997
been O 0 0.009766604751348495
put O 0 0.014891539700329304
forward O 0 0.014853724278509617
to O 0 0.01217998843640089
explain O 0 0.017583636566996574
partially O 0 0.02201923169195652
the O 0 0.015072161331772804
maintenance O 1 0.6399633884429932
of O 0 0.053231675177812576
DM B-Disease 1 1.0
in O 0 0.026667628437280655
the O 0 0.02520475536584854
population O 0 0.027055291458964348
. O 0 0.04215648025274277

In O 0 0.02818896807730198
a O 0 0.024773070588707924
survey O 0 0.031063757836818695
of O 0 0.026109904050827026
DM B-Disease 1 1.0
in O 0 0.02316662296652794
Northern O 0 0.026429874822497368
Ireland O 0 0.02933303825557232
, O 0 0.022797949612140656
59 O 0 0.049199219793081284
pedigrees O 0 0.06194596365094185
were O 0 0.02974381484091282
ascertained O 0 0.07648716866970062
. O 0 0.05140802264213562

Sibships O 1 0.9007202982902527
where O 0 0.023966321721673012
the O 0 0.014658412896096706
status O 0 0.014777728356420994
of O 0 0.009283262304961681
all O 0 0.007343302480876446
the O 0 0.008853738196194172
members O 0 0.008489970117807388
had O 0 0.009715594351291656
been O 0 0.008497138507664204
identified O 0 0.009539027698338032
were O 0 0.0067747957073152065
examined O 0 0.011920478194952011
to O 0 0.00827513076364994
determine O 0 0.009296371601521969
the O 0 0.00870893057435751
transmission O 0 0.014503742568194866
of O 0 0.01168346218764782
the O 0 0.022288421168923378
DM B-Disease 1 1.0
expansion O 0 0.24153339862823486
from O 0 0.020671427249908447
affected O 0 0.023072728887200356
parents O 0 0.021206051111221313
to O 0 0.018198123201727867
their O 0 0.022110452875494957
offspring O 0 0.058438416570425034
. O 0 0.04413143917918205

Where O 0 0.03640463575720787
the O 0 0.02663341350853443
transmitting O 0 0.21465660631656647
parent O 1 0.6666878461837769
was O 0 0.03128056228160858
male O 0 0.03502052277326584
, O 0 0.030394695699214935
58 O 0 0.07015173882246017
. O 0 0.047672685235738754

3 O 0 0.04406699910759926
% O 0 0.020820187404751778
of O 0 0.01491527259349823
the O 0 0.014551309868693352
offspring O 0 0.021950848400592804
were O 0 0.009790669195353985
affected O 0 0.012789687141776085
, O 0 0.009507534094154835
and O 0 0.008962741121649742
in O 0 0.008274638094007969
the O 0 0.009264184162020683
case O 0 0.011840444058179855
of O 0 0.009983084164559841
a O 0 0.014979753643274307
female O 0 0.03302978351712227
transmitting O 1 0.690803050994873
parent O 0 0.2911665141582489
, O 0 0.0314330980181694
68 O 0 0.06831973046064377
. O 0 0.05018315091729164

7 O 0 0.06534839421510696
% O 0 0.038332805037498474
were O 0 0.029554370790719986
affected O 0 0.04971585050225258
. O 0 0.05502086505293846

Studies O 0 0.042441464960575104
on O 0 0.028348637744784355
meiotic O 1 0.9975577592849731
drive O 0 0.04427126795053482
in O 0 0.024702835828065872
DM B-Disease 1 1.0
have O 0 0.014911677688360214
shown O 0 0.013884407468140125
increased O 0 0.013195870444178581
transmission O 0 0.017891494557261467
of O 0 0.01007823459804058
the O 0 0.011371332220733166
larger O 0 0.014672971330583096
allele O 0 0.022521428763866425
at O 0 0.015912214294075966
the O 0 0.020490828901529312
DM B-Disease 1 1.0
locus O 1 0.9864814281463623
in O 0 0.02143166959285736
non O 1 0.9923582673072815
- O 1 1.0
DM O 1 1.0
heterozygotes O 1 0.9998360872268677
for O 0 0.05135512724518776
CTGn O 1 0.9964160919189453
. O 0 0.06710465997457504

This O 0 0.02093231864273548
study O 0 0.01960703171789646
provides O 0 0.017846856266260147
further O 0 0.011711020953953266
evidence O 0 0.009205777198076248
that O 0 0.008513230830430984
the O 0 0.018967492505908012
DM B-Disease 1 1.0
expansion O 0 0.4008638262748718
tends O 0 0.035521045327186584
to O 0 0.018873827531933784
be O 0 0.02197415567934513
transmitted O 0 0.04741639271378517
preferentially O 0 0.07559654861688614
. O 0 0.05332239717245102

Diagnosis O 1 0.9999940395355225
of O 1 0.9467549920082092
hemochromatosis B-Disease 1 1.0
. O 0 0.20184341073036194

If O 0 0.050554949790239334
untreated O 1 0.999998927116394
, O 1 0.989687979221344
hemochromatosis B-Disease 1 1.0
can O 0 0.4230099320411682
cause O 1 0.9999940395355225
serious O 1 0.9999996423721313
illness O 1 1.0
and O 0 0.46023041009902954
early B-Disease 0 0.06601373851299286
death I-Disease 1 0.8201612830162048
, O 0 0.008390882052481174
but O 0 0.007509675808250904
the O 0 0.017936965450644493
disease O 1 0.999998927116394
is O 0 0.010200202465057373
still O 0 0.012672816403210163
substantially O 0 0.04190228506922722
under O 1 0.8695977926254272
- O 1 1.0
diagnosed O 1 0.9999998807907104
. O 0 0.05009238049387932

The O 0 0.04454997926950455
cornerstone O 1 0.5226706862449646
of O 0 0.025579841807484627
screening O 0 0.039294879883527756
and O 0 0.017027391120791435
case O 0 0.018802359700202942
detection O 0 0.024263089522719383
is O 0 0.011182944290339947
the O 0 0.012159209698438644
measurement O 0 0.021714936941862106
of O 0 0.020977426320314407
serum O 1 0.9998809099197388
transferrin O 1 0.9998974800109863
saturation O 1 0.910406768321991
and O 0 0.022454174235463142
the O 0 0.03179803490638733
serum O 1 0.9998881816864014
ferritin O 1 0.9998687505722046
level O 0 0.05918438732624054
. O 0 0.05742067098617554

Once O 0 0.04719209298491478
the O 0 0.02797091007232666
diagnosis O 1 0.9999798536300659
is O 0 0.014863445423543453
suspected O 0 0.020922956988215446
, O 0 0.013857560232281685
physicians O 0 0.15438605844974518
must O 0 0.012637817300856113
use O 0 0.017956284806132317
serum O 1 0.9999610185623169
ferritin O 1 0.9999717473983765
levels O 0 0.02686433307826519
and O 0 0.025547003373503685
hepatic O 1 0.9999997615814209
iron O 1 0.999994158744812
stores O 0 0.04617730528116226
on O 0 0.026222843676805496
liver O 1 0.999998927116394
biopsy O 1 0.9998822212219238
specimens O 0 0.03007430024445057
to O 0 0.016539031639695168
assess O 0 0.03028777427971363
patients O 0 0.02363213524222374
for O 0 0.011179633438587189
the O 0 0.014400914311408997
presence O 0 0.02174042910337448
of O 0 0.12502622604370117
iron B-Disease 1 0.9999998807907104
overload I-Disease 1 0.9999994039535522
. O 0 0.0686798170208931

Liver O 1 1.0
biopsy O 1 0.9999876022338867
is O 0 0.019756270572543144
also O 0 0.012457305565476418
used O 0 0.009084362536668777
to O 0 0.007967880927026272
establish O 0 0.011953064240515232
the O 0 0.009371952153742313
presence O 0 0.011270593851804733
or O 0 0.008533811196684837
absence O 0 0.01789499633014202
of O 0 0.12825389206409454
cirrhosis B-Disease 1 1.0
, O 0 0.2027440071105957
which O 0 0.010312800295650959
can O 0 0.010291126556694508
affect O 0 0.024196743965148926
prognosis O 1 0.9999997615814209
and O 0 0.047461044043302536
management O 1 0.943009614944458
. O 0 0.04875021427869797

A O 0 0.052816178649663925
DNA O 0 0.04249466955661774
- O 0 0.04442809149622917
based O 0 0.017781099304556847
test O 0 0.016820136457681656
for O 0 0.011805824004113674
the O 0 0.01616760529577732
HFE O 1 0.9999978542327881
gene O 0 0.018009614199399948
is O 0 0.011533464305102825
commercially O 0 0.01864054799079895
available O 0 0.010212981142103672
, O 0 0.008083611726760864
but O 0 0.006110586225986481
its O 0 0.006854114588350058
place O 0 0.009173856116831303
in O 0 0.007506118156015873
the O 0 0.011637506075203419
diagnosis O 1 0.9999754428863525
of O 1 0.9653922319412231
hemochromatosis B-Disease 1 1.0
is O 1 0.5325675010681152
still O 0 0.02185657247900963
being O 0 0.024365337565541267
evaluated O 0 0.05117413401603699
. O 0 0.04735124483704567

Currently O 0 0.046967748552560806
, O 0 0.021827781572937965
the O 0 0.01542631909251213
most O 0 0.012323394417762756
useful O 0 0.014232565648853779
role O 0 0.012072252109646797
for O 0 0.0075202761217951775
this O 0 0.007630515843629837
test O 0 0.012125913985073566
is O 0 0.008027592673897743
in O 0 0.008227401413023472
the O 0 0.010077339597046375
detection O 0 0.021780135110020638
of O 0 0.01707175001502037
hemochromatosis B-Disease 1 1.0
in O 0 0.01237473078072071
the O 0 0.011834174394607544
family O 0 0.01435674075037241
members O 0 0.008384963497519493
of O 0 0.01024671457707882
patients O 1 0.8789052963256836
with O 0 0.008484802208840847
a O 0 0.014381779357790947
proven O 0 0.12724338471889496
case O 0 0.01708851382136345
of O 0 0.01854126527905464
the O 0 0.07984928041696548
disease O 1 0.999998927116394
. O 0 0.05008015036582947

It O 0 0.02706960402429104
is O 0 0.0158157330006361
crucial O 0 0.020614804700016975
to O 0 0.019515885040163994
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999938011169434
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 1.0
because O 1 0.9700389504432678
phlebotomy O 1 1.0
therapy O 1 0.9999994039535522
can O 0 0.018301086500287056
avert O 1 0.9999998807907104
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 1 0.9996507167816162
can O 0 0.010612311773002148
even O 0 0.009202019311487675
lead O 0 0.011430159211158752
to O 0 0.010585300624370575
normal O 0 0.01563865691423416
life O 0 0.027602219954133034
expectancy O 0 0.4562869966030121
. O 0 0.029381612315773964
. O 0 0.04158903285861015

Prevalence O 0 0.403340607881546
of O 0 0.02962992899119854
the O 0 0.030964985489845276
I1307K O 1 0.9999374151229858
APC B-Disease 1 0.9999985694885254
gene O 0 0.027788639068603516
variant O 0 0.025765802711248398
in O 0 0.009951872751116753
Israeli O 0 0.014522990211844444
Jews O 0 0.013835604302585125
of O 0 0.009994576685130596
differing O 0 0.010886548087000847
ethnic O 0 0.008817329071462154
origin O 0 0.00897977501153946
and O 0 0.013605507090687752
risk O 1 0.9999396800994873
for O 1 0.9999923706054688
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9949730634689331

BACKGROUND O 0 0.09386508166790009
& O 1 0.5897049903869629
AIMS O 0 0.058170534670352936
Israeli O 0 0.024957003071904182
Jews O 0 0.018071074038743973
of O 0 0.013275648467242718
European O 0 0.017582911998033524
birth O 0 0.19776901602745056
, O 0 0.014898635447025299
i O 0 0.017000451683998108
. O 0 0.012818909250199795
e O 0 0.022323353216052055
. O 0 0.010654522106051445
, O 0 0.012650879099965096
Ashkenazim O 0 0.035037655383348465
, O 0 0.009980554692447186
have O 0 0.006731362547725439
the O 0 0.014675131067633629
highest O 1 0.9999979734420776
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 1 0.9999996423721313
of O 0 0.019502732902765274
any O 0 0.013911828398704529
Israeli O 0 0.023767588660120964
ethnic O 0 0.024602821096777916
group O 0 0.037285756319761276
. O 0 0.04065674915909767

The O 0 0.0602891780436039
I1307K O 1 0.9990094900131226
APC B-Disease 1 0.9999767541885376
gene O 0 0.04128244146704674
variant O 0 0.061642732471227646
was O 0 0.022038280963897705
found O 0 0.016914144158363342
in O 0 0.019366364926099777
6 O 0 0.040843378752470016
. O 0 0.04213346540927887

1 O 0 0.04479025676846504
% O 0 0.02027854695916176
of O 0 0.015154728665947914
American O 0 0.01751144416630268
Jews O 0 0.01617370918393135
, O 0 0.009978867135941982
28 O 0 0.014110196381807327
% O 0 0.008741147816181183
of O 0 0.009487532079219818
their O 0 0.0162225179374218
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 1 0.9999074935913086
, O 0 0.0246041938662529
but O 0 0.0072950078174471855
not O 0 0.006386068649590015
in O 0 0.010440967045724392
non O 0 0.032064683735370636
- O 1 0.9994052648544312
Jews O 0 0.04133191332221031
. O 0 0.044901058077812195

We O 0 0.03684738650918007
assessed O 0 0.04124099016189575
the O 0 0.02999592386186123
I1307K O 1 0.9929719567298889
prevalence O 1 0.9401594996452332
in O 0 0.01570834591984749
Israeli O 0 0.02049540914595127
Jews O 0 0.01684706099331379
of O 0 0.010854328982532024
differing O 0 0.011873663403093815
ethnic O 0 0.010690934024751186
origin O 0 0.009985003620386124
and O 0 0.012442203238606453
risk O 1 0.9997913241386414
for O 1 0.9999854564666748
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.99070143699646

METHODS O 0 0.04840847849845886
DNA O 0 0.02955855429172516
samples O 0 0.01845049113035202
from O 0 0.013566622510552406
500 O 0 0.026870662346482277
unrelated O 0 0.01565597578883171
Jews O 0 0.01202334649860859
of O 0 0.008783478289842606
European O 0 0.012101182714104652
or O 0 0.009780199266970158
non O 0 0.019383277744054794
- O 1 0.9492681622505188
European O 0 0.012361451052129269
origin O 0 0.008751541376113892
, O 0 0.008247253485023975
with O 0 0.0066809928975999355
or O 0 0.006516822148114443
without O 0 0.00721199344843626
a O 0 0.01025412604212761
personal O 0 0.11345032602548599
and O 0 0.01460754219442606
/ O 1 0.9967840909957886
or O 0 0.010368098504841328
family O 0 0.015074341557919979
history O 0 0.016243640333414078
of O 0 0.018472351133823395
neoplasia B-Disease 1 0.9999995231628418
, O 0 0.01597585156559944
were O 0 0.010208360850811005
examined O 0 0.01837320625782013
for O 0 0.011017878539860249
the O 0 0.015509297139942646
I1307K O 1 0.5319836735725403
variant O 0 0.027529198676347733
by O 0 0.01114696729928255
the O 0 0.016234438866376877
allele O 0 0.035863086581230164
- O 1 0.9350835084915161
specific O 0 0.02140292525291443
oligonucleotide O 1 0.8482692837715149
( O 0 0.034001462161540985
ASO O 1 0.9999970197677612
) O 0 0.03946516290307045
method O 0 0.04237411543726921
. O 0 0.04799390956759453

RESULTS O 0 0.038402244448661804
In O 0 0.017083067446947098
persons O 0 0.012209881097078323
at O 0 0.014765020459890366
average O 0 0.016965273767709732
risk O 1 0.5981640219688416
for O 1 0.9855901598930359
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 1 0.9870748519897461
I1307K O 1 0.9999754428863525
was O 0 0.027524029836058617
found O 0 0.015495731495320797
in O 0 0.01931365393102169
5 O 0 0.035137347877025604
. O 0 0.042974233627319336

0 O 0 0.05859814211726189
% O 0 0.024321146309375763
of O 0 0.018873393535614014
120 O 0 0.03393393009901047
European O 0 0.026014992967247963
and O 0 0.02551937662065029
1 O 0 0.04261746257543564
. O 0 0.04582491144537926

6 O 0 0.050782013684511185
% O 0 0.02437984012067318
of O 0 0.021220820024609566
188 O 0 0.046904779970645905
non O 0 0.029390914365649223
- O 1 0.8608718514442444
European O 0 0.019920872524380684
Jews O 0 0.022692278027534485
( O 0 0.0254452396184206
P O 1 0.8803116083145142
= O 0 0.05745894834399223
0 O 0 0.04254480078816414
. O 0 0.027920300140976906
08 O 0 0.12033364176750183
) O 0 0.04559725150465965
. O 0 0.05712266266345978

It O 0 0.03371980041265488
occurred O 0 0.0336378812789917
in O 0 0.025761360302567482
15 O 0 0.040606413036584854
. O 0 0.04200631380081177

4 O 0 0.047984909266233444
% O 0 0.020836161449551582
of O 0 0.01633107289671898
52 O 0 0.03342832997441292
Ashkenazi O 0 0.04972587898373604
Israelis O 0 0.02022351510822773
with O 0 0.019067738205194473
familial O 1 0.9999998807907104
cancer B-Disease 1 1.0
( O 1 0.7995025515556335
P O 1 0.9998420476913452
= O 0 0.06662790477275848
0 O 0 0.028864702209830284
. O 0 0.015807822346687317
02 O 1 0.9997655749320984
) O 0 0.015760229900479317
and O 0 0.012106360867619514
was O 0 0.01459930744022131
not O 0 0.007812842726707458
detected O 0 0.01316490862518549
in O 0 0.010225918143987656
51 O 0 0.024159014225006104
non O 0 0.01983361504971981
- O 0 0.08328795433044434
European O 0 0.01789752021431923
Jews O 0 0.0195637084543705
at O 0 0.02247423119843006
increased O 1 0.9274930357933044
cancer B-Disease 1 1.0
risk O 1 0.9998152852058411
. O 0 0.04835570603609085

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999997615814209
occurred O 0 0.07162755727767944
personally O 0 0.41028329730033875
or O 0 0.01594430021941662
in O 0 0.012566440738737583
the O 0 0.011692975647747517
families O 0 0.010675784200429916
of O 0 0.009887340478599072
13 O 0 0.015231538563966751
of O 0 0.010843751952052116
20 O 0 0.02253003418445587
Ashkenazi O 1 0.7489392757415771
I1307K O 1 0.9865732192993164
carriers O 0 0.03626140579581261
, O 0 0.01424479205161333
8 O 0 0.016045235097408295
of O 0 0.010315146297216415
whom O 0 0.013469752855598927
also O 0 0.009210865944623947
had O 0 0.00943257287144661
a O 0 0.010922224260866642
personal O 0 0.026604464277625084
or O 0 0.011821645312011242
family O 0 0.01909647136926651
history O 0 0.021789919584989548
of O 0 0.03111496940255165
noncolonic O 1 0.9999959468841553
neoplasia B-Disease 1 0.999998927116394
. O 0 0.07506628334522247

CONCLUSIONS O 0 0.07024748623371124
The O 0 0.05309339985251427
I1307K O 1 0.9996767044067383
APC O 1 0.9999921321868896
variant O 0 0.4834716320037842
may O 0 0.016793038696050644
represent O 0 0.01451084017753601
a O 0 0.01712677627801895
susceptibility O 1 0.6886826753616333
gene O 0 0.0160441342741251
for O 0 0.01806396059691906
colorectal B-Disease 1 1.0
, I-Disease 0 0.01593223586678505
or I-Disease 0 0.008746504783630371
other I-Disease 0 0.006749108899384737
, I-Disease 0 0.023477116599678993
cancers I-Disease 1 0.9999885559082031
in O 0 0.011163251474499702
Ashkenazi O 1 0.9997416138648987
Jews O 0 0.01694335602223873
, O 0 0.012088957242667675
and O 0 0.010924217291176319
partially O 0 0.019872823730111122
explains O 0 0.01575695350766182
the O 0 0.008813416585326195
higher O 0 0.013003852218389511
incidence O 1 0.999970555305481
of O 1 0.9999597072601318
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 1 0.6130505204200745
European O 0 0.03251965716481209
Israelis O 0 0.042261965572834015
. O 0 0.04215389862656593

Systematic O 0 0.04564294591546059
analysis O 0 0.02602398954331875
of O 0 0.02335943654179573
coproporphyrinogen O 1 0.999915599822998
oxidase O 1 0.9992504715919495
gene O 0 0.05230816826224327
defects O 1 0.9995682835578918
in O 0 0.02967936545610428
hereditary B-Disease 1 0.9999998807907104
coproporphyria I-Disease 1 0.9999991655349731
and O 0 0.42546263337135315
mutation O 0 0.317568838596344
update O 1 0.7214218378067017
. O 0 0.058444757014513016

Hereditary B-Disease 1 0.9999992847442627
coproporphyria I-Disease 1 0.9999986886978149
( O 1 0.9544392824172974
HC B-Disease 1 1.0
) O 0 0.025959456339478493
is O 0 0.017633723095059395
an O 0 0.1728615015745163
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9996750354766846
autosomal O 1 0.9999998807907104
dominant O 1 0.9999856948852539
inheritance O 1 0.9999771118164062
caused O 1 0.9989225268363953
by O 0 0.018248336389660835
deficient B-Disease 1 0.9977555871009827
activity I-Disease 0 0.01919337548315525
of I-Disease 0 0.024580882862210274
coproporphyrinogen I-Disease 1 0.9999997615814209
III I-Disease 1 1.0
oxidase I-Disease 1 0.9999841451644897
( O 0 0.06786833703517914
CPO O 1 0.9974120259284973
) O 0 0.05926879122853279
. O 0 0.05823983997106552

Clinical O 1 0.9961729645729065
manifestations O 1 0.7864736914634705
of O 0 0.029573945328593254
the O 1 0.7785879969596863
disease O 1 0.9999998807907104
are O 0 0.008471710607409477
characterized O 1 0.6697447299957275
by O 0 0.01252812147140503
acute O 1 1.0
attacks O 1 0.9990699887275696
of O 1 0.9999983310699463
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 1 0.9979860782623291
precipitated O 1 0.9999998807907104
by O 0 0.016473805531859398
drugs O 1 0.9889962673187256
, O 0 0.015569849871098995
fasting O 0 0.1470506191253662
, O 0 0.02091815508902073
cyclical O 1 0.9999688863754272
hormonal O 1 0.9999771118164062
changes O 0 0.02085121162235737
, O 0 0.4476253092288971
or O 1 0.9956446886062622
infectious B-Disease 1 1.0
diseases I-Disease 1 1.0
. O 1 0.9254503846168518

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 0.3696925640106201
also O 0 0.022697966545820236
be O 0 0.016489893198013306
present O 0 0.028680967167019844
. O 0 0.042661238461732864

The O 0 0.03923237323760986
seven O 0 0.03216566890478134
exons O 0 0.044025082141160965
, O 0 0.019262397661805153
the O 0 0.022170649841427803
exon O 1 0.9846398830413818
/ O 1 0.998200535774231
intron O 1 0.9725402593612671
boundaries O 0 0.018902836367487907
and O 0 0.012640275992453098
part O 0 0.0132505614310503
of O 0 0.012315706349909306
3 O 0 0.0214238204061985
noncoding O 0 0.04354267194867134
sequence O 0 0.01384405791759491
of O 0 0.012989591807126999
the O 0 0.017984844744205475
CPO O 1 0.9730316400527954
gene O 0 0.022016562521457672
were O 0 0.013238172978162766
systematically O 0 0.025064701214432716
analyzed O 0 0.01921048015356064
by O 0 0.00980038195848465
an O 0 0.016878992319107056
exon O 0 0.1805039644241333
- O 1 0.9271132946014404
by O 0 0.021320896223187447
- O 1 0.9599786400794983
exon O 0 0.30426186323165894
denaturing O 1 0.9822574257850647
gradient O 0 0.4600929021835327
gel O 1 0.999933123588562
electrophoresis O 1 0.9979069232940674
( O 0 0.04270036146044731
DGGE O 1 0.9999868869781494
) O 0 0.022272849455475807
strategy O 0 0.024725820869207382
followed O 0 0.015730153769254684
by O 0 0.009492614306509495
direct O 0 0.016180213540792465
sequencing O 0 0.023197054862976074
in O 0 0.01352690439671278
seven O 0 0.017970331013202667
unrelated O 0 0.02928868867456913
heterozygous O 0 0.05403176695108414
HC B-Disease 1 1.0
patients O 1 0.9994082450866699
from O 0 0.01869479939341545
France O 0 0.14379413425922394
, O 0 0.019844911992549896
Holland O 0 0.40297529101371765
, O 0 0.018693741410970688
and O 0 0.019199885427951813
Czech O 0 0.14261695742607117
Republic O 0 0.06408384442329407
. O 0 0.05020338296890259

Seven O 0 0.04937819764018059
novel O 0 0.04923374205827713
mutations O 0 0.023373890668153763
and O 0 0.013572601601481438
two O 0 0.012453023344278336
new O 0 0.021487193182110786
polymorphisms O 0 0.0402577705681324
were O 0 0.019542071968317032
detected O 0 0.04449104890227318
. O 0 0.04426993057131767

Among O 0 0.034001242369413376
these O 0 0.013688086532056332
mutations O 0 0.017933133989572525
two O 0 0.009531042538583279
are O 0 0.009216547943651676
missense O 0 0.036093566566705704
( O 0 0.02030281536281109
G197W O 1 0.9951580166816711
, O 0 0.0230643879622221
W427R O 1 0.9719914793968201
) O 0 0.016395272687077522
, O 0 0.011704620905220509
two O 0 0.008337094448506832
are O 0 0.007294977083802223
nonsense O 0 0.02698235958814621
( O 0 0.01922784559428692
Q306X O 1 0.9245527982711792
, O 0 0.020576519891619682
Q385X O 1 0.9807515144348145
) O 0 0.015331103466451168
, O 0 0.01144081074744463
two O 0 0.0076522440649569035
are O 0 0.006793012842535973
small O 0 0.014865148812532425
deletions O 0 0.03412433713674545
( O 0 0.02238316275179386
662de14bp O 1 0.9689040780067444
; O 0 0.022465448826551437
1168del3bp O 0 0.22638928890228271
removing O 0 0.030640417709946632
a O 0 0.022808248177170753
glycine O 0 0.03871425613760948
at O 0 0.02066590078175068
position O 0 0.0236098300665617
390 O 0 0.05551334097981453
) O 0 0.01602013222873211
, O 0 0.012568180449306965
and O 0 0.009674345143139362
one O 0 0.00962307583540678
is O 0 0.009833146817982197
a O 0 0.01309515256434679
splicing O 0 0.030379710718989372
mutation O 0 0.0209168940782547
( O 0 0.019801322370767593
IVS1 O 1 0.9997444748878479
- O 1 0.9998651742935181
15c O 1 0.999976634979248
- O 1 0.9999963045120239
- O 1 0.9999932050704956
> O 1 0.9994524121284485
g O 1 0.534023106098175
) O 0 0.019213158637285233
which O 0 0.012844517827033997
creates O 0 0.025674177333712578
a O 0 0.018697289749979973
new O 0 0.02558005414903164
acceptor O 0 0.07163719832897186
splice O 0 0.2940043807029724
site O 0 0.06178177893161774
. O 0 0.05193578824400902

The O 0 0.040954750031232834
pathological O 0 0.04978398233652115
significance O 0 0.02805844508111477
of O 0 0.015176399610936642
the O 0 0.015297774225473404
point O 0 0.018910259008407593
mutations O 0 0.024163922294974327
G197W O 1 0.9351493716239929
, O 0 0.019314350560307503
W427R O 0 0.3985063433647156
, O 0 0.012462517246603966
and O 0 0.00891043245792389
the O 0 0.009535050019621849
in O 0 0.013362199999392033
- O 1 0.9992039799690247
frame O 0 0.05257297679781914
deletion O 0 0.06289398670196533
390delGly O 1 0.6437458992004395
were O 0 0.012009805999696255
assessed O 0 0.016436593607068062
by O 0 0.0073896064423024654
their O 0 0.008838235400617123
respective O 0 0.01267935149371624
expression O 0 0.01106193196028471
in O 0 0.011119915172457695
a O 0 0.014496044255793095
prokaryotic O 0 0.03109043650329113
system O 0 0.020821992307901382
using O 0 0.019093826413154602
site O 0 0.03834711015224457
- O 1 0.7377375364303589
directed O 0 0.05750652775168419
mutagenesis O 0 0.1171397939324379
. O 0 0.05472747981548309

These O 0 0.027719005942344666
mutations O 0 0.026889970526099205
resulted O 0 0.01865287497639656
in O 0 0.010615256614983082
the O 0 0.011539794504642487
absence O 0 0.020758405327796936
or O 0 0.010875657200813293
a O 0 0.015397051349282265
dramatic O 0 0.037798646837472916
decrease O 0 0.029338277876377106
of O 0 0.026807483285665512
CPO O 1 0.9997541308403015
activity O 0 0.04373138025403023
. O 0 0.051988307386636734

The O 0 0.03906966373324394
two O 0 0.023827118799090385
polymorphisms O 0 0.03543635457754135
were O 0 0.015553596429526806
localized O 0 0.029010111466050148
in O 0 0.015132889151573181
noncoding O 0 0.03697719797492027
part O 0 0.014806706458330154
of O 0 0.011113578453660011
the O 0 0.011472667567431927
gene O 0 0.015278423205018044
1 O 0 0.01818760298192501
) O 0 0.013806598260998726
a O 0 0.021003227680921555
C O 1 0.9942266941070557
/ O 1 0.9847768545150757
G O 0 0.244332954287529
polymorphism O 0 0.03876541554927826
in O 0 0.018769126385450363
the O 0 0.022942498326301575
promotor O 1 0.9995692372322083
region O 0 0.027879079803824425
, O 0 0.02208578586578369
142 O 0 0.05357712507247925
bp O 0 0.04714982211589813
upstream O 0 0.028765836730599403
from O 0 0.012936318293213844
the O 0 0.014653819613158703
transcriptional O 0 0.02798563987016678
initiation O 0 0.028022542595863342
site O 0 0.027239762246608734
( O 0 0.02197548747062683
- O 1 0.9986985921859741
142C O 1 0.9995961785316467
/ O 1 0.9999033212661743
G O 1 0.9960766434669495
) O 0 0.016444820910692215
, O 0 0.012831748463213444
and O 0 0.0125529570505023
2 O 0 0.01944177970290184
) O 0 0.013103499077260494
a O 0 0.017628800123929977
6 O 0 0.02871025539934635
bp O 0 0.04988517239689827
deletion O 0 0.046999070793390274
polymorphism O 0 0.03390853852033615
in O 0 0.015042586252093315
the O 0 0.01599234528839588
3 O 0 0.024836275726556778
noncoding O 0 0.03930458426475525
part O 0 0.01674536056816578
of O 0 0.014179660938680172
the O 0 0.01751009002327919
CPO O 1 0.9974842071533203
gene O 0 0.024131309241056442
, O 0 0.019230328500270844
574 O 0 0.07230537384748459
bp O 0 0.0420386977493763
downstream O 0 0.023140963166952133
of O 0 0.010580787435173988
the O 0 0.012379808351397514
last O 0 0.01259674597531557
base O 0 0.017012590542435646
of O 0 0.009016415104269981
the O 0 0.012606795877218246
normal O 0 0.017911087721586227
termination O 0 0.17142419517040253
codon O 0 0.04959072917699814
( O 0 0.04002261906862259
+ O 0 0.29794803261756897
574 O 1 0.9896824955940247
delATTCTT O 1 0.9977017045021057
) O 0 0.05348372459411621
. O 0 0.05927656218409538

Five O 0 0.055997688323259354
intragenic O 1 0.9764624238014221
dimorphisms O 1 0.926845371723175
are O 0 0.013323122635483742
now O 0 0.01585579104721546
well O 0 0.012661902233958244
characterized O 0 0.017821457237005234
and O 0 0.010885115712881088
the O 0 0.010037763975560665
high O 0 0.016651121899485588
degree O 0 0.01804659515619278
of O 0 0.01720801740884781
allelic O 1 0.9002019762992859
heterogeneity O 1 0.6046591401100159
in O 0 0.024863915517926216
HC B-Disease 1 1.0
is O 0 0.01611929014325142
demonstrated O 0 0.01834101788699627
with O 0 0.008914719335734844
seven O 0 0.011426964774727821
new O 0 0.012247122824192047
different O 0 0.00733006140217185
mutations O 0 0.012089047580957413
making O 0 0.010248432867228985
a O 0 0.011425920762121677
total O 0 0.012284373864531517
of O 0 0.014955315738916397
nineteen O 0 0.16709087789058685
CPO O 1 0.9999849796295166
gene B-Disease 1 0.7933999300003052
defects I-Disease 1 0.9999812841415405
reported O 0 0.024677487090229988
so O 0 0.017300371080636978
far O 0 0.020610108971595764
. O 0 0.02297286130487919
. O 0 0.038761649280786514

Coincidence O 0 0.07566742599010468
of O 0 0.026377510279417038
two O 0 0.021546846255660057
novel O 0 0.043029677122831345
arylsulfatase O 1 0.5894654393196106
A O 0 0.03545200452208519
alleles O 0 0.03664208948612213
and O 0 0.025170965120196342
mutation O 0 0.04358453303575516
459 O 1 0.9997715353965759
+ O 1 0.9952581524848938
1G O 1 0.9998335838317871
> O 0 0.09437033534049988
A O 0 0.02988492138683796
within O 0 0.016719622537493706
a O 0 0.017673512920737267
family O 0 0.023684075102210045
with O 0 0.02246442250907421
metachromatic B-Disease 1 0.9999990463256836
leukodystrophy I-Disease 1 1.0
: O 0 0.03510376438498497
molecular O 0 0.029530009254813194
basis O 0 0.01857890374958515
of O 0 0.025948839262127876
phenotypic O 0 0.072261743247509
heterogeneity O 1 0.7380461096763611
. O 0 0.060651034116744995

In O 0 0.0330548919737339
a O 0 0.02512175217270851
family O 0 0.022189006209373474
with O 0 0.013595988042652607
three O 0 0.014609681442379951
siblings O 0 0.030514350160956383
, O 0 0.011300330981612206
one O 0 0.01057393103837967
developed O 0 0.01605411246418953
classical O 0 0.021383797749876976
late O 0 0.05544337257742882
infantile O 1 1.0
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 1 0.9993185997009277
MLD B-Disease 1 1.0
) O 0 0.025319939479231834
, O 0 0.019761087372899055
fatal O 1 0.6215008497238159
at O 0 0.01716809719800949
age O 0 0.01688569411635399
5 O 0 0.0175155159085989
years O 0 0.013556957244873047
, O 0 0.013458751142024994
with O 0 0.014253162778913975
deficient O 1 0.9981178045272827
arylsulfatase O 1 0.9995290040969849
A O 1 0.7689753174781799
( O 0 0.033701784908771515
ARSA O 1 0.9999812841415405
) O 0 0.016900228336453438
activity O 0 0.012672197073698044
and O 0 0.011872152797877789
increased O 0 0.0228191539645195
galactosylsulfatide O 1 0.9999971389770508
( O 1 0.8933789134025574
GS O 1 1.0
) O 0 0.04989751800894737
excretion O 1 0.5829285979270935
. O 0 0.05599335581064224

The O 0 0.029096538200974464
two O 0 0.015198609791696072
other O 0 0.013926409184932709
siblings O 0 0.026954879984259605
, O 0 0.012511389330029488
apparently O 0 0.01431255042552948
healthy O 0 0.015993110835552216
at O 0 0.011911575682461262
12 O 0 0.014183522202074528
( O 0 0.011093933135271072
1 O 0 0.020870890468358994
/ O 0 0.36220934987068176
2 O 0 0.016594797372817993
) O 0 0.009630650281906128
and O 0 0.008694986812770367
15 O 0 0.012213572859764099
years O 0 0.010165818966925144
, O 0 0.009416778571903706
respectively O 0 0.011350402608513832
, O 0 0.009094524197280407
and O 0 0.00815696269273758
their O 0 0.008658072911202908
father O 0 0.04798508808016777
, O 0 0.013120109215378761
apparently O 0 0.017302025109529495
healthy O 0 0.020094262436032295
as O 0 0.010989399626851082
well O 0 0.012351946905255318
, O 0 0.012990630231797695
presented O 0 0.028347454965114594
ARSA O 1 0.9999994039535522
and O 0 0.02919406071305275
GS O 1 0.9999998807907104
values O 0 0.018521886318922043
within O 0 0.010796007700264454
the O 0 0.014705470763146877
range O 0 0.02299880050122738
of O 0 0.034749746322631836
MLD B-Disease 1 1.0
patients O 1 0.9999825954437256
. O 0 0.06813462823629379

Mutation O 0 0.07386685907840729
screening O 0 0.04221430793404579
and O 0 0.017560916021466255
sequence O 0 0.01574494130909443
analysis O 0 0.013795947656035423
disclosed O 0 0.022658726200461388
the O 0 0.0118522047996521
involvement O 0 0.015444515272974968
of O 0 0.009776366874575615
three O 0 0.010612307116389275
different O 0 0.014313087798655033
ARSA O 1 0.9999945163726807
mutations O 0 0.025017762556672096
being O 0 0.015580830164253712
the O 0 0.01638553850352764
molecular O 0 0.02360820583999157
basis O 0 0.01642209105193615
of O 0 0.024330981075763702
intrafamilial O 1 0.9748411774635315
phenotypic O 0 0.14175006747245789
heterogeneity O 1 0.5457016229629517
. O 0 0.06722912192344666

The O 0 0.04723624512553215
late O 0 0.09962891787290573
infantile O 1 0.9999998807907104
patient O 1 0.9999978542327881
inherited O 1 0.9999963045120239
from O 0 0.014983447268605232
his O 0 0.03882768377661705
mother O 0 0.05063434690237045
the O 0 0.013025043532252312
frequent O 0 0.02048802748322487
0 O 0 0.030826382339000702
- O 1 0.9283226728439331
type O 0 0.03154989331960678
mutation O 0 0.034173596650362015
459 O 1 0.9983235001564026
+ O 1 0.9855947494506836
1G O 1 0.9999467134475708
> O 1 0.5376436114311218
A O 0 0.02592807449400425
, O 0 0.013984710909426212
and O 0 0.009540613740682602
from O 0 0.008767273277044296
his O 0 0.015333221293985844
father O 0 0.1258753091096878
a O 0 0.017208097502589226
novel O 0 0.026469143107533455
, O 0 0.016418850049376488
single O 0 0.022593790665268898
basepair O 1 0.5890795588493347
microdeletion O 0 0.20587176084518433
of O 0 0.024300267919898033
guanine O 0 0.052367351949214935
at O 0 0.023546162992715836
nucleotide O 0 0.026223914697766304
7 O 0 0.02345546893775463
in O 0 0.0168550256639719
exon O 0 0.07733267545700073
1 O 0 0.035918090492486954
( O 0 0.03545854240655899
7delG O 1 0.9378665685653687
) O 0 0.047683097422122955
. O 0 0.05268276482820511

The O 0 0.04427773505449295
two O 0 0.03261905536055565
clinically O 1 0.9919569492340088
unaffected O 0 0.4089188277721405
siblings O 0 0.04394180700182915
carried O 0 0.02072610706090927
the O 0 0.020715346559882164
maternal O 1 0.9138646721839905
mutation O 0 0.08929949253797531
459 O 1 0.9999858140945435
+ O 1 0.9995018243789673
1G O 1 0.9999912977218628
> O 1 0.8351635932922363
A O 0 0.02813846990466118
and O 0 0.013603804633021355
, O 0 0.013033155351877213
on O 0 0.01068959105759859
their O 0 0.013244753703474998
paternal O 0 0.3780434727668762
allele O 0 0.03544895723462105
, O 0 0.016960399225354195
a O 0 0.021779172122478485
novel O 0 0.03823791816830635
cytosine O 0 0.05515141412615776
to O 0 0.022495964542031288
thymidine O 0 0.07376524060964584
transition O 0 0.04112409055233002
at O 0 0.03562881052494049
nucleotide O 0 0.05866888538002968
2435 O 1 0.5335618257522583
in O 0 0.02908778376877308
exon O 0 0.07255962491035461
8 O 0 0.03442152217030525
, O 0 0.01982586272060871
resulting O 0 0.020506074652075768
in O 0 0.015930136665701866
substitution O 0 0.02681901678442955
of O 0 0.022089876234531403
alanine O 0 0.1847938895225525
464 O 1 0.990180492401123
by O 0 0.02765183337032795
valine O 1 0.998606264591217
( O 0 0.04764268547296524
A464V O 1 0.9968826770782471
) O 0 0.0452360175549984
. O 0 0.055441755801439285

The O 0 0.05493105202913284
fathers O 0 0.07147462666034698
genotype O 0 0.08218774199485779
thus O 0 0.03293689712882042
was O 0 0.10785145312547684
7delG O 1 0.9999696016311646
/ O 1 0.9998570680618286
A464V O 1 0.9963828325271606
. O 0 0.06993144750595093

Mutation O 0 0.13646262884140015
A464V O 1 0.9098749756813049
was O 0 0.026577632874250412
not O 0 0.010857482440769672
found O 0 0.009628008119761944
in O 0 0.011372759006917477
18 O 0 0.025345124304294586
unrelated O 1 0.7429955005645752
MLD B-Disease 1 1.0
patients O 1 0.9999516010284424
and O 0 0.024324912577867508
50 O 0 0.04003817215561867
controls O 0 0.05367225408554077
. O 0 0.04742003604769707

A464V O 1 0.8505971431732178
, O 0 0.032437875866889954
although O 0 0.020986085757613182
clearly O 0 0.02793297730386257
modifying O 0 0.05586083233356476
ARSA O 1 0.9999985694885254
and O 0 0.3746127486228943
GS O 1 1.0
levels O 0 0.030490534380078316
, O 0 0.017916280776262283
apparently O 0 0.02047017030417919
bears O 0 0.02253330498933792
little O 0 0.01595950312912464
significance O 0 0.01857573725283146
for O 0 0.01638985238969326
clinical O 1 0.9964286684989929
manifestation O 1 0.999920129776001
of O 1 0.9326682090759277
MLD B-Disease 1 1.0
, O 0 0.06492854654788971
mimicking O 0 0.4666030704975128
the O 0 0.03223282843828201
frequent O 0 0.3077312707901001
ARSA O 1 0.9999991655349731
pseudodeficiency O 1 0.9996627569198608
allele O 0 0.1284976303577423
. O 0 0.07049763947725296

Our O 0 0.0398094579577446
results O 0 0.024348976090550423
demonstrate O 0 0.020219821482896805
that O 0 0.008380135521292686
in O 0 0.008742883801460266
certain O 0 0.010195735841989517
genetic O 0 0.017226818948984146
conditions O 1 0.65324866771698
MLD B-Disease 1 1.0
- O 1 0.9999990463256836
like O 0 0.06881438940763474
ARSA O 1 0.9999984502792358
and O 0 0.048198092728853226
GS O 1 1.0
values O 0 0.018089504912495613
need O 0 0.01337498053908348
not O 0 0.007311715744435787
be O 0 0.008385146968066692
paralleled O 0 0.0236995667219162
by O 0 0.013673493638634682
clinical O 1 0.9999998807907104
disease O 1 1.0
, O 0 0.01404250506311655
a O 0 0.013515475206077099
finding O 0 0.015559985302388668
with O 0 0.01323256827890873
serious O 1 0.9983939528465271
diagnostic O 1 0.9999891519546509
and O 0 0.39582177996635437
prognostic O 1 0.999998927116394
implications O 1 0.9331639409065247
. O 0 0.06304901093244553

Moreover O 0 0.06458448618650436
, O 0 0.030460963025689125
further O 0 0.03205488249659538
ARSA O 1 0.9998875856399536
alleles O 0 0.04558594897389412
functionally O 0 0.03892621770501137
similar O 0 0.013457344844937325
to O 0 0.014800154604017735
A464V O 1 0.9299474954605103
might O 0 0.012155143544077873
exist O 0 0.008221861906349659
which O 0 0.006714116781949997
, O 0 0.007457396015524864
together O 0 0.0081927590072155
with O 0 0.009275994263589382
0 O 0 0.022730348631739616
- O 1 0.9996614456176758
type O 0 0.06396669149398804
mutations O 0 0.017338132485747337
, O 0 0.01162836141884327
may O 0 0.012891661375761032
cause O 0 0.35265830159187317
pathological O 1 0.9999969005584717
ARSA O 1 1.0
and O 1 0.9964989423751831
GS O 1 1.0
levels O 0 0.04756902903318405
, O 0 0.012091006152331829
but O 0 0.008112275041639805
not O 0 0.008231441490352154
clinical O 1 0.9469056725502014
outbreak O 1 0.9968892931938171
of O 0 0.04760337248444557
the O 1 0.9949949979782104
disease O 1 1.0
. O 0 0.0324455201625824
. O 0 0.04603377729654312

Human O 1 0.9105197787284851
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 1 0.9999985694885254
to O 1 0.7196658253669739
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 1 0.9999582767486572
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999731779098511
1 I-Disease 0 0.15508908033370972
. O 0 0.05848151072859764

Heterozygous O 0 0.2222250998020172
germ O 1 0.9999856948852539
- O 1 0.9997996687889099
line O 0 0.035650886595249176
mutations O 0 0.021474113687872887
in O 0 0.010930628515779972
the O 0 0.01326186303049326
DNA O 0 0.02406924031674862
mismatch O 1 0.9998853206634521
repair O 1 0.9978110194206238
genes O 0 0.017989108338952065
lead O 0 0.022316407412290573
to O 0 0.025317875668406487
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.9571400284767151

The O 0 0.4181400537490845
disease O 1 0.9999995231628418
susceptibility O 1 0.9964703321456909
of O 0 0.018145261332392693
individuals O 0 0.011673415079712868
who O 0 0.01698373444378376
constitutionally O 0 0.10272037982940674
lack O 0 0.015000853687524796
both O 0 0.011631228029727936
wild O 0 0.02485007978975773
- O 1 0.9999904632568359
type O 1 0.5255186557769775
alleles O 0 0.02939676307141781
is O 0 0.019582338631153107
unknown O 0 0.03175036236643791
. O 0 0.037624139338731766

We O 0 0.021953506395220757
have O 0 0.011722023598849773
identified O 0 0.013405381701886654
three O 0 0.008776943199336529
offspring O 0 0.016016095876693726
in O 0 0.009883293882012367
a O 0 0.020946327596902847
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 1 0.9999747276306152
who O 1 0.961480975151062
developed O 1 0.9991161227226257
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
at O 0 0.022281549870967865
a O 0 0.01238330639898777
very O 0 0.009151777252554893
early O 0 0.009850596077740192
age O 0 0.012523554265499115
, O 0 0.009110645391047001
and O 0 0.007862763479351997
at O 0 0.008763905614614487
least O 0 0.0060823336243629456
two O 0 0.005340456031262875
of O 0 0.006716277450323105
them O 0 0.007062018848955631
displayed O 0 0.016974221915006638
signs O 0 0.01986553706228733
of O 0 0.023367490619421005
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9997766613960266
1 I-Disease 0 0.46621838212013245
( O 0 0.04746830835938454
NF1 B-Disease 1 0.9998780488967896
) O 0 0.05043239891529083
. O 0 0.05713435262441635

DNA O 0 0.04483289271593094
sequence O 0 0.019200565293431282
analysis O 0 0.017247440293431282
and O 0 0.017971256747841835
allele O 0 0.04008809104561806
- O 0 0.4830215871334076
specific O 0 0.015929384157061577
amplification O 0 0.029239296913146973
in O 0 0.013142787851393223
two O 0 0.015044629573822021
siblings O 0 0.028592770919203758
revealed O 0 0.022318003699183464
a O 0 0.022449741140007973
homozygous O 0 0.0583757609128952
MLH1 O 1 0.9999936819076538
mutation O 0 0.03910261392593384
( O 0 0.027606787160038948
C676T O 1 0.9998506307601929
- O 1 0.9999995231628418
- O 1 0.9999990463256836
> O 1 0.9999066591262817
Arg226Stop O 1 0.9995384216308594
) O 0 0.05168524757027626
. O 0 0.058587200939655304

Thus O 0 0.03890533372759819
, O 0 0.022028442472219467
a O 0 0.023665649816393852
homozygous O 0 0.05620812997221947
germ O 1 0.999987006187439
- O 1 0.9999580383300781
line O 0 0.13906796276569366
MLH1 O 1 0.9999948740005493
mutation O 0 0.038504693657159805
and O 0 0.023669088259339333
consequent O 1 0.9999995231628418
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 1.0
results O 0 0.04130182042717934
in O 0 0.01799456588923931
a O 0 0.028908496722579002
mutator O 1 0.9999942779541016
phenotype O 1 0.9951571822166443
characterized O 1 0.5011794567108154
by O 0 0.02150919660925865
leukemia B-Disease 1 1.0
and O 1 0.9989224672317505
/ O 1 1.0
or O 1 0.9988760352134705
lymphoma B-Disease 1 1.0
associated O 1 0.8675729632377625
with O 1 0.8937805891036987
neurofibromatosis B-Disease 1 1.0
type I-Disease 1 0.9999722242355347
1 I-Disease 0 0.11686231195926666
. O 0 0.03456159681081772
. O 0 0.046711258590221405

Missense O 0 0.11817608028650284
mutations O 0 0.03755385801196098
in O 0 0.013781001791357994
the O 0 0.013956030830740929
most O 0 0.01153756957501173
ancient O 0 0.01942576840519905
residues O 0 0.020004961639642715
of O 0 0.015295756980776787
the O 0 0.023846816271543503
PAX6 O 1 0.9999905824661255
paired O 0 0.09952870011329651
domain O 0 0.03130079060792923
underlie O 0 0.039175473153591156
a O 0 0.016527486965060234
spectrum O 0 0.028915615752339363
of O 0 0.025626497343182564
human O 1 0.9999215602874756
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 1 0.9970548152923584

Mutations O 0 0.048575010150671005
of O 0 0.018971486017107964
the O 0 0.01767798513174057
human O 0 0.021104751154780388
PAX6 O 1 0.9999994039535522
gene O 0 0.2277713418006897
underlie O 1 0.9999886751174927
aniridia B-Disease 1 1.0
( O 1 0.9992644190788269
congenital B-Disease 1 1.0
absence I-Disease 1 0.9888198971748352
of I-Disease 0 0.0807863175868988
the I-Disease 1 0.6510281562805176
iris I-Disease 1 0.9999938011169434
) O 0 0.01492991577833891
, O 0 0.012050434947013855
a O 0 0.013223817571997643
rare O 0 0.027071109041571617
dominant O 1 0.9907280206680298
malformation B-Disease 1 0.9999996423721313
of I-Disease 0 0.23557238280773163
the I-Disease 1 0.9615423679351807
eye I-Disease 1 0.9999986886978149
. O 0 0.05535496398806572

The O 0 0.03505784273147583
spectrum O 0 0.04742983728647232
of O 0 0.03271881490945816
PAX6 O 1 0.9999984502792358
mutations O 0 0.04520513489842415
in O 0 0.025952173396945
aniridia B-Disease 1 1.0
patients O 1 0.9999420642852783
is O 0 0.014400143176317215
highly O 0 0.017732294276356697
biased O 0 0.017055563628673553
, O 0 0.010645201429724693
with O 0 0.008307826705276966
92 O 0 0.026193538680672646
% O 0 0.009377406910061836
of O 0 0.008224752731621265
all O 0 0.00890916958451271
reported O 0 0.01548214815557003
mutations O 0 0.015183757990598679
leading O 0 0.015766674652695656
to O 0 0.01376449316740036
premature O 0 0.04151428863406181
truncation O 0 0.0394274927675724
of O 0 0.014812681823968887
the O 0 0.016358884051442146
protein O 0 0.020059363916516304
( O 0 0.01614627242088318
nonsense O 0 0.03322795778512955
, O 0 0.019802358001470566
splicing O 0 0.03249216824769974
, O 0 0.01956348866224289
insertions O 0 0.04632570222020149
and O 0 0.01787545718252659
deletions O 0 0.03373434394598007
) O 0 0.013314781710505486
and O 0 0.010466383770108223
just O 0 0.013059020973742008
2 O 0 0.016867592930793762
% O 0 0.011082054115831852
leading O 0 0.015941916033625603
to O 0 0.009754464961588383
substitution O 0 0.017477143555879593
of O 0 0.011205206625163555
one O 0 0.01393200270831585
amino O 0 0.01812291331589222
acid O 0 0.017660420387983322
by O 0 0.011083193123340607
another O 0 0.01838728040456772
( O 0 0.026865199208259583
missense O 0 0.06498516350984573
) O 0 0.03575539588928223
. O 0 0.04476805403828621

The O 0 0.043773673474788666
extraordinary O 0 0.04424981027841568
conservation O 0 0.03320702165365219
of O 0 0.02037743292748928
the O 0 0.023895133286714554
PAX6 O 1 0.9999799728393555
protein O 0 0.024924272671341896
at O 0 0.018795939162373543
the O 0 0.018241720274090767
amino O 0 0.0251376423984766
acid O 0 0.030104581266641617
level O 0 0.020269598811864853
amongst O 0 0.02828478068113327
vertebrates O 0 0.04302649199962616
predicts O 0 0.0434546135365963
that O 0 0.013441793620586395
pathological O 0 0.490707665681839
missense O 0 0.11187436431646347
mutations O 0 0.016383789479732513
should O 0 0.009346362203359604
in O 0 0.008076159283518791
fact O 0 0.008950499817728996
be O 0 0.006674931850284338
common O 0 0.007778769358992577
even O 0 0.007235654629766941
though O 0 0.007216429337859154
they O 0 0.005684672389179468
are O 0 0.005744023248553276
hardly O 0 0.016354918479919434
ever O 0 0.015675446018576622
seen O 0 0.018813148140907288
in O 0 0.024549085646867752
aniridia B-Disease 1 0.9999973773956299
patients O 1 0.9996088147163391
. O 0 0.05315088853240013

This O 0 0.025242894887924194
indicates O 0 0.025395816192030907
that O 0 0.009736518375575542
there O 0 0.00912532676011324
is O 0 0.009972839616239071
a O 0 0.014424392022192478
heavy O 1 0.8526952862739563
ascertainment O 1 0.9999796152114868
bias O 0 0.023562798276543617
in O 0 0.010692224837839603
the O 0 0.010962046682834625
selection O 0 0.01761871948838234
of O 0 0.014441045001149178
patients O 1 0.9303680062294006
for O 0 0.018757477402687073
PAX6 O 1 0.9999983310699463
mutation O 0 0.026829920709133148
analysis O 0 0.014675728976726532
and O 0 0.009867595508694649
that O 0 0.007856691256165504
the O 0 0.014626777730882168
missing O 0 0.035251036286354065
PAX6 O 1 0.999997615814209
missense O 1 0.9002555012702942
mutations O 0 0.032130736857652664
frequently O 0 0.02335403673350811
may O 0 0.021878430619835854
underlie O 0 0.4999774098396301
phenotypes O 0 0.19053256511688232
distinct O 0 0.02601844258606434
from O 0 0.027997927740216255
textbook O 1 0.9999954700469971
aniridia B-Disease 1 0.9999991655349731
. O 0 0.059143196791410446

Here O 0 0.03591657429933548
we O 0 0.01767243817448616
present O 0 0.01936541311442852
four O 0 0.01979544386267662
novel O 0 0.045603059232234955
PAX6 O 1 0.9999762773513794
missense O 0 0.16999134421348572
mutations O 0 0.023052990436553955
, O 0 0.011823159642517567
two O 0 0.00774355698376894
in O 0 0.010100025683641434
association O 0 0.018002210184931755
with O 0 0.014854189939796925
atypical O 1 0.999995231628418
phenotypes O 1 0.9999819993972778
ectopia B-Disease 1 0.9999995231628418
pupillae I-Disease 1 0.9999934434890747
( O 0 0.022808481007814407
displaced B-Disease 0 0.04245394468307495
pupils I-Disease 1 0.587828516960144
) O 0 0.0220973938703537
and O 1 0.6302405595779419
congenital B-Disease 1 1.0
nystagmus I-Disease 1 1.0
( O 0 0.3626304864883423
searching B-Disease 0 0.06567293405532837
gaze I-Disease 1 0.9957517385482788
) O 0 0.015242565423250198
, O 0 0.010604875162243843
and O 0 0.007963335141539574
two O 0 0.007494816090911627
in O 0 0.00987938977777958
association O 0 0.013602012768387794
with O 0 0.011717887595295906
more O 0 0.019513677805662155
recognizable O 1 0.9960522055625916
aniridia B-Disease 1 0.9999923706054688
phenotypes O 1 0.9609788060188293
. O 0 0.06227952614426613

Strikingly O 0 0.07388150691986084
, O 0 0.020136773586273193
all O 0 0.01242856029421091
four O 0 0.01293639000505209
mutations O 0 0.013269697315990925
are O 0 0.006503440905362368
located O 0 0.014161990955471992
within O 0 0.010082087479531765
the O 0 0.016894666478037834
PAX6 O 1 0.9999910593032837
paired O 0 0.2184065580368042
domain O 0 0.022646676748991013
and O 0 0.014186724089086056
affect O 0 0.017642589285969734
amino O 0 0.01870674639940262
acids O 0 0.01624978892505169
which O 0 0.008542465046048164
are O 0 0.0064819250255823135
highly O 0 0.014209295623004436
conserved O 0 0.016010506078600883
in O 0 0.010634614154696465
all O 0 0.013345425017178059
known O 0 0.02495371364057064
paired O 0 0.05906686186790466
domain O 0 0.047662876546382904
proteins O 0 0.04493727162480354
. O 0 0.051107846200466156

Our O 0 0.036935653537511826
results O 0 0.021437162533402443
support O 0 0.016630440950393677
the O 0 0.012852375395596027
hypothesis O 0 0.01649485155940056
that O 0 0.0071800388395786285
the O 0 0.008250938728451729
under O 0 0.013811474665999413
- O 0 0.16131146252155304
representation O 0 0.01516143511980772
of O 0 0.01742883399128914
missense O 0 0.26458221673965454
mutations O 0 0.021950721740722656
is O 0 0.013379435054957867
caused O 0 0.018506178632378578
by O 0 0.013455166481435299
ascertainment O 1 0.9999927282333374
bias O 0 0.36409834027290344
and O 0 0.012644460424780846
suggest O 0 0.010223828256130219
that O 0 0.0062972805462777615
a O 0 0.009300320409238338
substantial O 0 0.013898607343435287
burden O 0 0.4663776457309723
of O 0 0.03988919034600258
PAX6 B-Disease 1 1.0
- I-Disease 1 1.0
related I-Disease 1 0.9998530149459839
disease I-Disease 1 0.9999998807907104
remains O 0 0.062450286000967026
to O 0 0.016319893300533295
be O 0 0.014633783139288425
uncovered O 0 0.040662575513124466
. O 0 0.02650514803826809
. O 0 0.036598529666662216

The O 0 0.04897095635533333
chromosomal O 0 0.05694732442498207
order O 0 0.02250758372247219
of O 0 0.01705506630241871
genes O 0 0.02018832229077816
controlling O 0 0.025046203285455704
the O 0 0.01653986983001232
major O 1 0.6571197509765625
histocompatibility O 1 0.9999997615814209
complex O 0 0.03994537517428398
, O 0 0.022169604897499084
properdin O 1 0.998492956161499
factor O 1 0.685999870300293
B O 1 0.9999256134033203
, O 0 0.020984230563044548
and O 0 0.021155307069420815
deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.01581973396241665
the I-Disease 0 0.019095078110694885
second I-Disease 0 0.056303296238183975
component I-Disease 0 0.15496906638145447
of I-Disease 0 0.029645659029483795
complement I-Disease 0 0.0702953040599823
. O 0 0.046251680701971054

The O 0 0.0327906496822834
relationship O 0 0.024301568046212196
of O 0 0.01534769032150507
the O 0 0.016600975766777992
genes O 0 0.017650101333856583
coding O 0 0.02783440798521042
for O 0 0.017353061586618423
HLA O 1 0.9999502897262573
to O 0 0.016045626252889633
those O 0 0.012576945126056671
coding O 0 0.026534058153629303
for O 0 0.01757029816508293
properdin O 1 0.9976392984390259
Factor O 0 0.47949668765068054
B O 1 0.9996126294136047
allotypes O 1 0.8881523013114929
and O 0 0.017176553606987
for O 0 0.01778944581747055
deficiency B-Disease 1 0.9999997615814209
of I-Disease 0 0.01269762497395277
the I-Disease 0 0.012306957505643368
second I-Disease 0 0.018450258299708366
component I-Disease 0 0.026155022904276848
of I-Disease 0 0.014396950602531433
complement I-Disease 1 0.7575942277908325
( O 0 0.31728342175483704
C2 O 1 1.0
) O 0 0.015613087452948093
was O 0 0.01409823540598154
studied O 0 0.01339334063231945
in O 0 0.007698324043303728
families O 0 0.008380048908293247
of O 0 0.011807694099843502
patients O 1 0.9999723434448242
with O 1 0.9997618794441223
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 1 0.9904211759567261

Patients O 1 0.9076136946678162
were O 0 0.016710374504327774
selected O 0 0.021019531413912773
because O 0 0.011480733752250671
they O 0 0.007778136990964413
were O 0 0.009664691053330898
heterozygous O 0 0.02259780280292034
or O 0 0.01603814586997032
homozygous O 0 0.06730656325817108
for O 1 0.9843995571136475
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.7559614777565002

12 O 0 0.04683167114853859
families O 0 0.024218561127781868
with O 0 0.015295613557100296
15 O 0 0.025430036708712578
matings O 0 0.055096495896577835
informative O 0 0.06743655353784561
for O 1 0.9422948956489563
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 0.031433433294296265
found O 0 0.030383264645934105
. O 0 0.04290980100631714

Of O 0 0.047031499445438385
57 O 0 0.06635729968547821
informative O 0 0.0665057823061943
meioses O 1 0.6659746766090393
, O 0 0.019227037206292152
two O 0 0.011512900702655315
crossovers O 0 0.025838015601038933
were O 0 0.008775134570896626
noted O 0 0.012685369700193405
between O 0 0.011643958278000355
the O 0 0.043076902627944946
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.0267038531601429
and O 0 0.013484137132763863
the O 0 0.24372966587543488
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999933242797852
gene O 0 0.01792154088616371
, O 0 0.011663977988064289
with O 0 0.01077223289757967
a O 0 0.015661686658859253
recombinant O 0 0.038154542446136475
fraction O 0 0.02995711751282215
of O 0 0.023659437894821167
0 O 0 0.049650564789772034
. O 0 0.04462699219584465

035 O 1 0.976847231388092
. O 0 0.13624440133571625

A O 0 0.06558969616889954
lod O 1 0.8805619478225708
score O 0 0.029440421611070633
of O 0 0.017139405012130737
13 O 0 0.020208846777677536
was O 0 0.016551166772842407
calculated O 0 0.015388336032629013
for O 0 0.010184673592448235
linkage O 0 0.03347018361091614
between O 0 0.040892843157052994
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9999984502792358
HLA O 1 1.0
- O 1 1.0
B O 1 0.9997294545173645
at O 0 0.019539441913366318
a O 0 0.0160641111433506
maximum O 0 0.016947928816080093
likelihood O 0 0.01979602687060833
value O 0 0.012264890596270561
of O 0 0.010542686097323895
the O 0 0.014168182387948036
recombinant O 0 0.047071222215890884
fraction O 0 0.03262944146990776
of O 0 0.02429676428437233
0 O 0 0.04950267821550369
. O 0 0.04368709400296211

04 O 1 0.9984971284866333
. O 0 0.10553530603647232

18 O 0 0.045894935727119446
families O 0 0.02568170614540577
with O 0 0.01729077473282814
21 O 0 0.03153730183839798
informative O 0 0.04274400696158409
matings O 0 0.044360365718603134
for O 0 0.014617200940847397
both O 0 0.015484473668038845
properdin O 1 0.6016172766685486
Factor O 0 0.04987309128046036
B O 1 0.9917995929718018
allotype O 1 0.9965184926986694
and O 0 0.13685233891010284
HLA O 1 1.0
- O 1 0.9999997615814209
B O 1 0.9991592168807983
were O 0 0.02108875848352909
found O 0 0.028601115569472313
. O 0 0.03766832873225212

Of O 0 0.056773390620946884
72 O 0 0.07629812508821487
informative O 0 0.06912106275558472
meioses O 1 0.574182391166687
, O 0 0.022342292591929436
three O 0 0.019790075719356537
recombinants O 0 0.1563708335161209
were O 0 0.012548110447824001
found O 0 0.013317362405359745
, O 0 0.012950255535542965
giving O 0 0.01644810661673546
a O 0 0.01760552078485489
recombinant O 0 0.046061281114816666
fraction O 0 0.032980211079120636
of O 0 0.0280874315649271
0 O 0 0.0512070469558239
. O 0 0.04767696186900139

042 O 1 0.9763197898864746
. O 0 0.10981353372335434

A O 0 0.06728344410657883
lod O 0 0.12110545486211777
score O 0 0.027656976133584976
of O 0 0.016080623492598534
16 O 0 0.021683363243937492
between O 0 0.018962524831295013
HLA O 1 1.0
- O 1 0.9999995231628418
B O 1 0.9996938705444336
and O 0 0.02035580575466156
Factor O 0 0.3067605793476105
B O 1 0.9993036985397339
allotypes O 1 0.9557754397392273
was O 0 0.019502950832247734
calculated O 0 0.017817210406064987
at O 0 0.012958389706909657
a O 0 0.011484756134450436
maximum O 0 0.016821477562189102
likelihood O 0 0.01764899492263794
value O 0 0.011829379945993423
of O 0 0.011479240842163563
the O 0 0.014392037875950336
recombinant O 0 0.04354346916079521
fraction O 0 0.04120059311389923
of O 0 0.029438480734825134
0 O 0 0.05841473117470741
. O 0 0.05092049017548561

04 O 1 0.9947949051856995
. O 0 0.11019331216812134

A O 0 0.05135282501578331
crossover O 0 0.05747774988412857
was O 0 0.026827070862054825
shown O 0 0.01485490333288908
to O 0 0.0089873056858778
have O 0 0.007011284586042166
occurred O 0 0.010081607848405838
between O 0 0.007465179078280926
genes O 0 0.010105687193572521
for O 0 0.010886414907872677
Factor O 0 0.03149357810616493
B O 1 0.9915711879730225
and O 0 0.02629842795431614
HLA O 1 1.0
- O 1 0.999998927116394
D O 1 0.9989935755729675
, O 0 0.015272777527570724
in O 0 0.01236227247864008
which O 0 0.016978783532977104
HLA O 1 0.9999998807907104
- O 1 0.9999911785125732
D O 1 0.9998539686203003
segregared O 1 0.959977924823761
with O 0 0.03345189243555069
HLA O 1 1.0
- O 1 0.9999399185180664
A O 0 0.27750253677368164
and O 0 0.03962961956858635
B O 1 0.9968474507331848
. O 0 0.054764945060014725

These O 0 0.021743997931480408
studies O 0 0.0182501170784235
suggest O 0 0.013738598674535751
that O 0 0.007087245583534241
the O 0 0.009586352854967117
genes O 0 0.011572588235139847
for O 0 0.012034964747726917
Factor O 1 0.8365448117256165
B O 1 0.9999983310699463
and O 1 0.9976181387901306
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 0.0100946594029665
located O 0 0.017124084755778313
outside O 0 0.013207320123910904
those O 0 0.00862062443047762
for O 0 0.013836581259965897
HLA O 1 0.9999998807907104
, O 0 0.011827691458165646
that O 0 0.006576125510036945
the O 0 0.00817160028964281
order O 0 0.009485838003456593
of O 0 0.011022455990314484
genese O 1 0.9801483154296875
is O 0 0.02012910507619381
HLA O 1 1.0
- O 1 0.9987926483154297
A O 0 0.02556992881000042
, O 0 0.019285868853330612
- O 1 0.9988396763801575
B O 1 0.8961922526359558
, O 0 0.02185426838696003
- O 1 0.9987713694572449
D O 1 0.985293984413147
, O 0 0.022783316671848297
Factor O 0 0.039174579083919525
B O 1 0.9949082732200623
allotype O 1 0.99996018409729
, O 1 0.9995354413986206
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 0.01714073121547699
that O 0 0.00832903292030096
the O 0 0.010663894936442375
genes O 0 0.013932946138083935
coding O 0 0.03940221294760704
for O 1 0.6893110275268555
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 1 0.9824590682983398
Factor O 1 0.9993444085121155
B O 1 0.9994768500328064
allotypes O 0 0.0541754849255085
are O 0 0.008293837308883667
approximately O 0 0.011923783458769321
3 O 0 0.022695884108543396
- O 1 0.9644798636436462
- O 0 0.43927711248397827
5 O 0 0.025241535156965256
centimorgans O 0 0.04302854463458061
from O 0 0.01456273440271616
the O 0 0.02007467858493328
HLA O 1 0.9999991655349731
- O 1 0.9879420399665833
A O 0 0.026158494874835014
and O 0 0.02625216916203499
HLA O 1 1.0
- O 1 1.0
B O 1 0.9999908208847046
loci O 0 0.02690785750746727
, O 0 0.010257397778332233
and O 0 0.007669045124202967
that O 0 0.005486987065523863
the O 0 0.008622323162853718
apparent O 0 0.015928007662296295
lack O 0 0.012552130036056042
of O 0 0.01192466914653778
recombinants O 1 0.9736604690551758
between O 0 0.011724118143320084
the O 0 0.014542712830007076
Factor O 0 0.07916011661291122
B O 1 0.9984639883041382
gene O 0 0.025644268840551376
and O 1 0.8701719641685486
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 0.16579727828502655
suggests O 0 0.014911720529198647
that O 0 0.007143722381442785
these O 0 0.005959322676062584
two O 0 0.008694944903254509
genes O 0 0.011845388449728489
lie O 0 0.014895947650074959
in O 0 0.00908851157873869
close O 0 0.014745285734534264
proximity O 0 0.017726650461554527
to O 0 0.013809098862111568
one O 0 0.016794400289654732
another O 0 0.028273971751332283
. O 0 0.037057649344205856

Distribution O 0 0.046705715358257294
of O 0 0.027255240827798843
emerin O 1 0.9741750955581665
and O 0 0.026099035516381264
lamins O 1 0.9897666573524475
in O 0 0.01902044750750065
the O 0 0.019534004852175713
heart O 1 0.9960355162620544
and O 0 0.01421522069722414
implications O 0 0.024551983922719955
for O 0 0.023001771420240402
Emery B-Disease 1 0.9999995231628418
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.9693534970283508

Emerin O 1 0.5887510776519775
is O 0 0.02741551771759987
a O 0 0.024810791015625
nuclear O 0 0.03568675369024277
membrane O 0 0.04010763764381409
protein O 0 0.018154224380850792
which O 0 0.00971305277198553
is O 0 0.00979681871831417
missing O 0 0.01539513561874628
or O 0 0.011724239215254784
defective O 1 0.519048273563385
in O 0 0.015697453171014786
Emery B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999966621398926
EDMD B-Disease 1 1.0
) O 0 0.06651507318019867
. O 0 0.0659199133515358

It O 0 0.027053218334913254
is O 0 0.015542073175311089
one O 0 0.011922064237296581
member O 0 0.012340744026005268
of O 0 0.009627154096961021
a O 0 0.012447524815797806
family O 0 0.01739693246781826
of O 0 0.018685124814510345
lamina O 1 0.9999998807907104
- O 1 0.9999916553497314
associated O 0 0.021870696917176247
proteins O 0 0.014392226934432983
which O 0 0.009672462940216064
includes O 0 0.019603809341788292
LAP1 O 1 0.9997368454933167
, O 0 0.023079508915543556
LAP2 O 1 0.9998801946640015
and O 0 0.031017763540148735
lamin O 1 0.9999959468841553
B O 1 0.9999978542327881
receptor O 1 0.8271346092224121
( O 0 0.05770855396986008
LBR O 1 0.9999892711639404
) O 0 0.05300469696521759
. O 0 0.06040014699101448

A O 0 0.046362120658159256
panel O 0 0.03791649267077446
of O 0 0.023892786353826523
16 O 0 0.039905596524477005
monoclonal O 1 0.9990957975387573
antibodies O 1 0.9951251149177551
( O 0 0.05166036635637283
mAbs O 1 0.9998137354850769
) O 0 0.018455207347869873
has O 0 0.013138224370777607
been O 0 0.011630125343799591
mapped O 0 0.02150666154921055
to O 0 0.010618762113153934
six O 0 0.011558753438293934
specific O 0 0.010094434954226017
sites O 0 0.011598542332649231
throughout O 0 0.011130664497613907
the O 0 0.014409255236387253
emerin O 0 0.3642226457595825
molecule O 0 0.027120649814605713
using O 0 0.02061343565583229
phage O 1 0.9964854717254639
- O 1 0.9950618147850037
displayed O 0 0.04155566915869713
peptide O 0 0.03428675979375839
libraries O 0 0.018979065120220184
and O 0 0.011406508274376392
has O 0 0.010321227833628654
been O 0 0.008774105459451675
used O 0 0.009048988111317158
to O 0 0.011988833546638489
localize O 0 0.10947944223880768
emerin O 1 0.8008618354797363
in O 0 0.015350651927292347
human O 0 0.01780094765126705
and O 0 0.14581039547920227
rabbit O 1 0.9999946355819702
heart O 1 0.9999974966049194
. O 0 0.05406588315963745

Several O 0 0.0434829406440258
mAbs O 0 0.12043451517820358
against O 0 0.029736557975411415
different O 0 0.019855763763189316
emerin O 1 0.8983168005943298
epitopes O 0 0.42039719223976135
did O 0 0.020332561805844307
not O 0 0.012409990653395653
recognize O 0 0.02517550252377987
intercalated O 1 0.9979694485664368
discs O 0 0.040479350835084915
in O 0 0.01395504828542471
the O 0 0.01793367974460125
heart O 1 0.9998987913131714
, O 0 0.012178553268313408
though O 0 0.009664016775786877
they O 0 0.008150981739163399
recognized O 0 0.018547913059592247
cardiomyocyte O 1 0.9825238585472107
nuclei O 0 0.03188030421733856
strongly O 0 0.01649813912808895
, O 0 0.011159257031977177
both O 0 0.00810991320759058
at O 0 0.012761108577251434
the O 0 0.013322338461875916
rim O 0 0.1375432312488556
and O 0 0.013260933570563793
in O 0 0.015563557855784893
intranuclear O 1 0.9983019828796387
spots O 0 0.04373310133814812
or O 0 0.020964456722140312
channels O 0 0.033933382481336594
. O 0 0.04086783900856972

A O 0 0.11269485950469971
polyclonal O 1 0.9988558292388916
rabbit O 1 0.9945408701896667
antiserum O 1 0.9952793121337891
against O 0 0.041920255869627
emerin O 1 0.9800087213516235
did O 0 0.020107204094529152
recognize O 0 0.023493170738220215
both O 0 0.015225195325911045
nuclear O 0 0.03147633746266365
membrane O 0 0.03956270590424538
and O 0 0.023206088691949844
intercalated O 1 0.9999403953552246
discs O 0 0.2622119188308716
but O 0 0.014387804083526134
, O 0 0.014264865778386593
after O 0 0.01659485697746277
affinity O 0 0.02599245123565197
purification O 0 0.0441456213593483
against O 0 0.01803598552942276
a O 0 0.020973283797502518
pure O 0 0.05391993373632431
- O 1 0.9997265934944153
emerin O 1 0.7499755024909973
band O 0 0.03057282604277134
on O 0 0.014465847983956337
a O 0 0.016150956973433495
western O 0 0.02059352956712246
blot O 1 0.987779974937439
, O 0 0.017810795456171036
it O 0 0.017858555540442467
stained O 1 0.9981374740600586
only O 0 0.016327304765582085
the O 0 0.02431080862879753
nuclear O 0 0.052385445684194565
membrane O 0 0.08677638322114944
. O 0 0.05482253059744835

These O 0 0.019818168133497238
results O 0 0.014686890877783298
would O 0 0.009747798554599285
not O 0 0.007242685649544001
be O 0 0.007196536287665367
expected O 0 0.01286764070391655
if O 0 0.011624328792095184
immunostaining O 0 0.1628391593694687
at O 0 0.024811524897813797
intercalated O 1 0.9993628859519958
discs O 0 0.03810592740774155
were O 0 0.009363100863993168
due O 0 0.009679929353296757
to O 0 0.008752260357141495
a O 0 0.01091379951685667
product O 0 0.011700915172696114
of O 0 0.009429125115275383
the O 0 0.01328505203127861
emerin O 1 0.999488353729248
gene O 0 0.015534091740846634
and O 0 0.01033695973455906
, O 0 0.010328640230000019
therefore O 0 0.009965149685740471
, O 0 0.009074170142412186
cast O 0 0.010777095332741737
some O 0 0.0063029695302248
doubt O 0 0.011742830276489258
upon O 0 0.009020647034049034
the O 0 0.011369005776941776
hypothesis O 0 0.020726727321743965
that O 0 0.013323906809091568
cardiac B-Disease 1 1.0
defects I-Disease 1 0.9999997615814209
in O 0 0.46256282925605774
EDMD B-Disease 1 1.0
are O 0 0.011724327690899372
caused O 0 0.01769927144050598
by O 0 0.010548563674092293
absence O 0 0.023994386196136475
of O 0 0.023466305807232857
emerin O 1 0.9996366500854492
from O 0 0.03733763098716736
intercalated O 1 0.9999386072158813
discs O 1 0.7601849436759949
. O 0 0.06790212541818619

Although O 0 0.05240737274289131
emerin O 1 0.6888984441757202
was O 0 0.030932040885090828
abundant O 0 0.02717818319797516
in O 0 0.014834964647889137
the O 0 0.018284955993294716
membranes O 0 0.03465688228607178
of O 0 0.02050209790468216
cardiomyocyte O 1 0.9999138116836548
nuclei O 0 0.03420336917042732
, O 0 0.013014192692935467
it O 0 0.00880558043718338
was O 0 0.01536928117275238
absent O 0 0.015674732625484467
from O 0 0.008961597457528114
many O 0 0.008667083457112312
non O 0 0.06358804553747177
- O 1 0.9999921321868896
myocyte O 1 0.9999945163726807
cells O 0 0.028535380959510803
in O 0 0.021022621542215347
the O 0 0.032326966524124146
heart O 1 0.9996703863143921
. O 0 0.053573284298181534

This O 0 0.025631319731473923
distribution O 0 0.024138344451785088
of O 0 0.0193799901753664
emerin O 1 0.9726034998893738
was O 0 0.02050403319299221
similar O 0 0.012278051115572453
to O 0 0.010209387168288231
that O 0 0.009373057633638382
of O 0 0.014880666509270668
lamin O 1 0.9905707836151123
A O 0 0.025245005264878273
, O 0 0.014342893846333027
a O 0 0.014168914407491684
candidate O 0 0.01866956241428852
gene O 0 0.012829110026359558
for O 0 0.010576135478913784
an O 0 0.015643775463104248
autosomal O 1 0.9412267208099365
form O 0 0.02451399154961109
of O 0 0.1403273344039917
EDMD B-Disease 1 0.9999998807907104
. O 0 0.07235653698444366

In O 0 0.039911504834890366
contrast O 0 0.04558882862329483
, O 0 0.041940122842788696
lamin O 1 0.9999973773956299
B1 O 1 0.9999998807907104
was O 0 0.04503605514764786
absent O 0 0.04100444167852402
from O 0 0.022316845133900642
cardiomyocyte O 1 0.96306973695755
nuclei O 0 0.03303807973861694
, O 0 0.016718322411179543
showing O 0 0.023265989497303963
that O 0 0.019388992339372635
lamin O 1 0.9999997615814209
B1 O 1 1.0
is O 0 0.01560486014932394
not O 0 0.009798900224268436
essential O 0 0.01618906855583191
for O 0 0.012551207095384598
localization O 0 0.035421207547187805
of O 0 0.01966128870844841
emerin O 1 0.7465017437934875
to O 0 0.020083224400877953
the O 0 0.029076576232910156
nuclear O 0 0.06663036346435547
lamina O 1 0.9999443292617798
. O 0 0.07124552130699158

Lamin O 1 0.9999986886978149
B1 O 1 0.9999996423721313
is O 0 0.025894027203321457
also O 0 0.017829714342951775
almost O 0 0.017489053308963776
completely O 0 0.02673368901014328
absent O 0 0.06777804344892502
from O 0 0.031431812793016434
skeletal O 1 0.999997615814209
muscle O 1 0.9999886751174927
nuclei O 0 0.4841350018978119
. O 0 0.061677321791648865

In O 0 0.05048010125756264
EDMD B-Disease 1 0.9999269247055054
, O 0 0.020447302609682083
the O 0 0.013158059678971767
additional O 0 0.01631854474544525
absence O 0 0.023456180468201637
of O 0 0.023904800415039062
lamin O 1 0.9999994039535522
B1 O 1 1.0
from O 0 0.025483189150691032
heart O 1 0.9999988079071045
and O 1 0.9777381420135498
skeletal O 1 1.0
muscle O 1 0.9999998807907104
nuclei O 1 0.5865874886512756
which O 0 0.009952794760465622
already O 0 0.014946824871003628
lack O 0 0.024015164002776146
emerin O 1 0.9992608428001404
may O 0 0.011753392405807972
offer O 0 0.01292404904961586
an O 0 0.00886610709130764
alternative O 0 0.0139249162748456
explanation O 0 0.014071839861571789
of O 0 0.010252791456878185
why O 0 0.014431152492761612
these O 0 0.010392040014266968
tissues O 0 0.037076402455568314
are O 0 0.009503768756985664
particularly O 0 0.01870540715754032
affected O 0 0.02382410131394863
. O 0 0.02492356114089489
. O 0 0.04132245108485222

Genetic O 0 0.0499630942940712
mapping O 0 0.04301073029637337
of O 0 0.02513548731803894
the O 0 0.03141814097762108
copper B-Disease 1 0.9998350143432617
toxicosis I-Disease 1 0.9999988079071045
locus O 1 0.9173470139503479
in O 0 0.033295802772045135
Bedlington O 1 0.998565137386322
terriers O 0 0.10278526693582535
to O 0 0.02098333276808262
dog O 0 0.03847164288163185
chromosome O 0 0.023812606930732727
10 O 0 0.014473826624453068
, O 0 0.010493031702935696
in O 0 0.009979686699807644
a O 0 0.01458816323429346
region O 0 0.01889679953455925
syntenic O 1 0.5043660402297974
to O 0 0.016768891364336014
human O 0 0.020160438492894173
chromosome O 0 0.0421876534819603
region O 0 0.04134134203195572
2p13 O 1 0.9999433755874634
- O 1 0.9999706745147705
p16 O 1 0.9789743423461914
. O 0 0.06963646411895752

Abnormal O 1 0.9999953508377075
hepatic B-Disease 1 1.0
copper I-Disease 1 0.999994158744812
accumulation I-Disease 1 0.9328942894935608
is O 0 0.015177462249994278
recognized O 0 0.015184776857495308
as O 0 0.012080716900527477
an O 1 0.5358504056930542
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 1 0.9402272701263428
man O 1 0.999640941619873
, O 0 0.19283360242843628
mouse O 1 0.9800706505775452
, O 0 0.03157687559723854
rat O 1 0.9996776580810547
and O 0 0.03183496743440628
dog O 0 0.23424237966537476
. O 0 0.049250900745391846

The O 0 0.036129482090473175
major O 0 0.03873797133564949
cause O 0 0.4853626489639282
of O 1 0.712124228477478
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999995231628418
accumulation I-Disease 1 0.9980974793434143
in O 0 0.016320060938596725
man O 0 0.02089327573776245
is O 0 0.011802409775555134
a O 0 0.01721271127462387
dysfunctional O 1 0.9559419751167297
ATP7B O 1 0.9999911785125732
gene O 0 0.024621961638331413
, O 0 0.020188068971037865
causing O 1 0.9994388222694397
Wilson B-Disease 1 0.9999994039535522
disease I-Disease 1 1.0
( O 1 0.9999151229858398
WD B-Disease 1 1.0
) O 0 0.058667175471782684
. O 0 0.06580697000026703

Mutations O 0 0.04643338546156883
in O 0 0.019466577097773552
the O 0 0.022647906094789505
ATP7B O 1 0.9999122619628906
genes O 0 0.018707728013396263
have O 0 0.0093885138630867
also O 0 0.011787447147071362
been O 0 0.0101149408146739
demonstrated O 0 0.01862790249288082
in O 0 0.017078088596463203
mouse O 1 0.6870871186256409
and O 0 0.02966821752488613
rat O 1 0.9898625612258911
. O 0 0.05283421650528908

The O 0 0.05034410208463669
ATP7B O 1 0.999961256980896
gene O 0 0.026784339919686317
has O 0 0.014913422055542469
been O 0 0.012162650935351849
excluded O 0 0.015658877789974213
in O 0 0.008331798948347569
the O 0 0.009689129889011383
much O 0 0.014269164763391018
rarer O 1 0.9331623911857605
human O 0 0.02468883991241455
copper B-Disease 1 0.9999998807907104
overload I-Disease 1 1.0
disease O 1 1.0
non B-Disease 1 0.9998741149902344
- I-Disease 1 0.9999997615814209
Indian I-Disease 1 0.9941197633743286
childhood I-Disease 1 0.9999998807907104
cirrhosis I-Disease 1 1.0
, O 0 0.2529134750366211
indicating O 0 0.05515088886022568
genetic O 0 0.05533003807067871
heterogeneity O 1 0.8705384135246277
. O 0 0.0611545592546463

By O 0 0.025694482028484344
investigating O 0 0.027339821681380272
the O 0 0.021723680198192596
common O 0 0.030921516939997673
autosomal O 1 0.9999973773956299
recessive O 1 1.0
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 1 0.9995105266571045
CT B-Disease 1 0.9999998807907104
) O 0 0.02243483066558838
in O 0 0.02361513301730156
Bedlington O 1 0.9999011754989624
terriers O 1 0.9491975903511047
, O 0 0.013828151859343052
we O 0 0.008494860492646694
have O 0 0.0063386037945747375
identified O 0 0.008397439494729042
a O 0 0.008754933252930641
new O 0 0.011942758224904537
locus O 0 0.034328117966651917
involved O 0 0.01387098990380764
in O 0 0.2908078134059906
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 1 0.9928590059280396

We O 0 0.03203941509127617
examined O 0 0.03528662398457527
whether O 0 0.020756902173161507
the O 0 0.02519366890192032
WD B-Disease 1 0.9999995231628418
gene O 0 0.04878133162856102
ATP7B O 1 0.9999514818191528
was O 0 0.03536296635866165
also O 0 0.01851317659020424
causative O 0 0.0835355669260025
for O 0 0.016624145209789276
CT B-Disease 1 0.9979565143585205
by O 0 0.012440059334039688
investigating O 0 0.021088413894176483
the O 0 0.019196029752492905
chromosomal O 1 0.7093995809555054
co O 1 0.9977213740348816
- O 1 0.9988518953323364
localization O 0 0.04933931306004524
of O 0 0.02352915331721306
ATP7B O 1 0.9998047947883606
and O 0 0.022905105724930763
C04107 O 0 0.4201573133468628
, O 0 0.017131632193922997
using O 0 0.01418720930814743
fluorescence O 0 0.028674988076090813
in O 0 0.019279787316918373
situ O 1 0.6040870547294617
hybridization O 0 0.048372164368629456
( O 0 0.031678393483161926
FISH O 0 0.04549206420779228
) O 0 0.0350763201713562
. O 0 0.04410696402192116

C04107 O 0 0.2549622654914856
is O 0 0.030807508155703545
an O 0 0.025793109089136124
anonymous O 0 0.04896494001150131
microsatellite O 1 0.982464611530304
marker O 0 0.11362376064062119
closely O 0 0.03219902515411377
linked O 0 0.039009179919958115
to O 0 0.03805435821413994
CT B-Disease 1 0.9998857975006104
. O 0 0.06315698474645615

However O 0 0.04949362203478813
, O 0 0.045365091413259506
BAC O 1 0.9998026490211487
clones O 1 0.6657466888427734
containing O 0 0.04939178377389908
ATP7B O 1 0.9990220069885254
and O 0 0.02467244490981102
C04107 O 0 0.09155282378196716
mapped O 0 0.035596977919340134
to O 0 0.015270326286554337
the O 0 0.01938687637448311
canine O 1 0.9791356921195984
chromosome O 0 0.03370752930641174
regions O 0 0.01956542767584324
CFA22q11 O 1 0.9998549222946167
and O 0 0.01901814341545105
CFA10q26 O 1 0.9999115467071533
, O 0 0.0156884603202343
respectively O 0 0.01627391017973423
, O 0 0.012746892869472504
demonstrating O 0 0.021903302520513535
that O 0 0.013636378571391106
WD B-Disease 1 0.999997615814209
cannot O 0 0.017578430473804474
be O 0 0.014369208365678787
homologous O 0 0.03202188014984131
to O 0 0.029189299792051315
CT B-Disease 1 0.9999513626098633
. O 0 0.05132751539349556

The O 0 0.04957880079746246
copper O 1 0.5749422907829285
transport O 0 0.044858939945697784
genes O 0 0.03362466022372246
CTR1 O 1 0.9998445510864258
and O 0 0.02420453540980816
CTR2 O 1 0.9994685053825378
were O 0 0.014279194176197052
also O 0 0.012946771457791328
excluded O 0 0.017449792474508286
as O 0 0.0099099176004529
candidate O 0 0.018758106976747513
genes O 0 0.015537147410213947
for O 0 0.01393911149352789
CT B-Disease 1 0.9999512434005737
since O 0 0.015837019309401512
they O 0 0.009304530918598175
both O 0 0.011471202597022057
mapped O 0 0.03511105105280876
to O 0 0.02546466700732708
canine O 1 0.9965178966522217
chromosome O 0 0.06941359490156174
region O 0 0.05783258005976677
CFA11q22 O 1 0.9990793466567993
. O 0 0.06503701955080032

2 O 0 0.09599483013153076
- O 1 0.8236083984375
22 O 0 0.07504508644342422
. O 0 0.061615075916051865

5 O 0 0.11464933305978775
. O 0 0.08508338034152985

A O 0 0.05575617402791977
transcribed O 0 0.045834943652153015
sequence O 0 0.017213044688105583
identified O 0 0.013309219852089882
from O 0 0.00953197106719017
the O 0 0.014365670271217823
C04107 O 1 0.9950177073478699
- O 1 0.999750554561615
containing O 0 0.03732466325163841
BAC O 1 0.9999797344207764
was O 0 0.019826291128993034
found O 0 0.009939031675457954
to O 0 0.00844289269298315
be O 0 0.007609865162521601
homologous O 0 0.015173578634858131
to O 0 0.00845261849462986
a O 0 0.01265980489552021
gene O 0 0.013266606256365776
expressed O 0 0.012826019898056984
from O 0 0.010266929864883423
human O 0 0.015823669731616974
chromosome O 0 0.03595815226435661
2p13 O 1 0.9995684027671814
- O 1 0.9999853372573853
p16 O 1 0.9957082271575928
, O 0 0.017887147143483162
a O 0 0.018800636753439903
region O 0 0.018654830753803253
devoid O 0 0.03231865540146828
of O 0 0.01628153771162033
any O 0 0.01727762259542942
positional O 0 0.08123501390218735
candidate O 0 0.05120792239904404
genes O 0 0.045741938054561615
. O 0 0.04592440649867058

Molecular O 0 0.0574367418885231
analysis O 0 0.02340848743915558
of O 0 0.01966097578406334
the O 0 0.022746851667761803
APC B-Disease 1 0.999607264995575
gene O 0 0.021558118984103203
in O 0 0.015434837900102139
205 O 0 0.03879418969154358
families O 0 0.014941764064133167
: O 0 0.01617969572544098
extended O 0 0.026696640998125076
genotype O 1 0.7763692736625671
- O 1 0.9999020099639893
phenotype O 1 0.8204642534255981
correlations O 0 0.04237961024045944
in O 0 0.02237127162516117
FAP B-Disease 1 0.9999995231628418
and O 0 0.015263737179338932
evidence O 0 0.012011242099106312
for O 0 0.009377725422382355
the O 0 0.01082542072981596
role O 0 0.015149576589465141
of O 0 0.015750883147120476
APC B-Disease 1 0.9999896287918091
amino O 0 0.024950407445430756
acid O 0 0.029366306960582733
changes O 0 0.02083994634449482
in O 1 0.967857837677002
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 1.0
. O 0 0.397186815738678

BACKGROUND O 0 0.08274662494659424
/ O 0 0.3157399594783783
AIMS O 0 0.04287203028798103
The O 0 0.017614800482988358
development O 0 0.026544369757175446
of O 1 0.9995991587638855
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 0.02838817983865738
a O 0 0.016924278810620308
variable O 0 0.01551190298050642
range O 0 0.015542729757726192
of O 0 0.01429757010191679
extracolonic O 1 0.9458755254745483
manifestations O 1 0.7779155969619751
in O 0 0.04796285182237625
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 1 0.9999995231628418
FAP B-Disease 1 1.0
) O 0 0.024787623435258865
is O 0 0.012332511134445667
the O 0 0.010841895826160908
result O 0 0.009088648483157158
of O 0 0.009003067389130592
the O 0 0.011785004287958145
dominant O 0 0.0315655954182148
inheritance O 1 0.5978624224662781
of O 1 0.9906076192855835
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 1 0.9999550580978394
APC B-Disease 1 0.9999998807907104
) O 0 0.04725256934762001
gene O 0 0.053127069026231766
mutations O 0 0.05147498846054077
. O 0 0.04493604227900505

In O 0 0.026799162849783897
this O 0 0.01350813452154398
study O 0 0.01642649807035923
, O 0 0.01266736350953579
direct O 0 0.012692837044596672
mutation O 0 0.014532308094203472
analysis O 0 0.008954983204603195
of O 0 0.01099095493555069
the O 0 0.01518341526389122
APC B-Disease 1 0.9999935626983643
gene O 0 0.02133071795105934
was O 0 0.018225664272904396
performed O 0 0.01514239888638258
to O 0 0.013009102083742619
determine O 0 0.022187475115060806
genotype O 0 0.224887877702713
- O 1 0.9918491840362549
phenotype O 0 0.0447450652718544
correlations O 0 0.02842346578836441
for O 0 0.014212608337402344
nine O 0 0.023925097659230232
extracolonic O 1 0.9994819760322571
manifestations O 1 0.9068537950515747
and O 0 0.01317073404788971
to O 0 0.012693643569946289
investigate O 0 0.019803611561655998
the O 0 0.014735907316207886
incidence O 1 0.6877907514572144
of O 0 0.01767854019999504
APC B-Disease 1 0.9999978542327881
mutations O 0 0.021031156182289124
in O 0 0.01692533679306507
non O 1 0.9999327659606934
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7030634880065918

METHODS O 0 0.05773782730102539
The O 0 0.046956636011600494
APC B-Disease 1 0.9996242523193359
gene O 0 0.033384572714567184
was O 0 0.025117574259638786
analysed O 0 0.03097366914153099
in O 0 0.015634790062904358
190 O 0 0.0401056744158268
unrelated O 0 0.03266496956348419
FAP B-Disease 1 0.9999833106994629
and O 0 0.014528750441968441
15 O 0 0.023809898644685745
non O 1 0.9863128066062927
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.999996542930603
using O 0 0.033575963228940964
denaturing O 1 0.9999326467514038
gradient O 1 0.989734411239624
gel O 1 0.9999580383300781
electrophoresis O 1 0.7128274440765381
, O 0 0.020854370668530464
the O 0 0.01927194744348526
protein O 0 0.02573331445455551
truncation O 0 0.060797061771154404
test O 0 0.03073793277144432
, O 0 0.01855945773422718
and O 0 0.018686775118112564
direct O 0 0.03267423063516617
sequencing O 0 0.06100679934024811
. O 0 0.05116860195994377

RESULTS O 0 0.06327256560325623
Chain O 0 0.07332617044448853
terminating O 0 0.03832181543111801
signals O 0 0.018804850056767464
were O 0 0.009314258582890034
only O 0 0.008397439494729042
identified O 0 0.01227655354887247
in O 0 0.010333550162613392
patients O 0 0.08357112854719162
belonging O 0 0.013965660706162453
to O 0 0.010480443947017193
the O 0 0.01698671095073223
FAP B-Disease 1 1.0
group O 0 0.16660074889659882
( O 0 0.024817677214741707
105 O 1 0.9011384844779968
patients O 1 0.9995133876800537
) O 0 0.03291155770421028
. O 0 0.03962869569659233

Amino O 0 0.06356543302536011
acid O 0 0.036636725068092346
changes O 0 0.013427875936031342
were O 0 0.0082146180793643
identified O 0 0.009742551483213902
in O 0 0.007744173519313335
four O 0 0.01036282442510128
patients O 1 0.7003822326660156
, O 0 0.007985636591911316
three O 0 0.00619465159252286
of O 0 0.008175833150744438
whom O 0 0.011608758941292763
belonged O 0 0.014592516236007214
to O 0 0.007622829172760248
the O 0 0.010358775965869427
non O 0 0.036164041608572006
- O 1 0.9999953508377075
FAP O 1 1.0
group O 1 0.8702976703643799
of O 1 0.9999560117721558
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.32699158787727356

Genotype O 1 0.9973875880241394
- O 1 0.9998189806938171
phenotype O 1 0.6968585848808289
correlations O 0 0.04436526075005531
identified O 0 0.021139642223715782
significant O 0 0.01243022084236145
differences O 0 0.011948436498641968
in O 0 0.009151526726782322
the O 0 0.010332735255360603
nature O 0 0.012005710043013096
of O 0 0.011333692818880081
certain O 0 0.01401804480701685
extracolonic O 1 0.9999444484710693
manifestations O 1 0.9998924732208252
in O 1 0.7283564805984497
FAP B-Disease 1 1.0
patients O 1 0.9999840259552002
belonging O 0 0.028052587062120438
to O 0 0.017904086038470268
three O 0 0.02243591658771038
mutation O 0 0.04661983996629715
subgroups O 0 0.07171651721000671
. O 0 0.05156823992729187

CONCLUSIONS O 0 0.06417156010866165
Extended O 0 0.061697255820035934
genotype O 1 0.8056238889694214
- O 1 0.9997134804725647
phenotype O 1 0.5802016854286194
correlations O 0 0.028783466666936874
made O 0 0.013774549588561058
in O 0 0.009129638783633709
this O 0 0.0075307078659534454
study O 0 0.01147446408867836
may O 0 0.008281643502414227
have O 0 0.005368961486965418
the O 0 0.007422043476253748
potential O 0 0.009662913158535957
to O 0 0.007154522463679314
determine O 0 0.008294445462524891
the O 0 0.008005307987332344
most O 0 0.007544673513621092
appropriate O 0 0.01252678781747818
surveillance O 0 0.02139664627611637
and O 0 0.01737160235643387
prophylactic O 1 0.9999943971633911
treatment O 1 0.9999957084655762
regimens O 1 0.9999958276748657
for O 0 0.012813093140721321
those O 0 0.011404326185584068
patients O 1 0.9732662439346313
with O 0 0.012445872649550438
mutations O 0 0.019891588017344475
associated O 0 0.013683858327567577
with O 0 0.014566744677722454
life O 1 0.503136396408081
threatening O 1 0.9989381432533264
conditions O 0 0.42699524760246277
. O 0 0.04957520589232445

This O 0 0.02246606908738613
study O 0 0.020320633426308632
also O 0 0.014514768496155739
provided O 0 0.013094636611640453
evidence O 0 0.01097910013049841
for O 0 0.00911147240549326
the O 0 0.013710805214941502
pathological O 0 0.1294100433588028
nature O 0 0.016802119091153145
of O 0 0.014814949594438076
amino O 0 0.02025168016552925
acid O 0 0.02452061139047146
changes O 0 0.01356992032378912
in O 0 0.015148034319281578
APC O 1 0.9995997548103333
associated O 0 0.015547924675047398
with O 0 0.010750203393399715
both O 0 0.014127359725534916
FAP B-Disease 1 0.9999979734420776
and O 0 0.029024766758084297
non O 1 0.9999837875366211
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 1.0
. O 0 0.11080502718687057
. O 0 0.04978059604763985

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9999951124191284
cancer B-Disease 1 1.0
risk O 1 0.9998443126678467
of O 0 0.1699824035167694
the O 1 0.6177738904953003
APC O 1 0.9999997615814209
I1307K O 1 0.9999594688415527
polymorphism O 0 0.4353271424770355
. O 0 0.06863737851381302

Germ O 1 0.9999932050704956
- O 1 0.9997236132621765
line O 0 0.04023384675383568
and O 0 0.023822437971830368
somatic O 0 0.05755872651934624
truncating O 0 0.07124362885951996
mutations O 0 0.024366192519664764
of O 0 0.015042770653963089
the O 0 0.019861312583088875
APC B-Disease 1 0.9999961853027344
gene O 0 0.0175007414072752
are O 0 0.006935544312000275
thought O 0 0.011278732679784298
to O 0 0.012586264871060848
initiate O 1 0.9832510352134705
colorectal B-Disease 1 1.0
tumor I-Disease 1 0.9999995231628418
formation O 1 0.7718157768249512
in O 1 0.9264680743217468
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 1 0.9999996423721313
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 1 0.9953063130378723
respectively O 0 0.06733828783035278
. O 0 0.061309196054935455

Recently O 0 0.05922874063253403
, O 0 0.027544040232896805
an O 0 0.026648618280887604
isoleucine O 1 0.9999897480010986
- O 1 0.999998927116394
- O 1 0.9999852180480957
> O 1 0.9351460337638855
lysine O 0 0.06750408560037613
polymorphism O 0 0.046090830117464066
at O 0 0.028787503018975258
codon O 0 0.054160021245479584
1307 O 1 0.9368431568145752
( O 0 0.028851620852947235
I1307K O 0 0.06178094446659088
) O 0 0.014934719540178776
of O 0 0.012976431287825108
the O 0 0.017464138567447662
APC B-Disease 1 0.9999665021896362
gene O 0 0.01869964972138405
has O 0 0.011122862808406353
been O 0 0.008846317417919636
identified O 0 0.009944133460521698
in O 0 0.008265307173132896
6 O 0 0.016633031889796257
% O 0 0.014651553705334663
- O 0 0.11149163544178009
7 O 0 0.01994915120303631
% O 0 0.012880579568445683
of O 0 0.012894130311906338
the O 0 0.018571477383375168
Ashkenazi O 0 0.36880257725715637
Jewish O 0 0.03607458993792534
population O 0 0.02652130275964737
. O 0 0.04636871814727783

To O 0 0.03489125892519951
assess O 0 0.044535402208566666
the O 0 0.020903635770082474
risk O 0 0.022184692323207855
of O 0 0.012556798756122589
this O 0 0.0118145402520895
common O 0 0.018371375277638435
APC B-Disease 1 0.9999949932098389
allelic O 1 0.9998931884765625
variant O 1 0.9996702671051025
in O 1 0.9857861995697021
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 0.024001331999897957
we O 0 0.011961148120462894
have O 0 0.009123594500124454
analyzed O 0 0.020173585042357445
a O 0 0.016955463215708733
large O 0 0.020192181691527367
cohort O 0 0.04773489758372307
of O 0 0.021407311782240868
unselected O 1 0.986374020576477
Ashkenazi O 1 0.5713996887207031
Jewish O 0 0.027657756581902504
subjects O 0 0.0278551634401083
with O 0 0.023923121392726898
adenomatous B-Disease 1 1.0
polyps I-Disease 1 0.9999992847442627
and O 0 0.10782438516616821
. O 0 0.2928580045700073
or O 1 0.999906063079834
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 0.02391921356320381
for O 0 0.017374858260154724
the O 0 0.03166525810956955
APC O 1 0.9999967813491821
I1307K O 1 0.9996384382247925
polymorphism O 0 0.10531387478113174
. O 0 0.06039022281765938

The O 0 0.07264608889818192
APC O 1 0.9991870522499084
I1307K O 1 0.9826439023017883
allele O 0 0.05572497844696045
was O 0 0.024822156876325607
identified O 0 0.01463988982141018
in O 0 0.011525106616318226
48 O 0 0.019857410341501236
( O 0 0.012734920717775822
10 O 0 0.013075153343379498
. O 0 0.010444662533700466
1 O 0 0.018305739387869835
% O 0 0.014082178473472595
) O 0 0.015932148322463036
of O 0 0.022649381309747696
476 O 1 0.9994738698005676
patients O 1 0.9987416863441467
. O 0 0.05583437904715538

Compared O 0 0.03633411228656769
with O 0 0.015484715811908245
the O 0 0.013373671099543571
frequency O 0 0.012358861044049263
in O 0 0.009298360906541348
two O 0 0.006872900761663914
separate O 0 0.008759967051446438
population O 0 0.007543923798948526
control O 0 0.014078972861170769
groups O 0 0.007913511246442795
, O 0 0.010701904073357582
the O 0 0.01599617302417755
APC O 1 0.999991774559021
I1307K O 1 0.999901294708252
allele O 0 0.05930732935667038
is O 0 0.012576513923704624
associated O 0 0.009398985654115677
with O 0 0.007000546436756849
an O 0 0.008497021161019802
estimated O 0 0.012606986798346043
relative O 0 0.016554227098822594
risk O 0 0.022909417748451233
of O 0 0.017691031098365784
1 O 0 0.0415000393986702
. O 0 0.04073558375239372

5 O 0 0.09494739025831223
- O 1 0.9495413303375244
1 O 0 0.08405760675668716
. O 0 0.06825477629899979

7 O 0 0.06586141884326935
for O 0 0.046664249151945114
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999998807907104
( O 0 0.03370815888047218
both O 0 0.02479461021721363
P O 1 0.9998362064361572
= O 0 0.497347891330719
. O 0 0.03153045102953911
01 O 1 0.9999638795852661
) O 0 0.04390760138630867
. O 0 0.05041004717350006

Furthermore O 0 0.04312102869153023
, O 0 0.019694827497005463
compared O 0 0.018826773390173912
with O 0 0.01521759107708931
noncarriers O 1 0.999657392501831
, O 0 0.02888478711247444
APC O 1 0.9999964237213135
I1307K O 1 0.9996048808097839
carriers O 0 0.03423381969332695
had O 0 0.013945025391876698
increased O 0 0.01207114476710558
numbers O 0 0.010934536345303059
of O 0 0.014735888689756393
adenomas B-Disease 1 0.9999995231628418
and O 1 0.9988698363304138
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 0.027958491817116737
patient O 1 0.9998576641082764
( O 0 0.024784095585346222
P O 1 0.994961142539978
= O 0 0.05934258922934532
. O 0 0.017358902841806412
03 O 1 0.9998090863227844
) O 0 0.014488019980490208
, O 0 0.012164020910859108
as O 0 0.009131787344813347
well O 0 0.008301586844027042
as O 0 0.009098504669964314
a O 0 0.0144516471773386
younger O 0 0.029937611892819405
age O 0 0.027640286833047867
at O 0 0.05796993523836136
diagnosis O 1 0.9999521970748901
. O 0 0.045985665172338486

We O 0 0.028292397037148476
conclude O 0 0.03282541781663895
that O 0 0.014424052089452744
the O 0 0.023663504049181938
APC O 1 0.9999232292175293
I1307K O 1 0.9924224019050598
variant O 0 0.07100076228380203
leads O 0 0.028782693669199944
to O 0 0.01675477996468544
increased O 0 0.04121997952461243
adenoma B-Disease 1 1.0
formation O 0 0.15348359942436218
and O 0 0.0156477689743042
directly O 0 0.014649337157607079
contributes O 0 0.019724734127521515
to O 0 0.010499385185539722
3 O 0 0.01878010854125023
% O 0 0.014968723990023136
- O 0 0.037785496562719345
4 O 0 0.019302252680063248
% O 0 0.010772110894322395
of O 0 0.010619409382343292
all O 0 0.013886665925383568
Ashkenazi O 1 0.9997724890708923
Jewish O 1 0.9999423027038574
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 1 0.7208488583564758

The O 0 0.03660355135798454
estimated O 0 0.027295295149087906
relative O 0 0.027512991800904274
risk O 0 0.027114475145936012
for O 0 0.015080743469297886
carriers O 0 0.4925156533718109
may O 0 0.01583707332611084
justify O 0 0.02318969927728176
specific O 0 0.014312039129436016
clinical O 1 0.7477140426635742
screening O 0 0.023661773651838303
for O 0 0.012617806904017925
the O 0 0.016287926584482193
360 O 0 0.03990143910050392
, O 0 0.018532032147049904
000 O 0 0.03449011594057083
Americans O 0 0.01765592209994793
expected O 0 0.01570318453013897
to O 0 0.013099739328026772
harbor O 0 0.032932594418525696
this O 0 0.012159809470176697
allele O 0 0.026487650349736214
, O 0 0.012012963183224201
and O 0 0.010450607165694237
genetic O 0 0.011765777133405209
testing O 0 0.011400681920349598
in O 0 0.007708730176091194
the O 0 0.008772256784141064
setting O 0 0.011883166618645191
of O 0 0.00972536951303482
long O 0 0.017342234030365944
- O 1 0.9871910810470581
term O 0 0.02274511754512787
- O 1 0.7134406566619873
outcome O 0 0.014851748943328857
studies O 0 0.010442139580845833
may O 0 0.009211298078298569
impact O 0 0.013264809735119343
significantly O 0 0.01857968047261238
on O 0 0.3994605839252472
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 1 1.0
in O 0 0.021438635885715485
this O 0 0.01606684736907482
population O 0 0.021244991570711136
. O 0 0.032429926097393036

Localization O 0 0.07939767092466354
of O 0 0.02444726787507534
human O 0 0.023650236427783966
BRCA1 O 1 0.9970742464065552
and O 0 0.011329028755426407
its O 0 0.011559374630451202
loss O 0 0.02128392457962036
in O 0 0.01059632282704115
high O 0 0.08988732099533081
- O 1 0.9999158382415771
grade O 0 0.3023897707462311
, O 0 0.015429534949362278
non B-Disease 1 0.7954390048980713
- I-Disease 1 0.9999998807907104
inherited I-Disease 1 1.0
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.20475773513317108

Although O 0 0.028672970831394196
the O 0 0.018980512395501137
link O 0 0.01988433301448822
between O 0 0.014326737262308598
the O 0 0.01982196234166622
BRCA1 O 1 0.9999998807907104
tumour B-Disease 1 1.0
- O 1 0.9999997615814209
suppressor O 1 0.9998862743377686
gene O 0 0.01970052532851696
and O 0 0.01710222288966179
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 1 0.7792716026306152
established O 0 0.08628199994564056
, O 0 0.00981161929666996
the O 0 0.008972660638391972
role O 0 0.01348073035478592
, O 0 0.009420698508620262
if O 0 0.007017149124294519
any O 0 0.007019445300102234
, O 0 0.009173531085252762
of O 0 0.011214202269911766
BRCA1 O 1 0.9760757684707642
in O 0 0.015456208027899265
non B-Disease 1 0.9938145875930786
- I-Disease 1 1.0
familial I-Disease 1 1.0
cancers I-Disease 1 1.0
is O 0 0.03454456478357315
unclear O 0 0.045751143246889114
. O 0 0.052151069045066833

BRCA1 O 1 0.9998051524162292
mutations O 0 0.037345584481954575
are O 0 0.010501902550458908
rare O 0 0.018001917749643326
in O 0 0.01572333462536335
sporadic B-Disease 1 0.9863495230674744
cancers I-Disease 1 0.9999983310699463
, O 0 0.013200988993048668
but O 0 0.010083287954330444
loss O 0 0.029029911383986473
of O 0 0.016121340915560722
BRCA1 O 1 0.9998500347137451
resulting O 0 0.016532106325030327
from O 0 0.013204031623899937
reduced O 0 0.01874884031713009
expression O 0 0.015598480589687824
or O 0 0.012611438520252705
incorrect O 0 0.025841059163212776
subcellular O 0 0.056458402425050735
localization O 0 0.04375041648745537
is O 0 0.014209534972906113
postulated O 0 0.023133454844355583
to O 0 0.008646257221698761
be O 0 0.00646572932600975
important O 0 0.007808208931237459
in O 0 0.009255888871848583
non B-Disease 0 0.13693475723266602
- I-Disease 1 0.9999998807907104
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 1 0.7993181943893433

Epigenetic O 0 0.41460883617401123
loss O 1 0.6435204744338989
, O 0 0.019500214606523514
however O 0 0.01233926136046648
, O 0 0.011228259652853012
has O 0 0.009427019394934177
not O 0 0.007188000716269016
received O 0 0.011526443995535374
general O 0 0.01669130101799965
acceptance O 0 0.0222662054002285
due O 0 0.013768596574664116
to O 0 0.012293134815990925
controversy O 0 0.021121731027960777
regarding O 0 0.015231002122163773
the O 0 0.016546618193387985
subcellular O 0 0.048141248524188995
localization O 0 0.04211112856864929
of O 0 0.023952465504407883
BRCA1 O 1 0.9998632669448853
proteins O 0 0.01627238281071186
, O 0 0.009799318388104439
reports O 0 0.009782195091247559
of O 0 0.008059993386268616
which O 0 0.006598836276680231
have O 0 0.006276189349591732
ranged O 0 0.01462208479642868
from O 0 0.008629325777292252
exclusively O 0 0.014982040040194988
nuclear O 0 0.018065234646201134
, O 0 0.011575648561120033
to O 0 0.01138332486152649
conditionally O 0 0.033773601055145264
nuclear O 0 0.021871378645300865
, O 0 0.012339354492723942
to O 0 0.012398571707308292
the O 0 0.021736541762948036
ER O 1 0.9999998807907104
/ O 1 0.9999754428863525
golgi O 1 0.9984458088874817
, O 0 0.024160517379641533
to O 0 0.025032663717865944
cytoplasmic O 0 0.05914875492453575
invaginations O 0 0.10566256195306778
into O 0 0.027257651090621948
the O 0 0.035037752240896225
nucleus O 0 0.07767151296138763
. O 0 0.052425555884838104

In O 0 0.02673478052020073
an O 0 0.016345655545592308
attempt O 0 0.021713081747293472
to O 0 0.0128496577963233
resolve O 0 0.020786259323358536
this O 0 0.00976620800793171
issue O 0 0.01543015893548727
, O 0 0.010170348919928074
we O 0 0.008621732704341412
have O 0 0.00815293937921524
comprehensively O 0 0.04132143035531044
characterized O 0 0.028507506474852562
19 O 0 0.04607560113072395
anti O 1 0.9999401569366455
- O 1 1.0
BRCA1 O 1 0.9999996423721313
antibodies O 1 0.9871663451194763
. O 0 0.062377117574214935

These O 0 0.03802921250462532
reagents O 0 0.07964607328176498
detect O 0 0.04299217462539673
a O 0 0.02816193737089634
220 O 0 0.06438881903886795
- O 1 0.9997686743736267
kD O 1 0.9997590184211731
protein O 0 0.03839365392923355
localized O 0 0.03400207310914993
in O 0 0.015604977495968342
discrete O 0 0.030564695596694946
nuclear O 0 0.029532207176089287
foci O 0 0.05015978962182999
in O 0 0.015487921424210072
all O 0 0.016161590814590454
epithelial O 1 0.9999179840087891
cell O 0 0.16606539487838745
lines O 0 0.017921892926096916
, O 0 0.010922418907284737
including O 0 0.009332085028290749
those O 0 0.008496937341988087
derived O 0 0.01844511739909649
from O 0 0.02988898567855358
breast B-Disease 1 1.0
malignancies I-Disease 1 0.9999984502792358
. O 0 0.07647661864757538

Immunohistochemical O 1 0.9987826943397522
staining O 0 0.4308983385562897
of O 0 0.027617597952485085
human O 0 0.13229656219482422
breast O 1 1.0
specimens O 0 0.1641167402267456
also O 0 0.01768162101507187
revealed O 0 0.039245083928108215
BRCA1 O 1 0.9997643828392029
nuclear O 0 0.03651290014386177
foci O 1 0.9959574341773987
in O 0 0.025281865149736404
benign O 1 0.9999998807907104
breast O 1 1.0
, O 1 0.998340368270874
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 1 0.8388342261314392
low B-Disease 1 0.9998950958251953
- I-Disease 1 1.0
grade I-Disease 1 0.9999980926513672
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.09088505059480667

Conversely O 0 0.08320426195859909
, O 0 0.03296785056591034
BRCA1 O 1 0.997815728187561
expression O 0 0.021543430164456367
was O 0 0.024555640295147896
reduced O 0 0.023640377447009087
or O 0 0.013657684437930584
undetectable O 1 0.522642970085144
in O 0 0.009864567779004574
the O 0 0.009125905111432076
majority O 0 0.008622697554528713
of O 0 0.009051085449755192
high O 0 0.4079033434391022
- O 1 0.9999996423721313
grade O 1 0.9997027516365051
, O 1 0.5325796604156494
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 0.019676340743899345
suggesting O 0 0.01725359819829464
that O 0 0.009318254888057709
absence O 0 0.01924947462975979
of O 0 0.018065955489873886
BRCA1 O 1 0.9999761581420898
may O 0 0.014195408672094345
contribute O 0 0.016630155965685844
to O 0 0.011842089705169201
the O 0 0.014324192889034748
pathogenesis O 1 0.9884483218193054
of O 0 0.01203558873385191
a O 0 0.01150340773165226
significant O 0 0.011809663847088814
percentage O 0 0.013924327678978443
of O 0 0.016468554735183716
sporadic B-Disease 1 0.9999299049377441
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.034442223608493805
. O 0 0.04986286535859108

